Genes,DisGeNET_Term,DisGeNET_Pvalue_Adjusted,GeDiPNet_Term,GeDiPNet_Pvalue_Adjusted,Orphanet_Term,Orphanet_Pvalue_Adjusted,Virus_Host_Term,Virus_Host_Pvalue_Adjusted,Host organism(s)_Intact,Confidence value(s)_Intact,Taxid interactor A_Intact,Taxid interactor B_Intact
ADM,"Inflammation; Reperfusion Injury; Asthma; Multiple Myeloma; Virus Diseases; Dermatitis, Atopic; Chronic Obstructive Airway Disease; Rheumatoid Arthritis; Arteriosclerosis; Autoimmune Diseases; Uveitis; Ovarian Carcinoma; cervical cancer; Infection; Malignant neoplasm of ovary; Colitis; Pancreatitis, Chronic; Tumor Angiogenesis; Malignant tumor of cervix; Lung Neoplasms; Cerebral Ischemia; Neoplasm Metastasis; Atherosclerosis; Pulmonary Fibrosis; Leukemia, Myelocytic, Acute; Glomerulonephritis; Hypertensive disease; Vascular Diseases; Eczema; Cervix carcinoma; Cerebrovascular accident; Degenerative polyarthritis; Obesity; Hyperglycemia; Liver neoplasms; Mammary Neoplasms; Bright Disease; Glioblastoma; leukemia; Diabetes Mellitus; Diabetes; Lupus Erythematosus, Systemic; Ischemic stroke; Pancreatic carcinoma; Coronary Artery Disease; Alzheimer's Disease; Adenocarcinoma of pancreas; Encephalitis; Glioma; Epithelial ovarian cancer; Malignant neoplasm of pancreas; Pain; Malignant neoplasm of mouth; Myocardial Infarction; Cerebral Infarction; Hepatitis C, Chronic; Anoxia; Brain Neoplasms; Gastric ulcer; Cardiovascular Diseases; Septicemia; Sepsis; Malignant neoplasm of lung; Middle Cerebral Artery Occlusion; Diabetes Mellitus, Insulin-Dependent; Severe Sepsis; Ureteral obstruction; Tumor Progression; Malignant neoplasm of breast; Bladder Neoplasm; Diabetic Nephropathy; Liver carcinoma; Colonic Neoplasms; Carcinogenesis; Lung Diseases, Interstitial; Endometrial Neoplasms; Hyperalgesia, Secondary; Allodynia; Carcinoma of lung; Hyperalgesia, Primary; Colon Carcinoma; Osteosarcoma of bone; Lip and Oral Cavity Carcinoma; Astrocytoma; Tactile Allodynia; Lupus Nephritis; Primary malignant neoplasm of lung; Breast Carcinoma; Osteosarcoma; Secondary malignant neoplasm of bone; Angina, Unstable; Liver Cirrhosis, Experimental; Mechanical Allodynia; Hyperalgesia, Thermal; Stable angina; Colorectal Neoplasms; Presenile dementia; Prostate carcinoma; Adenocarcinoma; Malignant tumor of colon; Hyperalgesia; ovarian neoplasm; Myeloid Leukemia; Kidney Failure, Chronic; Prostatic Neoplasms; Malignant neoplasm of endometrium; Uterine Corpus Cancer; Hypotension; Chorioamnionitis; Chronic kidney disease stage 5; Squamous cell carcinoma; Malignant neoplasm of prostate; Malignant neoplasm of urinary bladder; Pancreatic Neoplasm; Carcinoma of bladder; Systemic Inflammatory Response Syndrome; IGA Glomerulonephritis; Proliferative vitreoretinopathy; Myositis; Benign Prostatic Hyperplasia; Diabetic Angiopathies; Acute myocardial infarction; Carcinoma, Lewis Lung; Pulmonary Hypertension; Congestive heart failure; Other ureteric obstruction; Urinary tract infection; Mucocutaneous Lymph Node Syndrome; Malignant Pleural Mesothelioma; Age related macular degeneration; Mesothelioma; Neurodegenerative Disorders; Cardiomegaly; Peripheral Vascular Diseases; Solid Neoplasm; Endometrial Carcinoma; Colorectal Carcinoma; Diabetes Mellitus, Non-Insulin-Dependent; Encephalitis, St. Louis; Metabolic Syndrome X; Pain, Crushing; Pain, Migratory; Pain, Splitting; Suffering, Physical; Ache; Radiating pain; Pain, Burning; Neutropenia; Kidney Diseases; Kidney Failure; Heart failure; Community acquired pneumonia; Precursor B-cell lymphoblastic leukemia; Dementia; Central neuroblastoma; Secondary malignant neoplasm of lymph node; Colorectal Cancer; Skin Neoplasms; Neuroblastoma; Ischemia; Heart Diseases; Carcinoma breast stage IV; Pre-Eclampsia; Septic Shock; Toxic Shock Syndrome; HELLP Syndrome; Interstitial lung fibrosis; tumor vasculature; Kidney Neoplasm; Recurrent urinary tract infection; Cerebral Palsy; NONAKA MYOPATHY; Cardiomyopathies; Renal fibrosis; Hypoxic-Ischemic Encephalopathy; Mild cognitive disorder; Pyemia; Essential Hypertension; Glomerulosclerosis (disorder); Choriocarcinoma; Hyperlipidemia; Cardiomyopathy, Familial Idiopathic; Chronic heart failure; Proliferative diabetic retinopathy; Bipolar Disorder; Varicosity; Cleft palate, isolated; Muscular Dystrophy, Duchenne; Renal Insufficiency; Connective Tissue Diseases; Pyelonephritis; Arterial Occlusive Diseases; Schizophrenia; Pheochromocytoma; Conventional (Clear Cell) Renal Cell Carcinoma; Invasive Carcinoma; Dental caries; Stenosis; Caries (morphologic abnormality); Bipolar II disorder; Jaundice, Obstructive; Asphyxia Neonatorum; Sclerosis; Fluid overload; Angiogenic Switch; Cardiovascular morbidity; Impaired glucose tolerance; Neoplasms, Intracranial; Proteinuria; Hypertension, Renovascular; Eclampsia; Rous Sarcoma; Gastrointestinal Neoplasms; Neurofibromatosis 1; Chronic acquired lymphedema; Dysglycemia; Medullary Neoplasms; Hypertrophic Cardiomyopathy; Malignant Hypertension; Cardiomyopathy, Hypertrophic, Familial; Endometrial Hyperplasia; Transient ischemia; Anaplastic astrocytoma; Choroid Plexus Carcinoma; Well Differentiated Oligodendroglioma; oligodendroglioma; Diabetic Ketoacidosis; Central Serous Chorioretinopathy; Pilocytic Astrocytoma; Angle Closure Glaucoma; Plexiform Neurofibroma; Seizures; Hyperparathyroidism, Primary; Malignant Peripheral Nerve Sheath Tumor; Metabolic acidosis; Adrenal Cortical Adenoma; Autistic Disorder; Teratocarcinoma; Muscle Rigidity; Cardiac Arrhythmia",2.8114433253573326e-17; 4.4398736172867135e-14; 1.803641225501291e-12; 2.5279022064249716e-11; 6.332483647919588e-11; 7.448716379948652e-11; 1.3121548808139071e-10; 1.9241179247341838e-10; 2.377251819497684e-10; 5.452288254986118e-10; 6.429879513246633e-10; 6.870627395110916e-10; 1.1722433847661196e-09; 1.794870341379274e-09; 1.971893171900314e-09; 1.971893171900314e-09; 2.219129913614883e-09; 3.315537369635636e-09; 3.683115069310663e-09; 4.367699208727405e-09; 4.756590990483e-09; 5.670785186683756e-09; 7.195555613367576e-09; 7.547641288501485e-09; 8.303910954283738e-09; 1.0368326871660785e-08; 1.0368326871660785e-08; 1.4920329017331753e-08; 1.4920329017331753e-08; 1.5572986293211266e-08; 2.0570601164639797e-08; 2.1034803123367165e-08; 2.412608431251415e-08; 4.0898524252942674e-08; 4.3069383556698336e-08; 4.65353219894153e-08; 5.3111708677091025e-08; 5.518991037343798e-08; 5.784935444423772e-08; 5.8317433871210796e-08; 6.156981490555128e-08; 6.156981490555128e-08; 6.156981490555128e-08; 6.982287075725826e-08; 8.598175402882612e-08; 9.273260676030806e-08; 9.306686765839445e-08; 1.3150328464481586e-07; 1.427432458937347e-07; 1.479813245926713e-07; 1.4925759778299788e-07; 1.6759866477134858e-07; 2.0279723135488897e-07; 2.247163660896597e-07; 2.419125491442217e-07; 2.46778041958494e-07; 2.911052249927245e-07; 4.157277636684319e-07; 4.312772724439924e-07; 4.5433391667148853e-07; 5.254943571583271e-07; 5.313225371508493e-07; 6.299208964864026e-07; 6.805796735296268e-07; 6.851652105457608e-07; 7.873224494781308e-07; 7.99548070959303e-07; 8.297823048747685e-07; 8.660170029731726e-07; 9.822463166680949e-07; 1.083280646968723e-06; 1.3079916134634371e-06; 1.4185164995612263e-06; 1.51758575162775e-06; 1.6231490275716298e-06; 1.6397478315149087e-06; 1.9581146391906144e-06; 1.9581146391906144e-06; 2.027389637151193e-06; 2.086123696221558e-06; 2.205236928124383e-06; 2.560217628497434e-06; 2.576211756838249e-06; 2.608032323197001e-06; 2.782805018144785e-06; 3.4620043828295477e-06; 4.839188317483647e-06; 5.381279306135013e-06; 6.3131986281381465e-06; 6.378950690990071e-06; 7.095035199288336e-06; 7.691726899679507e-06; 1.033366177374635e-05; 1.0961931275541026e-05; 1.1652528807336014e-05; 1.3034577772762696e-05; 1.5064798896399038e-05; 1.527992765491583e-05; 1.5449280661407645e-05; 1.5498516107485843e-05; 1.8507296589967813e-05; 1.8507296589967813e-05; 2.042524345007846e-05; 2.0820699372778346e-05; 2.0820699372778346e-05; 2.389985034001877e-05; 2.483118059238325e-05; 2.7966054180512005e-05; 2.878916650522013e-05; 2.910435331986992e-05; 3.053335644618538e-05; 3.053335644618538e-05; 3.1491435270594376e-05; 3.192298841377222e-05; 3.9650653676454574e-05; 5.248375780672949e-05; 5.2700686057264086e-05; 5.592330076699809e-05; 5.9174130460768686e-05; 5.945938584340405e-05; 6.882388524696196e-05; 7.036498484894257e-05; 8.178614148996482e-05; 8.232890503539995e-05; 8.232890503539995e-05; 8.257883791168467e-05; 9.023170634543253e-05; 9.913294924271568e-05; 0.0001007621786326551; 0.00010334647523919963; 0.00010582598320524978; 0.00010914466609698448; 0.00011072370132707822; 0.00012202062264879416; 0.0001322335978675375; 0.0001322335978675375; 0.00016189346720036038; 0.00016189346720036038; 0.0001705179359230947; 0.00017808425336754297; 0.0001802305430549181; 0.0001802305430549181; 0.0001802305430549181; 0.0001802305430549181; 0.0001802305430549181; 0.0001802305430549181; 0.00021116105905857028; 0.00021611859123914996; 0.00022336414159326664; 0.0002559467947532168; 0.00027820432005572264; 0.00028056116385876946; 0.0002926994143155384; 0.0002983150880926112; 0.00032113080554701227; 0.000323910443746482; 0.00038453776693371663; 0.00041476222368508776; 0.0004601228759628894; 0.00047142552462714113; 0.0004814724943641282; 0.0004814724943641282; 0.0004934717082734151; 0.0007074539367893701; 0.0011626911115394; 0.0011626911115394; 0.00120990141675; 0.0013033444225859; 0.0014485445504404; 0.0015133919764529; 0.0017329922477138; 0.001881335207053; 0.0021326108499664; 0.0021970545999258; 0.0022378309697704; 0.0025876779926919; 0.0027942850562877; 0.0028759971272412; 0.0041157458728674; 0.0043105477873176; 0.0043427572763018; 0.0053570195415722; 0.0060818298848679; 0.0063571439329446; 0.0066006052483961; 0.0066401895279317; 0.0070090734514155; 0.007117388576245; 0.007861073629675; 0.0080667733705833; 0.0082763563641252; 0.0093060572422998; 0.0093325514582534; 0.0104376874453167; 0.0127059723723765; 0.0128516790501046; 0.0182000062506337; 0.018665947632861; 0.0187299613301643; 0.0203198961621158; 0.0220705590988414; 0.030006907592274; 0.0319682790952413; 0.0363737825516021; 0.0368286222044987; 0.0471006425252053; 0.0565343207837806; 0.0647102740274508; 0.0804567619234804; 0.083107903315643; 0.088963803794147; 0.0967179741949912; 0.0972679220674381; 0.1018377089033323; 0.1050724946352408; 0.1050724946352408; 0.1130019719865939; 0.1242757058018646; 0.1343310874911156; 0.1397055058487397; 0.1426816828546498; 0.1460848784791741; 0.1545590833140752; 0.1642913929691757; 0.1694286967803272; 0.1793722362893728; 0.181710614199711; 0.1932166112700285; 0.2475288081654744; 0.2520982519141255; 0.2622329318286966; 0.3243241301578816; 0.3446292548618789; 0.4055175521212118; 0.417000940404929; 0.4953639776155568; 0.5199487681301056; 0.5409958054489579; 0.5785803800876654; 0.6147591778990789,Bright Disease; Glomerulonephritis; Septicemia; Gastric Ulcer; Schizophrenia; Bipolar Disorder; Autism,1.1417484002988661e-07; 1.0086418491083646e-05; 0.007221192915733; 0.007221192915733; 0.175139305620004; 0.2978951863374514; 0.9566250318622398,"Lattice corneal dystrophy type I ORPHA:98964; Reis-Bucklers corneal dystrophy ORPHA:98961; Epithelial basement membrane dystrophy ORPHA:98956; Thiel-Behnke corneal dystrophy ORPHA:98960; Granular corneal dystrophy type I ORPHA:98962; Granular corneal dystrophy type II ORPHA:98963; Niemann-Pick disease type C, adult neurologic onset ORPHA:216986; Niemann-Pick disease type C, juvenile neurologic onset ORPHA:216981; Niemann-Pick disease type C, late infantile neurologic onset ORPHA:216978; Niemann-Pick disease type C, severe early infantile neurologic onset ORPHA:216975; Niemann-Pick disease type C, severe perinatal form ORPHA:216972; Tumor necrosis factor receptor 1 associated periodic syndrome ORPHA:32960; Heme oxygenase-1 deficiency ORPHA:562509; Autosomal recessive brachyolmia ORPHA:448242; Spondyloepimetaphyseal dysplasia, PAPSS2 type ORPHA:93282; Hemochromatosis type 5 ORPHA:447792; Musculocontractural Ehlers-Danlos syndrome ORPHA:2953; Glycogen storage disease due to liver glycogen phosphorylase deficiency ORPHA:369; MME-related autosomal dominant Charcot Marie Tooth disease type 2 ORPHA:497757; Charcot-Marie-Tooth disease type 2T ORPHA:495274; Congenital membranous nephropathy due to fetomaternal anti-neutral endopeptidase alloimmunization ORPHA:69063; Spinocerebellar ataxia type 43 ORPHA:497764",0.0002132495254484572; 0.0002132495254484572; 0.0002132495254484572; 0.0002132495254484572; 0.0002132495254484572; 0.0002132495254484572; 0.0002132495254484572; 0.0002132495254484572; 0.0002132495254484572; 0.0002132495254484572; 0.0002132495254484572; 0.0514345493431829; 0.0514345493431829; 0.1927589191138116; 0.1927589191138116; 0.1927589191138116; 0.1927589191138116; 0.4838060079820406; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659,,,In vitro,0.4,Homo sapiens,Homo sapiens
BDKRB2,"Inflammation; Asthma; Lung diseases; Rheumatoid Arthritis; Neoplasm Metastasis; Hypertensive disease; Degenerative polyarthritis; Inflammatory Bowel Diseases; Obesity; Diabetes Mellitus; Diabetes; Alzheimer's Disease; Glioma; Pain; Myocardial Infarction; Sciatic Neuropathy; Gastric ulcer; Cardiovascular Diseases; Other specified forms of pleural effusion, except tuberculous; Hyperalgesia, Secondary; Allodynia; Stomach Carcinoma; Hyperalgesia, Primary; Idiopathic pulmonary arterial hypertension; Malignant neoplasm of stomach; Tactile Allodynia; Kidney Failure, Acute; Stomach Neoplasms; Mechanical Allodynia; Hyperalgesia, Thermal; Diabetic Retinopathy; Hyperalgesia; Kidney Failure, Chronic; Hypotension; Chronic kidney disease stage 5; Pulmonary Hypertension; Malignant Glioma; Unipolar Depression; Pancreatitis; Adenocarcinoma of lung (disorder); Pain, Crushing; Pain, Migratory; Pain, Splitting; Suffering, Physical; Ache; Radiating pain; Pain, Burning; Myocardial Diseases, Secondary; Cardiomyopathies, Primary; Major Depressive Disorder; Hypertension, Portal; Pre-Eclampsia; Hemorrhage; Epilepsy, Temporal Lobe; Osteoarthritis, Knee; Cardiomyopathies; Thrombosis; Essential Hypertension; Bipolar Disorder; Vascular System Injuries; Coughing; Thrombus; Venous Engorgement; Active Hyperemia; Reactive Hyperemia; Angioedemas, Hereditary; Hyperemia; Acute Kidney Insufficiency; Acute kidney injury; Extravasation of Contrast Media; Extravasation of Diagnostic and Therapeutic Materials; Acute mountain sickness; ABLEPHARON-MACROSTOMIA SYNDROME; Epilepsy, Benign Psychomotor, Childhood; Uncinate Epilepsy; Left Ventricular Hypertrophy; Epilepsy, Lateral Temporal; Hyperaldosteronism; Epilepsy",2.8114433253573326e-17; 1.803641225501291e-12; 8.179290839744632e-11; 1.9241179247341838e-10; 5.670785186683756e-09; 1.0368326871660785e-08; 2.1034803123367165e-08; 2.3137704832524547e-08; 2.412608431251415e-08; 5.8317433871210796e-08; 6.156981490555128e-08; 9.273260676030806e-08; 1.427432458937347e-07; 1.6759866477134858e-07; 2.247163660896597e-07; 4.312772724439924e-07; 4.312772724439924e-07; 4.5433391667148853e-07; 1.10068355868735e-06; 1.9581146391906144e-06; 1.9581146391906144e-06; 2.07112526817849e-06; 2.086123696221558e-06; 2.263727724144348e-06; 2.450940162208615e-06; 2.782805018144785e-06; 3.485726441474513e-06; 3.878607667297475e-06; 1.033366177374635e-05; 1.0961931275541026e-05; 1.3410647656206684e-05; 1.8507296589967813e-05; 2.0820699372778346e-05; 2.7966054180512005e-05; 2.910435331986992e-05; 8.232890503539995e-05; 8.25206825409808e-05; 0.00010334647523919963; 0.00012858049944279123; 0.00013846515856925812; 0.0001802305430549181; 0.0001802305430549181; 0.0001802305430549181; 0.0001802305430549181; 0.0001802305430549181; 0.0001802305430549181; 0.00021116105905857028; 0.00022618385822819267; 0.00026467392475943254; 0.0003278023880903879; 0.0004136970830881728; 0.0004934717082734151; 0.0006445212280958682; 0.0012591553085125; 0.0020282798161214; 0.0021326108499664; 0.0025122887786423; 0.0028759971272412; 0.0066006052483961; 0.0083709650732796; 0.0120771273149872; 0.0120771273149872; 0.0123983633418964; 0.0123983633418964; 0.0123983633418964; 0.030006907592274; 0.0384689641633299; 0.0530344420162745; 0.0571842904809504; 0.0897127848630768; 0.0897127848630768; 0.1272255752567765; 0.1703929618871976; 0.1982833830495248; 0.1982833830495248; 0.2108300774722888; 0.2108300774722888; 0.3634167943130235; 0.5793939269095637,Rheumatoid Arthritis; Dermatitis; Myocardial Diseases; Hypertension; Hyperemia; Mental Depression; Kidney Failure; Acute Kidney Insufficiency; Cardiomyopathy; Industrial Dermatosis; Gout; Bipolar Disorder; Gouty Arthritis; Epilepsy,1.241997446075319e-05; 0.0002385365299919203; 0.0015169561374293; 0.0048927857621509; 0.0242477651311773; 0.0511376198481248; 0.1110148026021272; 0.1110148026021272; 0.1273861908316246; 0.1386032662139448; 0.2208427900599418; 0.2978951863374514; 0.3849207284113362; 0.5782751786750374,"AA amyloidosis ORPHA:85445; Juvenile Paget disease ORPHA:2801; Multiple paragangliomas associated with polycythemia ORPHA:324299; Benign recurrent intrahepatic cholestasis type 1 ORPHA:99960; Recessive X-linked ichthyosis ORPHA:461; Syndromic recessive X-linked ichthyosis ORPHA:281090; Autosomal recessive generalized dystrophic epidermolysis bullosa, severe form ORPHA:79408; Severe generalized junctional epidermolysis bullosa ORPHA:79404; Laryngo-onycho-cutaneous syndrome ORPHA:2407; Acute neonatal citrullinemia type I ORPHA:247546; Adult-onset citrullinemia type I ORPHA:247573; Ulnar-mammary syndrome ORPHA:3138; Isolated hyperchlorhidrosis ORPHA:542657; Erythrokeratodermia variabilis ORPHA:317; Progressive symmetric erythrokeratodermia ORPHA:316; Ablepharon macrostomia syndrome ORPHA:920; Alopecia universalis ORPHA:701; Atrichia with papular lesions ORPHA:86819; Barber-Say syndrome ORPHA:1231; Chronic enteropathy associated with SLCO2A1 gene ORPHA:468641; Focal facial dermal dysplasia type III ORPHA:1807; High myopia-sensorineural deafness syndrome ORPHA:363396; Marie Unna hereditary hypotrichosis ORPHA:444",0.0514345493431829; 0.0514345493431829; 0.1927589191138116; 0.1927589191138116; 0.1927589191138116; 0.1927589191138116; 0.1927589191138116; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659,,,Homo sapiens;In vitro,0.35;0.4,Homo sapiens;Human papillomavirus type 6b;ebvb9,Homo sapiens;chemical synthesis
BIRC3,"Pneumonia; Asthma; Lymphoma; Multiple Myeloma; Virus Diseases; Lung diseases; Neutrophilia (disorder); Arteriosclerosis; Non-Small Cell Lung Carcinoma; Autoimmune Diseases; Peritonitis; Ovarian Carcinoma; Endometriosis; cervical cancer; Ulcerative Colitis; Infection; Malignant neoplasm of ovary; Colitis; Malignant tumor of cervix; Lung Neoplasms; Multiple Sclerosis; Neoplasm Metastasis; Graves Disease; Cervix carcinoma; Infection caused by Helicobacter pylori; Obesity; Liver neoplasms; HIV Infections; Glioblastoma; leukemia; Pancreatic carcinoma; Alzheimer's Disease; Epithelial ovarian cancer; Malignant neoplasm of pancreas; Anoxia; Diffuse Large B-Cell Lymphoma; Malignant neoplasm of lung; Leukemia, T-Cell; Chronic Lymphocytic Leukemia; Malignant neoplasm of breast; Bladder Neoplasm; Anemia, Sickle Cell; Liver carcinoma; Colonic Neoplasms; Immunologic Deficiency Syndromes; Carcinogenesis; Nasopharyngeal carcinoma; Influenza; Carcinoma of lung; Stomach Carcinoma; B-Cell Lymphomas; Colon Carcinoma; Malignant neoplasm of stomach; Osteosarcoma of bone; melanoma; Fever; Primary malignant neoplasm of lung; Breast Carcinoma; Osteosarcoma; Liver Cirrhosis, Experimental; Small cell carcinoma of lung; MYELODYSPLASTIC SYNDROME; Prostate carcinoma; Adenocarcinoma; Malignant tumor of colon; Prostatic Neoplasms; Malignant neoplasm of endometrium; Uterine Corpus Cancer; Squamous cell carcinoma; Malignant neoplasm of prostate; Malignant neoplasm of urinary bladder; Endometrioma; Malignant Pleural Mesothelioma; Mesothelioma; Renal Cell Carcinoma; Endometrial Carcinoma; Retinoblastoma; Colorectal Carcinoma; Myeloid Leukemia, Chronic; Anemia; Leukemogenesis; Colorectal Cancer; Ataxia Telangiectasia; Adenocarcinoma Of Esophagus; Chronic Neutrophilic Leukemia; Metastatic Neoplasm; Trisomy; androgen independent prostate cancer; Fatty Liver; Progressive Neoplastic Disease; Progressive cGVHD; Marginal Zone B-Cell Lymphoma; Steatohepatitis; Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse; Glioblastoma Multiforme; Hereditary hemochromatosis; T-Cell Lymphoma; Mucosa-Associated Lymphoid Tissue Lymphoma; Pancreatic intraepithelial neoplasia; Splenic Marginal Zone B-Cell Lymphoma; Familial primary gastric lymphoma; Epithelioma; Gastric Mucosa-Associated Lymphoid Tissue Lymphoma; Gallbladder Carcinoma; Cyst; HIV Coinfection; Malignant neoplasm of gallbladder; Acute and chronic colitis; Gastrointestinal lymphoma; Congenital chromosomal disease; Chromosome 12, 12p trisomy; Vesicular Stomatitis; Fatigue; Extranodal marginal zone B-cell lymphoma; Low grade B-cell lymphoma; Chronic lymphocytic leukaemia refractory; Pulmonary Infiltrate; Sweating; Hyperhidrosis disorder; Increased sweating; Gastric lymphoma; Condylomata Acuminata; Macrothrombocytopenia; Malignant melanoma of eye; Richter's syndrome; Complete trisomy 18 syndrome; Weight decreased; Stereotyped Behavior; Constipation; Stereotypic Movement Disorder; Nausea and vomiting; Hemoglobin low; Dyschezia",7.980856456624717e-16; 1.803641225501291e-12; 4.5104266881389206e-12; 2.5279022064249716e-11; 6.332483647919588e-11; 8.179290839744632e-11; 1.1574161017103878e-10; 2.377251819497684e-10; 3.762648680673853e-10; 5.452288254986118e-10; 5.452288254986118e-10; 6.870627395110916e-10; 7.868397426275417e-10; 1.1722433847661196e-09; 1.6767489697325582e-09; 1.794870341379274e-09; 1.971893171900314e-09; 1.971893171900314e-09; 3.683115069310663e-09; 4.367699208727405e-09; 4.546836602575699e-09; 5.670785186683756e-09; 8.269524813140207e-09; 1.5572986293211266e-08; 1.7931366647560766e-08; 2.412608431251415e-08; 4.3069383556698336e-08; 4.638299267461546e-08; 5.518991037343798e-08; 5.784935444423772e-08; 6.982287075725826e-08; 9.273260676030806e-08; 1.479813245926713e-07; 1.4925759778299788e-07; 2.911052249927245e-07; 3.532371372262103e-07; 6.299208964864026e-07; 6.805796735296268e-07; 7.931659047151387e-07; 8.660170029731726e-07; 9.822463166680949e-07; 1.2482007026109775e-06; 1.3079916134634371e-06; 1.4185164995612263e-06; 1.4839502431758565e-06; 1.51758575162775e-06; 1.5208470671427406e-06; 2.027389637151193e-06; 2.027389637151193e-06; 2.07112526817849e-06; 2.1624936975752243e-06; 2.205236928124383e-06; 2.450940162208615e-06; 2.560217628497434e-06; 4.179146475474674e-06; 4.83171753412672e-06; 4.839188317483647e-06; 5.381279306135013e-06; 6.3131986281381465e-06; 7.691726899679507e-06; 1.0755368362337037e-05; 1.279493639647176e-05; 1.527992765491583e-05; 1.5449280661407645e-05; 1.5498516107485843e-05; 2.0820699372778346e-05; 2.389985034001877e-05; 2.483118059238325e-05; 3.053335644618538e-05; 3.053335644618538e-05; 3.1491435270594376e-05; 4.079834649355082e-05; 0.0001007621786326551; 0.00010582598320524978; 0.0001119048288448298; 0.0001322335978675375; 0.00015093372108149775; 0.00016189346720036038; 0.00021049732822064587; 0.00022254302103317592; 0.0002652452950458932; 0.00038453776693371663; 0.0005182771791848276; 0.0011303542860313; 0.0011876897533161; 0.001746579573497; 0.0026287893312444; 0.0037263522689301; 0.0038705790239355; 0.0040785542386402; 0.0043121462081946; 0.0060818298848679; 0.0067588219988478; 0.0094642528600355; 0.0171001534176385; 0.0171001534176385; 0.0196314124927668; 0.0203198961621158; 0.0220705590988414; 0.0324016809159931; 0.0335408281184641; 0.0407359064912377; 0.0493155676939993; 0.0511562825357515; 0.0647102740274508; 0.0729686376372628; 0.0967179741949912; 0.0972679220674381; 0.0972679220674381; 0.0996459063920158; 0.1050724946352408; 0.1107144880305473; 0.1266767196420385; 0.1401454825042905; 0.1460848784791741; 0.1525119847960956; 0.1703929618871976; 0.1911693299808857; 0.1911693299808857; 0.1911693299808857; 0.2166737845423457; 0.2226324872503657; 0.2272199982000937; 0.2272199982000937; 0.2520982519141255; 0.2570364810168682; 0.3417325482389482; 0.4462255858401349; 0.4481840103343354; 0.4953639776155568; 0.6147591778990789; 0.7181037063590973; 0.7199635967211335,"Fatty Liver; Multiple Myeloma; B-Cell Lymphoma; Bladder Neoplasm; Urinary Bladder Cancer; Uveitis; MALT Lymphoma; Mucosa-associated Lymphoma; Malignant Lymphoma, Lymphocytic, Intermediate Differentiation; Mediastinal Lymphadenopathy; Anemia; Leukemia; Lymphocytic Leukemia",0.0025464930497429; 0.0072990932027619; 0.0186439654623197; 0.021392225047824; 0.0264273671824767; 0.1110148026021272; 0.1110148026021272; 0.1110148026021272; 0.2072542702968064; 0.2072542702968064; 0.2344334553667355; 0.5399696510344362; 0.664640074476835,Nasopharyngeal carcinoma ORPHA:150; Hereditary pediatric Behcet-like disease ORPHA:476102; Autosomal dominant hyper-IgE syndrome ORPHA:2314; Chronic lymphoproliferative disorder of natural killer cells ORPHA:512017; STAT3-related early-onset multisystem autoimmune disease ORPHA:438159; T-cell large granular lymphocyte leukemia ORPHA:86872; Autosomal dominant dopa-responsive dystonia ORPHA:98808; GTP cyclohydrolase I deficiency ORPHA:2102; Herpes simplex virus encephalitis ORPHA:1930; Autosomal recessive mendelian susceptibility to mycobacterial diseases due to partial JAK1 deficiency ORPHA:574957; MALT lymphoma ORPHA:52417; Singleton-Merten dysplasia ORPHA:85191; Immunodeficiency by defective expression of MHC class I ORPHA:34592; Complement hyperactivation-angiopathic thrombosis-protein-losing enteropathy syndrome ORPHA:566175; Generalized glucocorticoid resistance syndrome ORPHA:786; Infantile-onset pulmonary alveolar proteinosis-hypogammaglobulinemia ORPHA:572428; MIRAGE syndrome ORPHA:494433; Mendelian susceptibility to mycobacterial diseases due to partial STAT1 deficiency ORPHA:319595; Autoimmune enteropathy and endocrinopathy-susceptibility to chronic infections syndrome ORPHA:391487; NIK deficiency ORPHA:447731; Odonto-onycho-dermal dysplasia ORPHA:2721; Schopf-Schulz-Passarge syndrome ORPHA:50944; Susceptibility to viral and mycobacterial infections due to STAT1 deficiency ORPHA:391311; Familial normophosphatemic tumoral calcinosis ORPHA:306658; Variant ABeta2M amyloidosis ORPHA:314652; Hyper-IgM syndrome type 3 ORPHA:101090; Vogt-Koyanagi-Harada disease ORPHA:3437; Diffuse cutaneous systemic sclerosis ORPHA:220393; Hypoplastic amelogenesis imperfecta ORPHA:100031; Autoimmune lymphoproliferative syndrome with recurrent viral infections ORPHA:275517; Combined immunodeficiency due to MALT1 deficiency ORPHA:397964; Proteasome-associated autoinflammatory syndrome ORPHA:324977; Hepatic veno-occlusive disease-immunodeficiency syndrome ORPHA:79124; Giant cell arteritis ORPHA:397; Ataxia-pancytopenia syndrome ORPHA:2585; Autosomal dominant Kenny-Caffey syndrome ORPHA:93325; Osteocraniostenosis ORPHA:2763,6.10801728836975e-11; 1.7877420438201673e-08; 2.859667220539484e-06; 2.859667220539484e-06; 2.859667220539484e-06; 2.859667220539484e-06; 3.28973817825433e-05; 3.28973817825433e-05; 0.00024116799717032887; 0.0019696624570933; 0.0022487953361182; 0.0133474287859103; 0.0133474287859103; 0.0133474287859103; 0.0133474287859103; 0.0133474287859103; 0.0514345493431829; 0.0514345493431829; 0.0514345493431829; 0.0514345493431829; 0.0514345493431829; 0.0514345493431829; 0.0514345493431829; 0.0514345493431829; 0.0514345493431829; 0.0514345493431829; 0.0514345493431829; 0.0557820633193028; 0.0565022767519947; 0.1927589191138116; 0.1927589191138116; 0.1927589191138116; 0.1927589191138116; 0.1950017883804084; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406,Yellow fever virus envelope protein; Japanese encephalitis virus anchored core protein C; Murray Valley encephalitis virus prodexcised_polyprotein 1..793; West Nile virus lineage 2 excised_polyprotein 1..791 (gene: flavivirus polyprotein); Powassan virus envelope protein; Japanese encephalitis virus hypothetical protein; Omsk hemorrhagic fever virus full_polyprotein 1..3414; Japanese encephalitis virus prodexcised_polyprotein 1..794; West Nile virus lineage 1 excised_polyprotein 1..787 (gene: flavivirus polyprotein); Wesselsbron virus full_polyprotein 1..3405; Zika virus capsid protein C (gene: flavivirus polyprotein); Murray Valley encephalitis virus core protein C; Murray Valley encephalitis virus ancC; West Nile virus lineage 2 anchored capsid protein C (gene: flavivirus polyprotein); Japanese encephalitis virus envelope protein; Karshi virus (Royal Farm virus) full_polyprotein 1..3416; Dengue virus full_polyprotein 1..3387; West Nile virus lineage 2 excised_polyprotein 1..2273 (gene: flavivirus polyprotein); SARS coronavirus excised_polyprotein 1..4369 (gene: orf1ab); SARS coronavirus P2 full_polyprotein 1..4382,0.2280934210760456; 0.312710113238199; 0.3677974393080778; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.4957785417461715; 0.5115772036634316; 0.6262498739240705; 0.7687382923472926; 0.7753822456801922,In vitro,0.35;0.44,Homo sapiens;chemical synthesis,Homo sapiens;chemical synthesis
C10ORF55,,,Inflammatory Bowel Disease; Crohn Disease,0.021392225047824; 0.0682669288241704,Quebec platelet disorder ORPHA:220436; COFS syndrome ORPHA:1466,3.28973817825433e-05; 0.4838060079820406,,,,,,
C11ORF96,,,,,"Roussy-Levy syndrome ORPHA:3115; Dejerine-Sottas syndrome ORPHA:64748; Lipoprotein glomerulopathy ORPHA:329481; Sea-blue histiocytosis ORPHA:158029; Dysbetalipoproteinemia ORPHA:412; Hypotrichosis-lymphedema-telangiectasia-renal defect syndrome ORPHA:69735; 46,XY gonadal dysgenesis-motor and sensory neuropathy syndrome ORPHA:168563; Late-onset retinal degeneration ORPHA:67042; Classical-like Ehlers-Danlos syndrome type 2 ORPHA:536532; Congenital alveolar capillary dysplasia ORPHA:210122; EMILIN-1-related connective tissue disease ORPHA:485418",0.1927589191138116; 0.1950017883804084; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659,,,,,,
CAMK1G,"Amyotrophic Lateral Sclerosis; Amyotrophic Lateral Sclerosis With Dementia; Amyotrophic Lateral Sclerosis, Guam Form; Infiltrating duct carcinoma of female breast",0.0009325953874753212; 0.0043470921917622; 0.0059257679306595; 0.1881045022168423,Amyotrophic Lateral Sclerosis With Dementia; Amyotrophic Lateral Sclerosis; Infiltrating Duct Carcinoma Of Female Breast; Leukemia,0.009505750723671; 0.1006919508743788; 0.2247736041224312; 0.5399696510344362,Episodic ataxia type 6 ORPHA:209967; Norrie disease ORPHA:649; Coats disease ORPHA:190; NON RARE IN EUROPE: Dementia with Lewy body ORPHA:1648,0.4838060079820406; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659,Human gammaherpesvirus 8 ORF72; Papiine alphaherpesvirus 2 serine/threonine protein kinase US3 (gene: US3); Human alphaherpesvirus 2 serine/threonine protein kinase US3 (gene: US3); Cercopithecine alphaherpesvirus 2 serine/threonine protein kinase US3 (gene: US3); Human alphaherpesvirus 1 serine/threonine protein kinase US3 (gene: US3),0.4627268298950313; 0.7356705979804892; 0.8015224820713857; 0.8381307845676164; 0.8710135911342001,yeasx,0.56,Homo sapiens,Homo sapiens
CCDC39,"Bronchiectasis; Otitis Media; Infertility; Chronic sinusitis; Abnormal ciliary motility; Kartagener Syndrome; Ciliary Motility Disorders; Congenital atresia of nasopharynx; Other specified congenital malformations of respiratory system; Chronic sinus disease; Ciliopathies; Heterotaxy, Visceral, 3, Autosomal; HETEROTAXY, VISCERAL, 4, AUTOSOMAL; CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 1, X-LINKED; HETEROTAXY, VISCERAL, 1, X-LINKED; HETEROTAXY, VISCERAL, 2, AUTOSOMAL; HETEROTAXY, VISCERAL, 6, AUTOSOMAL; Polynesian Bronchiectasis; Hydrocephalus; Recurrent respiratory infections; Intellectual Disability",9.846223464501226e-05; 0.0028187518310092; 0.0344821468860451; 0.0469394416375774; 0.0817897187940979; 0.0826378648181075; 0.1204795752338222; 0.1206032442301429; 0.1206032442301429; 0.1584804022044084; 0.176056923749369; 0.2316568843888361; 0.2316568843888361; 0.236709594559292; 0.236709594559292; 0.236709594559292; 0.236709594559292; 0.2777403930303475; 0.2921843338021302; 0.4596755087558572; 0.9388725395674395,Gastric Cancer; Asthma; Bronchiectasis; Asthenozoospermia; Ciliary Dyskinesia; Schizophrenia; Lung Diseases; Situs Inversus; Nasal Polyposis; Rhinitis; Asplenia; Corneal Dystrophy; Leukemia; Ciliopathies; Sinusitis; Hydrocephalus; Scoliosis; Otitis Media; Congenital Pectus Excavatum; Hearing Loss,0.0172144998405365; 0.064825092293108; 0.1203844668559877; 0.1448400284889975; 0.1586275460870988; 0.175139305620004; 0.2098525466439478; 0.2648173889661375; 0.4379696811796732; 0.4535032653524289; 0.4985163290591877; 0.525402170161049; 0.5399696510344362; 0.6088194135768727; 0.6088518085174112; 0.6903302995333075; 0.8310460270009882; 0.8384352852277333; 0.8680747290158279; 0.9252470124617264,Primary ciliary dyskinesia ORPHA:244,0.5312419675785659,,,,,,
CCL2,"Inflammation; Pneumonia; Reperfusion Injury; Asthma; Psoriasis; Familial M??ni??re disease; Lymphoma; Multiple Myeloma; Virus Diseases; Dermatitis, Atopic; Lung diseases; Lobar Pneumonia; Chronic Obstructive Airway Disease; Rheumatoid Arthritis; Thyroid associated opthalmopathies; Arteriosclerosis; Brain Injuries, Focal; Injuries, Acute Brain; Brain Injuries; Brain Lacerations; Pneumonitis; Non-Small Cell Lung Carcinoma; Crohn Disease; Autoimmune Diseases; Peritonitis; Uveitis; Ovarian Carcinoma; Sarcoidosis; Endometriosis; cervical cancer; Cirrhosis; MYELOPROLIFERATIVE DISORDER, CHRONIC, WITH EOSINOPHILIA; Ulcerative Colitis; Infection; Malignant neoplasm of ovary; Colitis; Pancreatitis, Chronic; Tumor Angiogenesis; Malignant tumor of cervix; Dermatitis; Lung Neoplasms; Multiple Sclerosis; Cerebral Ischemia; Neoplasm Metastasis; Experimental Lung Inflammation; Inflammatory dermatosis; Hodgkin Disease; Hepatitis C; Atherosclerosis; Pulmonary Fibrosis; Acute pancreatitis; Leukemia, Myelocytic, Acute; Anti-Basement Membrane Glomerulonephritis; Glomerulonephritis; Hypertensive disease; Liver Cirrhosis; Respiratory syncytial virus (RSV) infection in conditions classified elsewhere and of unspecified site; Vascular Diseases; Eczema; Cervix carcinoma; Arthritis; Infection caused by Helicobacter pylori; Brain Ischemia; Cerebrovascular accident; Degenerative polyarthritis; Respiratory Distress Syndrome, Adult; Allergic Reaction; Inflammatory Bowel Diseases; Obesity; Auricular swelling; Periodontitis; Hyperglycemia; Liver neoplasms; HIV Infections; Mammary Neoplasms; Aortic Aneurysm, Abdominal; Bright Disease; Glioblastoma; leukemia; Diabetes Mellitus; Juvenile rheumatoid arthritis; Leishmaniasis, Cutaneous; Diabetes; Lupus Erythematosus, Systemic; Pancreatic carcinoma; Coronary Artery Disease; Coronary heart disease; Alzheimer's Disease; Behcet Syndrome; Dermatitis, Allergic Contact; Right Middle Cerebral Artery Infarction; Embolic Infarction, Middle Cerebral Artery; Thrombotic Infarction, Middle Cerebral Artery; Left Middle Cerebral Artery Infarction; Middle Cerebral Artery Embolus; Middle Cerebral Artery Syndrome; Middle Cerebral Artery Thrombosis; Malaria; Encephalitis; Spondylarthropathies; Glioma; Epithelial ovarian cancer; Malignant neoplasm of pancreas; Van der Woude syndrome; Pain; Cerebral abscess; Acquired Immunodeficiency Syndrome; Respiratory Syncytial Virus Infections; Malignant neoplasm of mouth; Hamman-Rich syndrome; Inflammatory disorder; Myocardial Infarction; Infarction, Middle Cerebral Artery; Cerebral Infarction; Hepatitis C, Chronic; Adult T-Cell Lymphoma/Leukemia; Brain Abscess; Anoxia; Myocardial Ischemia; Bronchiolitis Obliterans; Diffuse Large B-Cell Lymphoma; Myocarditis; Brain Neoplasms; Sciatic Neuropathy; Gastric ulcer; Pneumococcal Infections; Cardiovascular Diseases; Septicemia; Sepsis; Peptic Esophagitis; Malignant neoplasm of lung; Fibroid Tumor; Restenosis; Tuberculosis; Leukemia, T-Cell; Middle Cerebral Artery Occlusion; Diabetes Mellitus, Insulin-Dependent; Liver diseases; Hepatitis, Alcoholic; Chronic Lymphocytic Leukemia; Ureteral obstruction; Tumor Progression; Spondylarthritis; Dryness of eye; Malignant neoplasm of breast; Premature Obstetric Labor; Cytomegalovirus Infections; Gastritis; Bladder Neoplasm; Coronary Arteriosclerosis; Graft-vs-Host Disease; Diabetic Nephropathy; Systemic Scleroderma; Hypersensitivity; Anemia, Sickle Cell; Liver carcinoma; Colonic Neoplasms; Immunologic Deficiency Syndromes; Carcinogenesis; Nasopharyngeal carcinoma; Transient Ischemic Attack; Lung Diseases, Interstitial; Endometrial Neoplasms; Hyperalgesia, Secondary; Allodynia; Diffuse cutaneous leishmaniasis; Influenza; Carcinoma of lung; Stomach Carcinoma; Hyperalgesia, Primary; Polycystic Ovary Syndrome; Ankylosing spondylitis; Colon Carcinoma; Idiopathic pulmonary arterial hypertension; Fibrosarcoma; Malignant neoplasm of stomach; Osteosarcoma of bone; Lip and Oral Cavity Carcinoma; Astrocytoma; Dry Eye Syndromes; Tactile Allodynia; Lupus Nephritis; Kidney Failure, Acute; Stomach Neoplasms; Tuberculosis, Pulmonary; Chronic liver disease; melanoma; Fever; Primary malignant neoplasm of lung; Bronchiolitis; Breast Carcinoma; Henoch-Schoenlein Purpura; Idiopathic Inflammatory Myopathies; Alveolitis; Urban cutaneous leishmaniasis; Polymyositis; Osteosarcoma; Secondary malignant neoplasm of bone; Thyroid carcinoma; Angina, Unstable; Acute anterior uveitis; Liver Cirrhosis, Experimental; Delirium; Leprosy; M5b Acute differentiated monocytic leukemia; Epstein-Barr Virus Infections; Obstructive nephropathy; Familial Alzheimer Disease (FAD); Hepatitis B, Chronic; Mechanical Allodynia; Small cell carcinoma of lung; Encephalomyelitis; Hyperalgesia, Thermal; Stable angina; Acute lymphocytic leukemia; Leishmaniasis, New World; Anterior uveitis; Retinal Diseases; Allergic asthma; Pleural Effusion, Malignant; Acute monocytic leukemia; Bronchial Hyperreactivity; Diabetic Retinopathy; Cachexia; Senile Plaques; Hepatitis B; Lupus Erythematosus; Presenile dementia; Lymphohistiocytosis, Hemophagocytic; Prostate carcinoma; Adenocarcinoma; Malignant tumor of colon; Vascular lesions; Idiopathic crescentic glomerulonephritis; Anthracosis; Acute Coronary Syndrome; Hyperalgesia; ovarian neoplasm; Nephritis; Nonalcoholic Steatohepatitis; Kidney Failure, Chronic; Prostatic Neoplasms; Severe Acute Respiratory Syndrome; Herpes Simplex Infections; Atherogenesis; Malignant neoplasm of endometrium; Contact Dermatitis; Uterine Corpus Cancer; Fibrosis; Chronic kidney disease stage 5; Squamous cell carcinoma; Malignant neoplasm of prostate; Hepatitis, Autoimmune; Meningitis; Malignant neoplasm of urinary bladder; Pancreatic Neoplasm; Parkinson Disease; Autoimmune thyroiditis; Sleep Apnea, Obstructive; Mouth Neoplasms; Carcinoma of bladder; Experimental Organism Basal Cell Carcinoma; Osteomyelitis; Lupus Vulgaris; Invasive Streptococcus pneumoniae disease; Viral respiratory infection; Periodontal Diseases; Uterine Fibroids; Thyroid Diseases; IGA Glomerulonephritis; Painful Bladder Syndrome; Proliferative vitreoretinopathy; Cardiomyopathy, Dilated; Myositis; Benign Prostatic Hyperplasia; Enterovirus Infections; Diabetic Angiopathies; Biliary Atresia; Acute myocardial infarction; TNF receptor-associated periodic fever syndrome (TRAPS); Lupus Erythematosus, Discoid; Pulmonary Hypertension; Congestive heart failure; Malignant Glioma; Celiac Disease; Familial lichen amyloidosis; Urinary tract infection; Latent Tuberculosis; Lung Injury; Other specified transient cerebral ischemias; Idiopathic Pulmonary Fibrosis; Mucocutaneous Lymph Node Syndrome; Chronic Kidney Diseases; Mitral Valve Stenosis; Unipolar Depression; Age related macular degeneration; Mesothelioma; Dermatomyositis; Gingival Diseases; Neurodegenerative Disorders; Renal Cell Carcinoma; Toxoplasmosis; Adenoma; Multiple Sclerosis, Relapsing-Remitting; Cerebral arterial aneurysm; Pancreatitis; Acute pyelonephritis; Cytomegalovirus encephalitis; Endometrial Carcinoma; Adenocarcinoma of lung (disorder); Nasal Polyps; Retinoblastoma; Status Epilepticus; Colorectal Carcinoma; Diabetes Mellitus, Non-Insulin-Dependent; Fibrosis, Liver; Encephalitis, St. Louis; Invasive Pulmonary Aspergillosis; Metabolic Syndrome X; Pancreatic Ductal Adenocarcinoma; Pulmonary Emphysema; Seronegative rheumatoid arthritis; Asthma attack; Alcoholic Liver Diseases; Gastritis, Atrophic; Tuberculosis, Meningeal; Adult type dermatomyositis; Metastatic melanoma; Chronic Lung Injury; Scleroderma; Anemia; Kidney Diseases; Myocardial Diseases, Secondary; Neoplasms; Plaque, Amyloid; Splenic Hypoplasia; Lymphoma, Follicular; Kidney Failure; Cardiomyopathies, Primary; Allergic disposition; Heart failure; Trachoma; Carotid Artery Diseases; airway disease; Sarcoma; Dementia; Severe Dengue; Silicosis; Diabetic macular edema; Ear Inflammation; Central neuroblastoma; Secondary malignant neoplasm of lymph node; Major Depressive Disorder; Amyloidosis; Drug-Induced Liver Disease; Colorectal Cancer; Idiopathic urticaria; Hemolytic-Uremic Syndrome; Squamous cell carcinoma of the head and neck; Secondary malignant neoplasm of lung; Invasive carcinoma of breast; Superinfection; Albuminuria; Periapical Periodontitis; Pleural Tuberculosis; Adrenoleukodystrophy; Neuroblastoma; Ischemia; Carcinoma breast stage IV; Precursor Cell Lymphoblastic Leukemia Lymphoma; Ataxia Telangiectasia; Refractory anemias; Joint swelling; Focal glomerulosclerosis; Squamous intraepithelial lesion; Oestrogen deficiency; Paranoid Schizophrenia; Stromal keratitis; Pulmonary Pathology; Uveomeningoencephalitic Syndrome; AIDS Dementia Complex; Q Fever; Giant Cell Arteritis; Amyotrophic Lateral Sclerosis; Pulmonary Edema; Secondary malignant neoplasm of liver; CNS disorder; Dengue Fever; Arthropathy; Chronic Q Fever; Interstitial lung fibrosis; Hypercholesterolemia; Hepatitis, Chronic; Neoplasm Invasiveness; Lyme Disease; Post MI; Recurrent urinary tract infection; Thyroid Gland Follicular Adenoma; DOSAGE-SENSITIVE SEX REVERSAL; Iron Overload; Clostridium; difficile (disorder); Huntington Disease; Allergic Conjunctivitis; Hepatitis, Toxic; Chemical and Drug Induced Liver Injury; Chemically-Induced Liver Toxicity; Drug-Induced Acute Liver Injury; Dejerine-Sottas Disease (disorder); Shock; Thyroid Neoplasm; Hepatitis, Drug-Induced; Cardiomyopathies; Cardiac Arrest; Renal fibrosis; Hypoxic-Ischemic Encephalopathy; Cerebral Aneurysm; Mild cognitive disorder; Ischemia of kidney; Aneurysm; Temporomandibular Joint Disorders; Metabolic Diseases; Otitis Media; Essential Hypertension; Chagas' disease without mention of organ involvement; Carotid Atherosclerosis; Cryoglobulinemia; Viral myocarditis; Incontinentia Pigmenti Achromians; gliosarcoma; Lymphangioleiomyomatosis; Temporomandibular Joint Dysfunction Syndrome; Oxalosis; Fatty Liver; Scrub Typhus; Progressive Neoplastic Disease; Glomerulosclerosis (disorder); Choriocarcinoma; Progressive cGVHD; Hyperlipidemia; Intracranial Aneurysm; Gestational Diabetes; Uveal melanoma; HIV Encephalopathy; PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS; Hyperhomocysteinemia; Overweight; HIV encephalitis; Anaplastic thyroid carcinoma; Stromal Neoplasm; Ovarian adenocarcinoma; Liver Failure, Acute; Cardiomyopathy, Familial Idiopathic; Nephrotic Syndrome; TIBIAL MUSCULAR DYSTROPHY, TARDIVE; Venous retinal branch occlusion; Hepatopulmonary Syndrome; Chronic heart failure; HTLV-I Infections; Malignant Fibrous Histiocytoma; Proliferative diabetic retinopathy; Bipolar Disorder; Varicosity; Steatohepatitis; Astrocytoma, low grade; Muscular Dystrophy, Duchenne; Asymptomatic bacteriuria; Infection by Leishmania braziliensis; Infections specific to perinatal period; Primary bacterial peritonitis; Glomerulonephritis, Membranoproliferative; Non-alcoholic Fatty Liver Disease; Arteriosclerotic cardiovascular disease, NOS; Medulloblastoma; Recurrent tumor; Schizophrenia; Arterial Diseases, Common Carotid; Coronavirus Infections; External Carotid Artery Diseases; Internal Carotid Artery Diseases; Vascular inflammations; Meningioma; Chagas Disease; Thyroiditis; Neurocognitive Disorders; Hyperactive behavior; Aortic Valve Insufficiency; Infectious Otitis Media; Atrial Fibrillation; Adenocarcinoma of prostate; Drusen; Invasive Ductal Breast Carcinoma; Antibiotic-associated diarrhea; Coronary Occlusion; Diabetic Foot; Membranous glomerulonephritis; Retinal Detachment; Steroid Sulfatase Deficiency Disease; Idiopathic pulmonary hypertension; cardiac event; Hemangioendothelioma; Frontotemporal Lobar Degeneration; Giant Cell Tumors; Hyperoxaluria; Metastatic malignant neoplasm to brain; Down Syndrome; Ichthyosis, X-Linked; Glioblastoma Multiforme; Leukoencephalopathy, Progressive Multifocal; Compression of spinal cord; Pleural Diseases; Heart valve disease; Brain Diseases; Squamous cell carcinoma of mouth; Sick Sinus Syndrome; Jaundice, Obstructive; Gastrointestinal inflammation; Hypotrichosis simplex; Chronic glomerulonephritis; Job Syndrome; Peripheral Arterial Diseases; Renal glomerular disease; Tuberous Sclerosis; Orchitis; Simple Partial Status Epilepticus; Status Epilepticus, Subclinical; Complex Partial Status Epilepticus; Grand Mal Status Epilepticus; Non-Convulsive Status Epilepticus; Apraxia, Developmental Verbal; Cancer of Digestive System; PACHYONYCHIA CONGENITA 3; Anaplasia; Carotid Artery Plaque; MUTYH-Associate Polyposis; Neuropathy; Hyperinsulinism; Petit mal status; Chronic colitis; Crohn's disease of large bowel; Pulmonary Embolism; Spinal Cord Myelodysplasia; Diastematomyelia; Iniencephaly; Neurenteric Cyst; Autism Spectrum Disorders; Delirium, Dementia, Amnestic, Cognitive Disorders; Myelomonocytic leukemia; Pulmonary Eosinophilia; Rhabdomyosarcoma; Peripheral Neuropathy; Hemochromatosis; Acrania; Lesion of brain; Nephritis, Interstitial; Tethered Cord Syndrome; Craniorachischisis; Exencephaly; Meningioma, benign, no ICD-O subtype; Neural Tube Defects; Nephritis, Tubulointerstitial; Idiopathic Membranous Glomerulonephritis; Aortic Aneurysm; Cardiac fibrosis; Neoplasms, Intracranial; nervous system disorder; Neuralgia; Rash and Dermatitis Adverse Event Associated with Chemoradiation; Microcalcification; Aortic aneurysm without mention of rupture NOS; HIV Coinfection; Carcinoma of urinary bladder, superficial; Becker Muscular Dystrophy; Dissection of aorta; Tumoral calcinosis; Muscle damage; Trichohepatoenteric Syndrome; Pleural effusion disorder; Inherited neuropathies; Regional enteritis; IIeocolitis; Luminal A Breast Carcinoma; Antiphospholipid Syndrome; Impaired cognition; Lipodystrophy; Renal tubular disorder; Abnormal behavior; Calcinosis; Infected ascites; Premature coronary artery disease; Neurologic Symptoms; Migraine Disorders; Nodular glomerulosclerosis; Dizziness; Squamous cell carcinoma of lip; Total Hypotrichosis, Mari type; Vasospasm, Intracranial; Osteoglophonic dwarfism; Liver Dysfunction; Crohn's disease of the ileum; Vertigo; Malignant neoplasm of large intestine; MYELOPROLIFERATIVE SYNDROME, TRANSIENT; Viremia; Retinal Drusen; Tuberculosis, Spinal; Anal intraepithelial neoplasia; Femoral artery occlusion; Gastrointestinal Carcinoid Tumor; High-Grade Squamous Intraepithelial Lesions; Acute recurrent pancreatitis; Giant Cell Tumor of Bone; GRN-related frontotemporal dementia; Bipolar I disorder; Encephalopathies; MYCOBACTERIUM TUBERCULOSIS, PROTECTION AGAINST; MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO (finding); Status Dysraphicus; cancer angiogenesis; Chronic superficial gastritis; Acute myocarditis; Patent ductus arteriosus; Acromegaly; Sclerosis of the skin; Complex Regional Pain Syndromes; Duchenne and Becker Muscular Dystrophy; Polyendocrinopathies, Autoimmune; Gliosis; Sore to touch; Cancer Pain; Rachischisis; Luminal B Breast Carcinoma; Central nervous system lesion; Endomyocardial Fibrosis; Keloid; Myocardial Reperfusion Injury; Spina Bifida; Retinal Degeneration; Asthmatic pulmonary eosinophilia; Chronic myocardial ischemia; Fibrosis of pancreas; Peyronie Disease; Xanthoma; fibroma; Spinal Muscular Atrophy; Diabetic foot ulcer; Homocystinuria; Angiofibroma; Coronary Aneurysm; Infection of bone; Arteriovenous fistula; Atherosclerosis of aorta; Invasive Skin Melanoma; Myxoma; Adult Acute Lymphocytic Leukemia; Prostate Cancer, Hereditary, 7; Cervical intraepithelial neoplasia grade 1; Cervical intraepithelial neoplasia grade 2; Disease due to Parvoviridae; Strawberry nevus of skin; Abetalipoproteinemia; Nervous System Neoplasms; Charcot-Marie-Tooth Disease; Fetal Growth Retardation; Chronic otitis media; Photoreceptor degeneration; Muscle Weakness; Prostatic Hyperplasia; Multiple tumors; PARKINSON DISEASE, LATE-ONSET; Manic; Gilles de la Tourette syndrome; Paresis; Epilepsy",2.8114433253573326e-17; 7.980856456624717e-16; 4.4398736172867135e-14; 1.803641225501291e-12; 3.118210553589307e-12; 3.861499575207375e-12; 4.5104266881389206e-12; 2.5279022064249716e-11; 6.332483647919588e-11; 7.448716379948652e-11; 8.179290839744632e-11; 8.179290839744632e-11; 1.3121548808139071e-10; 1.9241179247341838e-10; 2.377251819497684e-10; 2.377251819497684e-10; 2.377251819497684e-10; 2.377251819497684e-10; 2.377251819497684e-10; 2.377251819497684e-10; 2.813069300429449e-10; 3.762648680673853e-10; 4.2478505092738466e-10; 5.452288254986118e-10; 5.452288254986118e-10; 6.429879513246633e-10; 6.870627395110916e-10; 7.861255581007157e-10; 7.868397426275417e-10; 1.1722433847661196e-09; 1.4790998733426532e-09; 1.5734876414130875e-09; 1.6767489697325582e-09; 1.794870341379274e-09; 1.971893171900314e-09; 1.971893171900314e-09; 2.219129913614883e-09; 3.315537369635636e-09; 3.683115069310663e-09; 3.683115069310663e-09; 4.367699208727405e-09; 4.546836602575699e-09; 4.756590990483e-09; 5.670785186683756e-09; 5.670785186683756e-09; 6.0322241000340585e-09; 6.195332209150018e-09; 6.991207850982321e-09; 7.195555613367576e-09; 7.547641288501485e-09; 7.713813941246406e-09; 8.303910954283738e-09; 8.853567275424139e-09; 1.0368326871660785e-08; 1.0368326871660785e-08; 1.3128768066526236e-08; 1.452540845894924e-08; 1.4920329017331753e-08; 1.4920329017331753e-08; 1.5572986293211266e-08; 1.587872453479067e-08; 1.7931366647560766e-08; 1.8815395768840057e-08; 2.0570601164639797e-08; 2.1034803123367165e-08; 2.261634993097532e-08; 2.2764946043880388e-08; 2.3137704832524547e-08; 2.412608431251415e-08; 2.9730190499609582e-08; 3.9573009168853264e-08; 4.0898524252942674e-08; 4.3069383556698336e-08; 4.638299267461546e-08; 4.65353219894153e-08; 5.1290058242058653e-08; 5.3111708677091025e-08; 5.518991037343798e-08; 5.784935444423772e-08; 5.8317433871210796e-08; 5.989093556336469e-08; 6.016513497232253e-08; 6.156981490555128e-08; 6.156981490555128e-08; 6.982287075725826e-08; 8.598175402882612e-08; 9.273260676030806e-08; 9.273260676030806e-08; 9.393284022832733e-08; 1.0390067657961098e-07; 1.0390067657961098e-07; 1.0390067657961098e-07; 1.0390067657961098e-07; 1.0390067657961098e-07; 1.0390067657961098e-07; 1.0390067657961098e-07; 1.0390067657961098e-07; 1.0618136021459505e-07; 1.3150328464481586e-07; 1.427432458937347e-07; 1.427432458937347e-07; 1.479813245926713e-07; 1.4925759778299788e-07; 1.524221047360518e-07; 1.6759866477134858e-07; 1.7232014763277498e-07; 1.825346178149227e-07; 1.946794431045147e-07; 2.0279723135488897e-07; 2.0732395681104218e-07; 2.242497138958313e-07; 2.247163660896597e-07; 2.400988116471548e-07; 2.419125491442217e-07; 2.46778041958494e-07; 2.46778041958494e-07; 2.700227164716584e-07; 2.911052249927245e-07; 2.948344121290337e-07; 3.10587283755252e-07; 3.532371372262103e-07; 3.880986260207744e-07; 4.157277636684319e-07; 4.312772724439924e-07; 4.312772724439924e-07; 4.4307738632612236e-07; 4.5433391667148853e-07; 5.254943571583271e-07; 5.313225371508493e-07; 5.916066415963854e-07; 6.299208964864026e-07; 6.630279934320317e-07; 6.673805318525932e-07; 6.673805318525932e-07; 6.805796735296268e-07; 6.805796735296268e-07; 6.851652105457608e-07; 7.17979149467092e-07; 7.789160940651547e-07; 7.931659047151387e-07; 7.99548070959303e-07; 8.297823048747685e-07; 8.339674388418603e-07; 8.339674388418603e-07; 8.660170029731726e-07; 8.777200373497231e-07; 8.887379906686178e-07; 9.58028929735367e-07; 9.822463166680949e-07; 1.0094398444517938e-06; 1.0094667484349083e-06; 1.083280646968723e-06; 1.10068355868735e-06; 1.1523181751478311e-06; 1.2482007026109775e-06; 1.3079916134634371e-06; 1.4185164995612263e-06; 1.4839502431758565e-06; 1.51758575162775e-06; 1.5208470671427406e-06; 1.5208470671427406e-06; 1.6231490275716298e-06; 1.6397478315149087e-06; 1.9581146391906144e-06; 1.9581146391906144e-06; 1.96107848506464e-06; 2.027389637151193e-06; 2.027389637151193e-06; 2.07112526817849e-06; 2.086123696221558e-06; 2.086123696221558e-06; 2.1020461880694925e-06; 2.205236928124383e-06; 2.263727724144348e-06; 2.3419309731960144e-06; 2.450940162208615e-06; 2.560217628497434e-06; 2.576211756838249e-06; 2.608032323197001e-06; 2.7684459182091574e-06; 2.782805018144785e-06; 3.4620043828295477e-06; 3.485726441474513e-06; 3.878607667297475e-06; 3.990817553511259e-06; 3.990817553511259e-06; 4.179146475474674e-06; 4.83171753412672e-06; 4.839188317483647e-06; 5.021572339409501e-06; 5.381279306135013e-06; 5.457492980911677e-06; 5.457492980911677e-06; 6.140554546483986e-06; 6.140554546483986e-06; 6.169876404399104e-06; 6.3131986281381465e-06; 6.378950690990071e-06; 6.889889014378816e-06; 7.095035199288336e-06; 7.343355877356991e-06; 7.691726899679507e-06; 8.32456450186878e-06; 8.567994785462795e-06; 8.591027139424906e-06; 8.77532817235926e-06; 9.263589414966798e-06; 9.263589414966798e-06; 1.0172703923266036e-05; 1.033366177374635e-05; 1.0755368362337037e-05; 1.08089380369295e-05; 1.0961931275541026e-05; 1.1652528807336014e-05; 1.2375081616087569e-05; 1.2765469826010355e-05; 1.2765469826010355e-05; 1.3010173302726732e-05; 1.3268923055385737e-05; 1.3268923055385737e-05; 1.3268923055385737e-05; 1.3268923055385737e-05; 1.3410647656206684e-05; 1.3410647656206684e-05; 1.3673911177979942e-05; 1.3755659311680946e-05; 1.4805035395703202e-05; 1.5064798896399038e-05; 1.513340899972731e-05; 1.527992765491583e-05; 1.5449280661407645e-05; 1.5498516107485843e-05; 1.595911218164779e-05; 1.6659968656867144e-05; 1.6659968656867144e-05; 1.7090079578013972e-05; 1.8507296589967813e-05; 1.8507296589967813e-05; 1.9896942827707536e-05; 2.0234336876324372e-05; 2.0820699372778346e-05; 2.0820699372778346e-05; 2.1083292452040976e-05; 2.1109857936882128e-05; 2.223158928845764e-05; 2.389985034001877e-05; 2.428963273942594e-05; 2.483118059238325e-05; 2.7001454785434173e-05; 2.910435331986992e-05; 3.053335644618538e-05; 3.053335644618538e-05; 3.1066725823367694e-05; 3.14076229962439e-05; 3.1491435270594376e-05; 3.192298841377222e-05; 3.372277447426952e-05; 3.489427253341073e-05; 3.602405958537832e-05; 3.602405958537832e-05; 3.9650653676454574e-05; 3.9650653676454574e-05; 4.114864035295583e-05; 4.1934338365676246e-05; 4.351780357113137e-05; 4.545624383387551e-05; 4.550622830486202e-05; 5.013426562854155e-05; 5.248375780672949e-05; 5.2700686057264086e-05; 5.496580971003797e-05; 5.592330076699809e-05; 5.826428641192471e-05; 5.9174130460768686e-05; 5.945938584340405e-05; 6.709590381814368e-05; 6.882388524696196e-05; 6.964870190365813e-05; 7.036498484894257e-05; 7.519084418988331e-05; 8.133563964016694e-05; 8.232890503539995e-05; 8.232890503539995e-05; 8.25206825409808e-05; 8.730297037328594e-05; 8.937909010875455e-05; 9.023170634543253e-05; 9.476946799623076e-05; 9.476946799623076e-05; 9.56957692518114e-05; 9.780860153755674e-05; 9.913294924271568e-05; 9.913294924271568e-05; 0.0001015974347517202; 0.00010334647523919963; 0.00010334647523919963; 0.00010582598320524978; 0.00010776056908698134; 0.00010776056908698134; 0.00010914466609698448; 0.0001119048288448298; 0.00011927896769899647; 0.00012202062264879416; 0.00012202062264879416; 0.00012202062264879416; 0.00012858049944279123; 0.00012858049944279123; 0.00012949836610375056; 0.0001322335978675375; 0.00013846515856925812; 0.00015093372108149775; 0.00015093372108149775; 0.0001616561904035017; 0.00016189346720036038; 0.00016189346720036038; 0.0001690762138878921; 0.0001705179359230947; 0.00017292560623348305; 0.00017808425336754297; 0.0001802305430549181; 0.0001802305430549181; 0.0001802305430549181; 0.0001802305430549181; 0.000181883468787863; 0.00019131698235390912; 0.0001934869050618567; 0.0002043416381292249; 0.00021049732822064587; 0.0002214859278255797; 0.00022254302103317592; 0.00022254302103317592; 0.00022336414159326664; 0.00022618385822819267; 0.00022897551943886068; 0.00023793254517777995; 0.00024044665139790348; 0.0002484853090912064; 0.0002559467947532168; 0.00026467392475943254; 0.0002718864504795822; 0.00027820432005572264; 0.00028056116385876946; 0.0002812860791024885; 0.0002926994143155384; 0.00029355802758490503; 0.0002983150880926112; 0.0003022150453166086; 0.0003022150453166086; 0.00031217959139151507; 0.00031217959139151507; 0.00032113080554701227; 0.000323910443746482; 0.0003278023880903879; 0.0003495642888428815; 0.0003607853785819225; 0.00038453776693371663; 0.00039959635390179865; 0.000399963770573658; 0.000420950947096172; 0.00042196010900515655; 0.0004224524250828287; 0.0004336479443072768; 0.0004336479443072768; 0.0004336479443072768; 0.0004336479443072768; 0.00044420259326717257; 0.0004601228759628894; 0.00047142552462714113; 0.0004814724943641282; 0.000513309425513094; 0.0005182771791848276; 0.0005255837979904586; 0.0005445028206157281; 0.0005486681594044074; 0.0005873268650449521; 0.0005873268650449521; 0.0005873268650449521; 0.0007283216745489607; 0.0007283216745489607; 0.0008252744167874381; 0.0008452277316123234; 0.0008673605584216904; 0.0008932565002868814; 0.0009325953874753212; 0.0010244557923259; 0.0010244557923259; 0.0010897868460616; 0.0011261416978188; 0.0011303542860313; 0.0011876897533161; 0.00120990141675; 0.0012591553085125; 0.0013309210571735; 0.0013309210571735; 0.0013510612738592; 0.0014485445504404; 0.0015133919764529; 0.0015652768725765; 0.0015725978289892; 0.0016559602535146; 0.0017731038420892; 0.0017731038420892; 0.0017731038420892; 0.001881335207053; 0.001881335207053; 0.001881335207053; 0.001881335207053; 0.0019553944568237; 0.0020049274325175; 0.0020089634269714; 0.0020282798161214; 0.0021326108499664; 0.002135695462532; 0.0021970545999258; 0.0022378309697704; 0.0022674286916718; 0.0025876779926919; 0.0026189803532255; 0.0027534163536682; 0.0027942850562877; 0.0028187518310092; 0.0028187518310092; 0.0028759971272412; 0.0029063499863533; 0.0032682022992594; 0.0033783379034436; 0.0037244768508078; 0.0037244768508078; 0.0037263522689301; 0.0037263522689301; 0.003846910040485; 0.003846910040485; 0.0038705790239355; 0.0039908077871836; 0.0040785542386402; 0.0041157458728674; 0.0043105477873176; 0.0043121462081946; 0.0043427572763018; 0.0044046842540656; 0.0044831346315456; 0.0047339976311261; 0.0047351775110072; 0.0048028611524245; 0.0048044887750201; 0.0048496385019795; 0.0050738495859132; 0.0050844857197244; 0.0050894481995015; 0.0050894481995015; 0.0053122016520353; 0.0053570195415722; 0.0059257679306595; 0.0059257679306595; 0.0059257679306595; 0.0059257679306595; 0.0060818298848679; 0.006352455154555; 0.0063571439329446; 0.0063571439329446; 0.0066006052483961; 0.0066401895279317; 0.0067588219988478; 0.0068235619036629; 0.007117388576245; 0.007117388576245; 0.007117388576245; 0.007117388576245; 0.007117388576245; 0.0072083035574659; 0.0075325383349707; 0.0083709650732796; 0.0084568432337518; 0.0091914307650131; 0.0093325514582534; 0.0096630827054915; 0.0096630827054915; 0.0096630827054915; 0.0096630827054915; 0.0097159454554601; 0.0105367304020196; 0.010624513163997; 0.0109519728029571; 0.0109519728029571; 0.0111888062322808; 0.0114187031414039; 0.0114187031414039; 0.0118123250371176; 0.0118679153788039; 0.0120771273149872; 0.0123563544259949; 0.0123983633418964; 0.0123983633418964; 0.0125952576116424; 0.0127059723723765; 0.0131305979622119; 0.0131305979622119; 0.0131305979622119; 0.0138441633831498; 0.0138441633831498; 0.0138829566912713; 0.0145436543557976; 0.015507621739214; 0.0157194401523571; 0.0161428886050652; 0.0162139207824563; 0.0171001534176385; 0.0171001534176385; 0.018665947632861; 0.018665947632861; 0.0203198961621158; 0.0208452312614567; 0.021125667706065; 0.0220705590988414; 0.0220705590988414; 0.0259817880808067; 0.0259817880808067; 0.0279220892715439; 0.0279220892715439; 0.0280663273380655; 0.0295521651553568; 0.0299774405999183; 0.030006907592274; 0.0303319552791211; 0.0303319552791211; 0.0303319552791211; 0.0303319552791211; 0.0303319552791211; 0.0319682790952413; 0.0319682790952413; 0.0335408281184641; 0.033749008368017; 0.0340266852061135; 0.0340266852061135; 0.0340645241548108; 0.0378565625608719; 0.0380438970214283; 0.0384689641633299; 0.0402448379890702; 0.0402448379890702; 0.0404707605808569; 0.0404707605808569; 0.0404707605808569; 0.0404707605808569; 0.0411765978055933; 0.0427786786335321; 0.044901297966643; 0.044901297966643; 0.0462818499370266; 0.0465235764214223; 0.0469394416375774; 0.0471006425252053; 0.048123203710384; 0.0493155676939993; 0.0569213530455915; 0.0569213530455915; 0.0569213530455915; 0.057047868743524; 0.0583555368572174; 0.0623026316541814; 0.0623026316541814; 0.0630979595913369; 0.0630979595913369; 0.0647102740274508; 0.0678022600525665; 0.0692193903915762; 0.0692193903915762; 0.0700485361084771; 0.0723815120866587; 0.0729686376372628; 0.0749666609274744; 0.0749666609274744; 0.0749666609274744; 0.0777073264956258; 0.0777073264956258; 0.0784196844880443; 0.0791235961972295; 0.0805158056052076; 0.0817897187940979; 0.0817897187940979; 0.0817897187940979; 0.083107903315643; 0.0835641020831185; 0.0858871491124922; 0.0858871491124922; 0.0864853123692039; 0.0897127848630768; 0.0897127848630768; 0.0908772402064694; 0.0940427381982829; 0.0940427381982829; 0.0967179741949912; 0.0972679220674381; 0.0972679220674381; 0.0972679220674381; 0.0972679220674381; 0.0972679220674381; 0.098408395338696; 0.0987575443309834; 0.1016471070089966; 0.1128564106125758; 0.1130019719865939; 0.1130019719865939; 0.1130019719865939; 0.1130019719865939; 0.1130019719865939; 0.1130019719865939; 0.1173860265721715; 0.1204795752338222; 0.1206032442301429; 0.124149904653194; 0.124149904653194; 0.1270483391700474; 0.1272255752567765; 0.1272255752567765; 0.1272255752567765; 0.1343310874911156; 0.1343310874911156; 0.1343310874911156; 0.1401454825042905; 0.1435325826114705; 0.1456466465256486; 0.1460848784791741; 0.1460848784791741; 0.1460848784791741; 0.1520581530903516; 0.1520581530903516; 0.1525119847960956; 0.1525119847960956; 0.1525119847960956; 0.1525119847960956; 0.1584804022044084; 0.1584804022044084; 0.1621030999931119; 0.1658352215789179; 0.1703929618871976; 0.1728485512140097; 0.176056923749369; 0.176056923749369; 0.176056923749369; 0.176056923749369; 0.181710614199711; 0.1932166112700285; 0.1982833830495248; 0.2048516463561299; 0.2166737845423457; 0.2272199982000937; 0.2272199982000937; 0.2272199982000937; 0.2316568843888361; 0.236709594559292; 0.236709594559292; 0.236709594559292; 0.2459753912783288; 0.2570364810168682; 0.2670582190879765; 0.2921843338021302; 0.2921843338021302; 0.3023749229986328; 0.3066971380488823; 0.3258470663820326; 0.3726356761234091; 0.3837849438448272; 0.4129951424538438; 0.4324477881244095; 0.4424335623428572; 0.4712571109376817; 0.4781931916730066; 0.4979943388112239; 0.4979943388112239; 0.5112292444765246; 0.5609919179146893; 0.5793939269095637,Myocardial Ischemia; Cerebral Ischemia; Bright Disease; Cerebral Infraction; Cerebral Thrombosis; Alveolitis; Pulmonary Fibrosis; Glomerulonephritis; Thyroid Gland Follicular Adenoma; Atherosclerosis; Thyroid Neoplasm; Heart Failure; Myocardial Infarction; Thyroid Carcinoma; Bronchial Hyperreactivity; Fatty Liver; Congestive Heart Failure; Spinal Cord Compression; Hypertension; Autoimmune Hepatitis; Mouth Neoplasms; Multiple Myeloma; Carcinoma; Hyperoxaluria; Carotid Artery Disease; Carotid Atherosclerosis; Mental Depression; Nonconvulsive Status Epilepticus; Petit Mal Status; Grand Mal Status Epilepticus; Meningomyelocele; Asthma; Cardiac Valvular Disease; Compensatory Hyperinsulinemia; Endogenous Hyperinsulinism; Exogenous Hyperinsulinism; Crohn Disease; Acrania; Spinal Cord Myelodysplasia; Neurenteric Cyst; Diastematomyelia; Craniorachischisis; Hyperinsulinism; Endometrial Neoplasms; Neural Tube Defect; Primary Tethered Cord Syndrome; Nephritis; Kidney Failure; Tumoral Calcinosis; Becker Muscular Dystrophy; Duchenne And Becker Muscular Dystrophy; Crohn`s Disease Of Large Bowel; Crohn`s Disease Of The Ileum; Ileocolitis; Liver Cirrhosis; Respiratory Distress Syndrome; Anencephaly; Pleural Diseases; Schizophrenia; Status Dysraphicus; Rachischisis; Sacral Agenesis; Spina Bifida Occulta; Thyroid Diseases; Duchenne Muscular Dystrophy; Diabetic Nephropathy; Status Epilepticus; Liver Fibrosis; Posterolateral Diaphragmatic Hernia; Morgagni Diaphragmatic Hernia; Lipoma; Obesity; Endometrial Carcinoma; Glomerulosclerosis; Multiple Lipomata; Cardiovascular Diseases; Hyperglycemia; Spina Bifida; Manic Disorder; Metabolic Syndrome; Coronary Arteriosclerosis; Congenital Diaphragmatic Hernia; Hydrocephalus; Coronary Artery Disease,7.071068485513988e-10; 5.562961744202623e-09; 1.1417484002988661e-07; 2.009208013074685e-07; 2.739939098363423e-07; 3.1346476759108064e-07; 3.656047745092532e-06; 1.0086418491083646e-05; 3.882845009510541e-05; 5.254109803591956e-05; 7.782144775199944e-05; 0.00015071968444989745; 0.0005760978170082974; 0.0005818213110442873; 0.0010004280397286; 0.0025464930497429; 0.0028558709076653; 0.0034396632260297; 0.0048927857621509; 0.0051651768824686; 0.0069464092886356; 0.0072990932027619; 0.0107108189044139; 0.0168500742439455; 0.021392225047824; 0.0268526262997348; 0.0511376198481248; 0.0588219013114419; 0.0588219013114419; 0.0588219013114419; 0.0592733852980501; 0.064825092293108; 0.064825092293108; 0.064825092293108; 0.064825092293108; 0.064825092293108; 0.0682669288241704; 0.0682669288241704; 0.0682669288241704; 0.0682669288241704; 0.0682669288241704; 0.0724494984851027; 0.0810252439964338; 0.0910638962801208; 0.0910638962801208; 0.1054719783837416; 0.1110148026021272; 0.1110148026021272; 0.1110148026021272; 0.1110148026021272; 0.1110148026021272; 0.1173693299378481; 0.1173693299378481; 0.1202723965415913; 0.1273861908316246; 0.1507480783308755; 0.1546811849663119; 0.160518792997541; 0.175139305620004; 0.175139305620004; 0.175139305620004; 0.175139305620004; 0.1787826075739565; 0.1851562166631526; 0.1851562166631526; 0.191014576985413; 0.2062454941617454; 0.2072542702968064; 0.2089805590322066; 0.2089805590322066; 0.2502315247388869; 0.2736284003666279; 0.2856663281934009; 0.2980267897624452; 0.3122348651468142; 0.3636022406609426; 0.434268771817188; 0.4379696811796732; 0.504775797017495; 0.504775797017495; 0.5322591139664634; 0.5703214006370846; 0.6903302995333075; 0.699284778315046,Systemic-onset juvenile idiopathic arthritis ORPHA:85414; Lattice corneal dystrophy type I ORPHA:98964; Reis-Bucklers corneal dystrophy ORPHA:98961; Epithelial basement membrane dystrophy ORPHA:98956; Thiel-Behnke corneal dystrophy ORPHA:98960; Granular corneal dystrophy type I ORPHA:98962; Granular corneal dystrophy type II ORPHA:98963; Familial cavitary optic disc anomaly ORPHA:464760; Adenocarcinoma of ovary ORPHA:213504; Keratolytic winter erythema ORPHA:50943; Roussy-Levy syndrome ORPHA:3115; Dejerine-Sottas syndrome ORPHA:64748; Amyloidosis cutis dyschromia ORPHA:319635; Juvenile glaucoma ORPHA:98977; Adams-Oliver syndrome ORPHA:974; Pycnodysostosis ORPHA:763; Familial episodic pain syndrome with predominantly upper body involvement ORPHA:391389; Familial retinal arterial macroaneurysm ORPHA:284247; Transcobalamin deficiency ORPHA:859; Hereditary hemorrhagic telangiectasia ORPHA:774,1.514756890441811e-09; 0.0002132495254484572; 0.0002132495254484572; 0.0002132495254484572; 0.0002132495254484572; 0.0002132495254484572; 0.0002132495254484572; 0.0019696624570933; 0.0133474287859103; 0.1927589191138116; 0.1927589191138116; 0.1950017883804084; 0.4838060079820406; 0.4838060079820406; 0.491912282528682; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659,"Cercopithecine betaherpesvirus 5 chemokine vCXCL5 (gene: UL146B); Vaccinia virus chemokine binding protein (gene: C23L); Vaccinia virus Ankara viral chemokine binding protein; Cercopithecine betaherpesvirus 5 chemokine vCXCL10 (gene: UL146G); Cowpox virus CrmD or CPXV221 protein (gene: CrmD); Variola virus chemokine binding protein (gene: G5R); Variola virus hypothetical protein (gene: G4R); Ectromelia virus ERPV tumor necrosis factor receptor; Horsepox virus HSPV003 (Tumor necrosis factor receptor superfamily members); Human gammaherpesvirus 8 K6 (gene: K6); Cercopithecine betaherpesvirus 5 chemokine vCXCL9 (gene: UL146F); Monkeypox virus Zaire-96-I-16 J2L (gene: J2L); Cowpox virus CrmB or CPXV005 protein (gene: crmB); Human betaherpesvirus 5 chemokine vCXCL1 (gene: UL146); Cercopithecine betaherpesvirus 5 chemokine vCXCL2 (gene: UL147); Monkeypox virus TNF-alpha-receptor-like protein; Human betaherpesvirus 5 chemokine vCXCL2 (gene: UL147); Monkeypox virus chemokine-binding protein; Monkeypox virus Zaire-96-I-16 chemokine binding protein (gene: J1L); Human gammaherpesvirus 8 K4.1 (gene: K4.1); Molluscum contagiosum virus subtype 1 MC148R (gene: MC148R); Horsepox virus HSPV002 (chemokine binding protein; Provisional); Cowpox virus CPXV014 protein (gene: CPXV014 CDS); Vaccinia virus Ankara Haemagglutinin; Vaccinia virus hemagglutinin (gene: A56R); Horsepox virus HSPV177 (Immunoglobulin like); Ectromelia virus ERPV chemokine binding protein; Monkeypox virus Zaire-96-I-16 B2R (gene: B2R); Human adenovirus 18 CR1-beta protein (gene: E3); Ectromelia virus ERPV hemagglutinin; Human mastadenovirus F membrane glycoprotein E3 CR1-beta (gene: E3A); Human betaherpesvirus 6B glycoprotein (gene: U85); Human betaherpesvirus 6 U85, OX-2 homologue (gene: U85); Human betaherpesvirus 6A membrane glycoprotein UL119 (gene: U85)",3.855107856457681e-08; 5.6633714501424107e-08; 5.6633714501424107e-08; 2.3160451568389139e-07; 2.3160451568389139e-07; 3.201246660025618e-07; 5.350651473977266e-07; 5.350651473977266e-07; 5.350651473977266e-07; 9.087104857163152e-07; 9.087104857163152e-07; 9.087104857163152e-07; 1.12171834090951e-06; 1.12171834090951e-06; 1.12171834090951e-06; 1.12171834090951e-06; 1.3435225153003765e-06; 1.414266919056462e-06; 1.5653663269440003e-06; 1.7536244306421314e-06; 2.1974600826970047e-06; 2.6957073977079108e-05; 4.27038107129517e-05; 0.0096374079669374; 0.0223182816928385; 0.0401211861299026; 0.0401211861299026; 0.0816962571184375; 0.2880902732733083; 0.3911903778732946; 0.3911903778732946; 0.5402074049939289; 0.6257301036191548; 0.6257301036191548,In vitro;yeasx,0.44;0.56;0.68,Homo sapiens;Orf virus;chemical synthesis;mhv68,Homo sapiens;chemical synthesis
CCL20,"Inflammation; Pneumonia; Asthma; Psoriasis; Juvenile arthritis; Multiple Myeloma; Dermatitis, Atopic; Lobar Pneumonia; Chronic Obstructive Airway Disease; Rheumatoid Arthritis; Arteriosclerosis; Pneumonitis; Crohn Disease; cervical cancer; Arsenic Poisoning, Inorganic; Nervous System, Organic Arsenic Poisoning; Arsenic Encephalopathy; Arsenic Induced Polyneuropathy; Arsenic Poisoning; Ulcerative Colitis; Infection; Colitis; Pancreatitis, Chronic; Malignant tumor of cervix; Multiple Sclerosis; Neoplasm Metastasis; Experimental Lung Inflammation; Mammary Neoplasms, Human; Hodgkin Disease; Atherosclerosis; Eczema; Cervix carcinoma; Infection caused by Helicobacter pylori; Brain Ischemia; Degenerative polyarthritis; Allergic Reaction; Inflammatory Bowel Diseases; Obesity; Psoriasiform eczema; Kaposi Sarcoma; Periodontitis; Liver neoplasms; HIV Infections; Mammary Neoplasms; Diabetes Mellitus; Juvenile rheumatoid arthritis; Diabetes; Pancreatic carcinoma; Dermatologic disorders; Glioma; Malignant neoplasm of pancreas; Inflammatory disorder; Adult T-Cell Lymphoma/Leukemia; Malignant neoplasm of lung; Tuberculosis; Diabetes Mellitus, Insulin-Dependent; Liver diseases; Measles; Tumor Progression; Malignant neoplasm of breast; Premature Obstetric Labor; Gastritis; Diabetic Nephropathy; Hypersensitivity; Liver carcinoma; Colonic Neoplasms; Carcinogenesis; Transient Ischemic Attack; Carcinoma of lung; Stomach Carcinoma; Malignant neoplasm of stomach; Bone Diseases; Lymphoma, T-Cell, Cutaneous; Primary malignant neoplasm of lung; Breast Carcinoma; Mycoses; Thyroid carcinoma; Diabetes Mellitus, Experimental; Streptozotocin Diabetes; Alloxan Diabetes; Prostate carcinoma; Malignant tumor of colon; Malignant neoplasm of prostate; Endometrial adenocarcinoma; Carcinoma, Lewis Lung; Familial lichen amyloidosis; Osteoporosis; Helicobacter-associated gastritis; Other specified transient cerebral ischemias; Carcinoma, Transitional Cell; Colorectal Carcinoma; Central neuroblastoma; Epithelial hyperplasia of skin; Colorectal Cancer; Hepatitis; Urothelial Carcinoma; Neuroblastoma; Primary malignant neoplasm; Primary biliary cirrhosis; Joint swelling; Squamous intraepithelial lesion; Malignant Neoplasms; Diabetes, Autoimmune; Irritable Bowel Syndrome; Malignant neoplasm of thyroid; Secondary malignant neoplasm of liver; Mycosis Fungoides; Papillary thyroid carcinoma; Recurrent respiratory papillomatosis; Monoclonal Gammopathy of Undetermined Significance; Helicobacter Infections; Papilloma; Adenocarcinoma of large intestine; Brittle diabetes; Diabetes Mellitus, Ketosis-Prone; Rectal Carcinoma",2.8114433253573326e-17; 7.980856456624717e-16; 1.803641225501291e-12; 3.118210553589307e-12; 3.861499575207375e-12; 2.5279022064249716e-11; 7.448716379948652e-11; 8.179290839744632e-11; 1.3121548808139071e-10; 1.9241179247341838e-10; 2.377251819497684e-10; 2.813069300429449e-10; 4.2478505092738466e-10; 1.1722433847661196e-09; 1.1722433847661196e-09; 1.1722433847661196e-09; 1.1722433847661196e-09; 1.1722433847661196e-09; 1.1722433847661196e-09; 1.6767489697325582e-09; 1.794870341379274e-09; 1.971893171900314e-09; 2.219129913614883e-09; 3.683115069310663e-09; 4.546836602575699e-09; 5.670785186683756e-09; 5.670785186683756e-09; 5.791865115913735e-09; 6.195332209150018e-09; 7.195555613367576e-09; 1.4920329017331753e-08; 1.5572986293211266e-08; 1.7931366647560766e-08; 1.8815395768840057e-08; 2.1034803123367165e-08; 2.2764946043880388e-08; 2.3137704832524547e-08; 2.412608431251415e-08; 2.7368000175117756e-08; 3.149054123564124e-08; 3.9573009168853264e-08; 4.3069383556698336e-08; 4.638299267461546e-08; 4.65353219894153e-08; 5.8317433871210796e-08; 5.989093556336469e-08; 6.156981490555128e-08; 6.982287075725826e-08; 9.273260676030806e-08; 1.427432458937347e-07; 1.4925759778299788e-07; 2.242497138958313e-07; 2.46778041958494e-07; 6.299208964864026e-07; 6.673805318525932e-07; 6.851652105457608e-07; 7.17979149467092e-07; 7.99548070959303e-07; 8.297823048747685e-07; 8.660170029731726e-07; 8.777200373497231e-07; 9.58028929735367e-07; 1.083280646968723e-06; 1.1523181751478311e-06; 1.3079916134634371e-06; 1.4185164995612263e-06; 1.51758575162775e-06; 1.5208470671427406e-06; 2.027389637151193e-06; 2.07112526817849e-06; 2.450940162208615e-06; 3.282956820548434e-06; 3.7283259874612974e-06; 4.839188317483647e-06; 5.381279306135013e-06; 5.572620871465934e-06; 6.889889014378816e-06; 1.3410647656206684e-05; 1.3410647656206684e-05; 1.3410647656206684e-05; 1.527992765491583e-05; 1.5498516107485843e-05; 3.053335644618538e-05; 3.1066725823367694e-05; 8.178614148996482e-05; 8.937909010875455e-05; 9.117996105379778e-05; 9.476946799623076e-05; 9.56957692518114e-05; 0.0001474322229096163; 0.00016189346720036038; 0.00032113080554701227; 0.0003763308936382836; 0.00038453776693371663; 0.00040624424086014313; 0.0004243878730487336; 0.0004601228759628894; 0.00046565119871267287; 0.0005214896245221155; 0.0005445028206157281; 0.0005873268650449521; 0.0006352060750206054; 0.0006445212280958682; 0.0008252744167874381; 0.0009826472144539087; 0.0010244557923259; 0.0020056438913528; 0.0025122887786423; 0.0096630827054915; 0.0118303833860754; 0.0138441633831498; 0.0335408281184641; 0.0404707605808569; 0.0777073264956258; 0.0817897187940979; 0.0837469930808364,Arsenic Encephalopathy; Dermatologic Disorders; Marfan Syndrome; Mammary Neoplasms; Breast Carcinoma; Ulcerative Colitis; Breast Cancer; Pancreatic Cancer; Pancreatic Neoplasm; Inflammatory Bowel Disease; Asthma; Brittle Diabetes Mellitus; Colonic Neoplasms; Autoimmune Diabetes; Diabetes Mellitus,3.723977603538778e-09; 1.7417795410918816e-08; 8.921950872070284e-08; 1.1417484002988661e-07; 4.971054570440277e-05; 0.0002754573766813309; 0.00063387456654884; 0.00207663921483; 0.0054741435035425; 0.021392225047824; 0.064825092293108; 0.1173693299378481; 0.1203844668559877; 0.1203844668559877; 0.1718736907108893,Systemic-onset juvenile idiopathic arthritis ORPHA:85414,1.514756890441811e-09,,,,,,
CCL22,"Pneumonia; Asthma; Psoriasis; Dermatitis, Atopic; Chronic Obstructive Airway Disease; Rheumatoid Arthritis; Pneumonitis; Ovarian Carcinoma; Sarcoidosis; Malignant neoplasm of ovary; Lung Neoplasms; Multiple Sclerosis; Neoplasm Metastasis; Hodgkin Disease; Hepatitis C; Pulmonary Fibrosis; Leukemia, Myelocytic, Acute; Anti-Basement Membrane Glomerulonephritis; Glomerulonephritis; Hypertensive disease; Respiratory syncytial virus (RSV) infection in conditions classified elsewhere and of unspecified site; Eczema; Infection caused by Helicobacter pylori; Degenerative polyarthritis; Obesity; HIV Infections; Mammary Neoplasms; Arthritis, Psoriatic; Glioblastoma; Juvenile rheumatoid arthritis; Ischemic stroke; Coronary heart disease; Malaria; Glioma; Epithelial ovarian cancer; Hamman-Rich syndrome; Adult T-Cell Lymphoma/Leukemia; Diffuse Large B-Cell Lymphoma; Cardiovascular Diseases; Malignant neoplasm of lung; Leukemia, T-Cell; Liver diseases; Chronic Lymphocytic Leukemia; Malignant neoplasm of breast; Myasthenia Gravis; Bladder Neoplasm; Carcinoma of lung; Stomach Carcinoma; Immune System Diseases; Stomach Neoplasms; Primary malignant neoplasm of lung; Breast Carcinoma; Secondary malignant neoplasm of bone; Epstein-Barr Virus Infections; Pleural Effusion, Malignant; Idiopathic crescentic glomerulonephritis; Malignant neoplasm of urinary bladder; Carcinoma of bladder; Histiocytosis, Langerhans-Cell; Chronic graft-versus-host disease; Idiopathic Pulmonary Fibrosis; Classical Hodgkin's Lymphoma; Lymphoma, Follicular; Allergic disposition; Secondary malignant neoplasm of lymph node; Skin Neoplasms; Squamous cell carcinoma of the head and neck; Eczema, Infantile; Infectious Mononucleosis; Pseudohyperkalemia Cardiff; Airway Obstruction; Lymphopenia; Lymphoproliferative Disorders; Uveal melanoma; Undifferentiated carcinoma; Arteriosclerotic cardiovascular disease, NOS; Recurrent respiratory papillomatosis; Papilloma; Malignant neoplasm of tongue; Exanthema; Hypertriglyceridemia; Nodular Sclerosis Classical Hodgkin Lymphoma; X-linked agammaglobulinemia; Opsoclonus-Myoclonus Syndrome; Adenocarcinoma, Endometrioid; Cystadenoma, Serous",7.980856456624717e-16; 1.803641225501291e-12; 3.118210553589307e-12; 7.448716379948652e-11; 1.3121548808139071e-10; 1.9241179247341838e-10; 2.813069300429449e-10; 6.870627395110916e-10; 7.861255581007157e-10; 1.971893171900314e-09; 4.367699208727405e-09; 4.546836602575699e-09; 5.670785186683756e-09; 6.195332209150018e-09; 6.991207850982321e-09; 7.547641288501485e-09; 8.303910954283738e-09; 8.853567275424139e-09; 1.0368326871660785e-08; 1.0368326871660785e-08; 1.452540845894924e-08; 1.4920329017331753e-08; 1.7931366647560766e-08; 2.1034803123367165e-08; 2.412608431251415e-08; 4.638299267461546e-08; 4.65353219894153e-08; 5.071217747675114e-08; 5.518991037343798e-08; 5.989093556336469e-08; 6.156981490555128e-08; 9.273260676030806e-08; 1.0618136021459505e-07; 1.427432458937347e-07; 1.479813245926713e-07; 2.0732395681104218e-07; 2.46778041958494e-07; 3.532371372262103e-07; 4.5433391667148853e-07; 6.299208964864026e-07; 6.805796735296268e-07; 7.17979149467092e-07; 7.931659047151387e-07; 8.660170029731726e-07; 8.696626324623331e-07; 9.822463166680949e-07; 2.027389637151193e-06; 2.07112526817849e-06; 2.546221763226728e-06; 3.878607667297475e-06; 4.839188317483647e-06; 5.381279306135013e-06; 6.378950690990071e-06; 8.77532817235926e-06; 1.3268923055385737e-05; 1.6659968656867144e-05; 3.1491435270594376e-05; 3.9650653676454574e-05; 6.882388524696196e-05; 7.358523784131203e-05; 9.780860153755674e-05; 0.0001431024725510208; 0.0002484853090912064; 0.0002718864504795822; 0.000323910443746482; 0.00041476222368508776; 0.000420950947096172; 0.0007074539367893701; 0.0007074539367893701; 0.0014000542917314; 0.0016696601172499; 0.0017290799495295; 0.0030077293488194; 0.0047339976311261; 0.0048028611524245; 0.0083709650732796; 0.0096630827054915; 0.0335408281184641; 0.0447905037504535; 0.0458359347176422; 0.0524543292954025; 0.0817897187940979; 0.0939942521625741; 0.0972679220674381; 0.1204795752338222; 0.1401454825042905,Dermatitis; Endometrioma; Eczema; Endometriosis,0.0002385365299919203; 0.0987697358859238; 0.1110148026021272; 0.1286424863049623,"Charcot-Marie-Tooth disease type 1D ORPHA:101084; Charcot-Marie-Tooth disease type 4E ORPHA:99951; Mendelian susceptibility to mycobacterial diseases due to complete IL12B deficiency ORPHA:319558; GM2 gangliosidosis, AB variant ORPHA:309246; Hyper-IgM syndrome type 2 ORPHA:101089",3.598261936626476e-12; 3.598261936626476e-12; 0.1927589191138116; 0.1927589191138116; 0.5312419675785659,Cercopithecine betaherpesvirus 5 chemokine vCXCL5 (gene: UL146B); Vaccinia virus chemokine binding protein (gene: C23L); Vaccinia virus Ankara viral chemokine binding protein; Cercopithecine betaherpesvirus 5 chemokine vCXCL10 (gene: UL146G); Cowpox virus CrmD or CPXV221 protein (gene: CrmD); Variola virus chemokine binding protein (gene: G5R); Variola virus hypothetical protein (gene: G4R); Ectromelia virus ERPV tumor necrosis factor receptor; Horsepox virus HSPV003 (Tumor necrosis factor receptor superfamily members); Human gammaherpesvirus 8 K6 (gene: K6); Cercopithecine betaherpesvirus 5 chemokine vCXCL9 (gene: UL146F); Monkeypox virus Zaire-96-I-16 J2L (gene: J2L); Cowpox virus CrmB or CPXV005 protein (gene: crmB); Human betaherpesvirus 5 chemokine vCXCL1 (gene: UL146); Cercopithecine betaherpesvirus 5 chemokine vCXCL2 (gene: UL147); Monkeypox virus TNF-alpha-receptor-like protein; Human betaherpesvirus 5 chemokine vCXCL2 (gene: UL147); Monkeypox virus chemokine-binding protein; Monkeypox virus Zaire-96-I-16 chemokine binding protein (gene: J1L); Human gammaherpesvirus 8 K4.1 (gene: K4.1); Molluscum contagiosum virus subtype 1 MC148R (gene: MC148R); Horsepox virus HSPV002 (chemokine binding protein; Provisional); Cowpox virus CPXV014 protein (gene: CPXV014 CDS); Monkeypox virus bifunctional EEV membrane phosphoglycoprotein/associates with A36R; Monkeypox virus Zaire-96-I-16 A35R (gene: A35R); Vaccinia virus Ankara Haemagglutinin; Vaccinia virus hemagglutinin (gene: A56R); Horsepox virus HSPV177 (Immunoglobulin like); Ectromelia virus ERPV chemokine binding protein; Monkeypox virus Zaire-96-I-16 B2R (gene: B2R); Horsepox virus HSPV162; Cowpox virus CPXV206 protein (gene: CPXV206 CDS),3.855107856457681e-08; 5.6633714501424107e-08; 5.6633714501424107e-08; 2.3160451568389139e-07; 2.3160451568389139e-07; 3.201246660025618e-07; 5.350651473977266e-07; 5.350651473977266e-07; 5.350651473977266e-07; 9.087104857163152e-07; 9.087104857163152e-07; 9.087104857163152e-07; 1.12171834090951e-06; 1.12171834090951e-06; 1.12171834090951e-06; 1.12171834090951e-06; 1.3435225153003765e-06; 1.414266919056462e-06; 1.5653663269440003e-06; 1.7536244306421314e-06; 2.1974600826970047e-06; 2.6957073977079108e-05; 4.27038107129517e-05; 0.0004813727670816974; 0.0004813727670816974; 0.0096374079669374; 0.0223182816928385; 0.0401211861299026; 0.0401211861299026; 0.0816962571184375; 0.3911903778732946; 0.6028165858205247,,,,
CCL4,"Inflammation; Pneumonia; Psoriasis; Familial M??ni??re disease; Lymphoma; Multiple Myeloma; Lobar Pneumonia; Rheumatoid Arthritis; Arteriosclerosis; Pneumonitis; Crohn Disease; Ovarian Carcinoma; Arsenic Poisoning, Inorganic; Nervous System, Organic Arsenic Poisoning; Arsenic Encephalopathy; Arsenic Induced Polyneuropathy; Arsenic Poisoning; Cirrhosis; Ulcerative Colitis; Malignant neoplasm of ovary; Lung Neoplasms; Cerebral Ischemia; Experimental Lung Inflammation; Hepatitis C; Atherosclerosis; Pulmonary Fibrosis; Graves Disease; Anti-Basement Membrane Glomerulonephritis; Glomerulonephritis; Liver Cirrhosis; Brain Ischemia; Cerebrovascular accident; Allergic Reaction; Obesity; Liver neoplasms; HIV Infections; Mammary Neoplasms; Bright Disease; Glioblastoma; leukemia; Diabetes Mellitus; Dermatologic disorders; Malaria; Escherichia coli Infections; Acquired Immunodeficiency Syndrome; Malignant neoplasm of mouth; Hamman-Rich syndrome; Hepatitis C, Chronic; Glossitis, Benign Migratory; Myocardial Ischemia; Septicemia; Sepsis; Malignant neoplasm of lung; Tuberculosis; Leukemia, T-Cell; Liver diseases; Hepatitis, Alcoholic; Chronic Lymphocytic Leukemia; Ureteral obstruction; Malignant neoplasm of breast; Hypersensitivity; Liver carcinoma; Carcinogenesis; Influenza; Carcinoma of lung; Lip and Oral Cavity Carcinoma; Tuberculosis, Pulmonary; Erythema Chronicum Migrans; Primary malignant neoplasm of lung; Breast Carcinoma; Mycoses; Delirium; Leprosy; Encephalomyelitis; Hepatitis B; Active tuberculosis; Lymphohistiocytosis, Hemophagocytic; Atherogenesis; Leukemia, Large Granular Lymphocytic; Multinodular goiter; TNF receptor-associated periodic fever syndrome (TRAPS); Constitutional Symptom; Lung Injury; Mucocutaneous Lymph Node Syndrome; Chronic Kidney Diseases; Systemic candidiasis; Adenoma; Status Epilepticus; Diabetes Mellitus, Non-Insulin-Dependent; Fibrosis, Liver; Metabolic Syndrome X; Chronic Lung Injury; Liver Cirrhosis, Alcoholic; Acute colitis; Hepatitis; Epilepsy, Temporal Lobe; Situs Inversus; Pseudohyperkalemia Cardiff; Alcoholic Steatohepatitis; Iron Overload; Huntington Disease; Hemorrhagic Fever, Ebola; Hairy Cell Leukemia; Hepatocarcinogenesis; Progressive Neoplastic Disease; Progressive cGVHD; Liver Failure, Acute; Steatohepatitis; Abscess; Hepatitis A; Hay fever; Cutaneous Mastocytosis; Gonorrhea; Liver Failure; hiv-infection/aids; Tick-Borne Encephalitis; Neoplasm, Residual; Peripheral Neuropathy; Impaired glucose tolerance; Colorectal cancer metastatic; Polyomavirus Infections; AIDS (Disease); Hepatic necrosis; Aortic Aneurysm, Thoracic; Aortic valve disorder; Salivary duct carcinoma",2.8114433253573326e-17; 7.980856456624717e-16; 3.118210553589307e-12; 3.861499575207375e-12; 4.5104266881389206e-12; 2.5279022064249716e-11; 8.179290839744632e-11; 1.9241179247341838e-10; 2.377251819497684e-10; 2.813069300429449e-10; 4.2478505092738466e-10; 6.870627395110916e-10; 1.1722433847661196e-09; 1.1722433847661196e-09; 1.1722433847661196e-09; 1.1722433847661196e-09; 1.1722433847661196e-09; 1.4790998733426532e-09; 1.6767489697325582e-09; 1.971893171900314e-09; 4.367699208727405e-09; 4.756590990483e-09; 5.670785186683756e-09; 6.991207850982321e-09; 7.195555613367576e-09; 7.547641288501485e-09; 8.269524813140207e-09; 8.853567275424139e-09; 1.0368326871660785e-08; 1.3128768066526236e-08; 1.8815395768840057e-08; 2.0570601164639797e-08; 2.2764946043880388e-08; 2.412608431251415e-08; 4.3069383556698336e-08; 4.638299267461546e-08; 4.65353219894153e-08; 5.3111708677091025e-08; 5.518991037343798e-08; 5.784935444423772e-08; 5.8317433871210796e-08; 9.273260676030806e-08; 1.0618136021459505e-07; 1.4925759778299788e-07; 1.825346178149227e-07; 2.0279723135488897e-07; 2.0732395681104218e-07; 2.46778041958494e-07; 2.824526360848301e-07; 2.948344121290337e-07; 5.254943571583271e-07; 5.313225371508493e-07; 6.299208964864026e-07; 6.673805318525932e-07; 6.805796735296268e-07; 7.17979149467092e-07; 7.789160940651547e-07; 7.931659047151387e-07; 7.99548070959303e-07; 8.660170029731726e-07; 1.1523181751478311e-06; 1.3079916134634371e-06; 1.51758575162775e-06; 2.027389637151193e-06; 2.027389637151193e-06; 2.576211756838249e-06; 3.990817553511259e-06; 3.990817553511259e-06; 4.839188317483647e-06; 5.381279306135013e-06; 5.572620871465934e-06; 8.32456450186878e-06; 8.567994785462795e-06; 1.08089380369295e-05; 1.3755659311680946e-05; 1.3755659311680946e-05; 1.513340899972731e-05; 2.223158928845764e-05; 3.803310437251698e-05; 3.878191781014205e-05; 7.519084418988331e-05; 8.100290141298731e-05; 9.476946799623076e-05; 9.913294924271568e-05; 9.913294924271568e-05; 0.00011927896769899647; 0.00012202062264879416; 0.0001616561904035017; 0.00016189346720036038; 0.0001690762138878921; 0.00017808425336754297; 0.0002214859278255797; 0.0002792365191965819; 0.0003539177308293034; 0.00040624424086014313; 0.0012591553085125; 0.0013734265963756; 0.0014000542917314; 0.0015652768725765; 0.0016559602535146; 0.0017731038420892; 0.0033783379034436; 0.0035164243080016; 0.0040444907714877; 0.0040785542386402; 0.0043121462081946; 0.0053122016520353; 0.0067588219988478; 0.0072083035574659; 0.0075697193353146; 0.008634277457381; 0.0120771273149872; 0.0187299613301643; 0.0203198961621158; 0.0303319552791211; 0.0340266852061135; 0.0427786786335321; 0.0465235764214223; 0.0565343207837806; 0.0993028790023582; 0.1206032442301429; 0.1525119847960956; 0.1584804022044084; 0.1947536072778078; 0.2226324872503657; 0.2272199982000937,Myocardial Ischemia; Arsenic Encephalopathy; Cerebral Ischemia; Dermatologic Disorders; Bright Disease; Alveolitis; Pulmonary Fibrosis; Glomerulonephritis; Atherosclerosis,7.071068485513988e-10; 3.723977603538778e-09; 5.562961744202623e-09; 1.7417795410918816e-08; 1.1417484002988661e-07; 3.1346476759108064e-07; 3.656047745092532e-06; 1.0086418491083646e-05; 5.254109803591956e-05,"Charcot-Marie-Tooth disease type 1D ORPHA:101084; Charcot-Marie-Tooth disease type 4E ORPHA:99951; Nasopharyngeal carcinoma ORPHA:150; Hereditary pediatric Behcet-like disease ORPHA:476102; NON RARE IN EUROPE: Psoriatic arthritis ORPHA:40050; Autosomal dominant dopa-responsive dystonia ORPHA:98808; GTP cyclohydrolase I deficiency ORPHA:2102; Hypohidrotic ectodermal dysplasia with immunodeficiency ORPHA:98813; Pediatric systemic lupus erythematosus ORPHA:93552; NON RARE IN EUROPE: Crohn disease ORPHA:206; Birdshot chorioretinopathy ORPHA:179; Revesz syndrome ORPHA:3088; Takayasu arteritis ORPHA:3287; Systemic lupus erythematosus ORPHA:536; NON RARE IN EUROPE: Ankylosing spondylitis ORPHA:825; Pulmonary arterial hypertension associated with connective tissue disease ORPHA:275798; Galactose mutarotase deficiency ORPHA:570422; Hyper-IgM syndrome type 3 ORPHA:101090; Autoimmune lymphoproliferative syndrome ORPHA:3261; Diffuse cutaneous systemic sclerosis ORPHA:220393; Acute encephalopathy with biphasic seizures and late reduced diffusion ORPHA:363549; Mendelian susceptibility to mycobacterial diseases due to complete IFNgammaR1 deficiency ORPHA:99898; Autosomal dominant mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR1 deficiency ORPHA:319581; Autosomal recessive mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR1 deficiency ORPHA:319569; Blau syndrome ORPHA:90340; Charcot-Marie-Tooth disease type 1C ORPHA:101083; Combined immunodeficiency due to OX40 deficiency ORPHA:431149; Sterile multifocal osteomyelitis with periostitis and pustulosis ORPHA:210115; Glycerol kinase deficiency, adult form ORPHA:284414; Glycerol kinase deficiency, juvenile form ORPHA:284411; Immunodeficiency due to CD25 deficiency ORPHA:169100; Giant cell arteritis ORPHA:397; NON RARE IN EUROPE: Ulcerative colitis ORPHA:771; NON RARE IN EUROPE: Multiple sclerosis ORPHA:802; Behcet disease ORPHA:117; Obesity due to pro-opiomelanocortin deficiency ORPHA:71526; Spondyloenchondrodysplasia ORPHA:1855; WHIM syndrome ORPHA:51636; Nasu-Hakola disease ORPHA:2770; Adult-onset myasthenia gravis ORPHA:391490; Immune dysregulation-inflammatory bowel disease-arthritis-recurrent infections syndrome ORPHA:238569; Complete hydatidiform mole ORPHA:254688; Common variable immunodeficiency ORPHA:1572; Limited systemic sclerosis ORPHA:220407; Mendelian susceptibility to mycobacterial diseases due to partial IRF8 deficiency ORPHA:319600; Autosomal recessive primary immunodeficiency with defective spontaneous natural killer cell cytotoxicity ORPHA:437552; NON RARE IN EUROPE: Rheumatoid arthritis ORPHA:284130; Chronic beryllium disease ORPHA:133; Subcutaneous panniculitis-like T-cell lymphoma ORPHA:86884; Graham Little-Piccardi-Lassueur syndrome ORPHA:505; Limbic encephalitis with LGI1 antibodies ORPHA:163908; Bullous pemphigoid ORPHA:703; Pediatric multiple sclerosis ORPHA:477738; Sarcoidosis ORPHA:797; NON RARE IN EUROPE: Celiac disease ORPHA:555; NON RARE IN EUROPE: Diabetes mellitus type 1 ORPHA:243377; Narcolepsy type 2 ORPHA:83465; Follicular lymphoma ORPHA:545; Granulomatosis with polyangiitis ORPHA:900; Narcolepsy type 1 ORPHA:2073",3.598261936626476e-12; 3.598261936626476e-12; 6.10801728836975e-11; 1.7877420438201673e-08; 2.859667220539484e-06; 3.28973817825433e-05; 3.28973817825433e-05; 3.295782224790152e-05; 0.00021965881189185; 0.002691706985611; 0.0133474287859103; 0.0133474287859103; 0.0142744270060997; 0.0368542044009867; 0.0514345493431829; 0.0514345493431829; 0.0514345493431829; 0.0514345493431829; 0.0557820633193028; 0.0557820633193028; 0.1927589191138116; 0.1927589191138116; 0.1927589191138116; 0.1927589191138116; 0.1927589191138116; 0.1927589191138116; 0.1927589191138116; 0.1927589191138116; 0.1927589191138116; 0.1927589191138116; 0.1927589191138116; 0.1950017883804084; 0.1973394623267924; 0.1996794456641899; 0.2365535673573277; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.5109811637213543; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.534880881892026,Cercopithecine betaherpesvirus 5 chemokine vCXCL5 (gene: UL146B); Vaccinia virus chemokine binding protein (gene: C23L); Vaccinia virus Ankara viral chemokine binding protein; Cercopithecine betaherpesvirus 5 chemokine vCXCL10 (gene: UL146G); Cowpox virus CrmD or CPXV221 protein (gene: CrmD); Variola virus chemokine binding protein (gene: G5R); Variola virus hypothetical protein (gene: G4R); Ectromelia virus ERPV tumor necrosis factor receptor; Horsepox virus HSPV003 (Tumor necrosis factor receptor superfamily members); Human gammaherpesvirus 8 K6 (gene: K6); Cercopithecine betaherpesvirus 5 chemokine vCXCL9 (gene: UL146F); Monkeypox virus Zaire-96-I-16 J2L (gene: J2L); Cowpox virus CrmB or CPXV005 protein (gene: crmB); Human betaherpesvirus 5 chemokine vCXCL1 (gene: UL146); Cercopithecine betaherpesvirus 5 chemokine vCXCL2 (gene: UL147); Monkeypox virus TNF-alpha-receptor-like protein; Human betaherpesvirus 5 chemokine vCXCL2 (gene: UL147); Monkeypox virus chemokine-binding protein; Monkeypox virus Zaire-96-I-16 chemokine binding protein (gene: J1L); Human gammaherpesvirus 8 K4.1 (gene: K4.1); Molluscum contagiosum virus subtype 1 MC148R (gene: MC148R); Horsepox virus HSPV002 (chemokine binding protein; Provisional); Cowpox virus CPXV014 protein (gene: CPXV014 CDS); Monkeypox virus bifunctional EEV membrane phosphoglycoprotein/associates with A36R; Monkeypox virus Zaire-96-I-16 A35R (gene: A35R); Vaccinia virus Ankara Haemagglutinin; Vaccinia virus hemagglutinin (gene: A56R); Horsepox virus HSPV177 (Immunoglobulin like); Ectromelia virus ERPV chemokine binding protein; Cowpox virus vCCI or CPXV003 protein (gene: vCCI); Monkeypox virus Zaire-96-I-16 B2R (gene: B2R); Human adenovirus 18 CR1-beta protein (gene: E3); Human mastadenovirus F membrane glycoprotein E3 CR1-beta (gene: E3A); Human adenovirus 41 E3 31.6K; Yaba monkey tumor virus kelch-like protein,3.855107856457681e-08; 5.6633714501424107e-08; 5.6633714501424107e-08; 2.3160451568389139e-07; 2.3160451568389139e-07; 3.201246660025618e-07; 5.350651473977266e-07; 5.350651473977266e-07; 5.350651473977266e-07; 9.087104857163152e-07; 9.087104857163152e-07; 9.087104857163152e-07; 1.12171834090951e-06; 1.12171834090951e-06; 1.12171834090951e-06; 1.12171834090951e-06; 1.3435225153003765e-06; 1.414266919056462e-06; 1.5653663269440003e-06; 1.7536244306421314e-06; 2.1974600826970047e-06; 2.6957073977079108e-05; 4.27038107129517e-05; 0.0004813727670816974; 0.0004813727670816974; 0.0096374079669374; 0.0223182816928385; 0.0401211861299026; 0.0401211861299026; 0.0631001667367807; 0.0816962571184375; 0.2880902732733083; 0.3911903778732946; 0.3911903778732946; 0.7906710356919954,In vitro;yeasx,0.44;0.56;0.62,Homo sapiens;Rabbitpox virus,Homo sapiens
CCL5,"Inflammation; Pneumonia; Asthma; Psoriasis; Familial M??ni??re disease; Juvenile arthritis; Lymphoma; Multiple Myeloma; Virus Diseases; Dermatitis, Atopic; Lung diseases; Lobar Pneumonia; Neutrophilia (disorder); Chronic Obstructive Airway Disease; Synovitis; Rheumatoid Arthritis; Arteriosclerosis; Non-Small Cell Lung Carcinoma; Crohn Disease; Autoimmune Diseases; Peritonitis; Uveitis; Ovarian Carcinoma; Sarcoidosis; Endometriosis; Cirrhosis; Ulcerative Colitis; Infection; Malignant neoplasm of ovary; Tumor Angiogenesis; Lung Neoplasms; Multiple Sclerosis; Neoplasm Metastasis; Hodgkin Disease; Hepatitis C; Atherosclerosis; Pulmonary Fibrosis; Graves Disease; Leukemia, Myelocytic, Acute; Anti-Basement Membrane Glomerulonephritis; Glomerulonephritis; Liver Cirrhosis; Respiratory syncytial virus (RSV) infection in conditions classified elsewhere and of unspecified site; Eczema; Arthritis; Infection caused by Helicobacter pylori; Degenerative polyarthritis; Inflammatory Bowel Diseases; Obesity; Auricular swelling; Kaposi Sarcoma; Periodontitis; Hyperglycemia; Liver neoplasms; HIV Infections; Mammary Neoplasms; Arthritis, Psoriatic; Bright Disease; Glioblastoma; Diabetes Mellitus; Juvenile rheumatoid arthritis; Diabetes; Lupus Erythematosus, Systemic; Pancreatic carcinoma; Coronary Artery Disease; Coronary heart disease; Alzheimer's Disease; Retinoic acid syndrome; Malaria; Glioma; Epithelial ovarian cancer; Malignant neoplasm of pancreas; Pain; Acquired Immunodeficiency Syndrome; Respiratory Syncytial Virus Infections; Malignant neoplasm of mouth; Hamman-Rich syndrome; Myocardial Infarction; Cerebral Infarction; Hepatitis C, Chronic; Adult T-Cell Lymphoma/Leukemia; Bronchiolitis Obliterans; Diffuse Large B-Cell Lymphoma; Brain Neoplasms; Sciatic Neuropathy; Pneumococcal Infections; Cardiovascular Diseases; Cystic Fibrosis; Peptic Esophagitis; Malignant neoplasm of lung; Tuberculosis; Leukemia, T-Cell; Liver diseases; Hepatitis, Alcoholic; Ureteral obstruction; Tumor Progression; Malignant neoplasm of breast; Myasthenia Gravis; Premature Obstetric Labor; Cytomegalovirus Infections; Coronary Arteriosclerosis; Graft-vs-Host Disease; Diabetic Nephropathy; Systemic Scleroderma; Liver carcinoma; Colonic Neoplasms; Immunologic Deficiency Syndromes; Carcinogenesis; Nasopharyngeal carcinoma; Lung Diseases, Interstitial; Diffuse cutaneous leishmaniasis; Influenza; Carcinoma of lung; Stomach Carcinoma; Colon Carcinoma; Idiopathic pulmonary arterial hypertension; Fibrosarcoma; Malignant neoplasm of stomach; Osteosarcoma of bone; Lip and Oral Cavity Carcinoma; Astrocytoma; Bone Diseases; Lupus Nephritis; Stomach Neoplasms; Tuberculosis, Pulmonary; Chronic liver disease; melanoma; Primary malignant neoplasm of lung; Bronchiolitis; Breast Carcinoma; Henoch-Schoenlein Purpura; Alveolitis; Osteosarcoma; Bacterial Infections; Acute anterior uveitis; Malignant mesothelioma; Liver Cirrhosis, Experimental; Epstein-Barr Virus Infections; Sarcoidosis, Pulmonary; Obstructive nephropathy; Acute Promyelocytic Leukemia; Anterior uveitis; Colorectal Neoplasms; Allergic asthma; Bronchial Hyperreactivity; Sezary Syndrome; Senile Plaques; Hepatitis B; Active tuberculosis; Aplastic Anemia; Rabies (disorder); Prostate carcinoma; Adenocarcinoma; Malignant tumor of colon; Anthracosis; Acute Coronary Syndrome; Eosinophilic disorder; Kidney Failure, Chronic; Prostatic Neoplasms; Severe Acute Respiratory Syndrome; Acute GVH disease; Chronic kidney disease stage 5; Coinfection; Squamous cell carcinoma; Malignant neoplasm of prostate; Hepatitis, Autoimmune; Parkinson Disease; Leukemia, Large Granular Lymphocytic; Multinodular goiter; Experimental Organism Basal Cell Carcinoma; Tumor Immunity; Vasculitis; Invasive Streptococcus pneumoniae disease; Lymphoma, Non-Hodgkin; Viral respiratory infection; Thyroid Diseases; Eosinophilia; Hashimoto Disease; IGA Glomerulonephritis; Rhinitis; Painful Bladder Syndrome; Chronic Alcoholic Hepatitis; Benign Prostatic Hyperplasia; Streptococcal pneumonia; Chronic graft-versus-host disease; TNF receptor-associated periodic fever syndrome (TRAPS); Malignant neoplasm of liver; Urinary tract infection; Idiopathic Pulmonary Fibrosis; Chronic Kidney Diseases; Systemic candidiasis; Acute periodontitis; Adenoma; Multiple Sclerosis, Relapsing-Remitting; Pancreatitis; Acute pyelonephritis; Solid Neoplasm; Adenocarcinoma of lung (disorder); Peptic Ulcer; Nasal Polyps; Colorectal Carcinoma; Diabetes Mellitus, Non-Insulin-Dependent; Fibrosis, Liver; Metabolic Syndrome X; Pancreatic Ductal Adenocarcinoma; Pulmonary Emphysema; Asthma attack; Alcoholic Liver Diseases; Demyelinating Diseases; Chronic gastritis; Anemia; Kidney Diseases; Wheezing; Neoplasms; Plaque, Amyloid; Lymphoma, Follicular; Allergic disposition; Chondrosarcoma; airway disease; Colorectal Cancer; Secondary malignant neoplasm of lung; Albuminuria; Pleural Tuberculosis; Primary malignant neoplasm; Pre-Eclampsia; Primary biliary cirrhosis; Joint swelling; Malignant Neoplasms; Infant, Premature; Eczema, Infantile; West Nile viral infection; Q Fever; Giant Cell Arteritis; Secondary malignant neoplasm of liver; Nasal allergies; Dengue Fever; Chronic Q Fever; Interstitial lung fibrosis; Neoplasm Invasiveness; Situs Inversus; Recurrent urinary tract infection; Airway Obstruction; Malaria, Falciparum; Metastatic Neoplasm; Huntington Disease; Allergic Conjunctivitis; Polymyalgia Rheumatica; Periodontitis, Juvenile; Disseminated Malignant Neoplasm; Mycosis Fungoides; Lymphocytic infiltration; Cardiac Arrest; Ischemia of kidney; Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma; Temporomandibular Joint Disorders; Hyperlipoproteinemia Type IIa; Hypercholesterolemia, Familial; Chagas' disease without mention of organ involvement; SVEINSSON CHORIORETINAL ATROPHY; Hemorrhagic Fever, Ebola; Sinusitis; Lichen Planus, Oral; Oxalosis; Retinopathy of Prematurity; Hyperlipidemia; Boutonneuse Fever; Hyperhomocysteinemia; Overweight; Carcinomatosis; Collagen-vascular disease; Squamous cell carcinoma of esophagus; Childhood asthma; Rickettsia Infections; Pyelonephritis; Thrombocytopenia; Melanoma, B16; Cholangitis, Sclerosing; Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse; Oligoarticular Juvenile Idiopathic Arthritis; Childhood Osteosarcoma; Visual seizure; Pheochromocytoma; Neurocognitive Disorders; Aortic Valve Insufficiency; Adenocarcinoma of prostate; Cardiopulmonary Arrest; Lymphoid interstitial pneumonia; cardiac event; Hyperoxaluria; Glioblastoma Multiforme; Stenosis; Low grade glioma; Lymphocytosis; Orchitis; hiv-infection/aids; Tick-Borne Encephalitis; Collagen Diseases; Lymphoid hyperplasia; Delirium, Dementia, Amnestic, Cognitive Disorders; Rhabdomyosarcoma; Biliary Cirrhosis, Secondary; Nonnuclear polymorphic congenital cataract; Malignant neoplasm of stomach stage IV; Proliferative retinopathy; Basal cell carcinoma; Vesico-Ureteral Reflux; Luminal A Breast Carcinoma; colon cancer liver metastasis; Pneumonia in children; Allergic sensitization; Neurofibromatosis 1; Enteritis due to Norovirus; Breast cancer stage II; Acute asthma; Mycetoma; Biliary cirrhosis; ROSE Cluster 5; Optic Nerve Glioma; Childhood Astrocytoma; T-Lymphocytopenia; HER2-positive carcinoma of breast; Mannose-Binding Protein Deficiency; Adenocarcinoma of lung, stage I; Pathological accumulation of air in tissues; Thymus Neoplasms; Yellow Fever",2.8114433253573326e-17; 7.980856456624717e-16; 1.803641225501291e-12; 3.118210553589307e-12; 3.861499575207375e-12; 3.861499575207375e-12; 4.5104266881389206e-12; 2.5279022064249716e-11; 6.332483647919588e-11; 7.448716379948652e-11; 8.179290839744632e-11; 8.179290839744632e-11; 1.1574161017103878e-10; 1.3121548808139071e-10; 1.6797550790254382e-10; 1.9241179247341838e-10; 2.377251819497684e-10; 3.762648680673853e-10; 4.2478505092738466e-10; 5.452288254986118e-10; 5.452288254986118e-10; 6.429879513246633e-10; 6.870627395110916e-10; 7.861255581007157e-10; 7.868397426275417e-10; 1.4790998733426532e-09; 1.6767489697325582e-09; 1.794870341379274e-09; 1.971893171900314e-09; 3.315537369635636e-09; 4.367699208727405e-09; 4.546836602575699e-09; 5.670785186683756e-09; 6.195332209150018e-09; 6.991207850982321e-09; 7.195555613367576e-09; 7.547641288501485e-09; 8.269524813140207e-09; 8.303910954283738e-09; 8.853567275424139e-09; 1.0368326871660785e-08; 1.3128768066526236e-08; 1.452540845894924e-08; 1.4920329017331753e-08; 1.587872453479067e-08; 1.7931366647560766e-08; 2.1034803123367165e-08; 2.3137704832524547e-08; 2.412608431251415e-08; 2.9730190499609582e-08; 3.149054123564124e-08; 3.9573009168853264e-08; 4.0898524252942674e-08; 4.3069383556698336e-08; 4.638299267461546e-08; 4.65353219894153e-08; 5.071217747675114e-08; 5.3111708677091025e-08; 5.518991037343798e-08; 5.8317433871210796e-08; 5.989093556336469e-08; 6.156981490555128e-08; 6.156981490555128e-08; 6.982287075725826e-08; 8.598175402882612e-08; 9.273260676030806e-08; 9.273260676030806e-08; 1.0390067657961098e-07; 1.0618136021459505e-07; 1.427432458937347e-07; 1.479813245926713e-07; 1.4925759778299788e-07; 1.6759866477134858e-07; 1.825346178149227e-07; 1.946794431045147e-07; 2.0279723135488897e-07; 2.0732395681104218e-07; 2.247163660896597e-07; 2.419125491442217e-07; 2.46778041958494e-07; 2.46778041958494e-07; 3.10587283755252e-07; 3.532371372262103e-07; 4.157277636684319e-07; 4.312772724439924e-07; 4.4307738632612236e-07; 4.5433391667148853e-07; 5.577321626966352e-07; 5.916066415963854e-07; 6.299208964864026e-07; 6.673805318525932e-07; 6.805796735296268e-07; 7.17979149467092e-07; 7.789160940651547e-07; 7.99548070959303e-07; 8.297823048747685e-07; 8.660170029731726e-07; 8.696626324623331e-07; 8.777200373497231e-07; 8.887379906686178e-07; 1.0094398444517938e-06; 1.0094667484349083e-06; 1.083280646968723e-06; 1.10068355868735e-06; 1.3079916134634371e-06; 1.4185164995612263e-06; 1.4839502431758565e-06; 1.51758575162775e-06; 1.5208470671427406e-06; 1.6231490275716298e-06; 1.96107848506464e-06; 2.027389637151193e-06; 2.027389637151193e-06; 2.07112526817849e-06; 2.205236928124383e-06; 2.263727724144348e-06; 2.3419309731960144e-06; 2.450940162208615e-06; 2.560217628497434e-06; 2.576211756838249e-06; 2.608032323197001e-06; 3.282956820548434e-06; 3.4620043828295477e-06; 3.878607667297475e-06; 3.990817553511259e-06; 3.990817553511259e-06; 4.179146475474674e-06; 4.839188317483647e-06; 5.021572339409501e-06; 5.381279306135013e-06; 5.457492980911677e-06; 6.140554546483986e-06; 6.3131986281381465e-06; 6.378950690990071e-06; 7.343355877356991e-06; 7.439853898002338e-06; 7.691726899679507e-06; 8.77532817235926e-06; 9.263589414966798e-06; 9.263589414966798e-06; 1.2304362232150695e-05; 1.2765469826010355e-05; 1.3034577772762696e-05; 1.3268923055385737e-05; 1.3268923055385737e-05; 1.3410647656206684e-05; 1.3673911177979942e-05; 1.3755659311680946e-05; 1.3755659311680946e-05; 1.4583987015565183e-05; 1.513340899972731e-05; 1.527992765491583e-05; 1.5449280661407645e-05; 1.5498516107485843e-05; 1.6659968656867144e-05; 1.7090079578013972e-05; 1.8961926417889813e-05; 2.0820699372778346e-05; 2.0820699372778346e-05; 2.1083292452040976e-05; 2.365778380659297e-05; 2.910435331986992e-05; 2.929369913127532e-05; 3.053335644618538e-05; 3.053335644618538e-05; 3.1066725823367694e-05; 3.372277447426952e-05; 3.803310437251698e-05; 3.878191781014205e-05; 3.9650653676454574e-05; 3.971484221432504e-05; 4.351780357113137e-05; 4.351780357113137e-05; 4.360044574654907e-05; 4.545624383387551e-05; 5.248375780672949e-05; 5.248375780672949e-05; 5.248375780672949e-05; 5.2700686057264086e-05; 5.399364944210138e-05; 5.496580971003797e-05; 5.726577479376336e-05; 5.945938584340405e-05; 6.087890235661384e-05; 7.358523784131203e-05; 7.519084418988331e-05; 8.421319594446617e-05; 9.023170634543253e-05; 9.780860153755674e-05; 9.913294924271568e-05; 0.00011927896769899647; 0.00011927896769899647; 0.00012202062264879416; 0.00012202062264879416; 0.00012858049944279123; 0.00012858049944279123; 0.0001322335978675375; 0.00013846515856925812; 0.00014636999075042076; 0.00015093372108149775; 0.00016189346720036038; 0.00016189346720036038; 0.0001690762138878921; 0.00017808425336754297; 0.0001802305430549181; 0.0001802305430549181; 0.0001802305430549181; 0.000181883468787863; 0.000181883468787863; 0.0001932529498581875; 0.00022254302103317592; 0.00022336414159326664; 0.00022618385822819267; 0.00022897551943886068; 0.00023793254517777995; 0.0002484853090912064; 0.0002718864504795822; 0.0002792365191965819; 0.0002926994143155384; 0.00038453776693371663; 0.00042196010900515655; 0.0004336479443072768; 0.0004336479443072768; 0.00046565119871267287; 0.0004934717082734151; 0.0005214896245221155; 0.0005445028206157281; 0.0006352060750206054; 0.0007074539367893701; 0.0007074539367893701; 0.0007326127218377523; 0.0008673605584216904; 0.0008932565002868814; 0.0010244557923259; 0.0010244557923259; 0.0011261416978188; 0.0011876897533161; 0.00120990141675; 0.0013309210571735; 0.0013734265963756; 0.0015133919764529; 0.0016696601172499; 0.0017329922477138; 0.001746579573497; 0.0017731038420892; 0.0017731038420892; 0.0017731038420892; 0.0017856981020231; 0.0018360773814867; 0.0020056438913528; 0.0020056438913528; 0.002135695462532; 0.0026189803532255; 0.0027346449758241; 0.0027942850562877; 0.0028187518310092; 0.0029013169576144; 0.0029063499863533; 0.0030220891031719; 0.0033783379034436; 0.0033783379034436; 0.0037263522689301; 0.003846910040485; 0.0038895739770004; 0.0043427572763018; 0.0048028611524245; 0.0048044887750201; 0.0048496385019795; 0.0050844857197244; 0.0059257679306595; 0.0062748297137782; 0.0065999085088281; 0.007117388576245; 0.0082763563641252; 0.0083709650732796; 0.0083709650732796; 0.0093598514945993; 0.0094642528600355; 0.0097159454554601; 0.0097628826330308; 0.0099798889656483; 0.0104376874453167; 0.0109519728029571; 0.0114187031414039; 0.0118679153788039; 0.0123983633418964; 0.0123983633418964; 0.0138441633831498; 0.015507621739214; 0.0171001534176385; 0.018665947632861; 0.0238425854040518; 0.0265829029717646; 0.030006907592274; 0.0303319552791211; 0.0340266852061135; 0.0404707605808569; 0.0404707605808569; 0.0427786786335321; 0.0462818499370266; 0.0517499693438671; 0.0517499693438671; 0.0677694730935319; 0.0749666609274744; 0.0791235961972295; 0.0805908799965109; 0.0817897187940979; 0.0817897187940979; 0.0817897187940979; 0.0939942521625741; 0.1018377089033323; 0.1050724946352408; 0.1272255752567765; 0.1343310874911156; 0.1343310874911156; 0.1401454825042905; 0.1401454825042905; 0.1525119847960956; 0.1584804022044084; 0.1703929618871976; 0.1703929618871976; 0.1703929618871976; 0.176056923749369; 0.181710614199711; 0.1982833830495248; 0.2108300774722888,Bright Disease; Alveolitis; Pulmonary Fibrosis; Glomerulonephritis; Dermatitis; Malignant Mesothelioma; Autoimmune Hepatitis; Hyperoxaluria; Asthma; Eczema; Biliary Cholangitis; Biliary Cirrhosis,1.1417484002988661e-07; 3.1346476759108064e-07; 3.656047745092532e-06; 1.0086418491083646e-05; 0.0002385365299919203; 0.0015169561374293; 0.0051651768824686; 0.0168500742439455; 0.064825092293108; 0.1110148026021272; 0.1221238952720515; 0.1787826075739565,Nasopharyngeal carcinoma ORPHA:150; NON RARE IN EUROPE: Psoriatic arthritis ORPHA:40050; MALT lymphoma ORPHA:52417; NON RARE IN EUROPE: Crohn disease ORPHA:206; Infantile-onset pulmonary alveolar proteinosis-hypogammaglobulinemia ORPHA:572428; Takayasu arteritis ORPHA:3287; Galactose mutarotase deficiency ORPHA:570422; Variant ABeta2M amyloidosis ORPHA:314652; Griscelli syndrome type 2 ORPHA:79477; Autoimmune lymphoproliferative syndrome ORPHA:3261; Primary biliary cholangitis ORPHA:186; Autoimmune lymphoproliferative syndrome with recurrent viral infections ORPHA:275517; T-B+ severe combined immunodeficiency due to IL-7Ralpha deficiency ORPHA:169154; Hepatic veno-occlusive disease-immunodeficiency syndrome ORPHA:79124; Immunodeficiency due to CD25 deficiency ORPHA:169100; Familial Chilblain lupus ORPHA:481662; NON RARE IN EUROPE: Ulcerative colitis ORPHA:771; Behcet disease ORPHA:117; Neonatal acute respiratory distress due to SP-B deficiency ORPHA:217563; Severe combined immunodeficiency due to LAT deficiency ORPHA:504523; Familial isolated hypoparathyroidism due to impaired PTH secretion ORPHA:189466; Adult-onset myasthenia gravis ORPHA:391490; Immune dysregulation-inflammatory bowel disease-arthritis-recurrent infections syndrome ORPHA:238569; Oligoarticular juvenile idiopathic arthritis ORPHA:85410; Rheumatoid factor-negative polyarticular juvenile idiopathic arthritis ORPHA:85408; Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency ORPHA:319552; Bleeding diathesis due to thromboxane synthesis deficiency ORPHA:220443; Combined immunodeficiency due to CD3gamma deficiency ORPHA:169082; Congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency ORPHA:90795,6.10801728836975e-11; 2.859667220539484e-06; 0.0022487953361182; 0.002691706985611; 0.0133474287859103; 0.0142744270060997; 0.0514345493431829; 0.0514345493431829; 0.0514345493431829; 0.0557820633193028; 0.0597169850674746; 0.1927589191138116; 0.1927589191138116; 0.1927589191138116; 0.1927589191138116; 0.1938708167942525; 0.1973394623267924; 0.2365535673573277; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4927160916210667; 0.4927160916210667; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659,Cercopithecine betaherpesvirus 5 chemokine vCXCL5 (gene: UL146B); Vaccinia virus chemokine binding protein (gene: C23L); Vaccinia virus Ankara viral chemokine binding protein; Cercopithecine betaherpesvirus 5 chemokine vCXCL10 (gene: UL146G); Cowpox virus CrmD or CPXV221 protein (gene: CrmD); Variola virus chemokine binding protein (gene: G5R); Variola virus hypothetical protein (gene: G4R); Ectromelia virus ERPV tumor necrosis factor receptor; Horsepox virus HSPV003 (Tumor necrosis factor receptor superfamily members); Human gammaherpesvirus 8 K6 (gene: K6); Cercopithecine betaherpesvirus 5 chemokine vCXCL9 (gene: UL146F); Monkeypox virus Zaire-96-I-16 J2L (gene: J2L); Cowpox virus CrmB or CPXV005 protein (gene: crmB); Human betaherpesvirus 5 chemokine vCXCL1 (gene: UL146); Cercopithecine betaherpesvirus 5 chemokine vCXCL2 (gene: UL147); Monkeypox virus TNF-alpha-receptor-like protein; Human betaherpesvirus 5 chemokine vCXCL2 (gene: UL147); Monkeypox virus chemokine-binding protein; Monkeypox virus Zaire-96-I-16 chemokine binding protein (gene: J1L); Human gammaherpesvirus 8 K4.1 (gene: K4.1); Molluscum contagiosum virus subtype 1 MC148R (gene: MC148R); Horsepox virus HSPV002 (chemokine binding protein; Provisional); Cowpox virus CPXV014 protein (gene: CPXV014 CDS); Monkeypox virus bifunctional EEV membrane phosphoglycoprotein/associates with A36R; Monkeypox virus Zaire-96-I-16 A35R (gene: A35R); Vaccinia virus Ankara Haemagglutinin; Vaccinia virus hemagglutinin (gene: A56R); Horsepox virus HSPV177 (Immunoglobulin like); Cowpox virus vCCI or CPXV003 protein (gene: vCCI); Monkeypox virus Zaire-96-I-16 B2R (gene: B2R); Variola virus hypothetical protein (gene: J9R); Cowpox virus CPXV169 protein (gene: CPXV169 CDS); Monkeypox virus bifunctional hemagglutinin/type-I membrane glycoprotein; Horsepox virus HSPV009 (Hypothetical protein); Yaba monkey tumor virus IEV and EEV membrane glycoprotein; Vaccinia virus Ankara soluble TNF receptor II precursor f1; Cercopithecine betaherpesvirus 5 chemokine vCXCL7 (gene: UL146D); Orf virus ORF110 EEV glycoprotein,3.855107856457681e-08; 5.6633714501424107e-08; 5.6633714501424107e-08; 2.3160451568389139e-07; 2.3160451568389139e-07; 3.201246660025618e-07; 5.350651473977266e-07; 5.350651473977266e-07; 5.350651473977266e-07; 9.087104857163152e-07; 9.087104857163152e-07; 9.087104857163152e-07; 1.12171834090951e-06; 1.12171834090951e-06; 1.12171834090951e-06; 1.12171834090951e-06; 1.3435225153003765e-06; 1.414266919056462e-06; 1.5653663269440003e-06; 1.7536244306421314e-06; 2.1974600826970047e-06; 2.6957073977079108e-05; 4.27038107129517e-05; 0.0004813727670816974; 0.0004813727670816974; 0.0096374079669374; 0.0223182816928385; 0.0401211861299026; 0.0631001667367807; 0.0816962571184375; 0.2673783194071986; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3943583999375712; 0.4517965684624974,Escherichia coli;In vitro;yeasx,0.37;0.44;0.86,Homo sapiens;Orf virus;Yersinia pestis,Homo sapiens;Yersinia pestis
CD83,"Inflammation; Juvenile arthritis; Multiple Myeloma; Virus Diseases; Chronic Obstructive Airway Disease; Rheumatoid Arthritis; Non-Small Cell Lung Carcinoma; Crohn Disease; Autoimmune Diseases; cervical cancer; Arsenic Poisoning, Inorganic; Nervous System, Organic Arsenic Poisoning; Arsenic Encephalopathy; Arsenic Induced Polyneuropathy; Arsenic Poisoning; Infection; Malignant neoplasm of ovary; Colitis; Malignant tumor of cervix; Lung Neoplasms; Neoplasm Metastasis; Graves Disease; Leukemia, Myelocytic, Acute; Cervix carcinoma; Obesity; HIV Infections; Arthritis, Psoriatic; Lupus Erythematosus, Systemic; Dermatologic disorders; Alzheimer's Disease; Malignant neoplasm of pancreas; Diffuse Large B-Cell Lymphoma; Chronic Lymphocytic Leukemia; Malignant neoplasm of breast; Myasthenia Gravis; Cytomegalovirus Infections; Malignant neoplasm of vulva; Osteosarcoma of bone; melanoma; Dermatomyositis, Childhood Type; Breast Carcinoma; Secondary malignant neoplasm of bone; Liver Cirrhosis, Experimental; Acute lymphocytic leukemia; Prostate carcinoma; Adenocarcinoma; Juvenile psoriatic arthritis; Juvenile-Onset Still Disease; Squamous cell carcinoma; Vasculitis; Thyroid Diseases; Hashimoto Disease; Myositis; Hematologic Neoplasms; Histiocytosis, Langerhans-Cell; Malignant neoplasm of liver; CARCINOMA OF VULVA; Mesothelioma; Dermatomyositis; Infiltrating Cervical Carcinoma; Acne Vulgaris; Central neuroblastoma; Giant Cell Arteritis; Metastatic Neoplasm; Acne; Chronic Infantile Neurological, Cutaneous, and Articular Syndrome; Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse; Rotavirus Infections; Metastasis from malignant tumor of prostate; X-linked agammaglobulinemia",2.8114433253573326e-17; 3.861499575207375e-12; 2.5279022064249716e-11; 6.332483647919588e-11; 1.3121548808139071e-10; 1.9241179247341838e-10; 3.762648680673853e-10; 4.2478505092738466e-10; 5.452288254986118e-10; 1.1722433847661196e-09; 1.1722433847661196e-09; 1.1722433847661196e-09; 1.1722433847661196e-09; 1.1722433847661196e-09; 1.1722433847661196e-09; 1.794870341379274e-09; 1.971893171900314e-09; 1.971893171900314e-09; 3.683115069310663e-09; 4.367699208727405e-09; 5.670785186683756e-09; 8.269524813140207e-09; 8.303910954283738e-09; 1.5572986293211266e-08; 2.412608431251415e-08; 4.638299267461546e-08; 5.071217747675114e-08; 6.156981490555128e-08; 9.273260676030806e-08; 9.273260676030806e-08; 1.4925759778299788e-07; 3.532371372262103e-07; 7.931659047151387e-07; 8.660170029731726e-07; 8.696626324623331e-07; 8.887379906686178e-07; 1.8939430555623748e-06; 2.560217628497434e-06; 4.179146475474674e-06; 4.42396341877472e-06; 5.381279306135013e-06; 6.378950690990071e-06; 7.691726899679507e-06; 1.2375081616087569e-05; 1.527992765491583e-05; 1.5449280661407645e-05; 1.8961926417889813e-05; 2.5791573703443737e-05; 3.053335644618538e-05; 4.351780357113137e-05; 5.248375780672949e-05; 5.248375780672949e-05; 5.9174130460768686e-05; 6.058590126387572e-05; 6.882388524696196e-05; 8.421319594446617e-05; 9.913294924271568e-05; 0.00010582598320524978; 0.00010776056908698134; 0.00011927896769899647; 0.0001934869050618567; 0.00032113080554701227; 0.0008932565002868814; 0.001746579573497; 0.0030220891031719; 0.0033783379034436; 0.0094642528600355; 0.0173964199029194; 0.0503601986761658; 0.0939942521625741,"Arsenic Encephalopathy; Dermatologic Disorders; Juvenile Arthritis; Polyarthritis, Rheumatoid Factor Positive; Rheumatoid Arthritis; Seronegative Polyarthritis; Still Disease; Arthritis",3.723977603538778e-09; 1.7417795410918816e-08; 1.1394948069325325e-05; 1.1394948069325325e-05; 1.241997446075319e-05; 3.928596547519457e-05; 5.1065830658055726e-05; 0.0015169561374293,Charcot-Marie-Tooth disease type 1D ORPHA:101084; Charcot-Marie-Tooth disease type 4E ORPHA:99951; SLC39A8-CDG ORPHA:468699,3.598261936626476e-12; 3.598261936626476e-12; 0.5312419675785659,"Vaccinia virus Ankara Haemagglutinin; Vaccinia virus hemagglutinin (gene: A56R); Horsepox virus HSPV177 (Immunoglobulin like); Monkeypox virus Zaire-96-I-16 B2R (gene: B2R); Variola virus hypothetical protein (gene: J9R); Human adenovirus 18 CR1-beta protein (gene: E3); Cowpox virus CPXV194 protein (gene: CPXV194 CDS); Monkeypox virus bifunctional hemagglutinin/type-I membrane glycoprotein; Human mastadenovirus F membrane glycoprotein E3 CR1-beta (gene: E3A); Human adenovirus 41 E3 31.6K; Human adenovirus 31 cr1 beta protein (gene: E3 cr1 beta); Human gammaherpesvirus 4 BARF1 protein (gene: BARF1); Human adenovirus 61 E3 CR1 beta; Human herpesvirus 4 type 2 BARF1; Macacine alphaherpesvirus 1 envelope glycoprotein C (gene: UL44); Human betaherpesvirus 6B glycoprotein (gene: U85); Human betaherpesvirus 5 membrane glycoprotein UL11 (gene: UL11); Human adenovirus 52 E3 CR1-beta1 (gene: E3); Human betaherpesvirus 5 membrane glycoprotein UL7 (gene: UL7); Human betaherpesvirus 7 membrane glycoprotein UL119 (gene: U85); Human betaherpesvirus 6 U85, OX-2 homologue (gene: U85); Human betaherpesvirus 6A membrane glycoprotein UL119 (gene: U85); Human gammaherpesvirus 8 K14; Molluscum contagiosum virus subtype 1 MC162R (gene: MC162R); Human betaherpesvirus 5 membrane protein UL6 (gene: UL6); Cercopithecine betaherpesvirus 5 membrane protein RL11Q (gene: RL11Q); Human adenovirus D37 48.9 kDa (gene: E3); Papiine alphaherpesvirus 2 envelope glycoprotein C (gene: UL44); Human mastadenovirus A E3 CR1-beta1",0.0096374079669374; 0.0223182816928385; 0.0401211861299026; 0.0816962571184375; 0.2673783194071986; 0.2880902732733083; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.4488595345067562; 0.5402074049939289; 0.5483115333424627; 0.5491415646821286; 0.6008136744439901; 0.6053121062925791; 0.6257301036191548; 0.6257301036191548; 0.6656700551294978; 0.6729924013220109; 0.6845534995524503; 0.7494973497651086; 0.7871983209689735; 0.8971431767308904; 0.92077397197281,Homo sapiens HEK293T embryonic kidney cell;yeasx,0.35;0.37,Homo sapiens;Yersinia pestis,Homo sapiens
CFB,"Pneumonia; Psoriasis; Rheumatoid Arthritis; Brain Injuries, Focal; Injuries, Acute Brain; Brain Injuries; Brain Lacerations; Crohn Disease; Autoimmune Diseases; Peritonitis; Ulcerative Colitis; Pancreatitis, Chronic; Multiple Sclerosis; Inflammatory Bowel Diseases; Obesity; leukemia; Diabetes Mellitus; Diabetes; Lupus Erythematosus, Systemic; Coronary Artery Disease; Alzheimer's Disease; Septicemia; Sepsis; Diabetes Mellitus, Insulin-Dependent; Severe Sepsis; Myasthenia Gravis; Carcinogenesis; Carcinoma of lung; Stomach Carcinoma; Malignant neoplasm of stomach; Immune System Diseases; Kidney Failure, Acute; Meningococcal Infections; Acute anterior uveitis; Hepatitis B, Chronic; Acute lymphocytic leukemia; Anterior uveitis; Retinal Diseases; Diabetic Retinopathy; Coinfection; Parkinson Disease; Age related macular degeneration; Adenocarcinoma of lung (disorder); Pancreatic Ductal Adenocarcinoma; Amyloidosis; Premature Birth; Autoimmune thyroid disease; Preterm Premature Rupture of Fetal Membranes; Glomerulonephritis, Membranoproliferative; Myasthenia Gravis, Ocular; Drusen; Bacterial sepsis; Libman-Sacks Disease; Malignant neoplasm of gastrointestinal tract; C3 Glomerulonephritis; Postpartum Thyroiditis; Myasthenia Gravis, Generalized; Unspecified visual loss; Retinal Degeneration; Atypical Hemolytic Uremic Syndrome; exudative macular degeneration; Pyruvate Carboxylase Deficiency Disease; Geographic Atrophy; Azoospermia",7.980856456624717e-16; 3.118210553589307e-12; 1.9241179247341838e-10; 2.377251819497684e-10; 2.377251819497684e-10; 2.377251819497684e-10; 2.377251819497684e-10; 4.2478505092738466e-10; 5.452288254986118e-10; 5.452288254986118e-10; 1.6767489697325582e-09; 2.219129913614883e-09; 4.546836602575699e-09; 2.3137704832524547e-08; 2.412608431251415e-08; 5.784935444423772e-08; 5.8317433871210796e-08; 6.156981490555128e-08; 6.156981490555128e-08; 8.598175402882612e-08; 9.273260676030806e-08; 5.254943571583271e-07; 5.313225371508493e-07; 6.851652105457608e-07; 7.873224494781308e-07; 8.696626324623331e-07; 1.51758575162775e-06; 2.027389637151193e-06; 2.07112526817849e-06; 2.450940162208615e-06; 2.546221763226728e-06; 3.485726441474513e-06; 5.457492980911677e-06; 7.343355877356991e-06; 1.0172703923266036e-05; 1.2375081616087569e-05; 1.2765469826010355e-05; 1.3010173302726732e-05; 1.3410647656206684e-05; 2.929369913127532e-05; 3.372277447426952e-05; 0.00010334647523919963; 0.00013846515856925812; 0.0001802305430549181; 0.0003495642888428815; 0.0008932565002868814; 0.0014485445504404; 0.0059257679306595; 0.0072083035574659; 0.0096630827054915; 0.0120771273149872; 0.0138441633831498; 0.021125667706065; 0.0255085366814945; 0.0817897187940979; 0.0897127848630768; 0.1050724946352408; 0.1204795752338222; 0.1728485512140097; 0.2777403930303475; 0.2921843338021302; 0.2972644135001306; 0.3634167943130235; 0.3729268757986315,Glomerulonephritis; Rheumatoid Arthritis; Ulcerative Colitis; Hemolytic Uremic Syndrome; Hypertension; Lung Cancer; Nonbacterial Verrucal Endocardiosis; Mental Depression; Multiple Sclerosis; Lupus Erythematosus; Complement Component Deficiency; C3 Glomerulopathy; Age-Related Macular Degeneration; Diabetes Mellitus; Lung Adenocarcinoma; Non-obstructive Azoospermia; Microangiopathic Hemolytic Anemia; Geographic Atrophy; Exudative Macular Degeneration; Autoimmune Thyroiditis; Myasthenia Gravis; Coronary Artery Disease,1.0086418491083646e-05; 1.241997446075319e-05; 0.0002754573766813309; 0.00044653857220180814; 0.0048927857621509; 0.0153260870217676; 0.0446679463927015; 0.0511376198481248; 0.0682669288241704; 0.087745240825312; 0.1110148026021272; 0.1286424863049623; 0.1386032662139448; 0.1718736907108893; 0.1787826075739565; 0.1813044909798312; 0.2715051612173401; 0.3465144196435422; 0.3603176382172478; 0.367616394854405; 0.4956066226082672; 0.699284778315046,"Complement component 3 deficiency ORPHA:280133; AA amyloidosis ORPHA:85445; OBSOLETE: Alpha-1-antichymotrypsin deficiency ORPHA:93594; Juvenile Paget disease ORPHA:2801; Atypical hemolytic uremic syndrome with complement gene abnormality ORPHA:544472; Aceruloplasminemia ORPHA:48818; Multiple paragangliomas associated with polycythemia ORPHA:324299; Benign recurrent intrahepatic cholestasis type 1 ORPHA:99960; Recessive X-linked ichthyosis ORPHA:461; Syndromic recessive X-linked ichthyosis ORPHA:281090; Immunodeficiency with factor I anomaly ORPHA:200418; Familial hypercholanemia ORPHA:238475; Periodontal Ehlers-Danlos syndrome ORPHA:75392; De novo thrombotic microangiopathy after kidney transplantation ORPHA:244275; Hyperandrogenism due to cortisone reductase deficiency ORPHA:168588; Keratoderma hereditarium mutilans ORPHA:494; Knuckle pads-leukonychia-sensorineural deafness-palmoplantar hyperkeratosis syndrome ORPHA:2698; Amyloidosis cutis dyschromia ORPHA:319635; PPARG-related familial partial lipodystrophy ORPHA:79083; Charcot-Marie-Tooth disease type 4D ORPHA:99950; Porokeratotic eccrine ostial and dermal duct nevus ORPHA:166286; Congenital bile acid synthesis defect type 1 ORPHA:79301; Enamel-renal syndrome ORPHA:1031; Familial drusen ORPHA:75376; Palmoplantar keratoderma-deafness syndrome ORPHA:2202; HELLP syndrome ORPHA:244242; Autosomal dominant secondary polycythemia ORPHA:247511; Renal tubular dysgenesis of genetic origin ORPHA:97369; NON RARE IN EUROPE: Age-related macular degeneration ORPHA:279; Immunodeficiency due to a classical component pathway complement deficiency ORPHA:169147; Microcytic anemia with liver iron overload ORPHA:83642; NON RARE IN EUROPE: Trimethylaminuria ORPHA:35056; Severe primary trimethylaminuria ORPHA:468726; Sialuria ORPHA:3166; GNE myopathy ORPHA:602; Glutamate-cysteine ligase deficiency ORPHA:33574; Xanthinuria type I ORPHA:93601; Hyaluronidase deficiency ORPHA:67041; Hypertryptophanemia ORPHA:2224; Immunodeficiency with factor H anomaly ORPHA:200421; 46,XY disorder of sex development due to testicular 17,20-desmolase deficiency ORPHA:443087; Dense deposit disease ORPHA:93571; Keratosis follicularis spinulosa decalvans ORPHA:2340; NON RARE IN EUROPE: Heterozygous familial hypercholesterolemia ORPHA:406",0.0133474287859103; 0.0514345493431829; 0.0514345493431829; 0.0514345493431829; 0.0514345493431829; 0.1927589191138116; 0.1927589191138116; 0.1927589191138116; 0.1927589191138116; 0.1927589191138116; 0.1927589191138116; 0.1938708167942525; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4927160916210667; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5322893295716875,"Echovirus E7 VP2; Coxsackievirus B5 VP2 capsid protein, polyprotein region 3 (gene: 1A); Echovirus E11 1B(VP2); Enterovirus B 1B(VP2); Human rhinovirus B5 1B; Echovirus E19 VP2; Echovirus E15 VP2; Enterovirus H capsid protein VP2; Human enterovirus 79 1B (VP2); Echovirus E29 VP2; Echovirus E20 VP2; Echovirus E16 VP2; Echovirus E26 VP2; Echovirus E33 VP2; Echovirus E4 VP2; Echovirus 9 strain Barty VP2; Echovirus E14 VP2; Echovirus E21 VP2; Echovirus E24 VP2; Echovirus E27 VP2; Enterovirus B111 VP2; Echovirus E25 VP2; Echovirus E6 VP2; Enterovirus B97 VP2; Human cosavirus B VP2; Echovirus E13 VP2; Echovirus E3 VP2; Echovirus E31 VP2; Echovirus 9 strain Hill polyprotein region 2; Echovirus E2 VP2; Echovirus E32 VP2; Human cosavirus full_polyprotein 1..2121; Human poliovirus 3 VP2; Human rhinovirus B27 1B; Coxsackievirus A22 vp2; Coxsackievirus A11 vp2; Coxsackievirus A17 VP2; Coxsackievirus A18 VP2 protein; Coxsackievirus A1 VP2; Human enterovirus C117 VP2; Human enterovirus C118 VP2; Enterovirus C109 VP2; Human enterovirus C102 vp2; Human enterovirus C104 VP2; Echovirus E18 full_polyprotein 1..2189; Coxsackievirus A13 vp2; Echovirus E12 polyprotein; Coxsackievirus B4 full_polyprotein 1..2183; Echovirus E30 full_polyprotein 1..2194; Coxsackievirus B6 full_polyprotein 1..2184; Echovirus E17 VP2; Coxsackievirus B2 full_polyprotein 1..2187; Enterovirus B genome polyportein; Enterovirus B73 full_polyprotein 1..2188; Enterovirus B106 full_polyprotein 1..2192; Echovirus E5 full_polyprotein 1..2196; Echovirus E9 full_polyprotein 1..2203; Human gammaherpesvirus 8 KCP (gene: ORF4); Cosavirus JMY-2014 full_polyprotein 1..2119; Enterovirus C99 full_polyprotein 1..2210; Human enterovirus Ningbo3-02 full_polyprotein 1..2214; Human enterovirus Hangzhou13-02 full_polyprotein 1..2214; Coxsackievirus A20 full_polyprotein 1..2208; Human poliovirus 3 polyprotein; Human poliovirus 1 enterovirus precursor polypeptide; Human rhinovirus QCE VP2",0.0743949840752122; 0.0754322523003515; 0.0754322523003515; 0.0786466013864403; 0.0816962571184375; 0.086428048188775; 0.0898087823597772; 0.098953088813177; 0.098953088813177; 0.098953088813177; 0.098953088813177; 0.098953088813177; 0.098953088813177; 0.098953088813177; 0.098953088813177; 0.098953088813177; 0.098953088813177; 0.098953088813177; 0.098953088813177; 0.098953088813177; 0.098953088813177; 0.098953088813177; 0.098953088813177; 0.098953088813177; 0.098953088813177; 0.098953088813177; 0.098953088813177; 0.098953088813177; 0.1043071530279705; 0.1043071530279705; 0.1413266333748334; 0.2076496029500523; 0.2882370282257738; 0.312710113238199; 0.3250047687955704; 0.3292007522271798; 0.3292007522271798; 0.3292007522271798; 0.3295806534284816; 0.3295806534284816; 0.3295806534284816; 0.3295806534284816; 0.3338836035374137; 0.3432508452948237; 0.3432508452948237; 0.3522486336034194; 0.362875171240929; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946,Homo sapiens blood plasma;In vitro,0.35;0.4;0.44;0.57;0.75;0.87,Homo sapiens;chemical synthesis,Homo sapiens;Naja kaouthia
CHAC1,Ovarian Carcinoma; Malignant neoplasm of ovary; Mammary Neoplasms; Malignant neoplasm of breast; Carcinogenesis; Breast Carcinoma; Squamous cell carcinoma of the head and neck,6.870627395110916e-10; 1.971893171900314e-09; 4.65353219894153e-08; 8.660170029731726e-07; 1.51758575162775e-06; 5.381279306135013e-06; 0.000420950947096172,,,"Cystathioninuria ORPHA:212; Neu-Laxova syndrome ORPHA:2671; 3-phosphoglycerate dehydrogenase deficiency, infantile/juvenile form ORPHA:79351; Autosomal dominant Charcot-Marie-Tooth disease type 2D ORPHA:99938; Autosomal dominant Charcot-Marie-Tooth disease type 2N ORPHA:228174; Autosomal dominant Charcot-Marie-Tooth disease type 2U ORPHA:397735; Autosomal dominant intermediate Charcot-Marie-Tooth disease type C ORPHA:100045; Autosomal recessive cutis laxa type 2B ORPHA:357064; Autosomal recessive spastic paraplegia type 70 ORPHA:401835; PYCR1-related De Barsy syndrome ORPHA:293633; Phosphoserine aminotransferase deficiency, infantile/juvenile form ORPHA:284417; Congenital microcephaly-severe encephalopathy-progressive cerebral atrophy syndrome ORPHA:391376; Severe early-onset pulmonary alveolar proteinosis due to MARS deficiency ORPHA:440427",0.4838060079820406; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659,,,,,,
CITED2,"Ovarian Carcinoma; Neoplasm Metastasis; Leukemia, Myelocytic, Acute; Brain Ischemia; Mammary Neoplasms; Coronary heart disease; Malignant neoplasm of breast; Colonic Neoplasms; Carcinogenesis; Stomach Carcinoma; Colon Carcinoma; Malignant neoplasm of stomach; Stomach Neoplasms; Breast Carcinoma; Osteosarcoma; Secondary malignant neoplasm of bone; Malignant tumor of colon; Chronic Kidney Diseases; Myeloid Leukemia, Chronic; Neoplasms; Secondary malignant neoplasm of lymph node; Malignant Neoplasms; Situs Inversus; Benign Neoplasm; Adrenocortical carcinoma; Agenesis; Uremia; Malignant neoplasm of adrenal cortex; Ovarian Failure, Premature; Spindle cell rhabdomyosarcoma; Muscular Atrophy; Ischemic cardiomyopathy; Neoplasms, Bone Tissue; Congenital heart disease; Cardiac defects; Adrenal Gland Diseases; Premature Menopause; Congenital Abnormality; Abnormal nasal morphology; Ostium secundum atrial septal defect; Conotruncal defect; Breast cancer recurrent; Preauricular Fistulae, Congenital; Congenital preauricular sinus; Preauricular dimple; Neurogenic Muscular Atrophy; Adrenal gland hypofunction; Prominent eyes; Protruding eyes; Prominent globes; Exophthalmos; Underdeveloped brows; Underdeveloped supraorbital ridges; Congenital Heart Defects; Atrial Septal Defects; Heart Septal Defects; Fetal Growth Retardation; Thin lips; Brachydactyly; Ventricular Septal Defects; Turridolichocephaly; Narrow cranium shape; Narrow head shape; Narrow skull shape; Long narrow head; Broad forehead; Tetralogy of Fallot; Curvature of little finger; Clinodactyly of the 5th finger; Infant, Small for Gestational Age; Intrauterine retardation; Cryptorchidism",6.870627395110916e-10; 5.670785186683756e-09; 8.303910954283738e-09; 1.8815395768840057e-08; 4.65353219894153e-08; 9.273260676030806e-08; 8.660170029731726e-07; 1.4185164995612263e-06; 1.51758575162775e-06; 2.07112526817849e-06; 2.205236928124383e-06; 2.450940162208615e-06; 3.878607667297475e-06; 5.381279306135013e-06; 6.3131986281381465e-06; 6.378950690990071e-06; 1.5498516107485843e-05; 9.913294924271568e-05; 0.00021049732822064587; 0.00022897551943886068; 0.000323910443746482; 0.0006352060750206054; 0.0013734265963756; 0.0050894481995015; 0.0063306870511064; 0.0127059723723765; 0.0284314613047093; 0.0650424286909672; 0.0704851772553303; 0.0817897187940979; 0.083107903315643; 0.0897127848630768; 0.0897127848630768; 0.0972679220674381; 0.1046638861423046; 0.1343310874911156; 0.1397055058487397; 0.1722207384650883; 0.176056923749369; 0.1982833830495248; 0.2166737845423457; 0.2272199982000937; 0.2468771733501051; 0.2468771733501051; 0.2468771733501051; 0.2499636483007412; 0.2622329318286966; 0.2831951348626981; 0.2831951348626981; 0.2884480666215576; 0.2957377254678394; 0.320973096008708; 0.320973096008708; 0.3352509823890284; 0.3515273578586712; 0.3634167943130235; 0.3837849438448272; 0.4129951424538438; 0.4404527272820893; 0.4866653182016537; 0.4917864702292748; 0.4917864702292748; 0.4917864702292748; 0.4917864702292748; 0.5016579023754205; 0.507968267075787; 0.5956450465155394; 0.6767064352850668; 0.6808629014541201; 0.8589218409566095; 0.8617825719813154; 0.9460893947912036,Benign Neoplasm; Malignant Neoplasm; Neoplasms; Secundum Atrial Septal Defect; Pulmonary Venous Return Anomaly; Situs Inversus; Heart Septal Defects; Brachydactyly; Proptosis; Tetralogy Of Fallot; Dolichocephaly; Atrial Septal Defect; Camptodactyly Of Fingers; Ventricular Septal Defect; Cryptorchidism,0.010864842397815; 0.021392225047824; 0.064825092293108; 0.191014576985413; 0.191014576985413; 0.2648173889661375; 0.3975256936810483; 0.426652795095747; 0.4915822556820058; 0.7034401678988081; 0.714055704694497; 0.8659790783113521; 0.8881934161397249; 0.9101829064092936; 0.9920888769304664,"Atrial septal defect, sinus venosus type ORPHA:99105; NON RARE IN EUROPE: Ventricular septal defect ORPHA:1480; Atrial septal defect, ostium secundum type ORPHA:99103; Situs inversus totalis ORPHA:101063; Tetralogy of Fallot ORPHA:3303",0.4838060079820406; 0.5312419675785659; 0.5322893295716875; 0.5352376236648427; 0.5444454371439633,,,yeasx,0.37,Bacillus anthracis;Homo sapiens,Bacillus anthracis;Homo sapiens
CSF1,"Inflammation; Lymphoma; Synovitis; Rheumatoid Arthritis; Arteriosclerosis; Non-Small Cell Lung Carcinoma; Ovarian Carcinoma; Sarcoidosis; Endometriosis; cervical cancer; Cirrhosis; Malignant neoplasm of ovary; Tumor Angiogenesis; Malignant tumor of cervix; Lung Neoplasms; Neoplasm Metastasis; Mammary Neoplasms, Human; Hodgkin Disease; Atherosclerosis; Pulmonary Fibrosis; Leukemia, Myelocytic, Acute; Anti-Basement Membrane Glomerulonephritis; Liver Cirrhosis; Cervix carcinoma; Arthritis; Degenerative polyarthritis; Obesity; Periodontitis; Hyperglycemia; Liver neoplasms; Mammary Neoplasms; leukemia; Lupus Erythematosus, Systemic; Pancreatic carcinoma; Alzheimer's Disease; Glioma; Epithelial ovarian cancer; Van der Woude syndrome; Inflammatory disorder; Anoxia; Cardiovascular Diseases; Malignant neoplasm of lung; Ureteral obstruction; Tumor Progression; Thromboangiitis Obliterans; Malignant neoplasm of breast; Myasthenia Gravis; Systemic Scleroderma; Osteitis Deformans; Liver carcinoma; Carcinogenesis; Carcinoma of lung; Ankylosing spondylitis; Colon Carcinoma; Bone Diseases; Lupus Nephritis; Primary malignant neoplasm of lung; Breast Carcinoma; Secondary malignant neoplasm of bone; Thyroid carcinoma; Malignant mesothelioma; M5b Acute differentiated monocytic leukemia; Small cell carcinoma of lung; Acute Promyelocytic Leukemia; Acute lymphocytic leukemia; MYELODYSPLASTIC SYNDROME; Colorectal Neoplasms; Lupus Erythematosus; Adenocarcinoma; Malignant tumor of colon; ovarian neoplasm; Myeloid Leukemia; Prostatic Neoplasms; Malignant neoplasm of endometrium; Uterine Corpus Cancer; Squamous cell carcinoma; Endometrial adenocarcinoma; Pancreatic Neoplasm; precancerous lesions; Lupus Vulgaris; Histiocytosis, Langerhans-Cell; Lupus Erythematosus, Discoid; Congestive heart failure; Malignant Glioma; Osteoporosis; Mesothelioma; Solid Neoplasm; Endometrial Carcinoma; Acute myelomonocytic leukemia; Colorectal Carcinoma; Fibrosis, Liver; Uterine Cervical Neoplasm; Myeloid Leukemia, Chronic; Neutropenia; Kidney Diseases; Neoplasms; Heart failure; Sarcoma; Central neuroblastoma; Secondary malignant neoplasm of lymph node; Colorectal Cancer; Invasive carcinoma of breast; Monocytic leukemia; Chronic Periodontitis; Neuroblastoma; Pre-Eclampsia; Precursor Cell Lymphoblastic Leukemia Lymphoma; Refractory anemias; Skin Erosion; Stage IV Ovarian Carcinoma; Malignant neoplasm of thyroid; Secondary malignant neoplasm of liver; bone destruction; Kidney Neoplasm; Papillary thyroid carcinoma; Fibrous histiocytoma of tendon sheath; gliosarcoma; Stromal Neoplasm; Pigmented villonodular synovitis; Hematological Disease; Invasive Carcinoma; Giant Cell Tumors; Ameloblastoma; Leukopenia; Mammary Tumorigenesis; Memory impairment; Squamous cell carcinoma of lung; Neuropathy; Epithelioma; Refractory anemia, without ringed sideroblasts, without excess blasts; invasive cancer; PITUITARY ADENOMA PREDISPOSITION (disorder); Inherited neuropathies; Adamantinoma; leiomyosarcoma; Ocular Cicatricial Pemphigoid; Fibromatosis, Aggressive; Well Differentiated Pancreatic Endocrine Tumor; Osteopetrosis; Wiskott-Aldrich Syndrome; Osteofibrous Dysplasia; Solitary fibrous tumor; Arteriosclerosis Obliterans; Leukemia, Myelomonocytic, Chronic; Gastrointestinal Stromal Tumors; Testicular Germ Cell Tumor; LATERAL MENINGOCELE SYNDROME; LIMB-MAMMARY SYNDROME; Monocyte count procedure; Monocyte count result; Charcot-Marie-Tooth Disease; White Blood Cell Count procedure",2.8114433253573326e-17; 4.5104266881389206e-12; 1.6797550790254382e-10; 1.9241179247341838e-10; 2.377251819497684e-10; 3.762648680673853e-10; 6.870627395110916e-10; 7.861255581007157e-10; 7.868397426275417e-10; 1.1722433847661196e-09; 1.4790998733426532e-09; 1.971893171900314e-09; 3.315537369635636e-09; 3.683115069310663e-09; 4.367699208727405e-09; 5.670785186683756e-09; 5.791865115913735e-09; 6.195332209150018e-09; 7.195555613367576e-09; 7.547641288501485e-09; 8.303910954283738e-09; 8.853567275424139e-09; 1.3128768066526236e-08; 1.5572986293211266e-08; 1.587872453479067e-08; 2.1034803123367165e-08; 2.412608431251415e-08; 3.9573009168853264e-08; 4.0898524252942674e-08; 4.3069383556698336e-08; 4.65353219894153e-08; 5.784935444423772e-08; 6.156981490555128e-08; 6.982287075725826e-08; 9.273260676030806e-08; 1.427432458937347e-07; 1.479813245926713e-07; 1.524221047360518e-07; 2.242497138958313e-07; 2.911052249927245e-07; 4.5433391667148853e-07; 6.299208964864026e-07; 7.99548070959303e-07; 8.297823048747685e-07; 8.339674388418603e-07; 8.660170029731726e-07; 8.696626324623331e-07; 1.10068355868735e-06; 1.284982487562752e-06; 1.3079916134634371e-06; 1.51758575162775e-06; 2.027389637151193e-06; 2.1020461880694925e-06; 2.205236928124383e-06; 3.282956820548434e-06; 3.4620043828295477e-06; 4.839188317483647e-06; 5.381279306135013e-06; 6.378950690990071e-06; 6.889889014378816e-06; 7.439853898002338e-06; 8.591027139424906e-06; 1.0755368362337037e-05; 1.2304362232150695e-05; 1.2375081616087569e-05; 1.279493639647176e-05; 1.3034577772762696e-05; 1.4805035395703202e-05; 1.5449280661407645e-05; 1.5498516107485843e-05; 1.8507296589967813e-05; 2.042524345007846e-05; 2.0820699372778346e-05; 2.389985034001877e-05; 2.483118059238325e-05; 3.053335644618538e-05; 3.1066725823367694e-05; 3.192298841377222e-05; 3.602405958537832e-05; 4.1934338365676246e-05; 6.882388524696196e-05; 8.133563964016694e-05; 8.232890503539995e-05; 8.25206825409808e-05; 9.117996105379778e-05; 0.00010582598320524978; 0.0001322335978675375; 0.0001322335978675375; 0.00014636999075042076; 0.00016189346720036038; 0.0001690762138878921; 0.0001705179359230947; 0.00021049732822064587; 0.00021611859123914996; 0.00022336414159326664; 0.00022897551943886068; 0.00027820432005572264; 0.00029355802758490503; 0.00032113080554701227; 0.000323910443746482; 0.00038453776693371663; 0.0004224524250828287; 0.00042535405399404114; 0.0004303328941191692; 0.0004601228759628894; 0.0004934717082734151; 0.000513309425513094; 0.0005255837979904586; 0.0006721375816653799; 0.0007731114749585194; 0.0009826472144539087; 0.0010244557923259; 0.0013064343839031; 0.0014485445504404; 0.0025122887786423; 0.0029063499863533; 0.0037263522689301; 0.0050894481995015; 0.0083709650732796; 0.0110109843340769; 0.0128516790501046; 0.0145436543557976; 0.0196225707350576; 0.0196225707350576; 0.0203198961621158; 0.027071413490175; 0.033749008368017; 0.0340645241548108; 0.0407359064912377; 0.044901297966643; 0.0616475884230982; 0.0723815120866587; 0.0805158056052076; 0.0817897187940979; 0.087414326021809; 0.1050724946352408; 0.1080647222141486; 0.1080647222141486; 0.1204795752338222; 0.1272255752567765; 0.1642913929691757; 0.176056923749369; 0.176056923749369; 0.2166737845423457; 0.2277111144893269; 0.23058850720196; 0.3066971380488823; 0.316142834424839; 0.3266046709222248; 0.3266046709222248; 0.3726356761234091; 0.5441274116253537,Marfan Syndrome; Mammary Neoplasms; Breast Carcinoma; Breast Cancer; Malignant Mesothelioma; Paget Disease,8.921950872070284e-08; 1.1417484002988661e-07; 4.971054570440277e-05; 0.00063387456654884; 0.0015169561374293; 0.1851562166631526,Pediatric systemic lupus erythematosus ORPHA:93552; Familial cavitary optic disc anomaly ORPHA:464760; Keratolytic winter erythema ORPHA:50943; Roussy-Levy syndrome ORPHA:3115; Dejerine-Sottas syndrome ORPHA:64748; Hyperandrogenism due to cortisone reductase deficiency ORPHA:168588; Familial cerebral saccular aneurysm ORPHA:231160,0.00021965881189185; 0.0019696624570933; 0.1927589191138116; 0.1927589191138116; 0.1950017883804084; 0.4838060079820406; 0.5312419675785659,Vaccinia virus Ankara Haemagglutinin; Vaccinia virus hemagglutinin (gene: A56R); Horsepox virus HSPV177 (Immunoglobulin like); Variola virus hypothetical protein (gene: J9R); Human gammaherpesvirus 4 BARF1 protein (gene: BARF1); Human herpesvirus 4 type 2 BARF1,0.0096374079669374; 0.0223182816928385; 0.0401211861299026; 0.2673783194071986; 0.3911903778732946; 0.3911903778732946,Escherichia coli;In vitro,0.44;0.71;0.78,Homo sapiens,Homo sapiens;Macacine gammaherpesvirus 4;ebvb9
CSF2,"Inflammation; Pneumonia; Asthma; Psoriasis; Familial M??ni??re disease; Juvenile arthritis; Lymphoma; Multiple Myeloma; Virus Diseases; Dermatitis, Atopic; Lung diseases; Lobar Pneumonia; Neutrophilia (disorder); Chronic Obstructive Airway Disease; Synovitis; Rheumatoid Arthritis; Arteriosclerosis; Pneumonitis; Non-Small Cell Lung Carcinoma; Crohn Disease; Autoimmune Diseases; Ovarian Carcinoma; Sarcoidosis; Endometriosis; MYELOPROLIFERATIVE DISORDER, CHRONIC, WITH EOSINOPHILIA; Malignant neoplasm of ovary; Colitis; Tumor Angiogenesis; Lung Neoplasms; Multiple Sclerosis; Cerebral Ischemia; Neoplasm Metastasis; Experimental Lung Inflammation; Mammary Neoplasms, Human; Hodgkin Disease; Atherosclerosis; Pulmonary Fibrosis; Leukemia, Myelocytic, Acute; Hypertensive disease; Liver Cirrhosis; Eczema; Arthritis; Cerebrovascular accident; Degenerative polyarthritis; Inflammatory Bowel Diseases; Obesity; Kaposi Sarcoma; Hyperglycemia; Liver neoplasms; HIV Infections; Mammary Neoplasms; Aortic Aneurysm, Abdominal; Glioblastoma; leukemia; Diabetes Mellitus; Juvenile rheumatoid arthritis; Diabetes; Lupus Erythematosus, Systemic; Pancreatic carcinoma; Coronary Artery Disease; Coronary heart disease; Alzheimer's Disease; Adenocarcinoma of pancreas; Dermatitis, Allergic Contact; Encephalitis; Glioma; Epithelial ovarian cancer; Malignant neoplasm of pancreas; Van der Woude syndrome; Pain; Cerebral abscess; Acquired Immunodeficiency Syndrome; Hamman-Rich syndrome; Inflammatory disorder; Myocardial Infarction; Cerebral Infarction; Hepatitis C, Chronic; Adult T-Cell Lymphoma/Leukemia; Brain Abscess; Bronchiolitis Obliterans; Brain Neoplasms; Cardiovascular Diseases; Septicemia; Sepsis; Cystic Fibrosis; Malignant neoplasm of lung; Fibroid Tumor; Tuberculosis; Diabetes Mellitus, Insulin-Dependent; Chronic Lymphocytic Leukemia; Measles; Tumor Progression; Malignant neoplasm of breast; Cytomegalovirus Infections; Gastritis; Bladder Neoplasm; Coronary Arteriosclerosis; Graft-vs-Host Disease; Systemic Scleroderma; Anemia, Sickle Cell; Osteitis Deformans; Liver carcinoma; Dementia, Vascular; Colonic Neoplasms; Immunologic Deficiency Syndromes; Carcinogenesis; Nasopharyngeal carcinoma; Lung Diseases, Interstitial; Malignant neoplasm of vulva; Influenza; Carcinoma of lung; Ankylosing spondylitis; B-Cell Lymphomas; Colon Carcinoma; Leishmaniasis, Visceral; Fibrosarcoma; Immune System Diseases; Osteosarcoma of bone; Astrocytoma; Kidney Failure, Acute; Lymphoma, T-Cell, Cutaneous; Chronic liver disease; melanoma; Tauopathies; Primary malignant neoplasm of lung; Breast Carcinoma; Meningococcal Infections; Pustulosis of Palms and Soles; Osteosarcoma; Secondary malignant neoplasm of bone; Thyroid carcinoma; Malignant mesothelioma; M5b Acute differentiated monocytic leukemia; Epstein-Barr Virus Infections; Guillain-Barre Syndrome; Sarcoidosis, Pulmonary; Familial Alzheimer Disease (FAD); Hepatitis B, Chronic; Small cell carcinoma of lung; Encephalomyelitis; Acute Promyelocytic Leukemia; Acute lymphocytic leukemia; MYELODYSPLASTIC SYNDROME; Retinal Diseases; Colorectal Neoplasms; Allergic asthma; Pleural Effusion, Malignant; Acute monocytic leukemia; Senile Plaques; Hepatitis B; Candidiasis; Agranulocytosis; Aplastic Anemia; Presenile dementia; Rabies (disorder); Prostate carcinoma; Adenocarcinoma; Malignant tumor of colon; ovarian neoplasm; Eosinophilic disorder; Nonalcoholic Steatohepatitis; Myeloid Leukemia; Allergic rhinitis (disorder); Kidney Failure, Chronic; Prostatic Neoplasms; Herpes Simplex Infections; Malignant neoplasm of endometrium; Contact Dermatitis; Uterine Corpus Cancer; Granulocytosis; Coinfection; Squamous cell carcinoma; Malignant neoplasm of prostate; Meningitis; Malignant neoplasm of urinary bladder; Pancreatic Neoplasm; Parkinson Disease; Carcinoma of bladder; Experimental Organism Basal Cell Carcinoma; Tumor Immunity; Osteomyelitis; Malignant Head and Neck Neoplasm; Lymphoma, Non-Hodgkin; Myelofibrosis; Uterine Fibroids; Eosinophilia; Rhinitis; Childhood Glioblastoma; Proliferative vitreoretinopathy; Adult Glioblastoma; Benign Prostatic Hyperplasia; Hematologic Neoplasms; Hematopoietic Neoplasms; Enterovirus Infections; Spinal Cord Diseases; Heart Failure, Right-Sided; Carcinoma, Lewis Lung; Congestive heart failure; Malignant Glioma; Malignant neoplasm of liver; Familial lichen amyloidosis; Mitral Valve Stenosis; Unipolar Depression; Dermatomyositis; Congenital neutropenia; Neurodegenerative Disorders; Renal Cell Carcinoma; Alzheimer Disease, Early Onset; Toxoplasmosis; Adenoma; Severe congenital neutropenia; Cytomegalovirus encephalitis; Solid Neoplasm; Endometrial Carcinoma; Adenocarcinoma of lung (disorder); VITILIGO-ASSOCIATED MULTIPLE AUTOIMMUNE DISEASE SUSCEPTIBILITY 1 (finding); Acute myelomonocytic leukemia; Carcinoma, Transitional Cell; Nasal Polyps; Retinoblastoma; Colorectal Carcinoma; Pancreatic Ductal Adenocarcinoma; Pain, Crushing; Pain, Migratory; Pain, Splitting; Suffering, Physical; Ache; Radiating pain; Demyelinating Diseases; Severe Aplastic Anemia; Tuberculosis, Meningeal; Adult type dermatomyositis; Metastatic melanoma; Myeloid Leukemia, Chronic; Pain, Burning; Interstitial Cystitis; Neutropenia; Mumps; Scleroderma; Anemia; Neoplasms; Plaque, Amyloid; Lymphoma, Follicular; Ulcer; Leukemogenesis; Allergic disposition; Heart failure; Precursor B-cell lymphoblastic leukemia; Vitiligo; Sarcoma; Dementia; Silicosis; Central neuroblastoma; Major Depressive Disorder; Amyloidosis; Colorectal Cancer; Squamous cell carcinoma of the head and neck; Secondary malignant neoplasm of lung; Urothelial Carcinoma; Monocytic leukemia; Chronic Periodontitis; Heart Decompensation; Adrenoleukodystrophy; Neuroblastoma; Primary malignant neoplasm; Carcinoma breast stage IV; Myeloproliferative disease; Precursor Cell Lymphoblastic Leukemia Lymphoma; Osteopenia; Refractory anemias; Parasitemia; Myocardial Failure; Viral meningitis; Optic Atrophy, Hereditary, Leber; Malignant Neoplasms; Meningitis, Bacterial; Severe Combined Immunodeficiency; Infant, Premature; Stromal keratitis; Pulmonary Pathology; West Nile viral infection; Stage IV Ovarian Carcinoma; AIDS Dementia Complex; Empyema; Gastrointestinal mucositis; Amyotrophic Lateral Sclerosis; Secondary malignant neoplasm of liver; Pediatric Crohn's disease; Chronic granulomatous disease; CNS disorder; Carcinoma of larynx; Dengue Fever; Left-Sided Heart Failure; Chronic Neutrophilic Leukemia; Pleocytosis; Primary Myelofibrosis; Rett Syndrome; Malignant neoplasm of larynx; Lyme Disease; Inflammatory disease of mucous membrane; Kidney Neoplasm; Thyroid Gland Follicular Adenoma; Alzheimer Disease, Late Onset; Huntington Disease; Herpes encephalitis; Skin carcinoma; Disseminated Malignant Neoplasm; Thyroid Neoplasm; Subarachnoid Hemorrhage; Myeloid neoplasm; IMMUNE SUPPRESSION; Polycythemia Vera; Asymptomatic human immunodeficiency virus infection; Bronchitis; Mild cognitive disorder; Pneumocystis jiroveci pneumonia; Metabolic Diseases; Renal carcinoma; Fibrous histiocytoma of tendon sheath; Sinusitis; Atrial Premature Complexes; Reticulosarcoma; Lymphoma, AIDS-Related; Febrile Convulsions; Ki-1+ Anaplastic Large Cell Lymphoma; Meningitis, Pneumococcal; Ileitis; Progressive Neoplastic Disease; Cholera; Progressive cGVHD; Chronic myeloproliferative disorder; Promyelocytic leukemia; HIV Encephalopathy; Undifferentiated carcinoma; Reflux nephropathy (disorder); Aseptic Meningitis; Non-obstructive reflux-associated chronic pyelonephritis (disorder); Subacute Sclerosing Panencephalitis; HIV encephalitis; Anaplastic thyroid carcinoma; Carcinomatosis; Juvenile Myelomonocytic Leukemia; Peripheral T-Cell Lymphoma; Bipolar Disorder; Canavan Disease; Chronic skin ulcer; Bone Marrow Diseases; Paget Disease; Acute leukemia; Non-alcoholic Fatty Liver Disease; Tropical Spastic Paraparesis; Low Grade Lymphoma (neoplasm); Thrombocytopenia; Acute flaccid paralysis; Chronic cough; Lymphohistiocytosis; Melanoma, B16; Medulloblastoma; Esophageal carcinoma; Schizophrenia; Anaplastic carcinoma; Herpes NOS; Retroviridae Infections; intracranial glioma; Thrombocythemia, Essential; Frontotemporal dementia; Meningioma; Japanese Encephalitis; Neurocognitive Disorders; Hematological Disease; Age-related cognitive decline; Lysinuric Protein Intolerance; Hyperactive behavior; Blast Phase; Impulsive character (finding); Adenocarcinoma of prostate; Coughing; Myelodysplasia; Inflammatory neuropathy; Conventional (Clear Cell) Renal Cell Carcinoma; Agenesis; Steroid Sulfatase Deficiency Disease; PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE; Aspergillosis; Chronic ulcer; Fowlpox; Hypoplastic anemia; Pseudotumor Cerebri; Frontotemporal Lobar Degeneration; Fibromyalgia; Preleukemia; Metastatic malignant neoplasm to brain; Hippocampal sclerosis; Non-arthropod borne lymphocytic choriomeningitis; Ichthyosis, X-Linked; TARSAL-CARPAL COALITION SYNDROME; Adenomatous Polyposis Coli; Glioblastoma Multiforme; Leukoencephalopathy, Progressive Multifocal; Keratoconjunctivitis, Vernal; Central Nervous System Infection; Ileal Diseases; Meningoencephalitis; Rotavirus Infections; Childhood Leukemia; Lymphocytic Choriomeningitis; Tactile Amnesia; Temporary Amnesia; Amnestic State; Canarypox (disorder); Dissociative Amnesia; Global Amnesia; Hysterical amnesia; Immunosuppression; Adenoviral infections; Leukopenia; T-Cell Lymphoma; Burkitt Lymphoma; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Bipolar II disorder; Cavitation; FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder); Brain Diseases; Paraparesis, Spastic; AICARDI-GOUTIERES SYNDROME 1; AURAL ATRESIA, CONGENITAL; Pancreatic intraepithelial neoplasia; Malignant neoplasm of kidney; Low grade glioma; Convulsions; Bone Marrow failure syndromes; Carcinoma, Spindle-Cell; Lymphoma, Mixed-Cell; Lymphocytosis; Adenocarcinoma of colon; Memory impairment; Diffuse Mixed-Cell Lymphoma; Neurocysticercosis; Lymphoma, Undifferentiated; Diphtheria; Anemia, Diamond-Blackfan; Philadelphia chromosome-positive acute lymphoblastic leukemia; Lymphoma, Intermediate-Grade; Lewy Body Disease; Squamous cell carcinoma of lung; Borna Disease; Neuropathy; Pelizaeus-Merzbacher Disease; Fanconi Anemia; Seborrheic keratosis; Lymphoma, Small Noncleaved-Cell; Carcinoma; Spinal Cord Myelodysplasia; Diastematomyelia; Iniencephaly; Neurenteric Cyst; Autism Spectrum Disorders; Cutaneous Melanoma; Neoplasm, Residual; 21-hydroxylase deficiency; Antisocial Personality Disorder; Adverse reaction to drug; Drug toxicity; Acrania; Lymphoproliferative Disorder of the Skin; Lesion of brain; Chromosome 5, trisomy 5q; Congenital adrenal hyperplasia due to 21 hydroxylase deficiency; Sarcoma, Spindle Cell; Myelodysplastic Syndrome with Isolated del(5q); Polyradiculoneuropathy, Chronic Inflammatory Demyelinating; Turner Syndrome; Tethered Cord Syndrome; 5q-syndrome; Craniorachischisis; Exencephaly; Neural Tube Defects; Transitional cell carcinoma of bladder; nervous system disorder; Depressive disorder; Genitourinary Cancer; Adult Acute Myeloblastic Leukemia; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Optic Neuritis; PITUITARY ADENOMA PREDISPOSITION (disorder); Sarcoma, Epithelioid; Dissection of aorta; Flushing; High Grade Lymphoma (neoplasm); Trichohepatoenteric Syndrome; Nicotinamide adenine dinucleotide coenzyme Q reductase deficiency; Respiratory Failure; Dystonia, Dopa-Responsive, due to Sepiapterin Reductase Deficiency; Impaired cognition; Sleep Disorders; Abnormal behavior; Obsessive-Compulsive Disorder; Antisocial behavior; Mental Depression; Acute Myeloid Leukemia, M1; Pancytopenia; Varicella zoster; DYSTONIA, DOPA-RESPONSIVE, WITH OR WITHOUT HYPERPHENYLALANINEMIA, AUTOSOMAL RECESSIVE (disorder); HIV-associated neurocognitive disorder; Intermittent Explosive Disorder; Myelitis; Myeloid hyperplasia; Neuroborreliosis; Neurologic Symptoms; Acute Myeloid Leukemia (AML-M2); Acute Megakaryocytic Leukemias; Leukodystrophy; Schizotypal Personality Disorder; Meningeal Carcinomatosis; Neonatal infection; Lymphoma, Diffuse; Early Rheumatoid Arthritis; Primary central nervous system lymphoma; Pervasive Development Disorder; Parkinsonian Disorders; Status Asthmaticus; Vasculitic neuropathy; Wernicke Encephalopathy; Amnesia; Viremia; Encephalomyelitis, Acute Disseminated; Invasive meningococcal disease; Metastatic Malignant Neoplasm to the Leptomeninges; Acute Erythroblastic Leukemia; Unspecified visual loss; Paroxysmal nocturnal hemoglobinuria; stage, non-small cell lung cancer; GRN-related frontotemporal dementia; Hypoglycemia; Metastatic Renal Cell Cancer; Encephalopathies; Violence; Hereditary Connective Tissue Disorder; MPS III B; Pelizaeus Merzbacher like disease; Wiskott-Aldrich Syndrome; Progressive supranuclear palsy; Mood Disorders; Neck Neoplasms; Malignant Squamous Cell Neoplasm; Amyloid Neuropathies, Familial; secondary acute myeloid leukemia; Eating Disorders; Learning Disabilities; Chorea; Acoustic Neuroma; Toxoplasmosis, Congenital; Thrombocytopenic purpura; Visual symptoms; Corticobasal degeneration; Limbic Encephalitis; Purpura Fulminans; Patent ductus arteriosus; Hematochezia; Central nervous system lymphoma; Hypereosinophilic syndrome; Movement Disorders; Lesch-Nyhan Syndrome; Residual Cancer; Invasive Fungal Infections; Primary Progressive Aphasia (disorder); Amyloid angiopathy; Venous Thrombosis; Amino Acid Metabolism, Inborn Errors; Autoimmune gastritis; Cerebral Vasospasm; Infantile neuronal ceroid lipofuscinosis; Intrinsic asthma; Mastocytoma; Other Creutzfeldt-Jakob disease; polyps; Malignant neoplasm of testis; Benign Mastocytoma; Mucopolysaccharidosis Type IIIA; Nonketotic Hyperglycinemia; Camurati-Engelmann Syndrome; Pre B-cell acute lymphoblastic leukemia; Myalgia; Carcinoma, Papillary; Behavioral variant of frontotemporal dementia; Hyperphenylalaninaemia; Sleep disturbances; Hydrocephalus, Normal Pressure; CNS metastases; Hypersomnia; Mast Cell Neoplasm; Leukemia, Myelomonocytic, Chronic; Personality Disorders; Deep Vein Thrombosis; Creutzfeldt-Jakob Disease, Sporadic; Acquired CJD; Teratoma; Cataplexy; Hypereosinophilia; Pulmonary Alveolar Proteinosis; Congenital hypoplasia of lung; Therapy-related myelodysplastic syndrome; Ependymoma; Cognition Disorders; Dystonia Disorders; Motor Neuron Disease; Prostate cancer recurrent; Nephroblastoma; Hydrocephalus; Neuromyelitis Optica; Seizures; Choreoathetosis; HER2 gene amplification; Gastrointestinal Hemorrhage; Attention Deficit Disorder; Failure to Thrive; Sensorineural Hearing Loss (disorder); Axonal neuropathy; Cerebral atrophy; Muscle Weakness; Ataxia; Eosinophilic esophagitis; Hypogammaglobulinemia; Leukoencephalopathies; Creutzfeldt-Jakob disease; Bacteremia; Microcephaly; Autistic Disorder; Dystonia; Narcolepsy; Attention deficit hyperactivity disorder; Ataxia, Spinocerebellar; Dwarfism; Growth failure; Cerebellar Ataxia",2.8114433253573326e-17; 7.980856456624717e-16; 1.803641225501291e-12; 3.118210553589307e-12; 3.861499575207375e-12; 3.861499575207375e-12; 4.5104266881389206e-12; 2.5279022064249716e-11; 6.332483647919588e-11; 7.448716379948652e-11; 8.179290839744632e-11; 8.179290839744632e-11; 1.1574161017103878e-10; 1.3121548808139071e-10; 1.6797550790254382e-10; 1.9241179247341838e-10; 2.377251819497684e-10; 2.813069300429449e-10; 3.762648680673853e-10; 4.2478505092738466e-10; 5.452288254986118e-10; 6.870627395110916e-10; 7.861255581007157e-10; 7.868397426275417e-10; 1.5734876414130875e-09; 1.971893171900314e-09; 1.971893171900314e-09; 3.315537369635636e-09; 4.367699208727405e-09; 4.546836602575699e-09; 4.756590990483e-09; 5.670785186683756e-09; 5.670785186683756e-09; 5.791865115913735e-09; 6.195332209150018e-09; 7.195555613367576e-09; 7.547641288501485e-09; 8.303910954283738e-09; 1.0368326871660785e-08; 1.3128768066526236e-08; 1.4920329017331753e-08; 1.587872453479067e-08; 2.0570601164639797e-08; 2.1034803123367165e-08; 2.3137704832524547e-08; 2.412608431251415e-08; 3.149054123564124e-08; 4.0898524252942674e-08; 4.3069383556698336e-08; 4.638299267461546e-08; 4.65353219894153e-08; 5.1290058242058653e-08; 5.518991037343798e-08; 5.784935444423772e-08; 5.8317433871210796e-08; 5.989093556336469e-08; 6.156981490555128e-08; 6.156981490555128e-08; 6.982287075725826e-08; 8.598175402882612e-08; 9.273260676030806e-08; 9.273260676030806e-08; 9.306686765839445e-08; 1.0390067657961098e-07; 1.3150328464481586e-07; 1.427432458937347e-07; 1.479813245926713e-07; 1.4925759778299788e-07; 1.524221047360518e-07; 1.6759866477134858e-07; 1.7232014763277498e-07; 1.825346178149227e-07; 2.0732395681104218e-07; 2.242497138958313e-07; 2.247163660896597e-07; 2.419125491442217e-07; 2.46778041958494e-07; 2.46778041958494e-07; 2.700227164716584e-07; 3.10587283755252e-07; 4.157277636684319e-07; 4.5433391667148853e-07; 5.254943571583271e-07; 5.313225371508493e-07; 5.577321626966352e-07; 6.299208964864026e-07; 6.630279934320317e-07; 6.673805318525932e-07; 6.851652105457608e-07; 7.931659047151387e-07; 7.99548070959303e-07; 8.297823048747685e-07; 8.660170029731726e-07; 8.887379906686178e-07; 9.58028929735367e-07; 9.822463166680949e-07; 1.0094398444517938e-06; 1.0094667484349083e-06; 1.10068355868735e-06; 1.2482007026109775e-06; 1.284982487562752e-06; 1.3079916134634371e-06; 1.4042419564664515e-06; 1.4185164995612263e-06; 1.4839502431758565e-06; 1.51758575162775e-06; 1.5208470671427406e-06; 1.6231490275716298e-06; 1.8939430555623748e-06; 2.027389637151193e-06; 2.027389637151193e-06; 2.1020461880694925e-06; 2.1624936975752243e-06; 2.205236928124383e-06; 2.2411321306638023e-06; 2.3419309731960144e-06; 2.546221763226728e-06; 2.560217628497434e-06; 2.608032323197001e-06; 3.485726441474513e-06; 3.7283259874612974e-06; 3.990817553511259e-06; 4.179146475474674e-06; 4.218275676836033e-06; 4.839188317483647e-06; 5.381279306135013e-06; 5.457492980911677e-06; 5.457492980911677e-06; 6.3131986281381465e-06; 6.378950690990071e-06; 6.889889014378816e-06; 7.439853898002338e-06; 8.591027139424906e-06; 8.77532817235926e-06; 9.18171819472328e-06; 9.263589414966798e-06; 9.263589414966798e-06; 1.0172703923266036e-05; 1.0755368362337037e-05; 1.08089380369295e-05; 1.2304362232150695e-05; 1.2375081616087569e-05; 1.279493639647176e-05; 1.3010173302726732e-05; 1.3034577772762696e-05; 1.3268923055385737e-05; 1.3268923055385737e-05; 1.3268923055385737e-05; 1.3673911177979942e-05; 1.3755659311680946e-05; 1.3755659311680946e-05; 1.4439241578579364e-05; 1.4583987015565183e-05; 1.5064798896399038e-05; 1.513340899972731e-05; 1.527992765491583e-05; 1.5449280661407645e-05; 1.5498516107485843e-05; 1.8507296589967813e-05; 1.8961926417889813e-05; 2.0234336876324372e-05; 2.042524345007846e-05; 2.0736107376307555e-05; 2.0820699372778346e-05; 2.0820699372778346e-05; 2.1109857936882128e-05; 2.389985034001877e-05; 2.428963273942594e-05; 2.483118059238325e-05; 2.878916650522013e-05; 2.929369913127532e-05; 3.053335644618538e-05; 3.053335644618538e-05; 3.14076229962439e-05; 3.1491435270594376e-05; 3.192298841377222e-05; 3.372277447426952e-05; 3.9650653676454574e-05; 3.9650653676454574e-05; 3.971484221432504e-05; 4.114864035295583e-05; 4.3188904868696655e-05; 4.360044574654907e-05; 4.8257135411913726e-05; 5.013426562854155e-05; 5.248375780672949e-05; 5.399364944210138e-05; 5.437020241719231e-05; 5.592330076699809e-05; 5.800116505773043e-05; 5.945938584340405e-05; 6.058590126387572e-05; 6.484707207749309e-05; 6.709590381814368e-05; 6.758558746827128e-05; 7.358523784131203e-05; 8.178614148996482e-05; 8.232890503539995e-05; 8.25206825409808e-05; 8.421319594446617e-05; 8.937909010875455e-05; 0.0001015974347517202; 0.00010334647523919963; 0.00010776056908698134; 0.00010886951500201832; 0.00010914466609698448; 0.0001119048288448298; 0.00011927896769899647; 0.00011927896769899647; 0.00012202062264879416; 0.00012949836610375056; 0.00012949836610375056; 0.0001322335978675375; 0.0001322335978675375; 0.00013846515856925812; 0.0001431024725510208; 0.00014636999075042076; 0.0001474322229096163; 0.00015093372108149775; 0.00015093372108149775; 0.00016189346720036038; 0.0001802305430549181; 0.0001802305430549181; 0.0001802305430549181; 0.0001802305430549181; 0.0001802305430549181; 0.0001802305430549181; 0.0001802305430549181; 0.000181883468787863; 0.0001934869050618567; 0.0001934869050618567; 0.0002043416381292249; 0.00021049732822064587; 0.00021049732822064587; 0.00021116105905857028; 0.00021116105905857028; 0.00021611859123914996; 0.0002214859278255797; 0.00022254302103317592; 0.00022254302103317592; 0.00022897551943886068; 0.00023793254517777995; 0.0002484853090912064; 0.00026224811620659125; 0.0002652452950458932; 0.0002718864504795822; 0.00027820432005572264; 0.0002926994143155384; 0.0002933384035122236; 0.00029355802758490503; 0.0002983150880926112; 0.0003022150453166086; 0.00032113080554701227; 0.0003278023880903879; 0.0003495642888428815; 0.00038453776693371663; 0.000420950947096172; 0.00042196010900515655; 0.0004243878730487336; 0.00042535405399404114; 0.0004303328941191692; 0.0004303328941191692; 0.00044420259326717257; 0.0004601228759628894; 0.00046565119871267287; 0.0004814724943641282; 0.0005011878920853237; 0.000513309425513094; 0.0005214896245221155; 0.0005255837979904586; 0.0005445028206157281; 0.0005632660372960827; 0.0006046022723190866; 0.0006165924034839279; 0.0006352060750206054; 0.0006445212280958682; 0.0006993549316202267; 0.0007074539367893701; 0.0007283216745489607; 0.0007283216745489607; 0.0007326127218377523; 0.0007731114749585194; 0.0008452277316123234; 0.0008673605584216904; 0.0009174737515799856; 0.0009325953874753212; 0.0010244557923259; 0.0010244557923259; 0.0010798279940823; 0.0010897868460616; 0.0011261416978188; 0.0011261416978188; 0.00116764658012; 0.0011876897533161; 0.0011876897533161; 0.0012983918214284; 0.0013033444225859; 0.0013033444225859; 0.0013510612738592; 0.0013734265963756; 0.0014485445504404; 0.0015652768725765; 0.0017107913939493; 0.0017731038420892; 0.0017731038420892; 0.0017856981020231; 0.0018360773814867; 0.0020089634269714; 0.0020282798161214; 0.0021326108499664; 0.002304426449738; 0.0025118094772522; 0.0025122887786423; 0.0025122887786423; 0.0025876779926919; 0.0027346449758241; 0.0028187518310092; 0.0028626589910413; 0.0029063499863533; 0.0033783379034436; 0.0033785221929293; 0.0035629033641169; 0.0037244768508078; 0.0038895739770004; 0.0039908077871836; 0.0039908077871836; 0.0039908077871836; 0.0040785542386402; 0.0041157458728674; 0.0043121462081946; 0.0044119363017658; 0.0044119363017658; 0.0047351775110072; 0.0048028611524245; 0.0048028611524245; 0.0048028611524245; 0.0048028611524245; 0.0050738495859132; 0.0050738495859132; 0.0050844857197244; 0.0050844857197244; 0.0054814673835909; 0.0058870598454808; 0.0066006052483961; 0.007117388576245; 0.007117388576245; 0.0072083035574659; 0.0072083035574659; 0.0073444206109429; 0.0075325383349707; 0.0082763563641252; 0.0082763563641252; 0.0083709650732796; 0.0083709650732796; 0.0083709650732796; 0.0083709650732796; 0.0083709650732796; 0.0084568432337518; 0.0089906473426575; 0.0093325514582534; 0.0095206592087124; 0.0096630827054915; 0.0102680775483548; 0.010343569493973; 0.0105367304020196; 0.0105367304020196; 0.0105367304020196; 0.0109519728029571; 0.0109519728029571; 0.0110109843340769; 0.0110109843340769; 0.0110109843340769; 0.0111888062322808; 0.0114187031414039; 0.0114187031414039; 0.0118679153788039; 0.0120771273149872; 0.0123983633418964; 0.0123983633418964; 0.0127059723723765; 0.0127059723723765; 0.0131305979622119; 0.0131305979622119; 0.0138441633831498; 0.0138441633831498; 0.0138441633831498; 0.0138441633831498; 0.0138441633831498; 0.0138829566912713; 0.0145436543557976; 0.015507621739214; 0.0157194401523571; 0.0160005762734352; 0.0160005762734352; 0.0162139207824563; 0.016456143422954; 0.0166041002652209; 0.0171001534176385; 0.0171001534176385; 0.0171001534176385; 0.0171001534176385; 0.0171001534176385; 0.0171001534176385; 0.0173964199029194; 0.0173964199029194; 0.0182000062506337; 0.018665947632861; 0.018665947632861; 0.018665947632861; 0.018665947632861; 0.018665947632861; 0.018665947632861; 0.018665947632861; 0.018665947632861; 0.0187299613301643; 0.0196225707350576; 0.0196314124927668; 0.0196345173194062; 0.0198983219186433; 0.0203198961621158; 0.0203198961621158; 0.0204735864411232; 0.0208452312614567; 0.021125667706065; 0.021125667706065; 0.0220575875892222; 0.0220705590988414; 0.0230684256648711; 0.0238425854040518; 0.0238425854040518; 0.0239461944596263; 0.0254956360475327; 0.0259817880808067; 0.0265829029717646; 0.027071413490175; 0.027071413490175; 0.0279220892715439; 0.0279220892715439; 0.030006907592274; 0.0303319552791211; 0.0314638805510678; 0.0314638805510678; 0.0319682790952413; 0.0335408281184641; 0.033749008368017; 0.0340266852061135; 0.0340645241548108; 0.0363737825516021; 0.0371129390384053; 0.0384689641633299; 0.0384689641633299; 0.0404707605808569; 0.0404707605808569; 0.0404707605808569; 0.0404707605808569; 0.0404707605808569; 0.0411765978055933; 0.0425171404778382; 0.0427786786335321; 0.044901297966643; 0.044901297966643; 0.0457039625575448; 0.0457039625575448; 0.0471006425252053; 0.0471006425252053; 0.048123203710384; 0.0493155676939993; 0.0493155676939993; 0.0517499693438671; 0.0517499693438671; 0.0543546439241988; 0.0554191598986221; 0.0569213530455915; 0.0569213530455915; 0.0569213530455915; 0.0569213530455915; 0.0583555368572174; 0.0625091602151466; 0.0678022600525665; 0.0691714743582008; 0.0700485361084771; 0.0716386930157756; 0.0716386930157756; 0.0723815120866587; 0.0723815120866587; 0.0749666609274744; 0.0749666609274744; 0.0749666609274744; 0.0749666609274744; 0.0784196844880443; 0.0805158056052076; 0.0814119493993337; 0.0817897187940979; 0.0835641020831185; 0.0858871491124922; 0.0864853123692039; 0.087414326021809; 0.0887863766478173; 0.0887984457495041; 0.0897127848630768; 0.0897127848630768; 0.0897127848630768; 0.0897127848630768; 0.0897127848630768; 0.0897127848630768; 0.0897127848630768; 0.0897127848630768; 0.0897127848630768; 0.0940427381982829; 0.0958856529689566; 0.0972679220674381; 0.0972679220674381; 0.0972679220674381; 0.0972679220674381; 0.0972679220674381; 0.0987575443309834; 0.0987575443309834; 0.0987575443309834; 0.1050724946352408; 0.1050724946352408; 0.1050724946352408; 0.1050724946352408; 0.1050724946352408; 0.1050724946352408; 0.1130019719865939; 0.1130019719865939; 0.1130019719865939; 0.1130019719865939; 0.1159436893514271; 0.1204795752338222; 0.1212040226252925; 0.124149904653194; 0.124149904653194; 0.1245376567919059; 0.1270483391700474; 0.1272255752567765; 0.1272255752567765; 0.1272255752567765; 0.1272255752567765; 0.1272255752567765; 0.1272255752567765; 0.1303940745126324; 0.1308906437806309; 0.1332119202868411; 0.1343310874911156; 0.1343310874911156; 0.1369039689436487; 0.1369039689436487; 0.1369039689436487; 0.1397055058487397; 0.1401454825042905; 0.1401454825042905; 0.1401454825042905; 0.1401454825042905; 0.1401454825042905; 0.1401454825042905; 0.1401454825042905; 0.1435325826114705; 0.1460848784791741; 0.1525119847960956; 0.1525119847960956; 0.1584804022044084; 0.1584804022044084; 0.1642913929691757; 0.1642913929691757; 0.1642913929691757; 0.1703929618871976; 0.1758774326276071; 0.176056923749369; 0.176056923749369; 0.176056923749369; 0.176056923749369; 0.176056923749369; 0.176056923749369; 0.176056923749369; 0.1812446566929033; 0.181710614199711; 0.1881045022168423; 0.1881045022168423; 0.1881045022168423; 0.1932166112700285; 0.1932166112700285; 0.1978060932497189; 0.1982833830495248; 0.1982833830495248; 0.1982833830495248; 0.1984316492066875; 0.2048516463561299; 0.2048516463561299; 0.2108300774722888; 0.2108300774722888; 0.2166737845423457; 0.2166737845423457; 0.2222592445219346; 0.2226324872503657; 0.2272199982000937; 0.236709594559292; 0.2416367579687983; 0.2416367579687983; 0.2416367579687983; 0.2551143159281861; 0.2570364810168682; 0.2622329318286966; 0.2650101216681973; 0.2786853069571751; 0.2786853069571751; 0.2823835751171575; 0.2906935310192522; 0.2921843338021302; 0.3023749229986328; 0.3243241301578816; 0.3446292548618789; 0.3587690037565285; 0.3806434842117995; 0.4282129311389295; 0.4282129311389295; 0.4371385994351301; 0.4395651618287257; 0.4409199497849633; 0.4424335623428572; 0.4481840103343354; 0.4535514871248414; 0.4712571109376817; 0.4748899891767304; 0.4854332397830083; 0.4886282001917928; 0.504829873207973; 0.5199487681301056; 0.5377205954278872; 0.5512955319444776; 0.5586510196217223; 0.569727243769542; 0.5864218078879415; 0.7784195453186156; 0.9081655753114188,Marfan Syndrome; Mammary Neoplasms; Alveolitis; Pulmonary Fibrosis; Palmoplantar Pustules; Rheumatoid Arthritis; Thyroid Gland Follicular Adenoma; Breast Carcinoma; Thyroid Neoplasm; Heart Failure; Psoriasis; Myocardial Infarction; Thyroid Carcinoma; Breast Cancer; Congestive Heart Failure; Multiple Myeloma; Carcinoma; Hypoplastic Anemia; Agranulocytosis; Anaplastic Carcinoma; High Grade Lymphoma; Intermediate Grade Lymphoma; Low Grade Lymphoma; Reticulosarcoma; Aplastic Anemia; Neutropenia; Acrania; Spinal Cord Myelodysplasia; Neurenteric Cyst; Diastematomyelia; Craniorachischisis; Amnesia; Diffuse Lymphoma; Neural Tube Defect; Non-Alcoholic Fatty Liver Disease; Thrombosis; Non-Hodgkin Lymphoma; Primary Tethered Cord Syndrome; Sarcoma; Anencephaly; Eye Diseases; Liver Cancer; Schizophrenia; Melanoma; Lymphoma; Colorectal Neoplasms; Liver Neoplasms; Myeloid Leukemia; Anemia; Myelomonocytic Leukemia; Leukemia; Colorectal Cancer,8.921950872070284e-08; 1.1417484002988661e-07; 3.1346476759108064e-07; 3.656047745092532e-06; 5.775106030172258e-06; 1.241997446075319e-05; 3.882845009510541e-05; 4.971054570440277e-05; 7.782144775199944e-05; 0.00015071968444989745; 0.00044166586682199737; 0.0005760978170082974; 0.0005818213110442873; 0.00063387456654884; 0.0028558709076653; 0.0072990932027619; 0.0107108189044139; 0.0168500742439455; 0.0188620845735379; 0.0352250843106217; 0.0511376198481248; 0.0511376198481248; 0.0511376198481248; 0.0511376198481248; 0.0592733852980501; 0.064825092293108; 0.0682669288241704; 0.0682669288241704; 0.0682669288241704; 0.0682669288241704; 0.0724494984851027; 0.0810252439964338; 0.0854401019808814; 0.0910638962801208; 0.0984994301026393; 0.0992543625886142; 0.1054719783837416; 0.1054719783837416; 0.114447693673355; 0.1546811849663119; 0.160518792997541; 0.173101397516021; 0.175139305620004; 0.1871442361706843; 0.1946052298376077; 0.2039740835961235; 0.2039740835961235; 0.2089805590322066; 0.2344334553667355; 0.2828835905949769; 0.5399696510344362; 0.6963620089820088,,,,,,,,
CSF3,"Pneumonia; Asthma; Psoriasis; Lymphoma; Multiple Myeloma; Lung diseases; Neutrophilia (disorder); Chronic Obstructive Airway Disease; Brain Injuries, Focal; Injuries, Acute Brain; Brain Injuries; Brain Lacerations; Non-Small Cell Lung Carcinoma; Autoimmune Diseases; Peritonitis; Ovarian Carcinoma; Cirrhosis; MYELOPROLIFERATIVE DISORDER, CHRONIC, WITH EOSINOPHILIA; Infection; Malignant neoplasm of ovary; Colitis; Dermatitis; Lung Neoplasms; Multiple Sclerosis; Neoplasm Metastasis; Mammary Neoplasms, Human; Hodgkin Disease; Pulmonary Fibrosis; Leukemia, Myelocytic, Acute; Liver Cirrhosis; Vascular Diseases; Arthritis; Cerebrovascular accident; Inflammatory Bowel Diseases; Obesity; Psoriasiform eczema; Liver neoplasms; HIV Infections; Mammary Neoplasms; Glioblastoma; leukemia; Diabetes Mellitus; Diabetes; Ischemic stroke; Pancreatic carcinoma; Coronary Artery Disease; Coronary heart disease; Alzheimer's Disease; Retinoic acid syndrome; Glioma; Epithelial ovarian cancer; Malignant neoplasm of pancreas; Van der Woude syndrome; Pain; Acquired Immunodeficiency Syndrome; Hamman-Rich syndrome; Myocardial Infarction; Infarction, Middle Cerebral Artery; Myocarditis; Septicemia; Sepsis; Malignant neoplasm of lung; Restenosis; Neonatal Early-Onset Sepsis; Liver diseases; Severe Sepsis; Chronic Lymphocytic Leukemia; Measles; Tumor Progression; Malignant neoplasm of breast; Cytomegalovirus Infections; Bladder Neoplasm; Coronary Arteriosclerosis; Graft-vs-Host Disease; Anemia, Sickle Cell; Liver carcinoma; Colonic Neoplasms; Immunologic Deficiency Syndromes; Influenza; Carcinoma of lung; Stomach Carcinoma; B-Cell Lymphomas; Colon Carcinoma; Malignant neoplasm of stomach; Osteosarcoma of bone; Astrocytoma; Bone Diseases; melanoma; Fever; Primary malignant neoplasm of lung; Breast Carcinoma; Osteosarcoma; Bacterial Infections; Malignant mesothelioma; Liver Cirrhosis, Experimental; Small cell carcinoma of lung; Encephalomyelitis; Acute Promyelocytic Leukemia; Acute lymphocytic leukemia; MYELODYSPLASTIC SYNDROME; Retinal Diseases; Candidiasis; Agranulocytosis; Aplastic Anemia; Prostate carcinoma; Malignant tumor of colon; Eosinophilic disorder; Myeloid Leukemia; Acute GVH disease; Fibrosis; Granulocytosis; Squamous cell carcinoma; Malignant neoplasm of prostate; Malignant neoplasm of urinary bladder; Pancreatic Neoplasm; precancerous lesions; Leukemia, Large Granular Lymphocytic; Carcinoma of bladder; Malignant Head and Neck Neoplasm; Lymphoma, Non-Hodgkin; Myelofibrosis; Eosinophilia; Childhood Glioblastoma; Adult Glioblastoma; Cardiomyopathy, Dilated; Hematologic Neoplasms; Pneumonia, Bacterial; Heart Failure, Right-Sided; Chronic graft-versus-host disease; Congestive heart failure; Malignant neoplasm of liver; Osteoporosis; Infectious disease of lung; Mucocutaneous Lymph Node Syndrome; Unipolar Depression; Congenital neutropenia; Stomatitis; Severe congenital neutropenia; Acute myelomonocytic leukemia; Carcinoma, Transitional Cell; Fibrosis, Liver; Pain, Crushing; Pain, Migratory; Pain, Splitting; Suffering, Physical; Ache; Radiating pain; Severe Aplastic Anemia; Myeloid Leukemia, Chronic; Pain, Burning; Neutropenia; Esophageal Neoplasms; Scleroderma; Anemia; Kidney Diseases; Pseudomonas aeruginosa infection; Cystitis; Gastrointestinal Diseases; Leukemogenesis; Heart failure; Precursor B-cell lymphoblastic leukemia; Acute Chest Syndrome; Central neuroblastoma; Drug-Induced Liver Disease; Nodular Lymphocyte Predominant Hodgkin Lymphoma; Skin Neoplasms; Squamous cell carcinoma of the head and neck; Heart Decompensation; Neuroblastoma; Heart Diseases; Carcinoma breast stage IV; Myeloproliferative disease; Precursor Cell Lymphoblastic Leukemia Lymphoma; Osteopenia; Refractory anemias; Myocardial Failure; Severe Combined Immunodeficiency; Septic Shock; Empyema; Gastrointestinal mucositis; Amyotrophic Lateral Sclerosis; Chronic granulomatous disease; CNS disorder; Left-Sided Heart Failure; Chronic Neutrophilic Leukemia; Primary Myelofibrosis; Inflammatory disease of mucous membrane; Post MI; Spontaneous abortion; Cervical Squamous Intraepithelial Neoplasia; Skin carcinoma; Disseminated Malignant Neoplasm; Hepatitis, Toxic; Chemical and Drug Induced Liver Injury; Chemically-Induced Liver Toxicity; Drug-Induced Acute Liver Injury; Adult Hodgkin Lymphoma; Hepatitis, Drug-Induced; Cardiomyopathies; Myeloid neoplasm; IMMUNE SUPPRESSION; Polycythemia Vera; Asymptomatic human immunodeficiency virus infection; Tooth Attrition; Hepatic Veno-Occlusive Disease; Pyemia; Malignant neoplasm of esophagus; Appendicitis; Extramedullary Hematopoiesis (disorder); Localized scleroderma; Head and Neck Neoplasms; Reticulosarcoma; Lymphoma, AIDS-Related; Abortion, Tubal; Childhood Acute Lymphoblastic Leukemia; Plasmacytoma; Choriocarcinoma; Chronic myeloproliferative disorder; Promyelocytic leukemia; Undifferentiated carcinoma; acute aortic dissection; Carcinomatosis; Liver Failure, Acute; Cardiomyopathy, Familial Idiopathic; Cytomegalovirus Retinitis; Vaso-Occlusive Crisis; Chronic idiopathic neutropenia; Left ventricular dilatation; Acute leukemia; Low Grade Lymphoma (neoplasm); Thrombocytopenia; Medulloblastoma; Anaplastic carcinoma; Diabetic Neuropathies; Cervical Intraepithelial Neoplasia; Infarction; Clear Cell Sarcoma of Soft Tissue; Hemangiosarcoma; Meningioma; Hematological Disease; Hodgkin lymphoma, lymphocyte depletion; Mixed Cellularity Hodgkin Lymphoma; Morphea; Lymphoid leukemia; Hyperactive behavior; Myelodysplasia; Oral Mucositis; Agenesis; Hypoplastic anemia; Lymphocyte Rich Classical Hodgkin Lymphoma; Malignant neoplasm of skin; Refractory anemia with excess blasts in transformation (clinical); SPINOCEREBELLAR ATAXIA 17; Immunosuppression; Leukopenia; Staphylococcal Infections; Aortic Rupture; Diarrhea; Head and Neck Carcinoma; Leukemia, B-Cell; Bone Marrow failure syndromes; Chagas Cardiomyopathy; Carcinoma, Spindle-Cell; Lymphoma, Mixed-Cell; Acute-On-Chronic Liver Failure; Diffuse Mixed-Cell Lymphoma; Toxic Epidermal Necrolysis; Lymphoma, Undifferentiated; Uterine Neoplasms; Arthralgia; Diphtheria; Lymphoma, Intermediate-Grade; T-Cell Large Granular Lymphocyte Leukemia; Enterocolitis; Leukemia, Myeloid, Chronic-Phase; Hereditary gingival fibromatosis; Lymphoma, Small Noncleaved-Cell; Childhood Burkitt Lymphoma; Carcinoma; Staphylococcus aureus infection; Neoplasm, Residual; Ventricular Dysfunction, Left; Monosomy; Refractory anemia, without ringed sideroblasts, without excess blasts; Drug-Induced Stevens Johnson Syndrome; Mycoplasma-Induced Stevens-Johnson Syndrome; Myelomonocytic leukemia; Oral Ulcer; Adverse reaction to drug; Drug toxicity; Peripheral Neuropathy; Soft Tissue Neoplasms; Headache; Stevens-Johnson Syndrome Toxic Epidermal Necrolysis Spectrum; Meningioma, benign, no ICD-O subtype; nervous system disorder; Depressive disorder; Adult Acute Myeloblastic Leukemia; Ewings sarcoma; High Grade Lymphoma (neoplasm); Retro-Ocular Headache; Sharp Headache; Leiomyosarcoma, Myxoid; Neutropenia, severe chronic; Throbbing Headache; Vertex Headache; Bilateral Headache; Generalized Headache; Hemicrania; Ocular Headache; Orthostatic Headache; Periorbital Headache; leiomyosarcoma; Endogenous depression; Acute Myeloid Leukemia, M1; Ischemic cardiomyopathy; Pancytopenia; secondary myelodysplastic syndromes; Leiomyosarcoma, Epithelioid; Chronic neutropenia; Primary ulcer of intestine; Acute Myeloid Leukemia (AML-M2); Stevens-Johnson Syndrome; Neoplasms, Therapy-Associated; Treatment related secondary malignancy; Liver Dysfunction; Lymphoma, Diffuse; Congenital chromosomal disease; Hyperbilirubinemia; Neurofibromatosis 1; Vesicular Stomatitis; Severe beta thalassemia; Angioendotheliomatosis; Myelokathexis; Chromosome 8, trisomy; Neck Neoplasms; Cholera Infantum; Multiple Acyl Coenzyme A Dehydrogenase Deficiency; secondary acute myeloid leukemia; Thalassemia; Poisoning; 3-Methylglutaconic aciduria type 2; Narrowing; Refractory anemia with ringed sideroblasts; Hypertrophy; Undifferentiated (Embryonal) Sarcoma; Glycogen Storage Disease Type I; Platelet Storage Pool Deficiency; Neoplasms, Second Primary; Functional Gastrointestinal Disorders; Left Ventricular Hypertrophy; Cyclic neutropenia; Febrile Neutropenia; Upper Aerodigestive Tract Neoplasms; Head Neoplasms; Cancer of Head; Cancer of Neck; Plasma Cell Neoplasm; Albinism, Oculocutaneous; Refractory anaemia with excess blasts; Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative; Depression, Neurotic; Nephroblastoma; Dyskeratosis Congenita; Melancholia; Depressive Syndrome; Sickle Cell Trait; Hemoglobinopathies; Uterine Cancer; Cooley's anemia; Chest Pain; Muscle Weakness; Myopathy",7.980856456624717e-16; 1.803641225501291e-12; 3.118210553589307e-12; 4.5104266881389206e-12; 2.5279022064249716e-11; 8.179290839744632e-11; 1.1574161017103878e-10; 1.3121548808139071e-10; 2.377251819497684e-10; 2.377251819497684e-10; 2.377251819497684e-10; 2.377251819497684e-10; 3.762648680673853e-10; 5.452288254986118e-10; 5.452288254986118e-10; 6.870627395110916e-10; 1.4790998733426532e-09; 1.5734876414130875e-09; 1.794870341379274e-09; 1.971893171900314e-09; 1.971893171900314e-09; 3.683115069310663e-09; 4.367699208727405e-09; 4.546836602575699e-09; 5.670785186683756e-09; 5.791865115913735e-09; 6.195332209150018e-09; 7.547641288501485e-09; 8.303910954283738e-09; 1.3128768066526236e-08; 1.4920329017331753e-08; 1.587872453479067e-08; 2.0570601164639797e-08; 2.3137704832524547e-08; 2.412608431251415e-08; 2.7368000175117756e-08; 4.3069383556698336e-08; 4.638299267461546e-08; 4.65353219894153e-08; 5.518991037343798e-08; 5.784935444423772e-08; 5.8317433871210796e-08; 6.156981490555128e-08; 6.156981490555128e-08; 6.982287075725826e-08; 8.598175402882612e-08; 9.273260676030806e-08; 9.273260676030806e-08; 1.0390067657961098e-07; 1.427432458937347e-07; 1.479813245926713e-07; 1.4925759778299788e-07; 1.524221047360518e-07; 1.6759866477134858e-07; 1.825346178149227e-07; 2.0732395681104218e-07; 2.247163660896597e-07; 2.400988116471548e-07; 3.880986260207744e-07; 5.254943571583271e-07; 5.313225371508493e-07; 6.299208964864026e-07; 6.673805318525932e-07; 6.805796735296268e-07; 7.17979149467092e-07; 7.873224494781308e-07; 7.931659047151387e-07; 7.99548070959303e-07; 8.297823048747685e-07; 8.660170029731726e-07; 8.887379906686178e-07; 9.822463166680949e-07; 1.0094398444517938e-06; 1.0094667484349083e-06; 1.2482007026109775e-06; 1.3079916134634371e-06; 1.4185164995612263e-06; 1.4839502431758565e-06; 2.027389637151193e-06; 2.027389637151193e-06; 2.07112526817849e-06; 2.1624936975752243e-06; 2.205236928124383e-06; 2.450940162208615e-06; 2.560217628497434e-06; 2.608032323197001e-06; 3.282956820548434e-06; 4.179146475474674e-06; 4.83171753412672e-06; 4.839188317483647e-06; 5.381279306135013e-06; 6.3131986281381465e-06; 6.378950690990071e-06; 7.439853898002338e-06; 7.691726899679507e-06; 1.0755368362337037e-05; 1.08089380369295e-05; 1.2304362232150695e-05; 1.2375081616087569e-05; 1.279493639647176e-05; 1.3010173302726732e-05; 1.3755659311680946e-05; 1.4439241578579364e-05; 1.4583987015565183e-05; 1.527992765491583e-05; 1.5498516107485843e-05; 1.8961926417889813e-05; 2.042524345007846e-05; 2.365778380659297e-05; 2.7001454785434173e-05; 2.878916650522013e-05; 3.053335644618538e-05; 3.053335644618538e-05; 3.1491435270594376e-05; 3.192298841377222e-05; 3.602405958537832e-05; 3.803310437251698e-05; 3.9650653676454574e-05; 4.3188904868696655e-05; 4.360044574654907e-05; 4.8257135411913726e-05; 5.248375780672949e-05; 5.437020241719231e-05; 5.800116505773043e-05; 5.826428641192471e-05; 6.058590126387572e-05; 6.758558746827128e-05; 7.358523784131203e-05; 7.358523784131203e-05; 8.232890503539995e-05; 8.421319594446617e-05; 9.117996105379778e-05; 9.846223464501226e-05; 9.913294924271568e-05; 0.00010334647523919963; 0.00010886951500201832; 0.00012858049944279123; 0.00012949836610375056; 0.00014636999075042076; 0.0001474322229096163; 0.0001690762138878921; 0.0001802305430549181; 0.0001802305430549181; 0.0001802305430549181; 0.0001802305430549181; 0.0001802305430549181; 0.0001802305430549181; 0.0001934869050618567; 0.00021049732822064587; 0.00021116105905857028; 0.00021611859123914996; 0.00021804014782198476; 0.00022254302103317592; 0.00022254302103317592; 0.00022336414159326664; 0.0002496596482692862; 0.00026339787549714257; 0.00026339787549714257; 0.0002652452950458932; 0.00027820432005572264; 0.0002926994143155384; 0.00031439908493214593; 0.00032113080554701227; 0.0003607853785819225; 0.0003987632373118045; 0.00041476222368508776; 0.000420950947096172; 0.0004303328941191692; 0.0004601228759628894; 0.0004814724943641282; 0.0004814724943641282; 0.0005011878920853237; 0.000513309425513094; 0.0005214896245221155; 0.0005255837979904586; 0.0005632660372960827; 0.0006993549316202267; 0.0007074539367893701; 0.0008673605584216904; 0.0009174737515799856; 0.0009325953874753212; 0.0010798279940823; 0.0010897868460616; 0.00116764658012; 0.0011876897533161; 0.0012983918214284; 0.0013734265963756; 0.0014485445504404; 0.0017731038420892; 0.0017731038420892; 0.0017856981020231; 0.0018360773814867; 0.001881335207053; 0.001881335207053; 0.001881335207053; 0.001881335207053; 0.0020049274325175; 0.0020282798161214; 0.0021326108499664; 0.0021326108499664; 0.002304426449738; 0.0025118094772522; 0.0025122887786423; 0.0027942850562877; 0.0027942850562877; 0.0027942850562877; 0.0030940063712108; 0.0033783379034436; 0.0033783379034436; 0.0033783379034436; 0.0035164243080016; 0.0035629033641169; 0.0037244768508078; 0.0038705790239355; 0.0038705790239355; 0.0039908077871836; 0.0043105477873176; 0.0044119363017658; 0.0044119363017658; 0.0048028611524245; 0.0048028611524245; 0.0050844857197244; 0.0053122016520353; 0.0053570195415722; 0.0059257679306595; 0.007117388576245; 0.007117388576245; 0.007117388576245; 0.0073444206109429; 0.0082763563641252; 0.0083709650732796; 0.0084568432337518; 0.0095206592087124; 0.0096630827054915; 0.0096630827054915; 0.0096630827054915; 0.0097159454554601; 0.0098716431177839; 0.0105367304020196; 0.0110109843340769; 0.0110109843340769; 0.0110109843340769; 0.0110109843340769; 0.0111888062322808; 0.0111888062322808; 0.0123983633418964; 0.0123983633418964; 0.0127059723723765; 0.0138441633831498; 0.0138441633831498; 0.0156113267570298; 0.018665947632861; 0.018665947632861; 0.018665947632861; 0.0196225707350576; 0.0203198961621158; 0.0203198961621158; 0.0209435845696216; 0.0214892684107681; 0.0231910952149837; 0.0239461944596263; 0.0239461944596263; 0.0254956360475327; 0.0259817880808067; 0.0279220892715439; 0.0279220892715439; 0.0284314613047093; 0.030006907592274; 0.030006907592274; 0.0300972754548838; 0.0303319552791211; 0.0319682790952413; 0.0319682790952413; 0.0319682790952413; 0.0324016809159931; 0.0357364979606411; 0.0384689641633299; 0.0384689641633299; 0.0404707605808569; 0.0404707605808569; 0.0427786786335321; 0.0427786786335321; 0.0442524445580864; 0.044901297966643; 0.044901297966643; 0.044901297966643; 0.044901297966643; 0.044901297966643; 0.0457039625575448; 0.0457039625575448; 0.0465235764214223; 0.0469394416375774; 0.0493155676939993; 0.0493155676939993; 0.057047868743524; 0.0678022600525665; 0.0691714743582008; 0.0716386930157756; 0.0741310297608694; 0.0749666609274744; 0.0817897187940979; 0.0817897187940979; 0.0817897187940979; 0.0817897187940979; 0.0817897187940979; 0.0817897187940979; 0.0817897187940979; 0.0817897187940979; 0.0817897187940979; 0.0817897187940979; 0.0817897187940979; 0.0817897187940979; 0.087414326021809; 0.0887863766478173; 0.0897127848630768; 0.0897127848630768; 0.0897127848630768; 0.0897127848630768; 0.0897127848630768; 0.0897127848630768; 0.0897127848630768; 0.0958856529689566; 0.0967179741949912; 0.0972679220674381; 0.0972679220674381; 0.098408395338696; 0.0987575443309834; 0.0996459063920158; 0.1016471070089966; 0.1018377089033323; 0.1107144880305473; 0.1130019719865939; 0.1206032442301429; 0.1272255752567765; 0.1332119202868411; 0.1332119202868411; 0.1343310874911156; 0.1343310874911156; 0.1369039689436487; 0.1584804022044084; 0.1584804022044084; 0.1642913929691757; 0.1642913929691757; 0.1703929618871976; 0.1703929618871976; 0.176056923749369; 0.176056923749369; 0.1881045022168423; 0.1932166112700285; 0.1932166112700285; 0.2108300774722888; 0.2108300774722888; 0.2226324872503657; 0.2272199982000937; 0.2272199982000937; 0.2316568843888361; 0.2316568843888361; 0.236709594559292; 0.2468771733501051; 0.2468771733501051; 0.2622329318286966; 0.2823835751171575; 0.2906935310192522; 0.2921843338021302; 0.2921843338021302; 0.2972644135001306; 0.3023749229986328; 0.316142834424839; 0.3929133356162864; 0.417000940404929; 0.4395651618287257; 0.4424335623428572; 0.5632441764027045,"Marfan Syndrome; Mammary Neoplasms; Alveolitis; Pulmonary Fibrosis; Breast Carcinoma; Heart Failure; Myocardial Infarction; Breast Cancer; Congestive Heart Failure; Soft Tissue Neoplasms; Cirrhosis; Septicemia; Multiple Myeloma; Miscarriage; Carcinoma; Hypoplastic Anemia; B-Cell Lymphoma; Agranulocytosis; Bladder Neoplasm; Hodgkin Lymphoma; Hodgkin Lymphoma, Lymphocyte Depletion; Urinary Bladder Cancer; Anaplastic Carcinoma; Nervous System Disorder; Skin Cancer; Mental Depression; High Grade Lymphoma; Intermediate Grade Lymphoma; Low Grade Lymphoma; Reticulosarcoma; Classical Hodgkin Lymphoma; Aplastic Anemia; Neutropenia; Hodgkin Disease; Diffuse Lymphoma; Lung Carcinoma; Endometrial Neoplasms; Skin Neoplasms; Non-Hodgkin Lymphoma; Scleroderma; Hyperbilirubinemia; Treatment Related Secondary Malignancy; Cardiomyopathy; Leiomyosarcoma; Nervous System Diseases; Liver Cancer; Esophagus Neoplasm; Functional Gastrointestinal Disorders; Melanoma; Lymphoma; Gastrointestinal Diseases; Liver Neoplasms; Liver Failure; Myeloid Leukemia; Hemangiosarcoma; Anemia; Upper Aerodigestive Tract Neoplasms; Head Neoplasms; Neoplasm Of Head; Neck Neoplasms; Neck Cancer; Kidney Disease; Stomatitis; Stevens-Johnson Syndrome; Endometrial Cancer; Head And Neck Neoplasms; Melancholia; Head And Neck Cancer; Heart Diseases; Myopathy; Leukemia; Leukopenia; Pancytopenia",8.921950872070284e-08; 1.1417484002988661e-07; 3.1346476759108064e-07; 3.656047745092532e-06; 4.971054570440277e-05; 0.00015071968444989745; 0.0005760978170082974; 0.00063387456654884; 0.0028558709076653; 0.007221192915733; 0.007221192915733; 0.007221192915733; 0.0072990932027619; 0.0088732170532262; 0.0107108189044139; 0.0168500742439455; 0.0186439654623197; 0.0188620845735379; 0.021392225047824; 0.0242477651311773; 0.0242477651311773; 0.0264273671824767; 0.0352250843106217; 0.037484696011653; 0.0462866256396667; 0.0511376198481248; 0.0511376198481248; 0.0511376198481248; 0.0511376198481248; 0.0511376198481248; 0.0554517833122258; 0.0592733852980501; 0.064825092293108; 0.0668923554370046; 0.0854401019808814; 0.0868883392670891; 0.0910638962801208; 0.0992543625886142; 0.1054719783837416; 0.1110148026021272; 0.1202723965415913; 0.1203844668559877; 0.1273861908316246; 0.1386032662139448; 0.1700432900208007; 0.173101397516021; 0.175139305620004; 0.175139305620004; 0.1871442361706843; 0.1946052298376077; 0.2003502278196653; 0.2039740835961235; 0.2062454941617454; 0.2089805590322066; 0.2247736041224312; 0.2344334553667355; 0.2450716998247367; 0.2450716998247367; 0.2450716998247367; 0.2502315247388869; 0.2502315247388869; 0.2657257246540625; 0.2828835905949769; 0.3175014660376726; 0.3175014660376726; 0.3317467420738357; 0.337316260906421; 0.3603176382172478; 0.3636022406609426; 0.3849207284113362; 0.5399696510344362; 0.5497471152766266; 0.578940325503892,,,,,,,,
CX3CL1,"Inflammation; Pneumonia; Asthma; Psoriasis; Lymphoma; Virus Diseases; Dermatitis, Atopic; Lung diseases; Lobar Pneumonia; Rheumatoid Arthritis; Arteriosclerosis; Pneumonitis; Uveitis; Endometriosis; Ulcerative Colitis; Pancreatitis, Chronic; Multiple Sclerosis; Cerebral Ischemia; Neoplasm Metastasis; Experimental Lung Inflammation; Hepatitis C; Atherosclerosis; Acute pancreatitis; Anti-Basement Membrane Glomerulonephritis; Glomerulonephritis; Hypertensive disease; Vascular Diseases; Eczema; Allergic Reaction; Inflammatory Bowel Diseases; Obesity; HIV Infections; Mammary Neoplasms; Aortic Aneurysm, Abdominal; Coronary Artery Disease; Coronary heart disease; Alzheimer's Disease; Adenocarcinoma of pancreas; Sjogren's Syndrome; Encephalitis; Glioma; Epithelial ovarian cancer; Myocardial Infarction; Cerebral Infarction; Anoxia; Myocardial Ischemia; Myocarditis; Restenosis; Liver diseases; Malignant neoplasm of breast; Cytomegalovirus Infections; Coronary Arteriosclerosis; Systemic Scleroderma; Hypersensitivity; Transient Ischemic Attack; Immune System Diseases; Bronchiolitis; Breast Carcinoma; M5b Acute differentiated monocytic leukemia; Stable angina; Retinal Diseases; Acute monocytic leukemia; Diabetic Retinopathy; Diabetes Mellitus, Experimental; Streptozotocin Diabetes; Alloxan Diabetes; Prostate carcinoma; Prostatic Neoplasms; Malignant neoplasm of prostate; Parkinson Disease; Rhinitis; Biliary Atresia; Pulmonary Hypertension; Congestive heart failure; Other specified transient cerebral ischemias; Age related macular degeneration; Neurodegenerative Disorders; Multiple Sclerosis, Relapsing-Remitting; Status Epilepticus; Diabetes Mellitus, Non-Insulin-Dependent; Pancreatic Ductal Adenocarcinoma; Pulmonary Emphysema; Neoplasms; Cystitis; Heart failure; Sarcoma; Central neuroblastoma; Secondary malignant neoplasm of lymph node; Hemolytic-Uremic Syndrome; Hepatitis; Hypertension, Portal; Neuroblastoma; Ischemia; Refractory anemias; Sicca Syndrome; Prion Diseases; Malaria, Falciparum; Rheumatism; Carotid Atherosclerosis; Hepatopulmonary Syndrome; Connective Tissue Diseases; Cutaneous hypersensitivity; Cutaneous Mastocytosis; Steroid Sulfatase Deficiency Disease; PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE; Nephrosis; Ichthyosis, X-Linked; Pancreatic intraepithelial neoplasia; Borna Disease; Carotid Artery Plaque; Lung Diseases, Obstructive; Pulmonary Embolism; Sweet Syndrome; Neuralgia; Rheumatoid Vasculitis; Impaired cognition; Leukocytoclastic vasculitis; synovial sarcoma; Vasculitis, Leukocytoclastic, Cutaneous; Pruritus; Clinically isolated syndrome; Polyarteritis Nodosa",2.8114433253573326e-17; 7.980856456624717e-16; 1.803641225501291e-12; 3.118210553589307e-12; 4.5104266881389206e-12; 6.332483647919588e-11; 7.448716379948652e-11; 8.179290839744632e-11; 8.179290839744632e-11; 1.9241179247341838e-10; 2.377251819497684e-10; 2.813069300429449e-10; 6.429879513246633e-10; 7.868397426275417e-10; 1.6767489697325582e-09; 2.219129913614883e-09; 4.546836602575699e-09; 4.756590990483e-09; 5.670785186683756e-09; 5.670785186683756e-09; 6.991207850982321e-09; 7.195555613367576e-09; 7.713813941246406e-09; 8.853567275424139e-09; 1.0368326871660785e-08; 1.0368326871660785e-08; 1.4920329017331753e-08; 1.4920329017331753e-08; 2.2764946043880388e-08; 2.3137704832524547e-08; 2.412608431251415e-08; 4.638299267461546e-08; 4.65353219894153e-08; 5.1290058242058653e-08; 8.598175402882612e-08; 9.273260676030806e-08; 9.273260676030806e-08; 9.306686765839445e-08; 1.0276547515522002e-07; 1.3150328464481586e-07; 1.427432458937347e-07; 1.479813245926713e-07; 2.247163660896597e-07; 2.419125491442217e-07; 2.911052249927245e-07; 2.948344121290337e-07; 3.880986260207744e-07; 6.673805318525932e-07; 7.17979149467092e-07; 8.660170029731726e-07; 8.887379906686178e-07; 1.0094398444517938e-06; 1.10068355868735e-06; 1.1523181751478311e-06; 1.5208470671427406e-06; 2.546221763226728e-06; 5.021572339409501e-06; 5.381279306135013e-06; 8.591027139424906e-06; 1.1652528807336014e-05; 1.3010173302726732e-05; 1.3268923055385737e-05; 1.3410647656206684e-05; 1.3410647656206684e-05; 1.3410647656206684e-05; 1.3410647656206684e-05; 1.527992765491583e-05; 2.0820699372778346e-05; 3.053335644618538e-05; 3.372277447426952e-05; 5.399364944210138e-05; 6.964870190365813e-05; 8.232890503539995e-05; 8.232890503539995e-05; 9.56957692518114e-05; 0.00010334647523919963; 0.00010914466609698448; 0.00012202062264879416; 0.0001616561904035017; 0.00016189346720036038; 0.0001802305430549181; 0.0001802305430549181; 0.00022897551943886068; 0.00026339787549714257; 0.00027820432005572264; 0.00029355802758490503; 0.00032113080554701227; 0.000323910443746482; 0.000399963770573658; 0.00040624424086014313; 0.0004136970830881728; 0.0004601228759628894; 0.00047142552462714113; 0.0005255837979904586; 0.0010244557923259; 0.0011303542860313; 0.0017329922477138; 0.002213465225837; 0.0032682022992594; 0.0059257679306595; 0.0080667733705833; 0.0083709650732796; 0.0120771273149872; 0.0131305979622119; 0.0131305979622119; 0.0145436543557976; 0.0162139207824563; 0.0220705590988414; 0.0340266852061135; 0.0340266852061135; 0.0384689641633299; 0.0402448379890702; 0.0650424286909672; 0.0692193903915762; 0.0817897187940979; 0.0835641020831185; 0.0972679220674381; 0.1087303638328369; 0.1130019719865939; 0.1156074612838089; 0.1343310874911156; 0.2468771733501051,Myocardial Ischemia; Prostatic Neoplasms; Prostate Cancer,7.071068485513988e-10; 0.0567647407547259; 0.1386032662139448,"Complement component 3 deficiency ORPHA:280133; OBSOLETE: Alpha-1-antichymotrypsin deficiency ORPHA:93594; Aceruloplasminemia ORPHA:48818; Immunodeficiency with factor I anomaly ORPHA:200418; Lipoprotein glomerulopathy ORPHA:329481; Retinal macular dystrophy type 2 ORPHA:319640; Sea-blue histiocytosis ORPHA:158029; Dysbetalipoproteinemia ORPHA:412; Autosomal recessive spastic paraplegia type 5A ORPHA:100986; Chronic respiratory distress with surfactant metabolism deficiency ORPHA:217566; Congenital bile acid synthesis defect type 3 ORPHA:79302; X-linked intellectual disability, Stocco Dos Santos type ORPHA:85288; Interstitial lung disease due to SP-C deficiency ORPHA:440392; Pendred syndrome ORPHA:705",0.0133474287859103; 0.0514345493431829; 0.1927589191138116; 0.1927589191138116; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659,Cercopithecine betaherpesvirus 5 chemokine vCXCL5 (gene: UL146B); Vaccinia virus chemokine binding protein (gene: C23L); Vaccinia virus Ankara viral chemokine binding protein; Cercopithecine betaherpesvirus 5 chemokine vCXCL10 (gene: UL146G); Cowpox virus CrmD or CPXV221 protein (gene: CrmD); Variola virus chemokine binding protein (gene: G5R); Variola virus hypothetical protein (gene: G4R); Ectromelia virus ERPV tumor necrosis factor receptor; Horsepox virus HSPV003 (Tumor necrosis factor receptor superfamily members); Human gammaherpesvirus 8 K6 (gene: K6); Monkeypox virus Zaire-96-I-16 J2L (gene: J2L); Cowpox virus CrmB or CPXV005 protein (gene: crmB); Human betaherpesvirus 5 chemokine vCXCL1 (gene: UL146); Cercopithecine betaherpesvirus 5 chemokine vCXCL2 (gene: UL147); Monkeypox virus TNF-alpha-receptor-like protein; Human betaherpesvirus 5 chemokine vCXCL2 (gene: UL147); Monkeypox virus chemokine-binding protein; Monkeypox virus Zaire-96-I-16 chemokine binding protein (gene: J1L); Human gammaherpesvirus 8 K4.1 (gene: K4.1); Molluscum contagiosum virus subtype 1 MC148R (gene: MC148R); Horsepox virus HSPV002 (chemokine binding protein; Provisional); Cowpox virus CPXV014 protein (gene: CPXV014 CDS); Cowpox virus vCCI or CPXV003 protein (gene: vCCI); Human betaherpesvirus 5 envelope protein US28 (gene: US28),3.855107856457681e-08; 5.6633714501424107e-08; 5.6633714501424107e-08; 2.3160451568389139e-07; 2.3160451568389139e-07; 3.201246660025618e-07; 5.350651473977266e-07; 5.350651473977266e-07; 5.350651473977266e-07; 9.087104857163152e-07; 9.087104857163152e-07; 1.12171834090951e-06; 1.12171834090951e-06; 1.12171834090951e-06; 1.12171834090951e-06; 1.3435225153003765e-06; 1.414266919056462e-06; 1.5653663269440003e-06; 1.7536244306421314e-06; 2.1974600826970047e-06; 2.6957073977079108e-05; 4.27038107129517e-05; 0.0631001667367807; 0.3911903778732946,,,,
CXCL1,"Inflammation; Pneumonia; Reperfusion Injury; Asthma; Psoriasis; Familial M??ni??re disease; Juvenile arthritis; Virus Diseases; Dermatitis, Atopic; Lung diseases; Lobar Pneumonia; Chronic Obstructive Airway Disease; Rheumatoid Arthritis; Arteriosclerosis; Pneumonitis; Non-Small Cell Lung Carcinoma; Autoimmune Diseases; Peritonitis; Ovarian Carcinoma; Endometriosis; Cirrhosis; MYELOPROLIFERATIVE DISORDER, CHRONIC, WITH EOSINOPHILIA; Ulcerative Colitis; Malignant neoplasm of ovary; Tumor Angiogenesis; Dermatitis; Multiple Sclerosis; Neoplasm Metastasis; Experimental Lung Inflammation; Inflammatory dermatosis; Hepatitis C; Atherosclerosis; Leukemia, Myelocytic, Acute; Liver Cirrhosis; Eczema; Arthritis; Infection caused by Helicobacter pylori; Degenerative polyarthritis; Allergic Reaction; Kaposi Sarcoma; Mammary Neoplasms; Arthritis, Psoriatic; Coronary Artery Disease; Dermatologic disorders; Alzheimer's Disease; Sjogren's Syndrome; Encephalitis; Glioma; Epithelial ovarian cancer; Hepatitis C, Chronic; Glossitis, Benign Migratory; Malignant neoplasm of lung; Liver diseases; Tumor Progression; Malignant neoplasm of breast; Gastritis; Bladder Neoplasm; Hypersensitivity; Anemia, Sickle Cell; Liver carcinoma; Immunologic Deficiency Syndromes; Carcinogenesis; Carcinoma of lung; Stomach Carcinoma; Colon Carcinoma; Shock, Hemorrhagic; Malignant neoplasm of stomach; Astrocytoma; Kidney Failure, Acute; Erythema Chronicum Migrans; melanoma; Primary malignant neoplasm of lung; Breast Carcinoma; Mycoses; Bacterial Infections; Thyroid carcinoma; Liver Cirrhosis, Experimental; Guillain-Barre Syndrome; Encephalomyelitis; Aspiration Pneumonia; Bronchial Hyperreactivity; Prostate carcinoma; Malignant tumor of colon; Vascular lesions; ovarian neoplasm; Juvenile psoriatic arthritis; Severe Acute Respiratory Syndrome; Malignant neoplasm of endometrium; Uterine Corpus Cancer; Juvenile-Onset Still Disease; Chronic Airflow Obstruction; Squamous cell carcinoma; Malignant neoplasm of prostate; Hepatitis, Autoimmune; Endometrial adenocarcinoma; Meningitis; Malignant Head and Neck Neoplasm; Proliferative vitreoretinopathy; Cardiomyopathy, Dilated; Research-Related Injuries; Traumatic injury; Wounds and Injuries; Injury wounds; Pneumonia, Bacterial; Primary Sj??gren's syndrome; Adenoma; Cerebral arterial aneurysm; Chronic arthritis; Peritonsillar Abscess; Endometrial Carcinoma; Status Epilepticus; Colorectal Carcinoma; Esophageal Neoplasms; Liver Cirrhosis, Alcoholic; Amyloidosis; Acute colitis; Drug-Induced Liver Disease; Colorectal Cancer; Carcinoma breast stage IV; Focal glomerulosclerosis; Necrotizing enterocolitis in fetus OR newborn; Guillain-Barre Syndrome, Familial; Group B Streptococcal Infection; Secondary malignant neoplasm of liver; Precancerous Conditions; DOSAGE-SENSITIVE SEX REVERSAL; Hepatitis, Toxic; Chemical and Drug Induced Liver Injury; Chemically-Induced Liver Toxicity; Drug-Induced Acute Liver Injury; Adenoma of large intestine; Dejerine-Sottas Disease (disorder); Hepatitis, Drug-Induced; Cerebral Aneurysm; Cowpox; Malignant neoplasm of esophagus; Pneumonia, Viral; acute aortic dissection; Rhegmatogenous retinal detachment; Vaso-Occlusive Crisis; Arthus Reaction; Carcinoma, Neuroendocrine; Esophageal carcinoma; Thrombocythemia, Essential; Renal cyst; Retinal Detachment; Hemangioendothelioma; Chronic inflammatory disorder; Aortic Rupture; Respiratory Hypersensitivity; Craniosynostosis; prostatitis; Keloid; Infective vaginitis; Dysplastic Nevus",2.8114433253573326e-17; 7.980856456624717e-16; 4.4398736172867135e-14; 1.803641225501291e-12; 3.118210553589307e-12; 3.861499575207375e-12; 3.861499575207375e-12; 6.332483647919588e-11; 7.448716379948652e-11; 8.179290839744632e-11; 8.179290839744632e-11; 1.3121548808139071e-10; 1.9241179247341838e-10; 2.377251819497684e-10; 2.813069300429449e-10; 3.762648680673853e-10; 5.452288254986118e-10; 5.452288254986118e-10; 6.870627395110916e-10; 7.868397426275417e-10; 1.4790998733426532e-09; 1.5734876414130875e-09; 1.6767489697325582e-09; 1.971893171900314e-09; 3.315537369635636e-09; 3.683115069310663e-09; 4.546836602575699e-09; 5.670785186683756e-09; 5.670785186683756e-09; 6.0322241000340585e-09; 6.991207850982321e-09; 7.195555613367576e-09; 8.303910954283738e-09; 1.3128768066526236e-08; 1.4920329017331753e-08; 1.587872453479067e-08; 1.7931366647560766e-08; 2.1034803123367165e-08; 2.2764946043880388e-08; 3.149054123564124e-08; 4.65353219894153e-08; 5.071217747675114e-08; 8.598175402882612e-08; 9.273260676030806e-08; 9.273260676030806e-08; 1.0276547515522002e-07; 1.3150328464481586e-07; 1.427432458937347e-07; 1.479813245926713e-07; 2.46778041958494e-07; 2.824526360848301e-07; 6.299208964864026e-07; 7.17979149467092e-07; 8.297823048747685e-07; 8.660170029731726e-07; 9.58028929735367e-07; 9.822463166680949e-07; 1.1523181751478311e-06; 1.2482007026109775e-06; 1.3079916134634371e-06; 1.4839502431758565e-06; 1.51758575162775e-06; 2.027389637151193e-06; 2.07112526817849e-06; 2.205236928124383e-06; 2.3756085216561533e-06; 2.450940162208615e-06; 2.608032323197001e-06; 3.485726441474513e-06; 3.990817553511259e-06; 4.179146475474674e-06; 4.839188317483647e-06; 5.381279306135013e-06; 5.572620871465934e-06; 6.378950690990071e-06; 6.889889014378816e-06; 7.691726899679507e-06; 9.18171819472328e-06; 1.08089380369295e-05; 1.2765469826010355e-05; 1.3268923055385737e-05; 1.527992765491583e-05; 1.5498516107485843e-05; 1.595911218164779e-05; 1.8507296589967813e-05; 1.8961926417889813e-05; 2.1083292452040976e-05; 2.389985034001877e-05; 2.483118059238325e-05; 2.5791573703443737e-05; 2.9890125380431698e-05; 3.053335644618538e-05; 3.053335644618538e-05; 3.1066725823367694e-05; 3.1066725823367694e-05; 3.14076229962439e-05; 4.3188904868696655e-05; 5.592330076699809e-05; 5.826428641192471e-05; 6.734766728729227e-05; 6.734766728729227e-05; 6.734766728729227e-05; 6.734766728729227e-05; 6.758558746827128e-05; 8.232890503539995e-05; 0.00012202062264879416; 0.00012202062264879416; 0.00012858049944279123; 0.00012949836610375056; 0.0001322335978675375; 0.0001616561904035017; 0.00016189346720036038; 0.00021804014782198476; 0.0002792365191965819; 0.0003495642888428815; 0.0003539177308293034; 0.0003607853785819225; 0.00038453776693371663; 0.0004814724943641282; 0.0005486681594044074; 0.0008252744167874381; 0.0008673605584216904; 0.0008673605584216904; 0.0010244557923259; 0.0012688388196185; 0.0015725978289892; 0.001881335207053; 0.001881335207053; 0.001881335207053; 0.001881335207053; 0.001881335207053; 0.0019553944568237; 0.0020282798161214; 0.0022674286916718; 0.0029063499863533; 0.0030940063712108; 0.003846910040485; 0.0048028611524245; 0.0059257679306595; 0.007117388576245; 0.007117388576245; 0.008634277457381; 0.0089906473426575; 0.0105367304020196; 0.0127059723723765; 0.0131305979622119; 0.0138441633831498; 0.0145436543557976; 0.0203198961621158; 0.0239461944596263; 0.0392832161328838; 0.0517499693438671; 0.1621030999931119; 0.1642913929691757; 0.4282129311389295,"Juvenile Arthritis; Polyarthritis, Rheumatoid Factor Positive; Seronegative Polyarthritis; Still Disease; Bronchial Hyperreactivity; Arthritis; Autoimmune Hepatitis; Chronic Obstructive Pulmonary Disease",1.1394948069325325e-05; 1.1394948069325325e-05; 3.928596547519457e-05; 5.1065830658055726e-05; 0.0010004280397286; 0.0015169561374293; 0.0051651768824686; 0.0173324463553544,"Systemic-onset juvenile idiopathic arthritis ORPHA:85414; Quebec platelet disorder ORPHA:220436; Lattice corneal dystrophy type I ORPHA:98964; Reis-Bucklers corneal dystrophy ORPHA:98961; Cryptogenic multifocal ulcerous stenosing enteritis ORPHA:468635; Cytosolic phospholipase-A2 alpha deficiency associated bleeding disorder ORPHA:477787; Epithelial basement membrane dystrophy ORPHA:98956; Thiel-Behnke corneal dystrophy ORPHA:98960; Granular corneal dystrophy type I ORPHA:98962; Granular corneal dystrophy type II ORPHA:98963; Metaphyseal anadysplasia ORPHA:1040; Niemann-Pick disease type C, adult neurologic onset ORPHA:216986; Niemann-Pick disease type C, juvenile neurologic onset ORPHA:216981; Niemann-Pick disease type C, late infantile neurologic onset ORPHA:216978; Niemann-Pick disease type C, severe early infantile neurologic onset ORPHA:216975; Niemann-Pick disease type C, severe perinatal form ORPHA:216972; FTH1-related iron overload ORPHA:247790; Thrombomodulin-related bleeding disorder ORPHA:436169; Heme oxygenase-1 deficiency ORPHA:562509; Atypical hemolytic uremic syndrome with complement gene abnormality ORPHA:544472; Hypoplastic amelogenesis imperfecta ORPHA:100031; Keratolytic winter erythema ORPHA:50943; NON RARE IN EUROPE: Wolff-Parkinson-White syndrome ORPHA:907; Fatal congenital hypertrophic cardiomyopathy due to glycogen storage disease ORPHA:439854",1.514756890441811e-09; 3.28973817825433e-05; 0.0002132495254484572; 0.0002132495254484572; 0.0002132495254484572; 0.0002132495254484572; 0.0002132495254484572; 0.0002132495254484572; 0.0002132495254484572; 0.0002132495254484572; 0.0002132495254484572; 0.0002132495254484572; 0.0002132495254484572; 0.0002132495254484572; 0.0002132495254484572; 0.0002132495254484572; 0.0514345493431829; 0.0514345493431829; 0.0514345493431829; 0.0514345493431829; 0.0565022767519947; 0.1927589191138116; 0.1927589191138116; 0.1927589191138116,Cercopithecine betaherpesvirus 5 chemokine vCXCL5 (gene: UL146B); Vaccinia virus chemokine binding protein (gene: C23L); Vaccinia virus Ankara viral chemokine binding protein; Cercopithecine betaherpesvirus 5 chemokine vCXCL10 (gene: UL146G); Variola virus chemokine binding protein (gene: G5R); Cercopithecine betaherpesvirus 5 chemokine vCXCL9 (gene: UL146F); Human betaherpesvirus 5 chemokine vCXCL1 (gene: UL146); Cercopithecine betaherpesvirus 5 chemokine vCXCL2 (gene: UL147); Human betaherpesvirus 5 chemokine vCXCL2 (gene: UL147); Monkeypox virus chemokine-binding protein; Monkeypox virus Zaire-96-I-16 chemokine binding protein (gene: J1L); Human gammaherpesvirus 8 K4.1 (gene: K4.1); Molluscum contagiosum virus subtype 1 MC148R (gene: MC148R); Cercopithecine betaherpesvirus 5 chemokine vCXCL6 (gene: UL146C); Monkeypox virus Zaire-96-I-16 IEV and EEV membrane glycoprotein (gene: A36R); Monkeypox virus EEV glycoprotein; Cowpox virus CPXV177 protein (gene: CPXV177 CDS),3.855107856457681e-08; 5.6633714501424107e-08; 5.6633714501424107e-08; 2.3160451568389139e-07; 3.201246660025618e-07; 9.087104857163152e-07; 1.12171834090951e-06; 1.12171834090951e-06; 1.3435225153003765e-06; 1.414266919056462e-06; 1.5653663269440003e-06; 1.7536244306421314e-06; 2.1974600826970047e-06; 0.1015629191226059; 0.3911903778732946; 0.6410694868065719; 0.7363777254504653,,,,
CXCL10,"Inflammation; Pneumonia; Asthma; Psoriasis; Familial M??ni??re disease; Juvenile arthritis; Lymphoma; Multiple Myeloma; Virus Diseases; Dermatitis, Atopic; Lung diseases; Neutrophilia (disorder); Chronic Obstructive Airway Disease; Rheumatoid Arthritis; Thyroid associated opthalmopathies; Brain Injuries, Focal; Injuries, Acute Brain; Brain Injuries; Brain Lacerations; Pneumonitis; Non-Small Cell Lung Carcinoma; Autoimmune Diseases; Uveitis; Sarcoidosis; Endometriosis; cervical cancer; Cirrhosis; Ulcerative Colitis; Infection; Colitis; Pancreatitis, Chronic; Tumor Angiogenesis; Multiple Sclerosis; Cerebral Ischemia; Neoplasm Metastasis; Inflammatory dermatosis; Hodgkin Disease; Hepatitis C; Graves Disease; Glomerulonephritis; Liver Cirrhosis; Respiratory syncytial virus (RSV) infection in conditions classified elsewhere and of unspecified site; Eczema; Arthritis; Brain Ischemia; Cerebrovascular accident; Degenerative polyarthritis; Respiratory Distress Syndrome, Adult; Inflammatory Bowel Diseases; Obesity; Auricular swelling; Kaposi Sarcoma; Hyperglycemia; Liver neoplasms; HIV Infections; Mammary Neoplasms; Glioblastoma; leukemia; Diabetes Mellitus; Juvenile rheumatoid arthritis; Leishmaniasis, Cutaneous; Diabetes; Lupus Erythematosus, Systemic; Pancreatic carcinoma; Dermatologic disorders; Behcet Syndrome; Sjogren's Syndrome; Dermatitis, Allergic Contact; Malaria; Encephalitis; Glioma; Malignant neoplasm of pancreas; Pain; Acquired Immunodeficiency Syndrome; Respiratory Syncytial Virus Infections; Hamman-Rich syndrome; Inflammatory disorder; Myocardial Infarction; Hepatitis C, Chronic; Glossitis, Benign Migratory; Myocardial Ischemia; Bronchiolitis Obliterans; Myocarditis; Tuberculosis; Diabetes Mellitus, Insulin-Dependent; Liver diseases; Chronic Lymphocytic Leukemia; Measles; Tumor Progression; Thromboangiitis Obliterans; Malignant neoplasm of breast; Myasthenia Gravis; Cytomegalovirus Infections; Gastritis; Bladder Neoplasm; Diabetic Nephropathy; Systemic Scleroderma; Liver carcinoma; Colonic Neoplasms; Carcinogenesis; Nasopharyngeal carcinoma; Lung Diseases, Interstitial; Endometrial Neoplasms; Influenza; Stomach Carcinoma; Colon Carcinoma; Leishmaniasis, Visceral; Malignant neoplasm of stomach; Lupus Nephritis; Lymphoma, T-Cell, Cutaneous; Tuberculosis, Pulmonary; Erythema Chronicum Migrans; melanoma; Breast Carcinoma; Henoch-Schoenlein Purpura; Idiopathic Inflammatory Myopathies; Meningococcal Infections; Mycoses; Dermatitis, Irritant; Polymyositis; Thyroid carcinoma; Malignant mesothelioma; Liver Cirrhosis, Experimental; Epstein-Barr Virus Infections; Sarcoidosis, Pulmonary; Hepatitis B, Chronic; Encephalomyelitis; Stable angina; Acute lymphocytic leukemia; Colorectal Neoplasms; Diabetic Retinopathy; Sezary Syndrome; Hepatitis B; Presenile dementia; Rabies (disorder); Malignant tumor of colon; Eosinophilic disorder; Nephritis; Nonalcoholic Steatohepatitis; Prostatic Neoplasms; Severe Acute Respiratory Syndrome; Herpes Simplex Infections; Coinfection; Anemia of chronic disease; Squamous cell carcinoma; Hepatitis, Autoimmune; Malignant neoplasm of urinary bladder; Autoimmune thyroiditis; Multinodular goiter; Carcinoma of bladder; Experimental Organism Basal Cell Carcinoma; Vasculitis; Lichen Sclerosus et Atrophicus; Periodontal Diseases; Thyroid Diseases; Eosinophilia; Hashimoto Disease; Bacterial Vaginosis; Painful Bladder Syndrome; Hematologic Neoplasms; Enterovirus Infections; Biliary Atresia; Constitutional Symptom; Malignant Glioma; Fetid chronic bronchitis; Helicobacter-associated gastritis; Latent Tuberculosis; Idiopathic Pulmonary Fibrosis; Acquired aplastic anemia; Malignant Pleural Mesothelioma; Unipolar Depression; Mesothelioma; Gingival Diseases; Renal Cell Carcinoma; Cytomegalovirus encephalitis; Intestinal Graft Versus Host Disease; Colorectal Carcinoma; Diabetes Mellitus, Non-Insulin-Dependent; Fibrosis, Liver; Encephalitis, St. Louis; Uterine Cervical Neoplasm; Pancreatic Ductal Adenocarcinoma; Malaria, Cerebral; Interstitial Cystitis; Esophageal Neoplasms; Anemia; Wheezing; Neoplasms; Dementia; Alopecia Areata; Major Depressive Disorder; Chronic interstitial cystitis; Drug-Induced Liver Disease; Colorectal Cancer; Hepatitis; Inclusion Body Myopathy, Sporadic; Pre-Eclampsia; Precursor Cell Lymphoblastic Leukemia Lymphoma; Ataxia Telangiectasia; Primary biliary cirrhosis; Parasitemia; Mucocutaneous leishmaniasis; Skin Erosion; Eczema, Infantile; Stromal keratitis; AIDS Dementia Complex; Amyotrophic Lateral Sclerosis; Dengue Fever; tumor vasculature; bone destruction; Hepatitis, Chronic; Pseudohyperkalemia Cardiff; Autoimmune thyroid disease; Thyroid Gland Follicular Adenoma; Alcoholic Steatohepatitis; Airway Obstruction; Spontaneous abortion; Hepatitis, Toxic; Chemical and Drug Induced Liver Injury; Chemically-Induced Liver Toxicity; Drug-Induced Acute Liver Injury; Lymphocytic infiltration; Thyroid Neoplasm; Hepatitis, Drug-Induced; Endothelial dysfunction; Papillary thyroid carcinoma; Asymptomatic human immunodeficiency virus infection; Malignant neoplasm of esophagus; Cryoglobulinemia; Lichen Planus, Oral; Abortion, Tubal; Fatty Liver; Ileitis; Progressive Neoplastic Disease; Progressive cGVHD; Chronic myeloproliferative disorder; Promyelocytic leukemia; Leishmaniasis; Invasive aspergillosis; Arthritis, Bacterial; Squamous cell carcinoma of esophagus; Adrenocortical carcinoma; Steatohepatitis; Avellino corneal dystrophy; Hepatitis A; Thrombocytopenia; Hay fever; Polyglandular Type I Autoimmune Syndrome; Esophageal carcinoma; Arthritis, Infectious; Hemangiosarcoma; Retroviridae Infections; Pheochromocytoma; Thyroiditis; Lysinuric Protein Intolerance; Enterovirus 71 infection; Inflammatory neuropathy; Lymphoid interstitial pneumonia; Rhinovirus infection; Membranous glomerulonephritis; Common Cold; Malignant neoplasm of skin; Leukoencephalopathy, Progressive Multifocal; Complete atrioventricular block; Dental caries; Hypocholesterolemia; Sexually Transmitted Diseases; Pulpitis; Caries (morphologic abnormality); Somnolence; Chagas Cardiomyopathy; Granuloma; Lymphoid hyperplasia; African Trypanosomiasis; Fulminant hepatitis; Biliary Cirrhosis, Secondary; Anastomosis; Nonnuclear polymorphic congenital cataract; nervous system disorder; Chronic viral hepatitis; Mixed cryoglobulinemia; Flushing; Trichohepatoenteric Syndrome; Proteinuria; Nodular Sclerosis Classical Hodgkin Lymphoma; Histiocytic Necrotizing Lymphadenitis; Hypertension, Renovascular; Adenitis; Hantavirus Infections; Capillary Leak Syndrome; Cutaneous Candidiasis; Proliferative glomerulonephritis; Viral hepatitis; Chorea; Biliary cirrhosis; Stage 0 Breast Carcinoma; Gliosis; RETINOSCHISIS 1, X-LINKED, JUVENILE; Acute hepatitis C; Xanthomatosis; Myasthenias; Chronic thromboembolic pulmonary hypertension; Congenital hypoplasia of adrenal gland; Lymphadenitis; Peripheral demyelinating neuropathy; Seizures; Autoimmune Primary Adrenal Insufficiency; Addison Disease; Breast Cancer, Familial",2.8114433253573326e-17; 7.980856456624717e-16; 1.803641225501291e-12; 3.118210553589307e-12; 3.861499575207375e-12; 3.861499575207375e-12; 4.5104266881389206e-12; 2.5279022064249716e-11; 6.332483647919588e-11; 7.448716379948652e-11; 8.179290839744632e-11; 1.1574161017103878e-10; 1.3121548808139071e-10; 1.9241179247341838e-10; 2.377251819497684e-10; 2.377251819497684e-10; 2.377251819497684e-10; 2.377251819497684e-10; 2.377251819497684e-10; 2.813069300429449e-10; 3.762648680673853e-10; 5.452288254986118e-10; 6.429879513246633e-10; 7.861255581007157e-10; 7.868397426275417e-10; 1.1722433847661196e-09; 1.4790998733426532e-09; 1.6767489697325582e-09; 1.794870341379274e-09; 1.971893171900314e-09; 2.219129913614883e-09; 3.315537369635636e-09; 4.546836602575699e-09; 4.756590990483e-09; 5.670785186683756e-09; 6.0322241000340585e-09; 6.195332209150018e-09; 6.991207850982321e-09; 8.269524813140207e-09; 1.0368326871660785e-08; 1.3128768066526236e-08; 1.452540845894924e-08; 1.4920329017331753e-08; 1.587872453479067e-08; 1.8815395768840057e-08; 2.0570601164639797e-08; 2.1034803123367165e-08; 2.261634993097532e-08; 2.3137704832524547e-08; 2.412608431251415e-08; 2.9730190499609582e-08; 3.149054123564124e-08; 4.0898524252942674e-08; 4.3069383556698336e-08; 4.638299267461546e-08; 4.65353219894153e-08; 5.518991037343798e-08; 5.784935444423772e-08; 5.8317433871210796e-08; 5.989093556336469e-08; 6.016513497232253e-08; 6.156981490555128e-08; 6.156981490555128e-08; 6.982287075725826e-08; 9.273260676030806e-08; 9.393284022832733e-08; 1.0276547515522002e-07; 1.0390067657961098e-07; 1.0618136021459505e-07; 1.3150328464481586e-07; 1.427432458937347e-07; 1.4925759778299788e-07; 1.6759866477134858e-07; 1.825346178149227e-07; 1.946794431045147e-07; 2.0732395681104218e-07; 2.242497138958313e-07; 2.247163660896597e-07; 2.46778041958494e-07; 2.824526360848301e-07; 2.948344121290337e-07; 3.10587283755252e-07; 3.880986260207744e-07; 6.673805318525932e-07; 6.851652105457608e-07; 7.17979149467092e-07; 7.931659047151387e-07; 7.99548070959303e-07; 8.297823048747685e-07; 8.339674388418603e-07; 8.660170029731726e-07; 8.696626324623331e-07; 8.887379906686178e-07; 9.58028929735367e-07; 9.822463166680949e-07; 1.083280646968723e-06; 1.10068355868735e-06; 1.3079916134634371e-06; 1.4185164995612263e-06; 1.51758575162775e-06; 1.5208470671427406e-06; 1.6231490275716298e-06; 1.6397478315149087e-06; 2.027389637151193e-06; 2.07112526817849e-06; 2.205236928124383e-06; 2.2411321306638023e-06; 2.450940162208615e-06; 3.4620043828295477e-06; 3.7283259874612974e-06; 3.990817553511259e-06; 3.990817553511259e-06; 4.179146475474674e-06; 5.381279306135013e-06; 5.457492980911677e-06; 5.457492980911677e-06; 5.457492980911677e-06; 5.572620871465934e-06; 6.140554546483986e-06; 6.169876404399104e-06; 6.889889014378816e-06; 7.439853898002338e-06; 7.691726899679507e-06; 8.77532817235926e-06; 9.263589414966798e-06; 1.0172703923266036e-05; 1.08089380369295e-05; 1.1652528807336014e-05; 1.2375081616087569e-05; 1.3034577772762696e-05; 1.3410647656206684e-05; 1.3410647656206684e-05; 1.3755659311680946e-05; 1.5064798896399038e-05; 1.513340899972731e-05; 1.5498516107485843e-05; 1.8961926417889813e-05; 1.9896942827707536e-05; 2.0234336876324372e-05; 2.0820699372778346e-05; 2.1083292452040976e-05; 2.1109857936882128e-05; 2.929369913127532e-05; 2.9890125380431698e-05; 3.053335644618538e-05; 3.1066725823367694e-05; 3.1491435270594376e-05; 3.489427253341073e-05; 3.878191781014205e-05; 3.9650653676454574e-05; 3.9650653676454574e-05; 4.351780357113137e-05; 4.351780357113137e-05; 4.550622830486202e-05; 5.248375780672949e-05; 5.248375780672949e-05; 5.248375780672949e-05; 5.496580971003797e-05; 5.496580971003797e-05; 6.058590126387572e-05; 6.709590381814368e-05; 6.964870190365813e-05; 8.100290141298731e-05; 8.25206825409808e-05; 9.023170634543253e-05; 9.476946799623076e-05; 9.476946799623076e-05; 9.780860153755674e-05; 9.913294924271568e-05; 0.0001007621786326551; 0.00010334647523919963; 0.00010582598320524978; 0.00010776056908698134; 0.0001119048288448298; 0.00012949836610375056; 0.00012949836610375056; 0.00016189346720036038; 0.00016189346720036038; 0.0001690762138878921; 0.0001705179359230947; 0.0001705179359230947; 0.0001802305430549181; 0.0001932529498581875; 0.00021116105905857028; 0.00021804014782198476; 0.00022254302103317592; 0.00022618385822819267; 0.00022897551943886068; 0.0002983150880926112; 0.0003242363739584783; 0.0003278023880903879; 0.0003539177308293034; 0.0003607853785819225; 0.00038453776693371663; 0.00040624424086014313; 0.00042535405399404114; 0.0004934717082734151; 0.000513309425513094; 0.0005182771791848276; 0.0005214896245221155; 0.0005445028206157281; 0.0006046022723190866; 0.0006721375816653799; 0.0007074539367893701; 0.0007283216745489607; 0.0008452277316123234; 0.0009325953874753212; 0.0011261416978188; 0.0013033444225859; 0.0013064343839031; 0.0013309210571735; 0.0014000542917314; 0.0014485445504404; 0.0015652768725765; 0.0015652768725765; 0.0016696601172499; 0.0017731038420892; 0.001881335207053; 0.001881335207053; 0.001881335207053; 0.001881335207053; 0.0020056438913528; 0.0020089634269714; 0.0020282798161214; 0.0020505587731585; 0.0025122887786423; 0.0025122887786423; 0.0030940063712108; 0.0033783379034436; 0.0037263522689301; 0.0038705790239355; 0.0038705790239355; 0.0039908077871836; 0.0040785542386402; 0.0043121462081946; 0.0044119363017658; 0.0044119363017658; 0.0047329548368286; 0.0047351775110072; 0.0059257679306595; 0.0062748297137782; 0.0063306870511064; 0.0067588219988478; 0.0068235619036629; 0.0075697193353146; 0.0083709650732796; 0.008634277457381; 0.0087278589568942; 0.0089906473426575; 0.0096630827054915; 0.0098716431177839; 0.0102680775483548; 0.0104376874453167; 0.0109519728029571; 0.0110109843340769; 0.0123983633418964; 0.0123983633418964; 0.0123983633418964; 0.0125952576116424; 0.0127059723723765; 0.015507621739214; 0.0156113267570298; 0.0171001534176385; 0.0182000062506337; 0.0182000062506337; 0.0182000062506337; 0.018665947632861; 0.018665947632861; 0.0187299613301643; 0.0203198961621158; 0.0239461944596263; 0.0279220892715439; 0.0404707605808569; 0.0471006425252053; 0.0493155676939993; 0.0517499693438671; 0.0517499693438671; 0.0517499693438671; 0.0678022600525665; 0.0700485361084771; 0.0723815120866587; 0.0749666609274744; 0.0784196844880443; 0.0804567619234804; 0.0817897187940979; 0.0817897187940979; 0.083107903315643; 0.0897127848630768; 0.0987575443309834; 0.1050724946352408; 0.1050724946352408; 0.1130019719865939; 0.1176290148843425; 0.1397055058487397; 0.1401454825042905; 0.1460848784791741; 0.1520581530903516; 0.1525119847960956; 0.1584804022044084; 0.1642913929691757; 0.1932166112700285; 0.1982833830495248; 0.1982833830495248; 0.2316568843888361; 0.316142834424839; 0.3243241301578816; 0.335302985108383; 0.4016038424272534; 0.6700343003586396,Myocardial Ischemia; Cerebral Ischemia; Thyroid Gland Follicular Adenoma; Thyroid Neoplasm; Dermatitis; Thyroid Carcinoma; Miscarriage; Mental Depression; Eczema; Colonic Neoplasms; Biliary Cholangitis; Celiac Disease; Biliary Cirrhosis; Alopecia Areata,7.071068485513988e-10; 5.562961744202623e-09; 3.882845009510541e-05; 7.782144775199944e-05; 0.0002385365299919203; 0.0005818213110442873; 0.0088732170532262; 0.0511376198481248; 0.1110148026021272; 0.1203844668559877; 0.1221238952720515; 0.175139305620004; 0.1787826075739565; 0.2978951863374514,Charcot-Marie-Tooth disease type 1D ORPHA:101084; Charcot-Marie-Tooth disease type 4E ORPHA:99951; Systemic-onset juvenile idiopathic arthritis ORPHA:85414; Metaphyseal anadysplasia ORPHA:1040; Singleton-Merten dysplasia ORPHA:85191; Infantile-onset pulmonary alveolar proteinosis-hypogammaglobulinemia ORPHA:572428; Mendelian susceptibility to mycobacterial diseases due to partial STAT1 deficiency ORPHA:319595; Autoimmune enteropathy and endocrinopathy-susceptibility to chronic infections syndrome ORPHA:391487; Susceptibility to viral and mycobacterial infections due to STAT1 deficiency ORPHA:391311; Hyper-IgM syndrome type 3 ORPHA:101090; USP18 deficiency ORPHA:481665,3.598261936626476e-12; 3.598261936626476e-12; 1.514756890441811e-09; 0.0002132495254484572; 0.0133474287859103; 0.0133474287859103; 0.0514345493431829; 0.0514345493431829; 0.0514345493431829; 0.0514345493431829; 0.4838060079820406,,,,,,
CXCL11,"Inflammation; Asthma; Psoriasis; Juvenile arthritis; Lymphoma; Multiple Myeloma; Virus Diseases; Chronic Obstructive Airway Disease; Rheumatoid Arthritis; Non-Small Cell Lung Carcinoma; Ovarian Carcinoma; Malignant neoplasm of ovary; Dermatitis; Neoplasm Metastasis; Inflammatory dermatosis; Hepatitis C; Hypertensive disease; Inflammatory Bowel Diseases; HIV Infections; Glioblastoma; Coronary Artery Disease; Dermatologic disorders; Sjogren's Syndrome; Dermatitis, Allergic Contact; Malaria; Glioma; Acquired Immunodeficiency Syndrome; Hepatitis C, Chronic; Glossitis, Benign Migratory; Ureteral obstruction; Diabetic Nephropathy; Liver carcinoma; Carcinogenesis; Fibrosarcoma; Astrocytoma; Erythema Chronicum Migrans; Meningococcal Infections; Encephalomyelitis; Pleural Effusion, Malignant; ovarian neoplasm; Prostatic Neoplasms; Malignant neoplasm of endometrium; Uterine Corpus Cancer; Coinfection; Anemia of chronic disease; Squamous cell carcinoma; Malignant Head and Neck Neoplasm; Painful Bladder Syndrome; Malignant neoplasm of liver; Idiopathic Pulmonary Fibrosis; Age related macular degeneration; Renal Cell Carcinoma; Endometrial Carcinoma; Fibrosis, Liver; Interstitial Cystitis; Chronic interstitial cystitis; Inclusion Body Myopathy, Sporadic; Lyme Disease; Pseudohyperkalemia Cardiff; Periapical Granuloma; Mycosis Fungoides; Renal fibrosis; Liver and Intrahepatic Biliary Tract Carcinoma; Avellino corneal dystrophy; Muscular Dystrophy, Duchenne; Hay fever; MILES-CARPENTER X-LINKED MENTAL RETARDATION SYNDROME; Drusen; Mast-Cell Sarcoma; TARSAL-CARPAL COALITION SYNDROME; Epithelioma; Hepatitis D Infection; Mycobacterium Infections",2.8114433253573326e-17; 1.803641225501291e-12; 3.118210553589307e-12; 3.861499575207375e-12; 4.5104266881389206e-12; 2.5279022064249716e-11; 6.332483647919588e-11; 1.3121548808139071e-10; 1.9241179247341838e-10; 3.762648680673853e-10; 6.870627395110916e-10; 1.971893171900314e-09; 3.683115069310663e-09; 5.670785186683756e-09; 6.0322241000340585e-09; 6.991207850982321e-09; 1.0368326871660785e-08; 2.3137704832524547e-08; 4.638299267461546e-08; 5.518991037343798e-08; 8.598175402882612e-08; 9.273260676030806e-08; 1.0276547515522002e-07; 1.0390067657961098e-07; 1.0618136021459505e-07; 1.427432458937347e-07; 1.825346178149227e-07; 2.46778041958494e-07; 2.824526360848301e-07; 7.99548070959303e-07; 1.083280646968723e-06; 1.3079916134634371e-06; 1.51758575162775e-06; 2.3419309731960144e-06; 2.608032323197001e-06; 3.990817553511259e-06; 5.457492980911677e-06; 1.08089380369295e-05; 1.3268923055385737e-05; 1.8507296589967813e-05; 2.0820699372778346e-05; 2.389985034001877e-05; 2.483118059238325e-05; 2.929369913127532e-05; 2.9890125380431698e-05; 3.053335644618538e-05; 4.3188904868696655e-05; 5.496580971003797e-05; 8.421319594446617e-05; 9.780860153755674e-05; 0.00010334647523919963; 0.0001119048288448298; 0.0001322335978675375; 0.0001690762138878921; 0.00021116105905857028; 0.0003539177308293034; 0.00042535405399404114; 0.0013510612738592; 0.0014000542917314; 0.0017731038420892; 0.0020056438913528; 0.0021970545999258; 0.0038816440940594; 0.0068235619036629; 0.007117388576245; 0.008634277457381; 0.0110109843340769; 0.0120771273149872; 0.0138441633831498; 0.016456143422954; 0.0407359064912377; 0.0897127848630768; 0.1932166112700285,Celiac Disease,0.175139305620004,USP18 deficiency ORPHA:481665,0.4838060079820406,,,In vitro;yeasx,0.37;0.44,Homo sapiens;Yersinia pestis;chemical synthesis,Homo sapiens;chemical synthesis
CXCL2,"Inflammation; Pneumonia; Reperfusion Injury; Virus Diseases; Dermatitis, Atopic; Lung diseases; Neutrophilia (disorder); Chronic Obstructive Airway Disease; Rheumatoid Arthritis; Pneumonitis; Arsenic Poisoning, Inorganic; Nervous System, Organic Arsenic Poisoning; Arsenic Encephalopathy; Arsenic Induced Polyneuropathy; Arsenic Poisoning; Tumor Angiogenesis; Multiple Sclerosis; Neoplasm Metastasis; Mammary Neoplasms, Human; Pulmonary Fibrosis; Hypertensive disease; Respiratory syncytial virus (RSV) infection in conditions classified elsewhere and of unspecified site; Eczema; Arthritis; Degenerative polyarthritis; Obesity; Auricular swelling; Periodontitis; Mammary Neoplasms; Dermatologic disorders; Dermatitis, Allergic Contact; Retinoic acid syndrome; Right Middle Cerebral Artery Infarction; Embolic Infarction, Middle Cerebral Artery; Thrombotic Infarction, Middle Cerebral Artery; Left Middle Cerebral Artery Infarction; Middle Cerebral Artery Embolus; Middle Cerebral Artery Syndrome; Middle Cerebral Artery Thrombosis; Glioma; Van der Woude syndrome; Hamman-Rich syndrome; Infarction, Middle Cerebral Artery; Myocardial Ischemia; Septicemia; Sepsis; Cystic Fibrosis; Tuberculosis; Middle Cerebral Artery Occlusion; Liver diseases; Severe Sepsis; Malignant neoplasm of breast; Other specified forms of pleural effusion, except tuberculous; Influenza; Colon Carcinoma; Shock, Hemorrhagic; Stomach Neoplasms; melanoma; Breast Carcinoma; Mycoses; Bacterial Infections; Guillain-Barre Syndrome; Aspiration Pneumonia; Malignant neoplasm of endometrium; Uterine Corpus Cancer; Chronic Airflow Obstruction; Osteomyelitis; Research-Related Injuries; Traumatic injury; Wounds and Injuries; Injury wounds; Pneumonia, Bacterial; Heart Failure, Right-Sided; Congestive heart failure; Infectious disease of lung; Acute pyelonephritis; Endometrial Carcinoma; Carcinoma, Transitional Cell; Acute Lung Injury; Esophageal Neoplasms; Heart failure; Hepatitis; Urothelial Carcinoma; Heart Decompensation; Myocardial Failure; Guillain-Barre Syndrome, Familial; Group B Streptococcal Infection; Pulmonary Edema; Left-Sided Heart Failure; Malignant neoplasm of esophagus; Brain Edema; Pneumonia, Viral; Hepatitis A; Esophageal carcinoma; Cholestasis; Shigella Infections; Glycogen Storage Disease; Osteoarthrosis Deformans; Acanthamoeba Keratitis; Bone Resorption; Intrahepatic Cholestasis",2.8114433253573326e-17; 7.980856456624717e-16; 4.4398736172867135e-14; 6.332483647919588e-11; 7.448716379948652e-11; 8.179290839744632e-11; 1.1574161017103878e-10; 1.3121548808139071e-10; 1.9241179247341838e-10; 2.813069300429449e-10; 1.1722433847661196e-09; 1.1722433847661196e-09; 1.1722433847661196e-09; 1.1722433847661196e-09; 1.1722433847661196e-09; 3.315537369635636e-09; 4.546836602575699e-09; 5.670785186683756e-09; 5.791865115913735e-09; 7.547641288501485e-09; 1.0368326871660785e-08; 1.452540845894924e-08; 1.4920329017331753e-08; 1.587872453479067e-08; 2.1034803123367165e-08; 2.412608431251415e-08; 2.9730190499609582e-08; 3.9573009168853264e-08; 4.65353219894153e-08; 9.273260676030806e-08; 1.0390067657961098e-07; 1.0390067657961098e-07; 1.0390067657961098e-07; 1.0390067657961098e-07; 1.0390067657961098e-07; 1.0390067657961098e-07; 1.0390067657961098e-07; 1.0390067657961098e-07; 1.0390067657961098e-07; 1.427432458937347e-07; 1.524221047360518e-07; 2.0732395681104218e-07; 2.400988116471548e-07; 2.948344121290337e-07; 5.254943571583271e-07; 5.313225371508493e-07; 5.577321626966352e-07; 6.673805318525932e-07; 6.805796735296268e-07; 7.17979149467092e-07; 7.873224494781308e-07; 8.660170029731726e-07; 1.10068355868735e-06; 2.027389637151193e-06; 2.205236928124383e-06; 2.3756085216561533e-06; 3.878607667297475e-06; 4.179146475474674e-06; 5.381279306135013e-06; 5.572620871465934e-06; 6.378950690990071e-06; 9.18171819472328e-06; 1.2765469826010355e-05; 2.389985034001877e-05; 2.483118059238325e-05; 2.9890125380431698e-05; 4.114864035295583e-05; 6.734766728729227e-05; 6.734766728729227e-05; 6.734766728729227e-05; 6.734766728729227e-05; 6.758558746827128e-05; 7.358523784131203e-05; 8.232890503539995e-05; 9.846223464501226e-05; 0.00012858049944279123; 0.0001322335978675375; 0.0001474322229096163; 0.00014885785925249347; 0.00021804014782198476; 0.00027820432005572264; 0.00040624424086014313; 0.0004243878730487336; 0.0004303328941191692; 0.0005632660372960827; 0.0008673605584216904; 0.0008673605584216904; 0.0010244557923259; 0.00116764658012; 0.0030940063712108; 0.0037263522689301; 0.003846910040485; 0.0075697193353146; 0.0089906473426575; 0.0174410368983484; 0.0276267477370436; 0.044901297966643; 0.0530344420162745; 0.0817897187940979; 0.1050724946352408; 0.2570364810168682,Myocardial Ischemia; Arsenic Encephalopathy; Dermatologic Disorders; Marfan Syndrome; Mammary Neoplasms; Cerebral Infraction; Cerebral Thrombosis; Alveolitis; Pulmonary Fibrosis; Rheumatoid Arthritis; Breast Carcinoma; Heart Failure; Dermatitis; Myocardial Infarction; Breast Cancer; Arthritis; Congestive Heart Failure; Hypertension; Cholestasis; Chronic Obstructive Pulmonary Disease; Osteoarthrosis Deformans; Esophagus Neoplasm,7.071068485513988e-10; 3.723977603538778e-09; 1.7417795410918816e-08; 8.921950872070284e-08; 1.1417484002988661e-07; 2.009208013074685e-07; 2.739939098363423e-07; 3.1346476759108064e-07; 3.656047745092532e-06; 1.241997446075319e-05; 4.971054570440277e-05; 0.00015071968444989745; 0.0002385365299919203; 0.0005760978170082974; 0.00063387456654884; 0.0015169561374293; 0.0028558709076653; 0.0048927857621509; 0.0152037568688841; 0.0173324463553544; 0.1006919508743788; 0.175139305620004,Systemic-onset juvenile idiopathic arthritis ORPHA:85414; Cryptogenic multifocal ulcerous stenosing enteritis ORPHA:468635; Cytosolic phospholipase-A2 alpha deficiency associated bleeding disorder ORPHA:477787; Familial cavitary optic disc anomaly ORPHA:464760; Complement component 3 deficiency ORPHA:280133; Atypical hemolytic uremic syndrome with complement gene abnormality ORPHA:544472,1.514756890441811e-09; 0.0002132495254484572; 0.0002132495254484572; 0.0019696624570933; 0.0133474287859103; 0.0514345493431829,Cercopithecine betaherpesvirus 5 chemokine vCXCL5 (gene: UL146B); Cercopithecine betaherpesvirus 5 chemokine vCXCL10 (gene: UL146G); Human betaherpesvirus 5 chemokine vCXCL1 (gene: UL146); Cercopithecine betaherpesvirus 5 chemokine vCXCL2 (gene: UL147); Human betaherpesvirus 5 chemokine vCXCL2 (gene: UL147); Human gammaherpesvirus 8 K4.1 (gene: K4.1); Molluscum contagiosum virus subtype 1 MC148R (gene: MC148R),3.855107856457681e-08; 2.3160451568389139e-07; 1.12171834090951e-06; 1.12171834090951e-06; 1.3435225153003765e-06; 1.7536244306421314e-06; 2.1974600826970047e-06,,,,
CXCL3,"Arsenic Poisoning, Inorganic; Nervous System, Organic Arsenic Poisoning; Arsenic Encephalopathy; Arsenic Induced Polyneuropathy; Arsenic Poisoning; Neoplasm Metastasis; Mammary Neoplasms, Human; Hodgkin Disease; Mammary Neoplasms; Leishmaniasis, Cutaneous; Dermatologic disorders; Glioma; Malignant neoplasm of breast; Colon Carcinoma; Breast Carcinoma; Squamous cell carcinoma; Huntington Disease; aggressive cancer",1.1722433847661196e-09; 1.1722433847661196e-09; 1.1722433847661196e-09; 1.1722433847661196e-09; 1.1722433847661196e-09; 5.670785186683756e-09; 5.791865115913735e-09; 6.195332209150018e-09; 4.65353219894153e-08; 6.016513497232253e-08; 9.273260676030806e-08; 1.427432458937347e-07; 8.660170029731726e-07; 2.205236928124383e-06; 5.381279306135013e-06; 3.053335644618538e-05; 0.0017731038420892; 0.4424335623428572,Arsenic Encephalopathy; Dermatologic Disorders; Marfan Syndrome; Mammary Neoplasms; Breast Carcinoma; Heart Failure; Breast Cancer,3.723977603538778e-09; 1.7417795410918816e-08; 8.921950872070284e-08; 1.1417484002988661e-07; 4.971054570440277e-05; 0.00015071968444989745; 0.00063387456654884,"Systemic-onset juvenile idiopathic arthritis ORPHA:85414; Quebec platelet disorder ORPHA:220436; Cryptogenic multifocal ulcerous stenosing enteritis ORPHA:468635; Cytosolic phospholipase-A2 alpha deficiency associated bleeding disorder ORPHA:477787; Niemann-Pick disease type C, adult neurologic onset ORPHA:216986; Niemann-Pick disease type C, juvenile neurologic onset ORPHA:216981; Niemann-Pick disease type C, late infantile neurologic onset ORPHA:216978; Niemann-Pick disease type C, severe early infantile neurologic onset ORPHA:216975; Niemann-Pick disease type C, severe perinatal form ORPHA:216972; Familial cavitary optic disc anomaly ORPHA:464760; FTH1-related iron overload ORPHA:247790; Benign familial mesial temporal lobe epilepsy ORPHA:163717; Familial mesial temporal lobe epilepsy with febrile seizures ORPHA:165805; DNAJB6-related  limb-girdle muscular dystrophy D1 ORPHA:34516",1.514756890441811e-09; 3.28973817825433e-05; 0.0002132495254484572; 0.0002132495254484572; 0.0002132495254484572; 0.0002132495254484572; 0.0002132495254484572; 0.0002132495254484572; 0.0002132495254484572; 0.0019696624570933; 0.0514345493431829; 0.4838060079820406; 0.4838060079820406; 0.5312419675785659,Cercopithecine betaherpesvirus 5 chemokine vCXCL5 (gene: UL146B); Vaccinia virus chemokine binding protein (gene: C23L); Vaccinia virus Ankara viral chemokine binding protein; Cercopithecine betaherpesvirus 5 chemokine vCXCL10 (gene: UL146G); Human gammaherpesvirus 8 K6 (gene: K6); Cercopithecine betaherpesvirus 5 chemokine vCXCL9 (gene: UL146F); Human betaherpesvirus 5 chemokine vCXCL1 (gene: UL146); Cercopithecine betaherpesvirus 5 chemokine vCXCL2 (gene: UL147); Human betaherpesvirus 5 chemokine vCXCL2 (gene: UL147); Human gammaherpesvirus 8 K4.1 (gene: K4.1); Molluscum contagiosum virus subtype 1 MC148R (gene: MC148R); Monkeypox virus bifunctional EEV membrane phosphoglycoprotein/associates with A36R; Monkeypox virus Zaire-96-I-16 A35R (gene: A35R); Monkeypox virus Zaire-96-I-16 IEV and EEV membrane glycoprotein (gene: A36R); Cowpox virus CPXV169 protein (gene: CPXV169 CDS); Yaba-like disease virus 123R protein (gene: 123R); Horsepox virus HSPV162; Ectromelia virus ERPV EEV c-type lectin-like protein; Vaccinia virus IEV and EEV membrane glycoprotein (gene: A34R),3.855107856457681e-08; 5.6633714501424107e-08; 5.6633714501424107e-08; 2.3160451568389139e-07; 9.087104857163152e-07; 9.087104857163152e-07; 1.12171834090951e-06; 1.12171834090951e-06; 1.3435225153003765e-06; 1.7536244306421314e-06; 2.1974600826970047e-06; 0.0004813727670816974; 0.0004813727670816974; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946,,,,
CXCL5,"Pneumonia; Asthma; Virus Diseases; Lung diseases; Lobar Pneumonia; Neutrophilia (disorder); Chronic Obstructive Airway Disease; Pneumonitis; Non-Small Cell Lung Carcinoma; Crohn Disease; Autoimmune Diseases; Peritonitis; Sarcoidosis; Endometriosis; Cirrhosis; Ulcerative Colitis; Infection; Colitis; Tumor Angiogenesis; Lung Neoplasms; Neoplasm Metastasis; Experimental Lung Inflammation; Leukemia, Myelocytic, Acute; Hypertensive disease; Liver Cirrhosis; Allergic Reaction; Inflammatory Bowel Diseases; Obesity; Periodontitis; Mammary Neoplasms; Diabetes Mellitus; Leishmaniasis, Cutaneous; Diabetes; Pancreatic carcinoma; Coronary Artery Disease; Coronary heart disease; Malignant neoplasm of pancreas; Pneumococcal Infections; Cardiovascular Diseases; Malignant neoplasm of lung; Tumor Progression; Malignant neoplasm of breast; Premature Obstetric Labor; Bladder Neoplasm; Coronary Arteriosclerosis; Hypersensitivity; Liver carcinoma; Carcinogenesis; Carcinoma of lung; Stomach Carcinoma; Malignant neoplasm of stomach; Stomach Neoplasms; Chronic liver disease; melanoma; Primary malignant neoplasm of lung; Breast Carcinoma; Henoch-Schoenlein Purpura; Sarcoidosis, Pulmonary; Colorectal Neoplasms; Extrinsic allergic alveolitis; Aplastic Anemia; Prostate carcinoma; Adenocarcinoma; Acute Coronary Syndrome; Nonalcoholic Steatohepatitis; Prostatic Neoplasms; Squamous cell carcinoma; Malignant neoplasm of prostate; Malignant neoplasm of urinary bladder; Carcinoma of bladder; Adenoma; Peritonsillar Abscess; Colorectal Carcinoma; Diabetes Mellitus, Non-Insulin-Dependent; Neoplasms; Colorectal Cancer; Squamous cell carcinoma of the head and neck; Meningitis, Bacterial; Premature Birth; Pulmonary Cystic Fibrosis; Metastatic Neoplasm; Adenoma of large intestine; SVEINSSON CHORIORETINAL ATROPHY; androgen independent prostate cancer; Lymphangioleiomyomatosis; End Stage Liver Disease; Recurrent tumor; Renal cyst; Dental caries; Triple Negative Breast Neoplasms; Cholangiocarcinoma; Craniosynostosis; Malignant neoplasm of large intestine; stage, non-small cell lung cancer; Carcinoma of urinary bladder, invasive; Intrahepatic Cholangiocarcinoma",7.980856456624717e-16; 1.803641225501291e-12; 6.332483647919588e-11; 8.179290839744632e-11; 8.179290839744632e-11; 1.1574161017103878e-10; 1.3121548808139071e-10; 2.813069300429449e-10; 3.762648680673853e-10; 4.2478505092738466e-10; 5.452288254986118e-10; 5.452288254986118e-10; 7.861255581007157e-10; 7.868397426275417e-10; 1.4790998733426532e-09; 1.6767489697325582e-09; 1.794870341379274e-09; 1.971893171900314e-09; 3.315537369635636e-09; 4.367699208727405e-09; 5.670785186683756e-09; 5.670785186683756e-09; 8.303910954283738e-09; 1.0368326871660785e-08; 1.3128768066526236e-08; 2.2764946043880388e-08; 2.3137704832524547e-08; 2.412608431251415e-08; 3.9573009168853264e-08; 4.65353219894153e-08; 5.8317433871210796e-08; 6.016513497232253e-08; 6.156981490555128e-08; 6.982287075725826e-08; 8.598175402882612e-08; 9.273260676030806e-08; 1.4925759778299788e-07; 4.4307738632612236e-07; 4.5433391667148853e-07; 6.299208964864026e-07; 8.297823048747685e-07; 8.660170029731726e-07; 8.777200373497231e-07; 9.822463166680949e-07; 1.0094398444517938e-06; 1.1523181751478311e-06; 1.3079916134634371e-06; 1.51758575162775e-06; 2.027389637151193e-06; 2.07112526817849e-06; 2.450940162208615e-06; 3.878607667297475e-06; 3.990817553511259e-06; 4.179146475474674e-06; 4.839188317483647e-06; 5.381279306135013e-06; 5.457492980911677e-06; 9.263589414966798e-06; 1.3034577772762696e-05; 1.4439241578579364e-05; 1.4583987015565183e-05; 1.527992765491583e-05; 1.5449280661407645e-05; 1.7090079578013972e-05; 2.0234336876324372e-05; 2.0820699372778346e-05; 3.053335644618538e-05; 3.053335644618538e-05; 3.1491435270594376e-05; 3.9650653676454574e-05; 0.00012202062264879416; 0.00012949836610375056; 0.00016189346720036038; 0.00016189346720036038; 0.00022897551943886068; 0.00038453776693371663; 0.000420950947096172; 0.0006445212280958682; 0.0008932565002868814; 0.0010831910832595; 0.001746579573497; 0.001881335207053; 0.0030220891031719; 0.0037263522689301; 0.0037263522689301; 0.0077321746155735; 0.0091914307650131; 0.0127059723723765; 0.0182000062506337; 0.0302544192125064; 0.0334053723619937; 0.0392832161328838; 0.1128564106125758; 0.124149904653194; 0.1460848784791741; 0.7181037063590973,,,Hemochromatosis type 5 ORPHA:447792; Fetal and neonatal alloimmune thrombocytopenia ORPHA:853,0.1927589191138116; 0.4878757854606148,Cercopithecine betaherpesvirus 5 chemokine vCXCL5 (gene: UL146B); Vaccinia virus chemokine binding protein (gene: C23L); Vaccinia virus Ankara viral chemokine binding protein; Cercopithecine betaherpesvirus 5 chemokine vCXCL10 (gene: UL146G); Cowpox virus CrmD or CPXV221 protein (gene: CrmD); Variola virus chemokine binding protein (gene: G5R); Variola virus hypothetical protein (gene: G4R); Ectromelia virus ERPV tumor necrosis factor receptor; Horsepox virus HSPV003 (Tumor necrosis factor receptor superfamily members); Human gammaherpesvirus 8 K6 (gene: K6); Cercopithecine betaherpesvirus 5 chemokine vCXCL9 (gene: UL146F); Monkeypox virus Zaire-96-I-16 J2L (gene: J2L); Cowpox virus CrmB or CPXV005 protein (gene: crmB); Human betaherpesvirus 5 chemokine vCXCL1 (gene: UL146); Cercopithecine betaherpesvirus 5 chemokine vCXCL2 (gene: UL147); Monkeypox virus TNF-alpha-receptor-like protein; Human betaherpesvirus 5 chemokine vCXCL2 (gene: UL147); Monkeypox virus chemokine-binding protein; Monkeypox virus Zaire-96-I-16 chemokine binding protein (gene: J1L); Human gammaherpesvirus 8 K4.1 (gene: K4.1); Molluscum contagiosum virus subtype 1 MC148R (gene: MC148R); Horsepox virus HSPV002 (chemokine binding protein; Provisional); Monkeypox virus bifunctional EEV membrane phosphoglycoprotein/associates with A36R; Monkeypox virus Zaire-96-I-16 A35R (gene: A35R); Vaccinia virus hemagglutinin (gene: A56R); Monkeypox virus Zaire-96-I-16 B2R (gene: B2R); Human adenovirus 18 CR1-beta protein (gene: E3); Monkeypox virus Zaire-96-I-16 IEV and EEV membrane glycoprotein (gene: A36R); Cowpox virus CPXV169 protein (gene: CPXV169 CDS); Yaba-like disease virus 123R protein (gene: 123R); Yaba monkey tumor virus IEV and EEV membrane glycoprotein; Horsepox virus HSPV162; Human mastadenovirus F membrane glycoprotein E3 CR1-beta (gene: E3A); Human adenovirus 41 E3 31.6K; Ectromelia virus ERPV EEV c-type lectin-like protein; Vaccinia virus IEV and EEV membrane glycoprotein (gene: A34R),3.855107856457681e-08; 5.6633714501424107e-08; 5.6633714501424107e-08; 2.3160451568389139e-07; 2.3160451568389139e-07; 3.201246660025618e-07; 5.350651473977266e-07; 5.350651473977266e-07; 5.350651473977266e-07; 9.087104857163152e-07; 9.087104857163152e-07; 9.087104857163152e-07; 1.12171834090951e-06; 1.12171834090951e-06; 1.12171834090951e-06; 1.12171834090951e-06; 1.3435225153003765e-06; 1.414266919056462e-06; 1.5653663269440003e-06; 1.7536244306421314e-06; 2.1974600826970047e-06; 2.6957073977079108e-05; 0.0004813727670816974; 0.0004813727670816974; 0.0223182816928385; 0.0816962571184375; 0.2880902732733083; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946,Homo sapiens A549 lung carcinoma cell;yeasx,0.35;0.56,Homo sapiens;SARS-CoV-2,Homo sapiens
CXCL8,"Inflammation; Pneumonia; Reperfusion Injury; Asthma; Psoriasis; Familial M??ni??re disease; Juvenile arthritis; Lymphoma; Multiple Myeloma; Virus Diseases; Dermatitis, Atopic; Lung diseases; Neutrophilia (disorder); Chronic Obstructive Airway Disease; Synovitis; Rheumatoid Arthritis; Thyroid associated opthalmopathies; Arteriosclerosis; Pneumonitis; Non-Small Cell Lung Carcinoma; Crohn Disease; Autoimmune Diseases; Peritonitis; Ovarian Carcinoma; Sarcoidosis; Endometriosis; cervical cancer; Cirrhosis; MYELOPROLIFERATIVE DISORDER, CHRONIC, WITH EOSINOPHILIA; Ulcerative Colitis; Infection; Malignant neoplasm of ovary; Colitis; Pancreatitis, Chronic; Tumor Angiogenesis; Malignant tumor of cervix; Dermatitis; Lung Neoplasms; Multiple Sclerosis; Neoplasm Metastasis; Mammary Neoplasms, Human; Inflammatory dermatosis; Hodgkin Disease; Hepatitis C; Atherosclerosis; Pulmonary Fibrosis; Acute pancreatitis; Graves Disease; Leukemia, Myelocytic, Acute; Glomerulonephritis; Hypertensive disease; Liver Cirrhosis; Respiratory syncytial virus (RSV) infection in conditions classified elsewhere and of unspecified site; Vascular Diseases; Eczema; Cervix carcinoma; Arthritis; Infection caused by Helicobacter pylori; Cerebrovascular accident; Degenerative polyarthritis; Respiratory Distress Syndrome, Adult; Inflammatory Bowel Diseases; Obesity; Psoriasiform eczema; Kaposi Sarcoma; Periodontitis; Hyperglycemia; Liver neoplasms; HIV Infections; Mammary Neoplasms; Arthritis, Psoriatic; Aortic Aneurysm, Abdominal; Bright Disease; Glioblastoma; leukemia; Diabetes Mellitus; Juvenile rheumatoid arthritis; Leishmaniasis, Cutaneous; Diabetes; Lupus Erythematosus, Systemic; Ischemic stroke; Pancreatic carcinoma; Coronary Artery Disease; Dermatologic disorders; Coronary heart disease; Alzheimer's Disease; Adenocarcinoma of pancreas; Behcet Syndrome; Sjogren's Syndrome; Retinoic acid syndrome; Malaria; Encephalitis; Spondylarthropathies; Glioma; Epithelial ovarian cancer; Escherichia coli Infections; Malignant neoplasm of pancreas; Pain; Respiratory Syncytial Virus Infections; Malignant neoplasm of mouth; Hamman-Rich syndrome; Inflammatory disorder; Myocardial Infarction; Cerebral Infarction; Hepatitis C, Chronic; Adult T-Cell Lymphoma/Leukemia; Anoxia; Myocardial Ischemia; Bronchiolitis Obliterans; Myocarditis; Brain Neoplasms; Gastric ulcer; Cardiovascular Diseases; Septicemia; Sepsis; Cystic Fibrosis; Peptic Esophagitis; Malignant neoplasm of lung; Fibroid Tumor; Tuberculosis; Leukemia, T-Cell; Neonatal Early-Onset Sepsis; Diabetes Mellitus, Insulin-Dependent; Liver diseases; Hepatitis, Alcoholic; Severe Sepsis; Chronic Lymphocytic Leukemia; Measles; Tumor Progression; Spondylarthritis; Thromboangiitis Obliterans; Dryness of eye; Malignant neoplasm of breast; Premature Obstetric Labor; Cytomegalovirus Infections; Gastritis; Bladder Neoplasm; Coronary Arteriosclerosis; Diabetic Nephropathy; Systemic Scleroderma; Anemia, Sickle Cell; Osteitis Deformans; Liver carcinoma; Colonic Neoplasms; Immunologic Deficiency Syndromes; Carcinogenesis; Nasopharyngeal carcinoma; Lung Diseases, Interstitial; Endometrial Neoplasms; Hyperalgesia, Secondary; Allodynia; Diffuse cutaneous leishmaniasis; Influenza; Carcinoma of lung; Stomach Carcinoma; Hyperalgesia, Primary; Polycystic Ovary Syndrome; B-Cell Lymphomas; Colon Carcinoma; Leishmaniasis, Visceral; Idiopathic pulmonary arterial hypertension; Fibrosarcoma; Malignant neoplasm of stomach; Osteosarcoma of bone; Lip and Oral Cavity Carcinoma; Astrocytoma; Dry Eye Syndromes; Tactile Allodynia; Bone Diseases; Lupus Nephritis; Kidney Failure, Acute; Lymphoma, T-Cell, Cutaneous; Stomach Neoplasms; Tuberculosis, Pulmonary; inflammatory joint disease; melanoma; Dermatomyositis, Childhood Type; Fever; Primary malignant neoplasm of lung; Bronchiolitis; Breast Carcinoma; Henoch-Schoenlein Purpura; Mycoses; Dermatitis, Irritant; Alveolitis; Urban cutaneous leishmaniasis; Osteosarcoma; Bacterial Infections; Secondary malignant neoplasm of bone; Thyroid carcinoma; Angina, Unstable; Malignant mesothelioma; Delirium; Leprosy; M5b Acute differentiated monocytic leukemia; Epstein-Barr Virus Infections; Hepatitis B, Chronic; Mechanical Allodynia; Small cell carcinoma of lung; Hyperalgesia, Thermal; Acute Promyelocytic Leukemia; Acute lymphocytic leukemia; Leishmaniasis, New World; MYELODYSPLASTIC SYNDROME; Retinal Diseases; Colorectal Neoplasms; Allergic asthma; Pleural Effusion, Malignant; Acute monocytic leukemia; Diabetic Retinopathy; Sezary Syndrome; Cachexia; Hepatitis B; Active tuberculosis; Aplastic Anemia; Lymphohistiocytosis, Hemophagocytic; Prostate carcinoma; Adenocarcinoma; Malignant tumor of colon; Acute Coronary Syndrome; Hyperalgesia; ovarian neoplasm; Eosinophilic disorder; Nephritis; Nonalcoholic Steatohepatitis; Allergic rhinitis (disorder); Kidney Failure, Chronic; Prostatic Neoplasms; Severe Acute Respiratory Syndrome; Acute GVH disease; Malignant neoplasm of endometrium; Uterine Corpus Cancer; Fibrosis; Chronic kidney disease stage 5; Coinfection; Chronic Airflow Obstruction; Squamous cell carcinoma; Malignant neoplasm of prostate; Meningitis; Malignant neoplasm of urinary bladder; Pancreatic Neoplasm; Parkinson Disease; Sleep Apnea, Obstructive; Mouth Neoplasms; precancerous lesions; Multinodular goiter; Carcinoma of bladder; Experimental Organism Basal Cell Carcinoma; Endometrioma; Malignant Head and Neck Neoplasm; Lymphoma, Non-Hodgkin; Periodontal Diseases; Myelofibrosis; Uterine Fibroids; Systemic Inflammatory Response Syndrome; Eosinophilia; IGA Glomerulonephritis; Bacterial Vaginosis; Proliferative vitreoretinopathy; Chronic Alcoholic Hepatitis; Myositis; Benign Prostatic Hyperplasia; Streptococcal pneumonia; Enterovirus Infections; Spinal Cord Diseases; Biliary Atresia; Acute myocardial infarction; TNF receptor-associated periodic fever syndrome (TRAPS); Duodenal Ulcer; Amebic colitis; Constitutional Symptom; Carcinoma, Lewis Lung; Pulmonary Hypertension; Malignant Glioma; Malignant neoplasm of liver; Celiac Disease; Fetid chronic bronchitis; Urinary tract infection; Osteoporosis; Adult-Onset Still Disease; Helicobacter-associated gastritis; Idiopathic Pulmonary Fibrosis; Bronchiectasis; Infectious disease of lung; Mucocutaneous Lymph Node Syndrome; Chronic Kidney Diseases; Acquired aplastic anemia; Malignant Pleural Mesothelioma; Age related macular degeneration; Gingival Diseases; Renal Cell Carcinoma; Acute periodontitis; Adenoma; Peripheral Vascular Diseases; Pancreatitis; Acute pyelonephritis; Peritonsillar Abscess; Solid Neoplasm; Endometrial Carcinoma; Adenocarcinoma of lung (disorder); VITILIGO-ASSOCIATED MULTIPLE AUTOIMMUNE DISEASE SUSCEPTIBILITY 1 (finding); Peptic Ulcer; Carcinoma, Transitional Cell; Nasal Polyps; Colorectal Carcinoma; Diabetes Mellitus, Non-Insulin-Dependent; Fibrosis, Liver; Encephalitis, St. Louis; Metabolic Syndrome X; Pancreatic Ductal Adenocarcinoma; Pulmonary Emphysema; Seronegative rheumatoid arthritis; Alcoholic Liver Diseases; Gastritis, Atrophic; Chronic gastritis; Tuberculosis, Meningeal; Dermatitis Herpetiformis; Metastatic melanoma; Myeloid Leukemia, Chronic; Interstitial Cystitis; Anemia; Kidney Diseases; Wheezing; Neoplasms; Intrauterine infection; Pseudomonas aeruginosa infection; Ulcer; Gastrointestinal Diseases; Allergic disposition; Chondrosarcoma; Keratoconjunctivitis Sicca; Precursor B-cell lymphoblastic leukemia; Vitiligo; Dementia; Severe Dengue; Acute Chest Syndrome; Central neuroblastoma; Secondary malignant neoplasm of lymph node; Amyloidosis; Aggressive periodontitis, generalized; Chronic interstitial cystitis; Drug-Induced Liver Disease; Colorectal Cancer; Gastro-esophageal reflux disease with esophagitis; Congenital laryngeal adductor palsy; Coprophilia (disorder); Idiopathic urticaria; Hepatitis; Skin Neoplasms; Squamous cell carcinoma of the head and neck; Secondary malignant neoplasm of lung; Invasive carcinoma of breast; Urothelial Carcinoma; Chronic Periodontitis; Superinfection; Periapical Periodontitis; Pleural Tuberculosis; Esophagitis; Neuroblastoma; Primary malignant neoplasm; Carcinoma breast stage IV; Renal interstitial fibrosis; Immune Reconstitution Inflammatory Syndrome; Myeloproliferative disease; Precursor Cell Lymphoblastic Leukemia Lymphoma; Ataxia Telangiectasia; Osteopenia; Primary biliary cirrhosis; Viral meningitis; Mucocutaneous leishmaniasis; Malignant Neoplasms; Meningitis, Bacterial; Leukoplakia, Oral; Skin Erosion; Infant, Premature; Carcinoma, Cribriform; Carcinoma, Granular Cell; Keratitis; Necrotizing enterocolitis in fetus OR newborn; Irritable Bowel Syndrome; Adenocarcinoma, Basal Cell; Malignant neoplasm of thyroid; Adenocarcinoma, Oxyphilic; Pulmonary Edema; Secondary malignant neoplasm of liver; SPONDYLOCARPOTARSAL SYNOSTOSIS SYNDROME; Zollinger-Ellison syndrome; Pediatric Crohn's disease; Chronic granulomatous disease; Pulmonary Cystic Fibrosis; Carcinoma of larynx; Dengue Fever; Adenocarcinoma, Tubular; Arthropathy; Adenocarcinoma Of Esophagus; Toxic Shock Syndrome; Endometriosis of uterus; Pleocytosis; Interstitial lung fibrosis; Hypercholesterolemia; Primary Myelofibrosis; Rett Syndrome; Malignant neoplasm of larynx; Lyme Disease; Recurrent urinary tract infection; Thyroid Gland Follicular Adenoma; Pouchitis; Airway Obstruction; Cerebral Palsy; Metastatic Neoplasm; Cervical Squamous Intraepithelial Neoplasia; Clostridium; difficile (disorder); Huntington Disease; Otitis Media with Effusion; Periodontitis, Juvenile; Disseminated Malignant Neoplasm; NONAKA MYOPATHY; Adenoma of large intestine; Lymphocytic infiltration; Thyroid Neoplasm; Endothelial dysfunction; Cardiac Arrest; Rheumatism; Hemorrhagic Fever with Renal Syndrome; Polycythemia Vera; Papillary thyroid carcinoma; Staphylococcal toxic shock syndrome; Bronchitis; Ischemia of kidney; Pneumocystis jiroveci pneumonia; Aneurysm; Temporomandibular Joint Disorders; Hyperlipoproteinemia Type IIa; Mycoplasma Infections; Hypercholesterolemia, Familial; Lesion of stomach; Human anaplasmosis due to Anaplasma phagocytophilum; Subfertility, Male; Bullous pemphigoid; Appendicitis; Localized scleroderma; Atrial Premature Complexes; Hairy Cell Leukemia; androgen independent prostate cancer; Lichen Planus, Oral; Temporomandibular Joint Dysfunction Syndrome; Bacterial keratitis; Bronchiolitis Obliterans Organizing Pneumonia; Childhood Acute Lymphoblastic Leukemia; Fatty Liver; Liver and Intrahepatic Biliary Tract Carcinoma; Febrile Convulsions; Follicular thyroid carcinoma; Cholera; Choriocarcinoma; Hereditary Diffuse Gastric Cancer; gastritis h pylori; Chronic myeloproliferative disorder; Promyelocytic leukemia; Uveal melanoma; Bronchiolitis, Viral; Aseptic Meningitis; Infection - suppurative; Hepatolenticular Degeneration; Anaplastic thyroid carcinoma; Stromal Neoplasm; Cardiomyopathy, Familial Idiopathic; Nephrotic Syndrome; TIBIAL MUSCULAR DYSTROPHY, TARDIVE; psychosocial stressor; Immune thrombocytopenic purpura; Squamous cell carcinoma of esophagus; Adrenocortical carcinoma; Bipolar Disorder; Primary infection NOS; Steatohepatitis; Astrocytoma, low grade; Asymptomatic bacteriuria; Infections specific to perinatal period; Abscess; Hepatitis A; Lipoid nephrosis; Connective Tissue Diseases; Pyelonephritis; Thrombocytopenia; Chronic cough; HIV-Associated Lipodystrophy Syndrome; Immune reconstitution inflammatory syndrome [IRIS]; Postherpetic neuralgia; Psoriasis vulgaris; Recurrent tumor; Schizophrenia; Cervical Intraepithelial Neoplasia; Small Fiber Neuropathy; Female Genital Diseases; Hyaline Membrane Disease; Childhood Osteosarcoma; Thrombocythemia, Essential; American cutaneous leishmaniasis; Lymphoid leukemia; Hyperactive behavior; Aortic Valve Insufficiency; Enteritis; Lipoatrophy; Atrial Fibrillation; Coughing; Vasculitis of the skin; Antibiotic-associated diarrhea; Chronic active hepatitis C; Enterovirus 71 infection; Rhinovirus infection; Diabetic Foot; Conventional (Clear Cell) Renal Cell Carcinoma; Renal cyst; Limb ischemia; cardiac event; Down Syndrome, Partial Trisomy 21; Trisomy 21, Meiotic Nondisjunction; Trisomy 21, Mitotic Nondisjunction; Chronic ulcer; Fibromyalgia; Selenium deficiency; Steroid-sensitive nephrotic syndrome; Metastatic malignant neoplasm to brain; Down Syndrome; TARSAL-CARPAL COALITION SYNDROME; Adenomatous Polyposis Coli; Glioblastoma Multiforme; Parainfluenza; Anxiety Disorders; Rotavirus Infections; Cholestasis; Complete atrioventricular block; Dental caries; Hypocholesterolemia; Congenital bilateral aplasia of vas deferens; Gonorrhea; Barrett Esophagus; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Mammary Tumorigenesis; Staphylococcal Infections; Pyoderma Gangrenosum; Brain Diseases; Diarrhea; AICARDI-GOUTIERES SYNDROME 1; Oropharyngeal Carcinoma; Multiple System Atrophy; Leukemia, B-Cell; Syphilis; Malignant neoplasm of gastrointestinal tract; Polyp of large intestine; Aspergillosis, Allergic Bronchopulmonary; Hypotrichosis simplex; Lymphocytosis; Adenocarcinoma of colon; Superficial spreading malignant melanoma of skin; Enthesitis-Related Arthritis; Peripheral Arterial Diseases; Osteoarthritis of hip; Tuberous Sclerosis; CONSTRICTING BANDS, CONGENITAL; Healing ulcer; Arthralgia; Triple Negative Breast Neoplasms; Apraxia, Developmental Verbal; Congenital infectious disease; Enterocolitis; Hepatic Form of Wilson Disease; Neoplastic Cell Transformation; Cholangiocarcinoma; PACHYONYCHIA CONGENITA 3; Arthritis, Gouty; Hereditary gingival fibromatosis; Streptococcal Infections; Anxiety; Hyperinsulinism; Anasarca; Craniosynostosis; Crohn's disease of large bowel; Giant Cell Glioblastoma; Gastric Adenocarcinoma; Dyslipidemias; Adenocarcinoma of large intestine; Staphylococcus aureus infection; Upper Respiratory Infections; Epithelioma; Cutaneous Melanoma; Stomach Diseases; Glycogen Storage Disease; Exanthema; Rhabdomyosarcoma; Chronic sinusitis; Lymphoproliferative Disorder of the Skin; Squamous cell carcinoma of tongue; Ductal Carcinoma; Central Diabetes Insipidus; Leukocytosis; Pemphigus; Secondary malignant neoplasm of pancreas; prostatitis; Ventricular Fibrillation; invasive cancer; Pelvic Inflammatory Disease; stage, ovarian epithelial cancer; Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome; Depressive disorder; Alcoholic Intoxication; Vascular Neoplasms; CATARACT, ANTERIOR POLAR; Muscle damage; Basal cell carcinoma; Pleural effusion disorder; Vesico-Ureteral Reflux; Respiratory Failure; Early gastric cancer; Luminal A Breast Carcinoma; Bacteriuria; Megakaryocytic hyperplasia; Myeloid Metaplasia; Rectal Carcinoma; Lipodystrophy; leiomyosarcoma; Mental Depression; Eclampsia; Carcinoma, Small Cell; Ulcerative colitis in remission; Bronchial Diseases; Bullous keratopathy; Chiari malformation type II; Hemorrhagic colitis; Incontinence; Meningeal Neoplasms; Nose symptoms; Amaurosis congenita of Leber, type 1; Hypophosphatemia; Pituitary Adenoma; Rhinitis, Allergic, Perennial; Acute respiratory infections; fertility disorders; Gram-Positive Bacterial Infections; Colorectal cancer metastatic; Vaginal Diseases; Chondromalacia; Pericytic Neoplasm; Chlamydia Infections; Disorder of eye; Malignant neoplasm of large intestine; MYELOPROLIFERATIVE SYNDROME, TRANSIENT; Chronic idiopathic pulmonary fibrosis; Pruritus; Adenocarcinoma, Endometrioid; Necrotizing fasciitis; Plasma cell inflammation; Giant Cell Tumor of Bone; Fatigue; Encephalopathies; Amebiasis; Persistent infection; Gout; Pterygium; Acute appendicitis NOS (disorder); Rectal Neoplasms; Gastroesophageal reflux disease; Urinary Bladder Diseases; Depressed mood; Junctional Epidermolysis Bullosa; Soft Tissue Infections; Nicotine Use Disorder; Nodular melanoma; Acute type B viral hepatitis; Pleomorphic Xanthoastrocytoma; Rhinosinusitis; Clostridium difficile infection; Tobacco Use Disorder; Actinic keratosis; Alcohol Use Disorder; Edema; Little's Disease; AIDS with Kaposi's sarcoma; Stage III Colon Cancer AJCC v7; Familial benign pemphigus; Liver cyst; Leukemia, Mast-Cell; Stage III Colon Cancer; Familial primary pulmonary hypertension; Lyme Arthritis; Acute hepatitis; Epidermolysis Bullosa Simplex; Hyperplastic Polyp; Keratosis Follicularis; Primary peritoneal carcinoma; Tobacco Dependence; Gastric Cardia Adenocarcinoma; Nicotine Dependence; Ovarian Hyperstimulation Syndrome; Hormone refractory prostate cancer; Anthrax disease; Chronic rejection of renal transplant; Laryngeal neoplasm; Sleep Apnea, Central; Barrett Epithelium; Cervical Squamous Cell Carcinoma; Malignant hyperpyrexia due to anesthesia; Cockayne Syndrome, Type I; Malignant ascites; Pituitary Neoplasms; Alcoholic Intoxication, Chronic; Chronic lung disease; Leukocyte adhesion deficiency type 1; Bardet-Biedl Syndrome; Nijmegen Breakage Syndrome; Hepatic methionine adenosyltransferase deficiency; Cushing Syndrome; Multiple Chronic Conditions; Dyspnea; Adenomatous Polyps; Ovarian Cysts; Melanocytic nevus; Paroxysmal kinesigenic choreoathetosis; Skin Ulcer; Tremor; Inflammatory Breast Carcinoma; Intestinal Neoplasms",2.8114433253573326e-17; 7.980856456624717e-16; 4.4398736172867135e-14; 1.803641225501291e-12; 3.118210553589307e-12; 3.861499575207375e-12; 3.861499575207375e-12; 4.5104266881389206e-12; 2.5279022064249716e-11; 6.332483647919588e-11; 7.448716379948652e-11; 8.179290839744632e-11; 1.1574161017103878e-10; 1.3121548808139071e-10; 1.6797550790254382e-10; 1.9241179247341838e-10; 2.377251819497684e-10; 2.377251819497684e-10; 2.813069300429449e-10; 3.762648680673853e-10; 4.2478505092738466e-10; 5.452288254986118e-10; 5.452288254986118e-10; 6.870627395110916e-10; 7.861255581007157e-10; 7.868397426275417e-10; 1.1722433847661196e-09; 1.4790998733426532e-09; 1.5734876414130875e-09; 1.6767489697325582e-09; 1.794870341379274e-09; 1.971893171900314e-09; 1.971893171900314e-09; 2.219129913614883e-09; 3.315537369635636e-09; 3.683115069310663e-09; 3.683115069310663e-09; 4.367699208727405e-09; 4.546836602575699e-09; 5.670785186683756e-09; 5.791865115913735e-09; 6.0322241000340585e-09; 6.195332209150018e-09; 6.991207850982321e-09; 7.195555613367576e-09; 7.547641288501485e-09; 7.713813941246406e-09; 8.269524813140207e-09; 8.303910954283738e-09; 1.0368326871660785e-08; 1.0368326871660785e-08; 1.3128768066526236e-08; 1.452540845894924e-08; 1.4920329017331753e-08; 1.4920329017331753e-08; 1.5572986293211266e-08; 1.587872453479067e-08; 1.7931366647560766e-08; 2.0570601164639797e-08; 2.1034803123367165e-08; 2.261634993097532e-08; 2.3137704832524547e-08; 2.412608431251415e-08; 2.7368000175117756e-08; 3.149054123564124e-08; 3.9573009168853264e-08; 4.0898524252942674e-08; 4.3069383556698336e-08; 4.638299267461546e-08; 4.65353219894153e-08; 5.071217747675114e-08; 5.1290058242058653e-08; 5.3111708677091025e-08; 5.518991037343798e-08; 5.784935444423772e-08; 5.8317433871210796e-08; 5.989093556336469e-08; 6.016513497232253e-08; 6.156981490555128e-08; 6.156981490555128e-08; 6.156981490555128e-08; 6.982287075725826e-08; 8.598175402882612e-08; 9.273260676030806e-08; 9.273260676030806e-08; 9.273260676030806e-08; 9.306686765839445e-08; 9.393284022832733e-08; 1.0276547515522002e-07; 1.0390067657961098e-07; 1.0618136021459505e-07; 1.3150328464481586e-07; 1.427432458937347e-07; 1.427432458937347e-07; 1.479813245926713e-07; 1.4925759778299788e-07; 1.4925759778299788e-07; 1.6759866477134858e-07; 1.946794431045147e-07; 2.0279723135488897e-07; 2.0732395681104218e-07; 2.242497138958313e-07; 2.247163660896597e-07; 2.419125491442217e-07; 2.46778041958494e-07; 2.46778041958494e-07; 2.911052249927245e-07; 2.948344121290337e-07; 3.10587283755252e-07; 3.880986260207744e-07; 4.157277636684319e-07; 4.312772724439924e-07; 4.5433391667148853e-07; 5.254943571583271e-07; 5.313225371508493e-07; 5.577321626966352e-07; 5.916066415963854e-07; 6.299208964864026e-07; 6.630279934320317e-07; 6.673805318525932e-07; 6.805796735296268e-07; 6.805796735296268e-07; 6.851652105457608e-07; 7.17979149467092e-07; 7.789160940651547e-07; 7.873224494781308e-07; 7.931659047151387e-07; 7.99548070959303e-07; 8.297823048747685e-07; 8.339674388418603e-07; 8.339674388418603e-07; 8.339674388418603e-07; 8.660170029731726e-07; 8.777200373497231e-07; 8.887379906686178e-07; 9.58028929735367e-07; 9.822463166680949e-07; 1.0094398444517938e-06; 1.083280646968723e-06; 1.10068355868735e-06; 1.2482007026109775e-06; 1.284982487562752e-06; 1.3079916134634371e-06; 1.4185164995612263e-06; 1.4839502431758565e-06; 1.51758575162775e-06; 1.5208470671427406e-06; 1.6231490275716298e-06; 1.6397478315149087e-06; 1.9581146391906144e-06; 1.9581146391906144e-06; 1.96107848506464e-06; 2.027389637151193e-06; 2.027389637151193e-06; 2.07112526817849e-06; 2.086123696221558e-06; 2.086123696221558e-06; 2.1624936975752243e-06; 2.205236928124383e-06; 2.2411321306638023e-06; 2.263727724144348e-06; 2.3419309731960144e-06; 2.450940162208615e-06; 2.560217628497434e-06; 2.576211756838249e-06; 2.608032323197001e-06; 2.7684459182091574e-06; 2.782805018144785e-06; 3.282956820548434e-06; 3.4620043828295477e-06; 3.485726441474513e-06; 3.7283259874612974e-06; 3.878607667297475e-06; 3.990817553511259e-06; 3.990817553511259e-06; 4.179146475474674e-06; 4.42396341877472e-06; 4.83171753412672e-06; 4.839188317483647e-06; 5.021572339409501e-06; 5.381279306135013e-06; 5.457492980911677e-06; 5.572620871465934e-06; 6.140554546483986e-06; 6.140554546483986e-06; 6.140554546483986e-06; 6.3131986281381465e-06; 6.378950690990071e-06; 6.378950690990071e-06; 6.889889014378816e-06; 7.095035199288336e-06; 7.439853898002338e-06; 8.32456450186878e-06; 8.567994785462795e-06; 8.591027139424906e-06; 8.77532817235926e-06; 1.0172703923266036e-05; 1.033366177374635e-05; 1.0755368362337037e-05; 1.0961931275541026e-05; 1.2304362232150695e-05; 1.2375081616087569e-05; 1.2765469826010355e-05; 1.279493639647176e-05; 1.3010173302726732e-05; 1.3034577772762696e-05; 1.3268923055385737e-05; 1.3268923055385737e-05; 1.3268923055385737e-05; 1.3410647656206684e-05; 1.3410647656206684e-05; 1.3410647656206684e-05; 1.3755659311680946e-05; 1.3755659311680946e-05; 1.4583987015565183e-05; 1.513340899972731e-05; 1.527992765491583e-05; 1.5449280661407645e-05; 1.5498516107485843e-05; 1.7090079578013972e-05; 1.8507296589967813e-05; 1.8507296589967813e-05; 1.8961926417889813e-05; 1.9896942827707536e-05; 2.0234336876324372e-05; 2.0736107376307555e-05; 2.0820699372778346e-05; 2.0820699372778346e-05; 2.1083292452040976e-05; 2.365778380659297e-05; 2.389985034001877e-05; 2.483118059238325e-05; 2.7001454785434173e-05; 2.910435331986992e-05; 2.929369913127532e-05; 2.9890125380431698e-05; 3.053335644618538e-05; 3.053335644618538e-05; 3.14076229962439e-05; 3.1491435270594376e-05; 3.192298841377222e-05; 3.372277447426952e-05; 3.602405958537832e-05; 3.602405958537832e-05; 3.602405958537832e-05; 3.878191781014205e-05; 3.9650653676454574e-05; 3.9650653676454574e-05; 4.079834649355082e-05; 4.3188904868696655e-05; 4.360044574654907e-05; 4.550622830486202e-05; 4.8257135411913726e-05; 5.013426562854155e-05; 5.248375780672949e-05; 5.248375780672949e-05; 5.2700686057264086e-05; 5.496580971003797e-05; 5.592330076699809e-05; 5.726577479376336e-05; 5.9174130460768686e-05; 5.945938584340405e-05; 6.087890235661384e-05; 6.709590381814368e-05; 6.758558746827128e-05; 6.964870190365813e-05; 7.036498484894257e-05; 7.519084418988331e-05; 8.007340895515112e-05; 8.100290141298731e-05; 8.100290141298731e-05; 8.178614148996482e-05; 8.232890503539995e-05; 8.25206825409808e-05; 8.421319594446617e-05; 8.730297037328594e-05; 9.023170634543253e-05; 9.023170634543253e-05; 9.117996105379778e-05; 9.476946799623076e-05; 9.476946799623076e-05; 9.780860153755674e-05; 9.846223464501226e-05; 9.846223464501226e-05; 9.913294924271568e-05; 9.913294924271568e-05; 9.913294924271568e-05; 0.0001007621786326551; 0.00010334647523919963; 0.00010776056908698134; 0.0001119048288448298; 0.00011927896769899647; 0.00012202062264879416; 0.00012202062264879416; 0.00012858049944279123; 0.00012858049944279123; 0.00012949836610375056; 0.0001322335978675375; 0.0001322335978675375; 0.00013846515856925812; 0.0001431024725510208; 0.00014636999075042076; 0.0001474322229096163; 0.00015093372108149775; 0.00016189346720036038; 0.00016189346720036038; 0.0001690762138878921; 0.0001705179359230947; 0.00017808425336754297; 0.0001802305430549181; 0.0001802305430549181; 0.0001802305430549181; 0.000181883468787863; 0.00019131698235390912; 0.0001932529498581875; 0.0001934869050618567; 0.0001934869050618567; 0.00021049732822064587; 0.00021049732822064587; 0.00021116105905857028; 0.00022254302103317592; 0.00022336414159326664; 0.00022618385822819267; 0.00022897551943886068; 0.00024044665139790348; 0.0002496596482692862; 0.00026224811620659125; 0.00026339787549714257; 0.0002718864504795822; 0.0002792365191965819; 0.00028056116385876946; 0.0002926994143155384; 0.0002933384035122236; 0.0002983150880926112; 0.0003022150453166086; 0.00031439908493214593; 0.00032113080554701227; 0.000323910443746482; 0.0003495642888428815; 0.0003539177308293034; 0.0003539177308293034; 0.0003607853785819225; 0.00038453776693371663; 0.0003987632373118045; 0.00039959635390179865; 0.00039959635390179865; 0.00039959635390179865; 0.00040624424086014313; 0.00041476222368508776; 0.000420950947096172; 0.00042196010900515655; 0.0004224524250828287; 0.0004243878730487336; 0.0004303328941191692; 0.0004336479443072768; 0.0004336479443072768; 0.0004336479443072768; 0.00045185714020635207; 0.0004601228759628894; 0.00046565119871267287; 0.0004814724943641282; 0.0004814724943641282; 0.0004918069653418582; 0.0005011878920853237; 0.000513309425513094; 0.0005182771791848276; 0.0005214896245221155; 0.0005214896245221155; 0.0006046022723190866; 0.0006046022723190866; 0.0006352060750206054; 0.0006445212280958682; 0.0006540484469998963; 0.0006721375816653799; 0.0007074539367893701; 0.0007603472723798622; 0.0007603472723798622; 0.0008252744167874381; 0.0008252744167874381; 0.0008252744167874381; 0.0008280072185276037; 0.0009826472144539087; 0.0010170306665323; 0.0010244557923259; 0.0010244557923259; 0.0010244557923259; 0.0010244557923259; 0.0010244557923259; 0.0010798279940823; 0.0010831910832595; 0.0011261416978188; 0.0011261416978188; 0.0011303542860313; 0.0011303542860313; 0.0011303542860313; 0.0011626911115394; 0.0011626911115394; 0.0011876897533161; 0.00120990141675; 0.0012591553085125; 0.0012983918214284; 0.0013033444225859; 0.0013033444225859; 0.0013510612738592; 0.0015133919764529; 0.0015652768725765; 0.0015698089771612; 0.0016696601172499; 0.0017329922477138; 0.001746579573497; 0.0017731038420892; 0.0017731038420892; 0.0017731038420892; 0.0017731038420892; 0.0017856981020231; 0.0018360773814867; 0.001881335207053; 0.001881335207053; 0.0020056438913528; 0.0020089634269714; 0.0020505587731585; 0.002135695462532; 0.002213465225837; 0.0022378309697704; 0.0025118094772522; 0.0025122887786423; 0.0025122887786423; 0.0025122887786423; 0.0026189803532255; 0.0027346449758241; 0.0027534163536682; 0.0027942850562877; 0.0028187518310092; 0.0028759971272412; 0.0029013169576144; 0.0029063499863533; 0.0030585625765418; 0.0031934755667; 0.0031934755667; 0.0033783379034436; 0.0033783379034436; 0.0033785221929293; 0.0035164243080016; 0.0037263522689301; 0.0037263522689301; 0.003846910040485; 0.003846910040485; 0.003846910040485; 0.0038705790239355; 0.0038705790239355; 0.0038816440940594; 0.0038895739770004; 0.0040785542386402; 0.0041157458728674; 0.0043105477873176; 0.0043105477873176; 0.0043470921917622; 0.0044119363017658; 0.0044119363017658; 0.0047339976311261; 0.0048028611524245; 0.0048028611524245; 0.0048028611524245; 0.0048662864613419; 0.0050844857197244; 0.0050894481995015; 0.0053570195415722; 0.0059257679306595; 0.0059257679306595; 0.0059257679306595; 0.0060170797120173; 0.0062748297137782; 0.0063306870511064; 0.0066006052483961; 0.0066401895279317; 0.0067588219988478; 0.0068235619036629; 0.007117388576245; 0.007117388576245; 0.0072083035574659; 0.0075697193353146; 0.0077321746155735; 0.0080667733705833; 0.0082763563641252; 0.0083709650732796; 0.0083709650732796; 0.0083709650732796; 0.0083709650732796; 0.0083709650732796; 0.0088561754221927; 0.0091914307650131; 0.0093325514582534; 0.0096630827054915; 0.0096630827054915; 0.0096630827054915; 0.0096630827054915; 0.0097628826330308; 0.0105367304020196; 0.0110109843340769; 0.0111888062322808; 0.0111888062322808; 0.0114187031414039; 0.0114187031414039; 0.0114187031414039; 0.0118123250371176; 0.0120771273149872; 0.0123983633418964; 0.0123983633418964; 0.0123983633418964; 0.0123983633418964; 0.0125952576116424; 0.0125952576116424; 0.0127059723723765; 0.0127059723723765; 0.0127059723723765; 0.0138441633831498; 0.0138441633831498; 0.0138441633831498; 0.0138441633831498; 0.0138441633831498; 0.0145436543557976; 0.015507621739214; 0.015507621739214; 0.0157194401523571; 0.0161428886050652; 0.016456143422954; 0.0166041002652209; 0.0171001534176385; 0.0171001534176385; 0.0173384291015271; 0.0173964199029194; 0.0174410368983484; 0.0182000062506337; 0.0182000062506337; 0.0182000062506337; 0.018665947632861; 0.0187299613301643; 0.0193777520415227; 0.0198983219186433; 0.0203198961621158; 0.0203198961621158; 0.0203198961621158; 0.0208452312614567; 0.0209435845696216; 0.021125667706065; 0.0220575875892222; 0.0220705590988414; 0.0231910952149837; 0.0239461944596263; 0.0255085366814945; 0.0256587294742695; 0.0259817880808067; 0.0259817880808067; 0.0265829029717646; 0.027071413490175; 0.0279220892715439; 0.0279220892715439; 0.0280663273380655; 0.029552535105148; 0.0299774405999183; 0.030006907592274; 0.030006907592274; 0.0300972754548838; 0.0302544192125064; 0.0319682790952413; 0.0319682790952413; 0.0319682790952413; 0.0319682790952413; 0.0320403652557597; 0.0334053723619937; 0.0335408281184641; 0.0340266852061135; 0.0357364979606411; 0.0363737825516021; 0.0365699380189482; 0.0378565625608719; 0.0384689641633299; 0.0392832161328838; 0.0402448379890702; 0.0402448379890702; 0.0403198851338656; 0.0404707605808569; 0.0404707605808569; 0.0404707605808569; 0.0404707605808569; 0.0407359064912377; 0.0425171404778382; 0.0427786786335321; 0.044901297966643; 0.0458359347176422; 0.0462818499370266; 0.0469394416375774; 0.0471006425252053; 0.0491632343384016; 0.0492531776191947; 0.0493155676939993; 0.0493155676939993; 0.0493155676939993; 0.0517499693438671; 0.0517499693438671; 0.0543546439241988; 0.0616475884230982; 0.0623026316541814; 0.0677694730935319; 0.0677694730935319; 0.0691714743582008; 0.0700485361084771; 0.0723815120866587; 0.0749666609274744; 0.0777073264956258; 0.0791235961972295; 0.0791235961972295; 0.0805908799965109; 0.0814119493993337; 0.0817897187940979; 0.0817897187940979; 0.0817897187940979; 0.0817897187940979; 0.0817897187940979; 0.0837469930808364; 0.0858871491124922; 0.087414326021809; 0.0887984457495041; 0.088963803794147; 0.0897127848630768; 0.0897127848630768; 0.0897127848630768; 0.0897127848630768; 0.0897127848630768; 0.0897127848630768; 0.0897127848630768; 0.0897127848630768; 0.0897127848630768; 0.0908772402064694; 0.0967179741949912; 0.0972679220674381; 0.0972679220674381; 0.0972679220674381; 0.0972679220674381; 0.0972679220674381; 0.0993028790023582; 0.1050724946352408; 0.1050724946352408; 0.1050724946352408; 0.1050724946352408; 0.1070008331073374; 0.1128564106125758; 0.1130019719865939; 0.1130019719865939; 0.1156074612838089; 0.1204795752338222; 0.1206032442301429; 0.1206032442301429; 0.124149904653194; 0.1266767196420385; 0.1272255752567765; 0.1272255752567765; 0.1272255752567765; 0.1343310874911156; 0.1343310874911156; 0.1343310874911156; 0.1369039689436487; 0.1395859646277307; 0.1401454825042905; 0.1401454825042905; 0.1401454825042905; 0.1460848784791741; 0.1460848784791741; 0.1460848784791741; 0.1525119847960956; 0.1525119847960956; 0.1584804022044084; 0.1584804022044084; 0.1642913929691757; 0.1687319146389434; 0.1703929618871976; 0.181710614199711; 0.181710614199711; 0.1881045022168423; 0.1932166112700285; 0.1932166112700285; 0.1932166112700285; 0.1982833830495248; 0.1982833830495248; 0.1982833830495248; 0.1982833830495248; 0.2108300774722888; 0.2108300774722888; 0.2222592445219346; 0.2272199982000937; 0.2272199982000937; 0.2316568843888361; 0.2468771733501051; 0.2521777681302088; 0.2670582190879765; 0.2786853069571751; 0.2823835751171575; 0.2823835751171575; 0.2877158849893504; 0.3113515317868633; 0.320973096008708; 0.3216879895850248; 0.3258470663820326; 0.335302985108383; 0.340330994065175; 0.3696586134131318; 0.3697330558649637; 0.3718365496695985; 0.3718365496695985; 0.384785908220112; 0.384785908220112; 0.397280768882461; 0.4055175521212118; 0.4055175521212118; 0.4055175521212118; 0.4129951424538438; 0.4365091908885111; 0.4389761493558894; 0.4535514871248414; 0.4678790703646548; 0.4866653182016537; 0.5280301206455198; 0.6786928921054781,Marfan Syndrome; Mammary Neoplasms; Bright Disease; Alveolitis; Pulmonary Fibrosis; Glomerulonephritis; Rheumatoid Arthritis; Thyroid Gland Follicular Adenoma; Breast Carcinoma; Thyroid Neoplasm; Heart Failure; Ulcerative Colitis; Myocardial Infarction; Thyroid Carcinoma; Breast Cancer; Malignant Mesothelioma; Pancreatic Cancer; Fatty Liver; Congestive Heart Failure; Pancreatic Neoplasm; Carcinoma; Cholestasis; Stomach Neoplasms; Gastric Cancer; Chronic Obstructive Pulmonary Disease; Bladder Neoplasm; Adenocarcinoma; Urinary Bladder Cancer; Delirium; Oral Submucous Fibrosis; Trisomy 21; Down Syndrome; Mental Depression; Prostatic Neoplasms; Hepatolenticular Degeneration; Giant Cell Glioblastoma; Lung Carcinoma; Endometrial Neoplasms; Behcet Syndrome; Psoriatic Arthritis; Prostate Cancer; Barrett Epithelium; Liver Carcinoma; Colorectal Neoplasms; Ovarian Cancer; Endometrial Carcinoma; Ovarian Neoplasm; Bipolar Disorder; Barrett Esophagus; Keratitis; Glioblastoma; Colorectal Cancer; Gastroesophageal Reflux Disease,8.921950872070284e-08; 1.1417484002988661e-07; 1.1417484002988661e-07; 3.1346476759108064e-07; 3.656047745092532e-06; 1.0086418491083646e-05; 1.241997446075319e-05; 3.882845009510541e-05; 4.971054570440277e-05; 7.782144775199944e-05; 0.00015071968444989745; 0.0002754573766813309; 0.0005760978170082974; 0.0005818213110442873; 0.00063387456654884; 0.0015169561374293; 0.00207663921483; 0.0025464930497429; 0.0028558709076653; 0.0054741435035425; 0.0107108189044139; 0.0152037568688841; 0.0172144998405365; 0.0172144998405365; 0.0173324463553544; 0.021392225047824; 0.0249475037164364; 0.0264273671824767; 0.0378359748125562; 0.0418006551930827; 0.0446679463927015; 0.0446679463927015; 0.0511376198481248; 0.0567647407547259; 0.0592733852980501; 0.0841735094076256; 0.0868883392670891; 0.0910638962801208; 0.1054719783837416; 0.1286424863049623; 0.1386032662139448; 0.2003502278196653; 0.2008242041589438; 0.2039740835961235; 0.2048942314782707; 0.2856663281934009; 0.2978951863374514; 0.2978951863374514; 0.3020628161707281; 0.3020628161707281; 0.3677216857879628; 0.6963620089820088; 0.8881934161397249,"Charcot-Marie-Tooth disease type 1D ORPHA:101084; Charcot-Marie-Tooth disease type 4E ORPHA:99951; Nasopharyngeal carcinoma ORPHA:150; Systemic-onset juvenile idiopathic arthritis ORPHA:85414; Hereditary pediatric Behcet-like disease ORPHA:476102; Cryptogenic multifocal ulcerous stenosing enteritis ORPHA:468635; Cytosolic phospholipase-A2 alpha deficiency associated bleeding disorder ORPHA:477787; Metaphyseal anadysplasia ORPHA:1040; Niemann-Pick disease type C, adult neurologic onset ORPHA:216986; Niemann-Pick disease type C, juvenile neurologic onset ORPHA:216981; Niemann-Pick disease type C, late infantile neurologic onset ORPHA:216978; Niemann-Pick disease type C, severe early infantile neurologic onset ORPHA:216975; Niemann-Pick disease type C, severe perinatal form ORPHA:216972; Pediatric systemic lupus erythematosus ORPHA:93552; Exfoliative ichthyosis ORPHA:289586; FTH1-related iron overload ORPHA:247790; Hypoplastic amelogenesis imperfecta ORPHA:100031",3.598261936626476e-12; 3.598261936626476e-12; 6.10801728836975e-11; 1.514756890441811e-09; 1.7877420438201673e-08; 0.0002132495254484572; 0.0002132495254484572; 0.0002132495254484572; 0.0002132495254484572; 0.0002132495254484572; 0.0002132495254484572; 0.0002132495254484572; 0.0002132495254484572; 0.00021965881189185; 0.0514345493431829; 0.0514345493431829; 0.0565022767519947,Cercopithecine betaherpesvirus 5 chemokine vCXCL5 (gene: UL146B); Vaccinia virus chemokine binding protein (gene: C23L); Vaccinia virus Ankara viral chemokine binding protein; Cercopithecine betaherpesvirus 5 chemokine vCXCL10 (gene: UL146G); Variola virus chemokine binding protein (gene: G5R); Human gammaherpesvirus 8 K6 (gene: K6); Cercopithecine betaherpesvirus 5 chemokine vCXCL9 (gene: UL146F); Human betaherpesvirus 5 chemokine vCXCL1 (gene: UL146); Cercopithecine betaherpesvirus 5 chemokine vCXCL2 (gene: UL147); Human betaherpesvirus 5 chemokine vCXCL2 (gene: UL147); Human gammaherpesvirus 8 K4.1 (gene: K4.1); Molluscum contagiosum virus subtype 1 MC148R (gene: MC148R); Cercopithecine betaherpesvirus 5 chemokine vCXCL6 (gene: UL146C),3.855107856457681e-08; 5.6633714501424107e-08; 5.6633714501424107e-08; 2.3160451568389139e-07; 3.201246660025618e-07; 9.087104857163152e-07; 9.087104857163152e-07; 1.12171834090951e-06; 1.12171834090951e-06; 1.3435225153003765e-06; 1.7536244306421314e-06; 2.1974600826970047e-06; 0.1015629191226059,Homo sapiens HLMVEC lung microvascular endothelial cell;Homo sapiens diploid fibroblast;In vitro,0.61,Homo sapiens;chemical synthesis,Homo sapiens;chemical synthesis
CYP1A1,"Pneumonia; Psoriasis; Lymphoma; Virus Diseases; Dermatitis, Atopic; Lung diseases; Chronic Obstructive Airway Disease; Thyroid associated opthalmopathies; Arteriosclerosis; Non-Small Cell Lung Carcinoma; Crohn Disease; Ovarian Carcinoma; Endometriosis; cervical cancer; Malignant neoplasm of ovary; Colitis; Malignant tumor of cervix; Lung Neoplasms; Neoplasm Metastasis; Mammary Neoplasms, Human; Hepatitis C; Atherosclerosis; Graves Disease; Leukemia, Myelocytic, Acute; Hypertensive disease; Liver Cirrhosis; Vascular Diseases; Cervix carcinoma; Infection caused by Helicobacter pylori; Cerebrovascular accident; Respiratory Distress Syndrome, Adult; Allergic Reaction; Obesity; Periodontitis; Liver neoplasms; Mammary Neoplasms; Arthritis, Psoriatic; leukemia; Diabetes Mellitus; Diabetes; Lupus Erythematosus, Systemic; Pancreatic carcinoma; Coronary Artery Disease; Coronary heart disease; Adenocarcinoma of pancreas; Behcet Syndrome; Dermatitis, Allergic Contact; Glioma; Epithelial ovarian cancer; Malignant neoplasm of pancreas; Malignant neoplasm of mouth; Myocardial Infarction; Adult T-Cell Lymphoma/Leukemia; Diffuse Large B-Cell Lymphoma; Brain Neoplasms; Malignant neoplasm of lung; Fibroid Tumor; Tuberculosis; Chronic Lymphocytic Leukemia; Malignant neoplasm of breast; Bladder Neoplasm; Coronary Arteriosclerosis; Hypersensitivity; Liver carcinoma; Colonic Neoplasms; Carcinogenesis; Endometrial Neoplasms; Carcinoma of lung; Stomach Carcinoma; Polycystic Ovary Syndrome; Ankylosing spondylitis; Colon Carcinoma; Malignant neoplasm of stomach; Lip and Oral Cavity Carcinoma; Chronic liver disease; Primary malignant neoplasm of lung; Breast Carcinoma; Thyroid carcinoma; Malignant mesothelioma; Hepatitis B, Chronic; Tumor Promotion; Small cell carcinoma of lung; Acute lymphocytic leukemia; Colorectal Neoplasms; Diabetes Mellitus, Experimental; Streptozotocin Diabetes; Alloxan Diabetes; Aplastic Anemia; Prostate carcinoma; Adenocarcinoma; Malignant tumor of colon; Vascular lesions; ovarian neoplasm; Kidney Failure, Chronic; Prostatic Neoplasms; Herpes Simplex Infections; Malignant neoplasm of endometrium; Contact Dermatitis; Uterine Corpus Cancer; Fibrosis; Chorioamnionitis; Chronic kidney disease stage 5; Chronic Airflow Obstruction; Squamous cell carcinoma; Malignant neoplasm of prostate; Malignant neoplasm of urinary bladder; Parkinson Disease; precancerous lesions; Carcinoma of bladder; Experimental Organism Basal Cell Carcinoma; Malignant Head and Neck Neoplasm; Lymphoma, Non-Hodgkin; Uterine Fibroids; Benign Prostatic Hyperplasia; Osteoporosis; Lung Injury; Malignant Pleural Mesothelioma; Cardiomegaly; Renal Cell Carcinoma; Infiltrating Cervical Carcinoma; Adenoma; Cardiac Hypertrophy; Peripheral Vascular Diseases; Pancreatitis; Solid Neoplasm; Endometrial Carcinoma; Adenocarcinoma of lung (disorder); Peptic Ulcer; Colorectal Carcinoma; Diabetes Mellitus, Non-Insulin-Dependent; Uterine Cervical Neoplasm; Esophageal Neoplasms; Chronic Lung Injury; Wheezing; Neoplasms; Precursor B-cell lymphoblastic leukemia; Hyperoxia; Drug-Induced Liver Disease; Colorectal Cancer; Hospital acquired pneumonia; Squamous cell carcinoma of the head and neck; Invasive carcinoma of breast; Primary malignant neoplasm; Heart Diseases; Precursor Cell Lymphoblastic Leukemia Lymphoma; Malignant Neoplasms; Leukoplakia, Oral; Infant, Premature; Chemical Carcinogenesis; Malignant neoplasm of thyroid; Tumor Initiation; Carcinoma of larynx; Endometriosis of uterus; Malignant neoplasm of larynx; Kidney Neoplasm; Spontaneous abortion; Cervical Squamous Intraepithelial Neoplasia; Skin carcinoma; Adenoma of large intestine; Male infertility; Polycythemia Vera; Oral Cavity Carcinoma; Renal carcinoma; Chronic stable plaque psoriasis; Malignant neoplasm of esophagus; Subfertility, Male; Head and Neck Neoplasms; GASTRIC CANCER, INTESTINAL; Abortion, Tubal; Childhood Acute Lymphoblastic Leukemia; Hepatocarcinogenesis; Squamous cell carcinoma of esophagus; Acute leukemia; Arthritis, Reactive; Esophageal carcinoma; Cervical Intraepithelial Neoplasia; Female Genital Diseases; Depressive Symptoms; Hyperactive behavior; gallbladder neoplasm; Skin Manifestations; Malignant melanoma, metastatic; Childhood Leukemia; Leukopenia; T-Cell Lymphoma; Carcinoma of ampulla of Vater; Bile duct carcinoma; Malignant neoplasm of kidney; Slow acetylator due to N-acetyltransferase enzyme variant; Bronchopulmonary Dysplasia; Polyp of large intestine; Adenocarcinoma of colon; Cholangiocarcinoma; Squamous cell carcinoma of lung; Anxiety; Gastric Adenocarcinoma; Adenocarcinoma of large intestine; Echinococcosis; Gallbladder Carcinoma; Endometriosis of ovary; Malignant neoplasm of pharynx; Transitional cell carcinoma of bladder; Cyst; Hereditary Nonpolyposis Colorectal Neoplasms; Adult Acute Myeloblastic Leukemia; Male sterility; Rectal Carcinoma; Female Breast Carcinoma; Carcinoma, Small Cell; Malignant neoplasm of female breast; Malignant neoplasm of gallbladder; Prostate cancer, familial; Environmental Carcinogenesis; Pharyngeal Neoplasms; Congenital chromosomal disease; Hereditary Nonpolyposis Colorectal Cancer; Dysmenorrhea; Sickle Cell Dactylitis; Lymphoblastic leukemia in children; Palmar-plantar erythrodysesthesia syndrome; Occupational Diseases; Contact hypersensitivity; Hamartoma; Breast Fibrocystic Disease; Smoker's lung; Breast adenocarcinoma; Sinus Tachycardia; Gastric Cardia Carcinoma; Morbilliform Drug Reaction; Malignant neoplasm of testis; Porphyria Cutanea Tarda; Carcinoma, Papillary; Drug Eruptions; Pharyngeal Carcinoma; Hydronephrosis; Childhood Brain Neoplasm; Adenocarcinoma in Situ; Adult Acute Lymphocytic Leukemia; Oral cleft; Xeroderma pigmentosum, group A; Chloracne; Birth Weight; Single tumor; Basal Cell Nevus Syndrome; Seizures; Bradycardia; Leukoplakia; Fibroadenoma; Human papilloma virus infection; Long QT Syndrome; Cholecystolithiasis; Testicular Neoplasms; Hepatomegaly; Malignant Testicular Germ Cell Tumor; Epilepsy; Cholelithiasis; Penile hypospadias; Hypospadias",7.980856456624717e-16; 3.118210553589307e-12; 4.5104266881389206e-12; 6.332483647919588e-11; 7.448716379948652e-11; 8.179290839744632e-11; 1.3121548808139071e-10; 2.377251819497684e-10; 2.377251819497684e-10; 3.762648680673853e-10; 4.2478505092738466e-10; 6.870627395110916e-10; 7.868397426275417e-10; 1.1722433847661196e-09; 1.971893171900314e-09; 1.971893171900314e-09; 3.683115069310663e-09; 4.367699208727405e-09; 5.670785186683756e-09; 5.791865115913735e-09; 6.991207850982321e-09; 7.195555613367576e-09; 8.269524813140207e-09; 8.303910954283738e-09; 1.0368326871660785e-08; 1.3128768066526236e-08; 1.4920329017331753e-08; 1.5572986293211266e-08; 1.7931366647560766e-08; 2.0570601164639797e-08; 2.261634993097532e-08; 2.2764946043880388e-08; 2.412608431251415e-08; 3.9573009168853264e-08; 4.3069383556698336e-08; 4.65353219894153e-08; 5.071217747675114e-08; 5.784935444423772e-08; 5.8317433871210796e-08; 6.156981490555128e-08; 6.156981490555128e-08; 6.982287075725826e-08; 8.598175402882612e-08; 9.273260676030806e-08; 9.306686765839445e-08; 9.393284022832733e-08; 1.0390067657961098e-07; 1.427432458937347e-07; 1.479813245926713e-07; 1.4925759778299788e-07; 2.0279723135488897e-07; 2.247163660896597e-07; 2.46778041958494e-07; 3.532371372262103e-07; 4.157277636684319e-07; 6.299208964864026e-07; 6.630279934320317e-07; 6.673805318525932e-07; 7.931659047151387e-07; 8.660170029731726e-07; 9.822463166680949e-07; 1.0094398444517938e-06; 1.1523181751478311e-06; 1.3079916134634371e-06; 1.4185164995612263e-06; 1.51758575162775e-06; 1.6397478315149087e-06; 2.027389637151193e-06; 2.07112526817849e-06; 2.086123696221558e-06; 2.1020461880694925e-06; 2.205236928124383e-06; 2.450940162208615e-06; 2.576211756838249e-06; 3.990817553511259e-06; 4.839188317483647e-06; 5.381279306135013e-06; 6.889889014378816e-06; 7.439853898002338e-06; 1.0172703923266036e-05; 1.033366177374635e-05; 1.0755368362337037e-05; 1.2375081616087569e-05; 1.3034577772762696e-05; 1.3410647656206684e-05; 1.3410647656206684e-05; 1.3410647656206684e-05; 1.4583987015565183e-05; 1.527992765491583e-05; 1.5449280661407645e-05; 1.5498516107485843e-05; 1.595911218164779e-05; 1.8507296589967813e-05; 2.0820699372778346e-05; 2.0820699372778346e-05; 2.1109857936882128e-05; 2.389985034001877e-05; 2.428963273942594e-05; 2.483118059238325e-05; 2.7001454785434173e-05; 2.878916650522013e-05; 2.910435331986992e-05; 2.9890125380431698e-05; 3.053335644618538e-05; 3.053335644618538e-05; 3.1491435270594376e-05; 3.372277447426952e-05; 3.602405958537832e-05; 3.9650653676454574e-05; 3.9650653676454574e-05; 4.3188904868696655e-05; 4.360044574654907e-05; 5.013426562854155e-05; 5.945938584340405e-05; 9.117996105379778e-05; 9.476946799623076e-05; 0.0001007621786326551; 0.00011072370132707822; 0.0001119048288448298; 0.00011927896769899647; 0.00012202062264879416; 0.00012202062264879416; 0.00012202062264879416; 0.00012858049944279123; 0.0001322335978675375; 0.0001322335978675375; 0.00013846515856925812; 0.00014636999075042076; 0.00016189346720036038; 0.00016189346720036038; 0.0001705179359230947; 0.00021804014782198476; 0.0002214859278255797; 0.00022618385822819267; 0.00022897551943886068; 0.0002926994143155384; 0.00031217959139151507; 0.0003607853785819225; 0.00038453776693371663; 0.00039959635390179865; 0.000420950947096172; 0.0004224524250828287; 0.00046565119871267287; 0.0004814724943641282; 0.000513309425513094; 0.0006352060750206054; 0.0006540484469998963; 0.0007074539367893701; 0.0008452277316123234; 0.0009826472144539087; 0.0010897868460616; 0.0011261416978188; 0.0011626911115394; 0.0013033444225859; 0.0014485445504404; 0.0017731038420892; 0.0017731038420892; 0.0017856981020231; 0.001881335207053; 0.0021001259552496; 0.0025118094772522; 0.0027346449758241; 0.0028626589910413; 0.0029063499863533; 0.0030940063712108; 0.0031934755667; 0.0035164243080016; 0.0037244768508078; 0.0038705790239355; 0.0038705790239355; 0.0040444907714877; 0.0062748297137782; 0.0073444206109429; 0.0077321746155735; 0.0089906473426575; 0.0096630827054915; 0.0096630827054915; 0.0110109843340769; 0.0111888062322808; 0.0114187031414039; 0.015507621739214; 0.015507621739214; 0.0173964199029194; 0.0196225707350576; 0.0196314124927668; 0.0220705590988414; 0.0228665355725917; 0.0230684256648711; 0.0239461944596263; 0.0254956360475327; 0.0256587294742695; 0.027071413490175; 0.0334053723619937; 0.033749008368017; 0.0365699380189482; 0.0403198851338656; 0.0404707605808569; 0.0493155676939993; 0.0511562825357515; 0.0569213530455915; 0.0596340616186723; 0.0625091602151466; 0.0647102740274508; 0.0677694730935319; 0.0716386930157756; 0.083107903315643; 0.0837469930808364; 0.0887863766478173; 0.0897127848630768; 0.0908772402064694; 0.0967179741949912; 0.0967179741949912; 0.0972679220674381; 0.0972679220674381; 0.0996459063920158; 0.1041851789435272; 0.1130019719865939; 0.1272255752567765; 0.1272255752567765; 0.1272255752567765; 0.1343310874911156; 0.1369039689436487; 0.1401454825042905; 0.1426816828546498; 0.1460848784791741; 0.1584804022044084; 0.1584804022044084; 0.1703929618871976; 0.176056923749369; 0.181710614199711; 0.1932166112700285; 0.1982833830495248; 0.2108300774722888; 0.2108300774722888; 0.2242145974514848; 0.2272199982000937; 0.236709594559292; 0.2459753912783288; 0.2468771733501051; 0.2823835751171575; 0.2972644135001306; 0.3023749229986328; 0.3113515317868633; 0.3113515317868633; 0.3243241301578816; 0.3446292548618789; 0.3806434842117995; 0.3891257446735781; 0.4089444818350988; 0.4282129311389295; 0.4611495786563792; 0.4650392364999388; 0.4979414793353498; 0.5409958054489579; 0.5793939269095637; 0.6256858993169966; 0.7238516360019139; 0.7508739466036214,Marfan Syndrome; Mammary Neoplasms; Breast Carcinoma; Dermatitis; Breast Cancer; Hypertension; Miscarriage; Chronic Obstructive Pulmonary Disease; Prostatic Neoplasms; Vascular Diseases; Kidney Cancer; Kidney Neoplasm; Prostate Cancer; Liver Carcinoma; Hamartoma; Sinus Tachycardia; Long QT Syndrome,8.921950872070284e-08; 1.1417484002988661e-07; 4.971054570440277e-05; 0.0002385365299919203; 0.00063387456654884; 0.0048927857621509; 0.0088732170532262; 0.0173324463553544; 0.0567647407547259; 0.0592733852980501; 0.1202723965415913; 0.1286424863049623; 0.1386032662139448; 0.2008242041589438; 0.2326651051170249; 0.2648173889661375; 0.2715051612173401,,,,,,,,
CYP1B1,"Lymphoma; Multiple Myeloma; Non-Small Cell Lung Carcinoma; Ovarian Carcinoma; Endometriosis; cervical cancer; Malignant neoplasm of ovary; Malignant tumor of cervix; Lung Neoplasms; Neoplasm Metastasis; Mammary Neoplasms, Human; Leukemia, Myelocytic, Acute; Hypertensive disease; Cervix carcinoma; Degenerative polyarthritis; Obesity; Liver neoplasms; Mammary Neoplasms; leukemia; Pancreatic carcinoma; Glioma; Malignant neoplasm of pancreas; Malignant neoplasm of mouth; Myocardial Infarction; Cardiovascular Diseases; Malignant neoplasm of lung; Fibroid Tumor; Tumor Progression; Malignant neoplasm of breast; Bladder Neoplasm; Liver carcinoma; Colonic Neoplasms; Carcinogenesis; Endometrial Neoplasms; Carcinoma of lung; Stomach Carcinoma; Polycystic Ovary Syndrome; Idiopathic pulmonary arterial hypertension; Malignant neoplasm of stomach; melanoma; Primary malignant neoplasm of lung; Breast Carcinoma; Acute lymphocytic leukemia; MYELODYSPLASTIC SYNDROME; Retinal Diseases; Colorectal Neoplasms; Prostate carcinoma; Adenocarcinoma; ovarian neoplasm; Prostatic Neoplasms; Malignant neoplasm of endometrium; Contact Dermatitis; Uterine Corpus Cancer; Squamous cell carcinoma; Malignant neoplasm of prostate; Malignant neoplasm of urinary bladder; Mouth Neoplasms; Carcinoma of bladder; Malignant Head and Neck Neoplasm; Lymphoma, Non-Hodgkin; Uterine Fibroids; Benign Prostatic Hyperplasia; Familial lichen amyloidosis; Osteoporosis; Cardiomegaly; Renal Cell Carcinoma; Adenoma; Cardiac Hypertrophy; Endometrial Carcinoma; Adenocarcinoma of lung (disorder); Carcinoma, Transitional Cell; Colorectal Carcinoma; Diabetes Mellitus, Non-Insulin-Dependent; Pancreatic Ductal Adenocarcinoma; Pulmonary Emphysema; Esophageal Neoplasms; Neoplasms; Ulcer; Secondary malignant neoplasm of lymph node; Colorectal Cancer; Squamous cell carcinoma of the head and neck; Invasive carcinoma of breast; Urothelial Carcinoma; Corneal Ulcer; Primary malignant neoplasm; Precursor Cell Lymphoblastic Leukemia Lymphoma; Malignant Neoplasms; Leukoplakia, Oral; Stage IV Ovarian Carcinoma; Chemical Carcinogenesis; Tumor Initiation; Carcinoma of larynx; Precancerous Conditions; Malignant neoplasm of larynx; Kidney Neoplasm; Spontaneous abortion; Male infertility; Metabolic Diseases; Renal carcinoma; Chronic stable plaque psoriasis; SVEINSSON CHORIORETINAL ATROPHY; Malignant neoplasm of esophagus; Head and Neck Neoplasms; Childhood Acute Lymphoblastic Leukemia; Fatty Liver; Choriocarcinoma; Primary angle-closure glaucoma; Squamous cell carcinoma of esophagus; Steatohepatitis; Esophageal carcinoma; Recurrent tumor; Meningioma; Depressive Symptoms; OVERLAP CONNECTIVE TISSUE DISEASE; Hyperactive behavior; Retinal Detachment; Idiopathic pulmonary hypertension; Preleukemia; Mammary Tumorigenesis; Head and Neck Carcinoma; Malignant neoplasm of kidney; Slow acetylator due to N-acetyltransferase enzyme variant; Autism Spectrum Disorders; Optic Atrophy, Autosomal Dominant; Glaucoma, Primary Open Angle; Metastasis from malignant tumor of prostate; Gallbladder Carcinoma; Impaired glucose tolerance; Meningioma, benign, no ICD-O subtype; Neural Tube Defects; Intraepithelial Neoplasia; Thinning of Descemet membrane; Central opacification of the cornea; Raised intraocular pressure; Corneal Neovascularization; Female Breast Carcinoma; Glaucoma; Malignant neoplasm of female breast; Malignant neoplasm of gallbladder; Prostate cancer, familial; Anterior synechiae; Glaucoma of childhood; Hot flushes; Early-Onset Glaucoma; Anterior segment mesenchymal dysgenesis; Irido-corneal dysgenesis; Hereditary pancreatitis; Metastatic Prostate Carcinoma; Malignant Squamous Cell Neoplasm; Contact hypersensitivity; Breast Fibrocystic Disease; Patent ductus arteriosus; Primary congenital glaucoma; Subcapsular cataract; Refractory cancer; Aortopulmonary Septal Defect; Multiple adenomatous polyps; Congenital Abnormality; Oculo-dento-digital syndrome; Irido-corneo-trabecular dysgenesis (disorder); Globe of eye large; Port-Wine Stain; Premenopausal breast cancer; Primary amyloidosis; Gastrointestinal Stromal Tumors; Hydrophthalmos; Adenoma, Basal Cell; Adenoma, Monomorphic; Adenoma, Trabecular; Papillary adenoma; Adenoma, Microcystic; Leukemia, Lymphocytic, Acute, L2; Hepatocellular Adenoma; Atrial Septal Defects; Glaucoma, Open-Angle; Clouding of corneal stroma; Corneal Opacity; Microphthalmos; Hepatomegaly; Congenital ocular coloboma (disorder); Follicular adenoma; Intellectual Disability",4.5104266881389206e-12; 2.5279022064249716e-11; 3.762648680673853e-10; 6.870627395110916e-10; 7.868397426275417e-10; 1.1722433847661196e-09; 1.971893171900314e-09; 3.683115069310663e-09; 4.367699208727405e-09; 5.670785186683756e-09; 5.791865115913735e-09; 8.303910954283738e-09; 1.0368326871660785e-08; 1.5572986293211266e-08; 2.1034803123367165e-08; 2.412608431251415e-08; 4.3069383556698336e-08; 4.65353219894153e-08; 5.784935444423772e-08; 6.982287075725826e-08; 1.427432458937347e-07; 1.4925759778299788e-07; 2.0279723135488897e-07; 2.247163660896597e-07; 4.5433391667148853e-07; 6.299208964864026e-07; 6.630279934320317e-07; 8.297823048747685e-07; 8.660170029731726e-07; 9.822463166680949e-07; 1.3079916134634371e-06; 1.4185164995612263e-06; 1.51758575162775e-06; 1.6397478315149087e-06; 2.027389637151193e-06; 2.07112526817849e-06; 2.086123696221558e-06; 2.263727724144348e-06; 2.450940162208615e-06; 4.179146475474674e-06; 4.839188317483647e-06; 5.381279306135013e-06; 1.2375081616087569e-05; 1.279493639647176e-05; 1.3010173302726732e-05; 1.3034577772762696e-05; 1.527992765491583e-05; 1.5449280661407645e-05; 1.8507296589967813e-05; 2.0820699372778346e-05; 2.389985034001877e-05; 2.428963273942594e-05; 2.483118059238325e-05; 3.053335644618538e-05; 3.053335644618538e-05; 3.1491435270594376e-05; 3.602405958537832e-05; 3.9650653676454574e-05; 4.3188904868696655e-05; 4.360044574654907e-05; 5.013426562854155e-05; 5.945938584340405e-05; 8.937909010875455e-05; 9.117996105379778e-05; 0.00011072370132707822; 0.0001119048288448298; 0.00012202062264879416; 0.00012202062264879416; 0.0001322335978675375; 0.00013846515856925812; 0.0001474322229096163; 0.00016189346720036038; 0.00016189346720036038; 0.0001802305430549181; 0.0001802305430549181; 0.00021804014782198476; 0.00022897551943886068; 0.00026224811620659125; 0.000323910443746482; 0.00038453776693371663; 0.000420950947096172; 0.0004224524250828287; 0.0004243878730487336; 0.0004336479443072768; 0.00046565119871267287; 0.000513309425513094; 0.0006352060750206054; 0.0006540484469998963; 0.0007731114749585194; 0.0008452277316123234; 0.0010897868460616; 0.0011261416978188; 0.0012688388196185; 0.0013033444225859; 0.0014485445504404; 0.0017731038420892; 0.0021001259552496; 0.0028187518310092; 0.0028626589910413; 0.0029063499863533; 0.0030220891031719; 0.0030940063712108; 0.0035164243080016; 0.0038705790239355; 0.0038705790239355; 0.0043105477873176; 0.0054814673835909; 0.0062748297137782; 0.0067588219988478; 0.0089906473426575; 0.0091914307650131; 0.0105367304020196; 0.0110109843340769; 0.0110109843340769; 0.0111888062322808; 0.0131305979622119; 0.0131305979622119; 0.015507621739214; 0.0203198961621158; 0.0214892684107681; 0.0230684256648711; 0.0239461944596263; 0.0411765978055933; 0.0427786786335321; 0.0442524445580864; 0.0503601986761658; 0.0511562825357515; 0.0565343207837806; 0.057047868743524; 0.0583555368572174; 0.0587248614153099; 0.0817897187940979; 0.0817897187940979; 0.0817897187940979; 0.0858871491124922; 0.0887863766478173; 0.0905750994820178; 0.0908772402064694; 0.0967179741949912; 0.0967179741949912; 0.0972679220674381; 0.0972679220674381; 0.0972679220674381; 0.1130019719865939; 0.1272255752567765; 0.1272255752567765; 0.1332119202868411; 0.1343310874911156; 0.1343310874911156; 0.1369039689436487; 0.1426816828546498; 0.1435325826114705; 0.1460848784791741; 0.1525119847960956; 0.1703929618871976; 0.1703929618871976; 0.1703929618871976; 0.1722207384650883; 0.181710614199711; 0.1932166112700285; 0.2048516463561299; 0.2048516463561299; 0.2166737845423457; 0.2166737845423457; 0.2277111144893269; 0.2416367579687983; 0.2670582190879765; 0.2670582190879765; 0.2723453780817489; 0.2723453780817489; 0.3066971380488823; 0.3446292548618789; 0.3494335993143313; 0.3515273578586712; 0.417000940404929; 0.4365091908885111; 0.4535514871248414; 0.4781931916730066; 0.4979414793353498; 0.5469000270498892; 0.6256858993169966; 0.9388725395674395,"Marfan Syndrome; Mammary Neoplasms; Breast Carcinoma; Dermatitis; Breast Cancer; Fatty Liver; Mouth Neoplasms; Carcinoma; Lung Cancer; Prostatic Neoplasms; Lung Neoplasms; Temporal Pallor Of Optic Disc; Congenital Glaucoma; Frontal Fibrosing Alopecia; Retinal Vein Occlusion; Prostate Cancer; Segment Dysgenesis; Synechiae; Melanoma; Subcapsular Cataract; Colorectal Neoplasms; Corneal Neovascularization; Open Angle Glaucoma; Respiratory Tract Diseases; Ovarian Cancer; Ocular Hypertension; Anterior Segment Dysgenesis; Obesity; Malignant Melanoma Of Skin; Ovarian Neoplasm; Papillary Adenoma; Adenoma; Phakomatosis Pigmentovascularis; Glaucoma, Congenital; Basal Cell Neoplasm; Disorder Of Eye; Retinal Detachment; Glaucoma; Colorectal Cancer; Nystagmus; Lymphoblastic Leukemia; Myopia; Strabismus",8.921950872070284e-08; 1.1417484002988661e-07; 4.971054570440277e-05; 0.0002385365299919203; 0.00063387456654884; 0.0025464930497429; 0.0069464092886356; 0.0107108189044139; 0.0153260870217676; 0.0567647407547259; 0.0662475691169798; 0.1110148026021272; 0.1110148026021272; 0.1203844668559877; 0.1286424863049623; 0.1386032662139448; 0.1386032662139448; 0.1386032662139448; 0.1871442361706843; 0.191014576985413; 0.2039740835961235; 0.2039740835961235; 0.2039740835961235; 0.2043509272421185; 0.2048942314782707; 0.2072542702968064; 0.2389892939730545; 0.2736284003666279; 0.2943246801469203; 0.2978951863374514; 0.3122348651468142; 0.3175014660376726; 0.3317467420738357; 0.337316260906421; 0.426652795095747; 0.5111376489309558; 0.5111376489309558; 0.5118712646453717; 0.6963620089820088; 0.7206496565839581; 0.7428197151249574; 0.950998447866243; 0.9653060148705728,Cryptogenic multifocal ulcerous stenosing enteritis ORPHA:468635; Cytosolic phospholipase-A2 alpha deficiency associated bleeding disorder ORPHA:477787; NON RARE IN EUROPE: Primary adult open-angle glaucoma ORPHA:353225; Alagille syndrome due to a NOTCH2 point mutation ORPHA:261629; Hajdu-Cheney syndrome ORPHA:955; Juvenile glaucoma ORPHA:98977; Peters anomaly ORPHA:708; Congenital glaucoma ORPHA:98976,0.0002132495254484572; 0.0002132495254484572; 0.1996794456641899; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4878757854606148; 0.5312419675785659,,,Homo sapiens A549 lung carcinoma cell,0.35,SARS-CoV-2,Homo sapiens
DEDD2,,,,,Beta-propeller protein-associated neurodegeneration ORPHA:329284; CCDC115-CDG ORPHA:468684; Hermansky-Pudlak syndrome type 8 ORPHA:231537; Idiopathic CD4 lymphocytopenia ORPHA:228000,0.4838060079820406; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659,,,,,,
DKK1,"Asthma; Psoriasis; Multiple Myeloma; Synovitis; Rheumatoid Arthritis; Arteriosclerosis; Non-Small Cell Lung Carcinoma; Crohn Disease; Ovarian Carcinoma; Endometriosis; cervical cancer; Cirrhosis; Malignant neoplasm of ovary; Tumor Angiogenesis; Malignant tumor of cervix; Neoplasm Metastasis; Mammary Neoplasms, Human; Atherosclerosis; Leukemia, Myelocytic, Acute; Cervix carcinoma; Arthritis; Brain Ischemia; Degenerative polyarthritis; Periodontitis; Hyperglycemia; Mammary Neoplasms; Glioblastoma; leukemia; Diabetes Mellitus; Lupus Erythematosus, Systemic; Pancreatic carcinoma; Alzheimer's Disease; Adenocarcinoma of pancreas; Glioma; Malignant neoplasm of pancreas; Malignant neoplasm of mouth; Brain Neoplasms; Cardiovascular Diseases; Peptic Esophagitis; Malignant neoplasm of lung; Chronic Lymphocytic Leukemia; Tumor Progression; Spondylarthritis; Malignant neoplasm of breast; Diabetic Nephropathy; Systemic Scleroderma; Osteitis Deformans; Liver carcinoma; Colonic Neoplasms; Immunologic Deficiency Syndromes; Carcinogenesis; Carcinoma of lung; Polycystic Ovary Syndrome; Colon Carcinoma; Osteosarcoma of bone; Lip and Oral Cavity Carcinoma; Bone Diseases; Lupus Nephritis; melanoma; Primary malignant neoplasm of lung; Breast Carcinoma; Osteosarcoma; Secondary malignant neoplasm of bone; Thyroid carcinoma; Obstructive nephropathy; Tumor Promotion; Acute Promyelocytic Leukemia; Retinal Diseases; Colorectal Neoplasms; Senile Plaques; Hepatitis B; Lupus Erythematosus; Prostate carcinoma; Adenocarcinoma; Malignant tumor of colon; Prostatic Neoplasms; Malignant neoplasm of prostate; Endometrioma; Lupus Vulgaris; Malignant Head and Neck Neoplasm; Hematopoietic Neoplasms; Spinal Cord Diseases; Chronic small plaque psoriasis; Lupus Erythematosus, Discoid; Malignant Glioma; Osteoporosis; pathologic fistula; Idiopathic Pulmonary Fibrosis; Neurodegenerative Disorders; Renal Cell Carcinoma; Adenoma; Colorectal Carcinoma; Pancreatic Ductal Adenocarcinoma; Esophageal Neoplasms; Neoplasms; Plaque, Amyloid; Chondrosarcoma; Central neuroblastoma; Secondary malignant neoplasm of lymph node; Amyloidosis; Colorectal Cancer; Gastro-esophageal reflux disease with esophagitis; Esophagitis; Neuroblastoma; Primary malignant neoplasm; Osteopenia; Malignant Neoplasms; Malignant neoplasm of thyroid; Adenocarcinoma Of Esophagus; bone destruction; Alzheimer Disease, Late Onset; Metastatic Neoplasm; Disseminated Malignant Neoplasm; Papillary thyroid carcinoma; Oral Cavity Carcinoma; Renal carcinoma; Malignant neoplasm of esophagus; Hepatocarcinogenesis; Choriocarcinoma; Malignant Fibrous Histiocytoma; Rickettsia Infections; Paget Disease; Medulloblastoma; Esophageal carcinoma; Schizophrenia; Childhood Osteosarcoma; Visual seizure; Frontotemporal dementia; Trophoblastic Neoplasms; OVERLAP CONNECTIVE TISSUE DISEASE; Hyperactive behavior; Monoclonal Gammopathy of Undetermined Significance; Conventional (Clear Cell) Renal Cell Carcinoma; Sacroiliitis; Parasitic Diseases; Parasitic infection; Barrett Esophagus; FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder); Oropharyngeal Carcinoma; Malignant neoplasm of kidney; Lower limb hyperreflexia; Triple Negative Breast Neoplasms; Aortic Valve Stenosis; Fanconi Anemia; Vitamin D-Resistant Rickets, X-Linked; Alopecia; Hypophosphatemic Rickets, X-Linked Dominant; 21-hydroxylase deficiency; Squamous cell carcinoma of tongue; Congenital adrenal hyperplasia due to 21 hydroxylase deficiency; Metabolic Bone Disorder; Hepatoblastoma; Malignant neoplasm of oropharynx; Hemangioma; Ewings sarcoma; Pick Disease of the Brain; Klippel-Feil Syndrome; Neck Pain; Impaired cognition; Hypophosphatemia; Dizziness; Bone pain; Vertigo; early pregnancy; Malignant neoplasm of large intestine; Hypesthesia; Laryngeal Paralysis; Gastroesophageal reflux disease; Hamartoma; Recurrent paroxysmal headache; Fracture, spiral; Syringomyelia; Fracture; Vocal Cord Paralysis; Cranial nerve palsies; Dysesthesia; Gait Ataxia; Lobular Neoplasia; Arnold-Chiari Malformation, Type I; Van Buchem disease; Collapse of vertebra; Compression fracture of vertebral column; Tinnitus; Alopecia, Male Pattern; AIDS-Associated Nephropathy; Folic Acid Deficiency; Papillary serous cystadenocarcinoma; Intracranial Hypertension; Limb defects; Nephroblastoma; Refractive Errors; Colonic Polyps; Progressive cerebellar ataxia; Androgenetic Alopecia; Adenomatous polyp of colon; Deglutition Disorders; Gait abnormality; Varying degree of multiple fractures; Frequent fractures; Increased fracture rate; Fractures, Multiple; Ovarian Serous Adenocarcinoma; Nystagmus; Curvature of spine; Acquired scoliosis; Myopia",1.803641225501291e-12; 3.118210553589307e-12; 2.5279022064249716e-11; 1.6797550790254382e-10; 1.9241179247341838e-10; 2.377251819497684e-10; 3.762648680673853e-10; 4.2478505092738466e-10; 6.870627395110916e-10; 7.868397426275417e-10; 1.1722433847661196e-09; 1.4790998733426532e-09; 1.971893171900314e-09; 3.315537369635636e-09; 3.683115069310663e-09; 5.670785186683756e-09; 5.791865115913735e-09; 7.195555613367576e-09; 8.303910954283738e-09; 1.5572986293211266e-08; 1.587872453479067e-08; 1.8815395768840057e-08; 2.1034803123367165e-08; 3.9573009168853264e-08; 4.0898524252942674e-08; 4.65353219894153e-08; 5.518991037343798e-08; 5.784935444423772e-08; 5.8317433871210796e-08; 6.156981490555128e-08; 6.982287075725826e-08; 9.273260676030806e-08; 9.306686765839445e-08; 1.427432458937347e-07; 1.4925759778299788e-07; 2.0279723135488897e-07; 4.157277636684319e-07; 4.5433391667148853e-07; 5.916066415963854e-07; 6.299208964864026e-07; 7.931659047151387e-07; 8.297823048747685e-07; 8.339674388418603e-07; 8.660170029731726e-07; 1.083280646968723e-06; 1.10068355868735e-06; 1.284982487562752e-06; 1.3079916134634371e-06; 1.4185164995612263e-06; 1.4839502431758565e-06; 1.51758575162775e-06; 2.027389637151193e-06; 2.086123696221558e-06; 2.205236928124383e-06; 2.560217628497434e-06; 2.576211756838249e-06; 3.282956820548434e-06; 3.4620043828295477e-06; 4.179146475474674e-06; 4.839188317483647e-06; 5.381279306135013e-06; 6.3131986281381465e-06; 6.378950690990071e-06; 6.889889014378816e-06; 9.263589414966798e-06; 1.033366177374635e-05; 1.2304362232150695e-05; 1.3010173302726732e-05; 1.3034577772762696e-05; 1.3673911177979942e-05; 1.3755659311680946e-05; 1.4805035395703202e-05; 1.527992765491583e-05; 1.5449280661407645e-05; 1.5498516107485843e-05; 2.0820699372778346e-05; 3.053335644618538e-05; 4.079834649355082e-05; 4.1934338365676246e-05; 4.3188904868696655e-05; 6.484707207749309e-05; 6.758558746827128e-05; 8.100290141298731e-05; 8.133563964016694e-05; 8.25206825409808e-05; 9.117996105379778e-05; 9.476946799623076e-05; 9.780860153755674e-05; 0.00010914466609698448; 0.0001119048288448298; 0.00012202062264879416; 0.00016189346720036038; 0.0001802305430549181; 0.00021804014782198476; 0.00022897551943886068; 0.00023793254517777995; 0.0002792365191965819; 0.00032113080554701227; 0.000323910443746482; 0.0003495642888428815; 0.00038453776693371663; 0.0003987632373118045; 0.00045185714020635207; 0.0004601228759628894; 0.00046565119871267287; 0.0005214896245221155; 0.0006352060750206054; 0.0009826472144539087; 0.0011303542860313; 0.0013064343839031; 0.0017107913939493; 0.001746579573497; 0.0018360773814867; 0.0025122887786423; 0.0027346449758241; 0.0028626589910413; 0.0030940063712108; 0.0040444907714877; 0.0043105477873176; 0.0063571439329446; 0.007117388576245; 0.0072083035574659; 0.0084568432337518; 0.0089906473426575; 0.0093325514582534; 0.0097628826330308; 0.0099798889656483; 0.0105367304020196; 0.0110109843340769; 0.0110109843340769; 0.0111888062322808; 0.0118303833860754; 0.0127059723723765; 0.015507621739214; 0.0160005762734352; 0.0171001534176385; 0.0193777520415227; 0.0204735864411232; 0.0220575875892222; 0.0230684256648711; 0.0239461944596263; 0.0302544192125064; 0.0314638805510678; 0.0371129390384053; 0.0384689641633299; 0.0404707605808569; 0.044901297966643; 0.044901297966643; 0.0491632343384016; 0.0493155676939993; 0.0493155676939993; 0.0524566642172417; 0.0596340616186723; 0.0700485361084771; 0.0741310297608694; 0.0760236194881239; 0.0817897187940979; 0.0817897187940979; 0.0835641020831185; 0.0967179741949912; 0.0972679220674381; 0.0987575443309834; 0.1016471070089966; 0.1050724946352408; 0.1128564106125758; 0.1206032442301429; 0.1206032442301429; 0.1395859646277307; 0.1401454825042905; 0.1401454825042905; 0.1401454825042905; 0.1401454825042905; 0.1460848784791741; 0.1584804022044084; 0.1584804022044084; 0.1584804022044084; 0.1591507626487054; 0.1703929618871976; 0.176056923749369; 0.181710614199711; 0.1881045022168423; 0.1881045022168423; 0.1932166112700285; 0.236709594559292; 0.236709594559292; 0.2416367579687983; 0.2416367579687983; 0.2570364810168682; 0.2570364810168682; 0.2906935310192522; 0.3113515317868633; 0.316142834424839; 0.320973096008708; 0.3764478003879025; 0.4089444818350988; 0.4122626131720456; 0.4214414516582417; 0.4250139906398144; 0.4250139906398144; 0.4250139906398144; 0.4282129311389295; 0.5112292444765246; 0.6839463765862077; 0.7815489598370186; 0.7922500847545921; 0.8527475134093208,Marfan Syndrome; Mammary Neoplasms; Breast Carcinoma; Breast Cancer; Endometrioma; Spinal Cord Diseases; Distal Peripheral Sensory Neuropathy; Osteoporosis; Endometriosis; Brain Stem Compression; Klippel Feil Syndrome; Syringomyelia; Cranial Nerve Compression; Platybasia; Vocal Cord Paralysis; Arnold-Chiari Malformation; Cranial Nerve Paralysis; Cerebellar Ataxia; Sleep Apnea; Dysphagia; Nystagmus; Scoliosis,8.921950872070284e-08; 1.1417484002988661e-07; 4.971054570440277e-05; 0.00063387456654884; 0.0987697358859238; 0.1203844668559877; 0.1203844668559877; 0.1286424863049623; 0.1286424863049623; 0.1286424863049623; 0.1507480783308755; 0.191014576985413; 0.2072542702968064; 0.2072542702968064; 0.2943246801469203; 0.3887324036749158; 0.5111376489309558; 0.5856640063168574; 0.655887654706664; 0.7089244306861303; 0.7206496565839581; 0.8310460270009882,"Interstitial lung disease-nephrotic syndrome-epidermolysis bullosa syndrome ORPHA:306504; Arnold-Chiari malformation type I ORPHA:268882; Congenital plasminogen activator inhibitor type 1 deficiency ORPHA:465; Familial primary localized cutaneous amyloidosis ORPHA:353220; Thyroid ectopia ORPHA:95712; Aneurysm-osteoarthritis syndrome ORPHA:284984; Osteofibrous dysplasia ORPHA:488265; Chondrosarcoma ORPHA:55880; Hereditary arterial and articular multiple calcification syndrome ORPHA:289601; Hereditary papillary renal cell carcinoma ORPHA:47044; Cap myopathy ORPHA:171881; Crisponi syndrome ORPHA:1545; Auriculocondylar syndrome ORPHA:137888; Monilethrix ORPHA:573; Autosomal recessive nail dysplasia ORPHA:280654; Axenfeld anomaly ORPHA:98978; Axenfeld-Rieger syndrome ORPHA:782; Neonatal inflammatory skin and bowel disease ORPHA:294023; Rieger anomaly ORPHA:91483; Cold-induced sweating syndrome ORPHA:157820; Peters anomaly ORPHA:708; Multiple osteochondromas ORPHA:321; Lymphedema-distichiasis syndrome ORPHA:33001; Multiple epiphyseal dysplasia type 5 ORPHA:93311; Blepharophimosis-ptosis-epicanthus inversus syndrome plus ORPHA:572333; Blepharophimosis-ptosis-epicanthus inversus syndrome type 1 ORPHA:572354; Blepharophimosis-ptosis-epicanthus inversus syndrome type 2 ORPHA:572361; Branchio-oculo-facial syndrome ORPHA:1297; Parietal foramina with clavicular hypoplasia ORPHA:251290; Craniosynostosis, Boston type ORPHA:1541; Ring dermoid of cornea ORPHA:91481; Spondyloepimetaphyseal dysplasia, matrilin-3 type ORPHA:156728; Brachydactyly type E ORPHA:93387; Proximal symphalangism ORPHA:3250; Idiopathic juvenile osteoporosis ORPHA:85193",0.0133474287859103; 0.0514345493431829; 0.0514345493431829; 0.0514345493431829; 0.0514345493431829; 0.1927589191138116; 0.1927589191138116; 0.1927589191138116; 0.1927589191138116; 0.1927589191138116; 0.1927589191138116; 0.1927589191138116; 0.1938708167942525; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4878757854606148; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659,,,yeasx,0.56,Homo sapiens,Homo sapiens
DNAJB1,"Non-Small Cell Lung Carcinoma; Infection; Neoplasm Metastasis; Obesity; Liver neoplasms; Malaria; Tumor Progression; Liver carcinoma; Carcinogenesis; Influenza; Polycystic Ovary Syndrome; Idiopathic pulmonary arterial hypertension; Bacterial Infections; Hepatitis B; Herpes Simplex Infections; Parkinson Disease; Cardiomyopathy, Dilated; Malignant neoplasm of liver; Neurodegenerative Disorders; Renal Cell Carcinoma; Bulbo-Spinal Atrophy, X-Linked; Liver and Intrahepatic Biliary Tract Carcinoma; Cardiomyopathy, Familial Idiopathic; Bipolar Disorder; Machado-Joseph Disease; Schizophrenia; Neurologic Symptoms; Congenital chromosomal disease; Fibrolamellar Hepatocellular Carcinoma; Central Serous Chorioretinopathy; CREST Syndrome; Spinocerebellar Ataxia Type 6 (disorder); Adult Liver Carcinoma; Spinocerebellar Ataxia Type 7; Muscular Dystrophies, Limb-Girdle",3.762648680673853e-10; 1.794870341379274e-09; 5.670785186683756e-09; 2.412608431251415e-08; 4.3069383556698336e-08; 1.0618136021459505e-07; 8.297823048747685e-07; 1.3079916134634371e-06; 1.51758575162775e-06; 2.027389637151193e-06; 2.086123696221558e-06; 2.263727724144348e-06; 6.378950690990071e-06; 1.3755659311680946e-05; 2.1109857936882128e-05; 3.372277447426952e-05; 5.826428641192471e-05; 8.421319594446617e-05; 0.00010914466609698448; 0.0001119048288448298; 0.0037263522689301; 0.0038816440940594; 0.0053570195415722; 0.0066006052483961; 0.0066401895279317; 0.0093325514582534; 0.0940427381982829; 0.0996459063920158; 0.181710614199711; 0.1932166112700285; 0.2468771733501051; 0.320973096008708; 0.397280768882461; 0.4250139906398144; 0.4979943388112239,Bipolar Disorder,0.2978951863374514,Fibrolamellar hepatocellular carcinoma ORPHA:401920,0.5312419675785659,Molluscum contagiosum virus subtype 1 MC013L (gene: MC013L),0.3911903778732946,Homo sapiens;Homo sapiens A549 lung carcinoma cell;In vitro,0.35;0.44,Human SARS coronavirus;Ricinus communis;ebvb9,Homo sapiens
DNAJB4,Psoriasis; Rheumatoid Arthritis; Non-Small Cell Lung Carcinoma; Lung Neoplasms; Neoplasm Metastasis; Malignant neoplasm of lung; Tumor Progression; Malignant neoplasm of breast; Liver carcinoma; Carcinogenesis; Carcinoma of lung; Stomach Carcinoma; Malignant neoplasm of stomach; Primary malignant neoplasm of lung; Breast Carcinoma; Hepatitis B; Adenocarcinoma of lung (disorder); Hereditary Diffuse Gastric Cancer; Waist Circumference; Physical Activity Measurement; Smoking Behaviors; Body mass index; Finding of body mass index,3.118210553589307e-12; 1.9241179247341838e-10; 3.762648680673853e-10; 4.367699208727405e-09; 5.670785186683756e-09; 6.299208964864026e-07; 8.297823048747685e-07; 8.660170029731726e-07; 1.3079916134634371e-06; 1.51758575162775e-06; 2.027389637151193e-06; 2.07112526817849e-06; 2.450940162208615e-06; 4.839188317483647e-06; 5.381279306135013e-06; 1.3755659311680946e-05; 0.00013846515856925812; 0.0043105477873176; 0.4917864702292748; 0.5553733307745654; 0.7739486201443597; 0.9280950922440502; 0.9280950922440502,Psoriasis; Lung Carcinoma; Schizophrenia; Lung Adenocarcinoma,0.00044166586682199737; 0.0868883392670891; 0.175139305620004; 0.1787826075739565,"NON RARE IN EUROPE: Primary adult open-angle glaucoma ORPHA:353225; Kuru ORPHA:454745; Adult polyglucosan body disease ORPHA:206583; PrP systemic amyloidosis ORPHA:397606; Familial Alzheimer-like prion disease ORPHA:280397; Sporadic fatal insomnia ORPHA:586130; Fatal familial insomnia ORPHA:466; Gerstmann-Straussler-Scheinker syndrome ORPHA:356; Glycogen storage disease due to glycogen branching enzyme deficiency, adult neuromuscular form ORPHA:308712; Glycogen storage disease due to glycogen branching enzyme deficiency, childhood combined hepatic and myopathic form ORPHA:308684; Glycogen storage disease due to glycogen branching enzyme deficiency, childhood neuromuscular form ORPHA:308698; Glycogen storage disease due to glycogen branching enzyme deficiency, congenital neuromuscular form ORPHA:308670; Glycogen storage disease due to glycogen branching enzyme deficiency, fatal perinatal neuromuscular form ORPHA:308655; Glycogen storage disease due to glycogen branching enzyme deficiency, non progressive hepatic form ORPHA:308638; Glycogen storage disease due to glycogen branching enzyme deficiency, progressive hepatic form ORPHA:308621; Huntington disease-like 1 ORPHA:157941; Inherited Creutzfeldt-Jakob disease ORPHA:282166; Autosomal recessive spastic paraplegia type 53 ORPHA:319199; Obesity due to leptin receptor gene deficiency ORPHA:179494; Craniolenticulosutural dysplasia ORPHA:50814; Hypomyelination-congenital cataract syndrome ORPHA:85163; NON RARE IN EUROPE: Barrett esophagus ORPHA:1232",0.1996794456641899; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659,Molluscum contagiosum virus subtype 1 MC013L (gene: MC013L),0.3911903778732946,Homo sapiens;Homo sapiens HEK293 embryonic kidney cell;Homo sapiens Huh7 hepatoma cell,0.35,JC polyomavirus;SARS-CoV-2;ebvb9;hcvjf,Homo sapiens
DUSP2,"Juvenile arthritis; Multiple Myeloma; Ovarian Carcinoma; Endometriosis; Colitis; Hypertensive disease; Mammary Neoplasms; leukemia; Glioma; Epithelial ovarian cancer; Brain Neoplasms; Malignant neoplasm of lung; Chronic Lymphocytic Leukemia; Malignant neoplasm of breast; Carcinogenesis; Carcinoma of lung; B-Cell Lymphomas; Colon Carcinoma; Idiopathic pulmonary arterial hypertension; Primary malignant neoplasm of lung; Breast Carcinoma; Prostate carcinoma; Malignant tumor of colon; Juvenile psoriatic arthritis; Herpes Simplex Infections; Juvenile-Onset Still Disease; Malignant neoplasm of prostate; Stress, Psychological; Benign Prostatic Hyperplasia; Retinoblastoma; Pancreatic Ductal Adenocarcinoma; Central neuroblastoma; Nodular Lymphocyte Predominant Hodgkin Lymphoma; Neuroblastoma; Post-Traumatic Stress Disorder; Metastatic Neoplasm; Bipolar Disorder; Acute leukemia; Schizophrenia; Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse; Adenocarcinoma of prostate; Migraine Disorders; Pituitary Diseases; Well Differentiated Oligodendroglioma; Congenital Hydrocephalus; Congenital Abnormality; oligodendroglioma; Neurodevelopmental Disorders; Hydrocephalus; Neuroendocrine Tumors; Mental disorders; Merkel cell carcinoma",3.861499575207375e-12; 2.5279022064249716e-11; 6.870627395110916e-10; 7.868397426275417e-10; 1.971893171900314e-09; 1.0368326871660785e-08; 4.65353219894153e-08; 5.784935444423772e-08; 1.427432458937347e-07; 1.479813245926713e-07; 4.157277636684319e-07; 6.299208964864026e-07; 7.931659047151387e-07; 8.660170029731726e-07; 1.51758575162775e-06; 2.027389637151193e-06; 2.1624936975752243e-06; 2.205236928124383e-06; 2.263727724144348e-06; 4.839188317483647e-06; 5.381279306135013e-06; 1.527992765491583e-05; 1.5498516107485843e-05; 1.8961926417889813e-05; 2.1109857936882128e-05; 2.5791573703443737e-05; 3.053335644618538e-05; 5.248375780672949e-05; 5.945938584340405e-05; 0.00015093372108149775; 0.0001802305430549181; 0.00032113080554701227; 0.0003987632373118045; 0.0004601228759628894; 0.0006163914271817124; 0.001746579573497; 0.0066006052483961; 0.0073444206109429; 0.0093325514582534; 0.0094642528600355; 0.0118679153788039; 0.0940427381982829; 0.1332119202868411; 0.1694286967803272; 0.1703929618871976; 0.1722207384650883; 0.1793722362893728; 0.2189060263359596; 0.2921843338021302; 0.2995316643384945; 0.4265163370325311; 0.5581965394251631,"Juvenile Arthritis; Polyarthritis, Rheumatoid Factor Positive; Seronegative Polyarthritis; Still Disease; Arthritis",1.1394948069325325e-05; 1.1394948069325325e-05; 3.928596547519457e-05; 5.1065830658055726e-05; 0.0015169561374293,Charcot-Marie-Tooth disease type 1D ORPHA:101084; Charcot-Marie-Tooth disease type 4E ORPHA:99951; Odonto-onycho-dermal dysplasia ORPHA:2721; Schopf-Schulz-Passarge syndrome ORPHA:50944,3.598261936626476e-12; 3.598261936626476e-12; 0.0514345493431829; 0.0514345493431829,Orf virus ORF057 putative protein-tyrosine phosphatase,0.4627268298950313,,,,
EGOT,Renal Cell Carcinoma; Neoplasms,0.0001119048288448298; 0.00022897551943886068,,,,,,,,,,
ETS1,"Reperfusion Injury; Asthma; Psoriasis; Lymphoma; Rheumatoid Arthritis; Arteriosclerosis; Non-Small Cell Lung Carcinoma; Crohn Disease; Autoimmune Diseases; Uveitis; Ovarian Carcinoma; Endometriosis; cervical cancer; Ulcerative Colitis; Malignant neoplasm of ovary; Tumor Angiogenesis; Multiple Sclerosis; Neoplasm Metastasis; Hodgkin Disease; Atherosclerosis; Graves Disease; Leukemia, Myelocytic, Acute; Arthritis; Inflammatory Bowel Diseases; Kaposi Sarcoma; Mammary Neoplasms; Glioblastoma; leukemia; Diabetes Mellitus; Diabetes; Lupus Erythematosus, Systemic; Pancreatic carcinoma; Coronary Artery Disease; Coronary heart disease; Adenocarcinoma of pancreas; Behcet Syndrome; Glioma; Epithelial ovarian cancer; Malignant neoplasm of pancreas; Malignant neoplasm of mouth; Adult T-Cell Lymphoma/Leukemia; Diffuse Large B-Cell Lymphoma; Brain Neoplasms; Malignant neoplasm of lung; Fibroid Tumor; Chronic Lymphocytic Leukemia; Tumor Progression; Malignant neoplasm of breast; Bladder Neoplasm; Coronary Arteriosclerosis; Diabetic Nephropathy; Liver carcinoma; Carcinogenesis; Nasopharyngeal carcinoma; Endometrial Neoplasms; Carcinoma of lung; Stomach Carcinoma; Ankylosing spondylitis; B-Cell Lymphomas; Colon Carcinoma; Malignant neoplasm of stomach; Immune System Diseases; Lip and Oral Cavity Carcinoma; Astrocytoma; melanoma; Primary malignant neoplasm of lung; Breast Carcinoma; Secondary malignant neoplasm of bone; Thyroid carcinoma; M5b Acute differentiated monocytic leukemia; Colorectal Neoplasms; Acute monocytic leukemia; Lupus Erythematosus; Prostate carcinoma; Adenocarcinoma; Malignant tumor of colon; ovarian neoplasm; Allergic rhinitis (disorder); Prostatic Neoplasms; Squamous cell carcinoma; Malignant neoplasm of prostate; Endometrial adenocarcinoma; Malignant neoplasm of urinary bladder; Pancreatic Neoplasm; Carcinoma of bladder; Endometrioma; Osteomyelitis; Lupus Vulgaris; Childhood Glioblastoma; Adult Glioblastoma; Benign Prostatic Hyperplasia; Hematologic Neoplasms; Hematopoietic Neoplasms; Lupus Erythematosus, Discoid; Celiac Disease; pathologic fistula; Adenoma; Cerebral arterial aneurysm; Solid Neoplasm; Endometrial Carcinoma; Adenocarcinoma of lung (disorder); Acute myelomonocytic leukemia; Colorectal Carcinoma; Encephalitis, St. Louis; Uterine Cervical Neoplasm; Pancreatic Ductal Adenocarcinoma; Metastatic melanoma; Myeloid Leukemia, Chronic; Esophageal Neoplasms; Lymphoma, Follicular; Leukemogenesis; Sarcoma; Central neuroblastoma; Secondary malignant neoplasm of lymph node; Colorectal Cancer; Squamous cell carcinoma of the head and neck; Invasive carcinoma of breast; Monocytic leukemia; Neuroblastoma; Primary malignant neoplasm; Congenital arteriovenous malformation; Ataxia Telangiectasia; Malignant Neoplasms; Arteriovenous hemangioma; Uveomeningoencephalitic Syndrome; Tumor Initiation; Precancerous Conditions; Neoplasm Invasiveness; Kidney Neoplasm; Metastatic Neoplasm; Adenoma of large intestine; Thyroid Neoplasm; Cerebral Aneurysm; Malignant neoplasm of esophagus; Ki-1+ Anaplastic Large Cell Lymphoma; Follicular thyroid carcinoma; Squamous cell carcinoma of esophagus; Cleft palate, isolated; Acute leukemia; Thrombocytopenia; Carcinoma, Neuroendocrine; Psoriasis vulgaris; Esophageal carcinoma; Cholangitis, Sclerosing; Anaplastic carcinoma; Thymoma; Vascular inflammations; Meningioma; Lymphoid leukemia; Blast Phase; Carotid Stenosis; T-Cell Lymphoma; Burkitt Lymphoma; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Libman-Sacks Disease; Bile duct carcinoma; Triple Negative Breast Neoplasms; Anaplasia; Carcinoid Tumor; Gastric Adenocarcinoma; Adenocarcinoma of large intestine; Endometriosis of ovary; stage, ovarian epithelial cancer; Ewings sarcoma; Carcinoid tumor no ICD-O subtype; Proliferative retinopathy; Kaposi's sarcoma-associated herpesvirus infection; Erythroblastosis; Congenital heart disease; Malignant neoplasm of nasopharynx; Hereditary Nonpolyposis Colorectal Cancer; Neurilemmoma; Ankyloglossia; Friend leukemia; Cancer of Nasopharynx; Diffuse Astrocytoma; Gastric adenoma; Malignant Squamous Cell Neoplasm; Dysmorphism; Jacobsen Distal 11q Deletion Syndrome; Anaplastic astrocytoma; Refractory cancer; Congenital Abnormality; Cleft Palate; Gastrointestinal Stromal Tumors; Lymphocyte Count measurement; Fuchs Endothelial Dystrophy; Hypoplastic Left Heart Syndrome; Monocyte count procedure; Monocyte count result; Thyroid Nodule; Craniofacial Abnormalities; Ventricular Septal Defects; Mucinous Adenocarcinoma; Uranostaphyloschisis; Differentiated Thyroid Gland Carcinoma; Multiple malignancy",4.4398736172867135e-14; 1.803641225501291e-12; 3.118210553589307e-12; 4.5104266881389206e-12; 1.9241179247341838e-10; 2.377251819497684e-10; 3.762648680673853e-10; 4.2478505092738466e-10; 5.452288254986118e-10; 6.429879513246633e-10; 6.870627395110916e-10; 7.868397426275417e-10; 1.1722433847661196e-09; 1.6767489697325582e-09; 1.971893171900314e-09; 3.315537369635636e-09; 4.546836602575699e-09; 5.670785186683756e-09; 6.195332209150018e-09; 7.195555613367576e-09; 8.269524813140207e-09; 8.303910954283738e-09; 1.587872453479067e-08; 2.3137704832524547e-08; 3.149054123564124e-08; 4.65353219894153e-08; 5.518991037343798e-08; 5.784935444423772e-08; 5.8317433871210796e-08; 6.156981490555128e-08; 6.156981490555128e-08; 6.982287075725826e-08; 8.598175402882612e-08; 9.273260676030806e-08; 9.306686765839445e-08; 9.393284022832733e-08; 1.427432458937347e-07; 1.479813245926713e-07; 1.4925759778299788e-07; 2.0279723135488897e-07; 2.46778041958494e-07; 3.532371372262103e-07; 4.157277636684319e-07; 6.299208964864026e-07; 6.630279934320317e-07; 7.931659047151387e-07; 8.297823048747685e-07; 8.660170029731726e-07; 9.822463166680949e-07; 1.0094398444517938e-06; 1.083280646968723e-06; 1.3079916134634371e-06; 1.51758575162775e-06; 1.5208470671427406e-06; 1.6397478315149087e-06; 2.027389637151193e-06; 2.07112526817849e-06; 2.1020461880694925e-06; 2.1624936975752243e-06; 2.205236928124383e-06; 2.450940162208615e-06; 2.546221763226728e-06; 2.576211756838249e-06; 2.608032323197001e-06; 4.179146475474674e-06; 4.839188317483647e-06; 5.381279306135013e-06; 6.378950690990071e-06; 6.889889014378816e-06; 8.591027139424906e-06; 1.3034577772762696e-05; 1.3268923055385737e-05; 1.4805035395703202e-05; 1.527992765491583e-05; 1.5449280661407645e-05; 1.5498516107485843e-05; 1.8507296589967813e-05; 2.0736107376307555e-05; 2.0820699372778346e-05; 3.053335644618538e-05; 3.053335644618538e-05; 3.1066725823367694e-05; 3.1491435270594376e-05; 3.192298841377222e-05; 3.9650653676454574e-05; 4.079834649355082e-05; 4.114864035295583e-05; 4.1934338365676246e-05; 5.437020241719231e-05; 5.800116505773043e-05; 5.945938584340405e-05; 6.058590126387572e-05; 6.484707207749309e-05; 8.133563964016694e-05; 8.730297037328594e-05; 9.476946799623076e-05; 0.00012202062264879416; 0.00012202062264879416; 0.0001322335978675375; 0.0001322335978675375; 0.00013846515856925812; 0.00014636999075042076; 0.00016189346720036038; 0.0001705179359230947; 0.0001705179359230947; 0.0001802305430549181; 0.00021049732822064587; 0.00021049732822064587; 0.00021804014782198476; 0.0002484853090912064; 0.0002652452950458932; 0.00029355802758490503; 0.00032113080554701227; 0.000323910443746482; 0.00038453776693371663; 0.000420950947096172; 0.0004224524250828287; 0.00042535405399404114; 0.0004601228759628894; 0.00046565119871267287; 0.0005125353857651181; 0.0005182771791848276; 0.0006352060750206054; 0.0007074539367893701; 0.0008252744167874381; 0.0010897868460616; 0.0012688388196185; 0.0013309210571735; 0.0014485445504404; 0.001746579573497; 0.001881335207053; 0.0020089634269714; 0.0022674286916718; 0.0030940063712108; 0.0039908077871836; 0.0040785542386402; 0.0062748297137782; 0.0070090734514155; 0.0073444206109429; 0.0083709650732796; 0.008634277457381; 0.0088561754221927; 0.0089906473426575; 0.0093598514945993; 0.0095206592087124; 0.0096630827054915; 0.0097159454554601; 0.0105367304020196; 0.0111888062322808; 0.0114187031414039; 0.0187299613301643; 0.0196314124927668; 0.0196345173194062; 0.0198983219186433; 0.021125667706065; 0.0228665355725917; 0.0302544192125064; 0.033749008368017; 0.0386264970299853; 0.0403198851338656; 0.0404707605808569; 0.0569213530455915; 0.0677694730935319; 0.0741310297608694; 0.0746301710738675; 0.0749666609274744; 0.0817897187940979; 0.0897127848630768; 0.0972679220674381; 0.0972679220674381; 0.1041851789435272; 0.1130019719865939; 0.1130019719865939; 0.1130019719865939; 0.1146753245606438; 0.124149904653194; 0.1272255752567765; 0.1343310874911156; 0.1460848784791741; 0.1460848784791741; 0.1545590833140752; 0.1703929618871976; 0.1722207384650883; 0.2271585546986287; 0.2277111144893269; 0.23058850720196; 0.2670582190879765; 0.2877158849893504; 0.3266046709222248; 0.3266046709222248; 0.4016038424272534; 0.4037241172618553; 0.4866653182016537; 0.4979943388112239; 0.5808240999890296; 0.6333871940828376; 0.7164405424737054,Ulcerative Colitis; Psoriasis; Inflammatory Bowel Disease; Nonbacterial Verrucal Endocardiosis; Asthma; Multiple Sclerosis; Crohn Disease; Psoriasis Vulgaris; Systemic Lupus Erythematosus; Lupus Erythematosus; Diabetes Mellitus; Celiac Disease; Autoimmune Diseases; Cholangitis; Ankylosing Spondylitis; Immune System Diseases; Glaucoma,0.0002754573766813309; 0.00044166586682199737; 0.021392225047824; 0.0446679463927015; 0.064825092293108; 0.0682669288241704; 0.0682669288241704; 0.0682669288241704; 0.0841735094076256; 0.087745240825312; 0.1718736907108893; 0.175139305620004; 0.1847583217632609; 0.2039740835961235; 0.2072542702968064; 0.4128402607375798; 0.5118712646453717,Autosomal recessive mendelian susceptibility to mycobacterial diseases due to partial JAK1 deficiency ORPHA:574957; Generalized glucocorticoid resistance syndrome ORPHA:786; Systemic lupus erythematosus ORPHA:536; Marfan syndrome type 2 ORPHA:284973; Combined immunodeficiency due to MALT1 deficiency ORPHA:397964; Combined immunodeficiency due to Moesin deficiency ORPHA:504530; T-B+ severe combined immunodeficiency due to IL-7Ralpha deficiency ORPHA:169154; Growth retardation-mild developmental delay-chronic hepatitis syndrome ORPHA:391366; Loeys-Dietz syndrome ORPHA:60030; Juvenile hyaline fibromatosis ORPHA:2028; Infantile systemic hyalinosis ORPHA:2176; Chronic myelomonocytic leukemia ORPHA:98823,0.0019696624570933; 0.0133474287859103; 0.0368542044009867; 0.1927589191138116; 0.1927589191138116; 0.1927589191138116; 0.1927589191138116; 0.1927589191138116; 0.1927589191138116; 0.4838060079820406; 0.4838060079820406; 0.5312419675785659,Vaccinia virus Ankara CP77 Host range protein f1; Vaccinia virus Ankara 72.4k ankyrin repeat protein f2; Vaccinia virus ankyrin-like protein; Horsepox virus HSPV005c (Ankyrin repeats); Vaccinia virus Ankara CP77 host range protein f4; Horsepox virus HSPV011c (ankyrin repeats); Orf virus ORF126 ankyrin repeat protein; Monkeypox virus Zaire-96-I-16 ankyrin-like protein (gene: D7L); Horsepox virus HSPV005b (ankyrin repeats); Horsepox virus HSPV020e (ankyrin repeats); Horsepox virus HSPV181 (ankyrin repeats); Vaccinia virus Ankara 54.4k ankyrin repeat protein f2; Vaccinia virus ankyrin-like protein (gene: B4R); Yaba monkey tumor virus ankyrin repeat protein; Horsepox virus HSPV033b (Ankyrin repeats); Monkeypox virus Zaire-96-I-16 B5R (gene: B5R); Horsepox virus HSPV201a (ankyrin repeats); Yaba monkey tumor virus ankyrin-like protein; Horsepox virus HSPV020b (ankyrin repeats); Yaba-like disease virus 11L protein (gene: 11L); Orf virus ORF128 ankyrin repeat protein; Orf virus ORF123 ankyrin repeat protein; Vaccinia virus Ankara 65.4k Ankyrin repeat protein; Cowpox virus CPXV198 protein (gene: CPXV198 CDS); Ectromelia virus ERPV ankyrin; Vaccinia virus Ankara CP77 host range protein f2; Orf virus ORF008 ankyrin repeat protein; Variola virus hypothetical protein (gene: B6R); Monkeypox virus ankyrin-like protein,0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.396036820576385; 0.4088672649431711; 0.4602555770769919; 0.5134770656069968; 0.5349555669171289; 0.5717917933629476; 0.5961449913267739; 0.6234641868335487; 0.7010195275583045,,,,
FKBPL,"Lung Neoplasms; Neoplasm Metastasis; Mammary Neoplasms, Human; Mammary Neoplasms; Malignant neoplasm of lung; Malignant neoplasm of breast; Carcinoma of lung; Primary malignant neoplasm of lung; Breast Carcinoma; Age related macular degeneration; Non-obstructive azoospermia; Intellectual Disability",4.367699208727405e-09; 5.670785186683756e-09; 5.791865115913735e-09; 4.65353219894153e-08; 6.299208964864026e-07; 8.660170029731726e-07; 2.027389637151193e-06; 4.839188317483647e-06; 5.381279306135013e-06; 0.00010334647523919963; 0.010624513163997; 0.9388725395674395,Marfan Syndrome; Mammary Neoplasms; Breast Carcinoma; Breast Cancer,8.921950872070284e-08; 1.1417484002988661e-07; 4.971054570440277e-05; 0.00063387456654884,Male infertility due to large-headed multiflagellar polyploid spermatozoa ORPHA:137893; Arthrogryposis-renal dysfunction-cholestasis syndrome ORPHA:2697; Lethal congenital contracture syndrome type 1 ORPHA:1486; Lethal intrauterine growth restriction-cortical malformation-congenital contractures syndrome ORPHA:2570; Acute intermittent porphyria ORPHA:79276; MPDU1-CDG ORPHA:79323; Macrocephaly-developmental delay syndrome ORPHA:397612; Arthrogryposis-anterior horn cell disease syndrome ORPHA:53696; Auditory neuropathy-optic atrophy syndrome ORPHA:542585; Optic atrophy-ataxia-peripheral neuropathy-global developmental delay syndrome ORPHA:543470; CHILD syndrome ORPHA:139; CK syndrome ORPHA:251383; Pontocerebellar hypoplasia type 10 ORPHA:411493; DK1-CDG ORPHA:91131; SLC35A2-CDG ORPHA:356961; FADD-related immunodeficiency ORPHA:306550; Hyperammonemia due to N-acetylglutamate synthase deficiency ORPHA:927; Isolated focal cortical dysplasia type Ia ORPHA:268973; Oculootodental syndrome ORPHA:99806; Caudal regression sequence ORPHA:3027,0.4838060079820406; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659,Yellow fever virus envelope protein; Murray Valley encephalitis virus prodexcised_polyprotein 1..793; West Nile virus lineage 2 excised_polyprotein 1..791 (gene: flavivirus polyprotein); Powassan virus envelope protein; Omsk hemorrhagic fever virus full_polyprotein 1..3414; Wesselsbron virus full_polyprotein 1..3405; Alkhumra hemorrhagic fever virus envelope protein; West Nile virus lineage 2 envelope protein E (gene: flavivirus polyprotein); Langat virus envelope membrane-associated glycoprotein; Murray Valley encephalitis virus envelope protein E; Louping ill virus envelope protein; Vaccinia virus cowpox A-type inclusion protein,0.2280934210760456; 0.3677974393080778; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.4275573398203068; 0.4517965684624974; 0.4627268298950313; 0.4832965587118858; 0.7871983209689735,Homo sapiens HEK293T embryonic kidney cell,0.35;0.4,Homo sapiens,Homo sapiens
FOS,"Pneumonia; Reperfusion Injury; Asthma; Psoriasis; Familial M??ni??re disease; Juvenile arthritis; Lymphoma; Multiple Myeloma; Virus Diseases; Dermatitis, Atopic; Lung diseases; Rheumatoid Arthritis; Thyroid associated opthalmopathies; Arteriosclerosis; Brain Injuries, Focal; Injuries, Acute Brain; Brain Injuries; Brain Lacerations; Pneumonitis; Non-Small Cell Lung Carcinoma; Crohn Disease; Peritonitis; Ovarian Carcinoma; Sarcoidosis; Endometriosis; Ulcerative Colitis; Infection; Malignant neoplasm of ovary; Tumor Angiogenesis; Lung Neoplasms; Cerebral Ischemia; Neoplasm Metastasis; Mammary Neoplasms, Human; Hodgkin Disease; Atherosclerosis; Pulmonary Fibrosis; Leukemia, Myelocytic, Acute; Glomerulonephritis; Hypertensive disease; Vascular Diseases; Eczema; Cervix carcinoma; Arthritis; Infection caused by Helicobacter pylori; Degenerative polyarthritis; Obesity; Hyperglycemia; Liver neoplasms; HIV Infections; Mammary Neoplasms; Aortic Aneurysm, Abdominal; Glioblastoma; leukemia; Diabetes Mellitus; Lupus Erythematosus, Systemic; Pancreatic carcinoma; Coronary Artery Disease; Dermatologic disorders; Coronary heart disease; Alzheimer's Disease; Right Middle Cerebral Artery Infarction; Embolic Infarction, Middle Cerebral Artery; Thrombotic Infarction, Middle Cerebral Artery; Left Middle Cerebral Artery Infarction; Middle Cerebral Artery Embolus; Middle Cerebral Artery Syndrome; Middle Cerebral Artery Thrombosis; Malaria; Glioma; Epithelial ovarian cancer; Malignant neoplasm of pancreas; Van der Woude syndrome; Malignant neoplasm of mouth; Infarction, Middle Cerebral Artery; Cerebral Infarction; Hepatitis C, Chronic; Adult T-Cell Lymphoma/Leukemia; Anoxia; Cardiovascular Diseases; Septicemia; Sepsis; Cystic Fibrosis; Malignant neoplasm of lung; Fibroid Tumor; Restenosis; Leukemia, T-Cell; Middle Cerebral Artery Occlusion; Diabetes Mellitus, Insulin-Dependent; Chronic Lymphocytic Leukemia; Tumor Progression; Malignant neoplasm of breast; Cytomegalovirus Infections; Gastritis; Bladder Neoplasm; Coronary Arteriosclerosis; Systemic Scleroderma; Anemia, Sickle Cell; Osteitis Deformans; Liver carcinoma; Carcinogenesis; Endometrial Neoplasms; Hyperalgesia, Secondary; Allodynia; Influenza; Stomach Carcinoma; Hyperalgesia, Primary; Polycystic Ovary Syndrome; Colon Carcinoma; Fibrosarcoma; Malignant neoplasm of stomach; Osteosarcoma of bone; Tactile Allodynia; Lymphoma, T-Cell, Cutaneous; Stomach Neoplasms; melanoma; Breast Carcinoma; Osteosarcoma; Thyroid carcinoma; Liver Cirrhosis, Experimental; Familial Alzheimer Disease (FAD); Tumor Promotion; Mechanical Allodynia; Hyperalgesia, Thermal; Acute lymphocytic leukemia; MYELODYSPLASTIC SYNDROME; Colorectal Neoplasms; Prostate carcinoma; Adenocarcinoma; Malignant tumor of colon; Idiopathic crescentic glomerulonephritis; Hyperalgesia; Juvenile psoriatic arthritis; Myeloid Leukemia; Prostatic Neoplasms; Herpes Simplex Infections; Malignant neoplasm of endometrium; Uterine Corpus Cancer; Juvenile-Onset Still Disease; Squamous cell carcinoma; Malignant neoplasm of prostate; Malignant neoplasm of urinary bladder; Leukemia, Large Granular Lymphocytic; Carcinoma of bladder; Experimental Organism Basal Cell Carcinoma; Tumor Immunity; Endometrioma; Malignant Head and Neck Neoplasm; Uterine Fibroids; Thyroid Diseases; Heat Stroke; Congestive heart failure; Malignant Glioma; Unipolar Depression; Neurodegenerative Disorders; Adenoma; Endometrial Carcinoma; Adenocarcinoma of lung (disorder); Classical Hodgkin's Lymphoma; Nasal Polyps; Retinoblastoma; Status Epilepticus; Colorectal Carcinoma; Pulmonary Emphysema; Metastatic melanoma; Myeloid Leukemia, Chronic; Leukemogenesis; Heart failure; Sarcoma; Central neuroblastoma; Secondary malignant neoplasm of lymph node; Major Depressive Disorder; Colorectal Cancer; Squamous cell carcinoma of the head and neck; Neuroblastoma; Primary malignant neoplasm; Secondary Trigeminal Neuralgia; Trigeminal Neuralgia, Idiopathic; Refractory anemias; Malignant Neoplasms; Hemorrhage; Malignant neoplasm of thyroid; Precancerous Conditions; Clostridium; difficile (disorder); Thyroid Neoplasm; AMYOTROPHIC LATERAL SCLEROSIS 1; Papillary thyroid carcinoma; Scrub Typhus; Hepatocarcinogenesis; Trigeminal Neuralgia; Varicosity; Sudden infant death syndrome; Paget Disease; Non-alcoholic Fatty Liver Disease; Insulin Resistance; Amyotrophic Lateral Sclerosis, Sporadic; Clear Cell Sarcoma of Soft Tissue; Childhood Osteosarcoma; Visual seizure; Meningioma; Hyperactive behavior; Aortic Valve Insufficiency; Enteritis; Lipoatrophy; Giant Cell Tumors; Malignant neoplasm of skin; Adenomatous Polyposis Coli; Anxiety neurosis (finding); Glioblastoma Multiforme; Anxiety Disorders; Childhood Leukemia; Ameloblastoma; Liver Failure; Cholestasis, Extrahepatic; Convulsions; Adenocarcinoma of colon; Tumor Necrosis Factor Receptor 1-Associated Periodic Syndrome; Simple Partial Status Epilepticus; Status Epilepticus, Subclinical; Complex Partial Status Epilepticus; Grand Mal Status Epilepticus; Non-Convulsive Status Epilepticus; Aortic Valve Stenosis; Neoplastic Cell Transformation; Hyperinsulinism; Petit mal status; Carcinoid Tumor; Malignant neoplasm of tongue; Oropharyngeal disorders; Prolactinoma; Meningioma, benign, no ICD-O subtype; Prostatic Diseases; Anxiety States, Neurotic; nervous system disorder; Tonic - clonic seizures; Single Seizure; Seizures, Auditory; Seizures, Clonic; Seizures, Sensory; Seizures, Somatosensory; Vertiginous seizure; Atonic Absence Seizures; Generalized Absence Seizures; Gustatory seizure; Hemangioma; Jacksonian Seizure; Non-epileptic convulsion; Nonepileptic Seizures; Olfactory seizure; Vascular Neoplasms; Epileptic Seizures; Tonic Seizures; Carcinoid tumor no ICD-O subtype; Convulsive Seizures; Epileptic drop attack; Complex partial seizures; Erythroblastosis; Absence Seizures; Malignant neoplasm of border of tongue; Malignant neoplasm of dorsal surface of tongue; Malignant neoplasm of ventral surface of tongue; Malignant tumor of base of tongue; Malignant tumor of junctional zone of tongue; malignant tumor of lingual tonsil; Congenital chromosomal disease; Generalized seizures; Hyperandrogenism; Seizures, Focal; Neurilemmoma; Histiocytoid hemangioma; Perihilar Cholangiocarcinoma; Gastrointestinal Carcinoid Tumor; Lipoatrophic Diabetes Mellitus; Hypertrophic Cardiomyopathy; Medullary carcinoma of thyroid; Osteitis Fibrosa Disseminata; Myoclonic Seizures; Acromegaly; Polycystic Kidney, Autosomal Dominant; Growth hormone excess; Bone Cysts; Aneurysmal disease; Spina Bifida; Skeletal muscle hypertrophy; Familial generalized lipodystrophy; Sweating; Hyperhidrosis disorder; Increased sweating; Basophilic leukemia; Encephalopathy, Toxic; Toxic Encephalitis; Broad foot; Hyperplasia of supraorbital margins; Hyperplasia of supraorbital ridge; Hypertrophy of supraorbital margins; Hypertrophy of supraorbital ridge; Prominent supraorbital ridges; Nonorganic psychosis; Large hand; Neurotoxicity Syndromes; Hyperkinesia, Generalized; Abnormal pigmentation; Acanthosis Nigricans; Somatotropin deficiency; Familial medullary thyroid carcinoma; Serum triglycerides raised; Seizures; Advanced bone age; Generalized hirsutism; Drug Withdrawal Symptoms; Glucocorticoid Receptor Deficiency; Substance Withdrawal Syndrome; Cutis Laxa; Progeria; Aura; Awakening Epilepsy; Epilepsy, Cryptogenic; Precocious Puberty; Benign melanocytic nevus; Withdrawal Symptoms; Aplasia Cutis Congenita; Melanocytic nevus; Amphetamine-Related Disorders; Amphetamine Abuse; Amphetamine Addiction; Addictive Behavior; Constipation; Nevus; Hepatomegaly; Hypertrophy of lower jaw; mandibular excess (physical finding); Mandibular hyperplasia; Increased size of the mandible; Severe myopia; Class III malocclusion; Cocaine-Related Disorders; Epilepsy; Polycystic Kidney Diseases; Cocaine Abuse; Agenesis of corpus callosum; Cocaine Dependence; Intellectual Disability; Mental Retardation; Dull intelligence; Low intelligence; Poor school performance; Mental deficiency",7.980856456624717e-16; 4.4398736172867135e-14; 1.803641225501291e-12; 3.118210553589307e-12; 3.861499575207375e-12; 3.861499575207375e-12; 4.5104266881389206e-12; 2.5279022064249716e-11; 6.332483647919588e-11; 7.448716379948652e-11; 8.179290839744632e-11; 1.9241179247341838e-10; 2.377251819497684e-10; 2.377251819497684e-10; 2.377251819497684e-10; 2.377251819497684e-10; 2.377251819497684e-10; 2.377251819497684e-10; 2.813069300429449e-10; 3.762648680673853e-10; 4.2478505092738466e-10; 5.452288254986118e-10; 6.870627395110916e-10; 7.861255581007157e-10; 7.868397426275417e-10; 1.6767489697325582e-09; 1.794870341379274e-09; 1.971893171900314e-09; 3.315537369635636e-09; 4.367699208727405e-09; 4.756590990483e-09; 5.670785186683756e-09; 5.791865115913735e-09; 6.195332209150018e-09; 7.195555613367576e-09; 7.547641288501485e-09; 8.303910954283738e-09; 1.0368326871660785e-08; 1.0368326871660785e-08; 1.4920329017331753e-08; 1.4920329017331753e-08; 1.5572986293211266e-08; 1.587872453479067e-08; 1.7931366647560766e-08; 2.1034803123367165e-08; 2.412608431251415e-08; 4.0898524252942674e-08; 4.3069383556698336e-08; 4.638299267461546e-08; 4.65353219894153e-08; 5.1290058242058653e-08; 5.518991037343798e-08; 5.784935444423772e-08; 5.8317433871210796e-08; 6.156981490555128e-08; 6.982287075725826e-08; 8.598175402882612e-08; 9.273260676030806e-08; 9.273260676030806e-08; 9.273260676030806e-08; 1.0390067657961098e-07; 1.0390067657961098e-07; 1.0390067657961098e-07; 1.0390067657961098e-07; 1.0390067657961098e-07; 1.0390067657961098e-07; 1.0390067657961098e-07; 1.0618136021459505e-07; 1.427432458937347e-07; 1.479813245926713e-07; 1.4925759778299788e-07; 1.524221047360518e-07; 2.0279723135488897e-07; 2.400988116471548e-07; 2.419125491442217e-07; 2.46778041958494e-07; 2.46778041958494e-07; 2.911052249927245e-07; 4.5433391667148853e-07; 5.254943571583271e-07; 5.313225371508493e-07; 5.577321626966352e-07; 6.299208964864026e-07; 6.630279934320317e-07; 6.673805318525932e-07; 6.805796735296268e-07; 6.805796735296268e-07; 6.851652105457608e-07; 7.931659047151387e-07; 8.297823048747685e-07; 8.660170029731726e-07; 8.887379906686178e-07; 9.58028929735367e-07; 9.822463166680949e-07; 1.0094398444517938e-06; 1.10068355868735e-06; 1.2482007026109775e-06; 1.284982487562752e-06; 1.3079916134634371e-06; 1.51758575162775e-06; 1.6397478315149087e-06; 1.9581146391906144e-06; 1.9581146391906144e-06; 2.027389637151193e-06; 2.07112526817849e-06; 2.086123696221558e-06; 2.086123696221558e-06; 2.205236928124383e-06; 2.3419309731960144e-06; 2.450940162208615e-06; 2.560217628497434e-06; 2.782805018144785e-06; 3.7283259874612974e-06; 3.878607667297475e-06; 4.179146475474674e-06; 5.381279306135013e-06; 6.3131986281381465e-06; 6.889889014378816e-06; 7.691726899679507e-06; 9.263589414966798e-06; 1.033366177374635e-05; 1.033366177374635e-05; 1.0961931275541026e-05; 1.2375081616087569e-05; 1.279493639647176e-05; 1.3034577772762696e-05; 1.527992765491583e-05; 1.5449280661407645e-05; 1.5498516107485843e-05; 1.6659968656867144e-05; 1.8507296589967813e-05; 1.8961926417889813e-05; 2.042524345007846e-05; 2.0820699372778346e-05; 2.1109857936882128e-05; 2.389985034001877e-05; 2.483118059238325e-05; 2.5791573703443737e-05; 3.053335644618538e-05; 3.053335644618538e-05; 3.1491435270594376e-05; 3.803310437251698e-05; 3.9650653676454574e-05; 3.9650653676454574e-05; 3.971484221432504e-05; 4.079834649355082e-05; 4.3188904868696655e-05; 5.013426562854155e-05; 5.248375780672949e-05; 5.59220554762142e-05; 8.232890503539995e-05; 8.25206825409808e-05; 0.00010334647523919963; 0.00010914466609698448; 0.00012202062264879416; 0.0001322335978675375; 0.00013846515856925812; 0.0001431024725510208; 0.00015093372108149775; 0.00015093372108149775; 0.0001616561904035017; 0.00016189346720036038; 0.0001802305430549181; 0.00021049732822064587; 0.00021049732822064587; 0.0002652452950458932; 0.00027820432005572264; 0.00029355802758490503; 0.00032113080554701227; 0.000323910443746482; 0.0003278023880903879; 0.00038453776693371663; 0.000420950947096172; 0.0004601228759628894; 0.00046565119871267287; 0.0004918069653418582; 0.0004918069653418582; 0.0005255837979904586; 0.0006352060750206054; 0.0006445212280958682; 0.0009826472144539087; 0.0012688388196185; 0.0017731038420892; 0.0020089634269714; 0.0021222176147417; 0.0025122887786423; 0.0039908077871836; 0.0040444907714877; 0.0054814673835909; 0.0066401895279317; 0.0071410338306506; 0.0072083035574659; 0.0075325383349707; 0.0080667733705833; 0.0083709650732796; 0.0097159454554601; 0.0097628826330308; 0.0099798889656483; 0.0105367304020196; 0.0111888062322808; 0.0114187031414039; 0.0114187031414039; 0.0114187031414039; 0.0145436543557976; 0.0156113267570298; 0.0166041002652209; 0.0167904807006824; 0.0171001534176385; 0.0173384291015271; 0.0173964199029194; 0.0196225707350576; 0.0203198961621158; 0.0228665355725917; 0.0238425854040518; 0.027071413490175; 0.0279220892715439; 0.0303319552791211; 0.0303319552791211; 0.0303319552791211; 0.0303319552791211; 0.0303319552791211; 0.0314638805510678; 0.0320403652557597; 0.0378565625608719; 0.0380438970214283; 0.0386264970299853; 0.0447905037504535; 0.0471006425252053; 0.0559578912214163; 0.057047868743524; 0.0623026316541814; 0.0677694730935319; 0.0678022600525665; 0.069077962105579; 0.0700485361084771; 0.0700485361084771; 0.0700485361084771; 0.0700485361084771; 0.0700485361084771; 0.0700485361084771; 0.0700485361084771; 0.0700485361084771; 0.0700485361084771; 0.0700485361084771; 0.0700485361084771; 0.0700485361084771; 0.0700485361084771; 0.0700485361084771; 0.0723815120866587; 0.0729686376372628; 0.0746301710738675; 0.0746301710738675; 0.0817897187940979; 0.088963803794147; 0.0897127848630768; 0.0897127848630768; 0.0972679220674381; 0.0972679220674381; 0.0972679220674381; 0.0972679220674381; 0.0972679220674381; 0.0972679220674381; 0.0972679220674381; 0.0996459063920158; 0.1005686045203269; 0.1016471070089966; 0.1050724946352408; 0.1130019719865939; 0.1130019719865939; 0.1130019719865939; 0.1173860265721715; 0.1206032442301429; 0.1242757058018646; 0.131813871137714; 0.1343310874911156; 0.1404159644943249; 0.1456466465256486; 0.1472075252120941; 0.1525119847960956; 0.1584804022044084; 0.1642913929691757; 0.1703929618871976; 0.1703929618871976; 0.1881045022168423; 0.1911693299808857; 0.1911693299808857; 0.1911693299808857; 0.1982833830495248; 0.2166737845423457; 0.2166737845423457; 0.2316568843888361; 0.2316568843888361; 0.2316568843888361; 0.2316568843888361; 0.2316568843888361; 0.2316568843888361; 0.236709594559292; 0.236709594559292; 0.2416367579687983; 0.2468771733501051; 0.2570364810168682; 0.2570364810168682; 0.2622329318286966; 0.2622329318286966; 0.316142834424839; 0.3243241301578816; 0.3306602962670145; 0.340330994065175; 0.3494335993143313; 0.3587690037565285; 0.3678942528109082; 0.3678942528109082; 0.3718365496695985; 0.3806434842117995; 0.3806434842117995; 0.3891257446735781; 0.4089444818350988; 0.4250139906398144; 0.4282129311389295; 0.429535520054622; 0.4389761493558894; 0.4395651618287257; 0.4395651618287257; 0.4424335623428572; 0.4481840103343354; 0.4481840103343354; 0.4781931916730066; 0.4979414793353498; 0.5280301206455198; 0.5280301206455198; 0.5280301206455198; 0.5344870281804397; 0.5469000270498892; 0.5469000270498892; 0.5609919179146893; 0.5793939269095637; 0.5929777708658006; 0.6036850764340619; 0.657788228629759; 0.6767064352850668; 0.9388725395674395; 0.9620816473530824; 0.9620816473530824; 0.9620816473530824; 0.9690953460589412; 0.9758134967317544,"Marfan Syndrome; Mammary Neoplasms; Cerebral Infraction; Cerebral Thrombosis; Juvenile Arthritis; Polyarthritis, Rheumatoid Factor Positive; Seronegative Polyarthritis; Breast Carcinoma; Still Disease; Atherosclerosis; Myocardial Infarction; Breast Cancer; Arthritis; Fatty Liver; Trigeminal Neuralgia; Congestive Heart Failure; Hypertension; Cirrhosis; Cholestasis; Lung Cancer; Lateral Sclerosis; Nervous System Disorder; Nonconvulsive Status Epilepticus; Petit Mal Status; Grand Mal Status Epilepticus; Lung Neoplasms; Hyperinsulinism; Endometrioma; Jacksonian Seizure; Osteoporosis; Clonic Seizures; Endometriosis; Congenital Lipodystrophy; Hypotonic Seizures; Nervous System Diseases; Diabetes Mellitus; Liver Carcinoma; Status Epilepticus; Liver Failure; Kidney Disease; Polycystic Ovary Syndrome; Talipes Transversoplanus; Acanthosis Nigricans; Ventricular Hypertrophy; Ovarian Epithelial Carcinoma; Secondary Physiologic Amenorrhea; Myopathy; Somatotropin Deficiency; Lipoatrophy; Seizure; Renal Glomerular Disease; Precocious Puberty; Osteopenia; Isolated Somatotropin Deficiency; Anxiety Disorder; Epilepsy; Lipodystrophy; Renal Insufficiency; Pulmonary Arterial Hypertension; Pancreatitis; Malocclusion; Immunologic Deficiency Syndromes; Scoliosis; Atrial Fibrillation; Hypertrophic Cardiomyopathy; Mental Retardation",8.921950872070284e-08; 1.1417484002988661e-07; 2.009208013074685e-07; 2.739939098363423e-07; 1.1394948069325325e-05; 1.1394948069325325e-05; 3.928596547519457e-05; 4.971054570440277e-05; 5.1065830658055726e-05; 5.254109803591956e-05; 0.0005760978170082974; 0.00063387456654884; 0.0015169561374293; 0.0025464930497429; 0.0025464930497429; 0.0028558709076653; 0.0048927857621509; 0.007221192915733; 0.0152037568688841; 0.0153260870217676; 0.0183653432224121; 0.037484696011653; 0.0588219013114419; 0.0588219013114419; 0.0588219013114419; 0.0662475691169798; 0.0810252439964338; 0.0987697358859238; 0.1110148026021272; 0.1286424863049623; 0.1286424863049623; 0.1286424863049623; 0.1386032662139448; 0.1666102769501294; 0.1700432900208007; 0.1718736907108893; 0.2008242041589438; 0.2062454941617454; 0.2062454941617454; 0.2657257246540625; 0.2725906821661307; 0.2828835905949769; 0.3234286640962904; 0.3465144196435422; 0.3501279647290265; 0.3787488482725425; 0.3849207284113362; 0.4985163290591877; 0.5013672649546516; 0.5129718346081621; 0.5219056165239364; 0.5288531721017324; 0.5336711452646915; 0.5345251431933871; 0.577463872112795; 0.5782751786750374; 0.6012919933193765; 0.6306478602359603; 0.6400130375643096; 0.6831609579390381; 0.7006453064061828; 0.7702321772528723; 0.8310460270009882; 0.858926761707919; 0.8778442463114743; 0.9999792400275376,Charcot-Marie-Tooth disease type 1D ORPHA:101084; Charcot-Marie-Tooth disease type 4E ORPHA:99951; Congenital generalized lipodystrophy ORPHA:528,3.598261936626476e-12; 3.598261936626476e-12; 0.0565022767519947,,,Homo sapiens A549 lung carcinoma cell;Homo sapiens HEK293T embryonic kidney cell;Homo sapiens HLMVEC lung microvascular endothelial cell;Homo sapiens HMLE mammary epithelial cell;Homo sapiens HepG2 hepatocellular carcinoma cell;Homo sapiens LoVo colon adenocarcinoma cell;Homo sapiens MCF-7 mammary adenocarcinoma cell;Homo sapiens Type II pulmonary alveolar epithelial cell;In vitro;yeasx,0.35;0.37;0.4;0.46;0.5;0.56;0.59,HCV77;Homo sapiens;Mus musculus;chemical synthesis,Homo sapiens;Yersinia pestis
FOXJ1,"Virus Diseases; Rheumatoid Arthritis; Autoimmune Diseases; Ovarian Carcinoma; Malignant neoplasm of ovary; Neoplasm Metastasis; Respiratory syncytial virus (RSV) infection in conditions classified elsewhere and of unspecified site; Mammary Neoplasms; Lupus Erythematosus, Systemic; Cystic Fibrosis; Tumor Progression; Malignant neoplasm of breast; Liver carcinoma; Carcinogenesis; Stomach Carcinoma; Malignant neoplasm of stomach; Breast Carcinoma; Lupus Erythematosus; Allergic rhinitis (disorder); Lupus Vulgaris; Rhinitis; Lupus Erythematosus, Discoid; Gastritis, Atrophic; Secondary malignant neoplasm of lymph node; Lymphopenia; Bronchitis; Respiratory Tract Infections; Kartagener Syndrome; AL-RAQAD SYNDROME; Ciliary Motility Disorders; Anaplastic Ependymoma; Choroid Plexus Papilloma; Ependymoma",6.332483647919588e-11; 1.9241179247341838e-10; 5.452288254986118e-10; 6.870627395110916e-10; 1.971893171900314e-09; 5.670785186683756e-09; 1.452540845894924e-08; 4.65353219894153e-08; 6.156981490555128e-08; 5.577321626966352e-07; 8.297823048747685e-07; 8.660170029731726e-07; 1.3079916134634371e-06; 1.51758575162775e-06; 2.07112526817849e-06; 2.450940162208615e-06; 5.381279306135013e-06; 1.4805035395703202e-05; 2.0736107376307555e-05; 4.1934338365676246e-05; 5.399364944210138e-05; 8.133563964016694e-05; 0.00019131698235390912; 0.000323910443746482; 0.0017290799495295; 0.0025122887786423; 0.0050894481995015; 0.0826378648181075; 0.1050724946352408; 0.1204795752338222; 0.181710614199711; 0.181710614199711; 0.2622329318286966,Ciliary Dyskinesia; Kartagener Syndrome,0.1586275460870988; 0.3076038681026417,Retinal macular dystrophy type 2 ORPHA:319640; Primary ciliary dyskinesia ORPHA:244; Non-epidermolytic palmoplantar keratoderma ORPHA:2337; Congenital hereditary facial paralysis-variable hearing loss syndrome ORPHA:306530,0.4838060079820406; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659,,,Homo sapiens HEK293T embryonic kidney cell,0.35,Homo sapiens,Homo sapiens
FSCN2,"Obesity; melanoma; Age related macular degeneration; Human anaplasmosis due to Anaplasma phagocytophilum; Hyperinsulinism; Keratoconus; Glaucoma; Chorioretinal atrophy; Bone spicule pigmentation of the retina; Attenuation of retinal blood vessels; Hereditary retinal dystrophy; Macular degeneration; Autosomal dominant retinitis pigmentosa; Sensorineural Hearing Loss (disorder); Congenital anomaly of testis; Progressive night blindness; Abnormality of the retinal vasculature; Atypical scarring of skin; Cataract; Retinitis Pigmentosa; Anteverted nostril; Difficulties with night vision; Night Blindness; Electroretinogram abnormal; Ophthalmoplegia; Blindness, Legal; Nystagmus; Blindness; Retinal pigment epithelial abnormality; Abnormality of retinal pigmentation; Conductive hearing loss; Photodysphoria; Optic Atrophy; Photophobia; Hypogonadism; Visual Impairment; Low Vision; Congenital hypoplasia of penis; Broad flat nasal bridge; Nasal bridge wide; Lens Opacities; Intellectual Disability; Mental Retardation; Dull intelligence; Low intelligence; Poor school performance; Mental deficiency",2.412608431251415e-08; 4.179146475474674e-06; 0.00010334647523919963; 0.0030585625765418; 0.0378565625608719; 0.0616475884230982; 0.0905750994820178; 0.1642913929691757; 0.176056923749369; 0.2166737845423457; 0.2823835751171575; 0.384785908220112; 0.3929133356162864; 0.4371385994351301; 0.4424335623428572; 0.4424335623428572; 0.4712571109376817; 0.4817554402514458; 0.5019882754152939; 0.5557349584201475; 0.5977671298158864; 0.598109216787409; 0.6147591778990789; 0.6386105548962866; 0.6462051685029289; 0.6786928921054781; 0.6839463765862077; 0.6920684227470365; 0.6980158587103071; 0.6980158587103071; 0.7254518169463228; 0.7254518169463228; 0.7256088595255824; 0.7386098893530494; 0.7678938661655313; 0.8325211511182578; 0.84400108059922; 0.8682896702122112; 0.9047630615535728; 0.9066195975171044; 0.9099330454121676; 0.9388725395674395; 0.9620816473530824; 0.9620816473530824; 0.9620816473530824; 0.9690953460589412; 0.9758134967317544,Hyperinsulinism; Diabetes Mellitus; Chorioretinal Atrophy; Obesity; Disorder Of Eye; Glaucoma; Keratoconus; Nyctalopia; Nystagmus; Rod-cone Dystrophy; Congenital Hypoplasia Of Penis; Retinitis Pigmentosa; Hypogonadism; Optic Atrophy; Hearing Loss; Cataract; Mental Retardation,0.0810252439964338; 0.1718736907108893; 0.1787826075739565; 0.2736284003666279; 0.5111376489309558; 0.5118712646453717; 0.6088194135768727; 0.7206496565839581; 0.7206496565839581; 0.7491976385640269; 0.8501323313158521; 0.8612519228221063; 0.8765788936401022; 0.8983964555953942; 0.9252470124617264; 0.9920888769304664; 0.9999792400275376,Congenital myopathy with internal nuclei and atypical cores ORPHA:319160; Hereditary hypophosphatemic rickets with hypercalciuria ORPHA:157215; Retinitis pigmentosa ORPHA:791,0.4838060079820406; 0.5312419675785659; 0.6991726429357337,Monkeypox virus Zaire-96-I-16 B2R (gene: B2R); Human adenovirus 18 CR1-beta protein (gene: E3); Human adenovirus 31 cr1 beta protein (gene: E3 cr1 beta); Human mastadenovirus A E3 CR1-alpha1; Human betaherpesvirus 7 membrane glycoprotein UL119 (gene: U85),0.0816962571184375; 0.2880902732733083; 0.3911903778732946; 0.4476550758896243; 0.6053121062925791,,,,
GAPDHS,"Alzheimer's Disease; Familial Alzheimer Disease (FAD); Presenile dementia; Alzheimer Disease, Early Onset; Alzheimer's Disease, Focal Onset; Acute Confusional Senile Dementia; Alzheimer Disease, Late Onset",9.273260676030806e-08; 9.263589414966798e-06; 1.5064798896399038e-05; 0.00011927896769899647; 0.0014413188128666; 0.0014413188128666; 0.0017107913939493,Senile Dementia; Alzheimer Disease,0.0067487024308267; 0.2089805590322066,Congenital myopathy with internal nuclei and atypical cores ORPHA:319160; COFS syndrome ORPHA:1466; Leydig cell hypoplasia due to LHB deficiency ORPHA:325448; Acute infantile liver failure due to synthesis defect of mtDNA-encoded proteins ORPHA:217371; Combined oxidative phosphorylation defect type 8 ORPHA:319504; Short stature-pituitary and cerebellar defects-small sella turcica syndrome ORPHA:85442; Spinocerebellar ataxia type 4 ORPHA:98765; Frontorhiny ORPHA:391474; Tritanopia ORPHA:88629; Mitochondrial myopathy with reversible cytochrome C oxidase deficiency ORPHA:254864; Xeroderma pigmentosum-Cockayne syndrome complex ORPHA:220295; Autosomal dominant progressive external ophthalmoplegia ORPHA:254892,0.4838060079820406; 0.4838060079820406; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659,,,,,,
GPM6B,Glioblastoma; Lymphoid leukemia; Pelizaeus-Merzbacher Disease; Leukodystrophy,5.518991037343798e-08; 0.0111888062322808; 0.0363737825516021; 0.0972679220674381,,,"Macular corneal dystrophy ORPHA:98969; Autosomal recessive congenital cerebellar ataxia due to GRID2 deficiency ORPHA:363432; Episodic ataxia type 6 ORPHA:209967; Hyperprolinemia type 1 ORPHA:419; Juvenile myoclonic epilepsy ORPHA:307; NON RARE IN EUROPE: Autism ORPHA:106; Pitt-Hopkins-like syndrome ORPHA:221150; 12p12.1 microdeletion syndrome ORPHA:313884; ANK3-related intellectual disability-sleep disturbance syndrome ORPHA:356996; Acute mast cell leukemia ORPHA:566393; Lissencephaly type 1 due to doublecortin gene mutation ORPHA:2148; Anophthalmia/microphthalmia-esophageal atresia syndrome ORPHA:77298; Autism spectrum disorder due to AUTS2 deficiency ORPHA:352490; Autosomal dominant focal dystonia, DYT25 type ORPHA:329466; Monosomy 9q22.3 ORPHA:77301; Autosomal dominant spastic paraplegia type 3 ORPHA:100984; Autosomal dominant striatal neurodegeneration ORPHA:228169; Autosomal recessive spastic paraplegia type 67 ORPHA:401820; Nodular urticaria pigmentosa ORPHA:158772; Null syndrome ORPHA:280234; Bothnia retinal dystrophy ORPHA:85128; Oculocutaneous albinism type 6 ORPHA:370097; Bullous diffuse cutaneous mastocytosis ORPHA:280785; PMP2-related Charcot-Marie-Tooth disease type 1 ORPHA:476394; Pelizaeus-Merzbacher disease in female carriers ORPHA:280229; Pelizaeus-Merzbacher disease, classic form ORPHA:280219; Pelizaeus-Merzbacher disease, connatal form ORPHA:280210; Pelizaeus-Merzbacher disease, transitional form ORPHA:280224; Peripheral demyelinating neuropathy-central dysmyelinating leukodystrophy-Waardenburg syndrome-Hirschsprung disease ORPHA:163746; Chronic mast cell leukemia ORPHA:566396; Plaque-form urticaria pigmentosa ORPHA:158769; Pseudoxanthomatous diffuse cutaneous mastocytosis ORPHA:280794; Congenital lethal myopathy, Compton-North type ORPHA:210163; Cortical dysplasia-focal epilepsy syndrome ORPHA:163681; Cutaneous mastocytoma ORPHA:79455; Schilbach-Rott syndrome ORPHA:2353; Developmental and speech delay due to SOX5 deficiency ORPHA:313892; Donnai-Barrow syndrome ORPHA:2143; EAST syndrome ORPHA:199343; Early-onset myopathy-areflexia-respiratory distress-dysphagia syndrome ORPHA:439212; Smoldering systemic mastocytosis ORPHA:158775; Spastic paraplegia type 2 ORPHA:99015; Telangiectasia macularis eruptiva perstans ORPHA:90389; Testicular seminomatous germ cell tumor ORPHA:842; Typical urticaria pigmentosa ORPHA:158766; Xq21 microdeletion syndrome ORPHA:1435; Hyperekplexia-epilepsy syndrome ORPHA:163985; Isolated bone marrow mastocytosis ORPHA:158778; Isolated oxycephaly ORPHA:63440; Angelman syndrome due to maternal 15q11q13 deletion ORPHA:98794; Multiple epiphyseal dysplasia due to collagen 9 anomaly ORPHA:166002; NON RARE IN EUROPE: Asperger syndrome ORPHA:1162; CHARGE syndrome ORPHA:138; FRAXE intellectual disability ORPHA:100973; Hypomyelination with atrophy of basal ganglia and cerebellum ORPHA:139441; Alveolar rhabdomyosarcoma ORPHA:99756; NON RARE IN EUROPE: Tourette syndrome ORPHA:856; Subcortical band heterotopia ORPHA:99796; Zimmermann-Laband syndrome ORPHA:3473; Inherited congenital spastic tetraplegia ORPHA:210141; Alternating hemiplegia of childhood ORPHA:2131; Familial or sporadic hemiplegic migraine ORPHA:569; Autosomal recessive Stickler syndrome ORPHA:250984; Dysequilibrium syndrome ORPHA:1766; Lennox-Gastaut syndrome ORPHA:2382; Myoclonic-astatic epilepsy ORPHA:1942; Pilomyxoid astrocytoma ORPHA:251615; Situs ambiguus ORPHA:157769; Infantile spasms syndrome ORPHA:3451; Kallmann syndrome ORPHA:478; X-linked non-syndromic intellectual disability ORPHA:777",0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4982782825106929; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5333039990776665; 0.5333039990776665; 0.5333039990776665; 0.5352376236648427; 0.552214469388668; 0.5658599988943954; 0.6002191635204875,,,,,,
HAP1,"Multiple Sclerosis; Hypertensive disease; Cerebrovascular accident; Respiratory Distress Syndrome, Adult; Coronary heart disease; Alzheimer's Disease; Glioma; Malignant neoplasm of lung; Carcinoma of lung; Primary malignant neoplasm of lung; Prostate carcinoma; Malignant neoplasm of prostate; Osteoporosis; Unipolar Depression; Primary biliary cirrhosis; Epilepsy, Temporal Lobe; Huntington Disease; Male infertility; Essential Hypertension; Muscular Dystrophy, Duchenne; Hemophilia, NOS; SPINOCEREBELLAR ATAXIA 17; Icterus; Hemophilia A; Abnormal behavior; Endogenous depression; Amnesia, Transient Global; Obesity, Morbid; Familial aplasia of the vermis",4.546836602575699e-09; 1.0368326871660785e-08; 2.0570601164639797e-08; 2.261634993097532e-08; 9.273260676030806e-08; 9.273260676030806e-08; 1.427432458937347e-07; 6.299208964864026e-07; 2.027389637151193e-06; 4.839188317483647e-06; 1.527992765491583e-05; 3.053335644618538e-05; 9.117996105379778e-05; 0.00010334647523919963; 0.0005214896245221155; 0.0012591553085125; 0.0017731038420892; 0.0021001259552496; 0.0028759971272412; 0.007117388576245; 0.0173964199029194; 0.018665947632861; 0.0496760944377964; 0.0530344420162745; 0.0864853123692039; 0.0887863766478173; 0.176056923749369; 0.2277525841233998; 0.3891257446735781,,,"Macular corneal dystrophy ORPHA:98969; Nail-patella syndrome ORPHA:2614; Nail-patella-like renal disease ORPHA:2613; Congenital nephrotic syndrome, Finnish type ORPHA:839; Hyperprolinemia type 1 ORPHA:419; Leukoencephalopathy with mild cerebellar ataxia and white matter edema ORPHA:363540",0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.5312419675785659,,,,,,
HLA-L,"Lupus Erythematosus, Systemic; Diabetes Mellitus, Insulin-Dependent; Carcinoma of lung; Wolman Disease",6.156981490555128e-08; 6.851652105457608e-07; 2.027389637151193e-06; 0.1206032442301429,Lung Cancer; Lupus Erythematosus; Diabetes Mellitus,0.0153260870217676; 0.087745240825312; 0.1718736907108893,,,,,,,,
HS3ST3B1,"Virus Diseases; Endometriosis; Leukemia, Myelocytic, Acute; Pancreatic carcinoma; Malignant neoplasm of pancreas; Hepatitis B; Endometrioma",6.332483647919588e-11; 7.868397426275417e-10; 8.303910954283738e-09; 6.982287075725826e-08; 1.4925759778299788e-07; 1.3755659311680946e-05; 4.079834649355082e-05,Endometrioma; Endometriosis,0.0987697358859238; 0.1286424863049623,,,,,,,,
HSPA1A,"Pneumonia; Reperfusion Injury; Familial M??ni??re disease; Lymphoma; Multiple Myeloma; Thyroid associated opthalmopathies; Arteriosclerosis; Brain Injuries, Focal; Injuries, Acute Brain; Brain Injuries; Brain Lacerations; Pneumonitis; Non-Small Cell Lung Carcinoma; Crohn Disease; Autoimmune Diseases; Ovarian Carcinoma; Sarcoidosis; Ulcerative Colitis; Malignant neoplasm of ovary; Pancreatitis, Chronic; Multiple Sclerosis; Cerebral Ischemia; Neoplasm Metastasis; Atherosclerosis; Acute pancreatitis; Graves Disease; Vascular Diseases; Cerebrovascular accident; Respiratory Distress Syndrome, Adult; Inflammatory Bowel Diseases; Obesity; Hyperglycemia; Glioblastoma; leukemia; Diabetes Mellitus; Diabetes; Lupus Erythematosus, Systemic; Ischemic stroke; Coronary Artery Disease; Coronary heart disease; Alzheimer's Disease; Spondylarthropathies; Glioma; Cerebral Infarction; Myocardial Ischemia; Cardiovascular Diseases; Malignant neoplasm of lung; Diabetes Mellitus, Insulin-Dependent; Liver diseases; Severe Sepsis; Measles; Malignant neoplasm of breast; Bladder Neoplasm; Coronary Arteriosclerosis; Graft-vs-Host Disease; Diabetic Nephropathy; Liver carcinoma; Dementia, Vascular; Colonic Neoplasms; Immunologic Deficiency Syndromes; Carcinogenesis; Nasopharyngeal carcinoma; Transient Ischemic Attack; Carcinoma of lung; Stomach Carcinoma; Polycystic Ovary Syndrome; Ankylosing spondylitis; Colon Carcinoma; Leishmaniasis, Visceral; Fibrosarcoma; Malignant neoplasm of stomach; Immune System Diseases; Kidney Failure, Acute; melanoma; Tauopathies; Primary malignant neoplasm of lung; Breast Carcinoma; Small cell carcinoma of lung; Agranulocytosis; Prostate carcinoma; Malignant tumor of colon; Prostatic Neoplasms; Malignant neoplasm of prostate; Malignant neoplasm of urinary bladder; Parkinson Disease; Sleep Apnea, Obstructive; Carcinoma of bladder; Tumor Immunity; Benign Prostatic Hyperplasia; Duodenal Ulcer; Congestive heart failure; Chronic Kidney Diseases; Unipolar Depression; Neurodegenerative Disorders; Renal Cell Carcinoma; Pancreatitis; VITILIGO-ASSOCIATED MULTIPLE AUTOIMMUNE DISEASE SUSCEPTIBILITY 1 (finding); Carcinoma, Transitional Cell; Colorectal Carcinoma; Diabetes Mellitus, Non-Insulin-Dependent; Mumps; Kidney Failure; Community acquired pneumonia; Respiratory Distress Syndrome, Newborn; Vitiligo; Central neuroblastoma; Major Depressive Disorder; Amyloidosis; Colorectal Cancer; Urothelial Carcinoma; Neuroblastoma; Primary malignant neoplasm; Carcinoma breast stage IV; Osteopenia; Paranoid Schizophrenia; Malignant Neoplasms; Pulmonary Edema; Autoimmune thyroid disease; Male infertility; Metabolic Diseases; Childhood Acute Lymphoblastic Leukemia; Ki-1+ Anaplastic Large Cell Lymphoma; Major depression, single episode; High altitude pulmonary edema; Renal Insufficiency; Schizophrenia; Carcinoma, Pancreatic Ductal; Carotid Stenosis; Carotid artery occlusion; Zinc deficiency; Prediabetes syndrome; Acute Kidney Insufficiency; Acute kidney injury; Transitional cell carcinoma of bladder; Drug Allergy; Liver Dysfunction; Hypopigmentation disorder",7.980856456624717e-16; 4.4398736172867135e-14; 3.861499575207375e-12; 4.5104266881389206e-12; 2.5279022064249716e-11; 2.377251819497684e-10; 2.377251819497684e-10; 2.377251819497684e-10; 2.377251819497684e-10; 2.377251819497684e-10; 2.377251819497684e-10; 2.813069300429449e-10; 3.762648680673853e-10; 4.2478505092738466e-10; 5.452288254986118e-10; 6.870627395110916e-10; 7.861255581007157e-10; 1.6767489697325582e-09; 1.971893171900314e-09; 2.219129913614883e-09; 4.546836602575699e-09; 4.756590990483e-09; 5.670785186683756e-09; 7.195555613367576e-09; 7.713813941246406e-09; 8.269524813140207e-09; 1.4920329017331753e-08; 2.0570601164639797e-08; 2.261634993097532e-08; 2.3137704832524547e-08; 2.412608431251415e-08; 4.0898524252942674e-08; 5.518991037343798e-08; 5.784935444423772e-08; 5.8317433871210796e-08; 6.156981490555128e-08; 6.156981490555128e-08; 6.156981490555128e-08; 8.598175402882612e-08; 9.273260676030806e-08; 9.273260676030806e-08; 1.427432458937347e-07; 1.427432458937347e-07; 2.419125491442217e-07; 2.948344121290337e-07; 4.5433391667148853e-07; 6.299208964864026e-07; 6.851652105457608e-07; 7.17979149467092e-07; 7.873224494781308e-07; 7.99548070959303e-07; 8.660170029731726e-07; 9.822463166680949e-07; 1.0094398444517938e-06; 1.0094667484349083e-06; 1.083280646968723e-06; 1.3079916134634371e-06; 1.4042419564664515e-06; 1.4185164995612263e-06; 1.4839502431758565e-06; 1.51758575162775e-06; 1.5208470671427406e-06; 1.5208470671427406e-06; 2.027389637151193e-06; 2.07112526817849e-06; 2.086123696221558e-06; 2.1020461880694925e-06; 2.205236928124383e-06; 2.2411321306638023e-06; 2.3419309731960144e-06; 2.450940162208615e-06; 2.546221763226728e-06; 3.485726441474513e-06; 4.179146475474674e-06; 4.218275676836033e-06; 4.839188317483647e-06; 5.381279306135013e-06; 1.0755368362337037e-05; 1.4439241578579364e-05; 1.527992765491583e-05; 1.5498516107485843e-05; 2.0820699372778346e-05; 3.053335644618538e-05; 3.1491435270594376e-05; 3.372277447426952e-05; 3.602405958537832e-05; 3.9650653676454574e-05; 3.971484221432504e-05; 5.945938584340405e-05; 8.007340895515112e-05; 8.232890503539995e-05; 9.913294924271568e-05; 0.00010334647523919963; 0.00010914466609698448; 0.0001119048288448298; 0.00012858049944279123; 0.0001431024725510208; 0.0001474322229096163; 0.00016189346720036038; 0.00016189346720036038; 0.0002214859278255797; 0.0002559467947532168; 0.00028056116385876946; 0.0002812860791024885; 0.0002933384035122236; 0.00032113080554701227; 0.0003278023880903879; 0.0003495642888428815; 0.00038453776693371663; 0.0004243878730487336; 0.0004601228759628894; 0.00046565119871267287; 0.0004814724943641282; 0.0005214896245221155; 0.0005873268650449521; 0.0006352060750206054; 0.0010244557923259; 0.0014485445504404; 0.0021001259552496; 0.0028187518310092; 0.0038705790239355; 0.0039908077871836; 0.0047351775110072; 0.0054814673835909; 0.007861073629675; 0.0093325514582534; 0.0125952576116424; 0.0187299613301643; 0.030006907592274; 0.0340266852061135; 0.0447905037504535; 0.0530344420162745; 0.0571842904809504; 0.0625091602151466; 0.0723815120866587; 0.098408395338696; 0.1397055058487397,Myocardial Ischemia; Chronic Obstructive Pulmonary Disease; Mental Depression; Prostatic Neoplasms; Pancreatic Ductal Carcinoma; Kidney Failure; Acute Kidney Insufficiency; Prostate Cancer; Schizophrenia; Paranoid Schizophrenia; Melanoma,7.071068485513988e-10; 0.0173324463553544; 0.0511376198481248; 0.0567647407547259; 0.0592733852980501; 0.1110148026021272; 0.1110148026021272; 0.1386032662139448; 0.175139305620004; 0.1787826075739565; 0.1871442361706843,,,,,Homo sapiens A549 lung carcinoma cell;Homo sapiens HEK293T embryonic kidney cell;Homo sapiens HEK293flp-in embryonic kidney cell;In vitro,0.27;0.44;0.53,Homo sapiens;SARS-CoV-2;cioin,Homo sapiens;chemical synthesis
HSPA1B,"Pneumonia; Lymphoma; Multiple Myeloma; Thyroid associated opthalmopathies; Arteriosclerosis; Pneumonitis; Non-Small Cell Lung Carcinoma; Crohn Disease; Autoimmune Diseases; Ovarian Carcinoma; Sarcoidosis; Arsenic Poisoning, Inorganic; Nervous System, Organic Arsenic Poisoning; Arsenic Encephalopathy; Arsenic Induced Polyneuropathy; Arsenic Poisoning; Ulcerative Colitis; Malignant neoplasm of ovary; Pancreatitis, Chronic; Multiple Sclerosis; Cerebral Ischemia; Neoplasm Metastasis; Mammary Neoplasms, Human; Atherosclerosis; Acute pancreatitis; Graves Disease; Cerebrovascular accident; Respiratory Distress Syndrome, Adult; Inflammatory Bowel Diseases; Obesity; Hyperglycemia; Mammary Neoplasms; Glioblastoma; Diabetes Mellitus; Diabetes; Lupus Erythematosus, Systemic; Ischemic stroke; Coronary Artery Disease; Dermatologic disorders; Alzheimer's Disease; Spondylarthropathies; Glioma; Cerebral Infarction; Anoxia; Malignant neoplasm of lung; Diabetes Mellitus, Insulin-Dependent; Severe Sepsis; Measles; Malignant neoplasm of breast; Bladder Neoplasm; Graft-vs-Host Disease; Diabetic Nephropathy; Liver carcinoma; Dementia, Vascular; Immunologic Deficiency Syndromes; Carcinogenesis; Nasopharyngeal carcinoma; Transient Ischemic Attack; Carcinoma of lung; Stomach Carcinoma; Ankylosing spondylitis; Colon Carcinoma; Leishmaniasis, Visceral; Fibrosarcoma; Malignant neoplasm of stomach; Immune System Diseases; Kidney Failure, Acute; Stomach Neoplasms; melanoma; Tauopathies; Primary malignant neoplasm of lung; Breast Carcinoma; Small cell carcinoma of lung; Agranulocytosis; Prostate carcinoma; Malignant tumor of colon; Atherogenesis; Malignant neoplasm of prostate; Malignant neoplasm of urinary bladder; Parkinson Disease; Sleep Apnea, Obstructive; Carcinoma of bladder; Tumor Immunity; Cardiomyopathy, Dilated; Benign Prostatic Hyperplasia; Duodenal Ulcer; Congestive heart failure; Urinary tract infection; pathologic fistula; Chronic Kidney Diseases; Unipolar Depression; Neurodegenerative Disorders; Renal Cell Carcinoma; Pancreatitis; VITILIGO-ASSOCIATED MULTIPLE AUTOIMMUNE DISEASE SUSCEPTIBILITY 1 (finding); Carcinoma, Transitional Cell; Colorectal Carcinoma; Diabetes Mellitus, Non-Insulin-Dependent; Mumps; Kidney Failure; Community acquired pneumonia; Respiratory Distress Syndrome, Newborn; Vitiligo; Central neuroblastoma; Major Depressive Disorder; Colorectal Cancer; Urothelial Carcinoma; Neuroblastoma; Primary malignant neoplasm; Osteopenia; Paranoid Schizophrenia; Malignant Neoplasms; Hepatitis, Chronic; Autoimmune thyroid disease; Recurrent urinary tract infection; Male infertility; Metabolic Diseases; Essential Hypertension; Childhood Acute Lymphoblastic Leukemia; Ki-1+ Anaplastic Large Cell Lymphoma; Major depression, single episode; High altitude pulmonary edema; Chronic heart failure; Renal Insufficiency; Schizophrenia; Carcinoma, Pancreatic Ductal; Diabetic Foot; Anxiety Disorders; Carotid Stenosis; Carotid artery occlusion; Zinc deficiency; Prediabetes syndrome; Transitional cell carcinoma of bladder; Very Low Birth Weight; Foot Ulcer; Hypopigmentation disorder; Muscular Dystrophy, Facioscapulohumeral; Pancreatitis, Alcoholic; Age-related cataract; Familial dilated cardiomyopathy; Cataract",7.980856456624717e-16; 4.5104266881389206e-12; 2.5279022064249716e-11; 2.377251819497684e-10; 2.377251819497684e-10; 2.813069300429449e-10; 3.762648680673853e-10; 4.2478505092738466e-10; 5.452288254986118e-10; 6.870627395110916e-10; 7.861255581007157e-10; 1.1722433847661196e-09; 1.1722433847661196e-09; 1.1722433847661196e-09; 1.1722433847661196e-09; 1.1722433847661196e-09; 1.6767489697325582e-09; 1.971893171900314e-09; 2.219129913614883e-09; 4.546836602575699e-09; 4.756590990483e-09; 5.670785186683756e-09; 5.791865115913735e-09; 7.195555613367576e-09; 7.713813941246406e-09; 8.269524813140207e-09; 2.0570601164639797e-08; 2.261634993097532e-08; 2.3137704832524547e-08; 2.412608431251415e-08; 4.0898524252942674e-08; 4.65353219894153e-08; 5.518991037343798e-08; 5.8317433871210796e-08; 6.156981490555128e-08; 6.156981490555128e-08; 6.156981490555128e-08; 8.598175402882612e-08; 9.273260676030806e-08; 9.273260676030806e-08; 1.427432458937347e-07; 1.427432458937347e-07; 2.419125491442217e-07; 2.911052249927245e-07; 6.299208964864026e-07; 6.851652105457608e-07; 7.873224494781308e-07; 7.99548070959303e-07; 8.660170029731726e-07; 9.822463166680949e-07; 1.0094667484349083e-06; 1.083280646968723e-06; 1.3079916134634371e-06; 1.4042419564664515e-06; 1.4839502431758565e-06; 1.51758575162775e-06; 1.5208470671427406e-06; 1.5208470671427406e-06; 2.027389637151193e-06; 2.07112526817849e-06; 2.1020461880694925e-06; 2.205236928124383e-06; 2.2411321306638023e-06; 2.3419309731960144e-06; 2.450940162208615e-06; 2.546221763226728e-06; 3.485726441474513e-06; 3.878607667297475e-06; 4.179146475474674e-06; 4.218275676836033e-06; 4.839188317483647e-06; 5.381279306135013e-06; 1.0755368362337037e-05; 1.4439241578579364e-05; 1.527992765491583e-05; 1.5498516107485843e-05; 2.223158928845764e-05; 3.053335644618538e-05; 3.1491435270594376e-05; 3.372277447426952e-05; 3.602405958537832e-05; 3.9650653676454574e-05; 3.971484221432504e-05; 5.826428641192471e-05; 5.945938584340405e-05; 8.007340895515112e-05; 8.232890503539995e-05; 9.023170634543253e-05; 9.476946799623076e-05; 9.913294924271568e-05; 0.00010334647523919963; 0.00010914466609698448; 0.0001119048288448298; 0.00012858049944279123; 0.0001431024725510208; 0.0001474322229096163; 0.00016189346720036038; 0.00016189346720036038; 0.0002214859278255797; 0.0002559467947532168; 0.00028056116385876946; 0.0002812860791024885; 0.0002933384035122236; 0.00032113080554701227; 0.0003278023880903879; 0.00038453776693371663; 0.0004243878730487336; 0.0004601228759628894; 0.00046565119871267287; 0.0005214896245221155; 0.0005873268650449521; 0.0006352060750206054; 0.0013309210571735; 0.0014485445504404; 0.0015133919764529; 0.0021001259552496; 0.0028187518310092; 0.0028759971272412; 0.0038705790239355; 0.0039908077871836; 0.0047351775110072; 0.0054814673835909; 0.0060818298848679; 0.007861073629675; 0.0093325514582534; 0.0125952576116424; 0.0125952576116424; 0.0173384291015271; 0.0187299613301643; 0.030006907592274; 0.0340266852061135; 0.0447905037504535; 0.0625091602151466; 0.0972679220674381; 0.1272255752567765; 0.1397055058487397; 0.2271585546986287; 0.2877158849893504; 0.3066971380488823; 0.4395651618287257; 0.5019882754152939,Arsenic Encephalopathy; Dermatologic Disorders; Marfan Syndrome; Mammary Neoplasms; Breast Carcinoma; Atherosclerosis; Breast Cancer; Chronic Obstructive Pulmonary Disease; Mental Depression; Pancreatic Ductal Carcinoma; Schizophrenia; Facioscapulohumeral Muscular Dystrophy,3.723977603538778e-09; 1.7417795410918816e-08; 8.921950872070284e-08; 1.1417484002988661e-07; 4.971054570440277e-05; 5.254109803591956e-05; 0.00063387456654884; 0.0173324463553544; 0.0511376198481248; 0.0592733852980501; 0.175139305620004; 0.1787826075739565,,,,,Homo sapiens NCM460 colon mucosal epithelial cell;Homo sapiens U2OS osteosarcoma cell,0.35;0.4,Faecalibacterium prausnitzii;Homo sapiens,Homo sapiens
HSPA6,Juvenile arthritis; Vascular Diseases; Prostate carcinoma; Juvenile psoriatic arthritis; Juvenile-Onset Still Disease; Malignant neoplasm of prostate,3.861499575207375e-12; 1.4920329017331753e-08; 1.527992765491583e-05; 1.8961926417889813e-05; 2.5791573703443737e-05; 3.053335644618538e-05,"Juvenile Arthritis; Polyarthritis, Rheumatoid Factor Positive; Seronegative Polyarthritis; Still Disease; Arthritis",1.1394948069325325e-05; 1.1394948069325325e-05; 3.928596547519457e-05; 5.1065830658055726e-05; 0.0015169561374293,Metaphyseal anadysplasia ORPHA:1040,0.0002132495254484572,,,Homo sapiens HEK293 embryonic kidney cell;In vitro,0.35,In vitro;chemical synthesis;rotp5,Homo sapiens
HSPH1,"Lymphoma; Colitis; HIV Infections; Mammary Neoplasms; Pancreatic carcinoma; Alzheimer's Disease; Malignant neoplasm of pancreas; Tumor Progression; Malignant neoplasm of breast; Liver carcinoma; Immunologic Deficiency Syndromes; Stomach Carcinoma; B-Cell Lymphomas; Malignant neoplasm of stomach; melanoma; Tauopathies; Breast Carcinoma; Colorectal Neoplasms; Adenocarcinoma; Lymphoma, Non-Hodgkin; Renal Cell Carcinoma; Colorectal Carcinoma; Amyloidosis; Colorectal Cancer; Bulbo-Spinal Atrophy, X-Linked; Hepatocarcinogenesis; HIV Coinfection; Malignant neoplasm of large intestine",4.5104266881389206e-12; 1.971893171900314e-09; 4.638299267461546e-08; 4.65353219894153e-08; 6.982287075725826e-08; 9.273260676030806e-08; 1.4925759778299788e-07; 8.297823048747685e-07; 8.660170029731726e-07; 1.3079916134634371e-06; 1.4839502431758565e-06; 2.07112526817849e-06; 2.1624936975752243e-06; 2.450940162208615e-06; 4.179146475474674e-06; 4.218275676836033e-06; 5.381279306135013e-06; 1.3034577772762696e-05; 1.5449280661407645e-05; 4.360044574654907e-05; 0.0001119048288448298; 0.00016189346720036038; 0.0003495642888428815; 0.00038453776693371663; 0.0037263522689301; 0.0040444907714877; 0.0729686376372628; 0.1128564106125758,Esophagus Neoplasm,0.175139305620004,,,,,Homo sapiens HEK293T embryonic kidney cell;In vitro,0.35;0.4;0.5,Homo sapiens;chemical synthesis,Homo sapiens
ICAM1,"Inflammation; Pneumonia; Reperfusion Injury; Asthma; Psoriasis; Familial M??ni??re disease; Juvenile arthritis; Lymphoma; Multiple Myeloma; Virus Diseases; Dermatitis, Atopic; Chronic Obstructive Airway Disease; Synovitis; Rheumatoid Arthritis; Thyroid associated opthalmopathies; Arteriosclerosis; Pneumonitis; Non-Small Cell Lung Carcinoma; Crohn Disease; Autoimmune Diseases; Peritonitis; Uveitis; Ovarian Carcinoma; Endometriosis; cervical cancer; Cirrhosis; MYELOPROLIFERATIVE DISORDER, CHRONIC, WITH EOSINOPHILIA; Ulcerative Colitis; Infection; Malignant neoplasm of ovary; Colitis; Pancreatitis, Chronic; Malignant tumor of cervix; Dermatitis; Multiple Sclerosis; Cerebral Ischemia; Neoplasm Metastasis; Inflammatory dermatosis; Hodgkin Disease; Hepatitis C; Atherosclerosis; Pulmonary Fibrosis; Acute pancreatitis; Graves Disease; Leukemia, Myelocytic, Acute; Glomerulonephritis; Hypertensive disease; Liver Cirrhosis; Respiratory syncytial virus (RSV) infection in conditions classified elsewhere and of unspecified site; Vascular Diseases; Eczema; Cervix carcinoma; Arthritis; Infection caused by Helicobacter pylori; Brain Ischemia; Cerebrovascular accident; Degenerative polyarthritis; Inflammatory Bowel Diseases; Obesity; Psoriasiform eczema; Auricular swelling; Kaposi Sarcoma; Periodontitis; Hyperglycemia; Liver neoplasms; HIV Infections; Mammary Neoplasms; Arthritis, Psoriatic; Aortic Aneurysm, Abdominal; Glioblastoma; leukemia; Diabetes Mellitus; Diabetes; Lupus Erythematosus, Systemic; Ischemic stroke; Pancreatic carcinoma; Coronary Artery Disease; Coronary heart disease; Alzheimer's Disease; Adenocarcinoma of pancreas; Behcet Syndrome; Sjogren's Syndrome; Dermatitis, Allergic Contact; Retinoic acid syndrome; Right Middle Cerebral Artery Infarction; Embolic Infarction, Middle Cerebral Artery; Thrombotic Infarction, Middle Cerebral Artery; Left Middle Cerebral Artery Infarction; Middle Cerebral Artery Embolus; Middle Cerebral Artery Syndrome; Middle Cerebral Artery Thrombosis; Malaria; Encephalitis; Glioma; Epithelial ovarian cancer; Malignant neoplasm of pancreas; Cerebral abscess; Acquired Immunodeficiency Syndrome; Respiratory Syncytial Virus Infections; Malignant neoplasm of mouth; Inflammatory disorder; Myocardial Infarction; Infarction, Middle Cerebral Artery; Cerebral Infarction; Adult T-Cell Lymphoma/Leukemia; Brain Abscess; Anoxia; Myocardial Ischemia; Bronchiolitis Obliterans; Brain Neoplasms; Sciatic Neuropathy; Cardiovascular Diseases; Septicemia; Sepsis; Cystic Fibrosis; Malignant neoplasm of lung; Tuberculosis; Leukemia, T-Cell; Middle Cerebral Artery Occlusion; Neonatal Early-Onset Sepsis; Diabetes Mellitus, Insulin-Dependent; Liver diseases; Hepatitis, Alcoholic; Chronic Lymphocytic Leukemia; Tumor Progression; Thromboangiitis Obliterans; Dryness of eye; Malignant neoplasm of breast; Premature Obstetric Labor; Cytomegalovirus Infections; Bladder Neoplasm; Coronary Arteriosclerosis; Graft-vs-Host Disease; Diabetic Nephropathy; Systemic Scleroderma; Anemia, Sickle Cell; Liver carcinoma; Colonic Neoplasms; Immunologic Deficiency Syndromes; Carcinogenesis; Nasopharyngeal carcinoma; Transient Ischemic Attack; Carcinoma of lung; Stomach Carcinoma; Polycystic Ovary Syndrome; B-Cell Lymphomas; Colon Carcinoma; Shock, Hemorrhagic; Disorder characterized by fever; Malignant neoplasm of stomach; Osteosarcoma of bone; Lip and Oral Cavity Carcinoma; Astrocytoma; Dry Eye Syndromes; Lupus Nephritis; Kidney Failure, Acute; Stomach Neoplasms; Tuberculosis, Pulmonary; Chronic liver disease; melanoma; Primary malignant neoplasm of lung; Bronchiolitis; Breast Carcinoma; Henoch-Schoenlein Purpura; Polymyositis; Osteosarcoma; Secondary malignant neoplasm of bone; Thyroid carcinoma; Malignant mesothelioma; Epstein-Barr Virus Infections; Guillain-Barre Syndrome; Obstructive nephropathy; Small cell carcinoma of lung; Encephalomyelitis; Acute Promyelocytic Leukemia; Acute lymphocytic leukemia; Complicated pneumoconiosis; MYELODYSPLASTIC SYNDROME; Retinal Diseases; Colorectal Neoplasms; Bronchial Hyperreactivity; Diabetic Retinopathy; Diabetes Mellitus, Experimental; Streptozotocin Diabetes; Alloxan Diabetes; Senile Plaques; Hepatitis B; Lupus Erythematosus; Presenile dementia; Rabies (disorder); Prostate carcinoma; Adenocarcinoma; Malignant tumor of colon; Polymorphous light eruption; Acute Coronary Syndrome; ovarian neoplasm; Nephritis; Myeloid Leukemia; Allergic rhinitis (disorder); Kidney Failure, Chronic; Prostatic Neoplasms; Herpes Simplex Infections; Atherogenesis; Acute GVH disease; Fibrosis; Chronic kidney disease stage 5; Squamous cell carcinoma; Malignant neoplasm of prostate; Meningitis; Pancreatic Neoplasm; Parkinson Disease; Autoimmune thyroiditis; Mouth Neoplasms; precancerous lesions; Experimental Organism Basal Cell Carcinoma; Tumor Immunity; Endometrioma; Vasculitis; Lymphoma, Non-Hodgkin; Thyroid Diseases; Hashimoto Disease; IGA Glomerulonephritis; Rhinitis; Myositis; Hematologic Neoplasms; Enterovirus Infections; Research-Related Injuries; Traumatic injury; Wounds and Injuries; Injury wounds; Diabetic Angiopathies; Biliary Atresia; Acute myocardial infarction; Primary Sj??gren's syndrome; Malignant Glioma; Other ureteric obstruction; Malignant neoplasm of liver; Celiac Disease; Familial lichen amyloidosis; Osteoporosis; Adult-Onset Still Disease; Other specified transient cerebral ischemias; Bronchiectasis; Chronic Kidney Diseases; Malignant Pleural Mesothelioma; Age related macular degeneration; Mesothelioma; Dermatomyositis; Neurodegenerative Disorders; Renal Cell Carcinoma; Toxoplasmosis; Multiple Sclerosis, Relapsing-Remitting; Peripheral Vascular Diseases; Pancreatitis; Solid Neoplasm; Adenocarcinoma of lung (disorder); VITILIGO-ASSOCIATED MULTIPLE AUTOIMMUNE DISEASE SUSCEPTIBILITY 1 (finding); Classical Hodgkin's Lymphoma; Acute Lung Injury; Nasal Polyps; Retinoblastoma; Colorectal Carcinoma; Diabetes Mellitus, Non-Insulin-Dependent; Metabolic Syndrome X; Asthma attack; Demyelinating Diseases; Malaria, Cerebral; Dermatitis Herpetiformis; Adult type dermatomyositis; Metastatic melanoma; Myeloid Leukemia, Chronic; Esophageal Neoplasms; Leg Ulcer; Mumps; Scleroderma; Anemia; Kidney Diseases; Splenic Hypoplasia; Intrauterine infection; Acute Cerebrovascular Accidents; Chondrosarcoma; Carotid Artery Diseases; airway disease; Vitiligo; Dementia; Severe Dengue; Central neuroblastoma; Secondary malignant neoplasm of lymph node; Alopecia Areata; Amyloidosis; Colorectal Cancer; Hepatitis; Secondary malignant neoplasm of lung; Chronic Periodontitis; Neuroblastoma; Infective endocarditis; Pre-Eclampsia; Congenital arteriovenous malformation; Primary biliary cirrhosis; Parasitemia; Viral meningitis; Post-Traumatic Stress Disorder; Diabetes, Autoimmune; Bacterial Endocarditis; Infant, Premature; Arteriovenous hemangioma; Leptospirosis; Giant Cell Arteritis; Malignant neoplasm of thyroid; Secondary malignant neoplasm of liver; SPONDYLOCARPOTARSAL SYNOSTOSIS SYNDROME; Erythema Multiforme; Nasal allergies; CNS disorder; Adenocarcinoma Of Esophagus; Leprosy, Lepromatous; Multiple Sclerosis, Acute Fulminating; Cryptosporidiosis; Interstitial lung fibrosis; Hypercholesterolemia; Epilepsy, Temporal Lobe; Iron Overload; Malaria, Falciparum; Pleurisy; Polymyalgia Rheumatica; Adenovirus Infections; NONAKA MYOPATHY; Peritoneal adhesion; Endothelial dysfunction; Cardiomyopathies; Cardiac Arrest; Renal fibrosis; Osteoporosis, Postmenopausal; Papillary thyroid carcinoma; Trisomy; Hyperlipoproteinemia Type IIa; Renal carcinoma; Hypercholesterolemia, Familial; Lymphoproliferative Disorders; Malignant neoplasm of esophagus; Bullous pemphigoid; Atrial Premature Complexes; Brain Edema; Acute peritonitis; Childhood Acute Lymphoblastic Leukemia; Liver and Intrahepatic Biliary Tract Carcinoma; Retinopathy of Prematurity; Ki-1+ Anaplastic Large Cell Lymphoma; Plasmacytoma; Follicular thyroid carcinoma; Cholera; Glomerulosclerosis (disorder); Urticaria; Uveal melanoma; Hyperhomocysteinemia; Overweight; Ovarian adenocarcinoma; Hemorrhagic cystitis; Marginal Zone B-Cell Lymphoma; Proliferative diabetic retinopathy; Childhood asthma; Varicosity; Leukostasis; Polyglandular Type I Autoimmune Syndrome; Esophageal carcinoma; Arterial Occlusive Diseases; Schizophrenia; Cholangitis, Sclerosing; Herpes NOS; Thymoma; Hyaline Membrane Disease; Thyroiditis; Blast Phase; Atrial Fibrillation; Vasculitis of the skin; Rhinovirus infection; Malnutrition; Polyarthritis; Fowlpox; Nephrosis; Common Cold; Malignant neoplasm of skin; Adenomatous Polyposis Coli; Hereditary hemochromatosis; Schistosomiasis mansoni; Parainfluenza; Cholestasis; Barrett Esophagus; Burkitt Lymphoma; Mucosa-Associated Lymphoid Tissue Lymphoma; Eosinophilic leukemia; FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder); Erythema; Autoimmune liver disease; Multiple System Atrophy; Malignant neoplasm of kidney; Low grade glioma; Rheumatic Fever; FRIEDREICH ATAXIA 1; Neurocysticercosis; Uremia; Tuberous Sclerosis; Anaplasia; Hereditary gingival fibromatosis; Pregnancy in Diabetics; Fanconi Anemia; Childhood Burkitt Lymphoma; Lymphatic Metastasis; Alopecia; Cutaneous Melanoma; Neoplasm, Residual; Peripheral Neuropathy; Primary Effusion Lymphoma; Icterus; Metastasis from malignant tumor of prostate; Hypertriglyceridemia; Hepatoblastoma; Impaired glucose tolerance; Werner Syndrome; Anaphylaxis (non medication); Mixed anxiety and depressive disorder; Proteinuria; Leukemia, Plasma Cell; Niemann-Pick Disease, Type B; Bronchopulmonary Sequestration; Corneal Neovascularization; Fabry Disease; Medullary carcinoma; Noninfiltrating Intraductal Carcinoma; Sentinel node (disorder); Central nervous system leukaemia; Dyggve-Melchior-Clausen syndrome; Primary sclerosing cholangitis; Disorder of eye; Cavernous Hemangioma of Brain; Malignant neoplasm of large intestine; Disorder of vein; Diaphragmatic Hernia; Benign neoplasm of liver; Kallmann Syndrome 1; Diffuse Astrocytoma; Hypertrophic Cardiomyopathy; Metastatic Renal Cell Cancer; Medullary carcinoma of thyroid; Metastatic Prostate Carcinoma; Cardiomyopathy, Hypertrophic, Familial; Bone neoplasms; Biliary cirrhosis; Urinary tract obstruction; Poliomyelitis; Rapidly progressive glomerulonephritis; Acute malaria; Myocardial Reperfusion Injury; Aneurysm, Dissecting; Pregnancy associated hypertension; Malignant neoplasm of testis; Chronic venous insufficiency; CATARACT, MARNER TYPE; Cluster Headache; Capillary malformation (disorder); Precursor T-cell lymphoblastic lymphoma; Trichothiodystrophy Syndromes; Corneal Diseases; Nevus elasticus; Lymphocyte Count measurement; Parkinson Disease, Familial, Type 1; Ichthyosis linearis circumflexa; Pseudoxanthoma Elasticum; Prolymphocytic Leukemia; Coronary Stenosis; Low density lipoprotein cholesterol measurement; Xeroderma Pigmentosum, Complementation Group D; Cortical Dysplasia; Cockayne Syndrome; Myxoid cyst; Congenital contractural arachnodactyly; Tremor; Anemia, Hemolytic; Serum total cholesterol measurement; High density lipoprotein measurement",2.8114433253573326e-17; 7.980856456624717e-16; 4.4398736172867135e-14; 1.803641225501291e-12; 3.118210553589307e-12; 3.861499575207375e-12; 3.861499575207375e-12; 4.5104266881389206e-12; 2.5279022064249716e-11; 6.332483647919588e-11; 7.448716379948652e-11; 1.3121548808139071e-10; 1.6797550790254382e-10; 1.9241179247341838e-10; 2.377251819497684e-10; 2.377251819497684e-10; 2.813069300429449e-10; 3.762648680673853e-10; 4.2478505092738466e-10; 5.452288254986118e-10; 5.452288254986118e-10; 6.429879513246633e-10; 6.870627395110916e-10; 7.868397426275417e-10; 1.1722433847661196e-09; 1.4790998733426532e-09; 1.5734876414130875e-09; 1.6767489697325582e-09; 1.794870341379274e-09; 1.971893171900314e-09; 1.971893171900314e-09; 2.219129913614883e-09; 3.683115069310663e-09; 3.683115069310663e-09; 4.546836602575699e-09; 4.756590990483e-09; 5.670785186683756e-09; 6.0322241000340585e-09; 6.195332209150018e-09; 6.991207850982321e-09; 7.195555613367576e-09; 7.547641288501485e-09; 7.713813941246406e-09; 8.269524813140207e-09; 8.303910954283738e-09; 1.0368326871660785e-08; 1.0368326871660785e-08; 1.3128768066526236e-08; 1.452540845894924e-08; 1.4920329017331753e-08; 1.4920329017331753e-08; 1.5572986293211266e-08; 1.587872453479067e-08; 1.7931366647560766e-08; 1.8815395768840057e-08; 2.0570601164639797e-08; 2.1034803123367165e-08; 2.3137704832524547e-08; 2.412608431251415e-08; 2.7368000175117756e-08; 2.9730190499609582e-08; 3.149054123564124e-08; 3.9573009168853264e-08; 4.0898524252942674e-08; 4.3069383556698336e-08; 4.638299267461546e-08; 4.65353219894153e-08; 5.071217747675114e-08; 5.1290058242058653e-08; 5.518991037343798e-08; 5.784935444423772e-08; 5.8317433871210796e-08; 6.156981490555128e-08; 6.156981490555128e-08; 6.156981490555128e-08; 6.982287075725826e-08; 8.598175402882612e-08; 9.273260676030806e-08; 9.273260676030806e-08; 9.306686765839445e-08; 9.393284022832733e-08; 1.0276547515522002e-07; 1.0390067657961098e-07; 1.0390067657961098e-07; 1.0390067657961098e-07; 1.0390067657961098e-07; 1.0390067657961098e-07; 1.0390067657961098e-07; 1.0390067657961098e-07; 1.0390067657961098e-07; 1.0390067657961098e-07; 1.0618136021459505e-07; 1.3150328464481586e-07; 1.427432458937347e-07; 1.479813245926713e-07; 1.4925759778299788e-07; 1.7232014763277498e-07; 1.825346178149227e-07; 1.946794431045147e-07; 2.0279723135488897e-07; 2.242497138958313e-07; 2.247163660896597e-07; 2.400988116471548e-07; 2.419125491442217e-07; 2.46778041958494e-07; 2.700227164716584e-07; 2.911052249927245e-07; 2.948344121290337e-07; 3.10587283755252e-07; 4.157277636684319e-07; 4.312772724439924e-07; 4.5433391667148853e-07; 5.254943571583271e-07; 5.313225371508493e-07; 5.577321626966352e-07; 6.299208964864026e-07; 6.673805318525932e-07; 6.805796735296268e-07; 6.805796735296268e-07; 6.805796735296268e-07; 6.851652105457608e-07; 7.17979149467092e-07; 7.789160940651547e-07; 7.931659047151387e-07; 8.297823048747685e-07; 8.339674388418603e-07; 8.339674388418603e-07; 8.660170029731726e-07; 8.777200373497231e-07; 8.887379906686178e-07; 9.822463166680949e-07; 1.0094398444517938e-06; 1.0094667484349083e-06; 1.083280646968723e-06; 1.10068355868735e-06; 1.2482007026109775e-06; 1.3079916134634371e-06; 1.4185164995612263e-06; 1.4839502431758565e-06; 1.51758575162775e-06; 1.5208470671427406e-06; 1.5208470671427406e-06; 2.027389637151193e-06; 2.07112526817849e-06; 2.086123696221558e-06; 2.1624936975752243e-06; 2.205236928124383e-06; 2.3756085216561533e-06; 2.3756085216561533e-06; 2.450940162208615e-06; 2.560217628497434e-06; 2.576211756838249e-06; 2.608032323197001e-06; 2.7684459182091574e-06; 3.4620043828295477e-06; 3.485726441474513e-06; 3.878607667297475e-06; 3.990817553511259e-06; 3.990817553511259e-06; 4.179146475474674e-06; 4.839188317483647e-06; 5.021572339409501e-06; 5.381279306135013e-06; 5.457492980911677e-06; 6.169876404399104e-06; 6.3131986281381465e-06; 6.378950690990071e-06; 6.889889014378816e-06; 7.439853898002338e-06; 8.77532817235926e-06; 9.18171819472328e-06; 9.263589414966798e-06; 1.0755368362337037e-05; 1.08089380369295e-05; 1.2304362232150695e-05; 1.2375081616087569e-05; 1.2765469826010355e-05; 1.279493639647176e-05; 1.3010173302726732e-05; 1.3034577772762696e-05; 1.3268923055385737e-05; 1.3410647656206684e-05; 1.3410647656206684e-05; 1.3410647656206684e-05; 1.3410647656206684e-05; 1.3673911177979942e-05; 1.3755659311680946e-05; 1.4805035395703202e-05; 1.5064798896399038e-05; 1.513340899972731e-05; 1.527992765491583e-05; 1.5449280661407645e-05; 1.5498516107485843e-05; 1.651577640810321e-05; 1.7090079578013972e-05; 1.8507296589967813e-05; 1.9896942827707536e-05; 2.042524345007846e-05; 2.0736107376307555e-05; 2.0820699372778346e-05; 2.0820699372778346e-05; 2.1109857936882128e-05; 2.223158928845764e-05; 2.365778380659297e-05; 2.7001454785434173e-05; 2.910435331986992e-05; 3.053335644618538e-05; 3.053335644618538e-05; 3.14076229962439e-05; 3.192298841377222e-05; 3.372277447426952e-05; 3.489427253341073e-05; 3.602405958537832e-05; 3.602405958537832e-05; 3.9650653676454574e-05; 3.971484221432504e-05; 4.079834649355082e-05; 4.351780357113137e-05; 4.360044574654907e-05; 5.248375780672949e-05; 5.248375780672949e-05; 5.2700686057264086e-05; 5.399364944210138e-05; 5.9174130460768686e-05; 6.058590126387572e-05; 6.709590381814368e-05; 6.734766728729227e-05; 6.734766728729227e-05; 6.734766728729227e-05; 6.734766728729227e-05; 6.882388524696196e-05; 6.964870190365813e-05; 7.036498484894257e-05; 8.232890503539995e-05; 8.25206825409808e-05; 8.257883791168467e-05; 8.421319594446617e-05; 8.730297037328594e-05; 8.937909010875455e-05; 9.117996105379778e-05; 9.476946799623076e-05; 9.56957692518114e-05; 9.846223464501226e-05; 9.913294924271568e-05; 0.0001007621786326551; 0.00010334647523919963; 0.00010582598320524978; 0.00010776056908698134; 0.00010914466609698448; 0.0001119048288448298; 0.00011927896769899647; 0.00012202062264879416; 0.00012202062264879416; 0.00012858049944279123; 0.0001322335978675375; 0.00013846515856925812; 0.0001431024725510208; 0.0001431024725510208; 0.00014885785925249347; 0.00015093372108149775; 0.00015093372108149775; 0.00016189346720036038; 0.00016189346720036038; 0.00017808425336754297; 0.0001802305430549181; 0.000181883468787863; 0.0001932529498581875; 0.0001934869050618567; 0.0002043416381292249; 0.00021049732822064587; 0.00021049732822064587; 0.00021804014782198476; 0.0002214859278255797; 0.0002214859278255797; 0.00022254302103317592; 0.00022254302103317592; 0.00022336414159326664; 0.00024044665139790348; 0.00024044665139790348; 0.00025117420022058794; 0.0002792365191965819; 0.0002812860791024885; 0.0002926994143155384; 0.0002933384035122236; 0.0002983150880926112; 0.0003022150453166086; 0.00032113080554701227; 0.000323910443746482; 0.0003242363739584783; 0.0003495642888428815; 0.00038453776693371663; 0.00040624424086014313; 0.00042196010900515655; 0.0004303328941191692; 0.0004601228759628894; 0.0004814724943641282; 0.0004934717082734151; 0.0005125353857651181; 0.0005214896245221155; 0.0005445028206157281; 0.0006046022723190866; 0.0006163914271817124; 0.0006445212280958682; 0.0006445212280958682; 0.0007074539367893701; 0.0007074539367893701; 0.0007283216745489607; 0.0008932565002868814; 0.0009826472144539087; 0.0010244557923259; 0.0010244557923259; 0.0010244557923259; 0.0010244557923259; 0.0010897868460616; 0.0011303542860313; 0.0011626911115394; 0.0011626911115394; 0.0011876897533161; 0.00120990141675; 0.0012591553085125; 0.0012591553085125; 0.0016559602535146; 0.0017329922477138; 0.0017731038420892; 0.0017731038420892; 0.0017856981020231; 0.001881335207053; 0.0020049274325175; 0.0020505587731585; 0.0021326108499664; 0.002135695462532; 0.0021970545999258; 0.0024261178373806; 0.0025122887786423; 0.0026287893312444; 0.0028187518310092; 0.0028626589910413; 0.0029013169576144; 0.0030077293488194; 0.0030940063712108; 0.0031934755667; 0.0033785221929293; 0.0037263522689301; 0.003846910040485; 0.0038705790239355; 0.0038816440940594; 0.0038895739770004; 0.0039908077871836; 0.0039908077871836; 0.0040785542386402; 0.0041157458728674; 0.0041157458728674; 0.0044046842540656; 0.0047339976311261; 0.0048044887750201; 0.0048496385019795; 0.0050894481995015; 0.0059257679306595; 0.0060818298848679; 0.0063571439329446; 0.0065999085088281; 0.0066401895279317; 0.007117388576245; 0.0087278589568942; 0.0089906473426575; 0.0093060572422998; 0.0093325514582534; 0.0093598514945993; 0.0096630827054915; 0.0096630827054915; 0.0096630827054915; 0.0109519728029571; 0.0114187031414039; 0.0118123250371176; 0.0123983633418964; 0.0125952576116424; 0.0138441633831498; 0.0138441633831498; 0.0138441633831498; 0.0145436543557976; 0.015507621739214; 0.0156113267570298; 0.0166041002652209; 0.0171001534176385; 0.0171001534176385; 0.0171001534176385; 0.0174410368983484; 0.0193777520415227; 0.0196345173194062; 0.0203198961621158; 0.0203198961621158; 0.0204735864411232; 0.0209435845696216; 0.0220705590988414; 0.0220705590988414; 0.0230684256648711; 0.0238425854040518; 0.0246533435977568; 0.0265829029717646; 0.0279220892715439; 0.0284314613047093; 0.0299774405999183; 0.033749008368017; 0.0357364979606411; 0.0363737825516021; 0.0371129390384053; 0.0384689641633299; 0.040382673882237; 0.0404707605808569; 0.0425171404778382; 0.0427786786335321; 0.0465235764214223; 0.0491632343384016; 0.0496760944377964; 0.0503601986761658; 0.0524543292954025; 0.0524566642172417; 0.0565343207837806; 0.0630979595913369; 0.0723815120866587; 0.0777073264956258; 0.0804567619234804; 0.0805158056052076; 0.0817897187940979; 0.0817897187940979; 0.0858871491124922; 0.0858871491124922; 0.0887863766478173; 0.0908772402064694; 0.1046638861423046; 0.1050724946352408; 0.1050724946352408; 0.1051100679067119; 0.1070008331073374; 0.1110779437709126; 0.1128564106125758; 0.1130019719865939; 0.1204795752338222; 0.1206032442301429; 0.1206032442301429; 0.124149904653194; 0.1242757058018646; 0.1270483391700474; 0.131813871137714; 0.1343310874911156; 0.1397055058487397; 0.1397055058487397; 0.1401454825042905; 0.1401454825042905; 0.1460848784791741; 0.1460848784791741; 0.1584804022044084; 0.1658352215789179; 0.1703929618871976; 0.176056923749369; 0.181710614199711; 0.181710614199711; 0.1881045022168423; 0.1881045022168423; 0.1932166112700285; 0.1982833830495248; 0.2108300774722888; 0.2166737845423457; 0.2166737845423457; 0.23058850720196; 0.2520982519141255; 0.2520982519141255; 0.2670582190879765; 0.2877158849893504; 0.340330994065175; 0.3454778744069252; 0.3494335993143313; 0.3929133356162864; 0.4250139906398144; 0.4505816299373699; 0.4574492858750069; 0.4866653182016537; 0.575942141864452; 0.6408845518751061; 0.9006479336232927,Myocardial Ischemia; Cerebral Ischemia; Cerebral Infraction; Cerebral Thrombosis; Atherosclerosis; Ulcerative Colitis; Myocardial Infarction; Bronchial Hyperreactivity; Hypertension; Mouth Neoplasms; Pleuritis; Cholestasis; Inflammatory Bowel Disease; Urticaria; Prostatic Neoplasms; Stroke; Asthma; Diabetic Retinopathy; Multiple Sclerosis; Behcet Syndrome; Colonic Neoplasms; Bronchiectasis; Prostate Cancer; Nervous System Diseases; Diabetes Mellitus; Schizophrenia; Nephrosis; Uremia; Hypercholesterolemia; Obesity; Retinal Diseases; Cardiovascular Diseases,7.071068485513988e-10; 5.562961744202623e-09; 2.009208013074685e-07; 2.739939098363423e-07; 5.254109803591956e-05; 0.0002754573766813309; 0.0005760978170082974; 0.0010004280397286; 0.0048927857621509; 0.0069464092886356; 0.010864842397815; 0.0152037568688841; 0.021392225047824; 0.0418006551930827; 0.0567647407547259; 0.0588219013114419; 0.064825092293108; 0.064825092293108; 0.0682669288241704; 0.1054719783837416; 0.1203844668559877; 0.1203844668559877; 0.1386032662139448; 0.1700432900208007; 0.1718736907108893; 0.175139305620004; 0.191014576985413; 0.2039740835961235; 0.2302982759923013; 0.2736284003666279; 0.3317467420738357; 0.3636022406609426,"Charcot-Marie-Tooth disease type 1D ORPHA:101084; Charcot-Marie-Tooth disease type 4E ORPHA:99951; Nasopharyngeal carcinoma ORPHA:150; Systemic-onset juvenile idiopathic arthritis ORPHA:85414; Hereditary pediatric Behcet-like disease ORPHA:476102; Autosomal dominant hyper-IgE syndrome ORPHA:2314; Chronic lymphoproliferative disorder of natural killer cells ORPHA:512017; STAT3-related early-onset multisystem autoimmune disease ORPHA:438159; T-cell large granular lymphocyte leukemia ORPHA:86872; Niemann-Pick disease type C, adult neurologic onset ORPHA:216986; Niemann-Pick disease type C, juvenile neurologic onset ORPHA:216981; Niemann-Pick disease type C, late infantile neurologic onset ORPHA:216978; Niemann-Pick disease type C, severe early infantile neurologic onset ORPHA:216975; Niemann-Pick disease type C, severe perinatal form ORPHA:216972; Pediatric systemic lupus erythematosus ORPHA:93552; Herpes simplex virus encephalitis ORPHA:1930; Immune dysregulation-inflammatory bowel disease-arthritis-recurrent infections-lymphopenia syndrome ORPHA:529977; Deficiency in anterior pituitary function-variable immunodeficiency syndrome ORPHA:293978; Heme oxygenase-1 deficiency ORPHA:562509; Papillon-Lefevre ORPHA:678; GM2 gangliosidosis, AB variant ORPHA:309246; Haim-Munk syndrome ORPHA:2342; Solitary fibrous tumor/hemangiopericytoma ORPHA:2126",3.598261936626476e-12; 3.598261936626476e-12; 6.10801728836975e-11; 1.514756890441811e-09; 1.7877420438201673e-08; 2.859667220539484e-06; 2.859667220539484e-06; 2.859667220539484e-06; 2.859667220539484e-06; 0.0002132495254484572; 0.0002132495254484572; 0.0002132495254484572; 0.0002132495254484572; 0.0002132495254484572; 0.00021965881189185; 0.00024116799717032887; 0.0133474287859103; 0.0514345493431829; 0.0514345493431829; 0.1927589191138116; 0.1927589191138116; 0.1927589191138116; 0.1927589191138116,"Vaccinia virus Ankara Haemagglutinin; Vaccinia virus hemagglutinin (gene: A56R); Horsepox virus HSPV177 (Immunoglobulin like); Echovirus E7 VP2; Coxsackievirus B5 VP2 capsid protein, polyprotein region 3 (gene: 1A); Echovirus E11 1B(VP2); Enterovirus B 1B(VP2); Human rhinovirus B5 1B; Monkeypox virus Zaire-96-I-16 B2R (gene: B2R); Echovirus E19 VP2; Echovirus E15 VP2; Enterovirus H capsid protein VP2; Human enterovirus 79 1B (VP2); Echovirus E29 VP2; Echovirus E20 VP2; Echovirus E16 VP2; Echovirus E26 VP2; Echovirus E33 VP2; Echovirus E4 VP2; Echovirus 9 strain Barty VP2; Echovirus E14 VP2; Echovirus E21 VP2; Echovirus E24 VP2; Echovirus E27 VP2; Enterovirus B111 VP2; Echovirus E25 VP2; Echovirus E6 VP2; Enterovirus B97 VP2; Human cosavirus B VP2; Echovirus E13 VP2; Echovirus E3 VP2; Echovirus E31 VP2; Echovirus 9 strain Hill polyprotein region 2; Echovirus E2 VP2; Echovirus E32 VP2; Human cosavirus full_polyprotein 1..2121; Human cosavirus D VP2; Variola virus hypothetical protein (gene: J9R); Human adenovirus 18 CR1-beta protein (gene: E3); Human poliovirus 3 VP2; Human rhinovirus B27 1B; Coxsackievirus A22 vp2; Coxsackievirus A11 vp2; Coxsackievirus A17 VP2; Coxsackievirus A18 VP2 protein; Coxsackievirus A1 VP2; Human enterovirus C117 VP2; Human enterovirus C118 VP2; Enterovirus C109 VP2; Human enterovirus C102 vp2; Human enterovirus C104 VP2; Echovirus E18 full_polyprotein 1..2189; Coxsackievirus A13 vp2; Enterovirus A VP3 (1C); Echovirus E12 polyprotein; Coxsackievirus B4 full_polyprotein 1..2183; Echovirus E30 full_polyprotein 1..2194; Coxsackievirus B6 full_polyprotein 1..2184; Rhinovirus A81 2A; Rhinovirus B14 protease 3C; Coxsackievirus B2 full_polyprotein 1..2187; Enterovirus B genome polyportein; Enterovirus B73 full_polyprotein 1..2188; Enterovirus B106 full_polyprotein 1..2192; Enterovirus C protease 3C; Rhinovirus A81 3C; Echovirus E5 full_polyprotein 1..2196; Echovirus E9 full_polyprotein 1..2203; Human enterovirus 71 HZ08/Hangzhou/2008 full_polyprotein 1..2193; Cosavirus JMY-2014 full_polyprotein 1..2119; Salivirus NG-J1 VP3; Human enterovirus C102 vp4; Coxsackievirus A11 vp4; Mengo virus 1C; Coxsackievirus A14 full_polyprotein 1..2192; Coxsackievirus A10 full_polyprotein 1..2193; Enterovirus A120 full_polyprotein 1..2191; Rhinovirus B14 2A (P2-A); Ectromelia virus ERPV hemagglutinin; Coxsackievirus A4 full_polyprotein 1..2201; Enterovirus A76 full_polyprotein 1..2198; Encephalomyocarditis virus protein 1C; Enterovirus D capsid protein 1C version 1; Coxsackievirus A5 full_polyprotein 1..2191; Enterovirus C99 full_polyprotein 1..2210; Human rhinovirus QCE VP3; Coxsackievirus A6 VP3 protein; Human TMEV-like cardiovirus capsid protein VP3; Coxsackievirus A2 full_polyprotein 1..2190; Cowpox virus CPXV194 protein (gene: CPXV194 CDS); Human rhinovirus QCE VP1; Rhinovirus A81 1D; Rhinovirus C capsid protein VP2; Monkeypox virus bifunctional hemagglutinin/type-I membrane glycoprotein; Coxsackievirus A8 VP3 protein; Rhinovirus C capsid protein VP1; Saffold virus capsid protein VP3; Human enterovirus Ningbo3-02 full_polyprotein 1..2214; Cosavirus A VP1; Human cosavirus E VP3; Enterovirus C capsid protein VP2; Enterovirus C capsid protein VP1; Enterovirus D capsid protein 1D; Human rhinovirus A49 1B; Human rhinovirus A80 1D; Human enterovirus Hangzhou13-02 full_polyprotein 1..2214; Cosavirus A VP3; Human rhinovirus A46 1D (VP1); Human rhinovirus A53 1B (VP2); Human rhinovirus A1 1C; Human rhinovirus A30 1C; Human rhinovirus A43 1B; Rhinovirus A81 2C; Human rhinovirus A82 1B; Aichi virus 1 VP3; Cosavirus A VP2; Human cosavirus E VP2; Human rhinovirus A30 1D; Human rhinovirus A44 1B (VP2); Human rhinovirus A50 1B; Human rhinovirus A57 1B; Human rhinovirus A62 1B; Human rhinovirus B17 full_polyprotein 1..2186; Human enterovirus 94 VP3; Enterovirus C protein 3CD; Enterovirus C RNA-directed RNA polymerase; Human poliovirus 1 Mahoney excised_polyprotein 1566..2209; Human rhinovirus A100 1B; Human rhinovirus A23 1C (VP3); Human rhinovirus A58 1B; Rhinovirus B14 1B (VP2); Rhinovirus C capsid protein VP3; Human rhinovirus A80 1B; Human rhinovirus A90 1B; Human cosavirus B VP3; Human cosavirus B VP1; Human enterovirus 94 VP1; Coxsackievirus A12 VP3 protein; Human rhinovirus A23 1B (VP2); Human rhinovirus A23 1D (VP1); Human rhinovirus A24 1B; Human rhinovirus A47 1D; Human rhinovirus A60 1B; Human rhinovirus A76 1B; Human rhinovirus A94 1B; Coxsackievirus A20 full_polyprotein 1..2208; Human poliovirus 3 polyprotein; Coxsackievirus A11 vp1; Human poliovirus 1 Mahoney excised_polyprotein 1..341; Human poliovirus 3 VP1; Human rhinovirus A22 1B; Human rhinovirus A36 1C (VP3); Human rhinovirus A36 1D (VP1); Human rhinovirus A49 1D; Human rhinovirus A58 1C; Rhinovirus A capsid protein VP3; Human rhinovirus A64 1B; Human rhinovirus A71 1D; Human rhinovirus A75 1D (VP1); Human rhinovirus A77 1B; Human rhinovirus A82 1C; Human rhinovirus A89 1C; Human rhinovirus A15 1D (VP1); Human rhinovirus A28 1D (VP1); Human rhinovirus A30 1B; Human rhinovirus A31 1B; Human rhinovirus A33 1B; Human rhinovirus A38 1B; Human rhinovirus A51 1B; Human rhinovirus A56 1C; Human rhinovirus A7 1D; Human rhinovirus A71 1C; Human rhinovirus A74 1D (VP1); Human rhinovirus B3 1D (VP1); Human rhinovirus B35 1B; Human poliovirus 1 enterovirus precursor polypeptide; Human rhinovirus A1 1D; Human rhinovirus A10 1C; Human rhinovirus A13 1C; Human rhinovirus A21 1C; Human rhinovirus A29 1C; Human rhinovirus A31 1C; Human rhinovirus A40 1D; Human rhinovirus A40 1B; Human rhinovirus A40 1C; Human rhinovirus A41 1C (VP3); Human rhinovirus A43 1D; Human rhinovirus A44 1C (VP3); Human rhinovirus A46 1C (VP3); Human rhinovirus A47 1C; Human rhinovirus A50 1C; Human rhinovirus A51 1C; Human rhinovirus A53 1C (VP3); Human rhinovirus A59 1C (VP3); Human rhinovirus A61 1C; Rhinovirus A capsid protein VP1; Human rhinovirus A65 1C; Human rhinovirus A66 1D; Human rhinovirus A66 1C; Rhinovirus B14 3D; Human rhinovirus A68 1C; Human rhinovirus A7 1C; Human rhinovirus A77 1D; Human rhinovirus A85 1C; Human rhinovirus A96 1D; Human rhinovirus B84 1B; Human rhinovirus A100 1C; Human rhinovirus A13 1D; Human rhinovirus A18 1D; Human rhinovirus A19 1C; Human rhinovirus A20 1C; Human rhinovirus A20 1D; Human rhinovirus A21 1D; Human rhinovirus A25 1D; Human rhinovirus A29 1D; Human rhinovirus A34 1C; Human rhinovirus A38 1C; Human rhinovirus A43 1C; Human rhinovirus A45 1C; Human rhinovirus A45 1D; Human rhinovirus A51 1D; Human rhinovirus A53 1D (VP1); Human rhinovirus A54 1C; Human rhinovirus A60 1C; Human rhinovirus A60 1D; Human rhinovirus A63 1C; Human rhinovirus A64 1D; Rhinovirus A81 1C; Human rhinovirus A65 1D; Rhinovirus A98 1C; Rhinovirus B VP2; Rhinovirus B69 1B; Human rhinovirus A73 1C (VP3); Human rhinovirus A77 1C; Human rhinovirus A89 1D; Human rhinovirus A9 1C; Human rhinovirus A96 1C; Human rhinovirus B52 1B; Human rhinovirus B72 1B; Human rhinovirus B91 1B; Human rhinovirus B92 1B; Human rhinovirus B99 1D; Human cosavirus D VP3; Human rhinovirus A15 1B (VP2); Human rhinovirus A15 1C (VP3); Human rhinovirus A25 1C; Human rhinovirus A31 1D; Human rhinovirus A32 1D; Human rhinovirus A32 1C; Human rhinovirus A38 1D; Human rhinovirus A56 1D; Human rhinovirus A57 1D; Human rhinovirus A57 1C; Human rhinovirus A58 1D; Human rhinovirus A62 1C; Human rhinovirus A67 1D; Human rhinovirus A67 1C; Rhinovirus B14 2C (P2-C); Human rhinovirus A7 1B; Human rhinovirus A73 1D (VP1); Human rhinovirus A74 1C (VP3); Human rhinovirus A75 1C (VP3); Human rhinovirus A8 1D; Human rhinovirus A94 1C; Human rhinovirus B79 1B; Human rhinovirus B83 1B; Human rhinovirus B86 1B; Human rhinovirus B97 1B; Coxsackievirus A11 3d; Coxsackievirus A13 3d; Human poliovirus 3 POLYM; Human rhinovirus A24 1D; Human rhinovirus A49 1C; Human rhinovirus A59 1D (VP1); Rhinovirus B48 1B (VP2); Human rhinovirus A68 1D; Human rhinovirus A9 1D; Human rhinovirus A90 1D; Human rhinovirus B6 1B (VP2); Human enterovirus C102 3d; Coxsackievirus A17 3D; Coxsackievirus A18 3D protein; Human rhinovirus A33 1D; Human rhinovirus A54 1D; Human rhinovirus A55 1D (VP1); Human rhinovirus A62 1D; Rhinovirus A98 1D; Human rhinovirus A78 1D; Human rhinovirus A94 1D; Human rhinovirus B4 1B (VP2); Human rhinovirus B70 1B (VP2); Human rhinovirus B99 1B; Human cosavirus D VP1; Human TMEV-like cardiovirus protein 2B*; Human rhinovirus A19 1D; Human rhinovirus A41 1D (VP1); Human rhinovirus A44 1D (VP1); Human rhinovirus A61 1D; Rhinovirus B VP1; Human rhinovirus A76 1D; Human rhinovirus A78 1C; Human rhinovirus A82 1D; Human rhinovirus A88 1D (VP1); Human rhinovirus B26 1B; Human rhinovirus B4 1D (VP1); Human enterovirus C117 VP3; Coxsackievirus A22 vp3; Human rhinovirus A10 1D; Human rhinovirus A22 1D; Human rhinovirus A64 1C; Rhinovirus B48 1D (VP1); Human rhinovirus A76 1C; Human rhinovirus A8 1C; Saffold virus protein 2B*; Human rhinovirus A95 1C; Human rhinovirus B26 1D; Human rhinovirus B91 1D; Human rhinovirus B99 1C; Echovirus E20 VP3; Human rhinovirus A28 1C (VP3); Human rhinovirus A50 1D; Human rhinovirus A80 1C; Human rhinovirus A85 1D; Human rhinovirus A88 1C (VP3); Human rhinovirus A95 1D; Human rhinovirus B26 1C; Human rhinovirus B42 1C; Human adenovirus 41 E3 31.6K; Human rhinovirus B5 1C; Human rhinovirus B84 1D; Human rhinovirus B97 1C; Coxsackievirus A1 VP3; Human rhinovirus A18 1C; Human rhinovirus A34 1D; Human rhinovirus A55 1C (VP3); Human rhinovirus A63 1D; Human rhinovirus A90 1C; Human rhinovirus B27 1C; Human rhinovirus B4 1C (VP3); Human rhinovirus B42 1B; Human rhinovirus B52 1D; Coxsackievirus A8 VP1 protein; Echovirus E24 VP3; Echovirus E7 VP3; Encephalomyocarditis virus excised_polyprotein 1..1044; Human poliovirus 3 VP3; Human rhinovirus A100 1D; Human rhinovirus A33 1C; Human rhinovirus B79 1C; Human enterovirus 79 1C (VP3); Coxsackievirus A13 vp1; Coxsackievirus A22 vp1; Enterovirus C capsid protein VP3; Human poliovirus 1 Mahoney VP3 protein; Human rhinovirus A24 1C; Human adenovirus 31 cr1 beta protein (gene: E3 cr1 beta); Human rhinovirus B52 1C; Human rhinovirus B83 1D; Human rhinovirus B92 1D; Human enterovirus C102 vp1; Human enterovirus C104 VP3; Coxsackievirus A17 VP1; Coxsackievirus B5 VP1 capsid protein, polyprotein region 5 (gene: 1A); Echovirus E12 polyprotein region 3; Echovirus E26 VP3; Echovirus E27 VP3; Echovirus E31 VP3; Echovirus E33 VP3; Echovirus E4 VP1; Human rhinovirus A22 1C; Rhinovirus B VP3; Rhinovirus B14 1C (VP3); Human rhinovirus B72 1C; Human rhinovirus B79 1D; Human rhinovirus B84 1C; Human enterovirus C102 vp3; Coxsackievirus A11 vp3; Coxsackievirus A13 vp3; Coxsackievirus A17 VP3; Echovirus 9 strain Barty VP3; Echovirus 9 strain Hill polyprotein region 3; Echovirus E11 1D(VP1); Echovirus E16 VP3; Echovirus E3 VP3; Echovirus E7 VP1; Rhinovirus B69 1C; Human rhinovirus B27 1D; Human rhinovirus B3 1C (VP3); Human rhinovirus B35 1C; Human rhinovirus B42 1D; Human gammaherpesvirus 4 BARF1 protein (gene: BARF1); Human rhinovirus B92 1C; Coxsackievirus A18 VP3 protein; Coxsackievirus A18 VP1 protein; Coxsackievirus B5 VP3 capsid protein, polyprotein region 4 (gene: 1A); Echovirus E21 VP3; Echovirus E29 VP3; Echovirus E32 VP3; Enterovirus B 1C(VP3); Human poliovirus 1 Mahoney VP1 protein; Human rhinovirus B35 1D; Human rhinovirus B72 1D; Human rhinovirus B86 1D; Human rhinovirus B86 1C; Coxsackievirus A1 VP1; Echovirus E11 1C(VP3); Echovirus E19 VP1; Echovirus E4 VP3; Enterovirus B111 VP3; Human rhinovirus B5 1D; Human rhinovirus B70 1D (VP1); Human rhinovirus B83 1C; Human enterovirus 79 1D (VP1); Echovirus E32 VP1; Enterovirus B111 VP1; Enterovirus C109 VP3; Rhinovirus B14 1D (VP1); Human rhinovirus B6 1D (VP1); Human rhinovirus B97 1D; Echovirus E14 VP3; Echovirus E19 VP3; Rhinovirus B69 1D; Human enterovirus C118 VP3; Coxsackievirus A6 VP1 protein; Human rhinovirus B6 1C (VP3); Human rhinovirus B70 1C (VP3); Human rhinovirus B91 1C; Human enterovirus C118 VP1; Echovirus E12 polyprotein region 4; Echovirus E13 VP3; Echovirus E15 VP3; Echovirus E21 VP1; Echovirus E27 VP1; Enterovirus B 1D(VP1); Enterovirus B97 VP3; Rhinovirus B48 1C (VP3); Salivirus A full_polyprotein 1..2370; Human adenovirus 61 E3 CR1 beta; Human herpesvirus 4 type 2 BARF1; Human enterovirus C104 VP1; Echovirus E17 VP3; Echovirus E2 VP3; Encephalomyocarditis virus hypothetical protein; Human enterovirus C117 VP1; Echovirus 9 strain Barty VP1; Echovirus E14 VP1; Echovirus E2 VP1; Echovirus E6 VP3; Enterovirus B97 VP1; Yaba-like disease virus 141R protein (gene: 141R); Echovirus 9 strain Hill polyprotein region 4; Echovirus E13 VP1; Echovirus E15 VP1; Echovirus E17 VP1; Echovirus E25 VP3; Echovirus E31 VP1; Echovirus E26 VP1; Echovirus E3 VP1; Enterovirus C109 VP1; Echovirus E16 VP1; Echovirus E24 VP1; Echovirus E29 VP1; Echovirus E33 VP1; Echovirus E6 VP1; Enterovirus H capsid protein VP3; Echovirus E20 VP1; Salivirus FHB full_polyprotein 1..2365; Echovirus E25 VP1; Cowpox virus CPXV209 protein (gene: CPXV209 CDS); Horsepox virus HSPV192 (IL-beta-binding protein; Provisional); Enterovirus H capsid protein VP1; Yaba monkey tumor virus Ig domain OX-2-like protein; Human rhinovirus A12 full_polyprotein 1..2155; Vaccinia virus Ankara CD47-like protein; Human rhinovirus A39 full_polyprotein 1..2157; Human mastadenovirus A E3 CR1-alpha1; Human rhinovirus A11 full_polyprotein 1..2153; Rosavirus A2 full_polyprotein 1..2468; Human rhinovirus B93 full_polyprotein 1..2178; Human betaherpesvirus 6B glycoprotein (gene: U85); Human adenovirus 52 E3 CR1-beta1 (gene: E3); Human rhinovirus B37 full_polyprotein 1..2178; Human betaherpesvirus 7 membrane glycoprotein UL119 (gene: U85); Human betaherpesvirus 6 U85, OX-2 homologue (gene: U85); Human betaherpesvirus 6A membrane glycoprotein UL119 (gene: U85); Human adenovirus 19 CR1-beta (gene: E3)",0.0096374079669374; 0.0223182816928385; 0.0401211861299026; 0.0743949840752122; 0.0754322523003515; 0.0754322523003515; 0.0786466013864403; 0.0816962571184375; 0.0816962571184375; 0.086428048188775; 0.0898087823597772; 0.098953088813177; 0.098953088813177; 0.098953088813177; 0.098953088813177; 0.098953088813177; 0.098953088813177; 0.098953088813177; 0.098953088813177; 0.098953088813177; 0.098953088813177; 0.098953088813177; 0.098953088813177; 0.098953088813177; 0.098953088813177; 0.098953088813177; 0.098953088813177; 0.098953088813177; 0.098953088813177; 0.098953088813177; 0.098953088813177; 0.098953088813177; 0.1043071530279705; 0.1043071530279705; 0.1413266333748334; 0.2076496029500523; 0.2280934210760456; 0.2673783194071986; 0.2880902732733083; 0.2882370282257738; 0.312710113238199; 0.3250047687955704; 0.3292007522271798; 0.3292007522271798; 0.3292007522271798; 0.3295806534284816; 0.3295806534284816; 0.3295806534284816; 0.3295806534284816; 0.3338836035374137; 0.3432508452948237; 0.3432508452948237; 0.3522486336034194; 0.3522486336034194; 0.362875171240929; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.4048700216882856; 0.4048700216882856; 0.4145707851950257; 0.4209050542085626; 0.4275573398203068; 0.4360061131024446; 0.4476550758896243; 0.4485784929261809; 0.4554892648386431; 0.5324759243629956; 0.5402074049939289; 0.5491415646821286; 0.5527915175903153; 0.6053121062925791; 0.6257301036191548; 0.6257301036191548; 0.788087548595866,Homo sapiens;Homo sapiens QGY7703 hepatocellular carcinoma cell;In vitro,0.35;0.44,Homo sapiens;canen;ebvb9,Homo sapiens;chemical synthesis
ID1,"Psoriasis; Lymphoma; Multiple Myeloma; Non-Small Cell Lung Carcinoma; Ovarian Carcinoma; cervical cancer; MYELOPROLIFERATIVE DISORDER, CHRONIC, WITH EOSINOPHILIA; Malignant neoplasm of ovary; Tumor Angiogenesis; Malignant tumor of cervix; Neoplasm Metastasis; Pulmonary Fibrosis; Graves Disease; Hypertensive disease; Cervix carcinoma; Kaposi Sarcoma; Liver neoplasms; Mammary Neoplasms; leukemia; Pancreatic carcinoma; Adenocarcinoma of pancreas; Glioma; Epithelial ovarian cancer; Malignant neoplasm of pancreas; Myocardial Ischemia; Malignant neoplasm of lung; Ureteral obstruction; Tumor Progression; Malignant neoplasm of breast; Bladder Neoplasm; Liver carcinoma; Carcinogenesis; Carcinoma of lung; Stomach Carcinoma; Malignant neoplasm of stomach; Stomach Neoplasms; melanoma; Primary malignant neoplasm of lung; Breast Carcinoma; Thyroid carcinoma; Obstructive nephropathy; Acute Promyelocytic Leukemia; Colorectal Neoplasms; Diabetes Mellitus, Experimental; Streptozotocin Diabetes; Alloxan Diabetes; Prostate carcinoma; Adenocarcinoma; ovarian neoplasm; Prostatic Neoplasms; Squamous cell carcinoma; Malignant neoplasm of prostate; Malignant neoplasm of urinary bladder; Pancreatic Neoplasm; Multinodular goiter; Carcinoma of bladder; Pulmonary Hypertension; Malignant neoplasm of liver; Adenoma; Adenocarcinoma of lung (disorder); Colorectal Carcinoma; Diabetes Mellitus, Non-Insulin-Dependent; Uterine Cervical Neoplasm; Esophageal Neoplasms; Kidney Diseases; Neoplasms; Leukemogenesis; Secondary malignant neoplasm of lymph node; Colorectal Cancer; Secondary malignant neoplasm of lung; Primary malignant neoplasm; Carcinoma breast stage IV; Squamous intraepithelial lesion; Malignant Neoplasms; Malignant neoplasm of thyroid; Rett Syndrome; Thyroid Neoplasm; Papillary thyroid carcinoma; Liver and Intrahepatic Biliary Tract Carcinoma; Benign Neoplasm; Cholestasis; Anaplasia; Ductal Carcinoma; Mammary Neoplasms, Experimental; Neural Tube Defects; High-Grade Squamous Intraepithelial Lesions; Medullary carcinoma of thyroid; Non-small cell carcinoma; Adenoid Cystic Carcinoma",3.118210553589307e-12; 4.5104266881389206e-12; 2.5279022064249716e-11; 3.762648680673853e-10; 6.870627395110916e-10; 1.1722433847661196e-09; 1.5734876414130875e-09; 1.971893171900314e-09; 3.315537369635636e-09; 3.683115069310663e-09; 5.670785186683756e-09; 7.547641288501485e-09; 8.269524813140207e-09; 1.0368326871660785e-08; 1.5572986293211266e-08; 3.149054123564124e-08; 4.3069383556698336e-08; 4.65353219894153e-08; 5.784935444423772e-08; 6.982287075725826e-08; 9.306686765839445e-08; 1.427432458937347e-07; 1.479813245926713e-07; 1.4925759778299788e-07; 2.948344121290337e-07; 6.299208964864026e-07; 7.99548070959303e-07; 8.297823048747685e-07; 8.660170029731726e-07; 9.822463166680949e-07; 1.3079916134634371e-06; 1.51758575162775e-06; 2.027389637151193e-06; 2.07112526817849e-06; 2.450940162208615e-06; 3.878607667297475e-06; 4.179146475474674e-06; 4.839188317483647e-06; 5.381279306135013e-06; 6.889889014378816e-06; 9.263589414966798e-06; 1.2304362232150695e-05; 1.3034577772762696e-05; 1.3410647656206684e-05; 1.3410647656206684e-05; 1.3410647656206684e-05; 1.527992765491583e-05; 1.5449280661407645e-05; 1.8507296589967813e-05; 2.0820699372778346e-05; 3.053335644618538e-05; 3.053335644618538e-05; 3.1491435270594376e-05; 3.192298841377222e-05; 3.878191781014205e-05; 3.9650653676454574e-05; 8.232890503539995e-05; 8.421319594446617e-05; 0.00012202062264879416; 0.00013846515856925812; 0.00016189346720036038; 0.00016189346720036038; 0.0001705179359230947; 0.00021804014782198476; 0.00022336414159326664; 0.00022897551943886068; 0.0002652452950458932; 0.000323910443746482; 0.00038453776693371663; 0.00042196010900515655; 0.00046565119871267287; 0.0004814724943641282; 0.0005873268650449521; 0.0006352060750206054; 0.0009826472144539087; 0.0013033444225859; 0.0020089634269714; 0.0025122887786423; 0.0038816440940594; 0.0050894481995015; 0.0174410368983484; 0.033749008368017; 0.0492531776191947; 0.0554191598986221; 0.0583555368572174; 0.1204795752338222; 0.131813871137714; 0.1525119847960956; 0.4481840103343354,Myocardial Ischemia; Benign Neoplasm; Malignant Neoplasm; Neoplasms; Diabetes Mellitus,7.071068485513988e-10; 0.010864842397815; 0.021392225047824; 0.064825092293108; 0.1718736907108893,"LMNA-related cardiocutaneous progeria syndrome ORPHA:363618; Mandibuloacral dysplasia with type A lipodystrophy ORPHA:90153; Arnold-Chiari malformation type I ORPHA:268882; Atypical Werner syndrome ORPHA:79474; Autosomal recessive Emery-Dreifuss muscular dystrophy ORPHA:98855; Autosomal semi-dominant severe lipodystrophic laminopathy ORPHA:280365; Charcot-Marie-Tooth disease type 2B1 ORPHA:98856; Congenital muscular dystrophy due to LMNA mutation ORPHA:157973; Dilated cardiomyopathy-hypergonadotropic hypogonadism syndrome ORPHA:2229; Familial dilated cardiomyopathy with conduction defect due to LMNA mutation ORPHA:300751; Familial partial lipodystrophy, Dunnigan type ORPHA:2348; Familial partial lipodystrophy, Kobberling type ORPHA:79084; Heart-hand syndrome, Slovenian type ORPHA:168796; Congenital generalized lipodystrophy ORPHA:528; Osteofibrous dysplasia ORPHA:488265; Hereditary papillary renal cell carcinoma ORPHA:47044; Kindler epidermolysis bullosa ORPHA:2908; Acute neonatal citrullinemia type I ORPHA:247546; Adult-onset citrullinemia type I ORPHA:247573; Muscular dystrophy, Selcen type ORPHA:199340; Ulnar-mammary syndrome ORPHA:3138; Hypotrichosis-lymphedema-telangiectasia-renal defect syndrome ORPHA:69735; Axenfeld anomaly ORPHA:98978; Axenfeld-Rieger syndrome ORPHA:782; Rieger anomaly ORPHA:91483; 20p12.3 microdeletion syndrome ORPHA:261295; LAMA5-related multisystemic syndrome ORPHA:521450; LRP5-related primary osteoporosis ORPHA:498481; Achondroplasia ORPHA:15; Microphthalmia with brain and digit anomalies ORPHA:139471; Autosomal dominant osteopetrosis type 1 ORPHA:2783; Muenke syndrome ORPHA:53271; Osteoporosis-pseudoglioma syndrome ORPHA:2788; Osteosclerosis-developmental delay-craniosynostosis syndrome ORPHA:178377; Camptodactyly-tall stature-scoliosis-hearing loss syndrome ORPHA:85164; Pancreatic hypoplasia-diabetes-congenital heart disease syndrome ORPHA:2255; Crouzon syndrome-acanthosis nigricans syndrome ORPHA:93262; Severe achondroplasia-developmental delay-acanthosis nigricans syndrome ORPHA:85165; Endosteal hyperostosis, Worth type ORPHA:2790; Thanatophoric dysplasia type 1 ORPHA:1860; Thanatophoric dysplasia type 2 ORPHA:93274; Vein of Galen aneurysmal malformation ORPHA:1053; Hypochondroplasia ORPHA:429; Acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2) ORPHA:402020; Myelodysplastic syndrome ORPHA:52688; Radio-ulnar synostosis-amegakaryocytic thrombocytopenia syndrome ORPHA:71289; Hyperostosis corticalis generalisata ORPHA:3416; Aplasia cutis congenita ORPHA:1114; Familial bicuspid aortic valve ORPHA:402075",0.0514345493431829; 0.0514345493431829; 0.0514345493431829; 0.0514345493431829; 0.0514345493431829; 0.0514345493431829; 0.0514345493431829; 0.0514345493431829; 0.0514345493431829; 0.0514345493431829; 0.0514345493431829; 0.0514345493431829; 0.0514345493431829; 0.0565022767519947; 0.1927589191138116; 0.1927589191138116; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659,,,yeasx,0.56,Homo sapiens,Homo sapiens
IL1A,"Inflammation; Pneumonia; Reperfusion Injury; Asthma; Psoriasis; Familial M??ni??re disease; Juvenile arthritis; Lymphoma; Multiple Myeloma; Virus Diseases; Dermatitis, Atopic; Lung diseases; Neutrophilia (disorder); Chronic Obstructive Airway Disease; Synovitis; Rheumatoid Arthritis; Thyroid associated opthalmopathies; Arteriosclerosis; Brain Injuries, Focal; Injuries, Acute Brain; Brain Injuries; Brain Lacerations; Pneumonitis; Non-Small Cell Lung Carcinoma; Crohn Disease; Autoimmune Diseases; Uveitis; Ovarian Carcinoma; Sarcoidosis; Endometriosis; cervical cancer; Arsenic Poisoning, Inorganic; Nervous System, Organic Arsenic Poisoning; Arsenic Encephalopathy; Arsenic Induced Polyneuropathy; Arsenic Poisoning; Ulcerative Colitis; Malignant neoplasm of ovary; Colitis; Pancreatitis, Chronic; Tumor Angiogenesis; Malignant tumor of cervix; Dermatitis; Lung Neoplasms; Multiple Sclerosis; Cerebral Ischemia; Neoplasm Metastasis; Inflammatory dermatosis; Hodgkin Disease; Hepatitis C; Atherosclerosis; Pulmonary Fibrosis; Acute pancreatitis; Graves Disease; Leukemia, Myelocytic, Acute; Glomerulonephritis; Hypertensive disease; Liver Cirrhosis; Respiratory syncytial virus (RSV) infection in conditions classified elsewhere and of unspecified site; Vascular Diseases; Eczema; Cervix carcinoma; Arthritis; Infection caused by Helicobacter pylori; Brain Ischemia; Cerebrovascular accident; Degenerative polyarthritis; Respiratory Distress Syndrome, Adult; Inflammatory Bowel Diseases; Obesity; Psoriasiform eczema; Kaposi Sarcoma; Periodontitis; Hyperglycemia; Liver neoplasms; HIV Infections; Mammary Neoplasms; Arthritis, Psoriatic; Aortic Aneurysm, Abdominal; Glioblastoma; leukemia; Diabetes Mellitus; Juvenile rheumatoid arthritis; Leishmaniasis, Cutaneous; Diabetes; Lupus Erythematosus, Systemic; Ischemic stroke; Pancreatic carcinoma; Coronary Artery Disease; Dermatologic disorders; Coronary heart disease; Alzheimer's Disease; Adenocarcinoma of pancreas; Behcet Syndrome; Sjogren's Syndrome; Dermatitis, Allergic Contact; Malaria; Spondylarthropathies; Glioma; Epithelial ovarian cancer; Escherichia coli Infections; Malignant neoplasm of pancreas; Pain; Acquired Immunodeficiency Syndrome; Hamman-Rich syndrome; Inflammatory disorder; Myocardial Infarction; Cerebral Infarction; Hepatitis C, Chronic; Adult T-Cell Lymphoma/Leukemia; Myocardial Ischemia; Diffuse Large B-Cell Lymphoma; Pneumococcal Infections; Cardiovascular Diseases; Septicemia; Sepsis; Cystic Fibrosis; Malignant neoplasm of lung; Restenosis; Tuberculosis; Leukemia, T-Cell; Diabetes Mellitus, Insulin-Dependent; Liver diseases; Chronic Lymphocytic Leukemia; Measles; Tumor Progression; Spondylarthritis; Thromboangiitis Obliterans; Dryness of eye; Malignant neoplasm of breast; Myasthenia Gravis; Gastritis; Bladder Neoplasm; Coronary Arteriosclerosis; Graft-vs-Host Disease; Diabetic Nephropathy; Systemic Scleroderma; Osteitis Deformans; Liver carcinoma; Dementia, Vascular; Immunologic Deficiency Syndromes; Carcinogenesis; Nasopharyngeal carcinoma; Lung Diseases, Interstitial; Endometrial Neoplasms; Malignant neoplasm of vulva; Hyperalgesia, Secondary; Allodynia; Influenza; Carcinoma of lung; Stomach Carcinoma; Hyperalgesia, Primary; Polycystic Ovary Syndrome; Ankylosing spondylitis; B-Cell Lymphomas; Colon Carcinoma; Fibrosarcoma; Disorder characterized by fever; Malignant neoplasm of stomach; Immune System Diseases; Osteosarcoma of bone; Astrocytoma; Dry Eye Syndromes; Tactile Allodynia; Bone Diseases; Stomach Neoplasms; Tuberculosis, Pulmonary; inflammatory joint disease; melanoma; Tauopathies; Dermatomyositis, Childhood Type; Fever; Primary malignant neoplasm of lung; Breast Carcinoma; Idiopathic Inflammatory Myopathies; Meningococcal Infections; Dermatitis, Irritant; Polymyositis; Osteosarcoma; Bacterial Infections; Thyroid carcinoma; Malignant mesothelioma; Leprosy; Epstein-Barr Virus Infections; Familial Alzheimer Disease (FAD); Hepatitis B, Chronic; Mechanical Allodynia; Encephalomyelitis; Hyperalgesia, Thermal; Acute lymphocytic leukemia; Aspiration Pneumonia; Complicated pneumoconiosis; Cachexia; Senile Plaques; Hepatitis B; Active tuberculosis; Lupus Erythematosus; Presenile dementia; Lymphohistiocytosis, Hemophagocytic; Rabies (disorder); Prostate carcinoma; Adenocarcinoma; Malignant tumor of colon; Vascular lesions; Polymorphous light eruption; Idiopathic crescentic glomerulonephritis; Anthracosis; Acute Coronary Syndrome; Hyperalgesia; ovarian neoplasm; Eosinophilic disorder; Nephritis; Nonalcoholic Steatohepatitis; Allergic rhinitis (disorder); Kidney Failure, Chronic; Acute GVH disease; Malignant neoplasm of endometrium; Contact Dermatitis; Uterine Corpus Cancer; Hypotension; Chorioamnionitis; Chronic kidney disease stage 5; Anemia of chronic disease; Squamous cell carcinoma; Malignant neoplasm of prostate; Hepatitis, Autoimmune; Pancreatic Neoplasm; Parkinson Disease; Autoimmune thyroiditis; precancerous lesions; Carcinoma of bladder; Osteomyelitis; Lupus Vulgaris; Vasculitis; Lichen Sclerosus et Atrophicus; Periodontal Diseases; Myelofibrosis; Stress, Psychological; Eosinophilia; Hashimoto Disease; IGA Glomerulonephritis; Bacterial Vaginosis; Heat Stroke; Polymyositis, Idiopathic; Polymyositis Ossificans; Cardiomyopathy, Dilated; Myositis; Peri-Implantitis; Histiocytosis, Langerhans-Cell; Acute myocardial infarction; Chronic graft-versus-host disease; Duodenal Ulcer; Amebic colitis; Chronic small plaque psoriasis; Lupus Erythematosus, Discoid; Congestive heart failure; Malignant Glioma; Malignant neoplasm of liver; Celiac Disease; Arthritis by pattern of joint involvement; HIV Wasting Syndrome; Osteoporosis; Idiopathic Pulmonary Fibrosis; Bronchiectasis; Infectious disease of lung; Chronic Kidney Diseases; Acquired aplastic anemia; CARCINOMA OF VULVA; Mitral Valve Stenosis; Unipolar Depression; Mesothelioma; Dermatomyositis; Gingival Diseases; Congenital neutropenia; Neurodegenerative Disorders; Renal Cell Carcinoma; Alzheimer Disease, Early Onset; Toxoplasmosis; Acute periodontitis; Cerebral arterial aneurysm; Stomatitis; Chronic arthritis; Severe congenital neutropenia; Nephropathia Epidemica; Solid Neoplasm; Endometrial Carcinoma; Adenocarcinoma of lung (disorder); Peptic Ulcer; Nasal Polyps; Retinoblastoma; Colorectal Carcinoma; Diabetes Mellitus, Non-Insulin-Dependent; Invasive Pulmonary Aspergillosis; Metabolic Syndrome X; Pancreatic Ductal Adenocarcinoma; Luft Disease; Majeed syndrome; Megaconial Myopathies; Pleoconial Myopathies; Gastritis, Atrophic; Malaria, Cerebral; Chronic gastritis; Severe Aplastic Anemia; Acne Vulgaris; Adult type dermatomyositis; Metastatic melanoma; Myeloid Leukemia, Chronic; Anemia; Kidney Diseases; Myocardial Diseases, Secondary; Plaque, Amyloid; Schnitzler Syndrome; Burn injury; Osteitis; Pustular psoriasis; Pseudomonas aeruginosa infection; Kidney Failure; Ulcer; Gastrointestinal Diseases; Cardiomyopathies, Primary; Leukemogenesis; Allergic disposition; Heart failure; Chondrosarcoma; Trachoma; Keratoconjunctivitis Sicca; Respiratory Distress Syndrome, Newborn; Dementia; Silicosis; Central neuroblastoma; Secondary malignant neoplasm of lymph node; Alopecia Areata; Major Depressive Disorder; Amyloidosis; Aggressive periodontitis, generalized; Drug-Induced Liver Disease; Epithelial hyperplasia of skin; Colorectal Cancer; Pseudorabies; Hemolytic-Uremic Syndrome; Skin Neoplasms; Squamous cell carcinoma of the head and neck; Secondary malignant neoplasm of lung; Chronic Periodontitis; Corneal Ulcer; Adrenoleukodystrophy; Neuroblastoma; Heart Diseases; Renal interstitial fibrosis; Immune Reconstitution Inflammatory Syndrome; Precursor Cell Lymphoblastic Leukemia Lymphoma; Osteopenia; Primary biliary cirrhosis; Focal glomerulosclerosis; Oestrogen deficiency; Autoinflammatory Syndrome; Optic Atrophy, Hereditary, Leber; Diabetes, Autoimmune; Hemorrhage; Skin Erosion; Infectious Mononucleosis; Familial cold urticaria; Left ventricular systolic dysfunction; West Nile viral infection; Necrotizing enterocolitis in fetus OR newborn; Irritable Bowel Syndrome; Chemical Carcinogenesis; Severe periodontitis; Balkan Nephropathy; Premature Birth; Chronic granulomatous disease; Arthropathy; Prion Diseases; Hypercholesterolemia; Epilepsy, Temporal Lobe; Primary Myelofibrosis; Rett Syndrome; Hepatitis, Chronic; stage, gastric cancer; Candidiasis of vagina; Corneal pannus; Destructive Arthritis; Early onset periodontitis; Cerebral Palsy; Huntington Disease; Rheumatoid Nodule; Cryopyrin-Associated Periodic Syndromes; Periodontitis, Juvenile; Adenovirus Infections; Hepatitis, Toxic; Chemical and Drug Induced Liver Injury; Chemically-Induced Liver Toxicity; Drug-Induced Acute Liver Injury; Peritoneal adhesion; Chronic progressive external ophthalmoplegia; Hepatitis, Drug-Induced; Osteoarthritis, Knee; Subarachnoid Hemorrhage; Cardiomyopathies; Rheumatism; Smallpox; Typhoid Fever; IMMUNE SUPPRESSION; Osteoporosis, Postmenopausal; Papillary thyroid carcinoma; Hypercalcemia; Ischemia of kidney; Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma; Type II Mucolipidosis; Metabolic Diseases; Otitis Media; Mycoplasma Infections; Gingival Recession; Lymphoproliferative Disorders; Acne; AA amyloidosis; Generalized pustular psoriasis; Melioidosis; Sinusitis; Chronic Infantile Neurological, Cutaneous, and Articular Syndrome; Hairy Cell Leukemia; Incontinentia Pigmenti Achromians; Rat Insulinoma; Iron deficiency; Chemical Burns; Chronic synovitis; Fatty Liver; Plasmacytoma; Meningitis, Pneumococcal; Autoinflammatory disorder; Muckle-Wells Syndrome; Hepatocarcinogenesis; Follicular thyroid carcinoma; Urticaria; Intracranial Aneurysm; Leishmaniasis; Uveal melanoma; Invasive aspergillosis; Drug Hypersensitivity Syndrome; Ovarian adenocarcinoma; Primary angle-closure glaucoma; Nephrotic Syndrome; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Corneal infection; Immune thrombocytopenic purpura; Bipolar Disorder; Steatohepatitis; Cleft palate, isolated; Merkel Cell Polyomavirus Infection; Sudden infant death syndrome; Brucellosis; Non-alcoholic Fatty Liver Disease; Lipoid nephrosis; Renal Insufficiency; Skin Carcinogenesis; Aspirin exacerbated respiratory disease; MELAS Syndrome; Schizophrenia; Thymoma; Senile dementia; Raynaud Disease; Vascular inflammations; Hernia; Pheochromocytoma; Non-obstructive azoospermia; Pemphigoid, Benign Mucous Membrane; Kearns-Sayre syndrome; Impulsive character (finding); Monoclonal Gammopathy of Undetermined Significance; Malnutrition; Polyarthritis; Peroxisome Biogenesis Disorder, Complementation Group D; Stroke, Lacunar; Selenium deficiency; Malignant neoplasm of skin; Down Syndrome; Anxiety neurosis (finding); SYNOVITIS, GRANULOMATOUS, WITH UVEITIS AND CRANIAL NEUROPATHIES (disorder); Anxiety state; Cervical Intraepithelial Neoplasia Grade 2/3; Complement deficiency disease; Cholestasis; Complete atrioventricular block; Gingivitis; Tactile Amnesia; Temporary Amnesia; Tooth Loss; Amnestic State; Degeneration of lumbar intervertebral disc; Dissociative Amnesia; Global Amnesia; Hysterical amnesia; Low Back Pain; Familial Mediterranean Fever; T-Cell Lymphoma; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Angiolymphoid hyperplasia; Endocarditis; Diarrhea; Erythema; Cerebrovascular Disorders; Oropharyngeal Carcinoma; Chronic multifocal osteomyelitis; Cutaneous Fibrous Histiocytoma; Disruptive, Impulse Control, and Conduct Disorders; Raynaud Phenomenon; Severe depression; Memory impairment; Varicocele; Multi-infarct dementia; Osteoarthritis of hip; Lymphomatoid Papulosis; Papilloma; Infertility; Reactive systemic amyloidosis; Shy-Drager Syndrome; Hyperinsulinism; Superficial ulcer; Craniosynostosis; Alopecia; High Grade Cervical Intraepithelial Neoplasia; Autism Spectrum Disorders; Generalized osteoarthritis; MERRF Syndrome; Neoplasms, Experimental; Primary immune deficiency disorder; Glaucoma, Primary Open Angle; Monosomy; Mitochondrial Myopathies; Idiopathic osteoarthritis; Premature aging syndrome; Malignant neoplasm of oropharynx; Subfertility; Pelvic Inflammatory Disease; Werner Syndrome; Blood Coagulation Disorders; X-Linked Lymphoproliferative Disorder; Osteoarthritis of the hand; Depressive disorder; Intervertebral Disc Degeneration; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Monoclonal Gammapathies; Granulomatous Disease, Chronic, X-Linked; Cerebral Amyloid Angiopathy; Endometritis; Impaired cognition; Dupuytren Contracture; Fabry Disease; Abnormal behavior; Mental Depression; Bronchopulmonary Aspergillosis; Cerebral Atherosclerosis; Glaucoma; Migraine Disorders; Acute Megakaryocytic Leukemias; Pituitary Adenoma; Pulmonary Aspergillosis; Systemic onset juvenile chronic arthritis; Fetal Alcohol Syndrome; Amnesia; Kidney Calculi; Pituitary Diseases; Squamous cell carcinoma of oropharynx; Mesenchymal Chondrosarcoma; Niemann-Pick Disease, Type C; Degenerative disorder; insulinoma; Nephrolithiasis; Odontogenic Tumors; Congenital Nonbullous Ichthyosiform Erythroderma; Dysequilibrium syndrome; Mental Retardation, X-Linked; Cervical high grade squamous intraepithelial lesion; Hyperkeratosis; pricking of skin; Disease Exacerbation; Thrombasthenia; Seizures; Congenital absence of germinal epithelium of testes; Hypercalciuria; Alcoholic Intoxication, Chronic; Respiratory distress; Epilepsy",2.8114433253573326e-17; 7.980856456624717e-16; 4.4398736172867135e-14; 1.803641225501291e-12; 3.118210553589307e-12; 3.861499575207375e-12; 3.861499575207375e-12; 4.5104266881389206e-12; 2.5279022064249716e-11; 6.332483647919588e-11; 7.448716379948652e-11; 8.179290839744632e-11; 1.1574161017103878e-10; 1.3121548808139071e-10; 1.6797550790254382e-10; 1.9241179247341838e-10; 2.377251819497684e-10; 2.377251819497684e-10; 2.377251819497684e-10; 2.377251819497684e-10; 2.377251819497684e-10; 2.377251819497684e-10; 2.813069300429449e-10; 3.762648680673853e-10; 4.2478505092738466e-10; 5.452288254986118e-10; 6.429879513246633e-10; 6.870627395110916e-10; 7.861255581007157e-10; 7.868397426275417e-10; 1.1722433847661196e-09; 1.1722433847661196e-09; 1.1722433847661196e-09; 1.1722433847661196e-09; 1.1722433847661196e-09; 1.1722433847661196e-09; 1.6767489697325582e-09; 1.971893171900314e-09; 1.971893171900314e-09; 2.219129913614883e-09; 3.315537369635636e-09; 3.683115069310663e-09; 3.683115069310663e-09; 4.367699208727405e-09; 4.546836602575699e-09; 4.756590990483e-09; 5.670785186683756e-09; 6.0322241000340585e-09; 6.195332209150018e-09; 6.991207850982321e-09; 7.195555613367576e-09; 7.547641288501485e-09; 7.713813941246406e-09; 8.269524813140207e-09; 8.303910954283738e-09; 1.0368326871660785e-08; 1.0368326871660785e-08; 1.3128768066526236e-08; 1.452540845894924e-08; 1.4920329017331753e-08; 1.4920329017331753e-08; 1.5572986293211266e-08; 1.587872453479067e-08; 1.7931366647560766e-08; 1.8815395768840057e-08; 2.0570601164639797e-08; 2.1034803123367165e-08; 2.261634993097532e-08; 2.3137704832524547e-08; 2.412608431251415e-08; 2.7368000175117756e-08; 3.149054123564124e-08; 3.9573009168853264e-08; 4.0898524252942674e-08; 4.3069383556698336e-08; 4.638299267461546e-08; 4.65353219894153e-08; 5.071217747675114e-08; 5.1290058242058653e-08; 5.518991037343798e-08; 5.784935444423772e-08; 5.8317433871210796e-08; 5.989093556336469e-08; 6.016513497232253e-08; 6.156981490555128e-08; 6.156981490555128e-08; 6.156981490555128e-08; 6.982287075725826e-08; 8.598175402882612e-08; 9.273260676030806e-08; 9.273260676030806e-08; 9.273260676030806e-08; 9.306686765839445e-08; 9.393284022832733e-08; 1.0276547515522002e-07; 1.0390067657961098e-07; 1.0618136021459505e-07; 1.427432458937347e-07; 1.427432458937347e-07; 1.479813245926713e-07; 1.4925759778299788e-07; 1.4925759778299788e-07; 1.6759866477134858e-07; 1.825346178149227e-07; 2.0732395681104218e-07; 2.242497138958313e-07; 2.247163660896597e-07; 2.419125491442217e-07; 2.46778041958494e-07; 2.46778041958494e-07; 2.948344121290337e-07; 3.532371372262103e-07; 4.4307738632612236e-07; 4.5433391667148853e-07; 5.254943571583271e-07; 5.313225371508493e-07; 5.577321626966352e-07; 6.299208964864026e-07; 6.673805318525932e-07; 6.673805318525932e-07; 6.805796735296268e-07; 6.851652105457608e-07; 7.17979149467092e-07; 7.931659047151387e-07; 7.99548070959303e-07; 8.297823048747685e-07; 8.339674388418603e-07; 8.339674388418603e-07; 8.339674388418603e-07; 8.660170029731726e-07; 8.696626324623331e-07; 9.58028929735367e-07; 9.822463166680949e-07; 1.0094398444517938e-06; 1.0094667484349083e-06; 1.083280646968723e-06; 1.10068355868735e-06; 1.284982487562752e-06; 1.3079916134634371e-06; 1.4042419564664515e-06; 1.4839502431758565e-06; 1.51758575162775e-06; 1.5208470671427406e-06; 1.6231490275716298e-06; 1.6397478315149087e-06; 1.8939430555623748e-06; 1.9581146391906144e-06; 1.9581146391906144e-06; 2.027389637151193e-06; 2.027389637151193e-06; 2.07112526817849e-06; 2.086123696221558e-06; 2.086123696221558e-06; 2.1020461880694925e-06; 2.1624936975752243e-06; 2.205236928124383e-06; 2.3419309731960144e-06; 2.3756085216561533e-06; 2.450940162208615e-06; 2.546221763226728e-06; 2.560217628497434e-06; 2.608032323197001e-06; 2.7684459182091574e-06; 2.782805018144785e-06; 3.282956820548434e-06; 3.878607667297475e-06; 3.990817553511259e-06; 3.990817553511259e-06; 4.179146475474674e-06; 4.218275676836033e-06; 4.42396341877472e-06; 4.83171753412672e-06; 4.839188317483647e-06; 5.381279306135013e-06; 5.457492980911677e-06; 5.457492980911677e-06; 6.140554546483986e-06; 6.169876404399104e-06; 6.3131986281381465e-06; 6.378950690990071e-06; 6.889889014378816e-06; 7.439853898002338e-06; 8.567994785462795e-06; 8.77532817235926e-06; 9.263589414966798e-06; 1.0172703923266036e-05; 1.033366177374635e-05; 1.08089380369295e-05; 1.0961931275541026e-05; 1.2375081616087569e-05; 1.2765469826010355e-05; 1.2765469826010355e-05; 1.3410647656206684e-05; 1.3673911177979942e-05; 1.3755659311680946e-05; 1.3755659311680946e-05; 1.4805035395703202e-05; 1.5064798896399038e-05; 1.513340899972731e-05; 1.513340899972731e-05; 1.527992765491583e-05; 1.5449280661407645e-05; 1.5498516107485843e-05; 1.595911218164779e-05; 1.651577640810321e-05; 1.6659968656867144e-05; 1.6659968656867144e-05; 1.7090079578013972e-05; 1.8507296589967813e-05; 1.8507296589967813e-05; 1.8961926417889813e-05; 1.9896942827707536e-05; 2.0234336876324372e-05; 2.0736107376307555e-05; 2.0820699372778346e-05; 2.365778380659297e-05; 2.389985034001877e-05; 2.428963273942594e-05; 2.483118059238325e-05; 2.7966054180512005e-05; 2.878916650522013e-05; 2.910435331986992e-05; 2.9890125380431698e-05; 3.053335644618538e-05; 3.053335644618538e-05; 3.1066725823367694e-05; 3.192298841377222e-05; 3.372277447426952e-05; 3.489427253341073e-05; 3.602405958537832e-05; 3.9650653676454574e-05; 4.114864035295583e-05; 4.1934338365676246e-05; 4.351780357113137e-05; 4.351780357113137e-05; 4.550622830486202e-05; 4.8257135411913726e-05; 5.248375780672949e-05; 5.248375780672949e-05; 5.248375780672949e-05; 5.2700686057264086e-05; 5.496580971003797e-05; 5.59220554762142e-05; 5.726577479376336e-05; 5.726577479376336e-05; 5.826428641192471e-05; 5.9174130460768686e-05; 6.734766728729227e-05; 6.882388524696196e-05; 7.036498484894257e-05; 7.358523784131203e-05; 8.007340895515112e-05; 8.100290141298731e-05; 8.100290141298731e-05; 8.133563964016694e-05; 8.232890503539995e-05; 8.25206825409808e-05; 8.421319594446617e-05; 8.730297037328594e-05; 9.023170634543253e-05; 9.023170634543253e-05; 9.117996105379778e-05; 9.780860153755674e-05; 9.846223464501226e-05; 9.846223464501226e-05; 9.913294924271568e-05; 9.913294924271568e-05; 9.913294924271568e-05; 0.0001015974347517202; 0.00010334647523919963; 0.00010582598320524978; 0.00010776056908698134; 0.00010776056908698134; 0.00010886951500201832; 0.00010914466609698448; 0.0001119048288448298; 0.00011927896769899647; 0.00011927896769899647; 0.00011927896769899647; 0.00012202062264879416; 0.00012858049944279123; 0.00012858049944279123; 0.00012949836610375056; 0.00012949836610375056; 0.0001322335978675375; 0.0001322335978675375; 0.00013846515856925812; 0.00014636999075042076; 0.00015093372108149775; 0.00015093372108149775; 0.00016189346720036038; 0.00016189346720036038; 0.00017292560623348305; 0.00017808425336754297; 0.0001802305430549181; 0.0001802305430549181; 0.0001802305430549181; 0.0001802305430549181; 0.0001802305430549181; 0.00019131698235390912; 0.0001932529498581875; 0.0001932529498581875; 0.0001934869050618567; 0.0001934869050618567; 0.0002043416381292249; 0.00021049732822064587; 0.00021049732822064587; 0.00022254302103317592; 0.00022336414159326664; 0.00022618385822819267; 0.00023793254517777995; 0.00024044665139790348; 0.00024044665139790348; 0.00024044665139790348; 0.00024044665139790348; 0.0002496596482692862; 0.0002559467947532168; 0.00026224811620659125; 0.00026339787549714257; 0.00026467392475943254; 0.0002652452950458932; 0.0002718864504795822; 0.00027820432005572264; 0.0002792365191965819; 0.00028056116385876946; 0.00028056116385876946; 0.0002812860791024885; 0.0002983150880926112; 0.0003022150453166086; 0.00032113080554701227; 0.000323910443746482; 0.0003242363739584783; 0.0003278023880903879; 0.0003495642888428815; 0.0003539177308293034; 0.0003607853785819225; 0.0003763308936382836; 0.00038453776693371663; 0.00039959635390179865; 0.000399963770573658; 0.00041476222368508776; 0.000420950947096172; 0.00042196010900515655; 0.0004303328941191692; 0.0004336479443072768; 0.00044420259326717257; 0.0004601228759628894; 0.0004814724943641282; 0.0004814724943641282; 0.0004918069653418582; 0.000513309425513094; 0.0005214896245221155; 0.0005214896245221155; 0.0005486681594044074; 0.0005873268650449521; 0.0006046022723190866; 0.0006165924034839279; 0.0006445212280958682; 0.0006445212280958682; 0.0006721375816653799; 0.0007074539367893701; 0.0007283216745489607; 0.0007283216745489607; 0.0007326127218377523; 0.0008252744167874381; 0.0008252744167874381; 0.0008452277316123234; 0.0008673605584216904; 0.0008673605584216904; 0.0008932565002868814; 0.0010798279940823; 0.0011303542860313; 0.0011303542860313; 0.0012591553085125; 0.0012591553085125; 0.0012983918214284; 0.0013033444225859; 0.0013309210571735; 0.0015698089771612; 0.0015698089771612; 0.0015698089771612; 0.0015698089771612; 0.0015698089771612; 0.0017329922477138; 0.0017731038420892; 0.0017731038420892; 0.0017731038420892; 0.0017856981020231; 0.0017856981020231; 0.001881335207053; 0.001881335207053; 0.001881335207053; 0.001881335207053; 0.0020049274325175; 0.0020056438913528; 0.0020282798161214; 0.0020282798161214; 0.0020282798161214; 0.0021326108499664; 0.002213465225837; 0.0022378309697704; 0.0022378309697704; 0.002304426449738; 0.0024261178373806; 0.0025122887786423; 0.0025122887786423; 0.0026189803532255; 0.0027346449758241; 0.0027942850562877; 0.0028187518310092; 0.0028187518310092; 0.0028759971272412; 0.0029063499863533; 0.0030077293488194; 0.0030220891031719; 0.0030585625765418; 0.0030585625765418; 0.0030585625765418; 0.0033783379034436; 0.0033783379034436; 0.0035164243080016; 0.0037244768508078; 0.0037244768508078; 0.0037263522689301; 0.003846910040485; 0.003846910040485; 0.0038705790239355; 0.0039908077871836; 0.0039908077871836; 0.0039908077871836; 0.0039908077871836; 0.0040444907714877; 0.0040785542386402; 0.0044046842540656; 0.0044046842540656; 0.0047329548368286; 0.0047339976311261; 0.0047351775110072; 0.0048028611524245; 0.0050894481995015; 0.0054814673835909; 0.0059257679306595; 0.0059257679306595; 0.0059257679306595; 0.0060170797120173; 0.0066006052483961; 0.0067588219988478; 0.0070090734514155; 0.007117388576245; 0.0071410338306506; 0.0072083035574659; 0.0075325383349707; 0.0077321746155735; 0.007861073629675; 0.0080075092844381; 0.0087278589568942; 0.0093060572422998; 0.0093325514582534; 0.0096630827054915; 0.0096630827054915; 0.0096630827054915; 0.0097159454554601; 0.0097159454554601; 0.0104376874453167; 0.010624513163997; 0.0110109843340769; 0.0110109843340769; 0.0114187031414039; 0.0118303833860754; 0.0138441633831498; 0.0138441633831498; 0.0138441633831498; 0.0138441633831498; 0.015507621739214; 0.0156113267570298; 0.0161428886050652; 0.0167904807006824; 0.0171001534176385; 0.0171001534176385; 0.0171001534176385; 0.0171001534176385; 0.0174410368983484; 0.0182000062506337; 0.0182000062506337; 0.018665947632861; 0.018665947632861; 0.018665947632861; 0.018665947632861; 0.018665947632861; 0.018665947632861; 0.018665947632861; 0.018665947632861; 0.018665947632861; 0.0187299613301643; 0.0196314124927668; 0.0198983219186433; 0.0203198961621158; 0.0203198961621158; 0.0209435845696216; 0.0209435845696216; 0.0210446393275247; 0.0220575875892222; 0.0220705590988414; 0.0220705590988414; 0.0239461944596263; 0.0239461944596263; 0.0259817880808067; 0.027071413490175; 0.0279220892715439; 0.0279220892715439; 0.029552535105148; 0.0319682790952413; 0.0335408281184641; 0.0344821468860451; 0.0363737825516021; 0.0368286222044987; 0.0378565625608719; 0.0389987389006947; 0.0392832161328838; 0.0404707605808569; 0.0404707605808569; 0.0411765978055933; 0.0427786786335321; 0.0427786786335321; 0.0434849646646736; 0.0434849646646736; 0.0442524445580864; 0.0442524445580864; 0.0469394416375774; 0.0517499693438671; 0.0571842904809504; 0.0596340616186723; 0.0623026316541814; 0.0623026316541814; 0.0630979595913369; 0.0670239713427008; 0.0677694730935319; 0.0677694730935319; 0.0691714743582008; 0.0716386930157756; 0.0716386930157756; 0.0777073264956258; 0.0805158056052076; 0.0805158056052076; 0.0817897187940979; 0.0835641020831185; 0.0858871491124922; 0.0858871491124922; 0.0864853123692039; 0.0887984457495041; 0.0897127848630768; 0.0897127848630768; 0.0905750994820178; 0.0940427381982829; 0.0972679220674381; 0.0972679220674381; 0.0972679220674381; 0.0987575443309834; 0.0987575443309834; 0.1050724946352408; 0.1176290148843425; 0.1332119202868411; 0.1332119202868411; 0.1401454825042905; 0.1460848784791741; 0.1758774326276071; 0.176056923749369; 0.1947536072778078; 0.2226324872503657; 0.2316568843888361; 0.2316568843888361; 0.2385514460682989; 0.2416367579687983; 0.2596251484853132; 0.2622329318286966; 0.3006252432065827; 0.3113515317868633; 0.3243241301578816; 0.3258470663820326; 0.3306602962670145; 0.3697330558649637; 0.5344870281804397; 0.5793939269095637,Myocardial Ischemia; Arsenic Encephalopathy; Cerebral Ischemia; Dermatologic Disorders; Polymyositis Ossificans; Dermatitis; Polymyositis; Anthracosis; Hemolytic Uremic Syndrome; Luft Disease; Megaconial Myopathies; Pleoconial Myopathy; Dermatomyositis; Malignant Mesothelioma; Myocardial Diseases; Kearns Sayre Syndrome; Progressive External Ophthalmoplegia; MELAS Syndrome; MERRF Syndrome; Hereditary Leber Optic Atrophy; Skin Cancer; Mental Depression; Mitochondrial Myopathy; Amnesia; Non-Alcoholic Fatty Liver Disease; Skin Neoplasms; Mesenchymal Chondrosarcoma; Vitiligo; Cardiomyopathy; Carcinoma Of The Head And Neck,7.071068485513988e-10; 3.723977603538778e-09; 5.562961744202623e-09; 1.7417795410918816e-08; 7.782144775199944e-05; 0.0002385365299919203; 0.0002385365299919203; 0.00035261986034565066; 0.00044653857220180814; 0.00044653857220180814; 0.00044653857220180814; 0.00044653857220180814; 0.0005818213110442873; 0.0015169561374293; 0.0015169561374293; 0.007221192915733; 0.007221192915733; 0.010864842397815; 0.0268526262997348; 0.0378359748125562; 0.0462866256396667; 0.0511376198481248; 0.0682669288241704; 0.0810252439964338; 0.0984994301026393; 0.0992543625886142; 0.1110148026021272; 0.1231709853772602; 0.1273861908316246; 0.1813044909798312,"Quebec platelet disorder ORPHA:220436; Niemann-Pick disease type C, adult neurologic onset ORPHA:216986; Niemann-Pick disease type C, juvenile neurologic onset ORPHA:216981; Niemann-Pick disease type C, late infantile neurologic onset ORPHA:216978; Niemann-Pick disease type C, severe early infantile neurologic onset ORPHA:216975; Niemann-Pick disease type C, severe perinatal form ORPHA:216972; Adenocarcinoma of ovary ORPHA:213504; Palmoplantar keratoderma, Nagashima type ORPHA:140966; Acrodermatitis continua of Hallopeau ORPHA:163931; Pustulosis palmaris et plantaris ORPHA:163927; Generalized pustular psoriasis ORPHA:247353",3.28973817825433e-05; 0.0002132495254484572; 0.0002132495254484572; 0.0002132495254484572; 0.0002132495254484572; 0.0002132495254484572; 0.0133474287859103; 0.0514345493431829; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659,,,,,,
IL1B,"Inflammation; Pneumonia; Reperfusion Injury; Asthma; Psoriasis; Familial M??ni??re disease; Juvenile arthritis; Lymphoma; Multiple Myeloma; Virus Diseases; Dermatitis, Atopic; Lung diseases; Lobar Pneumonia; Neutrophilia (disorder); Chronic Obstructive Airway Disease; Synovitis; Rheumatoid Arthritis; Thyroid associated opthalmopathies; Arteriosclerosis; Brain Injuries, Focal; Injuries, Acute Brain; Brain Injuries; Brain Lacerations; Pneumonitis; Non-Small Cell Lung Carcinoma; Crohn Disease; Autoimmune Diseases; Peritonitis; Uveitis; Ovarian Carcinoma; Sarcoidosis; Endometriosis; cervical cancer; Arsenic Poisoning, Inorganic; Nervous System, Organic Arsenic Poisoning; Arsenic Encephalopathy; Arsenic Induced Polyneuropathy; Arsenic Poisoning; Cirrhosis; Ulcerative Colitis; Infection; Malignant neoplasm of ovary; Colitis; Pancreatitis, Chronic; Tumor Angiogenesis; Malignant tumor of cervix; Dermatitis; Lung Neoplasms; Multiple Sclerosis; Cerebral Ischemia; Neoplasm Metastasis; Experimental Lung Inflammation; Mammary Neoplasms, Human; Inflammatory dermatosis; Hodgkin Disease; Hepatitis C; Atherosclerosis; Pulmonary Fibrosis; Acute pancreatitis; Graves Disease; Leukemia, Myelocytic, Acute; Anti-Basement Membrane Glomerulonephritis; Glomerulonephritis; Hypertensive disease; Liver Cirrhosis; Respiratory syncytial virus (RSV) infection in conditions classified elsewhere and of unspecified site; Vascular Diseases; Eczema; Cervix carcinoma; Arthritis; Infection caused by Helicobacter pylori; Brain Ischemia; Cerebrovascular accident; Degenerative polyarthritis; Respiratory Distress Syndrome, Adult; Allergic Reaction; Inflammatory Bowel Diseases; Obesity; Kaposi Sarcoma; Periodontitis; Hyperglycemia; Liver neoplasms; HIV Infections; Mammary Neoplasms; Arthritis, Psoriatic; Aortic Aneurysm, Abdominal; Bright Disease; Glioblastoma; leukemia; Diabetes Mellitus; Juvenile rheumatoid arthritis; Leishmaniasis, Cutaneous; Diabetes; Lupus Erythematosus, Systemic; Ischemic stroke; Pancreatic carcinoma; Coronary Artery Disease; Dermatologic disorders; Coronary heart disease; Alzheimer's Disease; Adenocarcinoma of pancreas; Behcet Syndrome; Sjogren's Syndrome; Dermatitis, Allergic Contact; Retinoic acid syndrome; Right Middle Cerebral Artery Infarction; Embolic Infarction, Middle Cerebral Artery; Thrombotic Infarction, Middle Cerebral Artery; Left Middle Cerebral Artery Infarction; Middle Cerebral Artery Embolus; Middle Cerebral Artery Syndrome; Middle Cerebral Artery Thrombosis; Malaria; Encephalitis; Spondylarthropathies; Glioma; Epithelial ovarian cancer; Escherichia coli Infections; Malignant neoplasm of pancreas; Van der Woude syndrome; Pain; Cerebral abscess; Acquired Immunodeficiency Syndrome; Respiratory Syncytial Virus Infections; Malignant neoplasm of mouth; Hamman-Rich syndrome; Inflammatory disorder; Myocardial Infarction; Infarction, Middle Cerebral Artery; Cerebral Infarction; Hepatitis C, Chronic; Adult T-Cell Lymphoma/Leukemia; Brain Abscess; Glossitis, Benign Migratory; Anoxia; Myocardial Ischemia; Diffuse Large B-Cell Lymphoma; Myocarditis; Brain Neoplasms; Sciatic Neuropathy; Gastric ulcer; Pneumococcal Infections; Cardiovascular Diseases; Septicemia; Sepsis; Cystic Fibrosis; Peptic Esophagitis; Malignant neoplasm of lung; Fibroid Tumor; Restenosis; Tuberculosis; Leukemia, T-Cell; Middle Cerebral Artery Occlusion; Diabetes Mellitus, Insulin-Dependent; Liver diseases; Chronic Lymphocytic Leukemia; Ureteral obstruction; Measles; Tumor Progression; Spondylarthritis; Thromboangiitis Obliterans; Dryness of eye; Malignant neoplasm of breast; Myasthenia Gravis; Premature Obstetric Labor; Cytomegalovirus Infections; Gastritis; Bladder Neoplasm; Coronary Arteriosclerosis; Graft-vs-Host Disease; Diabetic Nephropathy; Systemic Scleroderma; Other specified forms of pleural effusion, except tuberculous; Hypersensitivity; Anemia, Sickle Cell; Osteitis Deformans; Liver carcinoma; Dementia, Vascular; Colonic Neoplasms; Immunologic Deficiency Syndromes; Carcinogenesis; Nasopharyngeal carcinoma; Transient Ischemic Attack; Lung Diseases, Interstitial; Endometrial Neoplasms; Malignant neoplasm of vulva; Hyperalgesia, Secondary; Allodynia; Diffuse cutaneous leishmaniasis; Influenza; Carcinoma of lung; Stomach Carcinoma; Hyperalgesia, Primary; Polycystic Ovary Syndrome; Ankylosing spondylitis; B-Cell Lymphomas; Colon Carcinoma; Leishmaniasis, Visceral; Idiopathic pulmonary arterial hypertension; Fibrosarcoma; Disorder characterized by fever; Malignant neoplasm of stomach; Immune System Diseases; Osteosarcoma of bone; Lip and Oral Cavity Carcinoma; Astrocytoma; Dry Eye Syndromes; Tactile Allodynia; Bone Diseases; Kidney Failure, Acute; Stomach Neoplasms; Tuberculosis, Pulmonary; Chronic liver disease; inflammatory joint disease; melanoma; Tauopathies; Dermatomyositis, Childhood Type; Fever; Primary malignant neoplasm of lung; Breast Carcinoma; Idiopathic Inflammatory Myopathies; Meningococcal Infections; Pustulosis of Palms and Soles; Mycoses; Dermatitis, Irritant; Urban cutaneous leishmaniasis; Polymyositis; Osteosarcoma; Bacterial Infections; Thyroid carcinoma; Angina, Unstable; Acute anterior uveitis; Malignant mesothelioma; Liver Cirrhosis, Experimental; Delirium; Leprosy; M5b Acute differentiated monocytic leukemia; Epstein-Barr Virus Infections; Guillain-Barre Syndrome; Familial Alzheimer Disease (FAD); Hepatitis B, Chronic; Tumor Promotion; Mechanical Allodynia; Encephalomyelitis; Hyperalgesia, Thermal; Stable angina; Acute Promyelocytic Leukemia; Acute lymphocytic leukemia; Leishmaniasis, New World; Complicated pneumoconiosis; MYELODYSPLASTIC SYNDROME; Retinal Diseases; Colorectal Neoplasms; Allergic asthma; Acute monocytic leukemia; Cachexia; Diabetes Mellitus, Experimental; Streptozotocin Diabetes; Alloxan Diabetes; Senile Plaques; Hepatitis B; Active tuberculosis; Candidiasis; Extrinsic allergic alveolitis; Aplastic Anemia; Lupus Erythematosus; Presenile dementia; Prostate carcinoma; Adenocarcinoma; Malignant tumor of colon; Vascular lesions; Polymorphous light eruption; Idiopathic crescentic glomerulonephritis; Anthracosis; Acute Coronary Syndrome; Hyperalgesia; ovarian neoplasm; Eosinophilic disorder; Nephritis; Nonalcoholic Steatohepatitis; Myeloid Leukemia; Allergic rhinitis (disorder); Kidney Failure, Chronic; Acute GVH disease; Malignant neoplasm of endometrium; Contact Dermatitis; Uterine Corpus Cancer; Fibrosis; Hypotension; Granulocytosis; Chronic kidney disease stage 5; Coinfection; Anemia of chronic disease; Squamous cell carcinoma; Malignant neoplasm of prostate; Hepatitis, Autoimmune; Malignant neoplasm of urinary bladder; Pancreatic Neoplasm; Parkinson Disease; Autoimmune thyroiditis; Mouth Neoplasms; precancerous lesions; Carcinoma of bladder; Endometrioma; Osteomyelitis; Lupus Vulgaris; Vasculitis; Invasive Streptococcus pneumoniae disease; Lichen Sclerosus et Atrophicus; Lymphoma, Non-Hodgkin; Viral respiratory infection; Periodontal Diseases; Myelofibrosis; Uterine Fibroids; Systemic Inflammatory Response Syndrome; Stress, Psychological; Thyroid Diseases; Eosinophilia; Hashimoto Disease; IGA Glomerulonephritis; Rhinitis; Childhood Glioblastoma; Bacterial Vaginosis; Heat Stroke; Polymyositis, Idiopathic; Polymyositis Ossificans; Adult Glioblastoma; Cardiomyopathy, Dilated; Myositis; Hematologic Neoplasms; Peri-Implantitis; Histiocytosis, Langerhans-Cell; Acute myocardial infarction; Heart Failure, Right-Sided; Chronic graft-versus-host disease; Duodenal Ulcer; Amebic colitis; Chronic small plaque psoriasis; Lupus Erythematosus, Discoid; Carcinoma, Lewis Lung; Congestive heart failure; Malignant Glioma; Other ureteric obstruction; Celiac Disease; Arthritis by pattern of joint involvement; Fetid chronic bronchitis; HIV Wasting Syndrome; Osteoporosis; Adult-Onset Still Disease; Other specified transient cerebral ischemias; Idiopathic Pulmonary Fibrosis; Bronchiectasis; Infectious disease of lung; Mucocutaneous Lymph Node Syndrome; Chronic Kidney Diseases; CARCINOMA OF VULVA; Mitral Valve Stenosis; Unipolar Depression; Age related macular degeneration; Mesothelioma; Dermatomyositis; Gingival Diseases; Congenital neutropenia; Neurodegenerative Disorders; Cardiomegaly; Renal Cell Carcinoma; Alzheimer Disease, Early Onset; Systemic candidiasis; Toxoplasmosis; Acute periodontitis; Adenoma; Multiple Sclerosis, Relapsing-Remitting; Cardiac Hypertrophy; Cerebral arterial aneurysm; Pancreatitis; Stomatitis; Chronic arthritis; Severe congenital neutropenia; Intestinal Graft Versus Host Disease; Nephropathia Epidemica; Solid Neoplasm; Endometrial Carcinoma; Adenocarcinoma of lung (disorder); VITILIGO-ASSOCIATED MULTIPLE AUTOIMMUNE DISEASE SUSCEPTIBILITY 1 (finding); Peptic Ulcer; Carcinoma, Transitional Cell; Acute Lung Injury; Nasal Polyps; Retinoblastoma; Status Epilepticus; Colorectal Carcinoma; Diabetes Mellitus, Non-Insulin-Dependent; Fibrosis, Liver; Encephalitis, St. Louis; Uterine Cervical Neoplasm; Invasive Pulmonary Aspergillosis; Metabolic Syndrome X; Pulmonary Emphysema; Luft Disease; Majeed syndrome; Megaconial Myopathies; Pleoconial Myopathies; Alcoholic Liver Diseases; Gastritis, Atrophic; Malaria, Cerebral; Chronic gastritis; Severe Aplastic Anemia; Acne Vulgaris; Adult type dermatomyositis; Metastatic melanoma; Myeloid Leukemia, Chronic; Neutropenia; Esophageal Neoplasms; Leg Ulcer; Anemia; Kidney Diseases; Myocardial Diseases, Secondary; Neoplasms; Plaque, Amyloid; Schnitzler Syndrome; Splenic Hypoplasia; Burn injury; Osteitis; Pustular psoriasis; Pseudomonas aeruginosa infection; Acute Cerebrovascular Accidents; Kidney Failure; Ulcer; Cystitis; Gastrointestinal Diseases; Cardiomyopathies, Primary; Leukemogenesis; Heart failure; Liver Cirrhosis, Alcoholic; Chondrosarcoma; Trachoma; Respiratory Distress Syndrome, Newborn; airway disease; Precursor B-cell lymphoblastic leukemia; Vitiligo; Dementia; Severe Dengue; Silicosis; Diabetic macular edema; Hyperoxia; Acute Chest Syndrome; Central neuroblastoma; Secondary malignant neoplasm of lymph node; Alopecia Areata; Major Depressive Disorder; Amyloidosis; Aggressive periodontitis, generalized; Acute colitis; Drug-Induced Liver Disease; Epithelial hyperplasia of skin; Colorectal Cancer; Gastro-esophageal reflux disease with esophagitis; Radiation Injuries, Experimental; Congenital laryngeal adductor palsy; Coprophilia (disorder); Pseudorabies; Hemolytic-Uremic Syndrome; Hepatitis; Hypertension, Portal; Skin Neoplasms; Secondary malignant neoplasm of lung; Inclusion Body Myopathy, Sporadic; Monocytic leukemia; Chronic Periodontitis; Heart Decompensation; Superinfection; Corneal Ulcer; Periapical Periodontitis; Adrenoleukodystrophy; Esophagitis; Neuroblastoma; Heart Diseases; Renal interstitial fibrosis; Infective endocarditis; Secondary Trigeminal Neuralgia; Trigeminal Neuralgia, Idiopathic; Immune Reconstitution Inflammatory Syndrome; Congenital arteriovenous malformation; Precursor Cell Lymphoblastic Leukemia Lymphoma; Osteopenia; Primary biliary cirrhosis; Refractory anemias; Focal glomerulosclerosis; Myocardial Failure; Oestrogen deficiency; Autoinflammatory Syndrome; Post-Traumatic Stress Disorder; Optic Atrophy, Hereditary, Leber; Malignant Neoplasms; Diabetes, Autoimmune; Meningitis, Bacterial; Bacterial Endocarditis; Leukoplakia, Oral; Skin Erosion; Infant, Premature; Eczema, Infantile; Septic Shock; Arteriovenous hemangioma; Infectious Mononucleosis; Familial cold urticaria; Left ventricular systolic dysfunction; Leptospirosis; West Nile viral infection; Carcinoma, Cribriform; Carcinoma, Granular Cell; Uveomeningoencephalitic Syndrome; Keratitis; Necrotizing enterocolitis in fetus OR newborn; Irritable Bowel Syndrome; Adenocarcinoma, Basal Cell; Chemical Carcinogenesis; Guillain-Barre Syndrome, Familial; Severe periodontitis; Balkan Nephropathy; Group B Streptococcal Infection; Reactive hypoglycemia; Premature Birth; Amyotrophic Lateral Sclerosis; Adenocarcinoma, Oxyphilic; Colitis, Collagenous; Chronic granulomatous disease; Pulmonary Cystic Fibrosis; Carcinoma of larynx; Dengue Fever; Adenocarcinoma, Tubular; Arthropathy; Prion Diseases; Multiple Sclerosis, Acute Fulminating; Toxic Shock Syndrome; Left-Sided Heart Failure; Cryptosporidiosis; Pleocytosis; Hypercholesterolemia; Epilepsy, Temporal Lobe; Precancerous Conditions; Primary Myelofibrosis; Rett Syndrome; Malignant neoplasm of larynx; Hepatitis, Chronic; Neoplasm Invasiveness; Lyme Disease; Inflammatory disease of mucous membrane; Alzheimer's Disease, Focal Onset; Acute Confusional Senile Dementia; Thyroid Gland Follicular Adenoma; stage, gastric cancer; Candidiasis of vagina; Corneal pannus; Destructive Arthritis; Early onset periodontitis; Endophthalmitis; Idiopathic Nephrotic Syndrome; DOSAGE-SENSITIVE SEX REVERSAL; Alzheimer Disease, Late Onset; Lymphopenia; Malaria, Falciparum; Cerebral Palsy; Spontaneous abortion; Huntington Disease; Rheumatoid Nodule; Cryopyrin-Associated Periodic Syndromes; Otitis Media with Effusion; Periapical Granuloma; Pleurisy; Periodontitis, Juvenile; Adenovirus Infections; Hepatitis, Toxic; Chemical and Drug Induced Liver Injury; Chemically-Induced Liver Toxicity; Drug-Induced Acute Liver Injury; Adenoma of large intestine; Dejerine-Sottas Disease (disorder); Shock; Peritoneal adhesion; Chronic progressive external ophthalmoplegia; Thyroid Neoplasm; Hepatitis, Drug-Induced; Osteoarthritis, Knee; Subarachnoid Hemorrhage; Endothelial dysfunction; Cardiomyopathies; Cardiac Arrest; Rheumatism; Smallpox; Typhoid Fever; IMMUNE SUPPRESSION; Osteoporosis, Postmenopausal; Thrombosis; Hypercalcemia; Staphylococcal toxic shock syndrome; Mild cognitive disorder; Ischemia of kidney; Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma; Pneumocystis jiroveci pneumonia; Aneurysm; Tooth Attrition; Hepatic Veno-Occlusive Disease; Metabolic Diseases; Hyperlipoproteinemia Type IIa; Otitis Media; Mycoplasma Infections; Hypercholesterolemia, Familial; Actinic prurigo; Cervical lymphadenitis; Gingival Recession; Lymphoproliferative Disorders; Acne; AA amyloidosis; Generalized pustular psoriasis; Melioidosis; Malignant neoplasm of esophagus; Sinusitis; Chronic Infantile Neurological, Cutaneous, and Articular Syndrome; Hairy Cell Leukemia; GASTRIC CANCER, INTESTINAL; Incontinentia Pigmenti Achromians; Rat Insulinoma; Iron deficiency; Necrotizing Enterocolitis; Acute peritonitis; Bacterial keratitis; Chemical Burns; Chronic synovitis; Abortion, Tubal; Fatty Liver; Retinopathy of Prematurity; Febrile Convulsions; Plasmacytoma; Scrub Typhus; Meningitis, Pneumococcal; Asbestosis; Autoinflammatory disorder; Muckle-Wells Syndrome; Hepatocarcinogenesis; Follicular thyroid carcinoma; Cholera; Glomerulosclerosis (disorder); Hereditary Diffuse Gastric Cancer; Hyperlipidemia; Fasting Hypoglycemia; Urticaria; Intracranial Aneurysm; Gestational Diabetes; Leishmaniasis; Uveal melanoma; Invasive aspergillosis; Drug Hypersensitivity Syndrome; Infection - suppurative; Overweight; Hepatolenticular Degeneration; Respiratory Tract Infections; Benign Neoplasm; Ovarian adenocarcinoma; Liver Failure, Acute; Cardiomyopathy, Familial Idiopathic; Juvenile Myelomonocytic Leukemia; Trigeminal Neuralgia; Primary angle-closure glaucoma; Nephrotic Syndrome; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Hypoxia-Ischemia, Brain; Corneal infection; Immune thrombocytopenic purpura; Squamous cell carcinoma of esophagus; Bipolar Disorder; Primary infection NOS; Steatohepatitis; Cleft palate, isolated; Acute otitis media; Merkel Cell Polyomavirus Infection; Pelvic Pain; Sudden infant death syndrome; Glomerulonephritis, Membranoproliferative; Brucellosis; Non-alcoholic Fatty Liver Disease; Hepatitis A; Salmonella infections; End Stage Liver Disease; Lipoid nephrosis; Renal Insufficiency; Burning Mouth Syndrome; Melanoma, B16; Aspirin exacerbated respiratory disease; Hamartoma Syndrome, Multiple; Esophageal carcinoma; Recurrent tumor; Nephrotic Syndrome, Minimal Change; MELAS Syndrome; Schizophrenia; Diabetic Neuropathies; Thymoma; Cervical Intraepithelial Neoplasia; Senile dementia; Raynaud Disease; Ewings sarcoma-primitive neuroectodermal tumor (PNET); Hernia; Childhood Osteosarcoma; Visual seizure; Retroviridae Infections; Chagas Disease; Non-obstructive azoospermia; Japanese Encephalitis; Depressive Symptoms; Hematological Disease; Pemphigoid, Benign Mucous Membrane; Autoinflammatory disease; Beryllium Disease; Kearns-Sayre syndrome; Lymphoid leukemia; Hyperactive behavior; Blast Phase; gallbladder neoplasm; Infectious Otitis Media; Atrial Fibrillation; Monoclonal Gammopathy of Undetermined Significance; Coughing; Venous Engorgement; Active Hyperemia; Chronic active hepatitis C; Deficiency of mevalonate kinase; Manganese Poisoning; Mastitis-metritis-agalactia syndrome; Radiation Damage; Reactive Hyperemia; Conventional (Clear Cell) Renal Cell Carcinoma; Limb ischemia; Membranous glomerulonephritis; PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE; Malnutrition; Intracranial Hemorrhages; Peroxisome Biogenesis Disorder, Complementation Group D; Stroke, Lacunar; Helicobacter Infections; Chronic inflammatory disorder; Microscopic Polyarteritis; Nephrosis; Disease caused by Shigella dysenteriae; Hippocampal sclerosis; Down Syndrome; Glioblastoma Multiforme; Hereditary hemochromatosis; Colitis, Lymphocytic; SYNOVITIS, GRANULOMATOUS, WITH UVEITIS AND CRANIAL NEUROPATHIES (disorder); Cervical Intraepithelial Neoplasia Grade 2/3; Complement deficiency disease; Mesangial proliferative glomerulonephritis; Anxiety Disorders; Gingivitis; Sexually Transmitted Diseases; Tooth Loss; Degeneration of lumbar intervertebral disc; Infection by Candida albicans; Low Back Pain; Autoimmune arthritis; Familial Mediterranean Fever; Gonorrhea; Necrosis; T-Cell Lymphoma; Liver Failure; Heart valve disease; Arteriovenous Malformations, Cerebral; Angiolymphoid hyperplasia; FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder); Diarrhea; Erythema; Cerebrovascular Disorders; AURAL ATRESIA, CONGENITAL; Fatty Liver, Alcoholic; Rift Valley Fever; Acral pseudolymphomatous angiokeratoma of children (APACHE); Chronic multifocal osteomyelitis; Cutaneous Fibrous Histiocytoma; Cholestasis, Extrahepatic; Convulsions; SMITH-MCCORT DYSPLASIA 1; Raynaud Phenomenon; Rheumatic Fever; Bronchopulmonary Dysplasia; Rosacea; Severe depression; FRIEDREICH ATAXIA 1; Memory impairment; Lupus Erythematosus, Subacute Cutaneous; Superficial spreading malignant melanoma of skin; Varicocele; Cholesteatoma; Multi-infarct dementia; Renal glomerular disease; Osteoarthritis of hip; Healing ulcer; Triple Negative Breast Neoplasms; Anemia, Diamond-Blackfan; Sclerosis; Congenital infectious disease; Lymphomatoid Papulosis; Cholangiocarcinoma; Anaplasia; Arthritis, Gouty; Malaria, Vivax; Increased drug resistance; Reactive systemic amyloidosis; Anxiety; Shy-Drager Syndrome; Fanconi Anemia; Aphthous Stomatitis; Hyperemia; Superficial ulcer; Giant Cell Glioblastoma; Gastric Adenocarcinoma; Alopecia; Upper Respiratory Infections; Alveolar Bone Loss; High Grade Cervical Intraepithelial Neoplasia; Autism Spectrum Disorders; Recurrent aphthous ulcer; Hemorrhagic Fevers, Viral; Generalized osteoarthritis; MERRF Syndrome; Neoplasms, Experimental; Primary immune deficiency disorder; Glaucoma, Primary Open Angle; Monosomy; Intervertebral disc disorder; Pulmonary Eosinophilia; Exanthema; Mitochondrial Myopathies; Iron deficiency anemia; Primary Effusion Lymphoma; Leukocytosis; Metastasis from malignant tumor of prostate; Idiopathic osteoarthritis; Hepatoblastoma; Osteoarthrosis Deformans; Premature aging syndrome; Malignant neoplasm of pharynx; Keratoconus; Subfertility; Werner Syndrome; Blood Coagulation Disorders; X-Linked Lymphoproliferative Disorder; Malignant neoplasm of stomach stage IV; Osteoarthritis of the hand; Tonic - clonic seizures; Depressive disorder; AIDS related complex; Microcalcification; Single Seizure; Seizures, Auditory; Seizures, Clonic; Seizures, Sensory; Seizures, Somatosensory; Vertiginous seizure; Atonic Absence Seizures; Generalized Absence Seizures; Gustatory seizure; Jacksonian Seizure; Non-epileptic convulsion; Nonepileptic Seizures; Olfactory seizure; Intervertebral Disc Degeneration; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Epileptic Seizures; Tonic Seizures; Arthritis, Adjuvant-Induced; Arthritis, Collagen-Induced; Arthritis, Experimental; Tumoral calcinosis; Monoclonal Gammapathies; Granulomatous Disease, Chronic, X-Linked; Waldenstrom Macroglobulinemia; Convulsive Seizures; PERIODONTITIS, LOCALIZED AGGRESSIVE; Bursitis; Granuloma Annulare; Pleural Neoplasms; Prostate Stromal Proliferation of Uncertain Malignant Potential; Impaired cognition; Renal tubular disorder; Sleep Disorders; Dupuytren Contracture; Abnormal behavior; Mental Depression; Epileptic drop attack; Complex partial seizures; Calcinosis; Acute glaucoma; Entamoeba histolytica Infection; Entamoebiasis; Loose stool; Papillary adenocarcinoma; Pelvic pain female; Peritoneal infections; Glaucoma; Acute Megakaryocytic Leukemias; Gastrointestinal Neoplasms; Pituitary Adenoma; Absence Seizures; Sleep-Related Neurogenic Tachypnea; Subwakefullness Syndrome; Tuberculous pleural effusion; Bacteremia due to Staphylococcus aureus; Candidiasis of the esophagus; Effects of heat; Long Sleeper Syndrome; Neutrophilic dermatosis; Systemic onset juvenile chronic arthritis; Generalized seizures; Seizures, Focal; Recurrent seizures; Short Sleeper Syndrome; Primary sclerosing cholangitis; synovial sarcoma; Brain Infarction; Pancreatitis, Acute Necrotizing; Pruritus; Kidney Calculi; Sleep Apnea, Mixed Central and Obstructive; Dengue Shock Syndrome; Erosive esophagitis; Fungal keratitis; Hypersomnia with Periodic Respiration; Hypoglycemia; Fatigue; Sleep Wake Disorders; Bleeding ulcer; Dyssomnias; Mood Disorders; Pituitary Diseases; Metastatic Prostate Carcinoma; Gout; Bacteroides fragilis infection in conditions classified elsewhere and of unspecified site; Learning Disabilities; Gastroesophageal reflux disease; ALZHEIMER DISEASE 5; POEMS Syndrome; Myoclonic Seizures; Inflammatory pain; Septicaemia due to gram-negative organism, unspecified; Primary gout; SPHEROCYTOSIS, TYPE 1 (disorder); Nephropathic cystinosis; Keloid; Smoldering myeloma; Idiopathic scoliosis; Pyothorax-Associated Lymphoma; Chronic active hepatitis; Alcohol Use Disorder; Venoocclusive disease; Degenerative disorder; insulinoma; 5,10-Methylenetetrahydrofolate reductase deficiency; polyps; Disorder of Achilles tendon; Retinal Vein Occlusion; Fleck corneal dystrophy; Osteophyte; Aortic Aneurysm, Thoracic; Nephrolithiasis; Sleep disturbances; Osteoarthrosis, localized, not specified whether primary or secondary; Hydronephrosis; Juvenile Neuronal Ceroid Lipofuscinosis; Neuroectodermal Tumor, Primitive; Stage II Colon Cancer AJCC v7; Adult Learning Disorders; Developmental Academic Disorder; Learning Disturbance; Stage II Colon Cancer; Mental Retardation, X-Linked; Anorexia; Gilbert Disease (disorder); Memory Loss; Hyperkeratosis; Learning Disorders; Memory Disorder, Semantic; Memory Disorder, Spatial; Age-Related Memory Disorders; Neuroendocrine Tumors; Memory Disorders; Purpura; Moyamoya disease 1; Seizures; Moyamoya Disease; Opiate Addiction; Drug usage; Familial multiple trichoepitheliomata; Alcoholic Intoxication, Chronic; Sleep Apnea Syndromes; Marijuana Abuse; Mental disorders; MRSA - Methicillin resistant Staphylococcus aureus infection; Lethargy; Retinitis Pigmentosa; Myopathy; Epilepsy; Drug habituation",2.8114433253573326e-17; 7.980856456624717e-16; 4.4398736172867135e-14; 1.803641225501291e-12; 3.118210553589307e-12; 3.861499575207375e-12; 3.861499575207375e-12; 4.5104266881389206e-12; 2.5279022064249716e-11; 6.332483647919588e-11; 7.448716379948652e-11; 8.179290839744632e-11; 8.179290839744632e-11; 1.1574161017103878e-10; 1.3121548808139071e-10; 1.6797550790254382e-10; 1.9241179247341838e-10; 2.377251819497684e-10; 2.377251819497684e-10; 2.377251819497684e-10; 2.377251819497684e-10; 2.377251819497684e-10; 2.377251819497684e-10; 2.813069300429449e-10; 3.762648680673853e-10; 4.2478505092738466e-10; 5.452288254986118e-10; 5.452288254986118e-10; 6.429879513246633e-10; 6.870627395110916e-10; 7.861255581007157e-10; 7.868397426275417e-10; 1.1722433847661196e-09; 1.1722433847661196e-09; 1.1722433847661196e-09; 1.1722433847661196e-09; 1.1722433847661196e-09; 1.1722433847661196e-09; 1.4790998733426532e-09; 1.6767489697325582e-09; 1.794870341379274e-09; 1.971893171900314e-09; 1.971893171900314e-09; 2.219129913614883e-09; 3.315537369635636e-09; 3.683115069310663e-09; 3.683115069310663e-09; 4.367699208727405e-09; 4.546836602575699e-09; 4.756590990483e-09; 5.670785186683756e-09; 5.670785186683756e-09; 5.791865115913735e-09; 6.0322241000340585e-09; 6.195332209150018e-09; 6.991207850982321e-09; 7.195555613367576e-09; 7.547641288501485e-09; 7.713813941246406e-09; 8.269524813140207e-09; 8.303910954283738e-09; 8.853567275424139e-09; 1.0368326871660785e-08; 1.0368326871660785e-08; 1.3128768066526236e-08; 1.452540845894924e-08; 1.4920329017331753e-08; 1.4920329017331753e-08; 1.5572986293211266e-08; 1.587872453479067e-08; 1.7931366647560766e-08; 1.8815395768840057e-08; 2.0570601164639797e-08; 2.1034803123367165e-08; 2.261634993097532e-08; 2.2764946043880388e-08; 2.3137704832524547e-08; 2.412608431251415e-08; 3.149054123564124e-08; 3.9573009168853264e-08; 4.0898524252942674e-08; 4.3069383556698336e-08; 4.638299267461546e-08; 4.65353219894153e-08; 5.071217747675114e-08; 5.1290058242058653e-08; 5.3111708677091025e-08; 5.518991037343798e-08; 5.784935444423772e-08; 5.8317433871210796e-08; 5.989093556336469e-08; 6.016513497232253e-08; 6.156981490555128e-08; 6.156981490555128e-08; 6.156981490555128e-08; 6.982287075725826e-08; 8.598175402882612e-08; 9.273260676030806e-08; 9.273260676030806e-08; 9.273260676030806e-08; 9.306686765839445e-08; 9.393284022832733e-08; 1.0276547515522002e-07; 1.0390067657961098e-07; 1.0390067657961098e-07; 1.0390067657961098e-07; 1.0390067657961098e-07; 1.0390067657961098e-07; 1.0390067657961098e-07; 1.0390067657961098e-07; 1.0390067657961098e-07; 1.0390067657961098e-07; 1.0618136021459505e-07; 1.3150328464481586e-07; 1.427432458937347e-07; 1.427432458937347e-07; 1.479813245926713e-07; 1.4925759778299788e-07; 1.4925759778299788e-07; 1.524221047360518e-07; 1.6759866477134858e-07; 1.7232014763277498e-07; 1.825346178149227e-07; 1.946794431045147e-07; 2.0279723135488897e-07; 2.0732395681104218e-07; 2.242497138958313e-07; 2.247163660896597e-07; 2.400988116471548e-07; 2.419125491442217e-07; 2.46778041958494e-07; 2.46778041958494e-07; 2.700227164716584e-07; 2.824526360848301e-07; 2.911052249927245e-07; 2.948344121290337e-07; 3.532371372262103e-07; 3.880986260207744e-07; 4.157277636684319e-07; 4.312772724439924e-07; 4.312772724439924e-07; 4.4307738632612236e-07; 4.5433391667148853e-07; 5.254943571583271e-07; 5.313225371508493e-07; 5.577321626966352e-07; 5.916066415963854e-07; 6.299208964864026e-07; 6.630279934320317e-07; 6.673805318525932e-07; 6.673805318525932e-07; 6.805796735296268e-07; 6.805796735296268e-07; 6.851652105457608e-07; 7.17979149467092e-07; 7.931659047151387e-07; 7.99548070959303e-07; 7.99548070959303e-07; 8.297823048747685e-07; 8.339674388418603e-07; 8.339674388418603e-07; 8.339674388418603e-07; 8.660170029731726e-07; 8.696626324623331e-07; 8.777200373497231e-07; 8.887379906686178e-07; 9.58028929735367e-07; 9.822463166680949e-07; 1.0094398444517938e-06; 1.0094667484349083e-06; 1.083280646968723e-06; 1.10068355868735e-06; 1.10068355868735e-06; 1.1523181751478311e-06; 1.2482007026109775e-06; 1.284982487562752e-06; 1.3079916134634371e-06; 1.4042419564664515e-06; 1.4185164995612263e-06; 1.4839502431758565e-06; 1.51758575162775e-06; 1.5208470671427406e-06; 1.5208470671427406e-06; 1.6231490275716298e-06; 1.6397478315149087e-06; 1.8939430555623748e-06; 1.9581146391906144e-06; 1.9581146391906144e-06; 1.96107848506464e-06; 2.027389637151193e-06; 2.027389637151193e-06; 2.07112526817849e-06; 2.086123696221558e-06; 2.086123696221558e-06; 2.1020461880694925e-06; 2.1624936975752243e-06; 2.205236928124383e-06; 2.2411321306638023e-06; 2.263727724144348e-06; 2.3419309731960144e-06; 2.3756085216561533e-06; 2.450940162208615e-06; 2.546221763226728e-06; 2.560217628497434e-06; 2.576211756838249e-06; 2.608032323197001e-06; 2.7684459182091574e-06; 2.782805018144785e-06; 3.282956820548434e-06; 3.485726441474513e-06; 3.878607667297475e-06; 3.990817553511259e-06; 3.990817553511259e-06; 3.990817553511259e-06; 4.179146475474674e-06; 4.218275676836033e-06; 4.42396341877472e-06; 4.83171753412672e-06; 4.839188317483647e-06; 5.381279306135013e-06; 5.457492980911677e-06; 5.457492980911677e-06; 5.457492980911677e-06; 5.572620871465934e-06; 6.140554546483986e-06; 6.140554546483986e-06; 6.169876404399104e-06; 6.3131986281381465e-06; 6.378950690990071e-06; 6.889889014378816e-06; 7.095035199288336e-06; 7.343355877356991e-06; 7.439853898002338e-06; 7.691726899679507e-06; 8.32456450186878e-06; 8.567994785462795e-06; 8.591027139424906e-06; 8.77532817235926e-06; 9.18171819472328e-06; 9.263589414966798e-06; 1.0172703923266036e-05; 1.033366177374635e-05; 1.033366177374635e-05; 1.08089380369295e-05; 1.0961931275541026e-05; 1.1652528807336014e-05; 1.2304362232150695e-05; 1.2375081616087569e-05; 1.2765469826010355e-05; 1.2765469826010355e-05; 1.279493639647176e-05; 1.3010173302726732e-05; 1.3034577772762696e-05; 1.3268923055385737e-05; 1.3268923055385737e-05; 1.3410647656206684e-05; 1.3410647656206684e-05; 1.3410647656206684e-05; 1.3410647656206684e-05; 1.3673911177979942e-05; 1.3755659311680946e-05; 1.3755659311680946e-05; 1.3755659311680946e-05; 1.4439241578579364e-05; 1.4583987015565183e-05; 1.4805035395703202e-05; 1.5064798896399038e-05; 1.527992765491583e-05; 1.5449280661407645e-05; 1.5498516107485843e-05; 1.595911218164779e-05; 1.651577640810321e-05; 1.6659968656867144e-05; 1.6659968656867144e-05; 1.7090079578013972e-05; 1.8507296589967813e-05; 1.8507296589967813e-05; 1.8961926417889813e-05; 1.9896942827707536e-05; 2.0234336876324372e-05; 2.042524345007846e-05; 2.0736107376307555e-05; 2.0820699372778346e-05; 2.365778380659297e-05; 2.389985034001877e-05; 2.428963273942594e-05; 2.483118059238325e-05; 2.7001454785434173e-05; 2.7966054180512005e-05; 2.878916650522013e-05; 2.910435331986992e-05; 2.929369913127532e-05; 2.9890125380431698e-05; 3.053335644618538e-05; 3.053335644618538e-05; 3.1066725823367694e-05; 3.1491435270594376e-05; 3.192298841377222e-05; 3.372277447426952e-05; 3.489427253341073e-05; 3.602405958537832e-05; 3.602405958537832e-05; 3.9650653676454574e-05; 4.079834649355082e-05; 4.114864035295583e-05; 4.1934338365676246e-05; 4.351780357113137e-05; 4.351780357113137e-05; 4.351780357113137e-05; 4.360044574654907e-05; 4.545624383387551e-05; 4.550622830486202e-05; 4.8257135411913726e-05; 5.013426562854155e-05; 5.248375780672949e-05; 5.248375780672949e-05; 5.248375780672949e-05; 5.248375780672949e-05; 5.248375780672949e-05; 5.2700686057264086e-05; 5.399364944210138e-05; 5.437020241719231e-05; 5.496580971003797e-05; 5.59220554762142e-05; 5.726577479376336e-05; 5.726577479376336e-05; 5.800116505773043e-05; 5.826428641192471e-05; 5.9174130460768686e-05; 6.058590126387572e-05; 6.734766728729227e-05; 6.882388524696196e-05; 7.036498484894257e-05; 7.358523784131203e-05; 7.358523784131203e-05; 8.007340895515112e-05; 8.100290141298731e-05; 8.100290141298731e-05; 8.133563964016694e-05; 8.178614148996482e-05; 8.232890503539995e-05; 8.25206825409808e-05; 8.257883791168467e-05; 8.730297037328594e-05; 9.023170634543253e-05; 9.023170634543253e-05; 9.023170634543253e-05; 9.117996105379778e-05; 9.476946799623076e-05; 9.56957692518114e-05; 9.780860153755674e-05; 9.846223464501226e-05; 9.846223464501226e-05; 9.913294924271568e-05; 9.913294924271568e-05; 9.913294924271568e-05; 0.0001015974347517202; 0.00010334647523919963; 0.00010334647523919963; 0.00010582598320524978; 0.00010776056908698134; 0.00010776056908698134; 0.00010886951500201832; 0.00010914466609698448; 0.00011072370132707822; 0.0001119048288448298; 0.00011927896769899647; 0.00011927896769899647; 0.00011927896769899647; 0.00011927896769899647; 0.00012202062264879416; 0.00012202062264879416; 0.00012202062264879416; 0.00012202062264879416; 0.00012858049944279123; 0.00012858049944279123; 0.00012858049944279123; 0.00012949836610375056; 0.00012949836610375056; 0.00012949836610375056; 0.0001322335978675375; 0.0001322335978675375; 0.00013846515856925812; 0.0001431024725510208; 0.00014636999075042076; 0.0001474322229096163; 0.00014885785925249347; 0.00015093372108149775; 0.00015093372108149775; 0.0001616561904035017; 0.00016189346720036038; 0.00016189346720036038; 0.0001690762138878921; 0.0001705179359230947; 0.0001705179359230947; 0.00017292560623348305; 0.00017808425336754297; 0.0001802305430549181; 0.0001802305430549181; 0.0001802305430549181; 0.0001802305430549181; 0.0001802305430549181; 0.000181883468787863; 0.00019131698235390912; 0.0001932529498581875; 0.0001932529498581875; 0.0001934869050618567; 0.0001934869050618567; 0.0002043416381292249; 0.00021049732822064587; 0.00021049732822064587; 0.00021611859123914996; 0.00021804014782198476; 0.0002214859278255797; 0.00022254302103317592; 0.00022336414159326664; 0.00022618385822819267; 0.00022897551943886068; 0.00023793254517777995; 0.00024044665139790348; 0.00024044665139790348; 0.00024044665139790348; 0.00024044665139790348; 0.00024044665139790348; 0.0002496596482692862; 0.00025117420022058794; 0.0002559467947532168; 0.00026224811620659125; 0.00026339787549714257; 0.00026339787549714257; 0.00026467392475943254; 0.0002652452950458932; 0.00027820432005572264; 0.0002792365191965819; 0.0002792365191965819; 0.00028056116385876946; 0.0002812860791024885; 0.0002926994143155384; 0.0002926994143155384; 0.0002933384035122236; 0.0002983150880926112; 0.0003022150453166086; 0.0003022150453166086; 0.00031217959139151507; 0.00031217959139151507; 0.00031439908493214593; 0.00032113080554701227; 0.000323910443746482; 0.0003242363739584783; 0.0003278023880903879; 0.0003495642888428815; 0.0003539177308293034; 0.0003539177308293034; 0.0003607853785819225; 0.0003763308936382836; 0.00038453776693371663; 0.0003987632373118045; 0.00039959635390179865; 0.00039959635390179865; 0.00039959635390179865; 0.00039959635390179865; 0.000399963770573658; 0.00040624424086014313; 0.0004136970830881728; 0.00041476222368508776; 0.00042196010900515655; 0.00042535405399404114; 0.00042535405399404114; 0.0004303328941191692; 0.0004303328941191692; 0.0004336479443072768; 0.0004336479443072768; 0.0004336479443072768; 0.00044420259326717257; 0.00045185714020635207; 0.0004601228759628894; 0.0004814724943641282; 0.0004814724943641282; 0.0004814724943641282; 0.0004918069653418582; 0.0004918069653418582; 0.0004918069653418582; 0.0005125353857651181; 0.000513309425513094; 0.0005214896245221155; 0.0005214896245221155; 0.0005255837979904586; 0.0005486681594044074; 0.0005632660372960827; 0.0005873268650449521; 0.0006046022723190866; 0.0006163914271817124; 0.0006165924034839279; 0.0006352060750206054; 0.0006445212280958682; 0.0006445212280958682; 0.0006445212280958682; 0.0006540484469998963; 0.0006721375816653799; 0.0007074539367893701; 0.0007074539367893701; 0.0007074539367893701; 0.0007074539367893701; 0.0007074539367893701; 0.0007283216745489607; 0.0007283216745489607; 0.0007283216745489607; 0.0007326127218377523; 0.0007603472723798622; 0.0007603472723798622; 0.0008252744167874381; 0.0008252744167874381; 0.0008252744167874381; 0.0008252744167874381; 0.0008280072185276037; 0.0008452277316123234; 0.0008673605584216904; 0.0008673605584216904; 0.0008673605584216904; 0.0008673605584216904; 0.0008673605584216904; 0.0008932565002868814; 0.0009325953874753212; 0.0010170306665323; 0.0010244557923259; 0.0010798279940823; 0.0010831910832595; 0.0011261416978188; 0.0011261416978188; 0.0011303542860313; 0.0011303542860313; 0.0011303542860313; 0.0011626911115394; 0.0011626911115394; 0.00116764658012; 0.0011876897533161; 0.0011876897533161; 0.0012591553085125; 0.0012591553085125; 0.0012688388196185; 0.0012983918214284; 0.0013033444225859; 0.0013033444225859; 0.0013309210571735; 0.0013309210571735; 0.0013510612738592; 0.0013734265963756; 0.0014413188128666; 0.0014413188128666; 0.0015652768725765; 0.0015698089771612; 0.0015698089771612; 0.0015698089771612; 0.0015698089771612; 0.0015698089771612; 0.0015698089771612; 0.0015698089771612; 0.0015725978289892; 0.0017107913939493; 0.0017290799495295; 0.0017329922477138; 0.0017329922477138; 0.0017731038420892; 0.0017731038420892; 0.0017731038420892; 0.0017731038420892; 0.0017731038420892; 0.0017731038420892; 0.0017731038420892; 0.0017856981020231; 0.0017856981020231; 0.001881335207053; 0.001881335207053; 0.001881335207053; 0.001881335207053; 0.001881335207053; 0.0019553944568237; 0.0020049274325175; 0.0020049274325175; 0.0020056438913528; 0.0020089634269714; 0.0020282798161214; 0.0020282798161214; 0.0020282798161214; 0.0020505587731585; 0.0021326108499664; 0.002135695462532; 0.002213465225837; 0.0022378309697704; 0.0022378309697704; 0.002304426449738; 0.0024261178373806; 0.0025122887786423; 0.0025122887786423; 0.0025122887786423; 0.0025876779926919; 0.0026189803532255; 0.0027346449758241; 0.0027346449758241; 0.0027534163536682; 0.0027942850562877; 0.0027942850562877; 0.0028187518310092; 0.0028187518310092; 0.0028187518310092; 0.0028759971272412; 0.0029013169576144; 0.0029063499863533; 0.0029063499863533; 0.0029063499863533; 0.0030077293488194; 0.0030220891031719; 0.0030585625765418; 0.0030585625765418; 0.0030585625765418; 0.0030940063712108; 0.0033783379034436; 0.0033783379034436; 0.0035164243080016; 0.0037244768508078; 0.0037244768508078; 0.0037244768508078; 0.0037263522689301; 0.0037263522689301; 0.003846910040485; 0.003846910040485; 0.003846910040485; 0.003846910040485; 0.0038705790239355; 0.0038705790239355; 0.0038895739770004; 0.0038895739770004; 0.0039908077871836; 0.0039908077871836; 0.0039908077871836; 0.0039908077871836; 0.0039908077871836; 0.0039908077871836; 0.0040444907714877; 0.0040785542386402; 0.0041157458728674; 0.0041157458728674; 0.0043105477873176; 0.0043427572763018; 0.0043470921917622; 0.0044046842540656; 0.0044046842540656; 0.0044831346315456; 0.0047329548368286; 0.0047339976311261; 0.0047351775110072; 0.0048028611524245; 0.0048028611524245; 0.0048496385019795; 0.0048662864613419; 0.0050894481995015; 0.0050894481995015; 0.0050894481995015; 0.0053122016520353; 0.0053570195415722; 0.0054814673835909; 0.0054814673835909; 0.0054814673835909; 0.0059257679306595; 0.0059257679306595; 0.0059257679306595; 0.0059257679306595; 0.0060170797120173; 0.0062748297137782; 0.0066006052483961; 0.0066401895279317; 0.0067588219988478; 0.0070090734514155; 0.007117388576245; 0.007117388576245; 0.007117388576245; 0.0071410338306506; 0.0072083035574659; 0.0072083035574659; 0.0075325383349707; 0.0075697193353146; 0.0077321746155735; 0.0077321746155735; 0.0077321746155735; 0.007861073629675; 0.0083709650732796; 0.0083709650732796; 0.0087278589568942; 0.0088561754221927; 0.0089906473426575; 0.0091914307650131; 0.0093060572422998; 0.0093060572422998; 0.0093325514582534; 0.0096630827054915; 0.0096630827054915; 0.0096630827054915; 0.0096630827054915; 0.0096630827054915; 0.0097159454554601; 0.0097159454554601; 0.0097628826330308; 0.0099798889656483; 0.0102680775483548; 0.010624513163997; 0.010624513163997; 0.0109519728029571; 0.0110109843340769; 0.0110109843340769; 0.0110109843340769; 0.0110109843340769; 0.0110109843340769; 0.0110109843340769; 0.0111888062322808; 0.0111888062322808; 0.0114187031414039; 0.0114187031414039; 0.0114187031414039; 0.0118123250371176; 0.0118303833860754; 0.0120771273149872; 0.0123983633418964; 0.0123983633418964; 0.0123983633418964; 0.0123983633418964; 0.0123983633418964; 0.0123983633418964; 0.0123983633418964; 0.0123983633418964; 0.0127059723723765; 0.0127059723723765; 0.0127059723723765; 0.0131305979622119; 0.0138441633831498; 0.0138441633831498; 0.0138441633831498; 0.0138441633831498; 0.0138441633831498; 0.0145436543557976; 0.0145436543557976; 0.0145436543557976; 0.015507621739214; 0.0160005762734352; 0.0161428886050652; 0.0171001534176385; 0.0171001534176385; 0.0171001534176385; 0.0171001534176385; 0.0171001534176385; 0.0171001534176385; 0.0171001534176385; 0.0173384291015271; 0.0182000062506337; 0.018665947632861; 0.018665947632861; 0.018665947632861; 0.018665947632861; 0.018665947632861; 0.0187299613301643; 0.0187299613301643; 0.0187299613301643; 0.0196225707350576; 0.0196314124927668; 0.0203198961621158; 0.0203198961621158; 0.0203198961621158; 0.0203198961621158; 0.0204735864411232; 0.0209435845696216; 0.0209435845696216; 0.0210446393275247; 0.0220575875892222; 0.0220575875892222; 0.0220705590988414; 0.0220705590988414; 0.0220705590988414; 0.0220705590988414; 0.0228665355725917; 0.0238425854040518; 0.0239461944596263; 0.0239461944596263; 0.0246533435977568; 0.0254956360475327; 0.0259817880808067; 0.0259817880808067; 0.0265829029717646; 0.027071413490175; 0.0279220892715439; 0.0279220892715439; 0.0279220892715439; 0.0279220892715439; 0.0279220892715439; 0.0295521651553568; 0.029552535105148; 0.030006907592274; 0.0302544192125064; 0.0314638805510678; 0.0319682790952413; 0.0319682790952413; 0.0319682790952413; 0.0334053723619937; 0.033749008368017; 0.0340266852061135; 0.0340266852061135; 0.0340266852061135; 0.0363737825516021; 0.0365699380189482; 0.0368286222044987; 0.0371129390384053; 0.0384689641633299; 0.0384689641633299; 0.0389987389006947; 0.0402448379890702; 0.0403198851338656; 0.0404707605808569; 0.0404707605808569; 0.0404707605808569; 0.0404707605808569; 0.0411765978055933; 0.0427786786335321; 0.0427786786335321; 0.0427786786335321; 0.0427786786335321; 0.0434849646646736; 0.0434849646646736; 0.0442524445580864; 0.0442524445580864; 0.044901297966643; 0.044901297966643; 0.0458359347176422; 0.0469394416375774; 0.0471006425252053; 0.0491632343384016; 0.0493155676939993; 0.0503601986761658; 0.0517499693438671; 0.0524566642172417; 0.0530344420162745; 0.0571842904809504; 0.0596340616186723; 0.0616475884230982; 0.0623026316541814; 0.0630979595913369; 0.0670239713427008; 0.0677694730935319; 0.0677694730935319; 0.0677694730935319; 0.069077962105579; 0.0691714743582008; 0.0700485361084771; 0.0700485361084771; 0.0700485361084771; 0.0700485361084771; 0.0700485361084771; 0.0700485361084771; 0.0700485361084771; 0.0700485361084771; 0.0700485361084771; 0.0700485361084771; 0.0700485361084771; 0.0700485361084771; 0.0700485361084771; 0.0700485361084771; 0.0700485361084771; 0.0716386930157756; 0.0716386930157756; 0.0729686376372628; 0.0746301710738675; 0.0777073264956258; 0.0777073264956258; 0.0777073264956258; 0.0777073264956258; 0.0777073264956258; 0.0805158056052076; 0.0805908799965109; 0.0817897187940979; 0.0817897187940979; 0.0817897187940979; 0.0817897187940979; 0.0817897187940979; 0.0817897187940979; 0.0835641020831185; 0.0858871491124922; 0.0858871491124922; 0.0858871491124922; 0.0864853123692039; 0.0887984457495041; 0.088963803794147; 0.0897127848630768; 0.0897127848630768; 0.0897127848630768; 0.0897127848630768; 0.0897127848630768; 0.0897127848630768; 0.0897127848630768; 0.0897127848630768; 0.0897127848630768; 0.0905750994820178; 0.0972679220674381; 0.0972679220674381; 0.0972679220674381; 0.0972679220674381; 0.0972679220674381; 0.0972679220674381; 0.0972679220674381; 0.0972679220674381; 0.0972679220674381; 0.0972679220674381; 0.0972679220674381; 0.0972679220674381; 0.0987575443309834; 0.1005686045203269; 0.1050724946352408; 0.1050724946352408; 0.1050724946352408; 0.1051100679067119; 0.1087303638328369; 0.1130019719865939; 0.1130019719865939; 0.1156074612838089; 0.1176290148843425; 0.1206032442301429; 0.1206032442301429; 0.1206032442301429; 0.1206032442301429; 0.1206032442301429; 0.1245376567919059; 0.1266767196420385; 0.1272255752567765; 0.1272255752567765; 0.1272255752567765; 0.1308906437806309; 0.1332119202868411; 0.1343310874911156; 0.1343310874911156; 0.1343310874911156; 0.1369039689436487; 0.1395859646277307; 0.1401454825042905; 0.1401454825042905; 0.1404159644943249; 0.1456466465256486; 0.1460848784791741; 0.1460848784791741; 0.1525119847960956; 0.1525119847960956; 0.1621030999931119; 0.1642913929691757; 0.1642913929691757; 0.1642913929691757; 0.1687319146389434; 0.1703929618871976; 0.1703929618871976; 0.1758774326276071; 0.176056923749369; 0.176056923749369; 0.1812446566929033; 0.1881045022168423; 0.1932166112700285; 0.1932166112700285; 0.1932166112700285; 0.1947536072778078; 0.1947536072778078; 0.1984316492066875; 0.2108300774722888; 0.2242145974514848; 0.2272199982000937; 0.23058850720196; 0.2316568843888361; 0.2316568843888361; 0.2316568843888361; 0.2316568843888361; 0.236709594559292; 0.2385514460682989; 0.2385514460682989; 0.2416367579687983; 0.2570364810168682; 0.2596251484853132; 0.2622329318286966; 0.2921843338021302; 0.2921843338021302; 0.2921843338021302; 0.2995316643384945; 0.3023749229986328; 0.3066971380488823; 0.3113515317868633; 0.3243241301578816; 0.3306602962670145; 0.3306602962670145; 0.340330994065175; 0.3417325482389482; 0.3697330558649637; 0.3718365496695985; 0.384785908220112; 0.4265163370325311; 0.4650392364999388; 0.5523550850146659; 0.5557349584201475; 0.5632441764027045; 0.5793939269095637; 0.6308405353995752,Myocardial Ischemia; Arsenic Encephalopathy; Cerebral Ischemia; Dermatologic Disorders; Marfan Syndrome; Mammary Neoplasms; Bright Disease; Cerebral Infraction; Cerebral Thrombosis; Alveolitis; Pulmonary Fibrosis; Palmoplantar Pustules; Glomerulonephritis; Rheumatoid Arthritis; Thyroid Gland Follicular Adenoma; Breast Carcinoma; Thyroid Neoplasm; Polymyositis Ossificans; Heart Failure; Dermatitis; Polymyositis; Ulcerative Colitis; Anthracosis; Psoriasis; Hemolytic Uremic Syndrome; Luft Disease; Megaconial Myopathies; Pleoconial Myopathy; Myocardial Infarction; Thyroid Carcinoma; Dermatomyositis; Breast Cancer; Reactive Hypoglycemia; Arthritis; Myocardial Diseases; Trigeminal Neuralgia; Congestive Heart Failure; Hypertension; Senile Dementia; Kearns Sayre Syndrome; Cirrhosis; Progressive External Ophthalmoplegia; Gastric Ulcer; Miscarriage; Carcinoma; Benign Neoplasm; MELAS Syndrome; Pleuritis; Cholestasis; Lung Cancer; Stomach Neoplasms; Gastric Cancer; Malignant Neoplasm; Hyperemia; Adenocarcinoma; MERRF Syndrome; Hereditary Leber Optic Atrophy; Urticaria; Mental Depression; Stroke; Neoplasms; Asthma; Cardiac Valvular Disease; Neutropenia; Lung Neoplasms; Mitochondrial Myopathy; Multiple Sclerosis; Giant Cell Glioblastoma; Osteoarthrosis Deformans; Eczema; Jacksonian Seizure; Tumoral Calcinosis; Colonic Neoplasms; Cardiomyopathy; Osteoporosis; Clonic Seizures; Short Sleeper Syndromes; Sleep Wake Disorders; CSF Pleocytosis; Colitis; Hypotonic Seizures; Bronchopulmonary Dysplasia; Schizophrenia; Alzheimer Disease; Peptic Ulcer; Gastritis; Gout; Hypoglycemia; Learning Disorders; Bipolar Disorder; Anorexia; Age-Related Memory Disorders; Memory Disorders; Glioblastoma; Myopathy; Lymphopenia; Seizure; Sleep Disorders,7.071068485513988e-10; 3.723977603538778e-09; 5.562961744202623e-09; 1.7417795410918816e-08; 8.921950872070284e-08; 1.1417484002988661e-07; 1.1417484002988661e-07; 2.009208013074685e-07; 2.739939098363423e-07; 3.1346476759108064e-07; 3.656047745092532e-06; 5.775106030172258e-06; 1.0086418491083646e-05; 1.241997446075319e-05; 3.882845009510541e-05; 4.971054570440277e-05; 7.782144775199944e-05; 7.782144775199944e-05; 0.00015071968444989745; 0.0002385365299919203; 0.0002385365299919203; 0.0002754573766813309; 0.00035261986034565066; 0.00044166586682199737; 0.00044653857220180814; 0.00044653857220180814; 0.00044653857220180814; 0.00044653857220180814; 0.0005760978170082974; 0.0005818213110442873; 0.0005818213110442873; 0.00063387456654884; 0.0015169561374293; 0.0015169561374293; 0.0015169561374293; 0.0025464930497429; 0.0028558709076653; 0.0048927857621509; 0.0067487024308267; 0.007221192915733; 0.007221192915733; 0.007221192915733; 0.007221192915733; 0.0088732170532262; 0.0107108189044139; 0.010864842397815; 0.010864842397815; 0.010864842397815; 0.0152037568688841; 0.0153260870217676; 0.0172144998405365; 0.0172144998405365; 0.021392225047824; 0.0242477651311773; 0.0249475037164364; 0.0268526262997348; 0.0378359748125562; 0.0418006551930827; 0.0511376198481248; 0.0588219013114419; 0.064825092293108; 0.064825092293108; 0.064825092293108; 0.064825092293108; 0.0662475691169798; 0.0682669288241704; 0.0682669288241704; 0.0841735094076256; 0.1006919508743788; 0.1110148026021272; 0.1110148026021272; 0.1110148026021272; 0.1203844668559877; 0.1273861908316246; 0.1286424863049623; 0.1286424863049623; 0.1286424863049623; 0.1286424863049623; 0.1286424863049623; 0.1301267238568565; 0.1666102769501294; 0.1716490205203499; 0.175139305620004; 0.2089805590322066; 0.2089805590322066; 0.2089805590322066; 0.2208427900599418; 0.2415240131894039; 0.2890629102516288; 0.2978951863374514; 0.3276530465188152; 0.3465144196435422; 0.3501279647290265; 0.3677216857879628; 0.3849207284113362; 0.5041604044703301; 0.5129718346081621; 0.7775832342220459,Nasopharyngeal carcinoma ORPHA:150; Systemic-onset juvenile idiopathic arthritis ORPHA:85414; Cryptogenic multifocal ulcerous stenosing enteritis ORPHA:468635; Cytosolic phospholipase-A2 alpha deficiency associated bleeding disorder ORPHA:477787; Metaphyseal anadysplasia ORPHA:1040; Pediatric systemic lupus erythematosus ORPHA:93552; Exfoliative ichthyosis ORPHA:289586; Thrombomodulin-related bleeding disorder ORPHA:436169; Mendelian susceptibility to mycobacterial diseases due to complete IFNgammaR2 deficiency ORPHA:319547; Metaphyseal dysplasia-maxillary hypoplasia-brachydacty syndrome ORPHA:2504; Autosomal dominant mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR2 deficiency ORPHA:319589; Autosomal recessive mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR2 deficiency ORPHA:319574; NON RARE IN EUROPE: Wolff-Parkinson-White syndrome ORPHA:907; Papillon-Lefevre ORPHA:678; Cleidocranial dysplasia ORPHA:1452; Sterile multifocal osteomyelitis with periostitis and pustulosis ORPHA:210115; Fatal congenital hypertrophic cardiomyopathy due to glycogen storage disease ORPHA:439854; Haim-Munk syndrome ORPHA:2342; Juvenile hyaline fibromatosis ORPHA:2028; Infantile systemic hyalinosis ORPHA:2176; Acral peeling skin syndrome ORPHA:263534; Early-onset Lafora body disease ORPHA:324290,6.10801728836975e-11; 1.514756890441811e-09; 0.0002132495254484572; 0.0002132495254484572; 0.0002132495254484572; 0.00021965881189185; 0.0514345493431829; 0.0514345493431829; 0.1927589191138116; 0.1927589191138116; 0.1927589191138116; 0.1927589191138116; 0.1927589191138116; 0.1927589191138116; 0.1927589191138116; 0.1927589191138116; 0.1927589191138116; 0.1927589191138116; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.5312419675785659,Vaccinia virus Ankara Haemagglutinin; Vaccinia virus hemagglutinin (gene: A56R); Horsepox virus HSPV177 (Immunoglobulin like); Monkeypox virus Zaire-96-I-16 B2R (gene: B2R); Variola virus hypothetical protein (gene: J9R); Human adenovirus 18 CR1-beta protein (gene: E3); Ectromelia virus ERPV hemagglutinin; Cowpox virus CPXV194 protein (gene: CPXV194 CDS); Monkeypox virus bifunctional hemagglutinin/type-I membrane glycoprotein; Human adenovirus 31 cr1 beta protein (gene: E3 cr1 beta); Human adenovirus 61 E3 CR1 beta; Cowpox virus CPXV209 protein (gene: CPXV209 CDS); Horsepox virus HSPV192 (IL-beta-binding protein; Provisional); Ectromelia virus ERPV IL-1 beta receptor; Monkeypox virus Zaire-96-I-16 IL-beta-binding protein (gene: B14R); Monkeypox virus bifunctional IL-1-beta-inhibitor; Vaccinia virus IL-beta-binding protein (gene: VACWR-B15R); Human adenovirus 23 CR1 b protein (gene: E3); Vaccinia virus Ankara Interleukin-1 beta receptor,0.0096374079669374; 0.0223182816928385; 0.0401211861299026; 0.0816962571184375; 0.2673783194071986; 0.2880902732733083; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.4048700216882856; 0.5115772036634316; 0.5215958137213983; 0.596048669869981; 0.6395276295677078; 0.6425846603888259; 0.7247310936525321,,,,
IL23A,"Inflammation; Pneumonia; Asthma; Psoriasis; Multiple Myeloma; Virus Diseases; Dermatitis, Atopic; Chronic Obstructive Airway Disease; Rheumatoid Arthritis; Thyroid associated opthalmopathies; Non-Small Cell Lung Carcinoma; Crohn Disease; Autoimmune Diseases; Uveitis; Ovarian Carcinoma; cervical cancer; Ulcerative Colitis; Infection; Malignant neoplasm of ovary; Colitis; Malignant tumor of cervix; Dermatitis; Multiple Sclerosis; Neoplasm Metastasis; Inflammatory dermatosis; Hepatitis C; Graves Disease; Eczema; Cervix carcinoma; Arthritis; Infection caused by Helicobacter pylori; Degenerative polyarthritis; Inflammatory Bowel Diseases; Obesity; Psoriasiform eczema; HIV Infections; Arthritis, Psoriatic; Aortic Aneurysm, Abdominal; Diabetes Mellitus; Diabetes; Lupus Erythematosus, Systemic; Pancreatic carcinoma; Dermatologic disorders; Behcet Syndrome; Sjogren's Syndrome; Malaria; Spondylarthropathies; Glioma; Escherichia coli Infections; Pain; Malignant neoplasm of mouth; Inflammatory disorder; Adult T-Cell Lymphoma/Leukemia; Bronchiolitis Obliterans; Diffuse Large B-Cell Lymphoma; Septicemia; Sepsis; Cystic Fibrosis; Peptic Esophagitis; Tuberculosis; Leukemia, T-Cell; Diabetes Mellitus, Insulin-Dependent; Liver diseases; Severe Sepsis; Tumor Progression; Spondylarthritis; Systemic Scleroderma; Liver carcinoma; Immunologic Deficiency Syndromes; Carcinogenesis; Influenza; Stomach Carcinoma; Ankylosing spondylitis; Colon Carcinoma; Leishmaniasis, Visceral; Idiopathic pulmonary arterial hypertension; Malignant neoplasm of stomach; Lip and Oral Cavity Carcinoma; Lupus Nephritis; Tuberculosis, Pulmonary; melanoma; Idiopathic Inflammatory Myopathies; Pustulosis of Palms and Soles; Mycoses; Bacterial Infections; Thyroid carcinoma; Leprosy; Guillain-Barre Syndrome; Hepatitis B, Chronic; Tumor Promotion; Encephalomyelitis; Acute Promyelocytic Leukemia; MYELODYSPLASTIC SYNDROME; Sezary Syndrome; Hepatitis B; Candidiasis; Extrinsic allergic alveolitis; Aplastic Anemia; Lupus Erythematosus; Malignant tumor of colon; Nephritis; Parkinson Disease; Carcinoma of bladder; Experimental Organism Basal Cell Carcinoma; Lupus Vulgaris; Hashimoto Disease; Hematologic Neoplasms; Peri-Implantitis; Pneumonia, Bacterial; Chronic small plaque psoriasis; Lupus Erythematosus, Discoid; Primary Sj??gren's syndrome; Celiac Disease; Latent Tuberculosis; Bronchiectasis; Infectious disease of lung; Mucocutaneous Lymph Node Syndrome; Acquired aplastic anemia; Chronic arthritis; Retinoblastoma; Colorectal Carcinoma; Diabetes Mellitus, Non-Insulin-Dependent; Fibrosis, Liver; Demyelinating Diseases; Anemia; Pustular psoriasis; Lymphoma, Follicular; Precursor B-cell lymphoblastic leukemia; Sarcoma; Ear Inflammation; Epithelial hyperplasia of skin; Colorectal Cancer; Gastro-esophageal reflux disease with esophagitis; Hospital acquired pneumonia; Secondary malignant neoplasm of lung; Superinfection; Infective endocarditis; Primary biliary cirrhosis; Refractory anemias; Joint swelling; Parasitemia; Bacterial Endocarditis; Severe Combined Immunodeficiency; Uveomeningoencephalitic Syndrome; Keratitis; Amyotrophic Lateral Sclerosis; Malignant neoplasm of thyroid; Colitis, Collagenous; Leprosy, Lepromatous; bone destruction; DOSAGE-SENSITIVE SEX REVERSAL; Dejerine-Sottas Disease (disorder); Mycosis Fungoides; Human T-cell lymphotrophic virus, type I [HTLV-I]; Extramedullary Hematopoiesis (disorder); gastritis h pylori; Promyelocytic leukemia; Immune thrombocytopenic purpura; Acute leukemia; Salmonella infections; Hamartoma Syndrome, Multiple; Psoriasis vulgaris; Thrombocytopenia due to platelet alloimmunization; Glioblastoma Multiforme; Colitis, Lymphocytic; Complete atrioventricular block; Squamous cell carcinoma of mouth; Acute-On-Chronic Liver Failure; Job Syndrome; Neuropathy; Autoimmune thrombocytopenia; Opportunistic Infections; Gallbladder Carcinoma; Takayasu Arteritis; Aortic Aneurysm; Mucocutaneous candidiasis; neurological disability; Pneumonia due to Klebsiella pneumoniae; Ganglioglioma; Melanoma astrocytoma syndrome; Neuritis; MYOTONIC DYSTROPHY 1; Parakeratosis; Primary antiphospholipid syndrome; Candidiasis, Chronic Mucocutaneous; Cholangitis; Sessile Serrated Adenoma/Polyp; Rat Adrenal Gland Pheochromocytoma; Embryonal Carcinoma; Dwarfism; Congenital deafness",2.8114433253573326e-17; 7.980856456624717e-16; 1.803641225501291e-12; 3.118210553589307e-12; 2.5279022064249716e-11; 6.332483647919588e-11; 7.448716379948652e-11; 1.3121548808139071e-10; 1.9241179247341838e-10; 2.377251819497684e-10; 3.762648680673853e-10; 4.2478505092738466e-10; 5.452288254986118e-10; 6.429879513246633e-10; 6.870627395110916e-10; 1.1722433847661196e-09; 1.6767489697325582e-09; 1.794870341379274e-09; 1.971893171900314e-09; 1.971893171900314e-09; 3.683115069310663e-09; 3.683115069310663e-09; 4.546836602575699e-09; 5.670785186683756e-09; 6.0322241000340585e-09; 6.991207850982321e-09; 8.269524813140207e-09; 1.4920329017331753e-08; 1.5572986293211266e-08; 1.587872453479067e-08; 1.7931366647560766e-08; 2.1034803123367165e-08; 2.3137704832524547e-08; 2.412608431251415e-08; 2.7368000175117756e-08; 4.638299267461546e-08; 5.071217747675114e-08; 5.1290058242058653e-08; 5.8317433871210796e-08; 6.156981490555128e-08; 6.156981490555128e-08; 6.982287075725826e-08; 9.273260676030806e-08; 9.393284022832733e-08; 1.0276547515522002e-07; 1.0618136021459505e-07; 1.427432458937347e-07; 1.427432458937347e-07; 1.4925759778299788e-07; 1.6759866477134858e-07; 2.0279723135488897e-07; 2.242497138958313e-07; 2.46778041958494e-07; 3.10587283755252e-07; 3.532371372262103e-07; 5.254943571583271e-07; 5.313225371508493e-07; 5.577321626966352e-07; 5.916066415963854e-07; 6.673805318525932e-07; 6.805796735296268e-07; 6.851652105457608e-07; 7.17979149467092e-07; 7.873224494781308e-07; 8.297823048747685e-07; 8.339674388418603e-07; 1.10068355868735e-06; 1.3079916134634371e-06; 1.4839502431758565e-06; 1.51758575162775e-06; 2.027389637151193e-06; 2.07112526817849e-06; 2.1020461880694925e-06; 2.205236928124383e-06; 2.2411321306638023e-06; 2.263727724144348e-06; 2.450940162208615e-06; 2.576211756838249e-06; 3.4620043828295477e-06; 3.990817553511259e-06; 4.179146475474674e-06; 5.457492980911677e-06; 5.457492980911677e-06; 5.572620871465934e-06; 6.378950690990071e-06; 6.889889014378816e-06; 8.567994785462795e-06; 9.18171819472328e-06; 1.0172703923266036e-05; 1.033366177374635e-05; 1.08089380369295e-05; 1.2304362232150695e-05; 1.279493639647176e-05; 1.3410647656206684e-05; 1.3755659311680946e-05; 1.3755659311680946e-05; 1.4439241578579364e-05; 1.4583987015565183e-05; 1.4805035395703202e-05; 1.5498516107485843e-05; 1.9896942827707536e-05; 3.372277447426952e-05; 3.9650653676454574e-05; 3.9650653676454574e-05; 4.1934338365676246e-05; 5.248375780672949e-05; 6.058590126387572e-05; 6.734766728729227e-05; 6.758558746827128e-05; 8.100290141298731e-05; 8.133563964016694e-05; 8.232890503539995e-05; 8.730297037328594e-05; 9.476946799623076e-05; 9.846223464501226e-05; 9.846223464501226e-05; 9.913294924271568e-05; 9.913294924271568e-05; 0.00012858049944279123; 0.00015093372108149775; 0.00016189346720036038; 0.00016189346720036038; 0.0001690762138878921; 0.000181883468787863; 0.00022254302103317592; 0.00024044665139790348; 0.0002484853090912064; 0.0002926994143155384; 0.00029355802758490503; 0.00031217959139151507; 0.0003763308936382836; 0.00038453776693371663; 0.0003987632373118045; 0.00039959635390179865; 0.00042196010900515655; 0.0004336479443072768; 0.0004814724943641282; 0.0005214896245221155; 0.0005255837979904586; 0.0005445028206157281; 0.0005445028206157281; 0.0006445212280958682; 0.0006993549316202267; 0.0008252744167874381; 0.0008252744167874381; 0.0009325953874753212; 0.0009826472144539087; 0.0010244557923259; 0.0011626911115394; 0.0013064343839031; 0.0015725978289892; 0.0019553944568237; 0.0020056438913528; 0.0027942850562877; 0.0033783379034436; 0.0043470921917622; 0.0044119363017658; 0.0060170797120173; 0.0073444206109429; 0.0077321746155735; 0.0088561754221927; 0.0088561754221927; 0.0167904807006824; 0.0171001534176385; 0.0171001534176385; 0.0182000062506337; 0.021125667706065; 0.0279220892715439; 0.0279220892715439; 0.0340645241548108; 0.0380438970214283; 0.044901297966643; 0.0511562825357515; 0.0623026316541814; 0.0630979595913369; 0.0897127848630768; 0.1050724946352408; 0.1050724946352408; 0.1130019719865939; 0.1130019719865939; 0.1401454825042905; 0.1426816828546498; 0.1642913929691757; 0.1642913929691757; 0.1982833830495248; 0.2520982519141255; 0.2670582190879765; 0.2921843338021302; 0.4424335623428572; 0.5864218078879415; 0.8718912101119344,Palmoplantar Pustules; Rheumatoid Arthritis; Psoriasis,5.775106030172258e-06; 1.241997446075319e-05; 0.00044166586682199737,Autosomal dominant dopa-responsive dystonia ORPHA:98808; GTP cyclohydrolase I deficiency ORPHA:2102; Deficiency in anterior pituitary function-variable immunodeficiency syndrome ORPHA:293978; Congenital muscular dystrophy-respiratory failure-skin abnormalities-joint hyperlaxity syndrome ORPHA:486815; Combined immunodeficiency due to CD70 deficiency ORPHA:538958; Severe combined immunodeficiency due to adenosine deaminase deficiency ORPHA:277; Autosomal recessive hypohidrotic ectodermal dysplasia ORPHA:248,3.28973817825433e-05; 3.28973817825433e-05; 0.0514345493431829; 0.4838060079820406; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659,,,,,,
INHBC,"Non-Small Cell Lung Carcinoma; Liver Cirrhosis, Experimental; Adenoma; Metastatic malignant neoplasm to brain; Triglycerides measurement",3.762648680673853e-10; 7.691726899679507e-06; 0.00012202062264879416; 0.0157194401523571; 0.9081655753114188,Kidney Failure; Gout; Gouty Arthritis,0.1110148026021272; 0.2208427900599418; 0.3849207284113362,Cystathioninuria ORPHA:212; Hemochromatosis type 3 ORPHA:225123; Hypermethioninemia due to glycine N-methyltransferase deficiency ORPHA:289891; Immunodeficiency due to MASP-2 deficiency ORPHA:331187; Atypical hemolytic uremic syndrome with anti-factor H antibodies ORPHA:93581; C3 glomerulonephritis ORPHA:329931; C3 glomerulopathy ORPHA:329918; Rotor syndrome ORPHA:3111; Mild hemophilia B ORPHA:169799; Moderately severe hemophilia B ORPHA:169796; NON RARE IN EUROPE: Congenital isolated thyroxine-binding globulin deficiency ORPHA:209893; NON RARE IN EUROPE: Familial dysalbuminemic hyperthyroxinemia ORPHA:276271; Brain demyelination due to methionine adenosyltransferase deficiency ORPHA:168598; Congenital analbuminemia ORPHA:86816; Congenital bile acid synthesis defect type 2 ORPHA:79303; Congenital factor II deficiency ORPHA:325; Sarcosinemia ORPHA:3129; Severe hemophilia B ORPHA:169793; Short stature due to primary acid-labile subunit deficiency ORPHA:140941; Familial apolipoprotein A5 deficiency ORPHA:530849; Symptomatic form of hemophilia B in female carriers ORPHA:177929; Thrombocythemia with distal limb defects ORPHA:329319; Formiminoglutamic aciduria ORPHA:51208; GCGR-related hyperglucagonemia ORPHA:438274; Tyrosinemia type 3 ORPHA:69723; Urocanic aciduria ORPHA:210128; Hawkinsinuria ORPHA:2118; Hemolytic anemia due to red cell pyruvate kinase deficiency ORPHA:766; Hereditary thrombophilia due to congenital antithrombin deficiency ORPHA:82; IRIDA syndrome ORPHA:209981; NON RARE IN EUROPE: Hyperlipoproteinemia type 4 ORPHA:413; NON RARE IN EUROPE: Non-alcoholic fatty liver disease ORPHA:33271; Cerebral sinovenous thrombosis ORPHA:329217; Congenital amegakaryocytic thrombocytopenia ORPHA:3319,0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659,,,,,,
IRF1,"Inflammation; Asthma; Psoriasis; Juvenile arthritis; Lymphoma; Multiple Myeloma; Virus Diseases; Lung diseases; Rheumatoid Arthritis; Arteriosclerosis; Brain Injuries, Focal; Injuries, Acute Brain; Brain Injuries; Brain Lacerations; Non-Small Cell Lung Carcinoma; Crohn Disease; Autoimmune Diseases; Ovarian Carcinoma; cervical cancer; Ulcerative Colitis; Infection; Malignant neoplasm of ovary; Colitis; Malignant tumor of cervix; Lung Neoplasms; Multiple Sclerosis; Neoplasm Metastasis; Hepatitis C; Atherosclerosis; Leukemia, Myelocytic, Acute; Hypertensive disease; Respiratory syncytial virus (RSV) infection in conditions classified elsewhere and of unspecified site; Cervix carcinoma; Cerebrovascular accident; Degenerative polyarthritis; Inflammatory Bowel Diseases; Kaposi Sarcoma; Liver neoplasms; HIV Infections; Mammary Neoplasms; Glioblastoma; leukemia; Juvenile rheumatoid arthritis; Lupus Erythematosus, Systemic; Pancreatic carcinoma; Coronary Artery Disease; Behcet Syndrome; Sjogren's Syndrome; Malaria; Glioma; Epithelial ovarian cancer; Malignant neoplasm of pancreas; Respiratory Syncytial Virus Infections; Hepatitis C, Chronic; Myocardial Ischemia; Diffuse Large B-Cell Lymphoma; Myocarditis; Cystic Fibrosis; Malignant neoplasm of lung; Restenosis; Tuberculosis; Tumor Progression; Spondylarthritis; Malignant neoplasm of breast; Premature Obstetric Labor; Bladder Neoplasm; Liver carcinoma; Carcinogenesis; Stomach Carcinoma; Colon Carcinoma; Malignant neoplasm of stomach; Stomach Neoplasms; melanoma; Breast Carcinoma; Acute Promyelocytic Leukemia; Acute lymphocytic leukemia; MYELODYSPLASTIC SYNDROME; Allergic asthma; Bronchial Hyperreactivity; Prostate carcinoma; Adenocarcinoma; Malignant tumor of colon; Vascular lesions; Acute Coronary Syndrome; Myeloid Leukemia; Malignant neoplasm of prostate; Sleep Apnea, Obstructive; Periodontal Diseases; Cardiomyopathy, Dilated; Hematopoietic Neoplasms; Congestive heart failure; Other ureteric obstruction; Malignant neoplasm of liver; Celiac Disease; Gingival Diseases; Renal Cell Carcinoma; Solid Neoplasm; Acute myelomonocytic leukemia; Colorectal Carcinoma; Metabolic Syndrome X; Myeloid Leukemia, Chronic; Acute Cerebrovascular Accidents; Leukemogenesis; Allergic disposition; Heart failure; Central neuroblastoma; Colorectal Cancer; Skin Neoplasms; Invasive carcinoma of breast; Neuroblastoma; Heart Diseases; Adenocarcinoma Of Esophagus; Pseudohyperkalemia Cardiff; Allergic Conjunctivitis; Endothelial dysfunction; Smallpox; Metabolic Diseases; Renal carcinoma; Hemorrhagic Fever, Ebola; Atrial Premature Complexes; GASTRIC CANCER, INTESTINAL; Liver and Intrahepatic Biliary Tract Carcinoma; Hereditary Diffuse Gastric Cancer; Subacute Sclerosing Panencephalitis; Cardiomyopathy, Familial Idiopathic; Juvenile Myelomonocytic Leukemia; Childhood asthma; Acute leukemia; Medulloblastoma; Hyperactive behavior; Invasive Ductal Breast Carcinoma; Myelodysplasia; Down Syndrome; Adenomatous Polyposis Coli; Primary HIV infection; Malignant neoplasm of gastrointestinal tract; Gastrointestinal inflammation; Leukemia, Myeloid, Chronic-Phase; Gastric Adenocarcinoma; Lipomatosis, Multiple; Chromosome 5, trisomy 5q; Myelodysplastic Syndrome with Isolated del(5q); 5q-syndrome; Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome; INFLAMMATORY BOWEL DISEASE 5; Varicella zoster; Atypical Ductal Breast Hyperplasia; Noninfiltrating Intraductal Carcinoma; Amaurosis congenita of Leber, type 1; Hereditary pancreatitis; Sporadic Breast Carcinoma; Monoblastic leukemia; Benign neoplasm of stomach; Carcinoma in situ of stomach; Neoplasm of uncertain or unknown behavior of stomach; Lipoma; Neoplasms, Radiation-Induced; Hyperplastic Polyp; Muscular Dystrophy, Facioscapulohumeral; Ventricular hypertrophy; Bronchioloalveolar Adenocarcinoma; Carcinoma, Endometrioid; Platelet Count measurement; Cytopenia; Congenital anemia",2.8114433253573326e-17; 1.803641225501291e-12; 3.118210553589307e-12; 3.861499575207375e-12; 4.5104266881389206e-12; 2.5279022064249716e-11; 6.332483647919588e-11; 8.179290839744632e-11; 1.9241179247341838e-10; 2.377251819497684e-10; 2.377251819497684e-10; 2.377251819497684e-10; 2.377251819497684e-10; 2.377251819497684e-10; 3.762648680673853e-10; 4.2478505092738466e-10; 5.452288254986118e-10; 6.870627395110916e-10; 1.1722433847661196e-09; 1.6767489697325582e-09; 1.794870341379274e-09; 1.971893171900314e-09; 1.971893171900314e-09; 3.683115069310663e-09; 4.367699208727405e-09; 4.546836602575699e-09; 5.670785186683756e-09; 6.991207850982321e-09; 7.195555613367576e-09; 8.303910954283738e-09; 1.0368326871660785e-08; 1.452540845894924e-08; 1.5572986293211266e-08; 2.0570601164639797e-08; 2.1034803123367165e-08; 2.3137704832524547e-08; 3.149054123564124e-08; 4.3069383556698336e-08; 4.638299267461546e-08; 4.65353219894153e-08; 5.518991037343798e-08; 5.784935444423772e-08; 5.989093556336469e-08; 6.156981490555128e-08; 6.982287075725826e-08; 8.598175402882612e-08; 9.393284022832733e-08; 1.0276547515522002e-07; 1.0618136021459505e-07; 1.427432458937347e-07; 1.479813245926713e-07; 1.4925759778299788e-07; 1.946794431045147e-07; 2.46778041958494e-07; 2.948344121290337e-07; 3.532371372262103e-07; 3.880986260207744e-07; 5.577321626966352e-07; 6.299208964864026e-07; 6.673805318525932e-07; 6.673805318525932e-07; 8.297823048747685e-07; 8.339674388418603e-07; 8.660170029731726e-07; 8.777200373497231e-07; 9.822463166680949e-07; 1.3079916134634371e-06; 1.51758575162775e-06; 2.07112526817849e-06; 2.205236928124383e-06; 2.450940162208615e-06; 3.878607667297475e-06; 4.179146475474674e-06; 5.381279306135013e-06; 1.2304362232150695e-05; 1.2375081616087569e-05; 1.279493639647176e-05; 1.3268923055385737e-05; 1.3268923055385737e-05; 1.527992765491583e-05; 1.5449280661407645e-05; 1.5498516107485843e-05; 1.595911218164779e-05; 1.7090079578013972e-05; 2.042524345007846e-05; 3.053335644618538e-05; 3.602405958537832e-05; 4.550622830486202e-05; 5.826428641192471e-05; 6.484707207749309e-05; 8.232890503539995e-05; 8.257883791168467e-05; 8.421319594446617e-05; 8.730297037328594e-05; 0.00010776056908698134; 0.0001119048288448298; 0.0001322335978675375; 0.00014636999075042076; 0.00016189346720036038; 0.00017808425336754297; 0.00021049732822064587; 0.00025117420022058794; 0.0002652452950458932; 0.0002718864504795822; 0.00027820432005572264; 0.00032113080554701227; 0.00038453776693371663; 0.00041476222368508776; 0.0004224524250828287; 0.0004601228759628894; 0.0004814724943641282; 0.0011303542860313; 0.0014000542917314; 0.0017731038420892; 0.0020505587731585; 0.0022378309697704; 0.0028187518310092; 0.0028626589910413; 0.0033783379034436; 0.0033785221929293; 0.0037244768508078; 0.0038816440940594; 0.0043105477873176; 0.0050738495859132; 0.0053570195415722; 0.0054814673835909; 0.0065999085088281; 0.0073444206109429; 0.0084568432337518; 0.0111888062322808; 0.0123563544259949; 0.0123983633418964; 0.0161428886050652; 0.0166041002652209; 0.0239461944596263; 0.0255085366814945; 0.0259817880808067; 0.0324016809159931; 0.0403198851338656; 0.044901297966643; 0.0493155676939993; 0.0517499693438671; 0.0569213530455915; 0.0677694730935319; 0.0817897187940979; 0.0897127848630768; 0.0897127848630768; 0.0908772402064694; 0.0908772402064694; 0.1332119202868411; 0.1460848784791741; 0.1460848784791741; 0.1642913929691757; 0.1642913929691757; 0.1642913929691757; 0.1687319146389434; 0.181710614199711; 0.2222592445219346; 0.2271585546986287; 0.2468771733501051; 0.4854332397830083; 0.5639295540745877; 0.7438844118069171; 0.7693693268291167; 0.7725102068383561,Myocardial Ischemia; Lung Cancer; Stomach Neoplasms; Gastric Cancer; Stroke; Lung Neoplasms; Lung Carcinoma; Lung Adenocarcinoma; Benign Neoplasm Of Stomach; Stomach Carcinoma; Leukemia,7.071068485513988e-10; 0.0153260870217676; 0.0172144998405365; 0.0172144998405365; 0.0588219013114419; 0.0662475691169798; 0.0868883392670891; 0.1787826075739565; 0.2039740835961235; 0.3465144196435422; 0.5399696510344362,Nasopharyngeal carcinoma ORPHA:150; Hereditary pediatric Behcet-like disease ORPHA:476102; Autosomal dominant hyper-IgE syndrome ORPHA:2314; NON RARE IN EUROPE: Psoriatic arthritis ORPHA:40050; Chronic lymphoproliferative disorder of natural killer cells ORPHA:512017; STAT3-related early-onset multisystem autoimmune disease ORPHA:438159; T-cell large granular lymphocyte leukemia ORPHA:86872; Autosomal dominant dopa-responsive dystonia ORPHA:98808; GTP cyclohydrolase I deficiency ORPHA:2102; Hypohidrotic ectodermal dysplasia with immunodeficiency ORPHA:98813; Herpes simplex virus encephalitis ORPHA:1930; Autosomal recessive mendelian susceptibility to mycobacterial diseases due to partial JAK1 deficiency ORPHA:574957; MALT lymphoma ORPHA:52417; NON RARE IN EUROPE: Crohn disease ORPHA:206; Singleton-Merten dysplasia ORPHA:85191; Immunodeficiency by defective expression of MHC class I ORPHA:34592; Birdshot chorioretinopathy ORPHA:179; Complement hyperactivation-angiopathic thrombosis-protein-losing enteropathy syndrome ORPHA:566175; Generalized glucocorticoid resistance syndrome ORPHA:786; Immune dysregulation-inflammatory bowel disease-arthritis-recurrent infections-lymphopenia syndrome ORPHA:529977; Infantile-onset pulmonary alveolar proteinosis-hypogammaglobulinemia ORPHA:572428; Takayasu arteritis ORPHA:3287; Systemic lupus erythematosus ORPHA:536; MIRAGE syndrome ORPHA:494433; Mendelian susceptibility to mycobacterial diseases due to partial STAT1 deficiency ORPHA:319595; Autoimmune enteropathy and endocrinopathy-susceptibility to chronic infections syndrome ORPHA:391487; NIK deficiency ORPHA:447731; NON RARE IN EUROPE: Ankylosing spondylitis ORPHA:825; Bacterial susceptibility due to TLR signaling pathway deficiency ORPHA:183713; Overgrowth-macrocephaly-facial dysmorphism syndrome ORPHA:137634; Pulmonary arterial hypertension associated with connective tissue disease ORPHA:275798; STING-associated vasculopathy with onset in infancy ORPHA:425120; Susceptibility to viral and mycobacterial infections due to STAT1 deficiency ORPHA:391311; Familial normophosphatemic tumoral calcinosis ORPHA:306658; Galactose mutarotase deficiency ORPHA:570422; Variant ABeta2M amyloidosis ORPHA:314652; Waldenstrom macroglobulinemia ORPHA:33226; Griscelli syndrome type 2 ORPHA:79477; Vogt-Koyanagi-Harada disease ORPHA:3437; Autoimmune lymphoproliferative syndrome ORPHA:3261; Diffuse cutaneous systemic sclerosis ORPHA:220393; Primary biliary cholangitis ORPHA:186; Marfan syndrome type 2 ORPHA:284973; Metaphyseal dysplasia-maxillary hypoplasia-brachydacty syndrome ORPHA:2504; Autoimmune lymphoproliferative syndrome with recurrent viral infections ORPHA:275517; Neutrophil immunodeficiency syndrome ORPHA:183707; Palmoplantar keratoderma-esophageal carcinoma syndrome ORPHA:2198; Charcot-Marie-Tooth disease type 1C ORPHA:101083; Cleidocranial dysplasia ORPHA:1452; Predisposition to severe viral infection due to IRF7 deficiency ORPHA:574918; Proteasome-associated autoinflammatory syndrome ORPHA:324977; T-B+ severe combined immunodeficiency due to IL-7Ralpha deficiency ORPHA:169154; Hepatic veno-occlusive disease-immunodeficiency syndrome ORPHA:79124; Intermittent hydrarthrosis ORPHA:329967; Familial Chilblain lupus ORPHA:481662; Familial hemophagocytic lymphohistiocytosis ORPHA:540; Giant cell arteritis ORPHA:397; NON RARE IN EUROPE: Ulcerative colitis ORPHA:771; Chronic mucocutaneous candidiasis ORPHA:1334; Aicardi-Goutieres syndrome ORPHA:51; Behcet disease ORPHA:117; Ataxia-pancytopenia syndrome ORPHA:2585; Autosomal dominant Kenny-Caffey syndrome ORPHA:93325; Beta-propeller protein-associated neurodegeneration ORPHA:329284; Osteocraniostenosis ORPHA:2763; Adenosine monophosphate deaminase deficiency ORPHA:45; Imerslund-Grasbeck syndrome ORPHA:35858; Dehydrated hereditary stomatocytosis ORPHA:3202; Squamous cell carcinoma of salivary glands ORPHA:500481; Squamous cell carcinoma of the hypopharynx ORPHA:494547; Squamous cell carcinoma of the larynx ORPHA:494550; Squamous cell carcinoma of the lip ORPHA:502366; Squamous cell carcinoma of the nasal cavity and paranasal sinuses ORPHA:500464; Squamous cell carcinoma of the oral cavity ORPHA:502363; Squamous cell carcinoma of the oropharynx ORPHA:500478; Familial platelet disorder with associated myeloid malignancy ORPHA:71290; High grade B-cell lymphoma with MYC and/ or BCL2 and/or BCL6 rearrangement ORPHA:480541; Epidermodysplasia verruciformis ORPHA:302; Limited cutaneous systemic sclerosis ORPHA:220402; 1p21.3 microdeletion syndrome ORPHA:293948; Multiple intestinal atresia ORPHA:2300; CLN3 disease ORPHA:228346; Combined immunodeficiency-enteropathy spectrum ORPHA:436252; Dihydropyrimidine dehydrogenase deficiency ORPHA:1675; Distal monosomy 15q ORPHA:1596; Severe combined immunodeficiency due to IKK2 deficiency ORPHA:397787; Immunodeficiency due to interleukin-1 receptor-associated kinase-4 deficiency ORPHA:70592; Primary immunodeficiency with post-measles-mumps-rubella vaccine viral infection ORPHA:431166; Squamous cell carcinoma of the esophagus ORPHA:99977,6.10801728836975e-11; 1.7877420438201673e-08; 2.859667220539484e-06; 2.859667220539484e-06; 2.859667220539484e-06; 2.859667220539484e-06; 2.859667220539484e-06; 3.28973817825433e-05; 3.28973817825433e-05; 3.295782224790152e-05; 0.00024116799717032887; 0.0019696624570933; 0.0022487953361182; 0.002691706985611; 0.0133474287859103; 0.0133474287859103; 0.0133474287859103; 0.0133474287859103; 0.0133474287859103; 0.0133474287859103; 0.0133474287859103; 0.0142744270060997; 0.0368542044009867; 0.0514345493431829; 0.0514345493431829; 0.0514345493431829; 0.0514345493431829; 0.0514345493431829; 0.0514345493431829; 0.0514345493431829; 0.0514345493431829; 0.0514345493431829; 0.0514345493431829; 0.0514345493431829; 0.0514345493431829; 0.0514345493431829; 0.0514345493431829; 0.0514345493431829; 0.0514345493431829; 0.0557820633193028; 0.0557820633193028; 0.0597169850674746; 0.1927589191138116; 0.1927589191138116; 0.1927589191138116; 0.1927589191138116; 0.1927589191138116; 0.1927589191138116; 0.1927589191138116; 0.1927589191138116; 0.1927589191138116; 0.1927589191138116; 0.1927589191138116; 0.1927589191138116; 0.1938708167942525; 0.1950017883804084; 0.1950017883804084; 0.1973394623267924; 0.1973394623267924; 0.2032240249605243; 0.2365535673573277; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.491912282528682; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659,Human gammaherpesvirus 8 vIRF-4 (gene: vIRF-4),0.4162402588521184,Homo sapiens;Homo sapiens HEK293 embryonic kidney cell;Homo sapiens T-cell;In vitro,0.35;0.4,Homo sapiens;chemical synthesis,Homo sapiens
ITPRIP,,,,,"Camurati-Engelmann disease ORPHA:1328; Tumor necrosis factor receptor 1 associated periodic syndrome ORPHA:32960; Infantile inflammatory bowel disease with neurological involvement ORPHA:565788; Combined immunodeficiency due to Moesin deficiency ORPHA:504530; Growth retardation-mild developmental delay-chronic hepatitis syndrome ORPHA:391366; Loeys-Dietz syndrome ORPHA:60030; Musculocontractural Ehlers-Danlos syndrome ORPHA:2953; Atrial septal defect, sinus venosus type ORPHA:99105; Paternal uniparental disomy of chromosome 6 ORPHA:96191; Squamous cell carcinoma of salivary glands ORPHA:500481; Squamous cell carcinoma of the hypopharynx ORPHA:494547; Squamous cell carcinoma of the larynx ORPHA:494550; Squamous cell carcinoma of the lip ORPHA:502366; Squamous cell carcinoma of the nasal cavity and paranasal sinuses ORPHA:500464; Squamous cell carcinoma of the oral cavity ORPHA:502363; Squamous cell carcinoma of the oropharynx ORPHA:500478; Mucopolysaccharidosis type 6, rapidly progressing ORPHA:276212; Mucopolysaccharidosis type 6, slowly progressing ORPHA:276223; BICD2-related autosomal dominant childhood-onset proximal spinal muscular atrophy ORPHA:363454; Polydactyly of a biphalangeal thumb ORPHA:93339; Temtamy preaxial brachydactyly syndrome ORPHA:363417",0.0514345493431829; 0.0514345493431829; 0.0514345493431829; 0.1927589191138116; 0.1927589191138116; 0.1927589191138116; 0.1927589191138116; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659,,,,,,
L3MBTL1,"Leukemia, Myelocytic, Acute; leukemia; Brain Neoplasms; Malignant neoplasm of breast; Breast Carcinoma; MYELODYSPLASTIC SYNDROME; Myeloid Leukemia; Hematologic Neoplasms; Hematopoietic Neoplasms; Myeloproliferative disease; Polycythemia Vera; Chronic myeloproliferative disorder; Malignant neoplasm of brain",8.303910954283738e-09; 5.784935444423772e-08; 4.157277636684319e-07; 8.660170029731726e-07; 5.381279306135013e-06; 1.279493639647176e-05; 2.042524345007846e-05; 6.058590126387572e-05; 6.484707207749309e-05; 0.0005011878920853237; 0.0025118094772522; 0.0044119363017658; 0.1545590833140752,,,"Primary lateral sclerosis ORPHA:35689; Spastic paraplegia type 7 ORPHA:99013; Deafness-infertility syndrome ORPHA:94064; Autosomal recessive anterior segment dysgenesis ORPHA:519388; Tatton-Brown-Rahman syndrome ORPHA:404443; X-linked dominant chondrodysplasia, Chassaing-Lacombe type ORPHA:163966; Congenital stationary night blindness ORPHA:215",0.4838060079820406; 0.4838060079820406; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5352376236648427,,,Homo sapiens;In vitro,0.4;0.44;0.56,Homo sapiens,Homo sapiens
LIF,"Inflammation; Asthma; Lymphoma; Multiple Myeloma; Rheumatoid Arthritis; Autoimmune Diseases; Ovarian Carcinoma; Malignant neoplasm of ovary; Multiple Sclerosis; Neoplasm Metastasis; Leukemia, Myelocytic, Acute; Arthritis; Brain Ischemia; Cerebrovascular accident; Degenerative polyarthritis; Liver neoplasms; Mammary Neoplasms; Glioblastoma; leukemia; Diabetes Mellitus; Diabetes; Ischemic stroke; Pancreatic carcinoma; Alzheimer's Disease; Glioma; Malignant neoplasm of pancreas; Pain; Malignant neoplasm of mouth; Myocardial Infarction; Adult T-Cell Lymphoma/Leukemia; Brain Neoplasms; Fibroid Tumor; Leukemia, T-Cell; Tumor Progression; Malignant neoplasm of breast; Myasthenia Gravis; Liver carcinoma; Carcinogenesis; Polycystic Ovary Syndrome; Ankylosing spondylitis; Colon Carcinoma; Osteosarcoma of bone; Lip and Oral Cavity Carcinoma; melanoma; Breast Carcinoma; Osteosarcoma; Delirium; Encephalomyelitis; MYELODYSPLASTIC SYNDROME; Cachexia; Senile Plaques; Prostate carcinoma; ovarian neoplasm; Nonalcoholic Steatohepatitis; Myeloid Leukemia; Herpes Simplex Infections; Squamous cell carcinoma; Malignant neoplasm of prostate; Endometrial adenocarcinoma; Parkinson Disease; Mouth Neoplasms; Uterine Fibroids; Congestive heart failure; Mitral Valve Stenosis; Cardiomegaly; Renal Cell Carcinoma; Adenoma; Cardiac Hypertrophy; Diabetes Mellitus, Non-Insulin-Dependent; Leukemogenesis; Heart failure; Myeloproliferative disease; Amyotrophic Lateral Sclerosis; Spontaneous abortion; Clostridium; difficile (disorder); NONAKA MYOPATHY; Hypercalcemia; Oral Cavity Carcinoma; Type II Mucolipidosis; Renal carcinoma; Abortion, Tubal; Choriocarcinoma; Stromal Neoplasm; Non-alcoholic Fatty Liver Disease; Medulloblastoma; Schizophrenia; Ewings sarcoma-primitive neuroectodermal tumor (PNET); Blast Phase; Microscopic Polyarteritis; Brain Diseases; Uterine Neoplasms; Cholangiocarcinoma; Pain, Postoperative; Cutaneous Melanoma; Rhabdomyosarcoma; Primary Effusion Lymphoma; Chordoma; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating; Prolactinoma; Cyst; Depressive disorder; Ovarian Failure, Premature; Ewings sarcoma; Trichohepatoenteric Syndrome; Cerebral Amyloid Angiopathy; Mental Depression; Cholangiolocellular Carcinoma; Desmoplastic infantile astrocytoma; Atrophy, Disuse; Neuroepithelioma, Peripheral; Blastocyst Disintegration; Ectopic Pregnancy; Embryo Disintegration; early pregnancy; Ganglioglioma; Embryo Loss; Medullary carcinoma of thyroid; Premature Menopause; Non-Functioning Pituitary Gland Neoplasm; Female Urogenital Diseases; Neuroepithelioma; Sterility, Postpartum; Subfertility, Female; Female sterility; Neuroectodermal Tumor, Primitive; Female infertility; Ascites; Weight decreased; Sclerocystic Ovaries; Agnosia for Pain; Pituitary Neoplasms; Neurofibromatosis 2; Muscular Dystrophy; Embryonal Carcinoma; Germ cell tumor",2.8114433253573326e-17; 1.803641225501291e-12; 4.5104266881389206e-12; 2.5279022064249716e-11; 1.9241179247341838e-10; 5.452288254986118e-10; 6.870627395110916e-10; 1.971893171900314e-09; 4.546836602575699e-09; 5.670785186683756e-09; 8.303910954283738e-09; 1.587872453479067e-08; 1.8815395768840057e-08; 2.0570601164639797e-08; 2.1034803123367165e-08; 4.3069383556698336e-08; 4.65353219894153e-08; 5.518991037343798e-08; 5.784935444423772e-08; 5.8317433871210796e-08; 6.156981490555128e-08; 6.156981490555128e-08; 6.982287075725826e-08; 9.273260676030806e-08; 1.427432458937347e-07; 1.4925759778299788e-07; 1.6759866477134858e-07; 2.0279723135488897e-07; 2.247163660896597e-07; 2.46778041958494e-07; 4.157277636684319e-07; 6.630279934320317e-07; 6.805796735296268e-07; 8.297823048747685e-07; 8.660170029731726e-07; 8.696626324623331e-07; 1.3079916134634371e-06; 1.51758575162775e-06; 2.086123696221558e-06; 2.1020461880694925e-06; 2.205236928124383e-06; 2.560217628497434e-06; 2.576211756838249e-06; 4.179146475474674e-06; 5.381279306135013e-06; 6.3131986281381465e-06; 8.32456450186878e-06; 1.08089380369295e-05; 1.279493639647176e-05; 1.3410647656206684e-05; 1.3673911177979942e-05; 1.527992765491583e-05; 1.8507296589967813e-05; 2.0234336876324372e-05; 2.042524345007846e-05; 2.1109857936882128e-05; 3.053335644618538e-05; 3.053335644618538e-05; 3.1066725823367694e-05; 3.372277447426952e-05; 3.602405958537832e-05; 5.013426562854155e-05; 8.232890503539995e-05; 0.0001015974347517202; 0.00011072370132707822; 0.0001119048288448298; 0.00012202062264879416; 0.00012202062264879416; 0.00016189346720036038; 0.0002652452950458932; 0.00027820432005572264; 0.0005011878920853237; 0.0009325953874753212; 0.0017731038420892; 0.0017731038420892; 0.001881335207053; 0.0025122887786423; 0.0027346449758241; 0.0027942850562877; 0.0028626589910413; 0.0038705790239355; 0.0043105477873176; 0.0050894481995015; 0.0075325383349707; 0.0084568432337518; 0.0093325514582534; 0.0097159454554601; 0.0114187031414039; 0.0145436543557976; 0.0208452312614567; 0.030006907592274; 0.0334053723619937; 0.0384689641633299; 0.0425171404778382; 0.0462818499370266; 0.0491632343384016; 0.0517499693438671; 0.0543546439241988; 0.0559578912214163; 0.0647102740274508; 0.0691714743582008; 0.0704851772553303; 0.0741310297608694; 0.0784196844880443; 0.0805158056052076; 0.0887984457495041; 0.0897127848630768; 0.0897127848630768; 0.0972679220674381; 0.0972679220674381; 0.0972679220674381; 0.0972679220674381; 0.0972679220674381; 0.1050724946352408; 0.1130019719865939; 0.1130019719865939; 0.131813871137714; 0.1397055058487397; 0.1584804022044084; 0.1703929618871976; 0.1932166112700285; 0.2272199982000937; 0.2272199982000937; 0.2272199982000937; 0.23058850720196; 0.2520982519141255; 0.3066971380488823; 0.3417325482389482; 0.3540699900993737; 0.3540699900993737; 0.3696586134131318; 0.417000940404929; 0.4389761493558894; 0.4424335623428572; 0.7753747415558083,Miscarriage; Delirium; Mental Depression; Non-Alcoholic Fatty Liver Disease; Female Urogenital Diseases; Polycystic Ovary Syndrome; Subfertility; Sclerocystic Ovaries,0.0088732170532262; 0.0378359748125562; 0.0511376198481248; 0.0984994301026393; 0.2072542702968064; 0.2725906821661307; 0.2943246801469203; 0.3498454359561224,"Quebec platelet disorder ORPHA:220436; Interstitial lung disease-nephrotic syndrome-epidermolysis bullosa syndrome ORPHA:306504; LMNA-related cardiocutaneous progeria syndrome ORPHA:363618; Mandibuloacral dysplasia with type A lipodystrophy ORPHA:90153; Atypical Werner syndrome ORPHA:79474; Autosomal recessive Emery-Dreifuss muscular dystrophy ORPHA:98855; Autosomal semi-dominant severe lipodystrophic laminopathy ORPHA:280365; Charcot-Marie-Tooth disease type 2B1 ORPHA:98856; Congenital muscular dystrophy due to LMNA mutation ORPHA:157973; Dilated cardiomyopathy-hypergonadotropic hypogonadism syndrome ORPHA:2229; Familial dilated cardiomyopathy with conduction defect due to LMNA mutation ORPHA:300751; Familial partial lipodystrophy, Dunnigan type ORPHA:2348; Familial partial lipodystrophy, Kobberling type ORPHA:79084; Heart-hand syndrome, Slovenian type ORPHA:168796; Juvenile Paget disease ORPHA:2801; Thyroid ectopia ORPHA:95712; Aneurysm-osteoarthritis syndrome ORPHA:284984; Crisponi syndrome ORPHA:1545; Giant cell glioblastoma ORPHA:251579; Gliosarcoma ORPHA:251576",3.28973817825433e-05; 0.0133474287859103; 0.0514345493431829; 0.0514345493431829; 0.0514345493431829; 0.0514345493431829; 0.0514345493431829; 0.0514345493431829; 0.0514345493431829; 0.0514345493431829; 0.0514345493431829; 0.0514345493431829; 0.0514345493431829; 0.0514345493431829; 0.0514345493431829; 0.0514345493431829; 0.1927589191138116; 0.1927589191138116; 0.5220015007747252; 0.5220015007747252,Cercopithecine betaherpesvirus 5 membrane protein US27B (gene: US27B),0.3911903778732946,,,,
LTB,"Asthma; Lymphoma; Chronic Obstructive Airway Disease; Rheumatoid Arthritis; Arteriosclerosis; Crohn Disease; Autoimmune Diseases; Peritonitis; Hodgkin Disease; Atherosclerosis; Leukemia, Myelocytic, Acute; Arthritis; Inflammatory Bowel Diseases; Liver neoplasms; Aortic Aneurysm, Abdominal; leukemia; Pancreatic carcinoma; Malaria; Malignant neoplasm of pancreas; Pain; Myocardial Infarction; Tuberculosis; Chronic Lymphocytic Leukemia; Tumor Progression; Bladder Neoplasm; Liver carcinoma; Liver Cirrhosis, Experimental; Leprosy; Acute lymphocytic leukemia; Hepatitis B; Kidney Failure, Chronic; Chronic kidney disease stage 5; Malignant neoplasm of urinary bladder; Sleep Apnea, Obstructive; Carcinoma of bladder; Malignant Head and Neck Neoplasm; Lymphoma, Non-Hodgkin; Chronic graft-versus-host disease; Primary Sj??gren's syndrome; Myeloid Leukemia, Chronic; Intrauterine infection; Leukemogenesis; airway disease; Situs Inversus; Pouchitis; Huntington Disease; Christ-Siemens-Touraine syndrome; Histoplasmosis; Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Head and Neck Carcinoma; Shigella Infections; Splenic Marginal Zone B-Cell Lymphoma; HIV-1 infection; Mature T ALL; Oedema auricular; Leprosy, Multibacillary; Bronchitis, Chronic; Small Lymphocytic Lymphoma",1.803641225501291e-12; 4.5104266881389206e-12; 1.3121548808139071e-10; 1.9241179247341838e-10; 2.377251819497684e-10; 4.2478505092738466e-10; 5.452288254986118e-10; 5.452288254986118e-10; 6.195332209150018e-09; 7.195555613367576e-09; 8.303910954283738e-09; 1.587872453479067e-08; 2.3137704832524547e-08; 4.3069383556698336e-08; 5.1290058242058653e-08; 5.784935444423772e-08; 6.982287075725826e-08; 1.0618136021459505e-07; 1.4925759778299788e-07; 1.6759866477134858e-07; 2.247163660896597e-07; 6.673805318525932e-07; 7.931659047151387e-07; 8.297823048747685e-07; 9.822463166680949e-07; 1.3079916134634371e-06; 7.691726899679507e-06; 8.567994785462795e-06; 1.2375081616087569e-05; 1.3755659311680946e-05; 2.0820699372778346e-05; 2.910435331986992e-05; 3.1491435270594376e-05; 3.602405958537832e-05; 3.9650653676454574e-05; 4.3188904868696655e-05; 4.360044574654907e-05; 7.358523784131203e-05; 8.232890503539995e-05; 0.00021049732822064587; 0.00024044665139790348; 0.0002652452950458932; 0.0002926994143155384; 0.0013734265963756; 0.0015698089771612; 0.0017731038420892; 0.0043470921917622; 0.0048028611524245; 0.0094642528600355; 0.0198983219186433; 0.0214892684107681; 0.0276267477370436; 0.0324016809159931; 0.0457039625575448; 0.0897127848630768; 0.0897127848630768; 0.1130019719865939; 0.124149904653194; 0.3306602962670145,,,Nasopharyngeal carcinoma ORPHA:150; NON RARE IN EUROPE: Psoriatic arthritis ORPHA:40050; Hypohidrotic ectodermal dysplasia with immunodeficiency ORPHA:98813; NON RARE IN EUROPE: Crohn disease ORPHA:206; Immunodeficiency by defective expression of MHC class I ORPHA:34592; Birdshot chorioretinopathy ORPHA:179; Revesz syndrome ORPHA:3088; Systemic lupus erythematosus ORPHA:536; NIK deficiency ORPHA:447731; NON RARE IN EUROPE: Ankylosing spondylitis ORPHA:825; Odonto-onycho-dermal dysplasia ORPHA:2721; Pulmonary arterial hypertension associated with connective tissue disease ORPHA:275798; Schopf-Schulz-Passarge syndrome ORPHA:50944; Autoimmune lymphoproliferative syndrome ORPHA:3261; Primary biliary cholangitis ORPHA:186; Acute encephalopathy with biphasic seizures and late reduced diffusion ORPHA:363549; Neutrophil immunodeficiency syndrome ORPHA:183707; Predisposition to severe viral infection due to IRF7 deficiency ORPHA:574918; Combined immunodeficiency due to OX40 deficiency ORPHA:431149; Immunodeficiency due to CD25 deficiency ORPHA:169100; Familial hemophagocytic lymphohistiocytosis ORPHA:540; NON RARE IN EUROPE: Multiple sclerosis ORPHA:802; Aicardi-Goutieres syndrome ORPHA:51; Laron syndrome with immunodeficiency ORPHA:220465; Obesity due to pro-opiomelanocortin deficiency ORPHA:71526; Combined immunodeficiency due to IL21R deficiency ORPHA:357329; Severe combined immunodeficiency due to LAT deficiency ORPHA:504523; WHIM syndrome ORPHA:51636; Imerslund-Grasbeck syndrome ORPHA:35858; Complete hydatidiform mole ORPHA:254688; Epidermodysplasia verruciformis ORPHA:302; Oligoarticular juvenile idiopathic arthritis ORPHA:85410; Rheumatoid factor-negative polyarticular juvenile idiopathic arthritis ORPHA:85408; Common variable immunodeficiency ORPHA:1572; Hairy cell leukemia variant ORPHA:300878; T-B+ severe combined immunodeficiency due to CD3delta/CD3epsilon/CD3zeta ORPHA:169160; Autoimmune lymphoproliferative syndrome due to CTLA4 haploinsuffiency ORPHA:436159; BENTA disease ORPHA:464336; Bleeding disorder due to CalDAG-GEFI deficiency ORPHA:420566; C syndrome ORPHA:1308; Osteogenesis imperfecta type 5 ORPHA:216828; Persistent polyclonal B-cell lymphocytosis ORPHA:300324; Combined immunodeficiency due to CD27 deficiency ORPHA:238505; Combined immunodeficiency due to ZAP70 deficiency ORPHA:911; Pyogenic arthritis-pyoderma gangrenosum-acne syndrome ORPHA:69126; Congenital non-communicating hydrocephalus ORPHA:269510; Severe combined immunodeficiency due to CARD11 deficiency ORPHA:357237; Severe combined immunodeficiency due to CARMIL2 deficiency ORPHA:542301; Severe combined immunodeficiency due to CORO1A deficiency ORPHA:228003; Severe combined immunodeficiency due to LCK deficiency ORPHA:280142; Short stature due to growth hormone qualitative anomaly ORPHA:629; Spinocerebellar ataxia type 40 ORPHA:423275; Susceptibility to respiratory infections associated with CD8alpha chain mutation ORPHA:169085; T-B+ severe combined immunodeficiency due to JAK3 deficiency ORPHA:35078; T-B+ severe combined immunodeficiency due to gamma chain deficiency ORPHA:276; T-cell immunodeficiency with epidermodysplasia verruciformis ORPHA:324294; TCR-alpha-beta-positive T-cell deficiency ORPHA:397959; Fatal post-viral neurodegenerative disorder ORPHA:391343; X-linked hyper-IgM syndrome ORPHA:101088; X-linked lymphoproliferative disease due to SH2D1A deficiency ORPHA:538931; X-linked severe congenital neutropenia ORPHA:86788; X-linked thrombocytopenia with normal platelets ORPHA:852; Hyperinsulinism due to UCP2 deficiency ORPHA:276556; Hyperzincemia and hypercalprotectinemia ORPHA:251523; Immune dysregulation-polyendocrinopathy-enteropathy-X-linked syndrome ORPHA:37042; Classic mycosis fungoides ORPHA:2584; Coats plus syndrome ORPHA:313838; Sezary syndrome ORPHA:3162; Stevens-Johnson syndrome ORPHA:36426; Isolated growth hormone deficiency type II ORPHA:231679; Female infertility due to oocyte meiotic arrest ORPHA:488191; Autosomal recessive malignant osteopetrosis ORPHA:667; Autosomal agammaglobulinemia ORPHA:33110,6.10801728836975e-11; 2.859667220539484e-06; 3.295782224790152e-05; 0.002691706985611; 0.0133474287859103; 0.0133474287859103; 0.0133474287859103; 0.0368542044009867; 0.0514345493431829; 0.0514345493431829; 0.0514345493431829; 0.0514345493431829; 0.0514345493431829; 0.0557820633193028; 0.0597169850674746; 0.1927589191138116; 0.1927589191138116; 0.1927589191138116; 0.1927589191138116; 0.1927589191138116; 0.1950017883804084; 0.1996794456641899; 0.2032240249605243; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4927160916210667; 0.4927160916210667; 0.5109811637213543; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659,Cowpox virus CrmC or CPXV191 protein (gene: CrmC); Vaccinia virus secreted TNF-receptor-like protein (gene: A53R); Horsepox virus HSPV175 (Tumor necrosis factor receptor superfamily (TNFRSF)); Yaba-like disease virus 2L protein (gene: 2L),0.0318026352788518; 0.0601536450796885; 0.0712548287392585; 0.086428048188775,yeasx,0.37,Homo sapiens,Bacillus anthracis;Yersinia pestis
MAFB,"Lymphoma; Multiple Myeloma; Leukemia, Myelocytic, Acute; Hypertensive disease; leukemia; Liver carcinoma; Nasopharyngeal carcinoma; Cachexia; Diabetes Mellitus, Non-Insulin-Dependent; Kidney Diseases; Kidney Failure; Osteopenia; Cleft palate, isolated; Renal Insufficiency; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Arthralgia; Dyslipidemias; Proteinuria; Leukemia, Plasma Cell; Oculomotor Nerve Paralysis; Abnormal vertebral segmentation and fusion; Ulnar deviation of hand; Duane Retraction Syndrome; Cleft Palate; Cardiac Lymphoma; Slender long bone; Congenital pes cavus; Milroy Disease; Prominent eyes; Protruding eyes; Prominent globes; Exophthalmos; Kidney damage; Limitation of joint mobility; Short palpebral fissure; Low posterior hairline; Gait abnormality; Sensorineural Hearing Loss (disorder); Electromyogram abnormal; Retrusion of upper jaw bones; Decreased projection of maxilla; Deficiency of upper jaw bones; Hypoplasia of the maxilla; Hypotrophic maxilla; Maxillary retrognathia; Triangular face; Blepharophimosis; Renal failure in adulthood; Sunken eyes; Enophthalmos; Flexion contracture of proximal interphalangeal joint; Uranostaphyloschisis; Anteverted nostril; Generalized osteopenia; Cleft upper lip; Increase in blood pressure; Osteogenesis Imperfecta; Intellectual Disability; Retrusion of lower jaw; Decreased projection of lower jaw; Decreased projection of mandible; Hypoplastic mandible condyle; Aplasia/Hypoplasia of the mandible; Micrognathism; Strabismus",4.5104266881389206e-12; 2.5279022064249716e-11; 8.303910954283738e-09; 1.0368326871660785e-08; 5.784935444423772e-08; 1.3079916134634371e-06; 1.5208470671427406e-06; 1.3410647656206684e-05; 0.00016189346720036038; 0.00022336414159326664; 0.0002559467947532168; 0.0005214896245221155; 0.0070090734514155; 0.007861073629675; 0.0198983219186433; 0.0300972754548838; 0.0404707605808569; 0.0804567619234804; 0.0805158056052076; 0.0897127848630768; 0.1206032442301429; 0.1401454825042905; 0.181710614199711; 0.2271585546986287; 0.2272199982000937; 0.2416367579687983; 0.2670582190879765; 0.2723453780817489; 0.2831951348626981; 0.2831951348626981; 0.2884480666215576; 0.2957377254678394; 0.316142834424839; 0.397280768882461; 0.4089444818350988; 0.4089444818350988; 0.4214414516582417; 0.4371385994351301; 0.4462255858401349; 0.4678790703646548; 0.4678790703646548; 0.4678790703646548; 0.4678790703646548; 0.4678790703646548; 0.4678790703646548; 0.4781931916730066; 0.4817554402514458; 0.507968267075787; 0.5314342460872805; 0.5344870281804397; 0.5499753095162228; 0.5808240999890296; 0.5977671298158864; 0.6484404076497645; 0.7022429631067875; 0.7124872261498931; 0.7664057555075189; 0.9388725395674395; 0.9391234856700628; 0.9391234856700628; 0.9391234856700628; 0.9391234856700628; 0.9397498663798326; 0.9408026747043652; 0.942254495202649,Hypertension; Spina Bifida Occulta; Duane Retraction Syndrome; Oculomotor Nerve Palsy; Stenosis Of External Auditory Canal; Kidney Disease; Blepharospasm; Hypoplasia Of Optic Disc; Congenital Hypoplasia Of Radius; Ectopic Kidney; Aniridia; Fundus Coloboma; Retinal Coloboma; Brachydactyly; Proptosis; Plagiocephaly; Neck Webbing; Osteopenia; Blepharophimosis; Hypoplasia Of The Maxilla; Congenital Camptodactyly; Renal Insufficiency; Microcornea; Congenital Coloboma Of Iris; Nystagmus; Polydactyly; Congenital Clubfoot; Hearing Loss; Strabismus; Micrognathism; Ptosis; Microcephaly; Developmental Delay,0.0048927857621509; 0.1787826075739565; 0.1851562166631526; 0.2089805590322066; 0.2502315247388869; 0.2657257246540625; 0.2780260029788479; 0.2828835905949769; 0.3122348651468142; 0.3317467420738357; 0.3501279647290265; 0.3940513235245542; 0.3975256936810483; 0.426652795095747; 0.4915822556820058; 0.4915822556820058; 0.5041604044703301; 0.5336711452646915; 0.5632344309031201; 0.6088518085174112; 0.6088518085174112; 0.6306478602359603; 0.6507064790248047; 0.702054812092573; 0.7206496565839581; 0.7544899707535798; 0.8567287583710481; 0.9252470124617264; 0.9653060148705728; 0.9920888769304664; 0.9920888769304664; 0.9920888769304664; 0.9999792400275376,Thrombomodulin-related bleeding disorder ORPHA:436169; Acute myeloid leukemia with CEBPA somatic mutations ORPHA:319480; Beckwith-Wiedemann syndrome due to CDKN1C mutation ORPHA:231120; Charcot-Marie-Tooth disease type 4D ORPHA:99950; Charcot-Marie-Tooth disease type 4H ORPHA:99954; Tangier disease ORPHA:31150; Intrauterine growth restriction-short stature-early adult-onset diabetes syndrome ORPHA:436144; ACys amyloidosis ORPHA:100008; Atypical Gaucher disease due to saposin C deficiency ORPHA:309252; Multicentric carpo-tarsal osteolysis with or without nephropathy ORPHA:2774; NON RARE IN EUROPE: Berger disease ORPHA:34145; Ayme-Gripp syndrome ORPHA:1272; C1 inhibitor deficiency ORPHA:459353; Cerebrotendinous xanthomatosis ORPHA:909; Congenital brain dysgenesis due to glutamine synthetase deficiency ORPHA:71278; Sanfilippo syndrome type C ORPHA:79271; Duane retraction syndrome with congenital deafness ORPHA:529574; Encephalopathy due to prosaposin deficiency ORPHA:139406; Hereditary angioedema type 1 ORPHA:100050; Hereditary angioedema type 2 ORPHA:100051; Duane retraction syndrome ORPHA:233; Inherited acute myeloid leukemia ORPHA:319465; Semantic dementia ORPHA:100069,0.0514345493431829; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5333039990776665,Japanese encephalitis virus anchored core protein C; Salivirus NG-J1 3D; Human enteric coronavirus 4408 spike protein (gene: S); Human enteric coronavirus strain 4408 spike protein; Japanese encephalitis virus hypothetical protein; Japanese encephalitis virus prodexcised_polyprotein 1..794; Sagiyama virus full_polyprotein 1..1253 (gene: C-E3-E2-6K-E1); West Nile virus lineage 1 capsid protein C (gene: flavivirus polyprotein); Human parainfluenza virus 1 strain Washington/1964 phosphoprotein (gene: P); Human respirovirus 1 phosphoprotein (gene: P); Rotavirus A NSP4; Variola virus hypothetical protein (gene: A28L),0.312710113238199; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.5527915175903153; 0.5527915175903153; 0.6410694868065719; 0.7069856179129146,Cricetulus griseus ovary K1;Homo sapiens HEK293T embryonic kidney cell;Homo sapiens THP-1 acute monocytic leukemia cell;Homo sapiens mononuclear cell;In vitro;yeasx,0.35;0.37;0.4;0.71,Homo sapiens,Homo sapiens
MASP2,"Inflammation; Pneumonia; Psoriasis; Virus Diseases; Rheumatoid Arthritis; Crohn Disease; Ovarian Carcinoma; Ulcerative Colitis; Infection; Malignant neoplasm of ovary; Multiple Sclerosis; Hepatitis C; Ischemic stroke; Malaria; Diffuse Large B-Cell Lymphoma; Septicemia; Sepsis; Cystic Fibrosis; Restenosis; Tuberculosis; Liver carcinoma; Leprosy; Colorectal Neoplasms; Severe Acute Respiratory Syndrome; Lymphoma, Non-Hodgkin; Systemic Inflammatory Response Syndrome; Streptococcal pneumonia; Lymphoma, Follicular; Amyotrophic Lateral Sclerosis; Erythema Multiforme; Leprosy, Lepromatous; Cardiomyopathies; Squamous cell carcinoma of esophagus; Coronavirus Infections; Frontotemporal dementia; Angioedemas, Hereditary; Immune Complex Diseases; Chronic Fatigue Syndrome; Chronic Chagas' disease; Serum total cholesterol measurement",2.8114433253573326e-17; 7.980856456624717e-16; 3.118210553589307e-12; 6.332483647919588e-11; 1.9241179247341838e-10; 4.2478505092738466e-10; 6.870627395110916e-10; 1.6767489697325582e-09; 1.794870341379274e-09; 1.971893171900314e-09; 4.546836602575699e-09; 6.991207850982321e-09; 6.156981490555128e-08; 1.0618136021459505e-07; 3.532371372262103e-07; 5.254943571583271e-07; 5.313225371508493e-07; 5.577321626966352e-07; 6.673805318525932e-07; 6.673805318525932e-07; 1.3079916134634371e-06; 8.567994785462795e-06; 1.3034577772762696e-05; 2.1083292452040976e-05; 4.360044574654907e-05; 5.248375780672949e-05; 6.087890235661384e-05; 0.0002484853090912064; 0.0009325953874753212; 0.0010244557923259; 0.0011626911115394; 0.0021326108499664; 0.0062748297137782; 0.0096630827054915; 0.0105367304020196; 0.030006907592274; 0.0972679220674381; 0.1204795752338222; 0.176056923749369; 0.6408845518751061,Ulcerative Colitis; Lupus Erythematosus; Complement Component Deficiency; Immunodeficiency,0.0002754573766813309; 0.087745240825312; 0.1110148026021272; 0.4739324128601933,Hemochromatosis type 3 ORPHA:225123; Hypermethioninemia due to glycine N-methyltransferase deficiency ORPHA:289891; Immunodeficiency due to MASP-2 deficiency ORPHA:331187; Argininemia ORPHA:90; Autosomal dominant multiple pterygium syndrome ORPHA:65743; PLG-related hereditary angioedema with normal C1Inh ORPHA:537072; Dopamine beta-hydroxylase deficiency ORPHA:230; Hypoplasminogenemia ORPHA:722,0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659,"Echovirus E7 VP2; Coxsackievirus B5 VP2 capsid protein, polyprotein region 3 (gene: 1A); Echovirus E11 1B(VP2); Enterovirus B 1B(VP2); Human rhinovirus B5 1B; Monkeypox virus Zaire-96-I-16 B2R (gene: B2R); Echovirus E19 VP2; Echovirus E15 VP2; Enterovirus H capsid protein VP2; Human enterovirus 79 1B (VP2); Echovirus E29 VP2; Echovirus E20 VP2; Echovirus E16 VP2; Echovirus E26 VP2; Echovirus E33 VP2; Echovirus E4 VP2; Echovirus 9 strain Barty VP2; Echovirus E14 VP2; Echovirus E21 VP2; Echovirus E24 VP2; Echovirus E27 VP2; Enterovirus B111 VP2; Echovirus E25 VP2; Echovirus E6 VP2; Enterovirus B97 VP2; Human cosavirus B VP2; Echovirus E13 VP2; Echovirus E3 VP2; Echovirus E31 VP2; Echovirus 9 strain Hill polyprotein region 2; Echovirus E2 VP2; Echovirus E32 VP2; Human cosavirus full_polyprotein 1..2121; Human cosavirus D VP2; Echovirus E18 full_polyprotein 1..2189; Echovirus E12 polyprotein; Coxsackievirus B4 full_polyprotein 1..2183; Echovirus E30 full_polyprotein 1..2194; Coxsackievirus B6 full_polyprotein 1..2184; Echovirus E17 VP2; Coxsackievirus B2 full_polyprotein 1..2187; Enterovirus B genome polyportein; Enterovirus B73 full_polyprotein 1..2188; Enterovirus B106 full_polyprotein 1..2192; Echovirus E5 full_polyprotein 1..2196; Echovirus E9 full_polyprotein 1..2203; Human enterovirus 71 HZ08/Hangzhou/2008 full_polyprotein 1..2193; Human gammaherpesvirus 8 KCP (gene: ORF4); Coxsackievirus A14 full_polyprotein 1..2192; Coxsackievirus A10 full_polyprotein 1..2193; Enterovirus A120 full_polyprotein 1..2191; Coxsackievirus A4 full_polyprotein 1..2201; Enterovirus A76 full_polyprotein 1..2198; Human enterovirus 94 VP2; Coxsackievirus A5 full_polyprotein 1..2191; Coxsackievirus A2 full_polyprotein 1..2190; Enterovirus A VP2 (1B); Coxsackievirus A12 VP2 protein; Vaccinia virus Ankara serine proteinase inhibitor / SPI-2 f2; Coxsackievirus A8 VP2 protein; Coxsackievirus A6 VP2 protein; Human adenovirus 35 fiber; Human adenovirus 34 fiber protein (gene: L5); Human adenovirus 66 fiber protein (gene: L5); Human adenovirus 3+7 fiber protein (gene: L5); Human adenovirus B3 L5 protein IV (fiber) (gene: L5); Norovirus Hu/GII.6/HS245/2010/USA protein p48 (gene: POL); Human adenovirus 21a fiber protein (gene: L5); Human adenovirus 21 fiber protein (gene: L5); Human adenovirus 50 fiber protein (gene: L5); Vaccinia virus Ankara EEV type 1 membrane protein; Human mastadenovirus B fiber (gene: L5); Vaccinia virus EEV membrane glycoprotein (gene: B5R); Horsepox virus HSPV182 (EEV membrane glycoprotein; Provisional)",0.0743949840752122; 0.0754322523003515; 0.0754322523003515; 0.0786466013864403; 0.0816962571184375; 0.0816962571184375; 0.086428048188775; 0.0898087823597772; 0.098953088813177; 0.098953088813177; 0.098953088813177; 0.098953088813177; 0.098953088813177; 0.098953088813177; 0.098953088813177; 0.098953088813177; 0.098953088813177; 0.098953088813177; 0.098953088813177; 0.098953088813177; 0.098953088813177; 0.098953088813177; 0.098953088813177; 0.098953088813177; 0.098953088813177; 0.098953088813177; 0.098953088813177; 0.098953088813177; 0.098953088813177; 0.1043071530279705; 0.1043071530279705; 0.1413266333748334; 0.2076496029500523; 0.2280934210760456; 0.3432508452948237; 0.362875171240929; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.4162402588521184; 0.425018220842737,Homo sapiens HEK293F embryonic kidney cell;Homo sapiens kidney;Homo sapiens serum;In vitro,0.27;0.35;0.4;0.44;0.54;0.56;0.62;0.68;0.75,Homo sapiens;chemical synthesis,-;Homo sapiens;chemical synthesis
MIR17HG,"Lymphoma; Multiple Myeloma; Rheumatoid Arthritis; Non-Small Cell Lung Carcinoma; Autoimmune Diseases; cervical cancer; Cirrhosis; Tumor Angiogenesis; Malignant tumor of cervix; Neoplasm Metastasis; Hodgkin Disease; Leukemia, Myelocytic, Acute; Hypertensive disease; Liver Cirrhosis; Cervix carcinoma; Kaposi Sarcoma; Liver neoplasms; Glioblastoma; leukemia; Lupus Erythematosus, Systemic; Pancreatic carcinoma; Coronary heart disease; Glioma; Malignant neoplasm of pancreas; Diffuse Large B-Cell Lymphoma; Brain Neoplasms; Malignant neoplasm of lung; Restenosis; Chronic Lymphocytic Leukemia; Tumor Progression; Malignant neoplasm of breast; Liver carcinoma; Colonic Neoplasms; Carcinogenesis; Nasopharyngeal carcinoma; Carcinoma of lung; Stomach Carcinoma; B-Cell Lymphomas; Colon Carcinoma; Malignant neoplasm of stomach; Osteosarcoma of bone; Astrocytoma; melanoma; Primary malignant neoplasm of lung; Breast Carcinoma; Osteosarcoma; Small cell carcinoma of lung; MYELODYSPLASTIC SYNDROME; Sezary Syndrome; Lupus Erythematosus; Prostate carcinoma; Adenocarcinoma; Malignant tumor of colon; Malignant neoplasm of prostate; Lupus Vulgaris; Lymphoma, Non-Hodgkin; Hematologic Neoplasms; Hematopoietic Neoplasms; Lupus Erythematosus, Discoid; Malignant neoplasm of liver; Renal Cell Carcinoma; Solid Neoplasm; Retinoblastoma; Colorectal Carcinoma; Diabetes Mellitus, Non-Insulin-Dependent; Pancreatic Ductal Adenocarcinoma; Myeloid Leukemia, Chronic; Esophageal Neoplasms; Neoplasms; Leukemogenesis; Central neuroblastoma; Colorectal Cancer; Secondary malignant neoplasm of lung; Neuroblastoma; Carcinoma breast stage IV; Ataxia Telangiectasia; Malignant Neoplasms; Severe Combined Immunodeficiency; Adenocarcinoma Of Esophagus; Adenoma of large intestine; Renal carcinoma; Lymphoproliferative Disorders; Malignant neoplasm of esophagus; Ki-1+ Anaplastic Large Cell Lymphoma; Hepatocarcinogenesis; Anaplastic thyroid carcinoma; Squamous cell carcinoma of esophagus; Acute leukemia; Medulloblastoma; Esophageal carcinoma; Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse; Hemangiosarcoma; Blast Phase; Atrial Fibrillation; Conventional (Clear Cell) Renal Cell Carcinoma; Glioblastoma Multiforme; Barrett Esophagus; Burkitt Lymphoma; Malignant neoplasm of kidney; Malignant neoplasm of gastrointestinal tract; Triple Negative Breast Neoplasms; Cholangiocarcinoma; Rhabdomyosarcoma; Ulnar-mammary syndrome; Gastrointestinal Neoplasms; Acute Erythroblastic Leukemia; Hashimoto's encephalitis; Short middle phalanx of finger; Primary cutaneous B-cell lymphoma; Congenital Abnormality; Sinus Node Dysfunction (disorder); Squamous cell carcinoma of skin; Gastrointestinal Stromal Tumors; Severe Congenital Microcephaly; Microlissencephaly; Growth Disorders; Hypoplasia of thumb; Limb Deformities, Congenital; Bone Diseases, Developmental; MIXED LINEAGE LEUKEMIA; Alveolar rhabdomyosarcoma; Aplasia Cutis Congenita; Brachydactyly; Marinesco-Sjogren syndrome; Adenoid Cystic Carcinoma; Microcephaly; Agenesis of corpus callosum; Intellectual Disability; Mental Retardation; Dull intelligence; Low intelligence; Poor school performance; Mental deficiency; Small head; Short stature",4.5104266881389206e-12; 2.5279022064249716e-11; 1.9241179247341838e-10; 3.762648680673853e-10; 5.452288254986118e-10; 1.1722433847661196e-09; 1.4790998733426532e-09; 3.315537369635636e-09; 3.683115069310663e-09; 5.670785186683756e-09; 6.195332209150018e-09; 8.303910954283738e-09; 1.0368326871660785e-08; 1.3128768066526236e-08; 1.5572986293211266e-08; 3.149054123564124e-08; 4.3069383556698336e-08; 5.518991037343798e-08; 5.784935444423772e-08; 6.156981490555128e-08; 6.982287075725826e-08; 9.273260676030806e-08; 1.427432458937347e-07; 1.4925759778299788e-07; 3.532371372262103e-07; 4.157277636684319e-07; 6.299208964864026e-07; 6.673805318525932e-07; 7.931659047151387e-07; 8.297823048747685e-07; 8.660170029731726e-07; 1.3079916134634371e-06; 1.4185164995612263e-06; 1.51758575162775e-06; 1.5208470671427406e-06; 2.027389637151193e-06; 2.07112526817849e-06; 2.1624936975752243e-06; 2.205236928124383e-06; 2.450940162208615e-06; 2.560217628497434e-06; 2.608032323197001e-06; 4.179146475474674e-06; 4.839188317483647e-06; 5.381279306135013e-06; 6.3131986281381465e-06; 1.0755368362337037e-05; 1.279493639647176e-05; 1.3410647656206684e-05; 1.4805035395703202e-05; 1.527992765491583e-05; 1.5449280661407645e-05; 1.5498516107485843e-05; 3.053335644618538e-05; 4.1934338365676246e-05; 4.360044574654907e-05; 6.058590126387572e-05; 6.484707207749309e-05; 8.133563964016694e-05; 8.421319594446617e-05; 0.0001119048288448298; 0.0001322335978675375; 0.00015093372108149775; 0.00016189346720036038; 0.00016189346720036038; 0.0001802305430549181; 0.00021049732822064587; 0.00021804014782198476; 0.00022897551943886068; 0.0002652452950458932; 0.00032113080554701227; 0.00038453776693371663; 0.00042196010900515655; 0.0004601228759628894; 0.0004814724943641282; 0.0005182771791848276; 0.0006352060750206054; 0.0006993549316202267; 0.0011303542860313; 0.001881335207053; 0.0028626589910413; 0.0030077293488194; 0.0030940063712108; 0.0039908077871836; 0.0040444907714877; 0.0050844857197244; 0.0062748297137782; 0.0073444206109429; 0.0084568432337518; 0.0089906473426575; 0.0094642528600355; 0.0098716431177839; 0.0114187031414039; 0.0118123250371176; 0.0127059723723765; 0.0171001534176385; 0.0193777520415227; 0.0196345173194062; 0.0230684256648711; 0.0255085366814945; 0.0302544192125064; 0.0334053723619937; 0.0462818499370266; 0.0817897187940979; 0.0972679220674381; 0.1159436893514271; 0.1401454825042905; 0.1642913929691757; 0.1642913929691757; 0.1722207384650883; 0.181710614199711; 0.2140040744036979; 0.2277111144893269; 0.2468771733501051; 0.2468771733501051; 0.2777403930303475; 0.2823835751171575; 0.3066971380488823; 0.3540699900993737; 0.3988203841308941; 0.4089444818350988; 0.429535520054622; 0.4404527272820893; 0.4462255858401349; 0.4481840103343354; 0.504829873207973; 0.657788228629759; 0.9388725395674395; 0.9620816473530824; 0.9620816473530824; 0.9620816473530824; 0.9690953460589412; 0.9758134967317544; 0.98178858977899; 0.9950631310768108,Diabetes Mellitus; Congenital Anomaly Of Limb; Microlissencephaly; Bone Disease; Hypoplasia Of Thumb; Brachydactyly; Congenital Microcephaly; Coronary Heart Disease; Microcephaly; Dwarfism; Mental Retardation,0.1718736907108893; 0.2039740835961235; 0.3020628161707281; 0.3276530465188152; 0.3603176382172478; 0.426652795095747; 0.4304968760599196; 0.504775797017495; 0.9920888769304664; 0.9999792400275376; 0.9999792400275376,,,,,,,,
MIR22HG,Juvenile arthritis; Malignant neoplasm of breast; Juvenile psoriatic arthritis; Juvenile-Onset Still Disease; Serum albumin measurement,3.861499575207375e-12; 8.660170029731726e-07; 1.8961926417889813e-05; 2.5791573703443737e-05; 0.1050724946352408,"Juvenile Arthritis; Polyarthritis, Rheumatoid Factor Positive; Seronegative Polyarthritis; Still Disease; Arthritis; Stomach Neoplasms; Gastric Cancer",1.1394948069325325e-05; 1.1394948069325325e-05; 3.928596547519457e-05; 5.1065830658055726e-05; 0.0015169561374293; 0.0172144998405365; 0.0172144998405365,,,,,,,,
MIR3142HG,Hypersensitivity,1.1523181751478311e-06,,,,,,,,,,
MIR3189,Glioblastoma; Astrocytoma,5.518991037343798e-08; 2.608032323197001e-06,,,,,,,,,,
MIR4492,"Drug-Induced Liver Disease; Hepatitis, Toxic; Chemical and Drug Induced Liver Injury; Chemically-Induced Liver Toxicity; Drug-Induced Acute Liver Injury; Hepatitis, Drug-Induced",0.0003607853785819225; 0.001881335207053; 0.001881335207053; 0.001881335207053; 0.001881335207053; 0.0020282798161214,,,,,,,,,,
MIR616,Non-Small Cell Lung Carcinoma; Neoplasm Metastasis; Alzheimer's Disease; Prostate carcinoma; Malignant neoplasm of prostate; Primary malignant neoplasm; Malignant Neoplasms; Metastatic Neoplasm; androgen independent prostate cancer,3.762648680673853e-10; 5.670785186683756e-09; 9.273260676030806e-08; 1.527992765491583e-05; 3.053335644618538e-05; 0.00046565119871267287; 0.0006352060750206054; 0.001746579573497; 0.0037263522689301,,,,,,,,,,
NANOS1,"Non-Small Cell Lung Carcinoma; Cirrhosis; Neoplasm Metastasis; Liver Cirrhosis; Malignant neoplasm of breast; Anemia, Sickle Cell; Breast Carcinoma; Malignant mesothelioma; Sleep Apnea, Obstructive; Acute Chest Syndrome; Hypertension, Portal; Schizophrenia; Non-obstructive azoospermia; Impulsive character (finding); Infertility; Autism Spectrum Disorders; Asthenozoospermia; Fundic gland polyp; Increased circulating gonadotropin level; Childhood Rhabdomyosarcoma; Obstructive azoospermia; Azoospermia; Small testicle",3.762648680673853e-10; 1.4790998733426532e-09; 5.670785186683756e-09; 1.3128768066526236e-08; 8.660170029731726e-07; 1.2482007026109775e-06; 5.381279306135013e-06; 7.439853898002338e-06; 3.602405958537832e-05; 0.00031439908493214593; 0.0004136970830881728; 0.0093325514582534; 0.010624513163997; 0.0114187031414039; 0.0344821468860451; 0.0411765978055933; 0.0543546439241988; 0.0897127848630768; 0.2226324872503657; 0.2316568843888361; 0.2670582190879765; 0.3729268757986315; 0.5523550850146659,Malignant Mesothelioma; Non-obstructive Azoospermia; Obstructive Azoospermia; Male Infertility; Spermatogenic Failure; Azoospermia,0.0015169561374293; 0.1813044909798312; 0.2089805590322066; 0.2389892939730545; 0.2890629102516288; 0.5632344309031201,Nail-patella syndrome ORPHA:2614; Nail-patella-like renal disease ORPHA:2613; Male infertility with teratozoospermia due to single gene mutation ORPHA:399808; Bradyopsia ORPHA:75374; Male infertility with azoospermia or oligozoospermia due to single gene mutation ORPHA:399805,0.4838060079820406; 0.4838060079820406; 0.5312419675785659; 0.5312419675785659; 0.552214469388668,,,,,,
NANOS3,"Arteriosclerosis; Non-Small Cell Lung Carcinoma; Cirrhosis; Lung Neoplasms; Atherosclerosis; Liver Cirrhosis; Coronary Artery Disease; Coronary heart disease; Alzheimer's Disease; Myocardial Infarction; Cardiovascular Diseases; Malignant neoplasm of lung; Coronary Arteriosclerosis; Carcinoma of lung; Polycystic Ovary Syndrome; Primary malignant neoplasm of lung; Unipolar Depression; Major Depressive Disorder; Hypertension, Portal; Endothelial dysfunction; Male infertility; Trisomy; Hyperlipidemia; Bipolar Disorder; Cerebrovascular Disorders; Turner Syndrome; Ovarian Failure, Premature; Feeling powerless; Vascular degeneration; Mood Disorders; Premature Menopause; Ovarian Insufficiency; Teratoma; Ovarian failure",2.377251819497684e-10; 3.762648680673853e-10; 1.4790998733426532e-09; 4.367699208727405e-09; 7.195555613367576e-09; 1.3128768066526236e-08; 8.598175402882612e-08; 9.273260676030806e-08; 9.273260676030806e-08; 2.247163660896597e-07; 4.5433391667148853e-07; 6.299208964864026e-07; 1.0094398444517938e-06; 2.027389637151193e-06; 2.086123696221558e-06; 4.839188317483647e-06; 0.00010334647523919963; 0.0003278023880903879; 0.0004136970830881728; 0.0020505587731585; 0.0021001259552496; 0.0026287893312444; 0.0043427572763018; 0.0066006052483961; 0.0210446393275247; 0.0554191598986221; 0.0704851772553303; 0.1050724946352408; 0.1130019719865939; 0.1308906437806309; 0.1397055058487397; 0.1460848784791741; 0.236709594559292; 0.2777403930303475,Ovarian Failure,0.2978951863374514,,,,,,,,
NCOA7,Malignant neoplasm of breast; Breast Carcinoma; Prostatic Neoplasms; Malignant neoplasm of prostate; Neuroblastoma; Reticulocyte count (procedure),8.660170029731726e-07; 5.381279306135013e-06; 2.0820699372778346e-05; 3.053335644618538e-05; 0.0004601228759628894; 0.7631660258958671,Prostatic Neoplasms; Prostate Cancer,0.0567647407547259; 0.1386032662139448,PDE4D haploinsufficiency syndrome ORPHA:439822; Immunoglobulin-mediated membranoproliferative glomerulonephritis ORPHA:329903,0.5312419675785659; 0.5312419675785659,,,yeasx,0.37,Yersinia pestis,Homo sapiens
NFKBIA,"Pneumonia; Psoriasis; Familial M??ni??re disease; Multiple Myeloma; Virus Diseases; Dermatitis, Atopic; Lung diseases; Rheumatoid Arthritis; Non-Small Cell Lung Carcinoma; Crohn Disease; Ovarian Carcinoma; Sarcoidosis; Endometriosis; cervical cancer; Ulcerative Colitis; Infection; Malignant neoplasm of ovary; Colitis; Malignant tumor of cervix; Lung Neoplasms; Cerebral Ischemia; Neoplasm Metastasis; Mammary Neoplasms, Human; Hodgkin Disease; Acute pancreatitis; Hypertensive disease; Liver Cirrhosis; Respiratory syncytial virus (RSV) infection in conditions classified elsewhere and of unspecified site; Cervix carcinoma; Brain Ischemia; Respiratory Distress Syndrome, Adult; Inflammatory Bowel Diseases; Hyperglycemia; Mammary Neoplasms; Arthritis, Psoriatic; Glioblastoma; Lupus Erythematosus, Systemic; Pancreatic carcinoma; Coronary Artery Disease; Coronary heart disease; Sjogren's Syndrome; Encephalitis; Glioma; Epithelial ovarian cancer; Malignant neoplasm of pancreas; Pain; Respiratory Syncytial Virus Infections; Malignant neoplasm of mouth; Myocardial Infarction; Infarction, Middle Cerebral Artery; Myocardial Ischemia; Brain Neoplasms; Sciatic Neuropathy; Malignant neoplasm of lung; Tuberculosis; Diabetes Mellitus, Insulin-Dependent; Malignant neoplasm of breast; Gastritis; Coronary Arteriosclerosis; Liver carcinoma; Carcinogenesis; Nasopharyngeal carcinoma; Carcinoma of lung; Stomach Carcinoma; Colon Carcinoma; Malignant neoplasm of stomach; Lip and Oral Cavity Carcinoma; Kidney Failure, Acute; melanoma; Primary malignant neoplasm of lung; Bronchiolitis; Breast Carcinoma; Pustulosis of Palms and Soles; Bacterial Infections; Liver Cirrhosis, Experimental; Sarcoidosis, Pulmonary; Hepatitis B, Chronic; Colorectal Neoplasms; Allergic asthma; Cachexia; Hepatitis B; Prostate carcinoma; Adenocarcinoma; Malignant tumor of colon; Herpes Simplex Infections; Squamous cell carcinoma; Malignant neoplasm of prostate; Pancreatic Neoplasm; Invasive Streptococcus pneumoniae disease; Stress, Psychological; Hashimoto Disease; Primary Sj??gren's syndrome; Malignant neoplasm of liver; Classical Hodgkin's Lymphoma; Colorectal Carcinoma; Fibrosis, Liver; Carotid Artery Diseases; Sarcoma; Colorectal Cancer; Nodular Lymphocyte Predominant Hodgkin Lymphoma; Myeloproliferative disease; Ataxia Telangiectasia; Irritable Bowel Syndrome; Empyema; Sicca Syndrome; Tumor Initiation; Precancerous Conditions; Anhydrotic Ectodermal Dysplasias; Adult Hodgkin Lymphoma; gliosarcoma; Liver and Intrahepatic Biliary Tract Carcinoma; Hepatocarcinogenesis; Undifferentiated carcinoma; Severe Bronchopulmonary Dysplasia; Squamous cell carcinoma of esophagus; Childhood asthma; Medulloblastoma; Hematological Disease; Hodgkin lymphoma, lymphocyte depletion; Mixed Cellularity Hodgkin Lymphoma; Lymphocyte Rich Classical Hodgkin Lymphoma; Burkitt Lymphoma; Bronchopulmonary Dysplasia; Squamous cell carcinoma of lung; Hyperinsulinism; Giant Cell Glioblastoma; Ewings sarcoma; Recurrent infection of the gastrointestinal tract; Empyema, Pleural; Gastrointestinal infection; Malignant neoplasm of nasopharynx; Saddle nose; Cancer of Nasopharynx; Ectodermal dysplasia, hypohidrotic, with immune deficiency; Intolerant of heat; Sporadic Breast Carcinoma; Peg-shaped teeth; Pointed tooth; Cerebellar Neoplasms; Activated B-cell type diffuse large B-cell lymphoma; Anhidrosis; Diminished sweating; Hypohidrosis; Ectodermal Dysplasia; Recurrent respiratory infections; Sparse hair; Thin, sparse hair; Hypodontia; Frontal bossing",7.980856456624717e-16; 3.118210553589307e-12; 3.861499575207375e-12; 2.5279022064249716e-11; 6.332483647919588e-11; 7.448716379948652e-11; 8.179290839744632e-11; 1.9241179247341838e-10; 3.762648680673853e-10; 4.2478505092738466e-10; 6.870627395110916e-10; 7.861255581007157e-10; 7.868397426275417e-10; 1.1722433847661196e-09; 1.6767489697325582e-09; 1.794870341379274e-09; 1.971893171900314e-09; 1.971893171900314e-09; 3.683115069310663e-09; 4.367699208727405e-09; 4.756590990483e-09; 5.670785186683756e-09; 5.791865115913735e-09; 6.195332209150018e-09; 7.713813941246406e-09; 1.0368326871660785e-08; 1.3128768066526236e-08; 1.452540845894924e-08; 1.5572986293211266e-08; 1.8815395768840057e-08; 2.261634993097532e-08; 2.3137704832524547e-08; 4.0898524252942674e-08; 4.65353219894153e-08; 5.071217747675114e-08; 5.518991037343798e-08; 6.156981490555128e-08; 6.982287075725826e-08; 8.598175402882612e-08; 9.273260676030806e-08; 1.0276547515522002e-07; 1.3150328464481586e-07; 1.427432458937347e-07; 1.479813245926713e-07; 1.4925759778299788e-07; 1.6759866477134858e-07; 1.946794431045147e-07; 2.0279723135488897e-07; 2.247163660896597e-07; 2.400988116471548e-07; 2.948344121290337e-07; 4.157277636684319e-07; 4.312772724439924e-07; 6.299208964864026e-07; 6.673805318525932e-07; 6.851652105457608e-07; 8.660170029731726e-07; 9.58028929735367e-07; 1.0094398444517938e-06; 1.3079916134634371e-06; 1.51758575162775e-06; 1.5208470671427406e-06; 2.027389637151193e-06; 2.07112526817849e-06; 2.205236928124383e-06; 2.450940162208615e-06; 2.576211756838249e-06; 3.485726441474513e-06; 4.179146475474674e-06; 4.839188317483647e-06; 5.021572339409501e-06; 5.381279306135013e-06; 5.457492980911677e-06; 6.378950690990071e-06; 7.691726899679507e-06; 9.263589414966798e-06; 1.0172703923266036e-05; 1.3034577772762696e-05; 1.3268923055385737e-05; 1.3410647656206684e-05; 1.3755659311680946e-05; 1.527992765491583e-05; 1.5449280661407645e-05; 1.5498516107485843e-05; 2.1109857936882128e-05; 3.053335644618538e-05; 3.053335644618538e-05; 3.192298841377222e-05; 4.351780357113137e-05; 5.248375780672949e-05; 5.248375780672949e-05; 8.232890503539995e-05; 8.421319594446617e-05; 0.0001431024725510208; 0.00016189346720036038; 0.0001690762138878921; 0.0002812860791024885; 0.00029355802758490503; 0.00038453776693371663; 0.0003987632373118045; 0.0005011878920853237; 0.0005182771791848276; 0.0008252744167874381; 0.0008673605584216904; 0.0010244557923259; 0.0010897868460616; 0.0012688388196185; 0.0013734265963756; 0.0020049274325175; 0.0037263522689301; 0.0038816440940594; 0.0040444907714877; 0.0048028611524245; 0.0059257679306595; 0.0062748297137782; 0.0065999085088281; 0.0084568432337518; 0.0110109843340769; 0.0110109843340769; 0.0110109843340769; 0.0138441633831498; 0.0196345173194062; 0.0254956360475327; 0.033749008368017; 0.0378565625608719; 0.0402448379890702; 0.0741310297608694; 0.0817897187940979; 0.0897127848630768; 0.0897127848630768; 0.0972679220674381; 0.1050724946352408; 0.1146753245606438; 0.1206032442301429; 0.1272255752567765; 0.1460848784791741; 0.1460848784791741; 0.1460848784791741; 0.1525119847960956; 0.1932166112700285; 0.2108300774722888; 0.3066971380488823; 0.3113515317868633; 0.3634167943130235; 0.4596755087558572; 0.507968267075787; 0.507968267075787; 0.5841285837808708; 0.7839087003672562,"Myocardial Ischemia; Cerebral Ischemia; Marfan Syndrome; Mammary Neoplasms; Palmoplantar Pustules; Breast Carcinoma; Psoriasis; Breast Cancer; Pancreatic Cancer; Pancreatic Neoplasm; Hodgkin Lymphoma; Hodgkin Lymphoma, Lymphocyte Depletion; Classical Hodgkin Lymphoma; Hodgkin Disease; Giant Cell Glioblastoma; Nasopharyngeal Cancer; Hypohidrotic Ectodermal Dysplasia; Gliosarcoma; Liver Carcinoma; Peg-Shaped Teeth; Anhidrosis; Ectodermal Dysplasia; Cardiovascular Diseases; Hypohidrosis; Hypodontia; Frontal Bossing",7.071068485513988e-10; 5.562961744202623e-09; 8.921950872070284e-08; 1.1417484002988661e-07; 5.775106030172258e-06; 4.971054570440277e-05; 0.00044166586682199737; 0.00063387456654884; 0.00207663921483; 0.0054741435035425; 0.0242477651311773; 0.0242477651311773; 0.0554517833122258; 0.0668923554370046; 0.0841735094076256; 0.1507480783308755; 0.1787826075739565; 0.2003502278196653; 0.2008242041589438; 0.2039740835961235; 0.2389892939730545; 0.3122348651468142; 0.3636022406609426; 0.434268771817188; 0.770874401260989; 0.9133373557216176,Charcot-Marie-Tooth disease type 1D ORPHA:101084; Charcot-Marie-Tooth disease type 4E ORPHA:99951; Nasopharyngeal carcinoma ORPHA:150; Systemic-onset juvenile idiopathic arthritis ORPHA:85414; Hereditary pediatric Behcet-like disease ORPHA:476102; Autosomal dominant hyper-IgE syndrome ORPHA:2314; NON RARE IN EUROPE: Psoriatic arthritis ORPHA:40050; Chronic lymphoproliferative disorder of natural killer cells ORPHA:512017; STAT3-related early-onset multisystem autoimmune disease ORPHA:438159; T-cell large granular lymphocyte leukemia ORPHA:86872; Autosomal dominant dopa-responsive dystonia ORPHA:98808; GTP cyclohydrolase I deficiency ORPHA:2102; Hypohidrotic ectodermal dysplasia with immunodeficiency ORPHA:98813; Herpes simplex virus encephalitis ORPHA:1930; MALT lymphoma ORPHA:52417; Revesz syndrome ORPHA:3088; Chronic mucocutaneous candidiasis ORPHA:1334; Giant cell glioblastoma ORPHA:251579; Gliosarcoma ORPHA:251576,3.598261936626476e-12; 3.598261936626476e-12; 6.10801728836975e-11; 1.514756890441811e-09; 1.7877420438201673e-08; 2.859667220539484e-06; 2.859667220539484e-06; 2.859667220539484e-06; 2.859667220539484e-06; 2.859667220539484e-06; 3.28973817825433e-05; 3.28973817825433e-05; 3.295782224790152e-05; 0.00024116799717032887; 0.0022487953361182; 0.0133474287859103; 0.1973394623267924; 0.5220015007747252; 0.5220015007747252,"Human rhinovirus A88 2C (P2-C); Cosavirus A 3C; Ectromelia virus ERPV DNA packaging and ATPase protein; Murray Valley encephalitis virus prodexcised_polyprotein 1..793; West Nile virus lineage 2 excised_polyprotein 1..791 (gene: flavivirus polyprotein); Horsepox virus HSPV153 (Poxvirus A32 protein); Vaccinia virus Ankara putative monoglyceride lipase f2; Vaccinia virus Ankara CP77 Host range protein f1; Human rhinovirus A47 2C; Horsepox virus HSPV011b (ankyrin repeats); Human adenovirus 49 fiber; Human adenovirus 23 fibre protein (gene: L5); Cowpox virus CPXV213 protein (gene: CPXV213 CDS); Human adenovirus 46 fiber; Cowpox virus CPXV011 protein (gene: CPXV011 CDS); Vaccinia virus Ankara 72.4k ankyrin repeat protein f2; West Nile virus lineage 1 excised_polyprotein 1..787 (gene: flavivirus polyprotein); Vaccinia virus ankyrin-like protein; Monkeypox virus Zaire-96-I-16 ankyrin-like protein (gene: C1L); Human rhinovirus A90 2C; Horsepox virus HSPV005c (Ankyrin repeats); Vaccinia virus Ankara CP77 host range protein f4; Human rhinovirus A21 2C; Horsepox virus HSPV196 (ankyrin-like protein; Provisional); Variola virus hypothetical protein (gene: D7L); Yaba-like disease virus 146R protein (gene: 146R); Human rhinovirus A44 2C (P2-C); Variola virus hypothetical protein (gene: B21R); Ectromelia virus ERPV ankyrin and nfkb inhibitor; Cowpox virus VHR1 or CPXV025 protein (gene: VHR1); Horsepox virus HSPV011c (ankyrin repeats); Vaccinia virus Ankara CP77 host range protein f3; Orf virus ORF126 ankyrin repeat protein; Monkeypox virus Zaire-96-I-16 ankyrin-like protein (gene: D7L); Cowpox virus CPXV017 protein (gene: CPXV017 CDS); Monkeypox virus Zaire-96-I-16 B17R (gene: B17R); Human adenovirus 1 fiber; Horsepox virus HSPV194 (ankyrin repeats); Human adenovirus 5 fiber; Horsepox virus HSPV005b (ankyrin repeats); Human enterovirus C102 2c; Monkeypox virus Zaire-96-I-16 ankyrin-like protein (gene: D9L); Cowpox virus CPXV019 protein (gene: CPXV019 CDS); Monkeypox virus Zaire-96-I-16 ankyrin-like protein (gene: D1L); Cowpox virus CPXV041 protein (gene: CPXV041 CDS); Horsepox virus HSPV020e (ankyrin repeats); Cowpox virus CPXV016 protein (gene: CPXV016 CDS); Horsepox virus HSPV035 (ankyrin repeats); Horsepox virus HSPV181 (ankyrin repeats); Vaccinia virus Ankara 54.4k ankyrin repeat protein f2; Vaccinia virus ankyrin-like protein (gene: B4R); Vaccinia virus ankyrin-like protein (gene: K1L); Variola virus hypothetical protein (gene: B19R); Vaccinia virus Ankara 67.9k ankyrin repeat protein; Cowpox virus CPXV008 protein (gene: CPXV008 CDS); Human adenovirus 71 fiber (gene: L5); Vaccinia virus Ankara Host range protein; Human adenovirus 19 fiber (gene: L5); Human adenovirus 58 fiber (gene: L5); Human adenovirus D10 fiber (gene: L5); Horsepox virus HSPV014c (ankyrin repeats); Cowpox virus CPXV027 protein (gene: CPXV027 CDS); Human adenovirus 65 L5 fiber; Human mastadenovirus D fiber (gene: L5); Human adenovirus 56 fiber protein (gene: L5); Human adenovirus 64 L5 fiber protein; Human adenovirus D37 fiber (gene: L5); Yaba monkey tumor virus ankyrin repeat protein; Human adenovirus D8 fiber (gene: L5); Human adenovirus 54 fiber; Vaccinia virus ankyrin-like protein (gene: B18R); Cowpox virus CPXV211 protein (gene: CPXV211 CDS); Human mastadenovirus D fiber; Human adenovirus 17 fiber; Human adenovirus 63 fiber protein (gene: L5); Horsepox virus HSPV033b (Ankyrin repeats); Monkeypox virus Zaire-96-I-16 B5R (gene: B5R); Horsepox virus HSPV033c (ankyrin repeats); Variola virus hypothetical protein (gene: G3R); Variola virus hypothetical protein (gene: D6L); Vaccinia virus Ankara 54.4k ankyrin repeat protein f1; Horsepox virus HSPV201a (ankyrin repeats); Human adenovirus 67 L5 fiber; Yaba-like disease virus 147R protein (gene: 147R); Horsepox virus HSPV022 (ankyrin-like protein; Provisional); Yaba monkey tumor virus ankyrin-like protein; Variola virus ankyin-like protein (gene: O1L); Horsepox virus HSPV020b (ankyrin repeats); Monkeypox virus Zaire-96-I-16 ankyin-like protein (gene: O1L); Vaccinia virus ankyrin-like protein (gene: C9L); Cowpox virus CPXV006 protein (gene: CPXV006 CDS); Horsepox virus HSPV012 (ankyrin-like protein; Provisional); Yaba-like disease virus 11L protein (gene: 11L); Yaba-like disease virus 148R protein (gene: 148R); Vaccinia virus hypothetical protein; Yaba-like disease virus 8L protein (gene: 8L); Orf virus ORF128 ankyrin repeat protein; Orf virus ORF123 ankyrin repeat protein; Horsepox virus HSPV011a; Cowpox virus CPXV039 (gene: CPXV039 CDS); Horsepox virus HSPV004 (ankyrin repeats); Horsepox virus HSPV014b (ankyrin repeats); Vaccinia virus ankyin-like protein (gene: M1L); Monkeypox virus Zaire-96-I-16 J3L (gene: J3L); Vaccinia virus Ankara 78.7k Ankyrin repeat protein f1; Vaccinia virus Ankara 72.4k ankyrin repeat protein f1; Vaccinia virus Ankara 65.4k Ankyrin repeat protein; Cowpox virus CPXV220 protein (gene: CPXV220 CDS); Cowpox virus CPXV198 protein (gene: CPXV198 CDS); Human adenovirus 28 fiber; Ectromelia virus ERPV ankyrin; Human adenovirus 22 fiber protein (gene: L5); Orf virus ORF129 ankyrin repeat protein; Vaccinia virus Ankara CP77 host range protein f2; Orf virus ORF008 ankyrin repeat protein; Human adenovirus Chiba_E086/2012 fiber (gene: L5); Variola virus hypothetical protein (gene: B6R); Vaccinia virus Ankara 78.7k Ankyrin repeat protein f3; Monkeypox virus ankyrin-like protein; Papiine alphaherpesvirus 2 serine/threonine protein kinase US3 (gene: US3); Human alphaherpesvirus 3 serine/threonine protein kinase US3 (gene: ORF66); Human herpesvirus 3 strain Dumas serine-threonine protein kinase; Human alphaherpesvirus 3 tegument serine/threonine protein kinase (gene: ORF47); Human alphaherpesvirus 2 serine/threonine protein kinase US3 (gene: US3); Variola virus Ser/Thr kinase (gene: C14L); Human herpesvirus 3 strain Dumas ring-finger protein; Human alphaherpesvirus 3 ubiquitin E3 ligase ICP0 (gene: ORF61); Cercopithecine alphaherpesvirus 2 serine/threonine protein kinase US3 (gene: US3); Macacine alphaherpesvirus 1 serine/threonine protein kinase US3 (gene: US3); Human alphaherpesvirus 1 serine/threonine protein kinase US3 (gene: US3); Human betaherpesvirus 6 U69, ganciclovir kinase, phosphotransferase (gene: U69); Human betaherpesvirus 6A tegument serine/threonine protein kinase (gene: U69)",0.2675352623334263; 0.2882370282257738; 0.3613718664490669; 0.3677974393080778; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3956197978099343; 0.3956197978099343; 0.396036820576385; 0.4088672649431711; 0.4139745988798983; 0.4145707851950257; 0.414682462349678; 0.424785222642393; 0.4264358713488607; 0.4311162645337849; 0.4342000778047719; 0.4524287065015616; 0.4602555770769919; 0.4777231148134931; 0.5134770656069968; 0.5324759243629956; 0.5349555669171289; 0.5450920252858983; 0.5491415646821286; 0.5717917933629476; 0.5961449913267739; 0.5981149957947038; 0.6234641868335487; 0.6342852581130124; 0.7010195275583045; 0.7356705979804892; 0.7471947418531064; 0.7640067973616771; 0.7871983209689735; 0.8015224820713857; 0.8217794967874373; 0.8317365809802599; 0.8317365809802599; 0.8381307845676164; 0.8472959300045919; 0.8710135911342001; 0.899491710093239; 0.899491710093239,Homo sapiens;Homo sapiens HEK293 embryonic kidney cell;Homo sapiens HEK293T embryonic kidney cell;Homo sapiens HMEC-1 microvascular endothelial cell;Homo sapiens MCF-7 mammary adenocarcinoma cell;Homo sapiens MDA-Panc-28 pancreatic adenocarcinoma cell;Homo sapiens keratinocyte;In vitro;Max kidney cell line;Saccharomyces cerevisiae;yeasx,0.35;0.37;0.4;0.51;0.52;0.59;0.69;0.72,Dengue virus 2;Homo sapiens;csfvb;den2n,Homo sapiens;Kunjin virus;Yersinia pestis;den2n
NFKBIZ,"Psoriasis; Dermatitis, Atopic; Crohn Disease; Lymphoma, T-Cell, Cutaneous; Liver Cirrhosis, Experimental; Mycosis Fungoides; Toxic Epidermal Necrolysis; Cutaneous Melanoma; Drug-Induced Stevens Johnson Syndrome; Mycoplasma-Induced Stevens-Johnson Syndrome; Stevens-Johnson Syndrome Toxic Epidermal Necrolysis Spectrum; Hereditary Nonpolyposis Colorectal Neoplasms; Stevens-Johnson Syndrome; Hereditary Nonpolyposis Colorectal Cancer; Hereditary non-polyposis colorectal cancer syndrome",3.118210553589307e-12; 7.448716379948652e-11; 4.2478505092738466e-10; 3.7283259874612974e-06; 7.691726899679507e-06; 0.0020056438913528; 0.0284314613047093; 0.0425171404778382; 0.044901297966643; 0.044901297966643; 0.0493155676939993; 0.0677694730935319; 0.0967179741949912; 0.1041851789435272; 0.2226324872503657,Colorectal Neoplasms; Hereditary Nonpolyposis Colorectal Cancer; Colorectal Cancer,0.2039740835961235; 0.3436005069161912; 0.6963620089820088,Charcot-Marie-Tooth disease type 1D ORPHA:101084; Charcot-Marie-Tooth disease type 4E ORPHA:99951; Nasopharyngeal carcinoma ORPHA:150; Hereditary pediatric Behcet-like disease ORPHA:476102; Autosomal dominant hyper-IgE syndrome ORPHA:2314; Chronic lymphoproliferative disorder of natural killer cells ORPHA:512017; STAT3-related early-onset multisystem autoimmune disease ORPHA:438159; T-cell large granular lymphocyte leukemia ORPHA:86872; Autosomal recessive mendelian susceptibility to mycobacterial diseases due to partial JAK1 deficiency ORPHA:574957; MALT lymphoma ORPHA:52417; Complement hyperactivation-angiopathic thrombosis-protein-losing enteropathy syndrome ORPHA:566175; Immune dysregulation-inflammatory bowel disease-arthritis-recurrent infections-lymphopenia syndrome ORPHA:529977; Marfan syndrome type 2 ORPHA:284973; Loeys-Dietz syndrome ORPHA:60030; Familial platelet disorder with associated myeloid malignancy ORPHA:71290,3.598261936626476e-12; 3.598261936626476e-12; 6.10801728836975e-11; 1.7877420438201673e-08; 2.859667220539484e-06; 2.859667220539484e-06; 2.859667220539484e-06; 2.859667220539484e-06; 0.0019696624570933; 0.0022487953361182; 0.0133474287859103; 0.0133474287859103; 0.1927589191138116; 0.1927589191138116; 0.4838060079820406,Vaccinia virus Ankara putative monoglyceride lipase f2; Vaccinia virus Ankara CP77 Host range protein f1; Horsepox virus HSPV011b (ankyrin repeats); Human adenovirus 49 fiber; Human adenovirus 23 fibre protein (gene: L5); Cowpox virus CPXV213 protein (gene: CPXV213 CDS); Human adenovirus 46 fiber; Cowpox virus CPXV011 protein (gene: CPXV011 CDS); Vaccinia virus Ankara 72.4k ankyrin repeat protein f2; Vaccinia virus ankyrin-like protein; Monkeypox virus Zaire-96-I-16 ankyrin-like protein (gene: C1L); Horsepox virus HSPV005c (Ankyrin repeats); Vaccinia virus Ankara CP77 host range protein f4; Horsepox virus HSPV196 (ankyrin-like protein; Provisional); Variola virus hypothetical protein (gene: D7L); Yaba-like disease virus 146R protein (gene: 146R); Variola virus hypothetical protein (gene: B21R); Ectromelia virus ERPV ankyrin and nfkb inhibitor; Cowpox virus VHR1 or CPXV025 protein (gene: VHR1); Horsepox virus HSPV011c (ankyrin repeats); Vaccinia virus Ankara CP77 host range protein f3; Orf virus ORF126 ankyrin repeat protein; Monkeypox virus Zaire-96-I-16 ankyrin-like protein (gene: D7L); Cowpox virus CPXV017 protein (gene: CPXV017 CDS); Monkeypox virus Zaire-96-I-16 B17R (gene: B17R); Human adenovirus 1 fiber; Horsepox virus HSPV194 (ankyrin repeats); Human adenovirus 5 fiber; Horsepox virus HSPV005b (ankyrin repeats); Monkeypox virus Zaire-96-I-16 ankyrin-like protein (gene: D9L); Cowpox virus CPXV019 protein (gene: CPXV019 CDS); Monkeypox virus Zaire-96-I-16 ankyrin-like protein (gene: D1L); Cowpox virus CPXV041 protein (gene: CPXV041 CDS); Cowpox virus CPXV016 protein (gene: CPXV016 CDS); Horsepox virus HSPV035 (ankyrin repeats); Horsepox virus HSPV181 (ankyrin repeats); Vaccinia virus Ankara 54.4k ankyrin repeat protein f2; Vaccinia virus ankyrin-like protein (gene: B4R); Vaccinia virus ankyrin-like protein (gene: K1L); Variola virus hypothetical protein (gene: B19R); Vaccinia virus Ankara 67.9k ankyrin repeat protein; Cowpox virus CPXV008 protein (gene: CPXV008 CDS); Vaccinia virus Ankara Host range protein; Horsepox virus HSPV014c (ankyrin repeats); Cowpox virus CPXV027 protein (gene: CPXV027 CDS); Yaba monkey tumor virus ankyrin repeat protein; Vaccinia virus ankyrin-like protein (gene: B18R); Cowpox virus CPXV211 protein (gene: CPXV211 CDS); Horsepox virus HSPV033b (Ankyrin repeats); Monkeypox virus Zaire-96-I-16 B5R (gene: B5R); Horsepox virus HSPV033c (ankyrin repeats); Variola virus hypothetical protein (gene: G3R); Variola virus hypothetical protein (gene: D6L); Vaccinia virus Ankara 54.4k ankyrin repeat protein f1; Horsepox virus HSPV201a (ankyrin repeats); Yaba-like disease virus 147R protein (gene: 147R); Horsepox virus HSPV022 (ankyrin-like protein; Provisional); Yaba monkey tumor virus ankyrin-like protein; Variola virus ankyin-like protein (gene: O1L); Monkeypox virus Zaire-96-I-16 ankyin-like protein (gene: O1L); Vaccinia virus ankyrin-like protein (gene: C9L); Cowpox virus CPXV006 protein (gene: CPXV006 CDS); Horsepox virus HSPV012 (ankyrin-like protein; Provisional); Yaba-like disease virus 11L protein (gene: 11L); Yaba-like disease virus 148R protein (gene: 148R); Vaccinia virus hypothetical protein; Yaba-like disease virus 8L protein (gene: 8L); Orf virus ORF128 ankyrin repeat protein; Orf virus ORF123 ankyrin repeat protein; Cowpox virus CPXV039 (gene: CPXV039 CDS); Horsepox virus HSPV004 (ankyrin repeats); Horsepox virus HSPV014b (ankyrin repeats); Vaccinia virus ankyin-like protein (gene: M1L); Monkeypox virus Zaire-96-I-16 J3L (gene: J3L); Vaccinia virus Ankara 78.7k Ankyrin repeat protein f1; Vaccinia virus Ankara 72.4k ankyrin repeat protein f1; Vaccinia virus Ankara 65.4k Ankyrin repeat protein; Cowpox virus CPXV220 protein (gene: CPXV220 CDS); Titi monkey adenovirus ECC-2011 fiber; Cowpox virus CPXV198 protein (gene: CPXV198 CDS); Human mastadenovirus E fiber (gene: L5); Human adenovirus E4 fiber protein; Ectromelia virus ERPV ankyrin; Orf virus ORF129 ankyrin repeat protein; Orf virus ORF008 ankyrin repeat protein; Variola virus hypothetical protein (gene: B6R); Monkeypox virus ankyrin-like protein; Papiine alphaherpesvirus 2 serine/threonine protein kinase US3 (gene: US3); Human alphaherpesvirus 3 serine/threonine protein kinase US3 (gene: ORF66); Human herpesvirus 3 strain Dumas serine-threonine protein kinase; Macacine alphaherpesvirus 1 serine/threonine protein kinase US3 (gene: US3); Monkeypox virus ser/thr kinase; Cowpox virus CPXV196 protein (gene: CPXV196 CDS); Yaba monkey tumor virus 142R,0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3956197978099343; 0.3956197978099343; 0.396036820576385; 0.4088672649431711; 0.4145707851950257; 0.414682462349678; 0.424785222642393; 0.4264358713488607; 0.4311162645337849; 0.4342000778047719; 0.4524287065015616; 0.4602555770769919; 0.4777231148134931; 0.4787750162272003; 0.5134770656069968; 0.513972987973838; 0.513972987973838; 0.5349555669171289; 0.5491415646821286; 0.5961449913267739; 0.6234641868335487; 0.7010195275583045; 0.7356705979804892; 0.7471947418531064; 0.7640067973616771; 0.8472959300045919; 0.8863410989269571; 0.92632075834417; 0.92632075834417,,,,
NPTX1,cervical cancer; Malignant tumor of cervix; Cervix carcinoma; Alzheimer's Disease; Small cell carcinoma of lung; Amyloidosis; Colorectal Cancer; Bipolar Disorder; Schizophrenia,1.1722433847661196e-09; 3.683115069310663e-09; 1.5572986293211266e-08; 9.273260676030806e-08; 1.0755368362337037e-05; 0.0003495642888428815; 0.00038453776693371663; 0.0066006052483961; 0.0093325514582534,,,,,,,Homo sapiens A549 lung carcinoma cell;Homo sapiens HEK293T embryonic kidney cell,0.71,SARS-CoV-2,Homo sapiens
NR4A3,"Asthma; Juvenile arthritis; Lymphoma; Rheumatoid Arthritis; Arteriosclerosis; Non-Small Cell Lung Carcinoma; Autoimmune Diseases; Neoplasm Metastasis; Atherosclerosis; Leukemia, Myelocytic, Acute; Hypertensive disease; Vascular Diseases; Obesity; HIV Infections; leukemia; Diabetes Mellitus; Diabetes; Ischemic stroke; Alzheimer's Disease; Hamman-Rich syndrome; Diffuse Large B-Cell Lymphoma; Fibroid Tumor; Diabetes Mellitus, Insulin-Dependent; Chronic Lymphocytic Leukemia; Malignant neoplasm of breast; Liver carcinoma; Carcinogenesis; Nasopharyngeal carcinoma; Influenza; Carcinoma of lung; Idiopathic pulmonary arterial hypertension; Lymphoma, T-Cell, Cutaneous; melanoma; Breast Carcinoma; Small cell carcinoma of lung; Retinal Diseases; Candidiasis; Prostate carcinoma; Juvenile psoriatic arthritis; Myeloid Leukemia; Juvenile-Onset Still Disease; Malignant neoplasm of prostate; Uterine Fibroids; Hematologic Neoplasms; Enterovirus Infections; Idiopathic Pulmonary Fibrosis; Diabetes Mellitus, Non-Insulin-Dependent; Lymphoma, Follicular; Kidney Failure; Leukemogenesis; Chondrosarcoma; Sarcoma; Central neuroblastoma; Neuroblastoma; Primary malignant neoplasm; Myeloproliferative disease; Malignant Neoplasms; Diabetes, Autoimmune; Hypercholesterolemia; Anhydrotic Ectodermal Dysplasias; Candidiasis of vagina; Myeloid neoplasm; Hypercalcemia; Hyperlipoproteinemia Type IIa; Essential Hypertension; Hypercholesterolemia, Familial; Christ-Siemens-Touraine syndrome; Bipolar Disorder; Skin Carcinogenesis; Insulin Resistance; Acute flaccid paralysis; Schizophrenia; Atrial Fibrillation; Hereditary hemochromatosis; Insulin Sensitivity; Diarrhea; Leukemia, B-Cell; Syphilis; Leukemia, Myeloid, Chronic-Phase; PACHYONYCHIA CONGENITA 3; Soft Tissue Neoplasms; Hepatitis E; Tonic - clonic seizures; Usher syndrome type 2; Malignant myoepithelioma; Myxoid chondrosarcoma; Congenital chromosomal disease; Ovarian Teratoma; synovial sarcoma; Hypertrophic Cardiomyopathy; Nonspecific interstitial pneumonia; Hand, Foot and Mouth Disease; Andersen Syndrome; Parathyroid Diseases; Extraskeletal Myxoid Chondrosarcoma; Oral candidiasis; Monocytosis; Nicotine Dependence; Mesenchymal Cell Neoplasm; Blood Platelet Disorders; Hyperparathyroidism, Secondary; Epilepsies, Partial; Holoprosencephaly; Restless Legs Syndrome; Epilepsy",1.803641225501291e-12; 3.861499575207375e-12; 4.5104266881389206e-12; 1.9241179247341838e-10; 2.377251819497684e-10; 3.762648680673853e-10; 5.452288254986118e-10; 5.670785186683756e-09; 7.195555613367576e-09; 8.303910954283738e-09; 1.0368326871660785e-08; 1.4920329017331753e-08; 2.412608431251415e-08; 4.638299267461546e-08; 5.784935444423772e-08; 5.8317433871210796e-08; 6.156981490555128e-08; 6.156981490555128e-08; 9.273260676030806e-08; 2.0732395681104218e-07; 3.532371372262103e-07; 6.630279934320317e-07; 6.851652105457608e-07; 7.931659047151387e-07; 8.660170029731726e-07; 1.3079916134634371e-06; 1.51758575162775e-06; 1.5208470671427406e-06; 2.027389637151193e-06; 2.027389637151193e-06; 2.263727724144348e-06; 3.7283259874612974e-06; 4.179146475474674e-06; 5.381279306135013e-06; 1.0755368362337037e-05; 1.3010173302726732e-05; 1.3755659311680946e-05; 1.527992765491583e-05; 1.8961926417889813e-05; 2.042524345007846e-05; 2.5791573703443737e-05; 3.053335644618538e-05; 5.013426562854155e-05; 6.058590126387572e-05; 6.709590381814368e-05; 9.780860153755674e-05; 0.00016189346720036038; 0.0002484853090912064; 0.0002559467947532168; 0.0002652452950458932; 0.0002792365191965819; 0.00029355802758490503; 0.00032113080554701227; 0.0004601228759628894; 0.00046565119871267287; 0.0005011878920853237; 0.0006352060750206054; 0.0006445212280958682; 0.0012591553085125; 0.0013734265963756; 0.0015698089771612; 0.0021326108499664; 0.0025122887786423; 0.0028187518310092; 0.0028759971272412; 0.0029013169576144; 0.0043470921917622; 0.0066006052483961; 0.0080075092844381; 0.0080667733705833; 0.0083709650732796; 0.0093325514582534; 0.0118123250371176; 0.0171001534176385; 0.0182000062506337; 0.0209435845696216; 0.0231910952149837; 0.0239461944596263; 0.0324016809159931; 0.0335408281184641; 0.0469394416375774; 0.0569213530455915; 0.069077962105579; 0.0897127848630768; 0.0897127848630768; 0.0972679220674381; 0.0996459063920158; 0.1050724946352408; 0.1087303638328369; 0.1242757058018646; 0.1401454825042905; 0.1703929618871976; 0.1932166112700285; 0.2048516463561299; 0.2166737845423457; 0.2272199982000937; 0.2520982519141255; 0.2521777681302088; 0.2622329318286966; 0.2670582190879765; 0.2723453780817489; 0.320973096008708; 0.3587690037565285; 0.4089444818350988; 0.5793939269095637,"Juvenile Arthritis; Polyarthritis, Rheumatoid Factor Positive; Rheumatoid Arthritis; Seronegative Polyarthritis; Still Disease; Arthritis; Extraskeletal Myxoid Chondrosarcoma; Chondrosarcoma; Hypercholesterolemia",1.1394948069325325e-05; 1.1394948069325325e-05; 1.241997446075319e-05; 3.928596547519457e-05; 5.1065830658055726e-05; 0.0015169561374293; 0.1110148026021272; 0.1386032662139448; 0.2302982759923013,Charcot-Marie-Tooth disease type 1D ORPHA:101084; Charcot-Marie-Tooth disease type 4E ORPHA:99951; Extraskeletal myxoid chondrosarcoma ORPHA:209916,3.598261936626476e-12; 3.598261936626476e-12; 0.5312419675785659,Yaba monkey tumor virus 66R; Yaba-like disease virus 66R protein (gene: 66R),0.3911903778732946; 0.3964867307280833,,,,
NUAK2,Ovarian Carcinoma; Malignant neoplasm of ovary; Hepatitis C; Tumor Progression; Carcinogenesis; melanoma; Increased drug resistance; Endometrioid carcinoma ovary,6.870627395110916e-10; 1.971893171900314e-09; 6.991207850982321e-09; 8.297823048747685e-07; 1.51758575162775e-06; 4.179146475474674e-06; 0.0340266852061135; 0.0700485361084771,Ovarian Endometrioid Carcinoma,0.0592733852980501,"Phocomelia, Schinzel type ORPHA:2879; Fuhrmann syndrome ORPHA:2854",0.5312419675785659; 0.5312419675785659,Orf virus ORF126 ankyrin repeat protein; Horsepox virus HSPV181 (ankyrin repeats); Vaccinia virus ankyrin-like protein (gene: B4R); Yaba monkey tumor virus ankyrin repeat protein; Monkeypox virus Zaire-96-I-16 B5R (gene: B5R); Yaba-like disease virus 11L protein (gene: 11L); Human gammaherpesvirus 8 ORF72; Monkeypox virus ankyrin-like protein; Papiine alphaherpesvirus 2 serine/threonine protein kinase US3 (gene: US3); Human alphaherpesvirus 3 serine/threonine protein kinase US3 (gene: ORF66); Human herpesvirus 3 strain Dumas serine-threonine protein kinase; Cercopithecine alphaherpesvirus 2 tegument serine/threonine protein kinase (gene: UL13); Human alphaherpesvirus 3 tegument serine/threonine protein kinase (gene: ORF47); Human alphaherpesvirus 2 serine/threonine protein kinase US3 (gene: US3); Variola virus Ser/Thr kinase (gene: C14L); Cercopithecine alphaherpesvirus 2 serine/threonine protein kinase US3 (gene: US3); Papiine alphaherpesvirus 2 tegument serine/threonine protein kinase (gene: UL13); Monkeypox virus Zaire-96-I-16 Ser/Thr kinase (gene: C16L); Macacine alphaherpesvirus 1 serine/threonine protein kinase US3 (gene: US3); Ectromelia virus ERPV serine/threonine kinase; Human alphaherpesvirus 1 serine/threonine protein kinase US3 (gene: US3); Cercopithecine betaherpesvirus 5 tegument serine/threonine protein kinase (gene: UL97); Vaccinia virus Ankara Serine/threonine-protein kinase 2; Horsepox virus HSPV050 (Ser/Thr kinase; Provisional); Vaccinia virus Ser/Thr kinase (gene: F10L),0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.4627268298950313; 0.7010195275583045; 0.7356705979804892; 0.7471947418531064; 0.7640067973616771; 0.7643953507454347; 0.7871983209689735; 0.8015224820713857; 0.8217794967874373; 0.8381307845676164; 0.8394459832786514; 0.8432258859311788; 0.8472959300045919; 0.8644768996264385; 0.8710135911342001; 0.8987731428306008; 0.9504020270631124; 0.9504020270631124; 0.956598071096336,,,,
OXTR,"Asthma; Virus Diseases; Non-Small Cell Lung Carcinoma; Ovarian Carcinoma; Lung Neoplasms; Hepatitis C; Hypertensive disease; Obesity; Epithelial ovarian cancer; Pain; Gastric ulcer; Malignant neoplasm of lung; Fibroid Tumor; Malignant neoplasm of breast; Carcinoma of lung; Osteosarcoma of bone; Primary malignant neoplasm of lung; Breast Carcinoma; Osteosarcoma; Small cell carcinoma of lung; Uterine Fibroids; Stress, Psychological; Unipolar Depression; Secondary malignant neoplasm of lymph node; Major Depressive Disorder; Post-Traumatic Stress Disorder; Adenocarcinoma Of Esophagus; psychosocial stressor; Schizophrenia; Social Anxiety; Depressive Symptoms; Hyperactive behavior; Phobia, Social; Anxiety Disorders; Barrett Esophagus; Hyperplasia; Anxiety; Autism Spectrum Disorders; Antisocial Personality Disorder; HIV-1 infection; Depressive disorder; Mixed anxiety and depressive disorder; Cholestasis of pregnancy; Impaired cognition; Abnormal behavior; Obsessive-Compulsive Disorder; Antisocial behavior; Mental Depression; Separation Anxiety Disorder; Alexithymia; High-functioning autism; Pervasive Development Disorder; Well Differentiated Pancreatic Endocrine Tumor; Nephrogenic Diabetes Insipidus, Type I; Anovulatory (finding); Asperger Syndrome; Eating Disorders; Depression, Postpartum; social stress; child abuse behavior; Completed Suicide; Psychological symptom; Rokitansky Kuster Hauser syndrome; Anorexia Nervosa; Drug abuse; Cognition Disorders; Psychiatric symptom; Bulimia Nervosa; Psychotic symptom; Amenorrhea; NEUROTICISM; Mental disorders; Autistic Disorder; Borderline Personality Disorder; Attention deficit hyperactivity disorder",1.803641225501291e-12; 6.332483647919588e-11; 3.762648680673853e-10; 6.870627395110916e-10; 4.367699208727405e-09; 6.991207850982321e-09; 1.0368326871660785e-08; 2.412608431251415e-08; 1.479813245926713e-07; 1.6759866477134858e-07; 4.312772724439924e-07; 6.299208964864026e-07; 6.630279934320317e-07; 8.660170029731726e-07; 2.027389637151193e-06; 2.560217628497434e-06; 4.839188317483647e-06; 5.381279306135013e-06; 6.3131986281381465e-06; 1.0755368362337037e-05; 5.013426562854155e-05; 5.248375780672949e-05; 0.00010334647523919963; 0.000323910443746482; 0.0003278023880903879; 0.0006163914271817124; 0.0011303542860313; 0.0059257679306595; 0.0093325514582534; 0.0096630827054915; 0.0110109843340769; 0.0111888062322808; 0.015507621739214; 0.0173384291015271; 0.0193777520415227; 0.0269131580640034; 0.0365699380189482; 0.0411765978055933; 0.044901297966643; 0.0457039625575448; 0.0691714743582008; 0.0777073264956258; 0.083107903315643; 0.0835641020831185; 0.0864853123692039; 0.087414326021809; 0.0887863766478173; 0.0887984457495041; 0.0972679220674381; 0.0972679220674381; 0.0972679220674381; 0.1050724946352408; 0.1080647222141486; 0.1206032442301429; 0.1206032442301429; 0.1272255752567765; 0.1369039689436487; 0.1525119847960956; 0.1525119847960956; 0.1584804022044084; 0.1584804022044084; 0.1584804022044084; 0.176056923749369; 0.1866447221848054; 0.251930120576978; 0.2650101216681973; 0.2823835751171575; 0.2921843338021302; 0.320973096008708; 0.3258470663820326; 0.3446292548618789; 0.4265163370325311; 0.5199487681301056; 0.5523550850146659; 0.5586510196217223,Mental Depression; Lung Carcinoma; Schizophrenia; Cognitive Disorder; Autism Spectrum Disorder; Autism,0.0511376198481248; 0.0868883392670891; 0.175139305620004; 0.3636022406609426; 0.5883864470152684; 0.9566250318622398,Familial isolated trichomegaly ORPHA:411788,0.5312419675785659,,,Homo sapiens HEK293A embryonic kidney cell,0.27,Homo sapiens,Homo sapiens
PLAU,"Inflammation; Pneumonia; Reperfusion Injury; Asthma; Psoriasis; Lymphoma; Dermatitis, Atopic; Chronic Obstructive Airway Disease; Synovitis; Rheumatoid Arthritis; Arteriosclerosis; Non-Small Cell Lung Carcinoma; Crohn Disease; Ovarian Carcinoma; Endometriosis; cervical cancer; Cirrhosis; Ulcerative Colitis; Infection; Malignant neoplasm of ovary; Tumor Angiogenesis; Malignant tumor of cervix; Dermatitis; Lung Neoplasms; Cerebral Ischemia; Neoplasm Metastasis; Hepatitis C; Atherosclerosis; Pulmonary Fibrosis; Leukemia, Myelocytic, Acute; Liver Cirrhosis; Cervix carcinoma; Brain Ischemia; Cerebrovascular accident; Degenerative polyarthritis; Inflammatory Bowel Diseases; Liver neoplasms; Mammary Neoplasms; Aortic Aneurysm, Abdominal; Glioblastoma; Ischemic stroke; Pancreatic carcinoma; Coronary heart disease; Alzheimer's Disease; Adenocarcinoma of pancreas; Right Middle Cerebral Artery Infarction; Embolic Infarction, Middle Cerebral Artery; Thrombotic Infarction, Middle Cerebral Artery; Left Middle Cerebral Artery Infarction; Middle Cerebral Artery Embolus; Middle Cerebral Artery Syndrome; Middle Cerebral Artery Thrombosis; Glioma; Epithelial ovarian cancer; Malignant neoplasm of pancreas; Malignant neoplasm of mouth; Myocardial Infarction; Infarction, Middle Cerebral Artery; Cerebral Infarction; Adult T-Cell Lymphoma/Leukemia; Brain Neoplasms; Sciatic Neuropathy; Gastric ulcer; Cardiovascular Diseases; Cystic Fibrosis; Malignant neoplasm of lung; Middle Cerebral Artery Occlusion; Diabetes Mellitus, Insulin-Dependent; Tumor Progression; Malignant neoplasm of breast; Bladder Neoplasm; Systemic Scleroderma; Liver carcinoma; Colonic Neoplasms; Immunologic Deficiency Syndromes; Carcinogenesis; Transient Ischemic Attack; Endometrial Neoplasms; Carcinoma of lung; Stomach Carcinoma; Ankylosing spondylitis; Colon Carcinoma; Fibrosarcoma; Malignant neoplasm of stomach; Osteosarcoma of bone; Lip and Oral Cavity Carcinoma; Astrocytoma; Stomach Neoplasms; melanoma; Primary malignant neoplasm of lung; Breast Carcinoma; Henoch-Schoenlein Purpura; Osteosarcoma; Angina, Unstable; Liver Cirrhosis, Experimental; Familial Alzheimer Disease (FAD); Small cell carcinoma of lung; Colorectal Neoplasms; Pleural Effusion, Malignant; Hepatitis B; Presenile dementia; Prostate carcinoma; Adenocarcinoma; Malignant tumor of colon; ovarian neoplasm; Nephritis; Myeloid Leukemia; Kidney Failure, Chronic; Prostatic Neoplasms; Herpes Simplex Infections; Malignant neoplasm of endometrium; Uterine Corpus Cancer; Hypotension; Chronic kidney disease stage 5; Squamous cell carcinoma; Malignant neoplasm of prostate; Malignant neoplasm of urinary bladder; Pancreatic Neoplasm; Mouth Neoplasms; Malignant Head and Neck Neoplasm; Periodontal Diseases; IGA Glomerulonephritis; Biliary Atresia; Acute myocardial infarction; Malignant Glioma; Malignant neoplasm of liver; Urinary tract infection; Other specified transient cerebral ischemias; Idiopathic Pulmonary Fibrosis; Malignant Pleural Mesothelioma; Mesothelioma; Renal Cell Carcinoma; Alzheimer Disease, Early Onset; Adenoma; Solid Neoplasm; Endometrial Carcinoma; Acute myelomonocytic leukemia; Carcinoma, Transitional Cell; Acute Lung Injury; Retinoblastoma; Status Epilepticus; Colorectal Carcinoma; Fibrosis, Liver; Pancreatic Ductal Adenocarcinoma; Dermatitis Herpetiformis; Metastatic melanoma; Esophageal Neoplasms; Leg Ulcer; Scleroderma; Neoplasms; Acute Cerebrovascular Accidents; Kidney Failure; Allergic disposition; Liver Cirrhosis, Alcoholic; Chondrosarcoma; Carotid Artery Diseases; Sarcoma; Secondary malignant neoplasm of lymph node; Amyloidosis; Colorectal Cancer; Secondary malignant neoplasm of lung; Invasive carcinoma of breast; Ischemia; Carcinoma breast stage IV; Ataxia Telangiectasia; Focal glomerulosclerosis; Hemorrhage; Severe Combined Immunodeficiency; Carcinoma, Cribriform; Carcinoma, Granular Cell; Stage IV Ovarian Carcinoma; Adenocarcinoma, Basal Cell; Adenocarcinoma, Oxyphilic; Secondary malignant neoplasm of liver; Adenocarcinoma, Tubular; HELLP Syndrome; Precancerous Conditions; tumor vasculature; Neoplasm Invasiveness; Alzheimer's Disease, Focal Onset; Acute Confusional Senile Dementia; Alzheimer Disease, Late Onset; Adenovirus Infections; Disseminated Malignant Neoplasm; Adenoma of large intestine; Thyroid Neoplasm; Osteoarthritis, Knee; Papillary thyroid carcinoma; Thrombosis; Aneurysm; Renal carcinoma; Bullous pemphigoid; Carotid Atherosclerosis; Brain Edema; gliosarcoma; Lymphangioleiomyomatosis; Childhood Acute Lymphoblastic Leukemia; Fatty Liver; Liver and Intrahepatic Biliary Tract Carcinoma; Hepatocarcinogenesis; Hereditary Diffuse Gastric Cancer; Vasogenic Brain Edema; Vasogenic Cerebral Edema; Cytotoxic Brain Edema; Cytotoxic Cerebral Edema; Pleural Mesothelioma; Respiratory Tract Infections; Squamous cell carcinoma of esophagus; Muscular Dystrophy, Duchenne; Quebec platelet disorder; Thrombocytopenia; Medulloblastoma; Carcinoma, Neuroendocrine; Arterial Occlusive Diseases; Cholangitis, Sclerosing; Arterial Diseases, Common Carotid; External Carotid Artery Diseases; Internal Carotid Artery Diseases; Clear Cell Sarcoma of Soft Tissue; intracranial glioma; Meningioma; Thrombus; Invasive Ductal Breast Carcinoma; Limb ischemia; Invasive Carcinoma; Intracranial Hemorrhages; TARSAL-CARPAL COALITION SYNDROME; Glioblastoma Multiforme; Keratoconjunctivitis, Vernal; Liver Failure; Cerebrovascular Disorders; Squamous cell carcinoma of mouth; Fatty Liver, Alcoholic; Pancreatic intraepithelial neoplasia; Carcinoma of ampulla of Vater; Malignant neoplasm of gastrointestinal tract; Hyperplasia; Adenocarcinoma of colon; Renal glomerular disease; Tuberous Sclerosis; Squamous cell carcinoma of lung; Carcinoid Tumor; Pulmonary Embolism; Lymphatic Metastasis; Epithelioma; Rhabdomyosarcoma; Chordoma; Secondary malignant neoplasm of pancreas; Ventricular Fibrillation; Asthenozoospermia; Meningioma, benign, no ICD-O subtype; Intraepithelial Neoplasia; Cardiac fibrosis; Blood Coagulation Disorders; Cerebral Edema; Carcinoid tumor no ICD-O subtype; Cerebrovascular Occlusion; Giant cell carcinoma of lung; Posterior Fossa Hemorrhage; Noninfiltrating Intraductal Carcinoma; Bone pain; Anuria; Hemoglobinuria, Paroxysmal; Pemphigus Vulgaris; Cerebral Hemorrhage; Cerebral Infarction, Left Hemisphere; Cerebral Infarction, Right Hemisphere; Anterior Choroidal Artery Infarction; Hemarthrosis; Posterior Choroidal Artery Infarction; Pterygium; Cystadenoma, Mucinous; Bone neoplasms; Subcortical Infarction; Meleda Disease; Anaplastic astrocytoma; Malignant neoplasm of brain; Laryngeal cleft; Pulmonary Thromboembolisms; Cicatrix, Hypertrophic; Thromboembolism; Venous Thrombosis; Spastic syndrome; Hypofibrinogenemia; Menorrhagia; Norrie disease; Deep Vein Thrombosis; Hepatitis C Virus Infection; Malignant Bone Neoplasm; Brain hemorrhage; Seminoma; Neoplasm Recurrence, Local; Hemangioblastoma; Epistaxis; Frequent nosebleeds; Hematuria; Angina Pectoris; Mitral Valve Prolapse Syndrome; ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 1; Neoplastic Syndromes, Hereditary; Increased tendency to bruise; Adult Hepatocellular Carcinoma; Von Hippel-Lindau Syndrome; Decreased platelet count; Prostatic Intraepithelial Neoplasias",2.8114433253573326e-17; 7.980856456624717e-16; 4.4398736172867135e-14; 1.803641225501291e-12; 3.118210553589307e-12; 4.5104266881389206e-12; 7.448716379948652e-11; 1.3121548808139071e-10; 1.6797550790254382e-10; 1.9241179247341838e-10; 2.377251819497684e-10; 3.762648680673853e-10; 4.2478505092738466e-10; 6.870627395110916e-10; 7.868397426275417e-10; 1.1722433847661196e-09; 1.4790998733426532e-09; 1.6767489697325582e-09; 1.794870341379274e-09; 1.971893171900314e-09; 3.315537369635636e-09; 3.683115069310663e-09; 3.683115069310663e-09; 4.367699208727405e-09; 4.756590990483e-09; 5.670785186683756e-09; 6.991207850982321e-09; 7.195555613367576e-09; 7.547641288501485e-09; 8.303910954283738e-09; 1.3128768066526236e-08; 1.5572986293211266e-08; 1.8815395768840057e-08; 2.0570601164639797e-08; 2.1034803123367165e-08; 2.3137704832524547e-08; 4.3069383556698336e-08; 4.65353219894153e-08; 5.1290058242058653e-08; 5.518991037343798e-08; 6.156981490555128e-08; 6.982287075725826e-08; 9.273260676030806e-08; 9.273260676030806e-08; 9.306686765839445e-08; 1.0390067657961098e-07; 1.0390067657961098e-07; 1.0390067657961098e-07; 1.0390067657961098e-07; 1.0390067657961098e-07; 1.0390067657961098e-07; 1.0390067657961098e-07; 1.427432458937347e-07; 1.479813245926713e-07; 1.4925759778299788e-07; 2.0279723135488897e-07; 2.247163660896597e-07; 2.400988116471548e-07; 2.419125491442217e-07; 2.46778041958494e-07; 4.157277636684319e-07; 4.312772724439924e-07; 4.312772724439924e-07; 4.5433391667148853e-07; 5.577321626966352e-07; 6.299208964864026e-07; 6.805796735296268e-07; 6.851652105457608e-07; 8.297823048747685e-07; 8.660170029731726e-07; 9.822463166680949e-07; 1.10068355868735e-06; 1.3079916134634371e-06; 1.4185164995612263e-06; 1.4839502431758565e-06; 1.51758575162775e-06; 1.5208470671427406e-06; 1.6397478315149087e-06; 2.027389637151193e-06; 2.07112526817849e-06; 2.1020461880694925e-06; 2.205236928124383e-06; 2.3419309731960144e-06; 2.450940162208615e-06; 2.560217628497434e-06; 2.576211756838249e-06; 2.608032323197001e-06; 3.878607667297475e-06; 4.179146475474674e-06; 4.839188317483647e-06; 5.381279306135013e-06; 5.457492980911677e-06; 6.3131986281381465e-06; 7.095035199288336e-06; 7.691726899679507e-06; 9.263589414966798e-06; 1.0755368362337037e-05; 1.3034577772762696e-05; 1.3268923055385737e-05; 1.3755659311680946e-05; 1.5064798896399038e-05; 1.527992765491583e-05; 1.5449280661407645e-05; 1.5498516107485843e-05; 1.8507296589967813e-05; 1.9896942827707536e-05; 2.042524345007846e-05; 2.0820699372778346e-05; 2.0820699372778346e-05; 2.1109857936882128e-05; 2.389985034001877e-05; 2.483118059238325e-05; 2.7966054180512005e-05; 2.910435331986992e-05; 3.053335644618538e-05; 3.053335644618538e-05; 3.1491435270594376e-05; 3.192298841377222e-05; 3.602405958537832e-05; 4.3188904868696655e-05; 4.550622830486202e-05; 5.2700686057264086e-05; 6.964870190365813e-05; 7.036498484894257e-05; 8.25206825409808e-05; 8.421319594446617e-05; 9.023170634543253e-05; 9.56957692518114e-05; 9.780860153755674e-05; 0.0001007621786326551; 0.00010582598320524978; 0.0001119048288448298; 0.00011927896769899647; 0.00012202062264879416; 0.0001322335978675375; 0.0001322335978675375; 0.00014636999075042076; 0.0001474322229096163; 0.00014885785925249347; 0.00015093372108149775; 0.0001616561904035017; 0.00016189346720036038; 0.0001690762138878921; 0.0001802305430549181; 0.0001934869050618567; 0.00021049732822064587; 0.00021804014782198476; 0.0002214859278255797; 0.00022254302103317592; 0.00022897551943886068; 0.00025117420022058794; 0.0002559467947532168; 0.0002718864504795822; 0.0002792365191965819; 0.0002792365191965819; 0.0002812860791024885; 0.00029355802758490503; 0.000323910443746482; 0.0003495642888428815; 0.00038453776693371663; 0.00042196010900515655; 0.0004224524250828287; 0.00047142552462714113; 0.0004814724943641282; 0.0005182771791848276; 0.0005486681594044074; 0.0006445212280958682; 0.0006993549316202267; 0.0007603472723798622; 0.0007603472723798622; 0.0007731114749585194; 0.0008280072185276037; 0.0010170306665323; 0.0010244557923259; 0.0011303542860313; 0.0011626911115394; 0.0012688388196185; 0.0013033444225859; 0.0013309210571735; 0.0014413188128666; 0.0014413188128666; 0.0017107913939493; 0.0017856981020231; 0.0018360773814867; 0.001881335207053; 0.0020089634269714; 0.0020282798161214; 0.0025122887786423; 0.0025122887786423; 0.0027534163536682; 0.0028626589910413; 0.0031934755667; 0.0032682022992594; 0.0037263522689301; 0.0037263522689301; 0.0037263522689301; 0.0038705790239355; 0.0038705790239355; 0.0038816440940594; 0.0040444907714877; 0.0043105477873176; 0.0048028611524245; 0.0048028611524245; 0.0048028611524245; 0.0048028611524245; 0.0048028611524245; 0.0050894481995015; 0.0062748297137782; 0.007117388576245; 0.007117388576245; 0.0083709650732796; 0.0084568432337518; 0.008634277457381; 0.0093060572422998; 0.0093598514945993; 0.0096630827054915; 0.0096630827054915; 0.0096630827054915; 0.0097159454554601; 0.010343569493973; 0.0105367304020196; 0.0120771273149872; 0.0123563544259949; 0.0127059723723765; 0.0128516790501046; 0.0138441633831498; 0.016456143422954; 0.0171001534176385; 0.0171001534176385; 0.0203198961621158; 0.0210446393275247; 0.021125667706065; 0.0220575875892222; 0.0220705590988414; 0.0220705590988414; 0.0255085366814945; 0.0269131580640034; 0.027071413490175; 0.0295521651553568; 0.0299774405999183; 0.033749008368017; 0.0386264970299853; 0.0402448379890702; 0.040382673882237; 0.0407359064912377; 0.0462818499370266; 0.0517499693438671; 0.0517499693438671; 0.0543546439241988; 0.0543546439241988; 0.057047868743524; 0.0587248614153099; 0.0630979595913369; 0.0670239713427008; 0.0723815120866587; 0.0746301710738675; 0.0817897187940979; 0.0817897187940979; 0.0817897187940979; 0.0908772402064694; 0.0987575443309834; 0.1050724946352408; 0.1130019719865939; 0.1146753245606438; 0.1270483391700474; 0.1272255752567765; 0.1272255752567765; 0.1272255752567765; 0.1272255752567765; 0.1272255752567765; 0.1343310874911156; 0.1343310874911156; 0.1397055058487397; 0.1401454825042905; 0.1460848784791741; 0.1545590833140752; 0.1545590833140752; 0.1584804022044084; 0.1584804022044084; 0.1642913929691757; 0.1703929618871976; 0.1758774326276071; 0.1881045022168423; 0.1932166112700285; 0.1932166112700285; 0.1982833830495248; 0.2222592445219346; 0.2226324872503657; 0.2226324872503657; 0.2316568843888361; 0.251930120576978; 0.2823835751171575; 0.316142834424839; 0.335302985108383; 0.335302985108383; 0.335302985108383; 0.3718365496695985; 0.3929133356162864; 0.4282129311389295; 0.4424335623428572; 0.4712571109376817; 0.5112292444765246; 0.5785803800876654; 0.6652972861073814; 0.7124872261498931,Cerebral Ischemia; Cerebral Infraction; Cerebral Thrombosis; Pulmonary Fibrosis; Glomerulonephritis; Ulcerative Colitis; Psoriasis; Myocardial Infarction; Pancreatic Cancer; Pancreatic Neoplasm; Senile Dementia; Carcinoma; Stomach Neoplasms; Gastric Cancer; Inflammatory Bowel Disease; Carotid Artery Disease; Adenocarcinoma; Carotid Atherosclerosis; Prostatic Neoplasms; Stroke; Asthma; Crohn Disease; Thrombosis; Nephritis; Liver Cirrhosis; Prostate Cancer; Bone Neoplasms; Malignant Bone Neoplasm; Asthenozoospermia; Cerebral Infarction; Pulmonary Thromboembolism; Brain Infarction; Cholangitis; Ankylosing Spondylitis; Liver Fibrosis; Alzheimer Disease; Diffuse Interstitial Pulmonary Fibrosis; Parkinson Disease; Ventricular Fibrillation; Coronary Heart Disease; Dementia,5.562961744202623e-09; 2.009208013074685e-07; 2.739939098363423e-07; 3.656047745092532e-06; 1.0086418491083646e-05; 0.0002754573766813309; 0.00044166586682199737; 0.0005760978170082974; 0.00207663921483; 0.0054741435035425; 0.0067487024308267; 0.0107108189044139; 0.0172144998405365; 0.0172144998405365; 0.021392225047824; 0.021392225047824; 0.0249475037164364; 0.0268526262997348; 0.0567647407547259; 0.0588219013114419; 0.064825092293108; 0.0682669288241704; 0.0992543625886142; 0.1110148026021272; 0.1273861908316246; 0.1386032662139448; 0.1386032662139448; 0.1386032662139448; 0.1448400284889975; 0.1716490205203499; 0.175139305620004; 0.191014576985413; 0.2039740835961235; 0.2072542702968064; 0.2072542702968064; 0.2089805590322066; 0.2089805590322066; 0.2943246801469203; 0.367616394854405; 0.504775797017495; 0.7178809809600589,"Quebec platelet disorder ORPHA:220436; Lattice corneal dystrophy type I ORPHA:98964; Reis-Bucklers corneal dystrophy ORPHA:98961; Epithelial basement membrane dystrophy ORPHA:98956; Thiel-Behnke corneal dystrophy ORPHA:98960; Granular corneal dystrophy type I ORPHA:98962; Granular corneal dystrophy type II ORPHA:98963; Niemann-Pick disease type C, adult neurologic onset ORPHA:216986; Niemann-Pick disease type C, juvenile neurologic onset ORPHA:216981; Niemann-Pick disease type C, late infantile neurologic onset ORPHA:216978; Niemann-Pick disease type C, severe early infantile neurologic onset ORPHA:216975; Niemann-Pick disease type C, severe perinatal form ORPHA:216972; Familial cavitary optic disc anomaly ORPHA:464760; Adenocarcinoma of ovary ORPHA:213504; Palmoplantar keratoderma, Nagashima type ORPHA:140966; Congenital plasminogen activator inhibitor type 1 deficiency ORPHA:465; Familial primary localized cutaneous amyloidosis ORPHA:353220; Thyroid ectopia ORPHA:95712; Hypoplastic amelogenesis imperfecta ORPHA:100031; Musculocontractural Ehlers-Danlos syndrome ORPHA:2953; Autosomal recessive generalized dystrophic epidermolysis bullosa, severe form ORPHA:79408; Cap myopathy ORPHA:171881; Lipoid proteinosis ORPHA:530; Male infertility due to large-headed multiflagellar polyploid spermatozoa ORPHA:137893; Adams-Oliver syndrome ORPHA:974; Multicentric osteolysis-nodulosis-arthropathy spectrum ORPHA:371428",3.28973817825433e-05; 0.0002132495254484572; 0.0002132495254484572; 0.0002132495254484572; 0.0002132495254484572; 0.0002132495254484572; 0.0002132495254484572; 0.0002132495254484572; 0.0002132495254484572; 0.0002132495254484572; 0.0002132495254484572; 0.0002132495254484572; 0.0019696624570933; 0.0133474287859103; 0.0514345493431829; 0.0514345493431829; 0.0514345493431829; 0.0514345493431829; 0.0565022767519947; 0.1927589191138116; 0.1927589191138116; 0.1927589191138116; 0.4838060079820406; 0.4838060079820406; 0.491912282528682; 0.5312419675785659,"Vaccinia virus Ankara Haemagglutinin; Vaccinia virus hemagglutinin (gene: A56R); Horsepox virus HSPV177 (Immunoglobulin like); Monkeypox virus Zaire-96-I-16 B2R (gene: B2R); Human cosavirus D 3C; Horsepox virus HSPV036 (serine protease inhibitor-like protein); Human rhinovirus B17 full_polyprotein 1..2186; Astrovirus VA1 non-structural protein 1a; Astrovirus SG nonstructural protein 1a; Astrovirus SG nonstructural protein 1ab; Astrovirus VA1 non-structural protein 1ab; Vaccinia virus Ankara serine protease inhibitor, SPI-3; Monkeypox virus Zaire-96-I-16 serine protease inhibitor-like protein (gene: C2L); Vaccinia virus Ankara serine proteinase inhibitor / SPI-2 f2; Yaba-like disease virus 10L protein (gene: 10L); Ectromelia virus ERPV serpin; Vaccinia virus serine protease inhibitor-like protein (gene: K2L); Variola virus serine protease inhibitor-like protein (gene: C2L); Cowpox virus SPI3 or CPXV042 protein (gene: SPI3)",0.0096374079669374; 0.0223182816928385; 0.0401211861299026; 0.0816962571184375; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3964867307280833,Homo sapiens A549 lung carcinoma cell,0.35,SARS-CoV-2,Homo sapiens
PLK2,"Juvenile arthritis; Lymphoma; Multiple Myeloma; Non-Small Cell Lung Carcinoma; Ovarian Carcinoma; Ulcerative Colitis; Malignant neoplasm of ovary; Lung Neoplasms; Leukemia, Myelocytic, Acute; Glioblastoma; Ischemic stroke; Pancreatic carcinoma; Alzheimer's Disease; Epithelial ovarian cancer; Malignant neoplasm of pancreas; Chronic Lymphocytic Leukemia; Tumor Progression; Liver carcinoma; Carcinogenesis; Osteosarcoma of bone; Osteosarcoma; MYELODYSPLASTIC SYNDROME; Adenocarcinoma; Juvenile psoriatic arthritis; Juvenile-Onset Still Disease; Squamous cell carcinoma; Parkinson Disease; Hematologic Neoplasms; Malignant neoplasm of liver; Adenocarcinoma of lung (disorder); Sarcoma; Irritable Bowel Syndrome; Carcinoma of larynx; Malignant neoplasm of larynx; Myeloid neoplasm; Mild cognitive disorder; Liver and Intrahepatic Biliary Tract Carcinoma; Undifferentiated carcinoma; Carcinomatosis; Anaplastic carcinoma; Childhood Osteosarcoma; Burkitt Lymphoma; Carcinoma, Spindle-Cell; Lewy Body Disease; Carcinoma; Adverse reaction to drug; Drug toxicity; Mammary Neoplasms, Experimental; Endometrioid carcinoma ovary; Hydroa Vacciniforme; Laryngeal Squamous Cell Carcinoma; Mammary Carcinoma, Animal; Animal Mammary Neoplasms",3.861499575207375e-12; 4.5104266881389206e-12; 2.5279022064249716e-11; 3.762648680673853e-10; 6.870627395110916e-10; 1.6767489697325582e-09; 1.971893171900314e-09; 4.367699208727405e-09; 8.303910954283738e-09; 5.518991037343798e-08; 6.156981490555128e-08; 6.982287075725826e-08; 9.273260676030806e-08; 1.479813245926713e-07; 1.4925759778299788e-07; 7.931659047151387e-07; 8.297823048747685e-07; 1.3079916134634371e-06; 1.51758575162775e-06; 2.560217628497434e-06; 6.3131986281381465e-06; 1.279493639647176e-05; 1.5449280661407645e-05; 1.8961926417889813e-05; 2.5791573703443737e-05; 3.053335644618538e-05; 3.372277447426952e-05; 6.058590126387572e-05; 8.421319594446617e-05; 0.00013846515856925812; 0.00029355802758490503; 0.0008252744167874381; 0.0011261416978188; 0.0013033444225859; 0.0021326108499664; 0.0025876779926919; 0.0038816440940594; 0.0048028611524245; 0.0050844857197244; 0.0095206592087124; 0.0097628826330308; 0.0196345173194062; 0.0254956360475327; 0.0335408281184641; 0.0404707605808569; 0.0457039625575448; 0.0457039625575448; 0.0554191598986221; 0.0700485361084771; 0.0817897187940979; 0.2570364810168682; 0.3027515681302206; 0.3027515681302206,"Juvenile Arthritis; Polyarthritis, Rheumatoid Factor Positive; Seronegative Polyarthritis; Still Disease; Arthritis; Carcinoma; Anaplastic Carcinoma; Ovarian Endometrioid Carcinoma; Lung Adenocarcinoma",1.1394948069325325e-05; 1.1394948069325325e-05; 3.928596547519457e-05; 5.1065830658055726e-05; 0.0015169561374293; 0.0107108189044139; 0.0352250843106217; 0.0592733852980501; 0.1787826075739565,"Interstitial lung disease-nephrotic syndrome-epidermolysis bullosa syndrome ORPHA:306504; Arnold-Chiari malformation type I ORPHA:268882; Chondrosarcoma ORPHA:55880; Auriculocondylar syndrome ORPHA:137888; Autosomal recessive nail dysplasia ORPHA:280654; NON RARE IN EUROPE: Idiopathic infantile nystagmus ORPHA:651; Neonatal inflammatory skin and bowel disease ORPHA:294023; Pediatric hepatocellular carcinoma ORPHA:33402; Trichorhinophalangeal syndrome type 2 ORPHA:502; ABeta amyloidosis, Arctic type ORPHA:324723; ABeta amyloidosis, Dutch type ORPHA:100006; ABeta amyloidosis, Iowa type ORPHA:324708; ABeta amyloidosis, Italian type ORPHA:324713; ABetaA21G amyloidosis ORPHA:324718; ABetaL34V amyloidosis ORPHA:324703; Alagille syndrome due to 20p12 microdeletion ORPHA:261600; Alagille syndrome due to a JAG1 point mutation ORPHA:261619; Chondrodysplasia-disorder of sex development syndrome ORPHA:1422; Colobomatous macrophthalmia-microcornea syndrome ORPHA:468672; Familial progressive hyper- and hypopigmentation ORPHA:280628; Familial progressive hyperpigmentation ORPHA:79146; Griscelli syndrome type 3 ORPHA:79478",0.0133474287859103; 0.0514345493431829; 0.1927589191138116; 0.1938708167942525; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659,"Vaccinia virus Ankara CP77 Host range protein f1; Horsepox virus HSPV011b (ankyrin repeats); Cowpox virus CPXV213 protein (gene: CPXV213 CDS); Cowpox virus CPXV011 protein (gene: CPXV011 CDS); Vaccinia virus Ankara 72.4k ankyrin repeat protein f2; Vaccinia virus ankyrin-like protein; Horsepox virus HSPV005c (Ankyrin repeats); Horsepox virus HSPV196 (ankyrin-like protein; Provisional); Yaba-like disease virus 146R protein (gene: 146R); Variola virus hypothetical protein (gene: B21R); Cowpox virus VHR1 or CPXV025 protein (gene: VHR1); Horsepox virus HSPV011c (ankyrin repeats); Orf virus ORF126 ankyrin repeat protein; Monkeypox virus Zaire-96-I-16 ankyrin-like protein (gene: D7L); Cowpox virus CPXV017 protein (gene: CPXV017 CDS); Monkeypox virus Zaire-96-I-16 B17R (gene: B17R); Horsepox virus HSPV194 (ankyrin repeats); Monkeypox virus Zaire-96-I-16 ankyrin-like protein (gene: D9L); Cowpox virus CPXV019 protein (gene: CPXV019 CDS); Monkeypox virus Zaire-96-I-16 ankyrin-like protein (gene: D1L); Horsepox virus HSPV020e (ankyrin repeats); Cowpox virus CPXV016 protein (gene: CPXV016 CDS); Horsepox virus HSPV181 (ankyrin repeats); Vaccinia virus Ankara 54.4k ankyrin repeat protein f2; Vaccinia virus ankyrin-like protein (gene: B4R); Variola virus hypothetical protein (gene: B19R); Vaccinia virus Ankara 67.9k ankyrin repeat protein; Cowpox virus CPXV008 protein (gene: CPXV008 CDS); Horsepox virus HSPV014c (ankyrin repeats); Yaba monkey tumor virus ankyrin repeat protein; Vaccinia virus ankyrin-like protein (gene: B18R); Cowpox virus CPXV211 protein (gene: CPXV211 CDS); Monkeypox virus Zaire-96-I-16 B5R (gene: B5R); Horsepox virus HSPV033c (ankyrin repeats); Variola virus hypothetical protein (gene: G3R); Variola virus hypothetical protein (gene: D6L); Vaccinia virus Ankara 54.4k ankyrin repeat protein f1; Yaba-like disease virus 147R protein (gene: 147R); Yaba monkey tumor virus ankyrin-like protein; Variola virus ankyin-like protein (gene: O1L); Monkeypox virus Zaire-96-I-16 ankyin-like protein (gene: O1L); Cowpox virus CPXV006 protein (gene: CPXV006 CDS); Horsepox virus HSPV012 (ankyrin-like protein; Provisional); Yaba-like disease virus 11L protein (gene: 11L); Yaba-like disease virus 148R protein (gene: 148R); Vaccinia virus hypothetical protein; Yaba-like disease virus 8L protein (gene: 8L); Orf virus ORF128 ankyrin repeat protein; Orf virus ORF123 ankyrin repeat protein; Horsepox virus HSPV011a; Cowpox virus CPXV039 (gene: CPXV039 CDS); Vaccinia virus ankyin-like protein (gene: M1L); Monkeypox virus Zaire-96-I-16 J3L (gene: J3L); Vaccinia virus Ankara 78.7k Ankyrin repeat protein f1; Vaccinia virus Ankara 65.4k Ankyrin repeat protein; Human gammaherpesvirus 8 ORF72; Cowpox virus CPXV220 protein (gene: CPXV220 CDS); Cowpox virus CPXV198 protein (gene: CPXV198 CDS); Ectromelia virus ERPV ankyrin; Orf virus ORF129 ankyrin repeat protein; Cowpox virus CPXV206 protein (gene: CPXV206 CDS); Monkeypox virus ankyrin-like protein; Papiine alphaherpesvirus 2 serine/threonine protein kinase US3 (gene: US3); Human alphaherpesvirus 3 serine/threonine protein kinase US3 (gene: ORF66); Human herpesvirus 3 strain Dumas serine-threonine protein kinase; Cercopithecine alphaherpesvirus 2 tegument serine/threonine protein kinase (gene: UL13); Human alphaherpesvirus 3 tegument serine/threonine protein kinase (gene: ORF47); Human alphaherpesvirus 2 serine/threonine protein kinase US3 (gene: US3); Cercopithecine alphaherpesvirus 2 serine/threonine protein kinase US3 (gene: US3); Papiine alphaherpesvirus 2 tegument serine/threonine protein kinase (gene: UL13); Macacine alphaherpesvirus 1 serine/threonine protein kinase US3 (gene: US3); Ectromelia virus ERPV serine/threonine kinase; Human alphaherpesvirus 1 serine/threonine protein kinase US3 (gene: US3); Cercopithecine betaherpesvirus 5 tegument serine/threonine protein kinase (gene: UL97); Human betaherpesvirus 6 U69, ganciclovir kinase, phosphotransferase (gene: U69); Human betaherpesvirus 6A tegument serine/threonine protein kinase (gene: U69); Human alphaherpesvirus 2 tegument serine/threonine protein kinase (gene: UL13); Human alphaherpesvirus 1 tegument serine/threonine protein kinase (gene: UL13); Macacine alphaherpesvirus 1 tegument serine/threonine protein kinase (gene: UL13); Human betaherpesvirus 7 tegument serine/threonine protein kinase (gene: U69); Human betaherpesvirus 6B Phosphotransferase (gene: U69); Human betaherpesvirus 5 tegument serine/threonine protein kinase (gene: UL97)",0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3956197978099343; 0.3956197978099343; 0.396036820576385; 0.4088672649431711; 0.4139745988798983; 0.4145707851950257; 0.4264358713488607; 0.4311162645337849; 0.4342000778047719; 0.4602555770769919; 0.4627268298950313; 0.4777231148134931; 0.5134770656069968; 0.5349555669171289; 0.5491415646821286; 0.6028165858205247; 0.7010195275583045; 0.7356705979804892; 0.7471947418531064; 0.7640067973616771; 0.7643953507454347; 0.7871983209689735; 0.8015224820713857; 0.8381307845676164; 0.8394459832786514; 0.8472959300045919; 0.8644768996264385; 0.8710135911342001; 0.8987731428306008; 0.899491710093239; 0.899491710093239; 0.9506084884522116; 0.9522950599270064; 0.9609647954389908; 0.9620034792895534; 0.9677125236725193; 0.9708961682067512,Homo sapiens HeLa epitheloid cervical carcinoma cell,0.4,Homo sapiens,Mus musculus
POTEF,"Asthma; Multiple Myeloma; Virus Diseases; Lobar Pneumonia; Chronic Obstructive Airway Disease; Non-Small Cell Lung Carcinoma; Autoimmune Diseases; Ovarian Carcinoma; Endometriosis; Cirrhosis; Malignant neoplasm of ovary; Colitis; Pancreatitis, Chronic; Lung Neoplasms; Hodgkin Disease; Hepatitis C; Leukemia, Myelocytic, Acute; Liver Cirrhosis; Infection caused by Helicobacter pylori; Obesity; Glioblastoma; leukemia; Diabetes Mellitus; Diabetes; Pancreatic carcinoma; Alzheimer's Disease; Adenocarcinoma of pancreas; Malignant neoplasm of pancreas; Hepatitis C, Chronic; Cystic Fibrosis; Malignant neoplasm of lung; Fibroid Tumor; Tuberculosis; Diabetes Mellitus, Insulin-Dependent; Hepatitis, Alcoholic; Malignant neoplasm of breast; Bladder Neoplasm; Liver carcinoma; Colonic Neoplasms; Carcinogenesis; Influenza; Carcinoma of lung; Stomach Carcinoma; B-Cell Lymphomas; Colon Carcinoma; Malignant neoplasm of stomach; Astrocytoma; Stomach Neoplasms; melanoma; Primary malignant neoplasm of lung; Breast Carcinoma; Small cell carcinoma of lung; Acute lymphocytic leukemia; MYELODYSPLASTIC SYNDROME; Colorectal Neoplasms; Hepatitis B; Prostate carcinoma; Adenocarcinoma; Malignant tumor of colon; Allergic rhinitis (disorder); Squamous cell carcinoma; Malignant neoplasm of prostate; Endometrial adenocarcinoma; Malignant neoplasm of urinary bladder; Parkinson Disease; Carcinoma of bladder; Uterine Fibroids; Cardiomyopathy, Dilated; Benign Prostatic Hyperplasia; Streptococcal pneumonia; Infiltrating Cervical Carcinoma; Retinoblastoma; Colorectal Carcinoma; Diabetes Mellitus, Non-Insulin-Dependent; Metabolic Syndrome X; Myeloid Leukemia, Chronic; Kidney Diseases; Precursor B-cell lymphoblastic leukemia; Colorectal Cancer; Hepatitis; Invasive carcinoma of breast; Adrenoleukodystrophy; Heart Diseases; Ataxia Telangiectasia; Post-Traumatic Stress Disorder; Optic Atrophy, Hereditary, Leber; Severe Combined Immunodeficiency; Infant, Premature; Secondary malignant neoplasm of liver; Adenocarcinoma Of Esophagus; HELLP Syndrome; Rett Syndrome; Lymphopenia; Hypoxic-Ischemic Encephalopathy; Childhood Acute Lymphoblastic Leukemia; Qualitative abnormality of granulocyte; High altitude pulmonary edema; Steatohepatitis; Astrocytoma, low grade; Hepatitis A; Schizophrenia; Pheochromocytoma; Down Syndrome; Adenomatous Polyposis Coli; Glioblastoma Multiforme; Hemophilia, NOS; Barrett Esophagus; Mucosa-Associated Lymphoid Tissue Lymphoma; Regurgitation; Familial primary gastric lymphoma; Neuropathy; Pregnancy in Diabetics; Vitamin D-Resistant Rickets, X-Linked; Familial Hypophosphatemic Rickets; Gastric Adenocarcinoma; Hypophosphatemic Rickets, X-Linked Dominant; Exanthema; Gastrinoma; Ductal Carcinoma; Meniere Disease; Hepatoblastoma; Hemophilia A; Keratoconus; Kartagener Syndrome; Eclampsia; Carcinoma, Small Cell; Noninfiltrating Intraductal Carcinoma; Rous Sarcoma; Pituitary Adenoma; Old myocardial infarction; Hyperthyroidism; Stage IV Colorectal Cancer; Pituitary Diseases; Stage IV Colorectal Cancer AJCC v7; Canine Osteosarcoma; Phosphate Diabetes; Parathyroid Adenoma; Leukodystrophy, Metachromatic; Malignant neoplasm tonsil; Congenital Abnormality; SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1; Spinal Muscular Atrophy; Choroideremia; Seminoma; Dystonia Disorders; Bronchogenic Carcinoma; Hypothyroidism; Cataract; Autistic Disorder; Dystonia; Multiple Endocrine Neoplasia Type 1",1.803641225501291e-12; 2.5279022064249716e-11; 6.332483647919588e-11; 8.179290839744632e-11; 1.3121548808139071e-10; 3.762648680673853e-10; 5.452288254986118e-10; 6.870627395110916e-10; 7.868397426275417e-10; 1.4790998733426532e-09; 1.971893171900314e-09; 1.971893171900314e-09; 2.219129913614883e-09; 4.367699208727405e-09; 6.195332209150018e-09; 6.991207850982321e-09; 8.303910954283738e-09; 1.3128768066526236e-08; 1.7931366647560766e-08; 2.412608431251415e-08; 5.518991037343798e-08; 5.784935444423772e-08; 5.8317433871210796e-08; 6.156981490555128e-08; 6.982287075725826e-08; 9.273260676030806e-08; 9.306686765839445e-08; 1.4925759778299788e-07; 2.46778041958494e-07; 5.577321626966352e-07; 6.299208964864026e-07; 6.630279934320317e-07; 6.673805318525932e-07; 6.851652105457608e-07; 7.789160940651547e-07; 8.660170029731726e-07; 9.822463166680949e-07; 1.3079916134634371e-06; 1.4185164995612263e-06; 1.51758575162775e-06; 2.027389637151193e-06; 2.027389637151193e-06; 2.07112526817849e-06; 2.1624936975752243e-06; 2.205236928124383e-06; 2.450940162208615e-06; 2.608032323197001e-06; 3.878607667297475e-06; 4.179146475474674e-06; 4.839188317483647e-06; 5.381279306135013e-06; 1.0755368362337037e-05; 1.2375081616087569e-05; 1.279493639647176e-05; 1.3034577772762696e-05; 1.3755659311680946e-05; 1.527992765491583e-05; 1.5449280661407645e-05; 1.5498516107485843e-05; 2.0736107376307555e-05; 3.053335644618538e-05; 3.053335644618538e-05; 3.1066725823367694e-05; 3.1491435270594376e-05; 3.372277447426952e-05; 3.9650653676454574e-05; 5.013426562854155e-05; 5.826428641192471e-05; 5.945938584340405e-05; 6.087890235661384e-05; 0.00011927896769899647; 0.00015093372108149775; 0.00016189346720036038; 0.00016189346720036038; 0.00017808425336754297; 0.00021049732822064587; 0.00022336414159326664; 0.0002926994143155384; 0.00038453776693371663; 0.00040624424086014313; 0.0004224524250828287; 0.00044420259326717257; 0.0004814724943641282; 0.0005182771791848276; 0.0006163914271817124; 0.0006165924034839279; 0.0006993549316202267; 0.0007074539367893701; 0.0010244557923259; 0.0011303542860313; 0.0011626911115394; 0.0013033444225859; 0.0017290799495295; 0.0022378309697704; 0.0038705790239355; 0.0048028611524245; 0.0054814673835909; 0.0067588219988478; 0.0068235619036629; 0.0075697193353146; 0.0093325514582534; 0.0104376874453167; 0.0161428886050652; 0.0166041002652209; 0.0171001534176385; 0.0173964199029194; 0.0193777520415227; 0.0203198961621158; 0.0239461944596263; 0.0335408281184641; 0.0340645241548108; 0.0363737825516021; 0.0384689641633299; 0.0384689641633299; 0.0403198851338656; 0.044901297966643; 0.0458359347176422; 0.0471006425252053; 0.0492531776191947; 0.0493155676939993; 0.0524566642172417; 0.0530344420162745; 0.0616475884230982; 0.0826378648181075; 0.088963803794147; 0.0897127848630768; 0.0908772402064694; 0.0967179741949912; 0.0972679220674381; 0.0972679220674381; 0.0974143314470534; 0.1272255752567765; 0.1332119202868411; 0.1343310874911156; 0.1343310874911156; 0.1401454825042905; 0.1460848784791741; 0.1525119847960956; 0.1642913929691757; 0.1722207384650883; 0.1881045022168423; 0.1982833830495248; 0.2108300774722888; 0.251930120576978; 0.2786853069571751; 0.3066971380488823; 0.3185255747306141; 0.5019882754152939; 0.5199487681301056; 0.5377205954278872; 0.5553733307745654,,,,,Salivirus NG-J1 3D; Vaccinia virus Ankara putative monoglyceride lipase f2; Vaccinia virus Ankara CP77 Host range protein f1; Horsepox virus HSPV011b (ankyrin repeats); Human adenovirus 49 fiber; Human adenovirus 23 fibre protein (gene: L5); Cowpox virus CPXV213 protein (gene: CPXV213 CDS); Human adenovirus 46 fiber; Cowpox virus CPXV011 protein (gene: CPXV011 CDS); Vaccinia virus Ankara 72.4k ankyrin repeat protein f2; Vaccinia virus ankyrin-like protein; Monkeypox virus Zaire-96-I-16 ankyrin-like protein (gene: C1L); Horsepox virus HSPV005c (Ankyrin repeats); Vaccinia virus Ankara CP77 host range protein f4; Horsepox virus HSPV196 (ankyrin-like protein; Provisional); Variola virus hypothetical protein (gene: D7L); Yaba-like disease virus 146R protein (gene: 146R); Variola virus hypothetical protein (gene: B21R); Ectromelia virus ERPV ankyrin and nfkb inhibitor; Cowpox virus VHR1 or CPXV025 protein (gene: VHR1); Human alphaherpesvirus 2 tegument protein VP22 (gene: UL49); Horsepox virus HSPV011c (ankyrin repeats); Vaccinia virus Ankara CP77 host range protein f3; Human alphaherpesvirus 1 tegument protein VP22 (gene: UL49); Orf virus ORF126 ankyrin repeat protein; Monkeypox virus Zaire-96-I-16 ankyrin-like protein (gene: D7L); Cowpox virus CPXV017 protein (gene: CPXV017 CDS); Monkeypox virus Zaire-96-I-16 B17R (gene: B17R); Human adenovirus 1 fiber; Horsepox virus HSPV194 (ankyrin repeats); Human adenovirus 5 fiber; Horsepox virus HSPV005b (ankyrin repeats); Monkeypox virus Zaire-96-I-16 ankyrin-like protein (gene: D9L); Cowpox virus CPXV019 protein (gene: CPXV019 CDS); Monkeypox virus Zaire-96-I-16 ankyrin-like protein (gene: D1L); Cowpox virus CPXV041 protein (gene: CPXV041 CDS); Horsepox virus HSPV020e (ankyrin repeats); Cowpox virus CPXV016 protein (gene: CPXV016 CDS); Horsepox virus HSPV035 (ankyrin repeats); Horsepox virus HSPV181 (ankyrin repeats); Vaccinia virus Ankara 54.4k ankyrin repeat protein f2; Vaccinia virus ankyrin-like protein (gene: B4R); Vaccinia virus ankyrin-like protein (gene: K1L); Variola virus hypothetical protein (gene: B19R); Vaccinia virus Ankara 67.9k ankyrin repeat protein; Cowpox virus CPXV008 protein (gene: CPXV008 CDS); Human adenovirus 71 fiber (gene: L5); Vaccinia virus Ankara Host range protein; Human adenovirus 19 fiber (gene: L5); Human adenovirus 58 fiber (gene: L5); Human adenovirus D10 fiber (gene: L5); Horsepox virus HSPV014c (ankyrin repeats); Cowpox virus CPXV027 protein (gene: CPXV027 CDS); Human adenovirus 65 L5 fiber; Human mastadenovirus D fiber (gene: L5); Human adenovirus 56 fiber protein (gene: L5); Human adenovirus 64 L5 fiber protein; Human adenovirus D37 fiber (gene: L5); Yaba monkey tumor virus ankyrin repeat protein; Human adenovirus D8 fiber (gene: L5); Human adenovirus 54 fiber; Vaccinia virus ankyrin-like protein (gene: B18R); Cowpox virus CPXV211 protein (gene: CPXV211 CDS); Human mastadenovirus D fiber; Human adenovirus 17 fiber; Human adenovirus 63 fiber protein (gene: L5); Horsepox virus HSPV033b (Ankyrin repeats); Monkeypox virus Zaire-96-I-16 B5R (gene: B5R); Horsepox virus HSPV033c (ankyrin repeats); Variola virus hypothetical protein (gene: G3R); Variola virus hypothetical protein (gene: D6L); Vaccinia virus Ankara 54.4k ankyrin repeat protein f1; Horsepox virus HSPV201a (ankyrin repeats); Human adenovirus 67 L5 fiber; Yaba-like disease virus 147R protein (gene: 147R); Horsepox virus HSPV022 (ankyrin-like protein; Provisional); Yaba monkey tumor virus ankyrin-like protein; Variola virus ankyin-like protein (gene: O1L); Horsepox virus HSPV020b (ankyrin repeats); Monkeypox virus Zaire-96-I-16 ankyin-like protein (gene: O1L); Vaccinia virus ankyrin-like protein (gene: C9L); Cowpox virus CPXV006 protein (gene: CPXV006 CDS); Horsepox virus HSPV012 (ankyrin-like protein; Provisional); Yaba-like disease virus 11L protein (gene: 11L); Yaba-like disease virus 148R protein (gene: 148R); Vaccinia virus hypothetical protein; Yaba-like disease virus 8L protein (gene: 8L); Orf virus ORF128 ankyrin repeat protein; Orf virus ORF123 ankyrin repeat protein; Horsepox virus HSPV011a; Cowpox virus CPXV039 (gene: CPXV039 CDS); Horsepox virus HSPV004 (ankyrin repeats); Horsepox virus HSPV014b (ankyrin repeats); Vaccinia virus ankyin-like protein (gene: M1L); Ectromelia virus ERPV profilin-like protein; Monkeypox virus Zaire-96-I-16 J3L (gene: J3L); Vaccinia virus Ankara 78.7k Ankyrin repeat protein f1; Vaccinia virus Ankara 72.4k ankyrin repeat protein f1; Vaccinia virus Ankara 65.4k Ankyrin repeat protein; Variola virus hypothetical protein (gene: A47R); Cowpox virus CPXV220 protein (gene: CPXV220 CDS); Monkeypox virus profilin-like protein; Monkeypox virus Zaire-96-I-16 A42R (gene: A42R); Horsepox virus HSPV164 (Profilin); Titi monkey adenovirus ECC-2011 fiber; Vaccinia virus profilin-like protein (gene: A42R); Vaccinia virus Ankara Profilin-1-like; Cowpox virus CPXV179 protein (gene: CPXV179 CDS); Human T-cell leukemia virus type I p21 TM (gene: env); Cowpox virus CPXV198 protein (gene: CPXV198 CDS); Human mastadenovirus E fiber (gene: L5); Human adenovirus E4 fiber protein; Ectromelia virus ERPV ankyrin; Orf virus ORF129 ankyrin repeat protein; Orf virus ORF008 ankyrin repeat protein; Variola virus hypothetical protein (gene: B6R); Monkeypox virus ankyrin-like protein; Human alphaherpesvirus 3 serine/threonine protein kinase US3 (gene: ORF66); Human herpesvirus 3 strain Dumas serine-threonine protein kinase; Human immunodeficiency virus envelope glycoprotein (gene: env); Monkeypox virus ser/thr kinase; Monkeypox virus cowpox A-type inclusion protein,0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3956197978099343; 0.3956197978099343; 0.396036820576385; 0.4088672649431711; 0.4139745988798983; 0.4145707851950257; 0.414682462349678; 0.424785222642393; 0.4264358713488607; 0.4275573398203068; 0.4311162645337849; 0.4342000778047719; 0.4524287065015616; 0.4602555770769919; 0.4754102525355624; 0.4777231148134931; 0.4777231148134931; 0.4777231148134931; 0.4777231148134931; 0.4787750162272003; 0.4799841923463797; 0.4799841923463797; 0.4799841923463797; 0.4832965587118858; 0.5134770656069968; 0.513972987973838; 0.513972987973838; 0.5349555669171289; 0.5491415646821286; 0.5961449913267739; 0.6234641868335487; 0.7010195275583045; 0.7471947418531064; 0.7640067973616771; 0.8536723182272641; 0.8863410989269571; 0.8920352134799755,Homo sapiens HCT116 colon carcinoma cell;Homo sapiens HEK293T embryonic kidney cell,0.35,Homo sapiens,Homo sapiens
PTAFR,"Pneumonia; Asthma; Lobar Pneumonia; Chronic Obstructive Airway Disease; Arteriosclerosis; Pneumonitis; Non-Small Cell Lung Carcinoma; Ovarian Carcinoma; Malignant neoplasm of ovary; Multiple Sclerosis; Neoplasm Metastasis; Atherosclerosis; Glomerulonephritis; leukemia; Sciatic Neuropathy; Pneumococcal Infections; Graft-vs-Host Disease; Other specified forms of pleural effusion, except tuberculous; Carcinogenesis; Transient Ischemic Attack; Polycystic Ovary Syndrome; Kidney Failure, Acute; Liver Cirrhosis, Experimental; Allergic asthma; ovarian neoplasm; Acute GVH disease; Invasive Streptococcus pneumoniae disease; Streptococcal pneumonia; Other specified transient cerebral ischemias; Neutropenia; Necrotizing Enterocolitis; Respiratory Tract Infections; Conjunctivitis; Erectile dysfunction; Low density lipoprotein cholesterol measurement; Sclerocystic Ovaries; Lissencephaly; Xeroderma Pigmentosum",7.980856456624717e-16; 1.803641225501291e-12; 8.179290839744632e-11; 1.3121548808139071e-10; 2.377251819497684e-10; 2.813069300429449e-10; 3.762648680673853e-10; 6.870627395110916e-10; 1.971893171900314e-09; 4.546836602575699e-09; 5.670785186683756e-09; 7.195555613367576e-09; 1.0368326871660785e-08; 5.784935444423772e-08; 4.312772724439924e-07; 4.4307738632612236e-07; 1.0094667484349083e-06; 1.10068355868735e-06; 1.51758575162775e-06; 1.5208470671427406e-06; 2.086123696221558e-06; 3.485726441474513e-06; 7.691726899679507e-06; 1.3268923055385737e-05; 1.8507296589967813e-05; 2.365778380659297e-05; 4.351780357113137e-05; 6.087890235661384e-05; 9.56957692518114e-05; 0.00021611859123914996; 0.0037263522689301; 0.0050894481995015; 0.0777073264956258; 0.2385514460682989; 0.3454778744069252; 0.3540699900993737; 0.3929133356162864; 0.5250786094080001,Polycystic Ovary Syndrome; Sclerocystic Ovaries,0.2725906821661307; 0.3498454359561224,"Metaphyseal anadysplasia ORPHA:1040; Infantile-onset pulmonary alveolar proteinosis-hypogammaglobulinemia ORPHA:572428; Exfoliative ichthyosis ORPHA:289586; Overgrowth-macrocephaly-facial dysmorphism syndrome ORPHA:137634; Hyper-IgM syndrome type 3 ORPHA:101090; Diffuse cutaneous systemic sclerosis ORPHA:220393; Primary biliary cholangitis ORPHA:186; Mendelian susceptibility to mycobacterial diseases due to complete IFNgammaR1 deficiency ORPHA:99898; Mendelian susceptibility to mycobacterial diseases due to complete IFNgammaR2 deficiency ORPHA:319547; Autosomal dominant mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR1 deficiency ORPHA:319581; Autosomal dominant mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR2 deficiency ORPHA:319589; Autosomal recessive mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR1 deficiency ORPHA:319569; Autosomal recessive mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR2 deficiency ORPHA:319574; Blau syndrome ORPHA:90340; Palmoplantar keratoderma-esophageal carcinoma syndrome ORPHA:2198; Papillon-Lefevre ORPHA:678; Charcot-Marie-Tooth disease type 1C ORPHA:101083; Sterile multifocal osteomyelitis with periostitis and pustulosis ORPHA:210115; GM2 gangliosidosis, AB variant ORPHA:309246; Glycerol kinase deficiency, adult form ORPHA:284414; Glycerol kinase deficiency, juvenile form ORPHA:284411; Haim-Munk syndrome ORPHA:2342; Intermittent hydrarthrosis ORPHA:329967; Chronic mucocutaneous candidiasis ORPHA:1334; NON RARE IN EUROPE: Multiple sclerosis ORPHA:802; Acute myeloid leukemia with CEBPA somatic mutations ORPHA:319480; Clear cell renal carcinoma ORPHA:319276; Acral peeling skin syndrome ORPHA:263534; Adenosine monophosphate deaminase deficiency ORPHA:45; Nasu-Hakola disease ORPHA:2770; Short stature due to isolated growth hormone deficiency with X-linked hypogammaglobulinemia ORPHA:632; Congenital vertebral-cardiac-renal anomalies syndrome ORPHA:521438; Limited cutaneous systemic sclerosis ORPHA:220402; Hypomaturation amelogenesis imperfecta ORPHA:100033; ALys amyloidosis ORPHA:93561; Lysinuric protein intolerance ORPHA:470; Alpha-1-antitrypsin deficiency ORPHA:60; Autosomal dominant Charcot-Marie-Tooth disease type 2 due to DGAT2 mutation ORPHA:487814; NLRC4-related familial cold autoinflammatory syndrome ORPHA:576349; Autosomal recessive severe congenital neutropenia due to CXCR2 deficiency ORPHA:420699; Neonatal alloimmune neutropenia ORPHA:464370; Osteopetrosis with renal tubular acidosis ORPHA:2785; Periodic fever-infantile enterocolitis-autoinflammatory syndrome ORPHA:436166; Cherubism ORPHA:184; Primary hypomagnesemia with secondary hypocalcemia ORPHA:30924; RNF13-related severe early-onset epileptic encephalopathy ORPHA:544503; Spinal muscular atrophy-progressive myoclonic epilepsy syndrome ORPHA:2590; Familial Mediterranean fever ORPHA:342; Susceptibility to localized juvenile periodontitis ORPHA:447740; Sweet syndrome ORPHA:3243; Farber disease ORPHA:333; Fowler vasculopaty ORPHA:221126; Fructose-1,6-bisphosphatase deficiency ORPHA:348; Tuberculosis ORPHA:3389; Vibratory urticaria ORPHA:493342; X-linked mendelian susceptibility to mycobacterial diseases due to CYBB deficiency ORPHA:319623; Hemorrhagic disease due to alpha-1-antitrypsin Pittsburgh mutation ORPHA:178396; Histidinemia ORPHA:2157; Jervell and Lange-Nielsen syndrome ORPHA:90647; Hereditary pulmonary alveolar proteinosis ORPHA:264675; Chronic granulomatous disease ORPHA:379; Familial hyperphosphatemic tumoral calcinosis/Hyperphosphatemic hyperostosis syndrome ORPHA:306661; NON RARE IN EUROPE: Alzheimer disease ORPHA:238616",0.0002132495254484572; 0.0133474287859103; 0.0514345493431829; 0.0514345493431829; 0.0514345493431829; 0.0557820633193028; 0.0597169850674746; 0.1927589191138116; 0.1927589191138116; 0.1927589191138116; 0.1927589191138116; 0.1927589191138116; 0.1927589191138116; 0.1927589191138116; 0.1927589191138116; 0.1927589191138116; 0.1927589191138116; 0.1927589191138116; 0.1927589191138116; 0.1927589191138116; 0.1927589191138116; 0.1927589191138116; 0.1927589191138116; 0.1973394623267924; 0.1996794456641899; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.491912282528682; 0.4927160916210667; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659,,,,,,
RASL11B,Inflammation; Arteriosclerosis; Tumor Progression,2.8114433253573326e-17; 2.377251819497684e-10; 8.297823048747685e-07,,,"NON RARE IN EUROPE: Idiopathic infantile nystagmus ORPHA:651; Simpson-Golabi-Behmel syndrome ORPHA:373; Kniest dysplasia ORPHA:485; Legg-Calve-Perthes disease ORPHA:2380; Achondrogenesis type 2 ORPHA:93296; Mild spondyloepiphyseal dysplasia due to COL2A1 mutation with early-onset osteoarthritis ORPHA:93279; Autosomal dominant rhegmatogenous retinal detachment ORPHA:209867; Multiple epiphyseal dysplasia, Beighton type ORPHA:166011; Brachydactyly type B1 ORPHA:572385; Platyspondylic dysplasia, Torrance type ORPHA:85166; Craniodiaphyseal dysplasia ORPHA:1513; Dysspondyloenchondromatosis ORPHA:85198; Spondyloepimetaphyseal dysplasia congenita, Strudwick type ORPHA:93346; Spondyloepiphyseal dysplasia congenita ORPHA:94068; Spondyloepiphyseal dysplasia with metatarsal shortening ORPHA:137678; Spondyloepiphyseal dysplasia, Stanescu type ORPHA:459051; Spondylometaphyseal dysplasia, Schmidt type ORPHA:93316; Spondyloperipheral dysplasia-short ulna syndrome ORPHA:1856; Stickler syndrome type 1 ORPHA:90653; Hypochondrogenesis ORPHA:93297",0.4838060079820406; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659,Human adenovirus 18 CR1-beta protein (gene: E3); Human adenovirus 31 cr1 beta protein (gene: E3 cr1 beta),0.2880902732733083; 0.3911903778732946,,,,
RCAN1,"Lymphoma; Rheumatoid Arthritis; Arteriosclerosis; Tumor Angiogenesis; Lung Neoplasms; Neoplasm Metastasis; Atherosclerosis; Cerebrovascular accident; Kaposi Sarcoma; Glioblastoma; leukemia; Alzheimer's Disease; Myocardial Infarction; Myocardial Ischemia; Septicemia; Sepsis; Cystic Fibrosis; Middle Cerebral Artery Occlusion; Coronary Arteriosclerosis; Carcinogenesis; Immune System Diseases; melanoma; Tauopathies; Thyroid carcinoma; Small cell carcinoma of lung; Senile Plaques; Endometrial adenocarcinoma; Cardiomyopathy, Dilated; Cardiomegaly; Colorectal Carcinoma; Central neuroblastoma; Amyloidosis; Colorectal Cancer; Secondary malignant neoplasm of lung; Neuroblastoma; Malignant neoplasm of thyroid; tumor vasculature; Post MI; Huntington Disease; Trisomy; Aneurysm; Tooth Attrition; Down Syndrome, Partial Trisomy 21; Trisomy 21, Meiotic Nondisjunction; Trisomy 21, Mitotic Nondisjunction; Down Syndrome; Anxiety Disorders; Brain Diseases; Anxiety; DOWN SYNDROME CRITICAL REGION; Cardiac defects; Emotional Stress; DISORGANIZATION, MOUSE, HOMOLOG OF; Akinetic-Rigid Variant of Huntington Disease; Juvenile Huntington Disease; Huntington Disease, Late Onset; Congenital Abnormality; Congenital Heart Defects; Craniofacial Abnormalities; Fragile X Syndrome; Intellectual Disability; Mental Retardation",4.5104266881389206e-12; 1.9241179247341838e-10; 2.377251819497684e-10; 3.315537369635636e-09; 4.367699208727405e-09; 5.670785186683756e-09; 7.195555613367576e-09; 2.0570601164639797e-08; 3.149054123564124e-08; 5.518991037343798e-08; 5.784935444423772e-08; 9.273260676030806e-08; 2.247163660896597e-07; 2.948344121290337e-07; 5.254943571583271e-07; 5.313225371508493e-07; 5.577321626966352e-07; 6.805796735296268e-07; 1.0094398444517938e-06; 1.51758575162775e-06; 2.546221763226728e-06; 4.179146475474674e-06; 4.218275676836033e-06; 6.889889014378816e-06; 1.0755368362337037e-05; 1.3673911177979942e-05; 3.1066725823367694e-05; 5.826428641192471e-05; 0.00011072370132707822; 0.00016189346720036038; 0.00032113080554701227; 0.0003495642888428815; 0.00038453776693371663; 0.00042196010900515655; 0.0004601228759628894; 0.0009826472144539087; 0.0013033444225859; 0.0014485445504404; 0.0017731038420892; 0.0026287893312444; 0.0027534163536682; 0.0027942850562877; 0.0138441633831498; 0.0138441633831498; 0.0138441633831498; 0.0161428886050652; 0.0173384291015271; 0.0208452312614567; 0.0365699380189482; 0.0623026316541814; 0.1046638861423046; 0.1130019719865939; 0.1343310874911156; 0.1343310874911156; 0.1343310874911156; 0.1401454825042905; 0.1722207384650883; 0.3352509823890284; 0.4037241172618553; 0.504829873207973; 0.9388725395674395; 0.9620816473530824,Rheumatoid Arthritis; Malignant Neoplasm; Trisomy 21; Down Syndrome; Akinetic-Rigid Variant Of Huntington Disease; Liver Carcinoma; Huntington Disease; Congenital Heart Defects,1.241997446075319e-05; 0.021392225047824; 0.0446679463927015; 0.0446679463927015; 0.175139305620004; 0.2008242041589438; 0.2579581542371572; 0.5910714567494176,Recessive X-linked ichthyosis ORPHA:461; Syndromic recessive X-linked ichthyosis ORPHA:281090; Kuru ORPHA:454745; PrP systemic amyloidosis ORPHA:397606; Familial Alzheimer-like prion disease ORPHA:280397; Sporadic fatal insomnia ORPHA:586130; Fatal familial insomnia ORPHA:466; Gerstmann-Straussler-Scheinker syndrome ORPHA:356; Huntington disease-like 1 ORPHA:157941; Inherited Creutzfeldt-Jakob disease ORPHA:282166; Spastic tetraplegia-thin corpus callosum-progressive postnatal microcephaly syndrome ORPHA:447997,0.1927589191138116; 0.1927589191138116; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.5312419675785659,Human papillomavirus type 14D early protein (gene: E2); Human papillomavirus 15 early protein (gene: E2); Human papillomavirus type 34 early protein (gene: E2); Human papillomavirus type 68b E2 protein (gene: E2); Human papillomavirus type 43 E2 protein (gene: E2); Human papillomavirus type 40 early protein (gene: E2); Human papillomavirus type 81 E2 protein (gene: E2); Human papillomavirus type 68 E2 (gene: E2); Human papillomavirus type 7 early protein (gene: E2); Alphapapillomavirus 4 early protein E2 (gene: E2); Human papillomavirus type 2 E2 protein (gene: E2); Human papillomavirus type 32 early protein (gene: E2),0.3911903778732946; 0.4668124840527851; 0.5352302535848827; 0.583528087109895; 0.6028165858205247; 0.623435350125708; 0.6262498739240705; 0.631011369238774; 0.6333529227612157; 0.6342852581130124; 0.6342852581130124; 0.6425846603888259,Homo sapiens HEK293 embryonic kidney cell;In vitro;yeasx,0.37;0.6,Homo sapiens,Homo sapiens;sv40
RGS2,"Asthma; Arteriosclerosis; Ovarian Carcinoma; Malignant neoplasm of ovary; Mammary Neoplasms, Human; Atherosclerosis; Leukemia, Myelocytic, Acute; Hypertensive disease; Obesity; Mammary Neoplasms; Alzheimer's Disease; Epithelial ovarian cancer; Cardiovascular Diseases; Diabetes Mellitus, Insulin-Dependent; Ureteral obstruction; Malignant neoplasm of breast; Bladder Neoplasm; Carcinogenesis; Malignant neoplasm of stomach; Astrocytoma; Stomach Neoplasms; Breast Carcinoma; Liver Cirrhosis, Experimental; Prostate carcinoma; Prostatic Neoplasms; Hypotension; Malignant neoplasm of prostate; Malignant neoplasm of urinary bladder; Parkinson Disease; Carcinoma of bladder; Metabolic Syndrome X; Huntington Disease; Cardiomyopathies; Renal fibrosis; Essential Hypertension; Carotid Atherosclerosis; androgen independent prostate cancer; Hereditary Diffuse Gastric Cancer; Overweight; Schizophrenia; Social Anxiety; Aortic Valve Insufficiency; Malnutrition; Tardive Dyskinesia; Drug-induced tardive dyskinesia; Phobia, Social; Anxiety Disorders; Anxiety; Acute Myeloid Leukemia, M1; Acute Myeloid Leukemia (AML-M2); Parkinsonian Disorders; Bradykinesia; Parkinson Disease, Secondary Vascular; Akathisia; Atherosclerotic Parkinsonism; Overweight or obesity; Secondary Parkinson Disease; Anxiety and fear; Movement Disorders; Observation of Neuromuscular Block; Gitelman Syndrome; Elastosis perforans serpiginosa; Seasonal Affective Disorder; Generalized Anxiety Disorder; EAR, PATELLA, SHORT STATURE SYNDROME; Extrapyramidal sign; PANIC DISORDER 1; Panic Disorder",1.803641225501291e-12; 2.377251819497684e-10; 6.870627395110916e-10; 1.971893171900314e-09; 5.791865115913735e-09; 7.195555613367576e-09; 8.303910954283738e-09; 1.0368326871660785e-08; 2.412608431251415e-08; 4.65353219894153e-08; 9.273260676030806e-08; 1.479813245926713e-07; 4.5433391667148853e-07; 6.851652105457608e-07; 7.99548070959303e-07; 8.660170029731726e-07; 9.822463166680949e-07; 1.51758575162775e-06; 2.450940162208615e-06; 2.608032323197001e-06; 3.878607667297475e-06; 5.381279306135013e-06; 7.691726899679507e-06; 1.527992765491583e-05; 2.0820699372778346e-05; 2.7966054180512005e-05; 3.053335644618538e-05; 3.1491435270594376e-05; 3.372277447426952e-05; 3.9650653676454574e-05; 0.00017808425336754297; 0.0017731038420892; 0.0021326108499664; 0.0021970545999258; 0.0028759971272412; 0.0032682022992594; 0.0037263522689301; 0.0043105477873176; 0.0048496385019795; 0.0093325514582534; 0.0096630827054915; 0.0114187031414039; 0.0138441633831498; 0.0153494479957135; 0.0153494479957135; 0.015507621739214; 0.0173384291015271; 0.0365699380189482; 0.0897127848630768; 0.0958856529689566; 0.1050724946352408; 0.1130019719865939; 0.1206032442301429; 0.1206032442301429; 0.1206032442301429; 0.1206032442301429; 0.1272255752567765; 0.1525119847960956; 0.1584804022044084; 0.176056923749369; 0.181710614199711; 0.1982833830495248; 0.236709594559292; 0.2520982519141255; 0.2622329318286966; 0.3929133356162864; 0.4424335623428572; 0.4979943388112239,Marfan Syndrome; Mammary Neoplasms; Breast Carcinoma; Breast Cancer; Hypertension; Stomach Neoplasms; Gastric Cancer; Schizophrenia; Atherosclerotic Parkinsonism; Myeloid Leukemia; Parkinson Disease; Leukemia,8.921950872070284e-08; 1.1417484002988661e-07; 4.971054570440277e-05; 0.00063387456654884; 0.0048927857621509; 0.0172144998405365; 0.0172144998405365; 0.175139305620004; 0.175139305620004; 0.2089805590322066; 0.2943246801469203; 0.5399696510344362,Isolated thyroid-stimulating hormone deficiency ORPHA:90674; Spinocerebellar ataxia type 18 ORPHA:98771,0.5312419675785659; 0.5312419675785659,,,Homo sapiens;yeasx,0.37;0.4,Homo sapiens,Homo sapiens;coxbu
RND1,Neoplasm Metastasis; Mammary Neoplasms; Alzheimer's Disease; Malignant neoplasm of breast; Liver carcinoma; Breast Carcinoma; Mammary Tumorigenesis; Triple Negative Breast Neoplasms,5.670785186683756e-09; 4.65353219894153e-08; 9.273260676030806e-08; 8.660170029731726e-07; 1.3079916134634371e-06; 5.381279306135013e-06; 0.0203198961621158; 0.0302544192125064,,,Autosomal dominant preaxial polydactyly-upperback hypertrichosis syndrome ORPHA:476119,0.5312419675785659,Sagiyama virus full_polyprotein 1..1253 (gene: C-E3-E2-6K-E1),0.3911903778732946,,,,
S100A3,Neoplasm Metastasis; Stomach Carcinoma; Malignant neoplasm of stomach,5.670785186683756e-09; 2.07112526817849e-06; 2.450940162208615e-06,,,"Quebec platelet disorder ORPHA:220436; Lattice corneal dystrophy type I ORPHA:98964; Reis-Bucklers corneal dystrophy ORPHA:98961; Epithelial basement membrane dystrophy ORPHA:98956; Thiel-Behnke corneal dystrophy ORPHA:98960; Granular corneal dystrophy type I ORPHA:98962; Granular corneal dystrophy type II ORPHA:98963; Interstitial lung disease-nephrotic syndrome-epidermolysis bullosa syndrome ORPHA:306504; LMNA-related cardiocutaneous progeria syndrome ORPHA:363618; Mandibuloacral dysplasia with type A lipodystrophy ORPHA:90153; Arnold-Chiari malformation type I ORPHA:268882; Atypical Werner syndrome ORPHA:79474; Autosomal recessive Emery-Dreifuss muscular dystrophy ORPHA:98855; Autosomal semi-dominant severe lipodystrophic laminopathy ORPHA:280365; Palmoplantar keratoderma, Nagashima type ORPHA:140966; Charcot-Marie-Tooth disease type 2B1 ORPHA:98856; Congenital muscular dystrophy due to LMNA mutation ORPHA:157973; Congenital plasminogen activator inhibitor type 1 deficiency ORPHA:465; Dilated cardiomyopathy-hypergonadotropic hypogonadism syndrome ORPHA:2229; Familial dilated cardiomyopathy with conduction defect due to LMNA mutation ORPHA:300751; Familial partial lipodystrophy, Dunnigan type ORPHA:2348; Familial partial lipodystrophy, Kobberling type ORPHA:79084; Heart-hand syndrome, Slovenian type ORPHA:168796; Familial primary localized cutaneous amyloidosis ORPHA:353220; Thyroid ectopia ORPHA:95712; Congenital generalized lipodystrophy ORPHA:528; Hereditary arterial and articular multiple calcification syndrome ORPHA:289601; Autosomal recessive generalized dystrophic epidermolysis bullosa, severe form ORPHA:79408; Cap myopathy ORPHA:171881; Crisponi syndrome ORPHA:1545; Lipoid proteinosis ORPHA:530; Adult polyglucosan body disease ORPHA:206583; Monilethrix ORPHA:573; Primary CD59 deficiency ORPHA:169464; Glycogen storage disease due to glycogen branching enzyme deficiency, adult neuromuscular form ORPHA:308712; Glycogen storage disease due to glycogen branching enzyme deficiency, childhood combined hepatic and myopathic form ORPHA:308684; Glycogen storage disease due to glycogen branching enzyme deficiency, childhood neuromuscular form ORPHA:308698; Glycogen storage disease due to glycogen branching enzyme deficiency, congenital neuromuscular form ORPHA:308670; Glycogen storage disease due to glycogen branching enzyme deficiency, fatal perinatal neuromuscular form ORPHA:308655; Glycogen storage disease due to glycogen branching enzyme deficiency, non progressive hepatic form ORPHA:308638; Glycogen storage disease due to glycogen branching enzyme deficiency, progressive hepatic form ORPHA:308621; Restrictive dermopathy ORPHA:1662; Hutchinson-Gilford progeria syndrome ORPHA:740; Cold-induced sweating syndrome ORPHA:157820; Familial porphyria cutanea tarda ORPHA:443062",3.28973817825433e-05; 0.0002132495254484572; 0.0002132495254484572; 0.0002132495254484572; 0.0002132495254484572; 0.0002132495254484572; 0.0002132495254484572; 0.0133474287859103; 0.0514345493431829; 0.0514345493431829; 0.0514345493431829; 0.0514345493431829; 0.0514345493431829; 0.0514345493431829; 0.0514345493431829; 0.0514345493431829; 0.0514345493431829; 0.0514345493431829; 0.0514345493431829; 0.0514345493431829; 0.0514345493431829; 0.0514345493431829; 0.0514345493431829; 0.0514345493431829; 0.0514345493431829; 0.0565022767519947; 0.1927589191138116; 0.1927589191138116; 0.1927589191138116; 0.1927589191138116; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.5312419675785659,,,,,,
SCTR,"Neoplasm Metastasis; Pancreatic carcinoma; Adenocarcinoma of pancreas; Malignant neoplasm of pancreas; Malignant neoplasm of lung; Liver carcinoma; Prostate carcinoma; Adenocarcinoma; Malignant neoplasm of prostate; Pancreatic Neoplasm; Malignant neoplasm of liver; Adenoma; Colorectal Cancer; Zollinger-Ellison syndrome; Liver and Intrahepatic Biliary Tract Carcinoma; Pheochromocytoma; Bile duct carcinoma; Cholangiocarcinoma; Carcinoid Tumor; Gastrinoma; Bile Duct Neoplasms; Pheochromocytoma, Extra-Adrenal; Endocrine Gland Neoplasms",5.670785186683756e-09; 6.982287075725826e-08; 9.306686765839445e-08; 1.4925759778299788e-07; 6.299208964864026e-07; 1.3079916134634371e-06; 1.527992765491583e-05; 1.5449280661407645e-05; 3.053335644618538e-05; 3.192298841377222e-05; 8.421319594446617e-05; 0.00012202062264879416; 0.00038453776693371663; 0.0010244557923259; 0.0038816440940594; 0.0104376874453167; 0.0228665355725917; 0.0334053723619937; 0.0386264970299853; 0.0471006425252053; 0.1130019719865939; 0.2316568843888361; 0.236709594559292,Diabetes Mellitus,0.1718736907108893,Autosomal dominant primary hypomagnesemia with hypocalciuria ORPHA:34528; Biotin-thiamine-responsive basal ganglia disease ORPHA:65284; Caroli disease ORPHA:53035; Familial hypocalciuric hypercalcemia type 1 ORPHA:93372; Thiamine-responsive encephalopathy ORPHA:199348; Infantile spasms-psychomotor retardation-progressive brain atrophy-basal ganglia disease syndrome ORPHA:263410; Neonatal severe primary hyperparathyroidism ORPHA:417; Congenital bilateral absence of vas deferens ORPHA:48; Hereditary chronic pancreatitis ORPHA:676; MODY ORPHA:552,0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.534880881892026,,,,,,
SDC4,"Asthma; Synovitis; Non-Small Cell Lung Carcinoma; Leukemia, Myelocytic, Acute; Degenerative polyarthritis; Liver neoplasms; Mammary Neoplasms; Dermatologic disorders; Myocardial Infarction; Malignant neoplasm of breast; Liver carcinoma; Colon Carcinoma; Osteosarcoma of bone; Lymphoma, T-Cell, Cutaneous; melanoma; Breast Carcinoma; Osteosarcoma; Bacterial Infections; Sezary Syndrome; Malignant tumor of colon; Hematopoietic Neoplasms; Acute myocardial infarction; Congestive heart failure; Leg Ulcer; Heart failure; Left ventricular dilatation; Aortic Valve Stenosis; Breast adenocarcinoma; Varicose Ulcer; Fibrodysplasia Ossificans Progressiva",1.803641225501291e-12; 1.6797550790254382e-10; 3.762648680673853e-10; 8.303910954283738e-09; 2.1034803123367165e-08; 4.3069383556698336e-08; 4.65353219894153e-08; 9.273260676030806e-08; 2.247163660896597e-07; 8.660170029731726e-07; 1.3079916134634371e-06; 2.205236928124383e-06; 2.560217628497434e-06; 3.7283259874612974e-06; 4.179146475474674e-06; 5.381279306135013e-06; 6.3131986281381465e-06; 6.378950690990071e-06; 1.3410647656206684e-05; 1.5498516107485843e-05; 6.484707207749309e-05; 7.036498484894257e-05; 8.232890503539995e-05; 0.0002214859278255797; 0.00027820432005572264; 0.007117388576245; 0.0314638805510678; 0.1584804022044084; 0.2570364810168682; 0.2823835751171575,Lung Carcinoma,0.0868883392670891,"Quebec platelet disorder ORPHA:220436; Adenocarcinoma of ovary ORPHA:213504; Complement component 3 deficiency ORPHA:280133; Interstitial lung disease-nephrotic syndrome-epidermolysis bullosa syndrome ORPHA:306504; AA amyloidosis ORPHA:85445; LMNA-related cardiocutaneous progeria syndrome ORPHA:363618; Mandibuloacral dysplasia with type A lipodystrophy ORPHA:90153; Atypical Werner syndrome ORPHA:79474; Autosomal recessive Emery-Dreifuss muscular dystrophy ORPHA:98855; Autosomal semi-dominant severe lipodystrophic laminopathy ORPHA:280365; OBSOLETE: Alpha-1-antichymotrypsin deficiency ORPHA:93594; Palmoplantar keratoderma, Nagashima type ORPHA:140966; Charcot-Marie-Tooth disease type 2B1 ORPHA:98856; Congenital muscular dystrophy due to LMNA mutation ORPHA:157973; Dilated cardiomyopathy-hypergonadotropic hypogonadism syndrome ORPHA:2229; Familial dilated cardiomyopathy with conduction defect due to LMNA mutation ORPHA:300751; Familial partial lipodystrophy, Dunnigan type ORPHA:2348; Familial partial lipodystrophy, Kobberling type ORPHA:79084; Heart-hand syndrome, Slovenian type ORPHA:168796; Juvenile Paget disease ORPHA:2801; Congenital generalized lipodystrophy ORPHA:528; Multiple paragangliomas associated with polycythemia ORPHA:324299; Autosomal recessive brachyolmia ORPHA:448242; Osteofibrous dysplasia ORPHA:488265; Spondyloepimetaphyseal dysplasia, PAPSS2 type ORPHA:93282; Hereditary papillary renal cell carcinoma ORPHA:47044; Familial hypercholanemia ORPHA:238475; NON RARE IN EUROPE: Primary adult open-angle glaucoma ORPHA:353225; Severe generalized junctional epidermolysis bullosa ORPHA:79404; Keratoderma hereditarium mutilans ORPHA:494; Kindler epidermolysis bullosa ORPHA:2908; Knuckle pads-leukonychia-sensorineural deafness-palmoplantar hyperkeratosis syndrome ORPHA:2698; Laryngo-onycho-cutaneous syndrome ORPHA:2407; Monoamine oxidase A deficiency ORPHA:3057; Muscular dystrophy, Selcen type ORPHA:199340; Benign familial mesial temporal lobe epilepsy ORPHA:163717; PPARG-related familial partial lipodystrophy ORPHA:79083; Porokeratotic eccrine ostial and dermal duct nevus ORPHA:166286; Primary CD59 deficiency ORPHA:169464; Congenital bile acid synthesis defect type 1 ORPHA:79301; Familial mesial temporal lobe epilepsy with febrile seizures ORPHA:165805; Fibrodysplasia ossificans progressiva ORPHA:337; Isolated hyperchlorhidrosis ORPHA:542657; Palmoplantar keratoderma-deafness syndrome ORPHA:2202; Pediatric hepatocellular carcinoma ORPHA:33402; Restrictive dermopathy ORPHA:1662; Hutchinson-Gilford progeria syndrome ORPHA:740; Erythrokeratodermia variabilis ORPHA:317; Progressive symmetric erythrokeratodermia ORPHA:316; Intermediate generalized junctional epidermolysis bullosa ORPHA:79402; Adult-onset autosomal recessive cerebellar ataxia ORPHA:284289; Metatropic dysplasia ORPHA:2635; Autosomal dominant Charcot-Marie-Tooth disease type 2C ORPHA:99937; Autosomal dominant Charcot-Marie-Tooth disease type 2F ORPHA:99940; Autosomal dominant brachyolmia ORPHA:93304; Autosomal dominant congenital benign spinal muscular atrophy ORPHA:1216; Neonatal ichthyosis-sclerosing cholangitis syndrome ORPHA:59303; Nephrotic syndrome-epidermolysis bullosa-sensorineural deafness syndrome ORPHA:300333; Neurodegenerative syndrome due to cerebral folate transport deficiency ORPHA:217382; Carvajal syndrome ORPHA:65282; Parastremmatic dwarfism ORPHA:2646; Progressive familial intrahepatic cholestasis type 4 ORPHA:480483; REN-related autosomal dominant tubulointerstitial kidney disease ORPHA:217330; Resistance to thyroid hormone due to a mutation in thyroid hormone receptor beta ORPHA:566243; Scapuloperoneal spinal muscular atrophy ORPHA:431255; Severe congenital hypochromic anemia with ringed sideroblasts ORPHA:300298; Dopa-responsive dystonia due to sepiapterin reductase deficiency ORPHA:70594; Skin fragility-woolly hair-palmoplantar keratoderma syndrome ORPHA:293165; Erythrokeratodermia-cardiomyopathy syndrome ORPHA:476096; Spondyloepiphyseal dysplasia, Maroteaux type ORPHA:263482; Spondylometaphyseal dysplasia, Kozlowski type ORPHA:93314; Familial digital arthropathy-brachydactyly ORPHA:85169; Familial steroid-resistant nephrotic syndrome with adrenal insufficiency ORPHA:506334; Gyrate atrophy of choroid and retina ORPHA:414; Xanthinuria type II ORPHA:93602; Papillary renal cell carcinoma ORPHA:319298; Dermatofibrosarcoma protuberans ORPHA:31112; Hereditary methemoglobinemia ORPHA:621; Mutilating palmoplantar keratoderma with periorificial keratotic plaques ORPHA:659; Hereditary diffuse gastric cancer ORPHA:26106; Behavioral variant of frontotemporal dementia ORPHA:275864",3.28973817825433e-05; 0.0133474287859103; 0.0133474287859103; 0.0133474287859103; 0.0514345493431829; 0.0514345493431829; 0.0514345493431829; 0.0514345493431829; 0.0514345493431829; 0.0514345493431829; 0.0514345493431829; 0.0514345493431829; 0.0514345493431829; 0.0514345493431829; 0.0514345493431829; 0.0514345493431829; 0.0514345493431829; 0.0514345493431829; 0.0514345493431829; 0.0514345493431829; 0.0565022767519947; 0.1927589191138116; 0.1927589191138116; 0.1927589191138116; 0.1927589191138116; 0.1927589191138116; 0.1938708167942525; 0.1996794456641899; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5352376236648427,,,Escherichia coli;In vitro,0.54,Homo sapiens,Homo sapiens
SERPINA3,"Inflammation; Asthma; Lung diseases; Chronic Obstructive Airway Disease; Ovarian Carcinoma; Malignant neoplasm of ovary; Pancreatitis, Chronic; Neoplasm Metastasis; Hepatitis C; Hypertensive disease; Vascular Diseases; Cervix carcinoma; Cerebrovascular accident; Liver neoplasms; Glioblastoma; Diabetes Mellitus; Diabetes; Ischemic stroke; Pancreatic carcinoma; Alzheimer's Disease; Malaria; Epithelial ovarian cancer; Malignant neoplasm of pancreas; Myocardial Infarction; Cystic Fibrosis; Liver diseases; Malignant neoplasm of breast; Liver carcinoma; Dementia, Vascular; Tauopathies; Liver Cirrhosis, Experimental; Familial Alzheimer Disease (FAD); Retinal Diseases; Allergic asthma; Diabetic Retinopathy; Senile Plaques; Presenile dementia; Prostate carcinoma; ovarian neoplasm; Prostatic Neoplasms; Malignant neoplasm of prostate; Parkinson Disease; Vasculitis; Childhood Glioblastoma; Adult Glioblastoma; Acute myocardial infarction; Congestive heart failure; Familial lichen amyloidosis; Neurodegenerative Disorders; Pulmonary Emphysema; Neoplasms; Plaque, Amyloid; Heart failure; Dementia; Amyloidosis; Inclusion Body Myopathy, Sporadic; Prion Diseases; Alzheimer Disease, Late Onset; Subarachnoid Hemorrhage; AMYOTROPHIC LATERAL SCLEROSIS 1; Trisomy; Cholera; Intracranial Aneurysm; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Malignant Fibrous Histiocytoma; Machado-Joseph Disease; Amyotrophic Lateral Sclerosis, Sporadic; Recurrent tumor; Schizophrenia; Pseudotumor Cerebri; Cerebrovascular Disorders; Lewy Body Disease; Anaplasia; Shy-Drager Syndrome; Lung Diseases, Obstructive; alpha-1-Antitrypsin Deficiency, Autosomal Recessive; invasive cancer; Prostatic Diseases; Blood Coagulation Disorders; alpha 1-Antitrypsin Deficiency; Impaired cognition; Cerebral Hemorrhage; Whooping cough due to unspecified organism; Pertussis; Chronic active hepatitis; Decreased Concentration; Nonorganic psychosis; Lipoidosis; Low density lipoprotein cholesterol measurement; Psychotic Disorders",2.8114433253573326e-17; 1.803641225501291e-12; 8.179290839744632e-11; 1.3121548808139071e-10; 6.870627395110916e-10; 1.971893171900314e-09; 2.219129913614883e-09; 5.670785186683756e-09; 6.991207850982321e-09; 1.0368326871660785e-08; 1.4920329017331753e-08; 1.5572986293211266e-08; 2.0570601164639797e-08; 4.3069383556698336e-08; 5.518991037343798e-08; 5.8317433871210796e-08; 6.156981490555128e-08; 6.156981490555128e-08; 6.982287075725826e-08; 9.273260676030806e-08; 1.0618136021459505e-07; 1.479813245926713e-07; 1.4925759778299788e-07; 2.247163660896597e-07; 5.577321626966352e-07; 7.17979149467092e-07; 8.660170029731726e-07; 1.3079916134634371e-06; 1.4042419564664515e-06; 4.218275676836033e-06; 7.691726899679507e-06; 9.263589414966798e-06; 1.3010173302726732e-05; 1.3268923055385737e-05; 1.3410647656206684e-05; 1.3673911177979942e-05; 1.5064798896399038e-05; 1.527992765491583e-05; 1.8507296589967813e-05; 2.0820699372778346e-05; 3.053335644618538e-05; 3.372277447426952e-05; 4.351780357113137e-05; 5.437020241719231e-05; 5.800116505773043e-05; 7.036498484894257e-05; 8.232890503539995e-05; 8.937909010875455e-05; 0.00010914466609698448; 0.0001802305430549181; 0.00022897551943886068; 0.00023793254517777995; 0.00027820432005572264; 0.0002983150880926112; 0.0003495642888428815; 0.00042535405399404114; 0.0011303542860313; 0.0017107913939493; 0.0020282798161214; 0.0021222176147417; 0.0026287893312444; 0.0041157458728674; 0.0044046842540656; 0.0059257679306595; 0.0063571439329446; 0.0066401895279317; 0.0083709650732796; 0.0091914307650131; 0.0093325514582534; 0.0138441633831498; 0.0210446393275247; 0.0335408281184641; 0.033749008368017; 0.0368286222044987; 0.0384689641633299; 0.0404707605808569; 0.0616475884230982; 0.0623026316541814; 0.0670239713427008; 0.0700485361084771; 0.0835641020831185; 0.1270483391700474; 0.1401454825042905; 0.1525119847960956; 0.1687319146389434; 0.1932166112700285; 0.236709594559292; 0.2570364810168682; 0.3454778744069252; 0.657788228629759,Prostatic Neoplasms; Prostate Cancer; Lipoidosis,0.0567647407547259; 0.1386032662139448; 0.2089805590322066,"Complement component 3 deficiency ORPHA:280133; AA amyloidosis ORPHA:85445; OBSOLETE: Alpha-1-antichymotrypsin deficiency ORPHA:93594; Atypical hemolytic uremic syndrome with complement gene abnormality ORPHA:544472; Aceruloplasminemia ORPHA:48818; Immunodeficiency with factor I anomaly ORPHA:200418; Familial hypercholanemia ORPHA:238475; Periodontal Ehlers-Danlos syndrome ORPHA:75392; De novo thrombotic microangiopathy after kidney transplantation ORPHA:244275; Monoamine oxidase A deficiency ORPHA:3057; Familial drusen ORPHA:75376; HELLP syndrome ORPHA:244242; Autosomal dominant secondary polycythemia ORPHA:247511; Renal tubular dysgenesis of genetic origin ORPHA:97369; NON RARE IN EUROPE: Age-related macular degeneration ORPHA:279; 46,XY disorder of sex development due to 17-beta-hydroxysteroid dehydrogenase 3 deficiency ORPHA:752; Keutel syndrome ORPHA:85202; PLIN1-related familial partial lipodystrophy ORPHA:280356; Congenital atransferrinemia ORPHA:1195; Progressive retinal dystrophy due to retinol transport defect ORPHA:352718; X-linked Charcot-Marie-Tooth disease type 1 ORPHA:101075; X-linked progressive cerebellar ataxia ORPHA:1175; Alopecia-intellectual disability syndrome ORPHA:2850",0.0133474287859103; 0.0514345493431829; 0.0514345493431829; 0.0514345493431829; 0.1927589191138116; 0.1927589191138116; 0.1938708167942525; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4927160916210667; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659,,,Homo sapiens blood plasma,0.4,chemical synthesis,Homo sapiens
SNORD14C,Non-Small Cell Lung Carcinoma; cervical cancer; Malignant tumor of cervix; Neoplasm Metastasis; Cervix carcinoma; Glioblastoma; leukemia; Malignant neoplasm of breast; Carcinogenesis; B-Cell Lymphomas; Osteosarcoma of bone; Breast Carcinoma; Osteosarcoma; Prostate carcinoma; Malignant neoplasm of prostate; Childhood Glioblastoma; Adult Glioblastoma; Adenocarcinoma of lung (disorder); Colorectal Carcinoma; Colorectal Cancer; Squamous cell carcinoma of the head and neck; Peripheral T-Cell Lymphoma; Conventional (Clear Cell) Renal Cell Carcinoma; Angelman Syndrome; Papillary Renal Cell Carcinoma; Neurodevelopmental Disorders; Prader-Willi Syndrome,3.762648680673853e-10; 1.1722433847661196e-09; 3.683115069310663e-09; 5.670785186683756e-09; 1.5572986293211266e-08; 5.518991037343798e-08; 5.784935444423772e-08; 8.660170029731726e-07; 1.51758575162775e-06; 2.1624936975752243e-06; 2.560217628497434e-06; 5.381279306135013e-06; 6.3131986281381465e-06; 1.527992765491583e-05; 3.053335644618538e-05; 5.437020241719231e-05; 5.800116505773043e-05; 0.00013846515856925812; 0.00016189346720036038; 0.00038453776693371663; 0.000420950947096172; 0.0058870598454808; 0.0127059723723765; 0.1110779437709126; 0.1584804022044084; 0.2189060263359596; 0.2415218414214505,,,,,,,,,,
SNORD14D,Non-Small Cell Lung Carcinoma; cervical cancer; Malignant tumor of cervix; Neoplasm Metastasis; Cervix carcinoma; Glioblastoma; leukemia; Malignant neoplasm of breast; Carcinogenesis; B-Cell Lymphomas; Osteosarcoma of bone; Breast Carcinoma; Osteosarcoma; Prostate carcinoma; Malignant neoplasm of prostate; Childhood Glioblastoma; Adult Glioblastoma; Adenocarcinoma of lung (disorder); Colorectal Carcinoma; Colorectal Cancer; Squamous cell carcinoma of the head and neck; Peripheral T-Cell Lymphoma; Conventional (Clear Cell) Renal Cell Carcinoma; Angelman Syndrome; Papillary Renal Cell Carcinoma; Neurodevelopmental Disorders; Prader-Willi Syndrome,3.762648680673853e-10; 1.1722433847661196e-09; 3.683115069310663e-09; 5.670785186683756e-09; 1.5572986293211266e-08; 5.518991037343798e-08; 5.784935444423772e-08; 8.660170029731726e-07; 1.51758575162775e-06; 2.1624936975752243e-06; 2.560217628497434e-06; 5.381279306135013e-06; 6.3131986281381465e-06; 1.527992765491583e-05; 3.053335644618538e-05; 5.437020241719231e-05; 5.800116505773043e-05; 0.00013846515856925812; 0.00016189346720036038; 0.00038453776693371663; 0.000420950947096172; 0.0058870598454808; 0.0127059723723765; 0.1110779437709126; 0.1584804022044084; 0.2189060263359596; 0.2415218414214505,,,,,,,,,,
SOD2,"Reperfusion Injury; Asthma; Psoriasis; Familial M??ni??re disease; Lymphoma; Multiple Myeloma; Lung diseases; Chronic Obstructive Airway Disease; Rheumatoid Arthritis; Arteriosclerosis; Brain Injuries, Focal; Injuries, Acute Brain; Brain Injuries; Brain Lacerations; Non-Small Cell Lung Carcinoma; Autoimmune Diseases; Uveitis; Ovarian Carcinoma; Sarcoidosis; Endometriosis; Arsenic Poisoning, Inorganic; Nervous System, Organic Arsenic Poisoning; Arsenic Encephalopathy; Arsenic Induced Polyneuropathy; Arsenic Poisoning; Cirrhosis; Ulcerative Colitis; Infection; Malignant neoplasm of ovary; Pancreatitis, Chronic; Lung Neoplasms; Multiple Sclerosis; Cerebral Ischemia; Neoplasm Metastasis; Mammary Neoplasms, Human; Hepatitis C; Atherosclerosis; Hypertensive disease; Liver Cirrhosis; Vascular Diseases; Brain Ischemia; Cerebrovascular accident; Degenerative polyarthritis; Respiratory Distress Syndrome, Adult; Obesity; Hyperglycemia; Liver neoplasms; HIV Infections; Mammary Neoplasms; Aortic Aneurysm, Abdominal; Glioblastoma; Diabetes Mellitus; Diabetes; Lupus Erythematosus, Systemic; Pancreatic carcinoma; Coronary Artery Disease; Dermatologic disorders; Coronary heart disease; Alzheimer's Disease; Behcet Syndrome; Right Middle Cerebral Artery Infarction; Embolic Infarction, Middle Cerebral Artery; Thrombotic Infarction, Middle Cerebral Artery; Left Middle Cerebral Artery Infarction; Middle Cerebral Artery Embolus; Middle Cerebral Artery Syndrome; Middle Cerebral Artery Thrombosis; Glioma; Epithelial ovarian cancer; Escherichia coli Infections; Malignant neoplasm of pancreas; Pain; Malignant neoplasm of mouth; Myocardial Infarction; Infarction, Middle Cerebral Artery; Hepatitis C, Chronic; Anoxia; Myocardial Ischemia; Diffuse Large B-Cell Lymphoma; Brain Neoplasms; Gastric ulcer; Cardiovascular Diseases; Sepsis; Malignant neoplasm of lung; Middle Cerebral Artery Occlusion; Diabetes Mellitus, Insulin-Dependent; Liver diseases; Tumor Progression; Malignant neoplasm of breast; Bladder Neoplasm; Coronary Arteriosclerosis; Diabetic Nephropathy; Liver carcinoma; Colonic Neoplasms; Carcinogenesis; Nasopharyngeal carcinoma; Transient Ischemic Attack; Lung Diseases, Interstitial; Carcinoma of lung; Stomach Carcinoma; B-Cell Lymphomas; Colon Carcinoma; Idiopathic pulmonary arterial hypertension; Malignant neoplasm of stomach; Lip and Oral Cavity Carcinoma; Stomach Neoplasms; melanoma; Fever; Primary malignant neoplasm of lung; Breast Carcinoma; Pustulosis of Palms and Soles; Alveolitis; Secondary malignant neoplasm of bone; Acute anterior uveitis; Malignant mesothelioma; Familial Alzheimer Disease (FAD); Acute lymphocytic leukemia; Anterior uveitis; Colorectal Neoplasms; Bronchial Hyperreactivity; Diabetic Retinopathy; Diabetes Mellitus, Experimental; Streptozotocin Diabetes; Alloxan Diabetes; Senile Plaques; Extrinsic allergic alveolitis; Presenile dementia; Prostate carcinoma; Adenocarcinoma; Malignant tumor of colon; Acute Coronary Syndrome; ovarian neoplasm; Nonalcoholic Steatohepatitis; Kidney Failure, Chronic; Prostatic Neoplasms; Atherogenesis; Fibrosis; Chronic kidney disease stage 5; Coinfection; Squamous cell carcinoma; Malignant neoplasm of prostate; Malignant neoplasm of urinary bladder; Pancreatic Neoplasm; Parkinson Disease; Mouth Neoplasms; Carcinoma of bladder; Experimental Organism Basal Cell Carcinoma; Lymphoma, Non-Hodgkin; Childhood Glioblastoma; Adult Glioblastoma; Cardiomyopathy, Dilated; Diabetic Angiopathies; Heart Failure, Right-Sided; Pulmonary Hypertension; Congestive heart failure; Malignant neoplasm of liver; Familial lichen amyloidosis; Osteoporosis; Chronic Kidney Diseases; Malignant Pleural Mesothelioma; Age related macular degeneration; Mesothelioma; Neurodegenerative Disorders; Cardiomegaly; Renal Cell Carcinoma; Alzheimer Disease, Early Onset; Cardiac Hypertrophy; Adenocarcinoma of lung (disorder); VITILIGO-ASSOCIATED MULTIPLE AUTOIMMUNE DISEASE SUSCEPTIBILITY 1 (finding); Classical Hodgkin's Lymphoma; Status Epilepticus; Colorectal Carcinoma; Diabetes Mellitus, Non-Insulin-Dependent; Metabolic Syndrome X; Alcoholic Liver Diseases; Demyelinating Diseases; Gastritis, Atrophic; Myeloid Leukemia, Chronic; Esophageal Neoplasms; Anemia; Kidney Diseases; Myocardial Diseases, Secondary; Neoplasms; Plaque, Amyloid; Ulcer; Cystitis; Cardiomyopathies, Primary; Heart failure; Liver Cirrhosis, Alcoholic; Vitiligo; Sarcoma; Dementia; Diabetic macular edema; Central neuroblastoma; Secondary malignant neoplasm of lymph node; Major Depressive Disorder; Amyloidosis; Drug-Induced Liver Disease; Colorectal Cancer; Radiation Injuries, Experimental; Skin Neoplasms; Squamous cell carcinoma of the head and neck; Heart Decompensation; Albuminuria; Adrenoleukodystrophy; Esophagitis; Neuroblastoma; Ischemia; Heart Diseases; Precursor Cell Lymphoblastic Leukemia Lymphoma; Ataxia Telangiectasia; Myocardial Failure; Optic Atrophy, Hereditary, Leber; Malignant Neoplasms; Infant, Premature; Carcinoma, Cribriform; Carcinoma, Granular Cell; Adenocarcinoma, Basal Cell; Reactive hypoglycemia; Premature Birth; Gastrointestinal mucositis; Amyotrophic Lateral Sclerosis; Adenocarcinoma, Oxyphilic; CNS disorder; Tumor Initiation; Adenocarcinoma, Tubular; Prion Diseases; Endometriosis of uterus; Left-Sided Heart Failure; Precancerous Conditions; Neoplasm Invasiveness; Alzheimer's Disease, Focal Onset; Acute Confusional Senile Dementia; Kidney Neoplasm; Alcoholic Steatohepatitis; Idiopathic Nephrotic Syndrome; Iron Overload; Alzheimer Disease, Late Onset; Hepatitis, Toxic; Chemical and Drug Induced Liver Injury; Chemically-Induced Liver Toxicity; Drug-Induced Acute Liver Injury; Chronic progressive external ophthalmoplegia; Hepatitis, Drug-Induced; Endothelial dysfunction; Male infertility; AMYOTROPHIC LATERAL SCLEROSIS 1; Cardiomyopathies; Trisomy; Oral Cavity Carcinoma; Metabolic Diseases; Malignant neoplasm of esophagus; Subfertility, Male; Carotid Atherosclerosis; Reticulosarcoma; Bulbo-Spinal Atrophy, X-Linked; Necrotizing Enterocolitis; Fatty Liver; Liver and Intrahepatic Biliary Tract Carcinoma; Asbestosis; Hereditary Diffuse Gastric Cancer; Hyperlipidemia; Amyotrophic Lateral Sclerosis With Dementia; Fasting Hypoglycemia; Urticaria; Gestational Diabetes; Undifferentiated carcinoma; Qualitative abnormality of granulocyte; Hyperhomocysteinemia; Hepatolenticular Degeneration; Anaplastic thyroid carcinoma; Carcinomatosis; Benign Neoplasm; Cardiomyopathy, Familial Idiopathic; Nephrotic Syndrome; Amyotrophic Lateral Sclerosis, Guam Form; Squamous cell carcinoma of esophagus; Bipolar Disorder; Machado-Joseph Disease; Steatohepatitis; Canavan Disease; Pelvic Pain; Non-alcoholic Fatty Liver Disease; Arthritis, Reactive; Skin Carcinogenesis; Insulin Resistance; Amyotrophic Lateral Sclerosis, Sporadic; Hamartoma Syndrome, Multiple; Nephrotic Syndrome, Minimal Change; MELAS Syndrome; Schizophrenia; Anaplastic carcinoma; Diabetic Neuropathies; Visual seizure; Age-related cognitive decline; MILES-CARPENTER X-LINKED MENTAL RETARDATION SYNDROME; Adenocarcinoma of prostate; Invasive Ductal Breast Carcinoma; Conventional (Clear Cell) Renal Cell Carcinoma; PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE; Mast-Cell Sarcoma; Frontotemporal Lobar Degeneration; Tardive Dyskinesia; Drug-induced tardive dyskinesia; Malignant neoplasm of skin; Down Syndrome; Adenomatous Polyposis Coli; Insulin Sensitivity; Necrosis; FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder); Malignant neoplasm of kidney; Convulsions; Leukomalacia, Periventricular; Carcinoma, Spindle-Cell; Bronchopulmonary Dysplasia; Aspergillosis, Allergic Bronchopulmonary; FRIEDREICH ATAXIA 1; Asphyxia Neonatorum; Neoplastic Cell Transformation; Papilloma; Lewy Body Disease; Angiogenic Switch; Fanconi Anemia; AMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL RECESSIVE; Lymphatic Metastasis; Carcinoma; Dyslipidemias; Autism Spectrum Disorders; Ventricular Dysfunction, Left; Malignant neoplasm of tongue; Histiocytic sarcoma; Peripheral Neuropathy; Hemochromatosis; Squamous cell carcinoma of tongue; Ductal Carcinoma; Headache; Pneumonia, Interstitial; Meniere Disease; Osteoarthrosis Deformans; Mammary Neoplasms, Experimental; Turner Syndrome; Premature aging syndrome; Neoplasms, Intracranial; Mitochondrial Respiratory Chain Deficiencies; Tonic - clonic seizures; Depressive disorder; Rash and Dermatitis Adverse Event Associated with Chemoradiation; Alcoholic Intoxication; Single Seizure; Seizures, Auditory; Seizures, Clonic; Seizures, Sensory; Seizures, Somatosensory; Vertiginous seizure; Atonic Absence Seizures; Generalized Absence Seizures; Gustatory seizure; Jacksonian Seizure; Non-epileptic convulsion; Nonepileptic Seizures; Olfactory seizure; Epileptic Seizures; Tonic Seizures; Nicotinamide adenine dinucleotide coenzyme Q reductase deficiency; Convulsive Seizures; Bonnevie-Ullrich Syndrome; Multiple Chemical Sensitivity; Male sterility; Rectal Carcinoma; Mental Depression; Epileptic drop attack; Complex partial seizures; Cataract and cardiomyopathy; Migraine Disorders; Nodular glomerulosclerosis; Congenital heart disease; Absence Seizures; Neuroleptic-Induced Tardive Dyskinesia; Hyperthyroidism; Common Migraine; Generalized seizures; Seizures, Focal; Parkinsonian Disorders; Bradykinesia; Brain Stem Ischemia, Transient; Electron Transport Chain Deficiencies, Mitochondrial; Transient Ischemic Attack, Anterior Circulation; Transient Ischemic Attack, Vertebrobasilar Circulation; Carotid Circulation Transient Ischemic Attack; Crescendo Transient Ischemic Attacks; Posterior Circulation Transient Ischemic Attack; Primary Hyperthyroidism; Mammary Ductal Carcinoma; Hypoglycemia; Bipolar I disorder; Nerve Degeneration; Hearing Loss, Central; Abnormal involuntary movement; Endotoxemia; Migraine with Aura; Mood Disorders; Transformed migraine; Oxidative Phosphorylation Deficiencies; Marfan Syndrome; Acoustic Neuroma; Myoclonic Seizures; Sudden sensorineural hearing loss; Intestinal Diseases; Malignant neoplasm of brain; Papillary Renal Cell Carcinoma; Gonadal Dysgenesis, 45,X; Polyposis, Adenomatous Intestinal; Ethylmalonic encephalopathy; Familial Intestinal Polyposis; Psychoses, Substance-Induced; Adrenomyeloneuropathy; Papillomatosis; Papilloma, Squamous Cell; Psychosis, Involutional; Acute Kidney Tubular Necrosis; Involutional Depression; Involutional paraphrenia; Esophageal Stenosis; Psychoses, Drug; Diabetic Polyneuropathies; Meningomyelocele; Aortic Diseases; Reticulocytosis; Hearing Loss, High-Frequency; Skin toxicity; Sideroblastic anemia; Chronic Kidney Insufficiency; Methylmalonic aciduria; Tongue Neoplasms; Methylmalonic acidemia; Condition, Preneoplastic; Nonorganic psychosis; Anoxemia; Hypoxia; Benign neoplasm of brain, unspecified; Hypoxemia; Bladder neck obstruction; Disorder of the optic nerve; Recurrent Brain Neoplasm; Neuronal Ceroid-Lipofuscinoses; Optic Neuropathy; Primary malignant neoplasm of brain; Motor Neuron Disease; Degenerative Diseases, Spinal Cord; Degenerative Diseases, Central Nervous System; Transient Cerebral Ischemia; Disease Exacerbation; Seizures; Laryngeal Diseases; Skin Abnormalities; Post-Traumatic Osteoporosis; Osteoporosis, Senile; Pulmonary arterial hypertension; Sensorineural Hearing Loss (disorder); Dyskinetic syndrome; Bloom Syndrome; Osteoporosis, Age-Related; Brain Tumor, Primary; Childhood Medulloblastoma; Cataract; Mitochondrial Diseases; Leigh Disease; Bilateral cataracts (disorder); Epilepsy; Sarcomatoid Renal Cell Carcinoma; Collecting Duct Carcinoma of the Kidney; Psychotic Disorders; Chromophobe Renal Cell Carcinoma; Intellectual Disability",4.4398736172867135e-14; 1.803641225501291e-12; 3.118210553589307e-12; 3.861499575207375e-12; 4.5104266881389206e-12; 2.5279022064249716e-11; 8.179290839744632e-11; 1.3121548808139071e-10; 1.9241179247341838e-10; 2.377251819497684e-10; 2.377251819497684e-10; 2.377251819497684e-10; 2.377251819497684e-10; 2.377251819497684e-10; 3.762648680673853e-10; 5.452288254986118e-10; 6.429879513246633e-10; 6.870627395110916e-10; 7.861255581007157e-10; 7.868397426275417e-10; 1.1722433847661196e-09; 1.1722433847661196e-09; 1.1722433847661196e-09; 1.1722433847661196e-09; 1.1722433847661196e-09; 1.4790998733426532e-09; 1.6767489697325582e-09; 1.794870341379274e-09; 1.971893171900314e-09; 2.219129913614883e-09; 4.367699208727405e-09; 4.546836602575699e-09; 4.756590990483e-09; 5.670785186683756e-09; 5.791865115913735e-09; 6.991207850982321e-09; 7.195555613367576e-09; 1.0368326871660785e-08; 1.3128768066526236e-08; 1.4920329017331753e-08; 1.8815395768840057e-08; 2.0570601164639797e-08; 2.1034803123367165e-08; 2.261634993097532e-08; 2.412608431251415e-08; 4.0898524252942674e-08; 4.3069383556698336e-08; 4.638299267461546e-08; 4.65353219894153e-08; 5.1290058242058653e-08; 5.518991037343798e-08; 5.8317433871210796e-08; 6.156981490555128e-08; 6.156981490555128e-08; 6.982287075725826e-08; 8.598175402882612e-08; 9.273260676030806e-08; 9.273260676030806e-08; 9.273260676030806e-08; 9.393284022832733e-08; 1.0390067657961098e-07; 1.0390067657961098e-07; 1.0390067657961098e-07; 1.0390067657961098e-07; 1.0390067657961098e-07; 1.0390067657961098e-07; 1.0390067657961098e-07; 1.427432458937347e-07; 1.479813245926713e-07; 1.4925759778299788e-07; 1.4925759778299788e-07; 1.6759866477134858e-07; 2.0279723135488897e-07; 2.247163660896597e-07; 2.400988116471548e-07; 2.46778041958494e-07; 2.911052249927245e-07; 2.948344121290337e-07; 3.532371372262103e-07; 4.157277636684319e-07; 4.312772724439924e-07; 4.5433391667148853e-07; 5.313225371508493e-07; 6.299208964864026e-07; 6.805796735296268e-07; 6.851652105457608e-07; 7.17979149467092e-07; 8.297823048747685e-07; 8.660170029731726e-07; 9.822463166680949e-07; 1.0094398444517938e-06; 1.083280646968723e-06; 1.3079916134634371e-06; 1.4185164995612263e-06; 1.51758575162775e-06; 1.5208470671427406e-06; 1.5208470671427406e-06; 1.6231490275716298e-06; 2.027389637151193e-06; 2.07112526817849e-06; 2.1624936975752243e-06; 2.205236928124383e-06; 2.263727724144348e-06; 2.450940162208615e-06; 2.576211756838249e-06; 3.878607667297475e-06; 4.179146475474674e-06; 4.83171753412672e-06; 4.839188317483647e-06; 5.381279306135013e-06; 5.457492980911677e-06; 6.140554546483986e-06; 6.378950690990071e-06; 7.343355877356991e-06; 7.439853898002338e-06; 9.263589414966798e-06; 1.2375081616087569e-05; 1.2765469826010355e-05; 1.3034577772762696e-05; 1.3268923055385737e-05; 1.3410647656206684e-05; 1.3410647656206684e-05; 1.3410647656206684e-05; 1.3410647656206684e-05; 1.3673911177979942e-05; 1.4439241578579364e-05; 1.5064798896399038e-05; 1.527992765491583e-05; 1.5449280661407645e-05; 1.5498516107485843e-05; 1.7090079578013972e-05; 1.8507296589967813e-05; 2.0234336876324372e-05; 2.0820699372778346e-05; 2.0820699372778346e-05; 2.223158928845764e-05; 2.7001454785434173e-05; 2.910435331986992e-05; 2.929369913127532e-05; 3.053335644618538e-05; 3.053335644618538e-05; 3.1491435270594376e-05; 3.192298841377222e-05; 3.372277447426952e-05; 3.602405958537832e-05; 3.9650653676454574e-05; 3.9650653676454574e-05; 4.360044574654907e-05; 5.437020241719231e-05; 5.800116505773043e-05; 5.826428641192471e-05; 6.882388524696196e-05; 7.358523784131203e-05; 8.232890503539995e-05; 8.232890503539995e-05; 8.421319594446617e-05; 8.937909010875455e-05; 9.117996105379778e-05; 9.913294924271568e-05; 0.0001007621786326551; 0.00010334647523919963; 0.00010582598320524978; 0.00010914466609698448; 0.00011072370132707822; 0.0001119048288448298; 0.00011927896769899647; 0.00012202062264879416; 0.00013846515856925812; 0.0001431024725510208; 0.0001431024725510208; 0.0001616561904035017; 0.00016189346720036038; 0.00016189346720036038; 0.00017808425336754297; 0.000181883468787863; 0.000181883468787863; 0.00019131698235390912; 0.00021049732822064587; 0.00021804014782198476; 0.00022254302103317592; 0.00022336414159326664; 0.00022618385822819267; 0.00022897551943886068; 0.00023793254517777995; 0.00026224811620659125; 0.00026339787549714257; 0.00026467392475943254; 0.00027820432005572264; 0.0002792365191965819; 0.0002933384035122236; 0.00029355802758490503; 0.0002983150880926112; 0.00031217959139151507; 0.00032113080554701227; 0.000323910443746482; 0.0003278023880903879; 0.0003495642888428815; 0.0003607853785819225; 0.00038453776693371663; 0.00039959635390179865; 0.00041476222368508776; 0.000420950947096172; 0.0004303328941191692; 0.0004336479443072768; 0.00044420259326717257; 0.00045185714020635207; 0.0004601228759628894; 0.00047142552462714113; 0.0004814724943641282; 0.000513309425513094; 0.0005182771791848276; 0.0005632660372960827; 0.0006165924034839279; 0.0006352060750206054; 0.0007074539367893701; 0.0007603472723798622; 0.0007603472723798622; 0.0008280072185276037; 0.0008673605584216904; 0.0008932565002868814; 0.0009174737515799856; 0.0009325953874753212; 0.0010170306665323; 0.0010897868460616; 0.0010897868460616; 0.0011303542860313; 0.0011303542860313; 0.0011626911115394; 0.00116764658012; 0.0012688388196185; 0.0013309210571735; 0.0014413188128666; 0.0014413188128666; 0.0014485445504404; 0.0015652768725765; 0.0015698089771612; 0.0016559602535146; 0.0017107913939493; 0.001881335207053; 0.001881335207053; 0.001881335207053; 0.001881335207053; 0.0020056438913528; 0.0020282798161214; 0.0020505587731585; 0.0021001259552496; 0.0021222176147417; 0.0021326108499664; 0.0026287893312444; 0.0027346449758241; 0.0028187518310092; 0.0030940063712108; 0.0031934755667; 0.0032682022992594; 0.0035629033641169; 0.0037263522689301; 0.0037263522689301; 0.0038705790239355; 0.0038816440940594; 0.0039908077871836; 0.0043105477873176; 0.0043427572763018; 0.0043470921917622; 0.0043470921917622; 0.0044046842540656; 0.0044831346315456; 0.0048028611524245; 0.0048028611524245; 0.0048044887750201; 0.0048662864613419; 0.0050844857197244; 0.0050844857197244; 0.0050894481995015; 0.0053570195415722; 0.0059257679306595; 0.0059257679306595; 0.0062748297137782; 0.0066006052483961; 0.0066401895279317; 0.0067588219988478; 0.007117388576245; 0.007117388576245; 0.0075325383349707; 0.0077321746155735; 0.0080075092844381; 0.0080667733705833; 0.0083709650732796; 0.0088561754221927; 0.0093060572422998; 0.0093060572422998; 0.0093325514582534; 0.0095206592087124; 0.0096630827054915; 0.0099798889656483; 0.0110109843340769; 0.0110109843340769; 0.0118679153788039; 0.0123563544259949; 0.0127059723723765; 0.0131305979622119; 0.0138441633831498; 0.0138829566912713; 0.0153494479957135; 0.0153494479957135; 0.0156113267570298; 0.0161428886050652; 0.0166041002652209; 0.0182000062506337; 0.0196225707350576; 0.0204735864411232; 0.0230684256648711; 0.0238425854040518; 0.0239461944596263; 0.0254956360475327; 0.0254956360475327; 0.0259817880808067; 0.0265829029717646; 0.030006907592274; 0.0320403652557597; 0.0335408281184641; 0.0335408281184641; 0.0368286222044987; 0.0371129390384053; 0.0384689641633299; 0.040382673882237; 0.0404707605808569; 0.0404707605808569; 0.0411765978055933; 0.0427786786335321; 0.0447905037504535; 0.044901297966643; 0.0465235764214223; 0.0469394416375774; 0.0491632343384016; 0.0492531776191947; 0.0493155676939993; 0.0493155676939993; 0.0493155676939993; 0.0530344420162745; 0.0554191598986221; 0.0554191598986221; 0.0571842904809504; 0.0647102740274508; 0.0677694730935319; 0.069077962105579; 0.0691714743582008; 0.0692193903915762; 0.0700485361084771; 0.0700485361084771; 0.0700485361084771; 0.0700485361084771; 0.0700485361084771; 0.0700485361084771; 0.0700485361084771; 0.0700485361084771; 0.0700485361084771; 0.0700485361084771; 0.0700485361084771; 0.0700485361084771; 0.0700485361084771; 0.0700485361084771; 0.0729686376372628; 0.0746301710738675; 0.0805158056052076; 0.0817897187940979; 0.0817897187940979; 0.0817897187940979; 0.083107903315643; 0.0837469930808364; 0.0887984457495041; 0.088963803794147; 0.0897127848630768; 0.0897127848630768; 0.0940427381982829; 0.0967179741949912; 0.0972679220674381; 0.0972679220674381; 0.0972679220674381; 0.0974143314470534; 0.0987575443309834; 0.1005686045203269; 0.1050724946352408; 0.1050724946352408; 0.1130019719865939; 0.1206032442301429; 0.1206032442301429; 0.1206032442301429; 0.1206032442301429; 0.1206032442301429; 0.1206032442301429; 0.1206032442301429; 0.1206032442301429; 0.1212040226252925; 0.1245376567919059; 0.1270483391700474; 0.1272255752567765; 0.1272255752567765; 0.1272255752567765; 0.1272255752567765; 0.1272255752567765; 0.1308906437806309; 0.1343310874911156; 0.1343310874911156; 0.1397055058487397; 0.1401454825042905; 0.1404159644943249; 0.1460848784791741; 0.1525119847960956; 0.1545590833140752; 0.1584804022044084; 0.1584804022044084; 0.1584804022044084; 0.1584804022044084; 0.1584804022044084; 0.1642913929691757; 0.1642913929691757; 0.1642913929691757; 0.1703929618871976; 0.176056923749369; 0.176056923749369; 0.176056923749369; 0.176056923749369; 0.181710614199711; 0.1881045022168423; 0.1881045022168423; 0.1932166112700285; 0.2048516463561299; 0.2108300774722888; 0.2166737845423457; 0.2166737845423457; 0.2226324872503657; 0.2272199982000937; 0.2272199982000937; 0.2316568843888361; 0.2316568843888361; 0.2344682406203465; 0.236709594559292; 0.2520982519141255; 0.2520982519141255; 0.2622329318286966; 0.2670582190879765; 0.2723453780817489; 0.2723453780817489; 0.2777403930303475; 0.2777403930303475; 0.2777403930303475; 0.2777403930303475; 0.2786853069571751; 0.2823835751171575; 0.2921843338021302; 0.2972644135001306; 0.3006252432065827; 0.3243241301578816; 0.3587690037565285; 0.3718365496695985; 0.3764478003879025; 0.3929133356162864; 0.417000940404929; 0.4371385994351301; 0.4462255858401349; 0.4535514871248414; 0.4611495786563792; 0.4817554402514458; 0.4979943388112239; 0.5019882754152939; 0.5150384865323906; 0.5182883644352592; 0.5581965394251631; 0.5793939269095637; 0.6036850764340619; 0.6308405353995752; 0.657788228629759; 0.6581560020402656; 0.9388725395674395,"Myocardial Ischemia; Arsenic Encephalopathy; Cerebral Ischemia; Dermatologic Disorders; Marfan Syndrome; Mammary Neoplasms; Cerebral Infraction; Cerebral Thrombosis; Palmoplantar Pustules; Rheumatoid Arthritis; Breast Carcinoma; Atherosclerosis; Heart Failure; Psoriasis; Myocardial Infarction; Breast Cancer; Reactive Hypoglycemia; Arthritis; Malignant Mesothelioma; Myocardial Diseases; Pancreatic Cancer; Fatty Liver; Congestive Heart Failure; Hypertension; Pancreatic Neoplasm; Senile Dementia; Mouth Neoplasms; Cirrhosis; Progressive External Ophthalmoplegia; Multiple Myeloma; Amyotrophic Lateral Sclerosis With Dementia; Carcinoma; Benign Neoplasm; MELAS Syndrome; Stomach Neoplasms; Gastric Cancer; Bladder Neoplasm; Malignant Neoplasm; Adenocarcinoma; Urinary Bladder Cancer; Anaplastic Carcinoma; Skin Cancer; Mental Depression; Prostatic Neoplasms; Vascular Diseases; Meningomyelocele; Neoplasms; Alcoholic Liver Cirrhosis; Diffuse Lymphoma; Lung Carcinoma; Skin Neoplasms; Amyotrophic Lateral Sclerosis; Osteoarthrosis Deformans; Jacksonian Seizure; Uveitis; Turner Syndrome; Myelocele; Renal Tubular Necrosis; Kidney Cancer; Colonic Neoplasms; Adrenomyeloneuropathy; Aortic Diseases; Cardiomyopathy; Osteoporosis; Kidney Neoplasm; Clonic Seizures; Prostate Cancer; Coronary Syndrome; Mitochondrial Electron Transport Chain Deficiencies; Mitochondrial Respiratory Chain Deficiencies; Respiratory Distress Syndrome; Malignant Neoplasm Of Tongue; Oxidative Phosphorylation Deficiency; Hypotonic Seizures; Nervous System Diseases; Diabetes Mellitus; Esophagus Neoplasm; Schizophrenia; Papillomatosis; Lung Adenocarcinoma; Invasive Duct And Lobular Carcinoma; Carcinoma Of The Head And Neck; Autoimmune Diseases; Esophageal Stenosis; Esophageal Stricture; Mitochondrial Diseases; Diabetic Nephropathy; Sideroblastic Anemia; Liver Carcinoma; Colorectal Neoplasms; Multiple Polyposis Syndrome; Postnatal Asphyxia; Ovarian Cancer; Alzheimer Disease; Adrenoleukodystrophy; Necrotizing Enterocolitis; Lung Diseases; Tongue Neoplasms; Anemia; Hypoglycemia; Esophagitis; Involutional Depression; Involutional Paraphrenia; Lymphatic Metastasis; Lewy Body Disease; Kidney Disease; Obesity; Papilloma; Ovarian Neoplasm; Bipolar Disorder; Intracranial Neoplasm; Glomerulosclerosis; Neurodegenerative Disorders; Degenerative Diseases, Central Nervous System; Mesothelioma; Gonadal Dysgenesis; Sarcoidosis; Transient Ischemic Attack; Hyperthyroidism; Brain Neoplasms; Seizure; Aortic Aneurysm; Nasopharyngeal Carcinoma; Chromophobe Carcinoma; Papillary Renal Carcinoma; Colorectal Cancer; Nephrotic Syndrome; Renal Carcinoma; Psychosis",7.071068485513988e-10; 3.723977603538778e-09; 5.562961744202623e-09; 1.7417795410918816e-08; 8.921950872070284e-08; 1.1417484002988661e-07; 2.009208013074685e-07; 2.739939098363423e-07; 5.775106030172258e-06; 1.241997446075319e-05; 4.971054570440277e-05; 5.254109803591956e-05; 0.00015071968444989745; 0.00044166586682199737; 0.0005760978170082974; 0.00063387456654884; 0.0015169561374293; 0.0015169561374293; 0.0015169561374293; 0.0015169561374293; 0.00207663921483; 0.0025464930497429; 0.0028558709076653; 0.0048927857621509; 0.0054741435035425; 0.0067487024308267; 0.0069464092886356; 0.007221192915733; 0.007221192915733; 0.0072990932027619; 0.009505750723671; 0.0107108189044139; 0.010864842397815; 0.010864842397815; 0.0172144998405365; 0.0172144998405365; 0.021392225047824; 0.021392225047824; 0.0249475037164364; 0.0264273671824767; 0.0352250843106217; 0.0462866256396667; 0.0511376198481248; 0.0567647407547259; 0.0592733852980501; 0.0592733852980501; 0.064825092293108; 0.0841735094076256; 0.0854401019808814; 0.0868883392670891; 0.0992543625886142; 0.1006919508743788; 0.1006919508743788; 0.1110148026021272; 0.1110148026021272; 0.1110148026021272; 0.1110148026021272; 0.1110148026021272; 0.1202723965415913; 0.1203844668559877; 0.1203844668559877; 0.1203844668559877; 0.1273861908316246; 0.1286424863049623; 0.1286424863049623; 0.1286424863049623; 0.1386032662139448; 0.1448400284889975; 0.1507480783308755; 0.1507480783308755; 0.1507480783308755; 0.160518792997541; 0.160518792997541; 0.1666102769501294; 0.1700432900208007; 0.1718736907108893; 0.175139305620004; 0.175139305620004; 0.175139305620004; 0.1787826075739565; 0.1787826075739565; 0.1813044909798312; 0.1847583217632609; 0.1851562166631526; 0.1851562166631526; 0.1875258274365185; 0.191014576985413; 0.191014576985413; 0.2008242041589438; 0.2039740835961235; 0.2039740835961235; 0.2039740835961235; 0.2048942314782707; 0.2089805590322066; 0.2089805590322066; 0.2089805590322066; 0.2098525466439478; 0.2173119367816199; 0.2344334553667355; 0.2415240131894039; 0.2450716998247367; 0.2502315247388869; 0.2502315247388869; 0.2579581542371572; 0.2648173889661375; 0.2657257246540625; 0.2736284003666279; 0.2828835905949769; 0.2978951863374514; 0.2978951863374514; 0.2978951863374514; 0.2980267897624452; 0.3276530465188152; 0.3276530465188152; 0.3465144196435422; 0.3603176382172478; 0.3636022406609426; 0.3975256936810483; 0.4128402607375798; 0.4128402607375798; 0.5129718346081621; 0.5632344309031201; 0.6038366238833056; 0.6577984082440063; 0.6725341384929935; 0.6963620089820088; 0.7347526086253271; 0.825622501350681; 0.8555677858540458,Charcot-Marie-Tooth disease type 4H ORPHA:99954; Enamel-renal syndrome ORPHA:1031; Tangier disease ORPHA:31150; Kyphoscoliosis-lateral tongue atrophy-hereditary spastic paraplegia syndrome ORPHA:496689; Kyphosis-lateral tongue atrophy-myofibrillar myopathy syndrome ORPHA:496686; MRCS syndrome ORPHA:263347; Autosomal dominant vitreoretinochoroidopathy ORPHA:3086; Autosomal recessive bestrophinopathy ORPHA:139455; Best vitelliform macular dystrophy ORPHA:1243; Peroxisomal acyl-CoA oxidase deficiency ORPHA:2971; Spinocerebellar ataxia type 1 ORPHA:98755; Hydroxykynureninuria ORPHA:79155; Andersen-Tawil syndrome ORPHA:37553,0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659,Cercopithecine betaherpesvirus 5 membrane protein US27B (gene: US27B); Vaccinia virus cowpox A-type inclusion protein,0.3911903778732946; 0.7871983209689735,Homo sapiens HLMVEC lung microvascular endothelial cell;In vitro;yeasx,0.4;0.57,Homo sapiens;chemical synthesis,Homo sapiens
SPG7,"Lymphoma; Multiple Myeloma; Virus Diseases; Ovarian Carcinoma; MYELOPROLIFERATIVE DISORDER, CHRONIC, WITH EOSINOPHILIA; Malignant neoplasm of ovary; Leukemia, Myelocytic, Acute; Obesity; Liver neoplasms; Glioblastoma; leukemia; Alzheimer's Disease; Adenocarcinoma of pancreas; Behcet Syndrome; Glioma; Brain Neoplasms; Restenosis; Chronic Lymphocytic Leukemia; Malignant neoplasm of breast; Liver carcinoma; Immunologic Deficiency Syndromes; Carcinogenesis; B-Cell Lymphomas; Osteosarcoma of bone; Astrocytoma; melanoma; Breast Carcinoma; Henoch-Schoenlein Purpura; Osteosarcoma; Tumor Promotion; Acute lymphocytic leukemia; Prostate carcinoma; Malignant neoplasm of prostate; Lymphoma, Non-Hodgkin; IGA Glomerulonephritis; Cardiomyopathy, Dilated; Hematologic Neoplasms; Neurodegenerative Disorders; Adenoma; Solid Neoplasm; Colorectal Carcinoma; Neutropenia; Acute Cerebrovascular Accidents; Precursor B-cell lymphoblastic leukemia; Sarcoma; Colorectal Cancer; Secondary malignant neoplasm of lung; Primary malignant neoplasm; Precursor Cell Lymphoblastic Leukemia Lymphoma; Ataxia Telangiectasia; Malignant Neoplasms; Tumor Initiation; Chronic progressive external ophthalmoplegia; Schizophrenia; TARSAL-CARPAL COALITION SYNDROME; Mesangial proliferative glomerulonephritis; Childhood Leukemia; Cholestasis; Adenoviral infections; Leukopenia; Paraparesis, Spastic; Lower limb hyperreflexia; Memory impairment; Optic Atrophy, Autosomal Dominant; Icterus; Mitochondrial Respiratory Chain Deficiencies; Genitourinary Cancer; Spastic Paraplegia Type 7; Lower limb hypertonia; Leukodystrophy; Supranuclear gaze palsy; Degeneration of the lateral corticospinal tracts; Progressive supranuclear palsy; Autosomal Recessive Hereditary Spastic Paraplegia; X-linked agammaglobulinemia with growth hormone deficiency; Hypoparathyroidism - autosomal dominant; Parathyroid Adenoma; Autosomal dominant hypocalcemia; Lateral Sclerosis; Gait Ataxia; Carney Complex, Type 1; Impaired vibration sensation in the lower limbs; Urgency frequency syndrome; Urinary bladder sphincter dysfunction; Papillon-Lefevre Disease; Paraplegia; Lower limb spasticity; Spastic Ataxia; Urgency of micturition; Overactive Bladder; Overactive bladder syndrome; Spastic; Cholestatic liver disease; Memory Loss; Congenital pes cavus; Spastic gait; Monoparesis - leg; Ragged-red muscle fibers; Hypoparathyroidism; Lower limb muscle weakness; Hypothyroidism; Seizures; Adult Lymphoma; Childhood Lymphoma; Urinary Incontinence; Forgetful; Charcot-Marie-Tooth Disease; Hypernasal voice; Nasal voice; Deglutition Disorders; Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor; Cerebral atrophy; Ataxia; Mitochondrial Diseases; Attention deficit hyperactivity disorder; Spastic Paraplegia; Spastic Paraplegia, Hereditary; Babinski Reflex; Nystagmus; Ataxias, Hereditary; Infratentorial atrophy; Muscle Spasticity; Optic Atrophy; Cerebellar atrophy; Cerebellar degeneration; Curvature of spine; Acquired scoliosis; Dysarthria; Hyperreflexia; Cerebellar Ataxia; Intellectual Disability; Genetic Diseases, Inborn",4.5104266881389206e-12; 2.5279022064249716e-11; 6.332483647919588e-11; 6.870627395110916e-10; 1.5734876414130875e-09; 1.971893171900314e-09; 8.303910954283738e-09; 2.412608431251415e-08; 4.3069383556698336e-08; 5.518991037343798e-08; 5.784935444423772e-08; 9.273260676030806e-08; 9.306686765839445e-08; 9.393284022832733e-08; 1.427432458937347e-07; 4.157277636684319e-07; 6.673805318525932e-07; 7.931659047151387e-07; 8.660170029731726e-07; 1.3079916134634371e-06; 1.4839502431758565e-06; 1.51758575162775e-06; 2.1624936975752243e-06; 2.560217628497434e-06; 2.608032323197001e-06; 4.179146475474674e-06; 5.381279306135013e-06; 5.457492980911677e-06; 6.3131986281381465e-06; 1.033366177374635e-05; 1.2375081616087569e-05; 1.527992765491583e-05; 3.053335644618538e-05; 4.360044574654907e-05; 5.2700686057264086e-05; 5.826428641192471e-05; 6.058590126387572e-05; 0.00010914466609698448; 0.00012202062264879416; 0.0001322335978675375; 0.00016189346720036038; 0.00021611859123914996; 0.00025117420022058794; 0.0002926994143155384; 0.00029355802758490503; 0.00038453776693371663; 0.00042196010900515655; 0.00046565119871267287; 0.000513309425513094; 0.0005182771791848276; 0.0006352060750206054; 0.0010897868460616; 0.0020056438913528; 0.0093325514582534; 0.016456143422954; 0.0171001534176385; 0.0173964199029194; 0.0174410368983484; 0.0187299613301643; 0.0196225707350576; 0.021125667706065; 0.0239461944596263; 0.027071413490175; 0.0427786786335321; 0.0496760944377964; 0.0677694730935319; 0.0700485361084771; 0.0817897187940979; 0.0817897187940979; 0.0972679220674381; 0.1050724946352408; 0.1050724946352408; 0.1303940745126324; 0.1343310874911156; 0.1401454825042905; 0.1401454825042905; 0.1460848784791741; 0.1525119847960956; 0.1525119847960956; 0.1591507626487054; 0.1642913929691757; 0.1642913929691757; 0.181710614199711; 0.181710614199711; 0.181710614199711; 0.181710614199711; 0.1932166112700285; 0.1982833830495248; 0.2048516463561299; 0.2108300774722888; 0.2108300774722888; 0.2468771733501051; 0.2468771733501051; 0.2570364810168682; 0.2670582190879765; 0.2723453780817489; 0.2723453780817489; 0.2921843338021302; 0.3066971380488823; 0.316142834424839; 0.3185255747306141; 0.3243241301578816; 0.335302985108383; 0.3446292548618789; 0.3718365496695985; 0.3718365496695985; 0.3726356761234091; 0.3806434842117995; 0.3806434842117995; 0.4122626131720456; 0.4365091908885111; 0.4409199497849633; 0.4481840103343354; 0.5150384865323906; 0.5586510196217223; 0.567011998436986; 0.598109216787409; 0.6484404076497645; 0.6839463765862077; 0.6980158587103071; 0.6980158587103071; 0.7124872261498931; 0.7256088595255824; 0.7422130901915708; 0.7474058089806206; 0.7815489598370186; 0.7922500847545921; 0.8655796812083151; 0.8825801353535081; 0.9081655753114188; 0.9388725395674395; 0.971820542810358,Spinal Cord Compression; Lateral Sclerosis; Intervertebral Disc Degeneration; Schizophrenia; Mitochondrial Diseases; Paraplegia; Sensorimotor Neuropathy; Spastic Paraplegia; Dysphagia; Nystagmus; Specific Learning Disorder; Hydronephrosis; Movement Disorders; Scoliosis; Cerebral Cortical Atrophy; Cerebellar Atrophy; Optic Atrophy; Attention Deficit Hyperactivity Disorder; Dysarthria,0.0034396632260297; 0.0183653432224121; 0.160518792997541; 0.175139305620004; 0.1875258274365185; 0.3234286640962904; 0.5013672649546516; 0.6310764823433659; 0.7089244306861303; 0.7206496565839581; 0.7337249683062903; 0.782091006861421; 0.8305909483151416; 0.8310460270009882; 0.8578481721034884; 0.8778442463114743; 0.8983964555953942; 0.9366392318621862; 0.9755337275978008,"Primary lateral sclerosis ORPHA:35689; Spastic paraplegia type 7 ORPHA:99013; Methylmalonic acidemia with homocystinuria, type cblJ ORPHA:369955; Birt-Hogg-Dube syndrome ORPHA:122; Early-onset progressive encephalopathy-hearing loss-pons hypoplasia-brain atrophy syndrome ORPHA:500144; Familial spontaneous pneumothorax ORPHA:2903",0.4838060079820406; 0.4838060079820406; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659,"Human rhinovirus A88 2C (P2-C); Cosavirus A 3C; Ectromelia virus ERPV DNA packaging and ATPase protein; Horsepox virus HSPV153 (Poxvirus A32 protein); Human cosavirus D 3C; Human rhinovirus A80 2C; Human rhinovirus A51 2C; Human rhinovirus A31 2C; Human rhinovirus A85 2C; Human rhinovirus A65 2C; Norovirus Hu/Norwalk/20067/2009/VNM NTPase (gene: POL); Human rhinovirus A33 2C; Human rhinovirus A75 2C (P2-C); Human rhinovirus B52 2C; Human rhinovirus B6 2C (P2-C); Human rhinovirus A71 2C; Coxsackievirus A13 2c; Norovirus Hu/GII.4/NIHIC17.5/2012/USA NTPase (gene: POL); Norovirus Hu/GII.4/NIHIC17.6/2012/USA NTPase (gene: POL); Norovirus Hu/GII.4/NIHIC17.8/2013/USA NTPase (gene: POL); Echovirus 9 strain Barty 2C; Human rhinovirus A43 2C; Human rhinovirus B27 2C; Coxsackievirus A1 2C; Echovirus E16 2C; Human rhinovirus A1 2C; Human rhinovirus A53 2C (P2-C); Human rhinovirus B70 2C (P2-C); Human cosavirus E 2C; Human enterovirus 79 2C; Coxsackievirus B5 helicase, polyprotein region 7 (gene: 1A); Human rhinovirus A22 2C; Salivirus NG-J1 2C; Human rhinovirus A30 2C; Human rhinovirus A68 2C; Human rhinovirus B97 2C; Echovirus E15 2C; Norovirus Hu/Norwalk/10062/2009/VNM NTPase (gene: POL); Human rhinovirus A9 2C; Echovirus E21 2C; Human rhinovirus A28 2C (P2-C); Human rhinovirus B92 2C; Human rhinovirus QCE 2C; Human rhinovirus A64 2C; Echovirus E29 2C; Vaccinia virus Ankara putative ATPase.; Vaccinia virus putative ATPase (gene: A32L); Variola virus hypothetical protein (gene: A35L); Echovirus E11 2C; Echovirus E27 2C; Echovirus E19 2C; Coxsackievirus A17 2C; Enterovirus C109 2C; Coxsackievirus A18 2C protein",0.2675352623334263; 0.2882370282257738; 0.3613718664490669; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.4404159746094867,yeasx,0.37;0.56,Homo sapiens;den27;hcvjf,Homo sapiens
STAT5A,"Asthma; Lymphoma; Multiple Myeloma; Dermatitis, Atopic; Rheumatoid Arthritis; Non-Small Cell Lung Carcinoma; Crohn Disease; Autoimmune Diseases; Ovarian Carcinoma; cervical cancer; Ulcerative Colitis; Colitis; Malignant tumor of cervix; Dermatitis; Lung Neoplasms; Neoplasm Metastasis; Mammary Neoplasms, Human; Inflammatory dermatosis; Hodgkin Disease; Hepatitis C; Leukemia, Myelocytic, Acute; Hypertensive disease; Vascular Diseases; Eczema; Cervix carcinoma; Respiratory Distress Syndrome, Adult; Inflammatory Bowel Diseases; Obesity; Liver neoplasms; Mammary Neoplasms; Aortic Aneurysm, Abdominal; Glioblastoma; leukemia; Diabetes Mellitus; Diabetes; Epithelial ovarian cancer; Adult T-Cell Lymphoma/Leukemia; Myocardial Ischemia; Diffuse Large B-Cell Lymphoma; Brain Neoplasms; Malignant neoplasm of lung; Leukemia, T-Cell; Diabetes Mellitus, Insulin-Dependent; Chronic Lymphocytic Leukemia; Tumor Progression; Malignant neoplasm of breast; Diabetic Nephropathy; Liver carcinoma; Carcinogenesis; Nasopharyngeal carcinoma; Stomach Carcinoma; B-Cell Lymphomas; Colon Carcinoma; Malignant neoplasm of stomach; Lymphoma, T-Cell, Cutaneous; Breast Carcinoma; Tumor Promotion; Acute Promyelocytic Leukemia; Acute lymphocytic leukemia; Sezary Syndrome; Cachexia; Prostate carcinoma; Adenocarcinoma; Malignant tumor of colon; Acute Coronary Syndrome; ovarian neoplasm; Myeloid Leukemia; Prostatic Neoplasms; Squamous cell carcinoma; Malignant neoplasm of prostate; Leukemia, Large Granular Lymphocytic; Malignant Head and Neck Neoplasm; Myelofibrosis; Hematologic Neoplasms; Hematopoietic Neoplasms; Primary Sj??gren's syndrome; Congenital neutropenia; Severe congenital neutropenia; Solid Neoplasm; Adenocarcinoma of lung (disorder); Classical Hodgkin's Lymphoma; Colorectal Carcinoma; Diabetes Mellitus, Non-Insulin-Dependent; Metastatic melanoma; Myeloid Leukemia, Chronic; Neoplasms; Lymphoma, Follicular; Leukemogenesis; Precursor B-cell lymphoblastic leukemia; Central neuroblastoma; Colorectal Cancer; Squamous cell carcinoma of the head and neck; Neuroblastoma; Primary malignant neoplasm; Myeloproliferative disease; Precursor Cell Lymphoblastic Leukemia Lymphoma; Malignant Neoplasms; Severe Combined Immunodeficiency; Carcinoma, Cribriform; Carcinoma, Granular Cell; Adenocarcinoma, Basal Cell; Amyotrophic Lateral Sclerosis; Adenocarcinoma, Oxyphilic; Tumor Initiation; Adenocarcinoma, Tubular; Precancerous Conditions; Primary Myelofibrosis; Lymphopenia; Polycythemia Vera; Head and Neck Neoplasms; Iron deficiency; Chronic myeloproliferative disorder; Undifferentiated carcinoma; Bronchiolitis, Viral; Carcinomatosis; Juvenile Myelomonocytic Leukemia; Adrenocortical carcinoma; Acute leukemia; Hamartoma Syndrome, Multiple; Anaplastic carcinoma; Thymoma; Thrombocythemia, Essential; Aortic Valve Insufficiency; Enteritis; Invasive Ductal Breast Carcinoma; Invasive Carcinoma; Idiopathic pulmonary hypertension; Malnutrition; Childhood Leukemia; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Mammary Tumorigenesis; Carcinoma, Spindle-Cell; Uremia; Philadelphia chromosome-positive acute lymphoblastic leukemia; Carcinoma; Adenocarcinoma of large intestine; Hypergammaglobulinemia; Monosomy; Lipomatosis, Multiple; Ductal Carcinoma; Mammary Neoplasms, Experimental; Prolactinoma; Intraepithelial Neoplasia; Waldenstrom Macroglobulinemia; Atypical Ductal Breast Hyperplasia; CHROMOSOME 8p11 MYELOPROLIFERATIVE SYNDROME; Noninfiltrating Intraductal Carcinoma; Secretory breast carcinoma; Erythema Infectiosum; Myelofibrosis due to another disorder; Neurilemmoma; Laron Syndrome; Liver Dysplastic Nodule; Acute Erythroblastic Leukemia; Gastrointestinal Carcinoid Tumor; Menstrual spotting; IMMUNODEFICIENCY 13; Polycystic Kidney, Autosomal Dominant; Mammary Analogue Secretory Carcinoma; Lipoma; insulinoma; Leukemia, T-Cell, Chronic; Spinal Muscular Atrophy; Familial erythrocytosis; Ovarian epithelial cancer recurrent; T-Cell Prolymphocytic Leukemia; Paget Disease Extramammary; Lymphoid neoplasm; Condition, Preneoplastic; Drug abuse; Chronic eosinophilic leukemia; Mammary Carcinoma, Animal; Animal Mammary Neoplasms; Chondrodysplasia; Turner Syndrome, Male; Carcinoma, Lobular; Noonan Syndrome; Mastocytosis; Mastocytosis, Systemic; Undifferentiated leukemia; Malignant neoplasm of salivary gland; Muscular Dystrophy; Acute Undifferentiated Leukemia; Addictive Behavior",1.803641225501291e-12; 4.5104266881389206e-12; 2.5279022064249716e-11; 7.448716379948652e-11; 1.9241179247341838e-10; 3.762648680673853e-10; 4.2478505092738466e-10; 5.452288254986118e-10; 6.870627395110916e-10; 1.1722433847661196e-09; 1.6767489697325582e-09; 1.971893171900314e-09; 3.683115069310663e-09; 3.683115069310663e-09; 4.367699208727405e-09; 5.670785186683756e-09; 5.791865115913735e-09; 6.0322241000340585e-09; 6.195332209150018e-09; 6.991207850982321e-09; 8.303910954283738e-09; 1.0368326871660785e-08; 1.4920329017331753e-08; 1.4920329017331753e-08; 1.5572986293211266e-08; 2.261634993097532e-08; 2.3137704832524547e-08; 2.412608431251415e-08; 4.3069383556698336e-08; 4.65353219894153e-08; 5.1290058242058653e-08; 5.518991037343798e-08; 5.784935444423772e-08; 5.8317433871210796e-08; 6.156981490555128e-08; 1.479813245926713e-07; 2.46778041958494e-07; 2.948344121290337e-07; 3.532371372262103e-07; 4.157277636684319e-07; 6.299208964864026e-07; 6.805796735296268e-07; 6.851652105457608e-07; 7.931659047151387e-07; 8.297823048747685e-07; 8.660170029731726e-07; 1.083280646968723e-06; 1.3079916134634371e-06; 1.51758575162775e-06; 1.5208470671427406e-06; 2.07112526817849e-06; 2.1624936975752243e-06; 2.205236928124383e-06; 2.450940162208615e-06; 3.7283259874612974e-06; 5.381279306135013e-06; 1.033366177374635e-05; 1.2304362232150695e-05; 1.2375081616087569e-05; 1.3410647656206684e-05; 1.3410647656206684e-05; 1.527992765491583e-05; 1.5449280661407645e-05; 1.5498516107485843e-05; 1.7090079578013972e-05; 1.8507296589967813e-05; 2.042524345007846e-05; 2.0820699372778346e-05; 3.053335644618538e-05; 3.053335644618538e-05; 3.803310437251698e-05; 4.3188904868696655e-05; 4.8257135411913726e-05; 6.058590126387572e-05; 6.484707207749309e-05; 8.232890503539995e-05; 0.00010886951500201832; 0.00012949836610375056; 0.0001322335978675375; 0.00013846515856925812; 0.0001431024725510208; 0.00016189346720036038; 0.00016189346720036038; 0.00021049732822064587; 0.00021049732822064587; 0.00022897551943886068; 0.0002484853090912064; 0.0002652452950458932; 0.0002926994143155384; 0.00032113080554701227; 0.00038453776693371663; 0.000420950947096172; 0.0004601228759628894; 0.00046565119871267287; 0.0005011878920853237; 0.000513309425513094; 0.0006352060750206054; 0.0006993549316202267; 0.0007603472723798622; 0.0007603472723798622; 0.0008280072185276037; 0.0009325953874753212; 0.0010170306665323; 0.0010897868460616; 0.0011303542860313; 0.0012688388196185; 0.0012983918214284; 0.0017290799495295; 0.0025118094772522; 0.0035164243080016; 0.0037263522689301; 0.0044119363017658; 0.0048028611524245; 0.0048028611524245; 0.0050844857197244; 0.0054814673835909; 0.0063306870511064; 0.0073444206109429; 0.0088561754221927; 0.0095206592087124; 0.0096630827054915; 0.0105367304020196; 0.0114187031414039; 0.0114187031414039; 0.0123563544259949; 0.0128516790501046; 0.0131305979622119; 0.0138441633831498; 0.0173964199029194; 0.0198983219186433; 0.0203198961621158; 0.0254956360475327; 0.0284314613047093; 0.0314638805510678; 0.0404707605808569; 0.0404707605808569; 0.0427786786335321; 0.0442524445580864; 0.044901297966643; 0.0492531776191947; 0.0554191598986221; 0.0559578912214163; 0.0587248614153099; 0.0805908799965109; 0.0897127848630768; 0.0897127848630768; 0.0908772402064694; 0.0972679220674381; 0.1050724946352408; 0.1050724946352408; 0.1130019719865939; 0.1130019719865939; 0.1130019719865939; 0.1159436893514271; 0.1173860265721715; 0.1272255752567765; 0.1343310874911156; 0.1472075252120941; 0.1525119847960956; 0.1687319146389434; 0.176056923749369; 0.1881045022168423; 0.1982833830495248; 0.2048516463561299; 0.2226324872503657; 0.2272199982000937; 0.2272199982000937; 0.2316568843888361; 0.2344682406203465; 0.251930120576978; 0.2723453780817489; 0.3027515681302206; 0.3027515681302206; 0.3066971380488823; 0.3446292548618789; 0.3678942528109082; 0.3806434842117995; 0.3929133356162864; 0.4055175521212118; 0.4089444818350988; 0.4129951424538438; 0.4389761493558894; 0.4395651618287257; 0.4481840103343354,Myocardial Ischemia; Marfan Syndrome; Mammary Neoplasms; Breast Carcinoma; Breast Cancer; Carcinoma; Lung Cancer; Adenocarcinoma; Anaplastic Carcinoma; Lung Neoplasms; Breast Hyperplasia; Ductal Carcinoma; Severe Combined Immunodeficiency Disease,7.071068485513988e-10; 8.921950872070284e-08; 1.1417484002988661e-07; 4.971054570440277e-05; 0.00063387456654884; 0.0107108189044139; 0.0153260870217676; 0.0249475037164364; 0.0352250843106217; 0.0662475691169798; 0.1110148026021272; 0.1716490205203499; 0.4781625413049046,Hereditary pediatric Behcet-like disease ORPHA:476102; Autosomal dominant hyper-IgE syndrome ORPHA:2314; Chronic lymphoproliferative disorder of natural killer cells ORPHA:512017; STAT3-related early-onset multisystem autoimmune disease ORPHA:438159; T-cell large granular lymphocyte leukemia ORPHA:86872; STING-associated vasculopathy with onset in infancy ORPHA:425120; Proteasome-associated autoinflammatory syndrome ORPHA:324977; Laron syndrome with immunodeficiency ORPHA:220465; Spondyloenchondrodysplasia ORPHA:1855; Autosomal dominant Charcot-Marie-Tooth disease type 2I ORPHA:99942; Autosomal dominant Charcot-Marie-Tooth disease type 2J ORPHA:99943; Autosomal dominant intermediate Charcot-Marie-Tooth disease type D ORPHA:100046; Autosomal dominant intermediate Charcot-Marie-Tooth disease with neuropathic pain ORPHA:324585; Charcot-Marie-Tooth disease type 1B ORPHA:101082; Nephrogenic diabetes insipidus ORPHA:223; Acute promyelocytic leukemia ORPHA:520,1.7877420438201673e-08; 2.859667220539484e-06; 2.859667220539484e-06; 2.859667220539484e-06; 2.859667220539484e-06; 0.0514345493431829; 0.1927589191138116; 0.4838060079820406; 0.4838060079820406; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5470627902183853,"Vaccinia virus Ankara Haemagglutinin; Vaccinia virus hemagglutinin (gene: A56R); Horsepox virus HSPV177 (Immunoglobulin like); Variola virus hypothetical protein (gene: J9R); Parainfluenza virus 5 phosphoprotein (gene: V/P); Macacine alphaherpesvirus 1 envelope glycoprotein C (gene: UL44); Menangle virus phosphoprotein (gene: V/P); Sosuga virus phosphoprotein; Mumps virus strain Jeryl Lynn phosphoprotein (gene: P); Tai Forest ebolavirus spike glycoprotein (gene: GP); Marburg virus - Musoke, Kenya, 1980 glycoprotein (gene: GP); Marburg marburgvirus glycoprotein (gene: GP); Mumps virus phoshoprotein (gene: V/P); Mumps virus genotype G phosphoprotein (gene: P); Nipah henipavirus P phosphoprotein; Hendra henipavirus phosphoprotein P (gene: P/V/C)",0.0096374079669374; 0.0223182816928385; 0.0401211861299026; 0.2673783194071986; 0.4275573398203068; 0.4488595345067562; 0.5385516813032791; 0.5632846735924478; 0.5898428022634319; 0.6636661154930864; 0.6749083860266357; 0.7029469899587416; 0.8349638375886056; 0.8402672136452302; 0.9277109860708432; 0.948649526789268,Homo sapiens T-lymphoblast;Homo sapiens YT natural-killer-like cell;In vitro;yeasx,0.35;0.37;0.4;0.52,Homo sapiens;chemical synthesis,Homo sapiens
STX11,"Leukemia, Myelocytic, Acute; Fever; MYELODYSPLASTIC SYNDROME; Lymphohistiocytosis, Hemophagocytic; Peripheral T-Cell Lymphoma; Lymphohistiocytosis; Non-arthropod borne lymphocytic choriomeningitis; Lymphocytic Choriomeningitis; Primary immune deficiency disorder; Leukodystrophy; Congenital cystic kidney disease; Cystic Kidney Diseases; Cystic kidney; Intellectual Disability; Global developmental delay",8.303910954283738e-09; 4.83171753412672e-06; 1.279493639647176e-05; 1.513340899972731e-05; 0.0058870598454808; 0.0083709650732796; 0.0160005762734352; 0.0182000062506337; 0.0434849646646736; 0.0972679220674381; 0.1642913929691757; 0.4282129311389295; 0.4886282001917928; 0.9388725395674395; 0.9995840056846864,Neutropenia; Histiocytosis Haematophagic; Hemophagocytic Lymphohistiocytosis; Anemia; Hypofibrinogenemia; Fibrinogen Deficiency,0.064825092293108; 0.1286424863049623; 0.1286424863049623; 0.2344334553667355; 0.3020628161707281; 0.3076038681026417,Charcot-Marie-Tooth disease type 1D ORPHA:101084; Charcot-Marie-Tooth disease type 4E ORPHA:99951; Nasopharyngeal carcinoma ORPHA:150; Hereditary pediatric Behcet-like disease ORPHA:476102; Autosomal dominant hyper-IgE syndrome ORPHA:2314; NON RARE IN EUROPE: Psoriatic arthritis ORPHA:40050; Chronic lymphoproliferative disorder of natural killer cells ORPHA:512017; STAT3-related early-onset multisystem autoimmune disease ORPHA:438159; T-cell large granular lymphocyte leukemia ORPHA:86872; Autosomal dominant dopa-responsive dystonia ORPHA:98808; GTP cyclohydrolase I deficiency ORPHA:2102; Hypohidrotic ectodermal dysplasia with immunodeficiency ORPHA:98813; Herpes simplex virus encephalitis ORPHA:1930; Autosomal recessive mendelian susceptibility to mycobacterial diseases due to partial JAK1 deficiency ORPHA:574957; Singleton-Merten dysplasia ORPHA:85191; Immunodeficiency by defective expression of MHC class I ORPHA:34592; Birdshot chorioretinopathy ORPHA:179; Complement hyperactivation-angiopathic thrombosis-protein-losing enteropathy syndrome ORPHA:566175; Revesz syndrome ORPHA:3088; Generalized glucocorticoid resistance syndrome ORPHA:786; Immune dysregulation-inflammatory bowel disease-arthritis-recurrent infections-lymphopenia syndrome ORPHA:529977; Takayasu arteritis ORPHA:3287; Exfoliative ichthyosis ORPHA:289586; MIRAGE syndrome ORPHA:494433; NON RARE IN EUROPE: Ankylosing spondylitis ORPHA:825; Bacterial susceptibility due to TLR signaling pathway deficiency ORPHA:183713; Overgrowth-macrocephaly-facial dysmorphism syndrome ORPHA:137634; Camurati-Engelmann disease ORPHA:1328; Pulmonary arterial hypertension associated with connective tissue disease ORPHA:275798; STING-associated vasculopathy with onset in infancy ORPHA:425120; Familial normophosphatemic tumoral calcinosis ORPHA:306658; Variant ABeta2M amyloidosis ORPHA:314652; Waldenstrom macroglobulinemia ORPHA:33226; Griscelli syndrome type 2 ORPHA:79477; Infantile inflammatory bowel disease with neurological involvement ORPHA:565788; Vogt-Koyanagi-Harada disease ORPHA:3437; Mendelian susceptibility to mycobacterial diseases due to complete IFNgammaR1 deficiency ORPHA:99898; Metaphyseal dysplasia-maxillary hypoplasia-brachydacty syndrome ORPHA:2504; Autosomal dominant mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR1 deficiency ORPHA:319581; Autosomal recessive mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR1 deficiency ORPHA:319569; NON RARE IN EUROPE: Wolff-Parkinson-White syndrome ORPHA:907; Neutrophil immunodeficiency syndrome ORPHA:183707; Cleidocranial dysplasia ORPHA:1452; Combined immunodeficiency due to Moesin deficiency ORPHA:504530; Fatal congenital hypertrophic cardiomyopathy due to glycogen storage disease ORPHA:439854; Growth retardation-mild developmental delay-chronic hepatitis syndrome ORPHA:391366; Familial Chilblain lupus ORPHA:481662; Familial hemophagocytic lymphohistiocytosis ORPHA:540; Congenital muscular dystrophy-respiratory failure-skin abnormalities-joint hyperlaxity syndrome ORPHA:486815; Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations ORPHA:247691; Paternal uniparental disomy of chromosome 6 ORPHA:96191; Short stature due to isolated growth hormone deficiency with X-linked hypogammaglobulinemia ORPHA:632; High grade B-cell lymphoma with MYC and/ or BCL2 and/or BCL6 rearrangement ORPHA:480541; Neutral lipid storage disease with ichthyosis ORPHA:98907; Autosomal dominant severe congenital neutropenia ORPHA:486; Primary myelofibrosis ORPHA:824; Essential thrombocythemia ORPHA:3318,3.598261936626476e-12; 3.598261936626476e-12; 6.10801728836975e-11; 1.7877420438201673e-08; 2.859667220539484e-06; 2.859667220539484e-06; 2.859667220539484e-06; 2.859667220539484e-06; 2.859667220539484e-06; 3.28973817825433e-05; 3.28973817825433e-05; 3.295782224790152e-05; 0.00024116799717032887; 0.0019696624570933; 0.0133474287859103; 0.0133474287859103; 0.0133474287859103; 0.0133474287859103; 0.0133474287859103; 0.0133474287859103; 0.0133474287859103; 0.0142744270060997; 0.0514345493431829; 0.0514345493431829; 0.0514345493431829; 0.0514345493431829; 0.0514345493431829; 0.0514345493431829; 0.0514345493431829; 0.0514345493431829; 0.0514345493431829; 0.0514345493431829; 0.0514345493431829; 0.0514345493431829; 0.0514345493431829; 0.0514345493431829; 0.1927589191138116; 0.1927589191138116; 0.1927589191138116; 0.1927589191138116; 0.1927589191138116; 0.1927589191138116; 0.1927589191138116; 0.1927589191138116; 0.1927589191138116; 0.1927589191138116; 0.1938708167942525; 0.1950017883804084; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5322893295716875,Cercopithecine betaherpesvirus 5 membrane protein US27B (gene: US27B); Human alphaherpesvirus 2 tegument protein VP22 (gene: UL49); Human alphaherpesvirus 1 tegument protein VP22 (gene: UL49); Lujo mammarenavirus large RNA-dependent RNA polymerase; Cercopithecine alphaherpesvirus 2 tegument protein VP22 (gene: UL49); Chapare mammarenavirus L polymerase; Macacine alphaherpesvirus 1 tegument protein VP22 (gene: UL49); Machupo mammarenavirus L protein; Junin mammarenavirus L protein; Guanarito mammarenavirus L protein,0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.401437206174097; 0.4162402588521184; 0.4162402588521184; 0.4485784929261809; 0.620955301962988; 0.631011369238774; 0.6476298180628958,yeasx,0.55;0.56,Homo sapiens,Homo sapiens
THBS1,"Inflammation; Reperfusion Injury; Asthma; Juvenile arthritis; Lymphoma; Multiple Myeloma; Virus Diseases; Synovitis; Rheumatoid Arthritis; Arteriosclerosis; Non-Small Cell Lung Carcinoma; Ovarian Carcinoma; Endometriosis; cervical cancer; Cirrhosis; Malignant neoplasm of ovary; Pancreatitis, Chronic; Tumor Angiogenesis; Malignant tumor of cervix; Dermatitis; Lung Neoplasms; Multiple Sclerosis; Neoplasm Metastasis; Mammary Neoplasms, Human; Inflammatory dermatosis; Atherosclerosis; Pulmonary Fibrosis; Hypertensive disease; Liver Cirrhosis; Vascular Diseases; Cervix carcinoma; Arthritis; Infection caused by Helicobacter pylori; Cerebrovascular accident; Degenerative polyarthritis; Obesity; Kaposi Sarcoma; Periodontitis; Hyperglycemia; Liver neoplasms; HIV Infections; Mammary Neoplasms; Aortic Aneurysm, Abdominal; Glioblastoma; leukemia; Diabetes Mellitus; Diabetes; Pancreatic carcinoma; Coronary Artery Disease; Coronary heart disease; Adenocarcinoma of pancreas; Sjogren's Syndrome; Glioma; Epithelial ovarian cancer; Malignant neoplasm of pancreas; Acquired Immunodeficiency Syndrome; Inflammatory disorder; Myocardial Infarction; Adult T-Cell Lymphoma/Leukemia; Anoxia; Cardiovascular Diseases; Cystic Fibrosis; Malignant neoplasm of lung; Fibroid Tumor; Restenosis; Leukemia, T-Cell; Ureteral obstruction; Tumor Progression; Dryness of eye; Malignant neoplasm of breast; Cytomegalovirus Infections; Coronary Arteriosclerosis; Diabetic Nephropathy; Systemic Scleroderma; Liver carcinoma; Immunologic Deficiency Syndromes; Carcinogenesis; Nasopharyngeal carcinoma; Malignant neoplasm of vulva; Carcinoma of lung; Stomach Carcinoma; Polycystic Ovary Syndrome; Colon Carcinoma; Idiopathic pulmonary arterial hypertension; Fibrosarcoma; Malignant neoplasm of stomach; Immune System Diseases; Osteosarcoma of bone; Astrocytoma; Dry Eye Syndromes; Lymphoma, T-Cell, Cutaneous; Stomach Neoplasms; Chronic liver disease; inflammatory joint disease; melanoma; Dermatomyositis, Childhood Type; Fever; Primary malignant neoplasm of lung; Breast Carcinoma; Polymyositis; Osteosarcoma; Thyroid carcinoma; Acute Promyelocytic Leukemia; Colorectal Neoplasms; Diabetic Retinopathy; Hepatitis B; Presenile dementia; Prostate carcinoma; Adenocarcinoma; Malignant tumor of colon; Juvenile psoriatic arthritis; Myeloid Leukemia; Prostatic Neoplasms; Herpes Simplex Infections; Malignant neoplasm of endometrium; Uterine Corpus Cancer; Juvenile-Onset Still Disease; Fibrosis; Squamous cell carcinoma; Malignant neoplasm of prostate; Meningitis; Pancreatic Neoplasm; Parkinson Disease; Endometrioma; Lichen Sclerosus et Atrophicus; Myelofibrosis; Benign Prostatic Hyperplasia; Spinal Cord Diseases; Diabetic Angiopathies; Carcinoma, Lewis Lung; Congestive heart failure; Malignant Glioma; CARCINOMA OF VULVA; Malignant Pleural Mesothelioma; Renal Cell Carcinoma; Systemic candidiasis; Infiltrating Cervical Carcinoma; Adenoma; Peripheral Vascular Diseases; Solid Neoplasm; Endometrial Carcinoma; Adenocarcinoma of lung (disorder); Carcinoma, Transitional Cell; Retinoblastoma; Colorectal Carcinoma; Fibrosis, Liver; Metabolic Syndrome X; Pancreatic Ductal Adenocarcinoma; Malaria, Cerebral; Chronic gastritis; Metastatic melanoma; Scleroderma; Kidney Diseases; Neoplasms; Heart failure; Keratoconjunctivitis Sicca; Sarcoma; Dementia; Central neuroblastoma; Secondary malignant neoplasm of lymph node; Colorectal Cancer; Secondary malignant neoplasm of lung; Invasive carcinoma of breast; Urothelial Carcinoma; Inclusion Body Myopathy, Sporadic; Neuroblastoma; Primary malignant neoplasm; Ischemia; Heart Diseases; Renal interstitial fibrosis; Congenital arteriovenous malformation; Focal glomerulosclerosis; Malignant Neoplasms; Keratitis; Malignant neoplasm of thyroid; Sicca Syndrome; Arthropathy; Precancerous Conditions; Primary Myelofibrosis; tumor vasculature; Metastatic Neoplasm; Skin carcinoma; Thyroid Neoplasm; Renal fibrosis; Hemorrhagic Fever with Renal Syndrome; Papillary thyroid carcinoma; Human T-cell lymphotrophic virus, type I [HTLV-I]; Renal carcinoma; Follicular thyroid carcinoma; Promyelocytic leukemia; Overweight; Squamous cell carcinoma of esophagus; Adrenocortical carcinoma; HTLV-I Infections; Quebec platelet disorder; Bone Marrow Diseases; Skin Carcinogenesis; Tropical Spastic Paraparesis; Cutaneous hypersensitivity; Medulloblastoma; Recurrent tumor; Schizophrenia; Cervical Intraepithelial Neoplasia; Hemangiosarcoma; Thrombocythemia, Essential; Meningioma; Invasive Ductal Breast Carcinoma; Carcinoma, Pancreatic Ductal; Conventional (Clear Cell) Renal Cell Carcinoma; Parasitic Diseases; Glioblastoma Multiforme; Parasitic infection; Arteriovenous Malformations, Cerebral; Diarrhea; Paraparesis, Spastic; Sick Sinus Syndrome; Peripheral Arterial Diseases; Triple Negative Breast Neoplasms; Papilloma; Angiogenic Switch; Carcinoid Tumor; Dyslipidemias; Nephritis, Interstitial; Echinococcosis; Impaired glucose tolerance; Nephritis, Tubulointerstitial; Aortic Aneurysm; nervous system disorder; Hemangioma; Aortic aneurysm without mention of rupture NOS; keratoacanthoma; Neonatal meningitis; Glaucoma; Premature coronary artery disease; Tumor-Associated Vasculature; Thrombotic thrombocytopenic purpura, acquired; Direct Contact Transmission Infection; Penile Neoplasms; Colorectal cancer metastatic; Sentinel node (disorder); Cavernous Hemangioma of Brain; Malignant neoplasm of large intestine; Schistosomiasis japonica; Congenital Mesoblastic Nephroma; Mammary Ductal Carcinoma; Vulvar Lichen Sclerosus; Keratoconjunctivitis; Gastroesophageal reflux disease; Marfan Syndrome; Vascular occlusion; Budd-Chiari Syndrome; Congenital Thrombotic Thrombocytopenic Purpura; Hepatic Vein Thrombosis; Desmoplastic; Hypertrophy of kidney; Malignant Childhood Neoplasm; Well Differentiated Oligodendroglioma; Squamous cell carcinoma of penis; Clear cell sarcoma of kidney; oligodendroglioma; polyps; Microangiopathy, Diabetic; Helminthiasis; Penis carcinoma; Malignant neoplasm of penis; Adult T Acute Lymphoblastic Leukemia; Squamous cell carcinoma of skin; ST segment elevation myocardial infarction; Hallopeau-Siemens Disease; Cancer of Urinary Tract; Pelvic Organ Prolapse; Skin lesion; Purpura, Thrombotic Thrombocytopenic; Nephroblastoma; Epiretinal Membrane; Primary Carcinoma; Obesity, Visceral; Cervical Squamous Cell Carcinoma; Tumors of Adrenal Cortex; Ganglioneuroma; Inclusion Body Myositis (disorder); Malformations of Cortical Development, Group II; Retinitis Pigmentosa; Myopathy",2.8114433253573326e-17; 4.4398736172867135e-14; 1.803641225501291e-12; 3.861499575207375e-12; 4.5104266881389206e-12; 2.5279022064249716e-11; 6.332483647919588e-11; 1.6797550790254382e-10; 1.9241179247341838e-10; 2.377251819497684e-10; 3.762648680673853e-10; 6.870627395110916e-10; 7.868397426275417e-10; 1.1722433847661196e-09; 1.4790998733426532e-09; 1.971893171900314e-09; 2.219129913614883e-09; 3.315537369635636e-09; 3.683115069310663e-09; 3.683115069310663e-09; 4.367699208727405e-09; 4.546836602575699e-09; 5.670785186683756e-09; 5.791865115913735e-09; 6.0322241000340585e-09; 7.195555613367576e-09; 7.547641288501485e-09; 1.0368326871660785e-08; 1.3128768066526236e-08; 1.4920329017331753e-08; 1.5572986293211266e-08; 1.587872453479067e-08; 1.7931366647560766e-08; 2.0570601164639797e-08; 2.1034803123367165e-08; 2.412608431251415e-08; 3.149054123564124e-08; 3.9573009168853264e-08; 4.0898524252942674e-08; 4.3069383556698336e-08; 4.638299267461546e-08; 4.65353219894153e-08; 5.1290058242058653e-08; 5.518991037343798e-08; 5.784935444423772e-08; 5.8317433871210796e-08; 6.156981490555128e-08; 6.982287075725826e-08; 8.598175402882612e-08; 9.273260676030806e-08; 9.306686765839445e-08; 1.0276547515522002e-07; 1.427432458937347e-07; 1.479813245926713e-07; 1.4925759778299788e-07; 1.825346178149227e-07; 2.242497138958313e-07; 2.247163660896597e-07; 2.46778041958494e-07; 2.911052249927245e-07; 4.5433391667148853e-07; 5.577321626966352e-07; 6.299208964864026e-07; 6.630279934320317e-07; 6.673805318525932e-07; 6.805796735296268e-07; 7.99548070959303e-07; 8.297823048747685e-07; 8.339674388418603e-07; 8.660170029731726e-07; 8.887379906686178e-07; 1.0094398444517938e-06; 1.083280646968723e-06; 1.10068355868735e-06; 1.3079916134634371e-06; 1.4839502431758565e-06; 1.51758575162775e-06; 1.5208470671427406e-06; 1.8939430555623748e-06; 2.027389637151193e-06; 2.07112526817849e-06; 2.086123696221558e-06; 2.205236928124383e-06; 2.263727724144348e-06; 2.3419309731960144e-06; 2.450940162208615e-06; 2.546221763226728e-06; 2.560217628497434e-06; 2.608032323197001e-06; 2.7684459182091574e-06; 3.7283259874612974e-06; 3.878607667297475e-06; 3.990817553511259e-06; 3.990817553511259e-06; 4.179146475474674e-06; 4.42396341877472e-06; 4.83171753412672e-06; 4.839188317483647e-06; 5.381279306135013e-06; 6.169876404399104e-06; 6.3131986281381465e-06; 6.889889014378816e-06; 1.2304362232150695e-05; 1.3034577772762696e-05; 1.3410647656206684e-05; 1.3755659311680946e-05; 1.5064798896399038e-05; 1.527992765491583e-05; 1.5449280661407645e-05; 1.5498516107485843e-05; 1.8961926417889813e-05; 2.042524345007846e-05; 2.0820699372778346e-05; 2.1109857936882128e-05; 2.389985034001877e-05; 2.483118059238325e-05; 2.5791573703443737e-05; 2.7001454785434173e-05; 3.053335644618538e-05; 3.053335644618538e-05; 3.14076229962439e-05; 3.192298841377222e-05; 3.372277447426952e-05; 4.079834649355082e-05; 4.351780357113137e-05; 4.8257135411913726e-05; 5.945938584340405e-05; 6.758558746827128e-05; 6.882388524696196e-05; 8.178614148996482e-05; 8.232890503539995e-05; 8.25206825409808e-05; 9.913294924271568e-05; 0.0001007621786326551; 0.0001119048288448298; 0.00011927896769899647; 0.00011927896769899647; 0.00012202062264879416; 0.00012202062264879416; 0.0001322335978675375; 0.0001322335978675375; 0.00013846515856925812; 0.0001474322229096163; 0.00015093372108149775; 0.00016189346720036038; 0.0001690762138878921; 0.00017808425336754297; 0.0001802305430549181; 0.0001932529498581875; 0.0001932529498581875; 0.00021049732822064587; 0.00022254302103317592; 0.00022336414159326664; 0.00022897551943886068; 0.00027820432005572264; 0.00028056116385876946; 0.00029355802758490503; 0.0002983150880926112; 0.00032113080554701227; 0.000323910443746482; 0.00038453776693371663; 0.00042196010900515655; 0.0004224524250828287; 0.0004243878730487336; 0.00042535405399404114; 0.0004601228759628894; 0.00046565119871267287; 0.00047142552462714113; 0.0004814724943641282; 0.0004814724943641282; 0.0005125353857651181; 0.0005486681594044074; 0.0006352060750206054; 0.0008252744167874381; 0.0009826472144539087; 0.0010244557923259; 0.0011303542860313; 0.0012688388196185; 0.0012983918214284; 0.0013033444225859; 0.001746579573497; 0.0017856981020231; 0.0020089634269714; 0.0021970545999258; 0.0022378309697704; 0.0025122887786423; 0.0027942850562877; 0.0028626589910413; 0.0040785542386402; 0.0044119363017658; 0.0048496385019795; 0.0062748297137782; 0.0063306870511064; 0.006352455154555; 0.007117388576245; 0.0072083035574659; 0.0080075092844381; 0.0082763563641252; 0.0083709650732796; 0.0084568432337518; 0.0091914307650131; 0.0093325514582534; 0.0096630827054915; 0.0098716431177839; 0.0105367304020196; 0.0105367304020196; 0.0123563544259949; 0.0125952576116424; 0.0127059723723765; 0.0160005762734352; 0.0171001534176385; 0.0171001534176385; 0.0203198961621158; 0.0209435845696216; 0.021125667706065; 0.0220705590988414; 0.0280663273380655; 0.0302544192125064; 0.0335408281184641; 0.0368286222044987; 0.0386264970299853; 0.0404707605808569; 0.0493155676939993; 0.0493155676939993; 0.0565343207837806; 0.0623026316541814; 0.0630979595913369; 0.0678022600525665; 0.0700485361084771; 0.0723815120866587; 0.0858871491124922; 0.0897127848630768; 0.0905750994820178; 0.0908772402064694; 0.0967179741949912; 0.0972679220674381; 0.0972679220674381; 0.0972679220674381; 0.0993028790023582; 0.1046638861423046; 0.1110779437709126; 0.1128564106125758; 0.1130019719865939; 0.1206032442301429; 0.1212040226252925; 0.1272255752567765; 0.1343310874911156; 0.1395859646277307; 0.1397055058487397; 0.1401454825042905; 0.1460848784791741; 0.1460848784791741; 0.1460848784791741; 0.1525119847960956; 0.1584804022044084; 0.1687319146389434; 0.1694286967803272; 0.176056923749369; 0.176056923749369; 0.1793722362893728; 0.1812446566929033; 0.1982833830495248; 0.1982833830495248; 0.1982833830495248; 0.2048516463561299; 0.2108300774722888; 0.2140040744036979; 0.2316568843888361; 0.2416367579687983; 0.2520982519141255; 0.2670582190879765; 0.2777403930303475; 0.2823835751171575; 0.2906935310192522; 0.2921843338021302; 0.2972644135001306; 0.3066971380488823; 0.3216879895850248; 0.335302985108383; 0.3540699900993737; 0.3678942528109082; 0.4712571109376817; 0.5557349584201475; 0.5632441764027045,"Marfan Syndrome; Mammary Neoplasms; Juvenile Arthritis; Polyarthritis, Rheumatoid Factor Positive; Seronegative Polyarthritis; Breast Carcinoma; Still Disease; Breast Cancer; Arthritis; Cirrhosis; Diabetic Retinopathy; Diabetic Cardiomyopathy; Nephritis; Liver Cirrhosis; Schizophrenia; Liver Fibrosis",8.921950872070284e-08; 1.1417484002988661e-07; 1.1394948069325325e-05; 1.1394948069325325e-05; 3.928596547519457e-05; 4.971054570440277e-05; 5.1065830658055726e-05; 0.00063387456654884; 0.0015169561374293; 0.007221192915733; 0.064825092293108; 0.0677813934673213; 0.1110148026021272; 0.1273861908316246; 0.175139305620004; 0.2072542702968064,"Lattice corneal dystrophy type I ORPHA:98964; Reis-Bucklers corneal dystrophy ORPHA:98961; Epithelial basement membrane dystrophy ORPHA:98956; Thiel-Behnke corneal dystrophy ORPHA:98960; Granular corneal dystrophy type I ORPHA:98962; Granular corneal dystrophy type II ORPHA:98963; Familial cavitary optic disc anomaly ORPHA:464760; Adenocarcinoma of ovary ORPHA:213504; Congenital plasminogen activator inhibitor type 1 deficiency ORPHA:465; Familial primary localized cutaneous amyloidosis ORPHA:353220; Aneurysm-osteoarthritis syndrome ORPHA:284984; Autosomal recessive brachyolmia ORPHA:448242; Benign recurrent intrahepatic cholestasis type 1 ORPHA:99960; Chondrosarcoma ORPHA:55880; Spondyloepimetaphyseal dysplasia, PAPSS2 type ORPHA:93282; Hemochromatosis type 5 ORPHA:447792; Hereditary arterial and articular multiple calcification syndrome ORPHA:289601; Auriculocondylar syndrome ORPHA:137888; Alagille syndrome due to a NOTCH2 point mutation ORPHA:261629; Fibrodysplasia ossificans progressiva ORPHA:337; Hajdu-Cheney syndrome ORPHA:955; Trichorhinophalangeal syndrome type 2 ORPHA:502; Fetal and neonatal alloimmune thrombocytopenia ORPHA:853; RIN2 syndrome ORPHA:217335; Glaucoma secondary to spherophakia/ectopia lentis and megalocornea ORPHA:238763; Congenital short bowel syndrome ORPHA:2301; Autosomal dominant Emery-Dreifuss muscular dystrophy ORPHA:98853",0.0002132495254484572; 0.0002132495254484572; 0.0002132495254484572; 0.0002132495254484572; 0.0002132495254484572; 0.0002132495254484572; 0.0019696624570933; 0.0133474287859103; 0.0514345493431829; 0.0514345493431829; 0.1927589191138116; 0.1927589191138116; 0.1927589191138116; 0.1927589191138116; 0.1927589191138116; 0.1927589191138116; 0.1927589191138116; 0.1938708167942525; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4878757854606148; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659,Norovirus Hu/GII-4/CGMH20/2009/TW major viral capsid protein (gene: VP1); Norovirus Hu/Norwalk/10074/2009/VNM capsid protein VP1 (gene: VP1); Norovirus Hu/Norwalk/20047/2009/VNM capsid protein VP1 (gene: VP1); Norovirus GII/Hu/JP/2010/GII.P4_GII.4/Shimada/ASC96 VP1 (gene: VP1); Norovirus Hu/GII-4/CBNU2/2007/KR capsid protein; Norovirus Hu/GII.4/Berowra/NSW767L/2012/AU VP1; Norovirus Hu/GII.4/NIHIC11.3/2013/USA capsid protein VP1 (gene: VP1); Norovirus Hu/Norwalk/10247/2009/VNM capsid protein VP1 (gene: VP1); Norovirus Hu/GII-4/CGMH13/2007/TW major viral capsid protein (gene: VP1); Norovirus Hu/GII.4/CHDC4108/1987/US VP1; Norovirus Hu/Norwalk/10051/2009/VNM capsid protein VP1 (gene: VP1); Norovirus Hu/Norwalk/10116/2009/VNM capsid protein VP1 (gene: VP1); Norovirus Hu/Norwalk/10183/2009/VNM capsid protein VP1 (gene: VP1); Norovirus Hu/Norwalk/10236/2009/VNM capsid protein VP1 (gene: VP1); Human calicivirus Hu/NLV/GII/MD145-12/1987/US capsid protein; Lordsdale virus capsid protein (gene: orf2); Norovirus GII/Hu/TW/2012/GII.Pe_GII.4_Sydney2012/Taipei/108 VP1 (gene: VP1); Norovirus GII/Hu/TW/2012/GII.Pe_GII.4_Sydney2012/Taipei/109 VP1 (gene: VP1); Norovirus Hu/GII-4/CGMH23/2010/TW major viral capsid protein (gene: VP1); Norovirus Hu/GII-4/CGMH26/2010/TW major viral capsid protein (gene: VP1); Norovirus Hu/GII-4/CUK-3/2008/KR capsid protein; Norovirus Hu/GII.4/CHDC3967/1988/US VP1; Norovirus Hu/GII.4/GZ2010-L87/Guangzhou/CHN/2011 major viral capsid protein (gene: VP1); Norovirus Hu/Norwalk/10368/2010/VNM capsid protein VP1 (gene: VP1); Norovirus Hu/GII-4/CGMH02/2006/TW major viral capsid protein (gene: VP1); Norovirus Hu/GII-4/CGMH03/2006/TW major viral capsid protein (gene: VP1); Norovirus Hu/GII-4/CGMH04/2006/TW major viral capsid protein (gene: VP1); Norovirus Hu/GII-4/CGMH06/2006/TW major viral capsid protein; Norovirus Hu/GII-4/CGMH07/2006/TW major viral capsid protein (gene: VP1); Norovirus Hu/GII-4/CGMH09/2006/TW major viral capsid protein (gene: VP1); Norovirus Hu/GII-4/CGMH12/2007/TW major viral capsid protein (gene: VP1); Norovirus Hu/GII-4/CGMH17/2007/TW major viral capsid protein (gene: VP1); Norovirus Hu/GII-4/CGMH21/2010/TW major viral capsid protein (gene: VP1); Norovirus Hu/GII-4/CGMH24/2010/TW major viral capsid protein (gene: VP1); Norovirus Hu/GII-4/CGMH25/2010/TW major viral capsid protein (gene: VP1); Norovirus Hu/GII-4/CGMH27/2010/TW major viral capsid protein (gene: VP1); Norovirus Hu/GII.4/Caringbah/NSW409G/2011/AU VP1; Norovirus Hu/GII.4/HS292/2012/USA capsid protein VP1 (gene: VP1); Norovirus Hu/GII.4/NIHIC13/2011/USA capsid protein VP1 (gene: VP1); Norovirus Hu/GII.4/NIHIC18.1/2012/USA capsid protein VP1 (gene: VP1); Norovirus Hu/GII.4/NIHIC27.1/2012/USA capsid protein VP1 (gene: VP1); Norovirus Hu/GII.4/NIHIC28.4/2012/USA capsid protein VP1 (gene: VP1); Norovirus Hu/GII.4/New Orleans/2010/USA VP1; Norovirus Hu/GII.4/SGU-110421/KOR/2011 VP1; Norovirus Hu/GII.4/Sydney/NSW0514/2012/AU VP1; Norovirus Hu/GII/20469/2010/VNM capsid protein VP1 (gene: VP1); Norovirus Hu/GII/BG1C0241-33/2011/BGD capsid protein VP1 (gene: VP1); Norovirus Hu/GII/Seoul1282/KOR/2010 major capsid protein; Norovirus Hu/GII/Seoul1488/KOR/2011 major capsid protein; Norovirus Hu/Norwalk/10325/2010/VNM capsid protein VP1 (gene: VP1); Norovirus Hu/Norwalk/10386/2010/VNM capsid protein VP1 (gene: VP1); Norovirus GII/Hu/JP/2012/GII.Pe_GII.4_Sydney2012/Fukuyama/1 VP1 (gene: VP1); Norovirus GII/Hu/JP/2012/GII.Pe_GII.4_Sydney2012/Fukuyama/2 VP1 (gene: VP1); Norovirus GII/Hu/JP/2012/GII.Pe_GII.4_Sydney2012/Fukuyama/3 VP1 (gene: VP1); Norovirus GII/Hu/JP/2012/GII.Pe_GII.4_Sydney2012/Fukuyama/5 VP1 (gene: VP1); Norovirus Hu/GII-4/CGMH05/2006/TW major viral capsid protein (gene: VP1); Norovirus Hu/GII-4/CGMH08/2006/TW major viral capsid protein (gene: VP1); Norovirus Hu/GII-4/CGMH16/2007/TW major viral capsid protein (gene: VP1); Norovirus Hu/GII.4/Doonside/NSW536I/2011/AU VP1; Norovirus Hu/GII.4/GZ2010-L26/Guangzhou/CHN/2010 major viral capsid protein (gene: VP1); Norovirus Hu/GII.4/Hong Kong/CUHK3630/2012/CHN VP1; Norovirus Hu/GII.4/Jiangsu1/2011/CHN major capsid protein; Norovirus Hu/GII.4/NIHIC2.2/2010/USA capsid protein VP1 (gene: VP1); Norovirus Hu/GII.4/NIHIC2.3/2010/USA capsid protein VP1 (gene: VP1); Norovirus Hu/GII.4/NIHIC27.2/2012/USA capsid protein VP1 (gene: VP1); Norovirus Hu/GII/Shanghai/SH2/2008/CHN VP1; Norovirus Hu/Norwalk/10285/2010/VNM capsid protein VP1 (gene: VP1); Norovirus Hu/Norwalk/10313/2010/VNM capsid protein VP1 (gene: VP1); Norovirus Hu/Norwalk/10378/2010/VNM capsid protein VP1 (gene: VP1); Norovirus Hu/Shanghai/SH5/2009/CHN VP1; Norovirus Hu/GII-4/CGMH11/2006/TW major viral capsid protein; Norovirus Hu/GII-4/CGMH14/2007/TW major viral capsid protein (gene: VP1); Norovirus Hu/GII-4/CGMH15/2007/TW major viral capsid protein; Norovirus Hu/GII.4/20199/2009/VNM capsid protein VP1 (gene: VP1); Norovirus Hu/GII.4/HS288/2012/USA capsid protein VP1 (gene: VP1); Norovirus Hu/GII.4/Hong Kong/CUHK6080/2012/CHN VP1; Norovirus Hu/GII.4/NIHIC17.1/2012/USA capsid protein VP1 (gene: VP1); Norovirus Hu/GII.4/NIHIC17.5/2012/USA capsid protein VP1 (gene: VP1); Norovirus Hu/GII.4/NIHIC17.6/2012/USA capsid protein VP1 (gene: VP1); Norovirus Hu/GII.4/NIHIC17.8/2013/USA capsid protein VP1 (gene: VP1); Norovirus Hu/GII.4/NIHIC17.9/2013/USA capsid protein VP1 (gene: VP1); Norovirus Hu/GII.4/NIHIC28.5/2012/USA capsid protein VP1 (gene: VP1); Norovirus Hu/GII.4/NIHIC35/2013/USA capsid protein VP1 (gene: VP1); Norovirus Hu/GII.4/Ohio/684/USA VP1; Norovirus Hu/GII.4/Rockdale/NSW006D/2009/AU VP1; Norovirus Hu/Norwalk/20123/2009/VNM capsid protein VP1 (gene: VP1); Norovirus Hu/GII-4/CGMH10/2006/TW major viral capsid protein (gene: VP1); Norovirus Hu/GII-4/CGMH22/2010/TW major viral capsid protein (gene: VP1); Norovirus Hu/GII.4/Miranda/NSW850K/2011/AU VP1; Norovirus Hu/Norwalk/20033/2009/VNM capsid protein VP1 (gene: VP1); Norovirus Hu/GII-4/CGMH18/2008/TW major viral capsid protein (gene: VP1); Norovirus Hu/GII-4/CGMH28/2010/TW major viral capsid protein (gene: VP1); Norovirus Hu/GII.4/Guangzhou/GZ2010-L88/CHN/2011 major viral capsid protein; Norovirus Hu/GII.4/Guangzhou/GZ2010-L91/CHN/2011 major viral capsid protein,0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3943583999375712; 0.3943583999375712; 0.3943583999375712; 0.3943583999375712; 0.3964867307280833; 0.3964867307280833; 0.4048700216882856; 0.4048700216882856,Homo sapiens HLMVEC lung microvascular endothelial cell;Homo sapiens blood plasma;In vitro;Saccharomyces cerevisiae,0.35;0.37;0.44;0.61;0.7,Homo sapiens;chemical synthesis;staa8,Homo sapiens;chemical synthesis;hcvco
TICAM1,"Pneumonia; Reperfusion Injury; Virus Diseases; Uveitis; Hepatitis C; Respiratory syncytial virus (RSV) infection in conditions classified elsewhere and of unspecified site; Brain Ischemia; Cerebrovascular accident; Lupus Erythematosus, Systemic; Pancreatic carcinoma; Malignant neoplasm of pancreas; Respiratory Syncytial Virus Infections; Myocarditis; Septicemia; Sepsis; Hepatitis, Alcoholic; Malignant neoplasm of breast; Carcinogenesis; Influenza; Lupus Erythematosus; Herpes Simplex Infections; Lupus Vulgaris; Pneumonia, Bacterial; Heart Failure, Right-Sided; Lupus Erythematosus, Discoid; Celiac Disease; Wheezing; Vitiligo; Endophthalmitis; Herpes encephalitis; Polycythemia Vera; Viral myocarditis; Primary infection NOS; Chagas Disease; Aspergillosis; Pneumoconiosis; Herpetic meningoencephalitis; Bagassosis",7.980856456624717e-16; 4.4398736172867135e-14; 6.332483647919588e-11; 6.429879513246633e-10; 6.991207850982321e-09; 1.452540845894924e-08; 1.8815395768840057e-08; 2.0570601164639797e-08; 6.156981490555128e-08; 6.982287075725826e-08; 1.4925759778299788e-07; 1.946794431045147e-07; 3.880986260207744e-07; 5.254943571583271e-07; 5.313225371508493e-07; 7.789160940651547e-07; 8.660170029731726e-07; 1.51758575162775e-06; 2.027389637151193e-06; 1.4805035395703202e-05; 2.1109857936882128e-05; 4.1934338365676246e-05; 6.758558746827128e-05; 7.358523784131203e-05; 8.133563964016694e-05; 8.730297037328594e-05; 0.00022618385822819267; 0.0002933384035122236; 0.0015698089771612; 0.0017731038420892; 0.0025118094772522; 0.0037244768508078; 0.0066401895279317; 0.010624513163997; 0.0138441633831498; 0.0259817880808067; 0.0897127848630768; 0.1460848784791741,Breast Cancer; Vitiligo,0.00063387456654884; 0.1231709853772602,Systemic-onset juvenile idiopathic arthritis ORPHA:85414; Hypohidrotic ectodermal dysplasia with immunodeficiency ORPHA:98813; Pediatric systemic lupus erythematosus ORPHA:93552; Herpes simplex virus encephalitis ORPHA:1930; NIK deficiency ORPHA:447731; Camurati-Engelmann disease ORPHA:1328; Deficiency in anterior pituitary function-variable immunodeficiency syndrome ORPHA:293978; FTH1-related iron overload ORPHA:247790; Infantile inflammatory bowel disease with neurological involvement ORPHA:565788; B4GALT1-CDG ORPHA:79332; Palmoplantar keratoderma-esophageal carcinoma syndrome ORPHA:2198; Solitary fibrous tumor/hemangiopericytoma ORPHA:2126; CLN11 disease ORPHA:314629; Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations ORPHA:247691; Hypocalcemic vitamin D-resistant rickets ORPHA:93160; Dysosteosclerosis ORPHA:1782; Autosomal dominant Charcot-Marie-Tooth disease type 2B ORPHA:99936; Mucolipidosis type IV ORPHA:578; NON RARE IN EUROPE: Parkinson disease ORPHA:319705; Neutral lipid storage myopathy ORPHA:98908; CLN2 disease ORPHA:228349; Carnitine palmitoyl transferase 1A deficiency ORPHA:156; Cathepsin A-related arteriopathy-strokes-leukoencephalopathy ORPHA:575553; Childhood-onset autosomal recessive slowly progressive spinocerebellar ataxia ORPHA:284324; Polyglucosan body myopathy type 1 ORPHA:397937; Progressive autosomal recessive ataxia-deafness syndrome ORPHA:448251; Embryonal rhabdomyosarcoma ORPHA:99757; Fetal Gaucher disease ORPHA:85212; Triglyceride deposit cardiomyovasculopathy ORPHA:565612; Galactosialidosis ORPHA:351; Gaucher disease type 2 ORPHA:77260; Gaucher disease type 3 ORPHA:77261; Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome ORPHA:2072; RELA fusion-positive ependymoma ORPHA:530792; Ependymoma ORPHA:251636; Multiple endocrine neoplasia type 1 ORPHA:652,1.514756890441811e-09; 3.295782224790152e-05; 0.00021965881189185; 0.00024116799717032887; 0.0514345493431829; 0.0514345493431829; 0.0514345493431829; 0.0514345493431829; 0.0514345493431829; 0.1927589191138116; 0.1927589191138116; 0.1927589191138116; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659,Hepatitis C virus subtype 1a NS5B RNA-dependent RNA polymerase; Hepacivirus C NS5B RNA-dependent RNA polymerase; Hepacivirus C NS2 protein; Hepacivirus C p7 protein; Hepacivirus C NS5A protein; Hepacivirus C E2 protein; Hepacivirus C NS3 protease/helicase; Hepacivirus C E1 protein; Hepatitis C virus subtype 1a NS3 protease/helicase,0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946,,,,
TMEM88,Neoplasm Metastasis; Malignant neoplasm of lung; Malignant neoplasm of breast; Carcinoma of lung; Primary malignant neoplasm of lung; Breast Carcinoma; Secondary malignant neoplasm of lymph node; Primary malignant neoplasm; Malignant Neoplasms; Triple Negative Breast Neoplasms; Body Height,5.670785186683756e-09; 6.299208964864026e-07; 8.660170029731726e-07; 2.027389637151193e-06; 4.839188317483647e-06; 5.381279306135013e-06; 0.000323910443746482; 0.00046565119871267287; 0.0006352060750206054; 0.0302544192125064; 0.8931918360637839,,,Beckwith-Wiedemann syndrome due to CDKN1C mutation ORPHA:231120; Intrauterine growth restriction-short stature-early adult-onset diabetes syndrome ORPHA:436144,0.4838060079820406; 0.4838060079820406,,,,,,
TNF,"Inflammation; Pneumonia; Reperfusion Injury; Asthma; Psoriasis; Juvenile arthritis; Lymphoma; Multiple Myeloma; Virus Diseases; Dermatitis, Atopic; Lung diseases; Lobar Pneumonia; Neutrophilia (disorder); Chronic Obstructive Airway Disease; Synovitis; Rheumatoid Arthritis; Thyroid associated opthalmopathies; Arteriosclerosis; Brain Injuries, Focal; Injuries, Acute Brain; Brain Injuries; Brain Lacerations; Pneumonitis; Non-Small Cell Lung Carcinoma; Crohn Disease; Autoimmune Diseases; Peritonitis; Uveitis; Ovarian Carcinoma; Sarcoidosis; Endometriosis; cervical cancer; Arsenic Poisoning, Inorganic; Nervous System, Organic Arsenic Poisoning; Arsenic Encephalopathy; Arsenic Induced Polyneuropathy; Arsenic Poisoning; Cirrhosis; MYELOPROLIFERATIVE DISORDER, CHRONIC, WITH EOSINOPHILIA; Ulcerative Colitis; Infection; Malignant neoplasm of ovary; Colitis; Pancreatitis, Chronic; Tumor Angiogenesis; Malignant tumor of cervix; Dermatitis; Lung Neoplasms; Multiple Sclerosis; Cerebral Ischemia; Neoplasm Metastasis; Experimental Lung Inflammation; Mammary Neoplasms, Human; Inflammatory dermatosis; Hodgkin Disease; Hepatitis C; Atherosclerosis; Pulmonary Fibrosis; Acute pancreatitis; Graves Disease; Leukemia, Myelocytic, Acute; Anti-Basement Membrane Glomerulonephritis; Glomerulonephritis; Hypertensive disease; Liver Cirrhosis; Respiratory syncytial virus (RSV) infection in conditions classified elsewhere and of unspecified site; Vascular Diseases; Eczema; Cervix carcinoma; Arthritis; Infection caused by Helicobacter pylori; Brain Ischemia; Cerebrovascular accident; Degenerative polyarthritis; Respiratory Distress Syndrome, Adult; Allergic Reaction; Inflammatory Bowel Diseases; Obesity; Psoriasiform eczema; Auricular swelling; Kaposi Sarcoma; Periodontitis; Hyperglycemia; Liver neoplasms; HIV Infections; Mammary Neoplasms; Arthritis, Psoriatic; Aortic Aneurysm, Abdominal; Bright Disease; Glioblastoma; leukemia; Diabetes Mellitus; Juvenile rheumatoid arthritis; Leishmaniasis, Cutaneous; Diabetes; Lupus Erythematosus, Systemic; Ischemic stroke; Pancreatic carcinoma; Coronary Artery Disease; Dermatologic disorders; Coronary heart disease; Alzheimer's Disease; Behcet Syndrome; Sjogren's Syndrome; Dermatitis, Allergic Contact; Malaria; Encephalitis; Spondylarthropathies; Glioma; Epithelial ovarian cancer; Escherichia coli Infections; Malignant neoplasm of pancreas; Van der Woude syndrome; Pain; Cerebral abscess; Acquired Immunodeficiency Syndrome; Respiratory Syncytial Virus Infections; Malignant neoplasm of mouth; Hamman-Rich syndrome; Inflammatory disorder; Myocardial Infarction; Infarction, Middle Cerebral Artery; Cerebral Infarction; Hepatitis C, Chronic; Adult T-Cell Lymphoma/Leukemia; Brain Abscess; Glossitis, Benign Migratory; Anoxia; Myocardial Ischemia; Bronchiolitis Obliterans; Diffuse Large B-Cell Lymphoma; Myocarditis; Brain Neoplasms; Sciatic Neuropathy; Gastric ulcer; Pneumococcal Infections; Cardiovascular Diseases; Septicemia; Sepsis; Cystic Fibrosis; Peptic Esophagitis; Malignant neoplasm of lung; Fibroid Tumor; Restenosis; Tuberculosis; Leukemia, T-Cell; Middle Cerebral Artery Occlusion; Neonatal Early-Onset Sepsis; Diabetes Mellitus, Insulin-Dependent; Liver diseases; Hepatitis, Alcoholic; Severe Sepsis; Chronic Lymphocytic Leukemia; Measles; Tumor Progression; Spondylarthritis; Thromboangiitis Obliterans; Dryness of eye; Malignant neoplasm of breast; Myasthenia Gravis; Premature Obstetric Labor; Cytomegalovirus Infections; Gastritis; Bladder Neoplasm; Coronary Arteriosclerosis; Graft-vs-Host Disease; Diabetic Nephropathy; Systemic Scleroderma; Other specified forms of pleural effusion, except tuberculous; Hypersensitivity; Anemia, Sickle Cell; Osteitis Deformans; Liver carcinoma; Dementia, Vascular; Colonic Neoplasms; Immunologic Deficiency Syndromes; Carcinogenesis; Nasopharyngeal carcinoma; Transient Ischemic Attack; Lung Diseases, Interstitial; Endometrial Neoplasms; Malignant neoplasm of vulva; Hyperalgesia, Secondary; Allodynia; Diffuse cutaneous leishmaniasis; Influenza; Carcinoma of lung; Stomach Carcinoma; Hyperalgesia, Primary; Polycystic Ovary Syndrome; Ankylosing spondylitis; B-Cell Lymphomas; Colon Carcinoma; Leishmaniasis, Visceral; Idiopathic pulmonary arterial hypertension; Fibrosarcoma; Shock, Hemorrhagic; Disorder characterized by fever; Malignant neoplasm of stomach; Immune System Diseases; Osteosarcoma of bone; Lip and Oral Cavity Carcinoma; Astrocytoma; Dry Eye Syndromes; Tactile Allodynia; Bone Diseases; Lupus Nephritis; Kidney Failure, Acute; Lymphoma, T-Cell, Cutaneous; Stomach Neoplasms; Tuberculosis, Pulmonary; Chronic liver disease; Erythema Chronicum Migrans; inflammatory joint disease; melanoma; Tauopathies; Dermatomyositis, Childhood Type; Fever; Primary malignant neoplasm of lung; Bronchiolitis; Breast Carcinoma; Idiopathic Inflammatory Myopathies; Meningococcal Infections; Pustulosis of Palms and Soles; Mycoses; Dermatitis, Irritant; Alveolitis; Urban cutaneous leishmaniasis; Polymyositis; Osteosarcoma; Bacterial Infections; Secondary malignant neoplasm of bone; Thyroid carcinoma; Angina, Unstable; Acute anterior uveitis; Malignant mesothelioma; Liver Cirrhosis, Experimental; Delirium; Leprosy; M5b Acute differentiated monocytic leukemia; Epstein-Barr Virus Infections; Guillain-Barre Syndrome; Sarcoidosis, Pulmonary; Obstructive nephropathy; Familial Alzheimer Disease (FAD); Hepatitis B, Chronic; Tumor Promotion; Mechanical Allodynia; Small cell carcinoma of lung; Encephalomyelitis; Hyperalgesia, Thermal; Stable angina; Acute Promyelocytic Leukemia; Acute lymphocytic leukemia; Leishmaniasis, New World; Aspiration Pneumonia; Complicated pneumoconiosis; Anterior uveitis; MYELODYSPLASTIC SYNDROME; Retinal Diseases; Colorectal Neoplasms; Allergic asthma; Pleural Effusion, Malignant; Acute monocytic leukemia; Bronchial Hyperreactivity; Diabetic Retinopathy; Sezary Syndrome; Cachexia; Diabetes Mellitus, Experimental; Streptozotocin Diabetes; Alloxan Diabetes; Senile Plaques; Hepatitis B; Active tuberculosis; Candidiasis; Agranulocytosis; Extrinsic allergic alveolitis; Aplastic Anemia; Lupus Erythematosus; Presenile dementia; Lymphohistiocytosis, Hemophagocytic; Rabies (disorder); Prostate carcinoma; Adenocarcinoma; Malignant tumor of colon; Vascular lesions; Polymorphous light eruption; Idiopathic crescentic glomerulonephritis; Anthracosis; Acute Coronary Syndrome; Hyperalgesia; ovarian neoplasm; Eosinophilic disorder; Nephritis; Nonalcoholic Steatohepatitis; Myeloid Leukemia; Allergic rhinitis (disorder); Kidney Failure, Chronic; Prostatic Neoplasms; Severe Acute Respiratory Syndrome; Herpes Simplex Infections; Atherogenesis; Acute GVH disease; Contact Dermatitis; Fibrosis; Hypotension; Chorioamnionitis; Granulocytosis; Chronic kidney disease stage 5; Coinfection; Anemia of chronic disease; Chronic Airflow Obstruction; Squamous cell carcinoma; Malignant neoplasm of prostate; Hepatitis, Autoimmune; Endometrial adenocarcinoma; Meningitis; Malignant neoplasm of urinary bladder; Pancreatic Neoplasm; Parkinson Disease; Autoimmune thyroiditis; Sleep Apnea, Obstructive; precancerous lesions; Leukemia, Large Granular Lymphocytic; Carcinoma of bladder; Experimental Organism Basal Cell Carcinoma; Tumor Immunity; Endometrioma; Lupus Vulgaris; Malignant Head and Neck Neoplasm; Vasculitis; Lichen Sclerosus et Atrophicus; Lymphoma, Non-Hodgkin; Viral respiratory infection; Periodontal Diseases; Uterine Fibroids; Systemic Inflammatory Response Syndrome; Stress, Psychological; Thyroid Diseases; Eosinophilia; Hashimoto Disease; IGA Glomerulonephritis; Rhinitis; Childhood Glioblastoma; Bacterial Vaginosis; Painful Bladder Syndrome; Heat Stroke; Proliferative vitreoretinopathy; Polymyositis, Idiopathic; Chronic Alcoholic Hepatitis; Polymyositis Ossificans; Adult Glioblastoma; Cardiomyopathy, Dilated; Myositis; Hematologic Neoplasms; Hematopoietic Neoplasms; Enterovirus Infections; Research-Related Injuries; Traumatic injury; Wounds and Injuries; Injury wounds; Peri-Implantitis; Spinal Cord Diseases; Histiocytosis, Langerhans-Cell; Diabetic Angiopathies; Biliary Atresia; Acute myocardial infarction; Heart Failure, Right-Sided; Chronic graft-versus-host disease; TNF receptor-associated periodic fever syndrome (TRAPS); Duodenal Ulcer; Amebic colitis; Constitutional Symptom; Lupus Erythematosus, Discoid; Carcinoma, Lewis Lung; Primary Sj??gren's syndrome; Pulmonary Hypertension; Congestive heart failure; Malignant Glioma; Other ureteric obstruction; Malignant neoplasm of liver; Celiac Disease; Familial lichen amyloidosis; Arthritis by pattern of joint involvement; HIV Wasting Syndrome; Osteoporosis; Adult-Onset Still Disease; Helicobacter-associated gastritis; Latent Tuberculosis; Lung Injury; pathologic fistula; Other specified transient cerebral ischemias; Idiopathic Pulmonary Fibrosis; Bronchiectasis; Infectious disease of lung; Mucocutaneous Lymph Node Syndrome; Chronic Kidney Diseases; Acquired aplastic anemia; CARCINOMA OF VULVA; Malignant Pleural Mesothelioma; Mitral Valve Stenosis; Unipolar Depression; Age related macular degeneration; Mesothelioma; Dermatomyositis; Gingival Diseases; Neurodegenerative Disorders; Cardiomegaly; Renal Cell Carcinoma; Alzheimer Disease, Early Onset; Systemic candidiasis; Acute periodontitis; Infiltrating Cervical Carcinoma; Multiple Sclerosis, Relapsing-Remitting; Cardiac Hypertrophy; Cerebral arterial aneurysm; Peripheral Vascular Diseases; Pancreatitis; Stomatitis; Intestinal Graft Versus Host Disease; Nephropathia Epidemica; Solid Neoplasm; Endometrial Carcinoma; Adenocarcinoma of lung (disorder); VITILIGO-ASSOCIATED MULTIPLE AUTOIMMUNE DISEASE SUSCEPTIBILITY 1 (finding); Classical Hodgkin's Lymphoma; Peptic Ulcer; Carcinoma, Transitional Cell; Nasal Polyps; Retinoblastoma; Status Epilepticus; Colorectal Carcinoma; Diabetes Mellitus, Non-Insulin-Dependent; Fibrosis, Liver; Encephalitis, St. Louis; Uterine Cervical Neoplasm; Invasive Pulmonary Aspergillosis; Metabolic Syndrome X; Pancreatic Ductal Adenocarcinoma; Pulmonary Emphysema; Pain, Crushing; Pain, Migratory; Pain, Splitting; Suffering, Physical; Ache; Radiating pain; Seronegative rheumatoid arthritis; Luft Disease; Majeed syndrome; Megaconial Myopathies; Pleoconial Myopathies; Alcoholic Liver Diseases; Demyelinating Diseases; Gastritis, Atrophic; Malaria, Cerebral; Chronic gastritis; Tuberculosis, Meningeal; Acne Vulgaris; Dermatitis Herpetiformis; Adult type dermatomyositis; Metastatic melanoma; Myeloid Leukemia, Chronic; Pain, Burning; Neutropenia; Esophageal Neoplasms; Chronic Lung Injury; Scleroderma; Anemia; Kidney Diseases; Myocardial Diseases, Secondary; Wheezing; Neoplasms; Plaque, Amyloid; Schnitzler Syndrome; Burn injury; Osteitis; Lymphoma, Follicular; Acute Cerebrovascular Accidents; Kidney Failure; Ulcer; Cystitis; Gastrointestinal Diseases; Cardiomyopathies, Primary; Leukemogenesis; Allergic disposition; Heart failure; Liver Cirrhosis, Alcoholic; Chondrosarcoma; Trachoma; Community acquired pneumonia; Keratoconjunctivitis Sicca; Respiratory Distress Syndrome, Newborn; Carotid Artery Diseases; airway disease; Precursor B-cell lymphoblastic leukemia; Vitiligo; Sarcoma; Dementia; Severe Dengue; Silicosis; Ear Inflammation; Hyperoxia; Central neuroblastoma; Secondary malignant neoplasm of lymph node; Alopecia Areata; Major Depressive Disorder; Amyloidosis; Aggressive periodontitis, generalized; Acute colitis; Drug-Induced Liver Disease; Epithelial hyperplasia of skin; Colorectal Cancer; Radiation Injuries, Experimental; Congenital laryngeal adductor palsy; Coprophilia (disorder); Hospital acquired pneumonia; Idiopathic urticaria; Pseudorabies; Hemolytic-Uremic Syndrome; Hepatitis; Hypertension, Portal; Skin Neoplasms; Squamous cell carcinoma of the head and neck; Secondary malignant neoplasm of lung; Invasive carcinoma of breast; Urothelial Carcinoma; Monocytic leukemia; Chronic Periodontitis; Heart Decompensation; Albuminuria; Corneal Ulcer; Periapical Periodontitis; Pleural Tuberculosis; Adrenoleukodystrophy; Esophagitis; Neuroblastoma; Primary malignant neoplasm; Heart Diseases; Carcinoma breast stage IV; Infective endocarditis; Secondary Trigeminal Neuralgia; Trigeminal Neuralgia, Idiopathic; Pre-Eclampsia; Myeloproliferative disease; Congenital arteriovenous malformation; Precursor Cell Lymphoblastic Leukemia Lymphoma; Osteopenia; Primary biliary cirrhosis; Refractory anemias; Joint swelling; Parasitemia; Focal glomerulosclerosis; Myocardial Failure; Squamous intraepithelial lesion; Oestrogen deficiency; Paranoid Schizophrenia; Autoinflammatory Syndrome; Mucocutaneous leishmaniasis; Post-Traumatic Stress Disorder; Malignant Neoplasms; Diabetes, Autoimmune; Bacterial Endocarditis; Leukoplakia, Oral; Skin Erosion; Severe Combined Immunodeficiency; Infant, Premature; Septic Shock; Arteriovenous hemangioma; Infectious Mononucleosis; Familial cold urticaria; Left ventricular systolic dysfunction; Leptospirosis; Pulmonary Pathology; West Nile viral infection; Carcinoma, Cribriform; Carcinoma, Granular Cell; Keratitis; Necrotizing enterocolitis in fetus OR newborn; Irritable Bowel Syndrome; Adenocarcinoma, Basal Cell; AIDS Dementia Complex; Severe periodontitis; Balkan Nephropathy; Q Fever; Reactive hypoglycemia; Giant Cell Arteritis; Premature Birth; Gastrointestinal mucositis; Amyotrophic Lateral Sclerosis; Malignant neoplasm of thyroid; Adenocarcinoma, Oxyphilic; Sicca Syndrome; Pulmonary Edema; Secondary malignant neoplasm of liver; Colitis, Collagenous; SPONDYLOCARPOTARSAL SYNOSTOSIS SYNDROME; Zollinger-Ellison syndrome; Erythema Multiforme; Nasal allergies; Pediatric Crohn's disease; Pulmonary Cystic Fibrosis; CNS disorder; Tumor Initiation; Carcinoma of larynx; Dengue Fever; Adenocarcinoma, Tubular; Arthropathy; Adenocarcinoma Of Esophagus; Leprosy, Lepromatous; Toxic Shock Syndrome; Endometriosis of uterus; HELLP Syndrome; Left-Sided Heart Failure; Chronic Q Fever; Cryptosporidiosis; Interstitial lung fibrosis; Hypercholesterolemia; Epilepsy, Temporal Lobe; Precancerous Conditions; tumor vasculature; bone destruction; Hepatitis, Chronic; Neoplasm Invasiveness; Lyme Disease; Situs Inversus; Anhydrotic Ectodermal Dysplasias; Pseudohyperkalemia Cardiff; Alzheimer's Disease, Focal Onset; Acute Confusional Senile Dementia; Kidney Neoplasm; Autoimmune thyroid disease; Post MI; Thyroid Gland Follicular Adenoma; Alcoholic Steatohepatitis; stage, gastric cancer; Corneal pannus; Destructive Arthritis; Early onset periodontitis; Endophthalmitis; Idiopathic Nephrotic Syndrome; Pouchitis; DOSAGE-SENSITIVE SEX REVERSAL; Iron Overload; Alzheimer Disease, Late Onset; Lymphopenia; Malaria, Falciparum; Cerebral Palsy; Metastatic Neoplasm; Cervical Squamous Intraepithelial Neoplasia; Huntington Disease; Rheumatoid Nodule; Cryopyrin-Associated Periodic Syndromes; Herpes encephalitis; Otitis Media with Effusion; Periapical Granuloma; Pleurisy; Polymyalgia Rheumatica; Skin carcinoma; Periodontitis, Juvenile; Adenovirus Infections; Disseminated Malignant Neoplasm; Hepatitis, Toxic; Chemical and Drug Induced Liver Injury; Chemically-Induced Liver Toxicity; Drug-Induced Acute Liver Injury; Dejerine-Sottas Disease (disorder); Shock; Mycosis Fungoides; Lymphocytic infiltration; Thyroid Neoplasm; Hepatitis, Drug-Induced; Osteoarthritis, Knee; Subarachnoid Hemorrhage; Endothelial dysfunction; Male infertility; AMYOTROPHIC LATERAL SCLEROSIS 1; Cardiomyopathies; Cardiac Arrest; Renal fibrosis; Rheumatism; Typhoid Fever; Hemorrhagic Fever with Renal Syndrome; Cerebral Aneurysm; IMMUNE SUPPRESSION; Osteoporosis, Postmenopausal; Papillary thyroid carcinoma; Thrombosis; Hypercalcemia; Staphylococcal toxic shock syndrome; Mild cognitive disorder; Oral Cavity Carcinoma; Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma; Pneumocystis jiroveci pneumonia; Aneurysm; Human T-cell lymphotrophic virus, type I [HTLV-I]; Type II Mucolipidosis; Hepatic Veno-Occlusive Disease; Pyemia; Metabolic Diseases; Hyperlipoproteinemia Type IIa; Otitis Media; Renal carcinoma; Mycoplasma Infections; Essential Hypertension; Hypercholesterolemia, Familial; Actinic prurigo; Cervical lymphadenitis; Cowpox; Lesion of stomach; Lymphoproliferative Disorders; SVEINSSON CHORIORETINAL ATROPHY; Acne; AA amyloidosis; Generalized pustular psoriasis; Human anaplasmosis due to Anaplasma phagocytophilum; Melioidosis; Malignant neoplasm of esophagus; Subfertility, Male; Bullous pemphigoid; Hemorrhagic Fever, Ebola; Appendicitis; Cryoglobulinemia; Extramedullary Hematopoiesis (disorder); Localized scleroderma; Atrial Premature Complexes; Hairy Cell Leukemia; Head and Neck Neoplasms; Reticulosarcoma; Viral myocarditis; Rat Insulinoma; androgen independent prostate cancer; Bulbo-Spinal Atrophy, X-Linked; Lichen Planus, Oral; Brain Edema; Iron deficiency; Lymphangioleiomyomatosis; Necrotizing Enterocolitis; Bronchiolitis Obliterans Organizing Pneumonia; Childhood Acute Lymphoblastic Leukemia; Fatty Liver; Liver and Intrahepatic Biliary Tract Carcinoma; Retinopathy of Prematurity; Febrile Convulsions; Ki-1+ Anaplastic Large Cell Lymphoma; Plasmacytoma; Asbestosis; Autoinflammatory disorder; Ileitis; Muckle-Wells Syndrome; Hepatocarcinogenesis; Progressive Neoplastic Disease; Glomerulosclerosis (disorder); Choriocarcinoma; Hereditary Diffuse Gastric Cancer; Progressive cGVHD; Hyperlipidemia; Christ-Siemens-Touraine syndrome; Fasting Hypoglycemia; gastritis h pylori; Urticaria; Intracranial Aneurysm; Chronic myeloproliferative disorder; Promyelocytic leukemia; Gestational Diabetes; Leishmaniasis; Uveal melanoma; Major depression, single episode; HIV Encephalopathy; Reflux nephropathy (disorder); PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS; Vasogenic Brain Edema; Vasogenic Cerebral Edema; Boutonneuse Fever; Cytotoxic Brain Edema; Cytotoxic Cerebral Edema; Histoplasmosis; Non-obstructive reflux-associated chronic pyelonephritis (disorder); Pleural Mesothelioma; Hyperhomocysteinemia; Overweight; Hepatolenticular Degeneration; Subacute Sclerosing Panencephalitis; HIV encephalitis; Anaplastic thyroid carcinoma; Liver Failure, Acute; Cardiomyopathy, Familial Idiopathic; Juvenile Myelomonocytic Leukemia; Trigeminal Neuralgia; Peripheral T-Cell Lymphoma; Nephrotic Syndrome; Arthritis, Bacterial; Rhegmatogenous retinal detachment; Severe Bronchopulmonary Dysplasia; Hypoxia-Ischemia, Brain; Venous retinal branch occlusion; Collagen-vascular disease; Cytomegalovirus Retinitis; Hemorrhagic cystitis; Preterm Premature Rupture of Fetal Membranes; Immune thrombocytopenic purpura; Chronic heart failure; Marginal Zone B-Cell Lymphoma; Squamous cell carcinoma of esophagus; Adrenocortical carcinoma; HTLV-I Infections; Malignant Fibrous Histiocytoma; Proliferative diabetic retinopathy; Childhood asthma; Bipolar Disorder; Machado-Joseph Disease; Primary infection NOS; Steatohepatitis; Avellino corneal dystrophy; Muscular Dystrophy, Duchenne; Acute otitis media; Arthus Reaction; Chronic idiopathic neutropenia; Chronic skin ulcer; Infection by Leishmania braziliensis; Leukostasis; Primary bacterial peritonitis; Sudden infant death syndrome; Abscess; Bone Marrow Diseases; Brucellosis; Acute leukemia; Non-alcoholic Fatty Liver Disease; Hepatitis A; Arthritis, Reactive; Salmonella infections; End Stage Liver Disease; Renal Insufficiency; Skin Carcinogenesis; Connective Tissue Diseases; Insulin Resistance; Tropical Spastic Paraparesis; Low Grade Lymphoma (neoplasm); Thrombocytopenia; Vascular System Injuries; Burning Mouth Syndrome; HIV-Associated Lipodystrophy Syndrome; Immune reconstitution inflammatory syndrome [IRIS]; Inflammatory polyarthritis; Pigmented villonodular synovitis; Postherpetic neuralgia; Amyotrophic Lateral Sclerosis, Sporadic; Melanoma, B16; Medulloblastoma; Carcinoma, Neuroendocrine; Hay fever; Aspirin exacerbated respiratory disease; Polyglandular Type I Autoimmune Syndrome; Hamartoma Syndrome, Multiple; Psoriasis vulgaris; Esophageal carcinoma; Recurrent tumor; Nephrotic Syndrome, Minimal Change; Schizophrenia; Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse; Diabetic Neuropathies; Herpes NOS; Thymoma; Cervical Intraepithelial Neoplasia; Arthritis, Infectious; Small Fiber Neuropathy; Myasthenia Gravis, Ocular; Infarction; Vascular inflammations; Ewings sarcoma-primitive neuroectodermal tumor (PNET); Hernia; Oligoarticular Juvenile Idiopathic Arthritis; Visual seizure; Retroviridae Infections; intracranial glioma; Pheochromocytoma; Frontotemporal dementia; Meningioma; Chagas Disease; Japanese Encephalitis; Depressive Symptoms; Trophoblastic Neoplasms; American cutaneous leishmaniasis; Autoinflammatory disease; Beryllium Disease; Morphea; Lymphoid leukemia; Hyperactive behavior; gallbladder neoplasm; Infectious Otitis Media; Lipoatrophy; Atrial Fibrillation; Monoclonal Gammopathy of Undetermined Significance; Adenocarcinoma of prostate; Thrombus; Cutaneous Mastocytosis; Myelodysplasia; Cardiopulmonary Arrest; Coronary Occlusion; Deficiency of mevalonate kinase; Manganese Poisoning; Mastitis-metritis-agalactia syndrome; Oral Mucositis; Radiation Damage; Conventional (Clear Cell) Renal Cell Carcinoma; Renal cyst; Agenesis; Limb ischemia; Membranous glomerulonephritis; Invasive Carcinoma; Retinal Detachment; Steroid Sulfatase Deficiency Disease; Idiopathic pulmonary hypertension; Malnutrition; Intracranial Hemorrhages; Polyarthritis; Bacterial sepsis; Frontotemporal Lobar Degeneration; Chronic inflammatory disorder; Fibromyalgia; Microscopic Polyarteritis; Tardive Dyskinesia; Drug-induced tardive dyskinesia; Sacroiliitis; Skin Manifestations; Malignant melanoma, metastatic; Steroid-sensitive nephrotic syndrome; Disease caused by Shigella dysenteriae; Malignant neoplasm of skin; Metastatic malignant neoplasm to brain; Hippocampal sclerosis; Non-arthropod borne lymphocytic choriomeningitis; Parasitic Diseases; Down Syndrome; Ichthyosis, X-Linked; Adenomatous Polyposis Coli; Thrombocytopenia due to platelet alloimmunization; Anxiety neurosis (finding); Glioblastoma Multiforme; Hereditary hemochromatosis; Leukoencephalopathy, Progressive Multifocal; Schistosomiasis mansoni; Anxiety state; Central Nervous System Infection; Ileal Diseases; Meningoencephalitis; Anxiety Disorders; Hemophilia, NOS; Cholestasis; Complete atrioventricular block; Dental caries; Gingivitis; Hypocholesterolemia; Insulin Sensitivity; Lymphocytic Choriomeningitis; Refractory anemia with excess blasts in transformation (clinical); Canarypox (disorder); Compression of spinal cord; Congenital bilateral aplasia of vas deferens; Infection by Candida albicans; Pleural Diseases; Pulpitis; Adenoviral infections; Autoimmune arthritis; Caries (morphologic abnormality); Familial Mediterranean Fever; Barrett Esophagus; Ameloblastoma; Necrosis; Leukopenia; T-Cell Lymphoma; Burkitt Lymphoma; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Liver Failure; Mucosa-Associated Lymphoid Tissue Lymphoma; Heart valve disease; Somnolence; Cavitation; Endocarditis; Eosinophilic leukemia; Pyoderma Gangrenosum; FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder); Brain Diseases; Diarrhea; Erythema; AICARDI-GOUTIERES SYNDROME 1; Head and Neck Carcinoma; AURAL ATRESIA, CONGENITAL; Fatty Liver, Alcoholic; Rift Valley Fever; Acral pseudolymphomatous angiokeratoma of children (APACHE); Autoimmune liver disease; Cholestasis, Extrahepatic; Malignant neoplasm of kidney; Leukemia, B-Cell; Regurgitation; Respiratory Hypersensitivity; Disruptive, Impulse Control, and Conduct Disorders; Leukomalacia, Periventricular; SMITH-MCCORT DYSPLASIA 1; Primary HIV infection; Rheumatic Fever; Bronchopulmonary Dysplasia; Malignant neoplasm of gastrointestinal tract; Polyp of large intestine; Rosacea; Pneumoconiosis; Hyperplasia; Adenocarcinoma of colon; Memory impairment; Shigella Infections; Lupus Erythematosus, Subacute Cutaneous; Tumor Necrosis Factor Receptor 1-Associated Periodic Syndrome; Cholesteatoma; Chronic glomerulonephritis; Enthesitis-Related Arthritis; Granuloma; Peripheral Arterial Diseases; Toxic Epidermal Necrolysis; Renal glomerular disease; Tuberous Sclerosis; CONSTRICTING BANDS, CONGENITAL; Arthralgia; Triple Negative Breast Neoplasms; Simple Partial Status Epilepticus; Status Epilepticus, Subclinical; Complex Partial Status Epilepticus; Diphtheria; Grand Mal Status Epilepticus; hiv-infection/aids; Non-Convulsive Status Epilepticus; Aortic Valve Stenosis; Anemia, Diamond-Blackfan; Philadelphia chromosome-positive acute lymphoblastic leukemia; Cancer of Digestive System; Hepatic Form of Wilson Disease; Cholangiocarcinoma; Familial primary gastric lymphoma; PACHYONYCHIA CONGENITA 3; Squamous cell carcinoma of lung; Malaria, Vivax; MUTYH-Associate Polyposis; Neuropathy; Streptococcal Infections; Fluid overload; Anxiety; Fanconi Anemia; Hyperinsulinism; Autoimmune thrombocytopenia; Petit mal status; Seborrheic keratosis; Pain, Postoperative; Anasarca; Aphthous Stomatitis; Chronic colitis; Familial Hypophosphatemic Rickets; Superficial ulcer; Craniosynostosis; Crohn's disease of large bowel; Gastric Adenocarcinoma; Lymphatic Metastasis; Alopecia; Dyslipidemias; Adenocarcinoma of large intestine; alpha-1-Antitrypsin Deficiency, Autosomal Recessive; Alveolar Bone Loss; Collagen Diseases; Epithelioma; Autism Spectrum Disorders; Cutaneous Melanoma; Neoplasm, Residual; Recurrent aphthous ulcer; Hemorrhagic Fevers, Viral; Stomach Diseases; Hypergammaglobulinemia; Neoplasms, Experimental; Glaucoma, Primary Open Angle; Prediabetes syndrome; Histiocytic sarcoma; Intervertebral disc disorder; Opportunistic Infections; Oral Ulcer; HIV-1 infection; Exanthema; Rhabdomyosarcoma; Peripheral Neuropathy; Soft Tissue Neoplasms; Chronic sinusitis; Hemochromatosis; Mitochondrial Myopathies; African Trypanosomiasis; Cardiovascular morbidity; Iron deficiency anemia; Oropharyngeal disorders; Periodic Fever Syndrome; Lesion of brain; Squamous cell carcinoma of tongue; Primary Effusion Lymphoma; Headache; Pneumonia, Interstitial; Central Diabetes Insipidus; Fulminant hepatitis; Gastric Mucosa-Associated Lymphoid Tissue Lymphoma; Metabolic Bone Disorder; Pemphigus; Icterus; Metastasis from malignant tumor of prostate; Gallbladder Carcinoma; Chordoma; Sarcoma, Spindle Cell; Anastomosis; Hypertriglyceridemia; Hepatoblastoma; Acute Kidney Insufficiency; Hemophilia A; Turner Syndrome; Impaired glucose tolerance; Hepatitis E; Acute kidney injury; invasive cancer; Keratoconus; Takayasu Arteritis; DOWN SYNDROME CRITICAL REGION; Idiopathic Membranous Glomerulonephritis; Cardiac fibrosis; Cyst; Sweet Syndrome; Malignant neoplasm of adrenal cortex; Anxiety States, Neurotic; nervous system disorder; Depressive disorder; Neuralgia; Rash and Dermatitis Adverse Event Associated with Chemoradiation; AIDS related complex; alpha 1-Antitrypsin Deficiency; Chronic viral hepatitis; Ovarian Failure, Premature; Intervertebral Disc Degeneration; Anaphylaxis (non medication); Cerebral Edema; Drug Allergy; Mixed cryoglobulinemia; Optic Neuritis; Ewings sarcoma; Carcinoma of urinary bladder, superficial; CATARACT, ANTERIOR POLAR; Sarcoma, Epithelioid; Becker Muscular Dystrophy; Pick Disease of the Brain; Arthritis, Adjuvant-Induced; Arthritis, Collagen-Induced; Arthritis, Experimental; Brittle diabetes; Conjunctivitis; Trichohepatoenteric Syndrome; Basal cell carcinoma; Pleural effusion disorder; Vesico-Ureteral Reflux; Waldenstrom Macroglobulinemia; Respiratory Failure; Regional enteritis; Diabetes Mellitus, Ketosis-Prone; Early gastric cancer; IIeocolitis; Sclerosing lymphocytic lobulitis; Stunned Myocardium; Tension Headache; Tumor necrosis factor receptor associated periodic syndrome [TRAPS]; Anemia in malignant neoplastic disease; Borderline lepromatous leprosy; Chorioretinitis; Familial neurocardiogenic syncope; Hantavirus infection in conditions classified elsewhere and of unspecified site; Hemodynamic instability; Localized vitiligo; Lung Melanoma; Periodic syndrome; Antiphospholipid Syndrome; Cholestasis of pregnancy; Muscular Atrophy; Impaired cognition; Rectal Carcinoma; Lipodystrophy; keratoacanthoma; Obsessive-Compulsive Disorder; Medullary carcinoma; Mental Depression; Eclampsia; Ischemic cardiomyopathy; Pancytopenia; Charcot-Marie-Tooth disease, Type 1C; Sore Throat; Acute-Phase Reaction; Acute Motor Axonal Neuropathy; Congo hemorrhagic fever; Conjunctivochalasis; Coxiella burnetii Infection; Endotoxic shock; Enthesitis; Epstein-Barr virus associated gastric carcinoma; Familial intrahepatic cholestasis of pregnancy; Hepatitis B and hepatitis C; Hepatorenal Syndrome; IgE-mediated allergic asthma; Joint Tuberculosis; Malignant neoplasm of muscle; Moderate obesity; Placenta Disorders; Glaucoma; Pauci-immune Glomerulonephritis associated with Granulomatosis with Polyangiitis; Allergic sensitization; Migraine Disorders; Malignant neoplasm of gallbladder; Tumor-Associated Vasculature; Pituitary Adenoma; Multiple Sclerosis, Secondary Progressive; Abdominal symptom; Visually threatening diabetic retinopathy; Adenofibroma; Chronic pelvic pain of female; Hand eczema; Human metapneumovirus infection; Hyperimmunoglobulinemia D; Myocardial Stunning; Panuveitis; Portal hypertensive gastropathy; Hyperthyroidism; Liver Dysfunction; Common Migraine; Crohn's disease of the ileum; Early Rheumatoid Arthritis; Fetal Alcohol Syndrome; Hantavirus Infections; Colorectal cancer metastatic; Congenital chromosomal disease; Hyperandrogenism; Hyperbilirubinemia; Neurofibromatosis 1; early pregnancy; Pervasive Development Disorder; Parkinsonian Disorders; Lymphoproliferative Syndrome, X-Linked, 2; Snoring; Spinal Diseases; Tophus; Acute alcoholic liver disease; Acute inflammatory demyelinating polyneuropathy; Wasting Syndrome; West Nile Fever; Brucella melitensis infection; Cardiovirus Infections; Chronic periaortitis; Ileal Pouches; Infection of ear; Limb-girdle muscular dystrophy type 2H; Other specified peritonitis; Chlamydia Infections; Primary sclerosing cholangitis; Disorder of eye; Fibromatosis, Aggressive; synovial sarcoma; Vesicular Stomatitis; Brain Infarction; Seropositive rheumatoid arthritis; Spondylitis; Neuropathy, Painful; Tuberculosis, Central Nervous System; Tuberculoid leprosy; Ventricular Dysfunction; Anterior myocardial infarction; Bisphosphonate-associated osteonecrosis; Hemoptysis; Hypoadiponectinemia; Induced hypothermia (finding); LATE-ONSET RETINAL DEGENERATION (disorder); Pemphigus Vulgaris; Acute Erythroblastic Leukemia; Gastrointestinal Carcinoid Tumor; Viral hepatitis; Chronic Fatigue Syndrome; Diaphragmatic Hernia; Osteopetrosis; Yersinia infections; Chills; Congenital cytomegalovirus infection; Idiopathic chronic pancreatitis; Osteochondritis Dissecans; Paroxysmal nocturnal hemoglobinuria; Bronchitis, Chronic; Hypertrophic Cardiomyopathy; Hypoglycemia; Fatigue; Encephalopathies; Nerve Degeneration; Acute viral hepatitis; Berylliosis; Carditis; Focal Emphysema; Ichthyosis Bullosa of Siemens; Immediate hypersensitivity; Nevus sebaceous; Oligoarticular Arthritis; Panacinar Emphysema; Pharyngitis; Placental dysfunction; PTEN Hamartoma Tumor Syndrome; Migraine with Aura; Persistent infection; Mood Disorders; Chromosome 8, trisomy; Squamous cell carcinoma of oropharynx; Metastatic Prostate Carcinoma; refractory plasma cell neoplasm; Relapsing Fever; Hypothermia, Accidental; Skin symptom; Pneumonia, Ventilator-Associated; Reticuloendotheliosis, X-linked; Congenital emphysema; Hydrosalpinx (disease); Idiopathic achalasia of esophagus; Musculoskeletal Diseases; Rectal Neoplasms; Depressive Disorder, Treatment-Resistant; ECTODERMAL DYSPLASIA 10A, HYPOHIDROTIC/HAIR/NAIL TYPE, AUTOSOMAL DOMINANT; ECTODERMAL DYSPLASIA 11A, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL DOMINANT; Multiple Sclerosis, Primary Progressive; Testicular embryonal carcinoma; Uterine Polyp; Absence of sensation; AIDS-Related Non-Hodgkin Lymphoma; Centriacinar Emphysema; Cherubism; Fulminant Hepatic Failure with Cerebral Edema; Granulomatous disorder; Hemophagocytic Syndrome; Hepatic Stupor; Lambert-Eaton Myasthenic Syndrome; Milk-Alkali Syndrome; Poikiloderma with Neutropenia; Endometrial Hyperplasia; MYOTONIC DYSTROPHY 1; Patent ductus arteriosus; Granulomatosis with polyangiitis; Inflammatory pain; Sporadic Breast Carcinoma; Niemann-Pick Disease, Type C; Reproductive tract infection; Selective immunoglobulin A deficiency; Gaucher Disease, Type 1; Heart Failure, Diastolic; Pyogenic Arthritis, Pyoderma Gangrenosum and Acne; Systemic amyloidosis; Hepatic Coma; Humoral hypercalcemia of malignancy (disorder); Malignant tumor of peritoneum; Middle East Respiratory Syndrome; Neurogenic Inflammation; Pemphigus Foliaceus; Periodic fever; Pulmonary Fibrosis - from Asbestos Exposure; Polycystic Kidney, Autosomal Dominant; Polyendocrinopathies, Autoimmune; Neuralgia, Atypical; Neuralgia, Iliohypogastric Nerve; Neuralgia, Ilioinguinal; Neuralgia, Perineal; Neuralgia, Stump; Neuralgia, Supraorbital; Neuralgia, Vidian; Achalasia; Congenital heart block; Familial Hemiplegic Migraine; Methamphetamine dependence; Paroxysmal Nerve Pain; premalignant lesion; Primary Systemic Amyloidosis; Desmoplastic; Intestinal Diseases; Luminal B Breast Carcinoma; Breast adenocarcinoma; Thalassemia; Retinal damage; Testicular dysfunction; Coronary Restenosis; Lofgrens syndrome; Memory dysfunction; Mucosal ulcer; Multiple Organ Failure; Nerve Pain; Post-transplant lymphoproliferative disorder; Lymphoma, Large-Cell, Follicular; Cicatrix, Hypertrophic; Recurrent Carcinoma; ECTODERMAL DYSPLASIA 10B, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL RECESSIVE; ECTODERMAL DYSPLASIA 11B, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL RECESSIVE; Leprosy, Paucibacillary; Coxsackievirus Infections; Disease due to Papilloma virus; Erythroid hyperplasia; Meningococcemia; Pancreatic carcinoma resectable; Post-kala-azar dermal leishmaniasis; Actinic keratosis; Malignant Childhood Neoplasm; Refractory cancer; Anaplastic Large Cell Lymphoma, ALK-Positive; Hypothermia, natural; Tachyarrhythmia; THANATOPHORIC DYSPLASIA, TYPE I (disorder); Chronic berylliosis; Filariasis; Ciliopathies; polyps; Edema; Sandhoff Disease; Sialadenitis; Siderosis; Simple renal cyst; Amyloid nephropathy; Diabetic peripheral neuropathy; Hemiplegia; Neonatal Systemic lupus erythematosus; Oropharynx (excludes nasopharynx); Anorexia Nervosa; Tuberculosis, extrapulmonary; Hidradenitis Suppurativa; Pancolitis; Mycobacterium Infections; Seborrheic dermatitis; Severe hereditary factor VIII deficiency disease; beta^0^ Thalassemia; Esophageal Achalasia; Listeriosis; Myalgia; Carcinoma, Papillary; Asthma, Occupational; Secondary hypothyroidism; Senile lentigo; Pseudohypoparathyroidism, Type Ia; Colonic Diseases; Complications of Diabetes Mellitus; Heart Block; Infant Leukemia; POLYCYSTIC KIDNEY DISEASE 1; Quadriplegia; Left Ventricular Hypertrophy; Squamous cell carcinoma of skin; Generalized vitiligo; Hereditary Leiomyomatosis and Renal Cell Cancer; Herpesviridae Infections; Sarcopenia; Agammaglobulinemia; Renal hypertension; Erythema Nodosum; Intermittent Claudication; Microvascular Angina; Obesity, Morbid; Testicular Germ Cell Tumor; Acute interstitial pneumonia; Childhood Ataxia with Central Nervous System Hypomyelinization; Hyperdiploid B Acute Lymphoblastic Leukemia; Anorexia; Erectile dysfunction; Hyper-IgM Immunodeficiency Syndrome, Type 1; Squamous cell carcinoma of the hypopharynx; Aortic valve calcification; Bunion; Fibrillation; Giant Cell Fibroblastoma; Lipid Metabolism Disorders; Stickler syndrome, type 1; Pilocytic Astrocytoma; Neurogenic Muscular Atrophy; Seminoma; Drug abuse; Gestational trophoblastic disease; Congenital hypoplasia of lung; Laryngeal Squamous Cell Carcinoma; COLORBLINDNESS, PARTIAL, DEUTAN SERIES; Deficiency of glucose-6-phosphate dehydrogenase; Excessive daytime somnolence; Inflammatory abnormality of the eye; Hepatic Encephalopathy; Cognition Disorders; Salivary Gland Pleomorphic Adenoma; Chronic leukemia (category); Coffin-Siris syndrome; Lichen Planus; Hormone refractory prostate cancer; Motor symptoms; Rheumatic Heart Disease; Lytic lesion; Macular dystrophy, corneal type 1; Acute intermittent porphyria; Insulin resistance syndrome; Neuroendocrine Tumors; Oral Submucous Fibrosis; Mammary adenocarcinoma; Telangiectasis; Disseminated Intravascular Coagulation; Hypoalbuminemia; Malonic aciduria; Hyperparathyroidism; Hypothyroidism; Seizures; Chronic schizophrenia; Congenital Heart Defects; Familial multiple trichoepitheliomata; Tachycardia; Diabetic Cardiomyopathies; Immunoglobulin A deficiency (disorder); Obsessive compulsive behavior; Respiratory Tract Diseases; Nausea; Pituitary Neoplasms; Alcoholic Intoxication, Chronic; Fetal Growth Retardation; Precursor cell lymphoblastic lymphoma; Dystrophia myotonica 2; Nephronophthisis; HEMOCHROMATOSIS, TYPE 1; MIXED LINEAGE LEUKEMIA; Dentatorubral-Pallidoluysian Atrophy; Schistosomiasis; Congenital Hypothyroidism; Malignant Peripheral Nerve Sheath Tumor; Carcinoma, Large Cell; Tracheal Diseases; Hyperuricemia; mixed gliomas; Respiration Disorders; Cerebral atrophy; Recurrent otitis media; Myxoid cyst; Congenital contractural arachnodactyly; Sensory neuropathy; Hyperlipidemia, Familial Combined; Thrombophilia; Venous Thromboembolism; Acquired Hypogammaglobulinemia; Microphthalmos; Gaucher Disease; Pregnancy Complications; Polyneuropathy; Mitochondrial Diseases; Autistic Disorder; Alcohol abuse; Secondary Neoplasm; Oligospermia; Narcolepsy; Weight Gain; Dry skin; Liver Neoplasms, Experimental; Experimental Hepatoma; Hepatoma, Novikoff; Hepatoma, Morris; Myotonic Dystrophy; Common Variable Immunodeficiency; Acidosis, Lactic",2.8114433253573326e-17; 7.980856456624717e-16; 4.4398736172867135e-14; 1.803641225501291e-12; 3.118210553589307e-12; 3.861499575207375e-12; 4.5104266881389206e-12; 2.5279022064249716e-11; 6.332483647919588e-11; 7.448716379948652e-11; 8.179290839744632e-11; 8.179290839744632e-11; 1.1574161017103878e-10; 1.3121548808139071e-10; 1.6797550790254382e-10; 1.9241179247341838e-10; 2.377251819497684e-10; 2.377251819497684e-10; 2.377251819497684e-10; 2.377251819497684e-10; 2.377251819497684e-10; 2.377251819497684e-10; 2.813069300429449e-10; 3.762648680673853e-10; 4.2478505092738466e-10; 5.452288254986118e-10; 5.452288254986118e-10; 6.429879513246633e-10; 6.870627395110916e-10; 7.861255581007157e-10; 7.868397426275417e-10; 1.1722433847661196e-09; 1.1722433847661196e-09; 1.1722433847661196e-09; 1.1722433847661196e-09; 1.1722433847661196e-09; 1.1722433847661196e-09; 1.4790998733426532e-09; 1.5734876414130875e-09; 1.6767489697325582e-09; 1.794870341379274e-09; 1.971893171900314e-09; 1.971893171900314e-09; 2.219129913614883e-09; 3.315537369635636e-09; 3.683115069310663e-09; 3.683115069310663e-09; 4.367699208727405e-09; 4.546836602575699e-09; 4.756590990483e-09; 5.670785186683756e-09; 5.670785186683756e-09; 5.791865115913735e-09; 6.0322241000340585e-09; 6.195332209150018e-09; 6.991207850982321e-09; 7.195555613367576e-09; 7.547641288501485e-09; 7.713813941246406e-09; 8.269524813140207e-09; 8.303910954283738e-09; 8.853567275424139e-09; 1.0368326871660785e-08; 1.0368326871660785e-08; 1.3128768066526236e-08; 1.452540845894924e-08; 1.4920329017331753e-08; 1.4920329017331753e-08; 1.5572986293211266e-08; 1.587872453479067e-08; 1.7931366647560766e-08; 1.8815395768840057e-08; 2.0570601164639797e-08; 2.1034803123367165e-08; 2.261634993097532e-08; 2.2764946043880388e-08; 2.3137704832524547e-08; 2.412608431251415e-08; 2.7368000175117756e-08; 2.9730190499609582e-08; 3.149054123564124e-08; 3.9573009168853264e-08; 4.0898524252942674e-08; 4.3069383556698336e-08; 4.638299267461546e-08; 4.65353219894153e-08; 5.071217747675114e-08; 5.1290058242058653e-08; 5.3111708677091025e-08; 5.518991037343798e-08; 5.784935444423772e-08; 5.8317433871210796e-08; 5.989093556336469e-08; 6.016513497232253e-08; 6.156981490555128e-08; 6.156981490555128e-08; 6.156981490555128e-08; 6.982287075725826e-08; 8.598175402882612e-08; 9.273260676030806e-08; 9.273260676030806e-08; 9.273260676030806e-08; 9.393284022832733e-08; 1.0276547515522002e-07; 1.0390067657961098e-07; 1.0618136021459505e-07; 1.3150328464481586e-07; 1.427432458937347e-07; 1.427432458937347e-07; 1.479813245926713e-07; 1.4925759778299788e-07; 1.4925759778299788e-07; 1.524221047360518e-07; 1.6759866477134858e-07; 1.7232014763277498e-07; 1.825346178149227e-07; 1.946794431045147e-07; 2.0279723135488897e-07; 2.0732395681104218e-07; 2.242497138958313e-07; 2.247163660896597e-07; 2.400988116471548e-07; 2.419125491442217e-07; 2.46778041958494e-07; 2.46778041958494e-07; 2.700227164716584e-07; 2.824526360848301e-07; 2.911052249927245e-07; 2.948344121290337e-07; 3.10587283755252e-07; 3.532371372262103e-07; 3.880986260207744e-07; 4.157277636684319e-07; 4.312772724439924e-07; 4.312772724439924e-07; 4.4307738632612236e-07; 4.5433391667148853e-07; 5.254943571583271e-07; 5.313225371508493e-07; 5.577321626966352e-07; 5.916066415963854e-07; 6.299208964864026e-07; 6.630279934320317e-07; 6.673805318525932e-07; 6.673805318525932e-07; 6.805796735296268e-07; 6.805796735296268e-07; 6.805796735296268e-07; 6.851652105457608e-07; 7.17979149467092e-07; 7.789160940651547e-07; 7.873224494781308e-07; 7.931659047151387e-07; 7.99548070959303e-07; 8.297823048747685e-07; 8.339674388418603e-07; 8.339674388418603e-07; 8.339674388418603e-07; 8.660170029731726e-07; 8.696626324623331e-07; 8.777200373497231e-07; 8.887379906686178e-07; 9.58028929735367e-07; 9.822463166680949e-07; 1.0094398444517938e-06; 1.0094667484349083e-06; 1.083280646968723e-06; 1.10068355868735e-06; 1.10068355868735e-06; 1.1523181751478311e-06; 1.2482007026109775e-06; 1.284982487562752e-06; 1.3079916134634371e-06; 1.4042419564664515e-06; 1.4185164995612263e-06; 1.4839502431758565e-06; 1.51758575162775e-06; 1.5208470671427406e-06; 1.5208470671427406e-06; 1.6231490275716298e-06; 1.6397478315149087e-06; 1.8939430555623748e-06; 1.9581146391906144e-06; 1.9581146391906144e-06; 1.96107848506464e-06; 2.027389637151193e-06; 2.027389637151193e-06; 2.07112526817849e-06; 2.086123696221558e-06; 2.086123696221558e-06; 2.1020461880694925e-06; 2.1624936975752243e-06; 2.205236928124383e-06; 2.2411321306638023e-06; 2.263727724144348e-06; 2.3419309731960144e-06; 2.3756085216561533e-06; 2.3756085216561533e-06; 2.450940162208615e-06; 2.546221763226728e-06; 2.560217628497434e-06; 2.576211756838249e-06; 2.608032323197001e-06; 2.7684459182091574e-06; 2.782805018144785e-06; 3.282956820548434e-06; 3.4620043828295477e-06; 3.485726441474513e-06; 3.7283259874612974e-06; 3.878607667297475e-06; 3.990817553511259e-06; 3.990817553511259e-06; 3.990817553511259e-06; 3.990817553511259e-06; 4.179146475474674e-06; 4.218275676836033e-06; 4.42396341877472e-06; 4.83171753412672e-06; 4.839188317483647e-06; 5.021572339409501e-06; 5.381279306135013e-06; 5.457492980911677e-06; 5.457492980911677e-06; 5.457492980911677e-06; 5.572620871465934e-06; 6.140554546483986e-06; 6.140554546483986e-06; 6.140554546483986e-06; 6.169876404399104e-06; 6.3131986281381465e-06; 6.378950690990071e-06; 6.378950690990071e-06; 6.889889014378816e-06; 7.095035199288336e-06; 7.343355877356991e-06; 7.439853898002338e-06; 7.691726899679507e-06; 8.32456450186878e-06; 8.567994785462795e-06; 8.591027139424906e-06; 8.77532817235926e-06; 9.18171819472328e-06; 9.263589414966798e-06; 9.263589414966798e-06; 9.263589414966798e-06; 1.0172703923266036e-05; 1.033366177374635e-05; 1.033366177374635e-05; 1.0755368362337037e-05; 1.08089380369295e-05; 1.0961931275541026e-05; 1.1652528807336014e-05; 1.2304362232150695e-05; 1.2375081616087569e-05; 1.2765469826010355e-05; 1.2765469826010355e-05; 1.2765469826010355e-05; 1.2765469826010355e-05; 1.279493639647176e-05; 1.3010173302726732e-05; 1.3034577772762696e-05; 1.3268923055385737e-05; 1.3268923055385737e-05; 1.3268923055385737e-05; 1.3268923055385737e-05; 1.3410647656206684e-05; 1.3410647656206684e-05; 1.3410647656206684e-05; 1.3410647656206684e-05; 1.3410647656206684e-05; 1.3410647656206684e-05; 1.3673911177979942e-05; 1.3755659311680946e-05; 1.3755659311680946e-05; 1.3755659311680946e-05; 1.4439241578579364e-05; 1.4439241578579364e-05; 1.4583987015565183e-05; 1.4805035395703202e-05; 1.5064798896399038e-05; 1.513340899972731e-05; 1.513340899972731e-05; 1.527992765491583e-05; 1.5449280661407645e-05; 1.5498516107485843e-05; 1.595911218164779e-05; 1.651577640810321e-05; 1.6659968656867144e-05; 1.6659968656867144e-05; 1.7090079578013972e-05; 1.8507296589967813e-05; 1.8507296589967813e-05; 1.8961926417889813e-05; 1.9896942827707536e-05; 2.0234336876324372e-05; 2.042524345007846e-05; 2.0736107376307555e-05; 2.0820699372778346e-05; 2.0820699372778346e-05; 2.1083292452040976e-05; 2.1109857936882128e-05; 2.223158928845764e-05; 2.365778380659297e-05; 2.428963273942594e-05; 2.7001454785434173e-05; 2.7966054180512005e-05; 2.878916650522013e-05; 2.878916650522013e-05; 2.910435331986992e-05; 2.929369913127532e-05; 2.9890125380431698e-05; 2.9890125380431698e-05; 3.053335644618538e-05; 3.053335644618538e-05; 3.1066725823367694e-05; 3.1066725823367694e-05; 3.14076229962439e-05; 3.1491435270594376e-05; 3.192298841377222e-05; 3.372277447426952e-05; 3.489427253341073e-05; 3.602405958537832e-05; 3.602405958537832e-05; 3.803310437251698e-05; 3.9650653676454574e-05; 3.9650653676454574e-05; 3.971484221432504e-05; 4.079834649355082e-05; 4.1934338365676246e-05; 4.3188904868696655e-05; 4.351780357113137e-05; 4.351780357113137e-05; 4.360044574654907e-05; 4.545624383387551e-05; 4.550622830486202e-05; 5.013426562854155e-05; 5.248375780672949e-05; 5.248375780672949e-05; 5.248375780672949e-05; 5.248375780672949e-05; 5.248375780672949e-05; 5.2700686057264086e-05; 5.399364944210138e-05; 5.437020241719231e-05; 5.496580971003797e-05; 5.496580971003797e-05; 5.59220554762142e-05; 5.592330076699809e-05; 5.726577479376336e-05; 5.726577479376336e-05; 5.726577479376336e-05; 5.800116505773043e-05; 5.826428641192471e-05; 5.9174130460768686e-05; 6.058590126387572e-05; 6.484707207749309e-05; 6.709590381814368e-05; 6.734766728729227e-05; 6.734766728729227e-05; 6.734766728729227e-05; 6.734766728729227e-05; 6.734766728729227e-05; 6.758558746827128e-05; 6.882388524696196e-05; 6.882388524696196e-05; 6.964870190365813e-05; 7.036498484894257e-05; 7.358523784131203e-05; 7.358523784131203e-05; 7.519084418988331e-05; 8.007340895515112e-05; 8.100290141298731e-05; 8.100290141298731e-05; 8.133563964016694e-05; 8.178614148996482e-05; 8.232890503539995e-05; 8.232890503539995e-05; 8.232890503539995e-05; 8.25206825409808e-05; 8.257883791168467e-05; 8.421319594446617e-05; 8.730297037328594e-05; 8.937909010875455e-05; 9.023170634543253e-05; 9.023170634543253e-05; 9.117996105379778e-05; 9.476946799623076e-05; 9.476946799623076e-05; 9.476946799623076e-05; 9.476946799623076e-05; 9.476946799623076e-05; 9.56957692518114e-05; 9.780860153755674e-05; 9.846223464501226e-05; 9.846223464501226e-05; 9.913294924271568e-05; 9.913294924271568e-05; 9.913294924271568e-05; 9.913294924271568e-05; 0.0001007621786326551; 0.0001015974347517202; 0.00010334647523919963; 0.00010334647523919963; 0.00010582598320524978; 0.00010776056908698134; 0.00010776056908698134; 0.00010914466609698448; 0.00011072370132707822; 0.0001119048288448298; 0.00011927896769899647; 0.00011927896769899647; 0.00011927896769899647; 0.00011927896769899647; 0.00012202062264879416; 0.00012202062264879416; 0.00012202062264879416; 0.00012202062264879416; 0.00012858049944279123; 0.00012858049944279123; 0.00012949836610375056; 0.00012949836610375056; 0.0001322335978675375; 0.0001322335978675375; 0.00013846515856925812; 0.0001431024725510208; 0.0001431024725510208; 0.00014636999075042076; 0.0001474322229096163; 0.00015093372108149775; 0.00015093372108149775; 0.0001616561904035017; 0.00016189346720036038; 0.00016189346720036038; 0.0001690762138878921; 0.0001705179359230947; 0.0001705179359230947; 0.00017292560623348305; 0.00017808425336754297; 0.0001802305430549181; 0.0001802305430549181; 0.0001802305430549181; 0.0001802305430549181; 0.0001802305430549181; 0.0001802305430549181; 0.0001802305430549181; 0.0001802305430549181; 0.0001802305430549181; 0.0001802305430549181; 0.0001802305430549181; 0.0001802305430549181; 0.0001802305430549181; 0.000181883468787863; 0.000181883468787863; 0.00019131698235390912; 0.0001932529498581875; 0.0001932529498581875; 0.0001934869050618567; 0.0001934869050618567; 0.0001934869050618567; 0.0002043416381292249; 0.00021049732822064587; 0.00021049732822064587; 0.00021116105905857028; 0.00021611859123914996; 0.00021804014782198476; 0.0002214859278255797; 0.00022254302103317592; 0.00022254302103317592; 0.00022336414159326664; 0.00022618385822819267; 0.00022618385822819267; 0.00022897551943886068; 0.00023793254517777995; 0.00024044665139790348; 0.00024044665139790348; 0.00024044665139790348; 0.0002484853090912064; 0.00025117420022058794; 0.0002559467947532168; 0.00026224811620659125; 0.00026339787549714257; 0.00026339787549714257; 0.00026467392475943254; 0.0002652452950458932; 0.0002718864504795822; 0.00027820432005572264; 0.0002792365191965819; 0.0002792365191965819; 0.00028056116385876946; 0.00028056116385876946; 0.00028056116385876946; 0.0002812860791024885; 0.0002812860791024885; 0.0002926994143155384; 0.0002926994143155384; 0.0002933384035122236; 0.00029355802758490503; 0.0002983150880926112; 0.0003022150453166086; 0.0003022150453166086; 0.00031217959139151507; 0.00031217959139151507; 0.00032113080554701227; 0.000323910443746482; 0.0003242363739584783; 0.0003278023880903879; 0.0003495642888428815; 0.0003539177308293034; 0.0003539177308293034; 0.0003607853785819225; 0.0003763308936382836; 0.00038453776693371663; 0.00039959635390179865; 0.00039959635390179865; 0.00039959635390179865; 0.00039959635390179865; 0.00039959635390179865; 0.00039959635390179865; 0.000399963770573658; 0.00040624424086014313; 0.0004136970830881728; 0.00041476222368508776; 0.000420950947096172; 0.00042196010900515655; 0.0004224524250828287; 0.0004243878730487336; 0.00042535405399404114; 0.0004303328941191692; 0.0004303328941191692; 0.0004336479443072768; 0.0004336479443072768; 0.0004336479443072768; 0.0004336479443072768; 0.00044420259326717257; 0.00045185714020635207; 0.0004601228759628894; 0.00046565119871267287; 0.0004814724943641282; 0.0004814724943641282; 0.0004814724943641282; 0.0004918069653418582; 0.0004918069653418582; 0.0004934717082734151; 0.0005011878920853237; 0.0005125353857651181; 0.000513309425513094; 0.0005214896245221155; 0.0005214896245221155; 0.0005255837979904586; 0.0005445028206157281; 0.0005445028206157281; 0.0005486681594044074; 0.0005632660372960827; 0.0005873268650449521; 0.0005873268650449521; 0.0005873268650449521; 0.0006046022723190866; 0.0006046022723190866; 0.0006163914271817124; 0.0006352060750206054; 0.0006445212280958682; 0.0006445212280958682; 0.0006540484469998963; 0.0006721375816653799; 0.0006993549316202267; 0.0007074539367893701; 0.0007074539367893701; 0.0007074539367893701; 0.0007074539367893701; 0.0007283216745489607; 0.0007283216745489607; 0.0007283216745489607; 0.0007283216745489607; 0.0007326127218377523; 0.0007603472723798622; 0.0007603472723798622; 0.0008252744167874381; 0.0008252744167874381; 0.0008252744167874381; 0.0008280072185276037; 0.0008452277316123234; 0.0008673605584216904; 0.0008673605584216904; 0.0008673605584216904; 0.0008673605584216904; 0.0008932565002868814; 0.0008932565002868814; 0.0009174737515799856; 0.0009325953874753212; 0.0009826472144539087; 0.0010170306665323; 0.0010244557923259; 0.0010244557923259; 0.0010244557923259; 0.0010244557923259; 0.0010244557923259; 0.0010244557923259; 0.0010244557923259; 0.0010244557923259; 0.0010244557923259; 0.0010831910832595; 0.0010897868460616; 0.0010897868460616; 0.0011261416978188; 0.0011261416978188; 0.0011303542860313; 0.0011303542860313; 0.0011303542860313; 0.0011626911115394; 0.0011626911115394; 0.0011626911115394; 0.0011626911115394; 0.00116764658012; 0.0011876897533161; 0.0011876897533161; 0.00120990141675; 0.0012591553085125; 0.0012591553085125; 0.0012688388196185; 0.0013033444225859; 0.0013064343839031; 0.0013309210571735; 0.0013309210571735; 0.0013510612738592; 0.0013734265963756; 0.0013734265963756; 0.0014000542917314; 0.0014413188128666; 0.0014413188128666; 0.0014485445504404; 0.0014485445504404; 0.0014485445504404; 0.0015652768725765; 0.0015652768725765; 0.0015698089771612; 0.0015698089771612; 0.0015698089771612; 0.0015698089771612; 0.0015698089771612; 0.0015698089771612; 0.0015698089771612; 0.0015725978289892; 0.0016559602535146; 0.0017107913939493; 0.0017290799495295; 0.0017329922477138; 0.0017329922477138; 0.001746579573497; 0.0017731038420892; 0.0017731038420892; 0.0017731038420892; 0.0017731038420892; 0.0017731038420892; 0.0017731038420892; 0.0017731038420892; 0.0017731038420892; 0.0017731038420892; 0.0017856981020231; 0.0017856981020231; 0.0017856981020231; 0.0018360773814867; 0.001881335207053; 0.001881335207053; 0.001881335207053; 0.001881335207053; 0.0019553944568237; 0.0020049274325175; 0.0020056438913528; 0.0020056438913528; 0.0020089634269714; 0.0020282798161214; 0.0020282798161214; 0.0020282798161214; 0.0020505587731585; 0.0021001259552496; 0.0021222176147417; 0.0021326108499664; 0.002135695462532; 0.0021970545999258; 0.002213465225837; 0.0022378309697704; 0.0022378309697704; 0.0022674286916718; 0.002304426449738; 0.0024261178373806; 0.0025122887786423; 0.0025122887786423; 0.0025122887786423; 0.0025122887786423; 0.0025876779926919; 0.0027346449758241; 0.0027346449758241; 0.0027346449758241; 0.0027534163536682; 0.0027942850562877; 0.0027942850562877; 0.0027942850562877; 0.0027942850562877; 0.0028187518310092; 0.0028187518310092; 0.0028187518310092; 0.0028626589910413; 0.0028759971272412; 0.0028759971272412; 0.0029013169576144; 0.0029063499863533; 0.0029063499863533; 0.0029063499863533; 0.0029063499863533; 0.0030077293488194; 0.0030220891031719; 0.0030220891031719; 0.0030585625765418; 0.0030585625765418; 0.0030585625765418; 0.0030585625765418; 0.0030940063712108; 0.0031934755667; 0.0031934755667; 0.0033783379034436; 0.0033783379034436; 0.0033783379034436; 0.0033783379034436; 0.0033783379034436; 0.0033785221929293; 0.0035164243080016; 0.0035164243080016; 0.0035629033641169; 0.0037244768508078; 0.0037244768508078; 0.0037263522689301; 0.0037263522689301; 0.0037263522689301; 0.0037263522689301; 0.0037263522689301; 0.0037263522689301; 0.0037263522689301; 0.003846910040485; 0.0038705790239355; 0.0038705790239355; 0.0038816440940594; 0.0038895739770004; 0.0038895739770004; 0.0039908077871836; 0.0039908077871836; 0.0039908077871836; 0.0039908077871836; 0.0039908077871836; 0.0039908077871836; 0.0040444907714877; 0.0040785542386402; 0.0041157458728674; 0.0043105477873176; 0.0043105477873176; 0.0043121462081946; 0.0043427572763018; 0.0043470921917622; 0.0043470921917622; 0.0043470921917622; 0.0044046842540656; 0.0044046842540656; 0.0044119363017658; 0.0044119363017658; 0.0044831346315456; 0.0047329548368286; 0.0047339976311261; 0.0047351775110072; 0.0047351775110072; 0.0048028611524245; 0.0048028611524245; 0.0048028611524245; 0.0048028611524245; 0.0048028611524245; 0.0048028611524245; 0.0048028611524245; 0.0048028611524245; 0.0048028611524245; 0.0048028611524245; 0.0048044887750201; 0.0048496385019795; 0.0048662864613419; 0.0050738495859132; 0.0050738495859132; 0.0050844857197244; 0.0053122016520353; 0.0053570195415722; 0.0054814673835909; 0.0054814673835909; 0.0058870598454808; 0.0059257679306595; 0.0059257679306595; 0.0059257679306595; 0.0059257679306595; 0.0059257679306595; 0.0059257679306595; 0.0059257679306595; 0.0059257679306595; 0.0059257679306595; 0.0059257679306595; 0.0060170797120173; 0.0060818298848679; 0.0060818298848679; 0.0062748297137782; 0.0063306870511064; 0.006352455154555; 0.0063571439329446; 0.0063571439329446; 0.0065999085088281; 0.0066006052483961; 0.0066401895279317; 0.0066401895279317; 0.0067588219988478; 0.0068235619036629; 0.007117388576245; 0.007117388576245; 0.007117388576245; 0.007117388576245; 0.007117388576245; 0.007117388576245; 0.007117388576245; 0.007117388576245; 0.0071410338306506; 0.0072083035574659; 0.0072083035574659; 0.0072083035574659; 0.0073444206109429; 0.0075325383349707; 0.0075697193353146; 0.0077321746155735; 0.0077321746155735; 0.0077321746155735; 0.007861073629675; 0.0080075092844381; 0.0080667733705833; 0.0080667733705833; 0.0082763563641252; 0.0082763563641252; 0.0083709650732796; 0.0083709650732796; 0.0083709650732796; 0.0083709650732796; 0.0083709650732796; 0.0083709650732796; 0.0083709650732796; 0.0083709650732796; 0.0083709650732796; 0.0083709650732796; 0.0084568432337518; 0.008634277457381; 0.008634277457381; 0.0087278589568942; 0.0087278589568942; 0.0088561754221927; 0.0088561754221927; 0.0089906473426575; 0.0091914307650131; 0.0093060572422998; 0.0093325514582534; 0.0094642528600355; 0.0096630827054915; 0.0096630827054915; 0.0096630827054915; 0.0096630827054915; 0.0096630827054915; 0.0096630827054915; 0.0096630827054915; 0.0096630827054915; 0.0097159454554601; 0.0097159454554601; 0.0097159454554601; 0.0097159454554601; 0.0099798889656483; 0.0102680775483548; 0.010343569493973; 0.0104376874453167; 0.0105367304020196; 0.0105367304020196; 0.010624513163997; 0.0109519728029571; 0.0110109843340769; 0.0110109843340769; 0.0110109843340769; 0.0110109843340769; 0.0110109843340769; 0.0110109843340769; 0.0111888062322808; 0.0111888062322808; 0.0114187031414039; 0.0114187031414039; 0.0114187031414039; 0.0118123250371176; 0.0118303833860754; 0.0118679153788039; 0.0120771273149872; 0.0120771273149872; 0.0123983633418964; 0.0123983633418964; 0.0123983633418964; 0.0123983633418964; 0.0123983633418964; 0.0123983633418964; 0.0123983633418964; 0.0123983633418964; 0.0127059723723765; 0.0127059723723765; 0.0127059723723765; 0.0127059723723765; 0.0127059723723765; 0.0128516790501046; 0.0131305979622119; 0.0131305979622119; 0.0131305979622119; 0.0138441633831498; 0.0138441633831498; 0.0138441633831498; 0.0138441633831498; 0.0138829566912713; 0.0145436543557976; 0.0145436543557976; 0.0145436543557976; 0.0153494479957135; 0.0153494479957135; 0.015507621739214; 0.015507621739214; 0.015507621739214; 0.015507621739214; 0.015507621739214; 0.0156113267570298; 0.0157194401523571; 0.0160005762734352; 0.0160005762734352; 0.0160005762734352; 0.0161428886050652; 0.0162139207824563; 0.0166041002652209; 0.0167904807006824; 0.0167904807006824; 0.0171001534176385; 0.0171001534176385; 0.0171001534176385; 0.0171001534176385; 0.0171001534176385; 0.0171001534176385; 0.0171001534176385; 0.0171001534176385; 0.0173384291015271; 0.0173964199029194; 0.0174410368983484; 0.0182000062506337; 0.0182000062506337; 0.0182000062506337; 0.0182000062506337; 0.0182000062506337; 0.0182000062506337; 0.018665947632861; 0.018665947632861; 0.018665947632861; 0.018665947632861; 0.018665947632861; 0.018665947632861; 0.018665947632861; 0.0187299613301643; 0.0187299613301643; 0.0187299613301643; 0.0187299613301643; 0.0193777520415227; 0.0196225707350576; 0.0196225707350576; 0.0196225707350576; 0.0196314124927668; 0.0196345173194062; 0.0198983219186433; 0.0203198961621158; 0.0203198961621158; 0.0203198961621158; 0.0203198961621158; 0.0203198961621158; 0.0203198961621158; 0.0203198961621158; 0.0203198961621158; 0.0204735864411232; 0.0208452312614567; 0.0209435845696216; 0.0209435845696216; 0.021125667706065; 0.0214892684107681; 0.0220575875892222; 0.0220575875892222; 0.0220705590988414; 0.0220705590988414; 0.0220705590988414; 0.0228665355725917; 0.0230684256648711; 0.0231910952149837; 0.0239461944596263; 0.0239461944596263; 0.0239461944596263; 0.0239461944596263; 0.0239461944596263; 0.0239461944596263; 0.0246533435977568; 0.0254956360475327; 0.0255085366814945; 0.0256587294742695; 0.0259817880808067; 0.0259817880808067; 0.0269131580640034; 0.027071413490175; 0.027071413490175; 0.0276267477370436; 0.0279220892715439; 0.0279220892715439; 0.0279220892715439; 0.0279220892715439; 0.0279220892715439; 0.0279220892715439; 0.0280663273380655; 0.0284314613047093; 0.0295521651553568; 0.0299774405999183; 0.030006907592274; 0.0300972754548838; 0.0302544192125064; 0.0303319552791211; 0.0303319552791211; 0.0303319552791211; 0.0303319552791211; 0.0303319552791211; 0.0303319552791211; 0.0303319552791211; 0.0314638805510678; 0.0314638805510678; 0.0314638805510678; 0.0319682790952413; 0.0319682790952413; 0.0334053723619937; 0.0335408281184641; 0.0335408281184641; 0.033749008368017; 0.0340266852061135; 0.0340266852061135; 0.0340645241548108; 0.0363737825516021; 0.0363737825516021; 0.0365699380189482; 0.0371129390384053; 0.0378565625608719; 0.0380438970214283; 0.0380438970214283; 0.0384689641633299; 0.0384689641633299; 0.0384689641633299; 0.0384689641633299; 0.0384689641633299; 0.0384689641633299; 0.0389987389006947; 0.0392832161328838; 0.0402448379890702; 0.0403198851338656; 0.040382673882237; 0.0404707605808569; 0.0404707605808569; 0.0404707605808569; 0.0404707605808569; 0.0404707605808569; 0.0404707605808569; 0.0407359064912377; 0.0411765978055933; 0.0425171404778382; 0.0427786786335321; 0.0427786786335321; 0.0427786786335321; 0.0427786786335321; 0.0427786786335321; 0.0434849646646736; 0.0442524445580864; 0.0447905037504535; 0.044901297966643; 0.044901297966643; 0.044901297966643; 0.044901297966643; 0.0457039625575448; 0.0458359347176422; 0.0462818499370266; 0.0465235764214223; 0.0469394416375774; 0.0469394416375774; 0.0469394416375774; 0.0469394416375774; 0.0471006425252053; 0.0471006425252053; 0.0471006425252053; 0.0471006425252053; 0.0471006425252053; 0.048123203710384; 0.0491632343384016; 0.0491632343384016; 0.0493155676939993; 0.0493155676939993; 0.0493155676939993; 0.0493155676939993; 0.0493155676939993; 0.0493155676939993; 0.0493155676939993; 0.0496760944377964; 0.0503601986761658; 0.0511562825357515; 0.0517499693438671; 0.0517499693438671; 0.0517499693438671; 0.0524543292954025; 0.0524566642172417; 0.0530344420162745; 0.0530344420162745; 0.0554191598986221; 0.0565343207837806; 0.0569213530455915; 0.0571842904809504; 0.0616475884230982; 0.0616475884230982; 0.0623026316541814; 0.0623026316541814; 0.0623026316541814; 0.0630979595913369; 0.0647102740274508; 0.0650424286909672; 0.0650424286909672; 0.0677694730935319; 0.0678022600525665; 0.0691714743582008; 0.0692193903915762; 0.0692193903915762; 0.0700485361084771; 0.0700485361084771; 0.0700485361084771; 0.0704851772553303; 0.0716386930157756; 0.0723815120866587; 0.0723815120866587; 0.0723815120866587; 0.0723815120866587; 0.0723815120866587; 0.0741310297608694; 0.0749666609274744; 0.0749666609274744; 0.0749666609274744; 0.0749666609274744; 0.0760236194881239; 0.0777073264956258; 0.0777073264956258; 0.0777073264956258; 0.0777073264956258; 0.0777073264956258; 0.0784196844880443; 0.0791235961972295; 0.0791235961972295; 0.0805908799965109; 0.0805908799965109; 0.0814119493993337; 0.0817897187940979; 0.0817897187940979; 0.0817897187940979; 0.0817897187940979; 0.0817897187940979; 0.0817897187940979; 0.0817897187940979; 0.0817897187940979; 0.0817897187940979; 0.0817897187940979; 0.0817897187940979; 0.0817897187940979; 0.0817897187940979; 0.0817897187940979; 0.0817897187940979; 0.0817897187940979; 0.0817897187940979; 0.083107903315643; 0.083107903315643; 0.083107903315643; 0.0835641020831185; 0.0837469930808364; 0.0858871491124922; 0.0858871491124922; 0.087414326021809; 0.0887863766478173; 0.0887984457495041; 0.088963803794147; 0.0897127848630768; 0.0897127848630768; 0.0897127848630768; 0.0897127848630768; 0.0897127848630768; 0.0897127848630768; 0.0897127848630768; 0.0897127848630768; 0.0897127848630768; 0.0897127848630768; 0.0897127848630768; 0.0897127848630768; 0.0897127848630768; 0.0897127848630768; 0.0897127848630768; 0.0897127848630768; 0.0897127848630768; 0.0897127848630768; 0.0897127848630768; 0.0897127848630768; 0.0905750994820178; 0.0908772402064694; 0.0939942521625741; 0.0940427381982829; 0.0967179741949912; 0.0967179741949912; 0.0972679220674381; 0.0972679220674381; 0.0972679220674381; 0.0972679220674381; 0.0972679220674381; 0.0972679220674381; 0.0972679220674381; 0.0972679220674381; 0.0972679220674381; 0.0972679220674381; 0.0972679220674381; 0.0972679220674381; 0.0974143314470534; 0.098408395338696; 0.0987575443309834; 0.0987575443309834; 0.0987575443309834; 0.0987575443309834; 0.0987575443309834; 0.0993028790023582; 0.0996459063920158; 0.1016471070089966; 0.1016471070089966; 0.1018377089033323; 0.1050724946352408; 0.1050724946352408; 0.1050724946352408; 0.1050724946352408; 0.1050724946352408; 0.1050724946352408; 0.1050724946352408; 0.1050724946352408; 0.1050724946352408; 0.1050724946352408; 0.1050724946352408; 0.1050724946352408; 0.1050724946352408; 0.1050724946352408; 0.1050724946352408; 0.1050724946352408; 0.1050724946352408; 0.1050724946352408; 0.1050724946352408; 0.1051100679067119; 0.1070008331073374; 0.1080647222141486; 0.1087303638328369; 0.1107144880305473; 0.1130019719865939; 0.1130019719865939; 0.1130019719865939; 0.1130019719865939; 0.1130019719865939; 0.1130019719865939; 0.1130019719865939; 0.1130019719865939; 0.1130019719865939; 0.1130019719865939; 0.1130019719865939; 0.1130019719865939; 0.1130019719865939; 0.1146753245606438; 0.1159436893514271; 0.1173860265721715; 0.1176290148843425; 0.1204795752338222; 0.1204795752338222; 0.1204795752338222; 0.1206032442301429; 0.1206032442301429; 0.1206032442301429; 0.1206032442301429; 0.1206032442301429; 0.1212040226252925; 0.124149904653194; 0.1242757058018646; 0.1245376567919059; 0.1266767196420385; 0.1272255752567765; 0.1272255752567765; 0.1272255752567765; 0.1272255752567765; 0.1272255752567765; 0.1272255752567765; 0.1272255752567765; 0.1272255752567765; 0.1272255752567765; 0.1272255752567765; 0.1272255752567765; 0.1272255752567765; 0.1272255752567765; 0.1272255752567765; 0.1272255752567765; 0.1272255752567765; 0.1308906437806309; 0.1332119202868411; 0.1332119202868411; 0.1343310874911156; 0.1343310874911156; 0.1343310874911156; 0.1343310874911156; 0.1343310874911156; 0.1343310874911156; 0.1343310874911156; 0.1343310874911156; 0.1343310874911156; 0.1343310874911156; 0.1343310874911156; 0.1369039689436487; 0.1401454825042905; 0.1401454825042905; 0.1401454825042905; 0.1401454825042905; 0.1401454825042905; 0.1401454825042905; 0.1401454825042905; 0.1401454825042905; 0.1401454825042905; 0.1401454825042905; 0.1401454825042905; 0.1401454825042905; 0.1401454825042905; 0.1401454825042905; 0.1401454825042905; 0.1401454825042905; 0.1401454825042905; 0.1426816828546498; 0.1426816828546498; 0.1435325826114705; 0.1456466465256486; 0.1456466465256486; 0.1460848784791741; 0.1460848784791741; 0.1460848784791741; 0.1460848784791741; 0.1460848784791741; 0.1460848784791741; 0.1460848784791741; 0.1460848784791741; 0.1460848784791741; 0.1460848784791741; 0.1460848784791741; 0.1460848784791741; 0.1460848784791741; 0.1460848784791741; 0.1460848784791741; 0.1460848784791741; 0.1472075252120941; 0.1520581530903516; 0.1525119847960956; 0.1525119847960956; 0.1525119847960956; 0.1525119847960956; 0.1525119847960956; 0.1525119847960956; 0.1525119847960956; 0.1525119847960956; 0.1525119847960956; 0.1525119847960956; 0.1525119847960956; 0.1525119847960956; 0.1525119847960956; 0.1525119847960956; 0.1525119847960956; 0.1525119847960956; 0.1525119847960956; 0.1584804022044084; 0.1584804022044084; 0.1584804022044084; 0.1584804022044084; 0.1584804022044084; 0.1584804022044084; 0.1584804022044084; 0.1584804022044084; 0.1584804022044084; 0.1584804022044084; 0.1584804022044084; 0.1591507626487054; 0.1642913929691757; 0.1642913929691757; 0.1642913929691757; 0.1642913929691757; 0.1642913929691757; 0.1642913929691757; 0.1642913929691757; 0.1642913929691757; 0.1642913929691757; 0.1642913929691757; 0.1642913929691757; 0.1687319146389434; 0.1687319146389434; 0.1703929618871976; 0.1703929618871976; 0.1703929618871976; 0.1703929618871976; 0.1703929618871976; 0.1703929618871976; 0.1703929618871976; 0.176056923749369; 0.1812446566929033; 0.181710614199711; 0.181710614199711; 0.181710614199711; 0.181710614199711; 0.181710614199711; 0.181710614199711; 0.181710614199711; 0.181710614199711; 0.181710614199711; 0.181710614199711; 0.1866447221848054; 0.1881045022168423; 0.1881045022168423; 0.1881045022168423; 0.1932166112700285; 0.1932166112700285; 0.1932166112700285; 0.1932166112700285; 0.1932166112700285; 0.1932166112700285; 0.1978060932497189; 0.1982833830495248; 0.1982833830495248; 0.1982833830495248; 0.1982833830495248; 0.1982833830495248; 0.1982833830495248; 0.1982833830495248; 0.1982833830495248; 0.1982833830495248; 0.1982833830495248; 0.2048516463561299; 0.2108300774722888; 0.2140040744036979; 0.2166737845423457; 0.2166737845423457; 0.2166737845423457; 0.2226324872503657; 0.2226324872503657; 0.2272199982000937; 0.2272199982000937; 0.2272199982000937; 0.2272199982000937; 0.2277525841233998; 0.23058850720196; 0.236709594559292; 0.236709594559292; 0.236709594559292; 0.2385514460682989; 0.2385514460682989; 0.2416367579687983; 0.2416367579687983; 0.2416367579687983; 0.2416367579687983; 0.2416367579687983; 0.2416367579687983; 0.2416367579687983; 0.2468771733501051; 0.2475288081654744; 0.2499636483007412; 0.251930120576978; 0.251930120576978; 0.2520982519141255; 0.2551143159281861; 0.2570364810168682; 0.2570364810168682; 0.2570364810168682; 0.2570364810168682; 0.2570364810168682; 0.2622329318286966; 0.2650101216681973; 0.2670582190879765; 0.2670582190879765; 0.2723453780817489; 0.2723453780817489; 0.2786853069571751; 0.2823835751171575; 0.2877158849893504; 0.2877158849893504; 0.2972644135001306; 0.2972644135001306; 0.2972644135001306; 0.2995316643384945; 0.3023749229986328; 0.3066971380488823; 0.3113515317868633; 0.3113515317868633; 0.3113515317868633; 0.3113515317868633; 0.316142834424839; 0.3185255747306141; 0.3243241301578816; 0.3258470663820326; 0.3352509823890284; 0.3417325482389482; 0.3446292548618789; 0.3494335993143313; 0.3540699900993737; 0.3634167943130235; 0.3678942528109082; 0.3678942528109082; 0.3696586134131318; 0.3697330558649637; 0.3837849438448272; 0.384785908220112; 0.3891257446735781; 0.3929133356162864; 0.397280768882461; 0.3988203841308941; 0.4016038424272534; 0.4055175521212118; 0.4055175521212118; 0.4055175521212118; 0.4089444818350988; 0.4214414516582417; 0.4250139906398144; 0.4282129311389295; 0.4395651618287257; 0.4409199497849633; 0.4424335623428572; 0.4505816299373699; 0.4574492858750069; 0.4575108585903957; 0.4611495786563792; 0.4678790703646548; 0.4678790703646548; 0.4748899891767304; 0.4781931916730066; 0.4886282001917928; 0.4979943388112239; 0.504829873207973; 0.5150384865323906; 0.5199487681301056; 0.5441274116253537; 0.5469000270498892; 0.5499753095162228; 0.5512955319444776; 0.5523550850146659; 0.5523550850146659; 0.569727243769542; 0.569727243769542; 0.5785803800876654; 0.5841285837808708; 0.5956450465155394; 0.6652972861073814; 0.7290355152458122,"Myocardial Ischemia; Arsenic Encephalopathy; Cerebral Ischemia; Dermatologic Disorders; Marfan Syndrome; Mammary Neoplasms; Bright Disease; Alveolitis; Pulmonary Fibrosis; Palmoplantar Pustules; Glomerulonephritis; Rheumatoid Arthritis; Thyroid Gland Follicular Adenoma; Breast Carcinoma; Atherosclerosis; Thyroid Neoplasm; Polymyositis Ossificans; Heart Failure; Dermatitis; Polymyositis; Ulcerative Colitis; Anthracosis; Psoriasis; Hemolytic Uremic Syndrome; Luft Disease; Megaconial Myopathies; Pleoconial Myopathy; Myocardial Infarction; Thyroid Carcinoma; Dermatomyositis; Breast Cancer; Reactive Hypoglycemia; Myocardial Diseases; Pancreatic Cancer; Fatty Liver; Trigeminal Neuralgia; Congestive Heart Failure; Spinal Cord Compression; Hypertension; Pancreatic Neoplasm; Senile Dementia; Soft Tissue Neoplasms; Cirrhosis; Septicemia; Gastric Ulcer; Carcinoma; Pleuritis; Cholestasis; Lung Cancer; Stomach Neoplasms; Gastric Cancer; Chronic Obstructive Pulmonary Disease; Lateral Sclerosis; Bladder Neoplasm; Inflammatory Bowel Disease; Adenocarcinoma; Urinary Bladder Cancer; Nervous System Disorder; Oral Submucous Fibrosis; Urticaria; Mental Depression; Stroke; Nonconvulsive Status Epilepticus; Petit Mal Status; Grand Mal Status Epilepticus; Vascular Diseases; Hepatolenticular Degeneration; Asthma; Compensatory Hyperinsulinemia; Endogenous Hyperinsulinism; Exogenous Hyperinsulinism; Lung Neoplasms; Diabetic Cardiomyopathy; Mitochondrial Myopathy; Crohn Disease; Hyperinsulinism; Alcoholic Liver Cirrhosis; Scleroderma; Kidney Failure; Acute Kidney Insufficiency; Synovitis, Acne, Pustulosis, Hyperostosis, And Osteitis (SAPHO) Syndrome; Coronary Restenosis; Sarcoma; Crohn`s Disease Of Large Bowel; Crohn`s Disease Of The Ileum; Brittle Diabetes Mellitus; Hyperbilirubinemia; Ileocolitis; Colonic Neoplasms; Autoimmune Diabetes; Bronchiectasis; Toxic Shock Syndrome; Carditis; Vitiligo; Cardiomyopathy; Psoriatic Arthritis; Osteoporosis; Colitis; Cholestasis Of Pregnancy; Coronary Syndrome; Myocarditis; Fibromatosis; Hyperhomocysteinemia; Diabetes Mellitus; Liver Cancer; Schizophrenia; Panacinar Emphysema; Emphysema; Migraine With Aura; Milk-Alkali Syndrome; Fulminant Hepatic Failure With Cerebral Edema; Hemochromatosis; Hepatic Coma; Hepatic Stupor; Hereditary Hemochromatosis; Asbestosis; Melanoma; Liver Carcinoma; Colorectal Neoplasms; Liver Neoplasms; Respiratory Tract Diseases; Status Epilepticus; Liver Failure; Alzheimer Disease; Common Migraine; Hepatic Encephalopathy; Lung Diseases; Pulmonary Emphysema; Anemia; Hypoglycemia; Obesity; Bipolar Disorder; Fanconi Anemia; Anorexia; Retinal Diseases; Pleural Effusion; Hypercalcemia; Graves Disease; Anxiety Disorder; Glioma; Colorectal Cancer; Mood Disorder",7.071068485513988e-10; 3.723977603538778e-09; 5.562961744202623e-09; 1.7417795410918816e-08; 8.921950872070284e-08; 1.1417484002988661e-07; 1.1417484002988661e-07; 3.1346476759108064e-07; 3.656047745092532e-06; 5.775106030172258e-06; 1.0086418491083646e-05; 1.241997446075319e-05; 3.882845009510541e-05; 4.971054570440277e-05; 5.254109803591956e-05; 7.782144775199944e-05; 7.782144775199944e-05; 0.00015071968444989745; 0.0002385365299919203; 0.0002385365299919203; 0.0002754573766813309; 0.00035261986034565066; 0.00044166586682199737; 0.00044653857220180814; 0.00044653857220180814; 0.00044653857220180814; 0.00044653857220180814; 0.0005760978170082974; 0.0005818213110442873; 0.0005818213110442873; 0.00063387456654884; 0.0015169561374293; 0.0015169561374293; 0.00207663921483; 0.0025464930497429; 0.0025464930497429; 0.0028558709076653; 0.0034396632260297; 0.0048927857621509; 0.0054741435035425; 0.0067487024308267; 0.007221192915733; 0.007221192915733; 0.007221192915733; 0.007221192915733; 0.0107108189044139; 0.010864842397815; 0.0152037568688841; 0.0153260870217676; 0.0172144998405365; 0.0172144998405365; 0.0173324463553544; 0.0183653432224121; 0.021392225047824; 0.021392225047824; 0.0249475037164364; 0.0264273671824767; 0.037484696011653; 0.0418006551930827; 0.0418006551930827; 0.0511376198481248; 0.0588219013114419; 0.0588219013114419; 0.0588219013114419; 0.0588219013114419; 0.0592733852980501; 0.0592733852980501; 0.064825092293108; 0.064825092293108; 0.064825092293108; 0.064825092293108; 0.0662475691169798; 0.0677813934673213; 0.0682669288241704; 0.0682669288241704; 0.0810252439964338; 0.0841735094076256; 0.1110148026021272; 0.1110148026021272; 0.1110148026021272; 0.1110148026021272; 0.1110148026021272; 0.114447693673355; 0.1173693299378481; 0.1173693299378481; 0.1173693299378481; 0.1202723965415913; 0.1202723965415913; 0.1203844668559877; 0.1203844668559877; 0.1203844668559877; 0.1203844668559877; 0.1203844668559877; 0.1231709853772602; 0.1273861908316246; 0.1286424863049623; 0.1286424863049623; 0.1301267238568565; 0.1386032662139448; 0.1448400284889975; 0.160518792997541; 0.160518792997541; 0.1716490205203499; 0.1718736907108893; 0.173101397516021; 0.175139305620004; 0.175139305620004; 0.175139305620004; 0.1787826075739565; 0.1787826075739565; 0.1787826075739565; 0.1787826075739565; 0.1787826075739565; 0.1787826075739565; 0.1787826075739565; 0.1851562166631526; 0.1871442361706843; 0.2008242041589438; 0.2039740835961235; 0.2039740835961235; 0.2043509272421185; 0.2062454941617454; 0.2062454941617454; 0.2089805590322066; 0.2089805590322066; 0.2089805590322066; 0.2098525466439478; 0.2247736041224312; 0.2344334553667355; 0.2415240131894039; 0.2736284003666279; 0.2978951863374514; 0.2978951863374514; 0.3276530465188152; 0.3317467420738357; 0.4178187895000149; 0.426652795095747; 0.4304968760599196; 0.577463872112795; 0.6487077413517064; 0.6963620089820088; 0.8765788936401022,Charcot-Marie-Tooth disease type 1D ORPHA:101084; Charcot-Marie-Tooth disease type 4E ORPHA:99951; Nasopharyngeal carcinoma ORPHA:150; Hereditary pediatric Behcet-like disease ORPHA:476102; NON RARE IN EUROPE: Psoriatic arthritis ORPHA:40050; Autosomal dominant dopa-responsive dystonia ORPHA:98808; GTP cyclohydrolase I deficiency ORPHA:2102; Hypohidrotic ectodermal dysplasia with immunodeficiency ORPHA:98813; NON RARE IN EUROPE: Crohn disease ORPHA:206; Revesz syndrome ORPHA:3088; Takayasu arteritis ORPHA:3287; Bacterial susceptibility due to TLR signaling pathway deficiency ORPHA:183713; Odonto-onycho-dermal dysplasia ORPHA:2721; Schopf-Schulz-Passarge syndrome ORPHA:50944; Waldenstrom macroglobulinemia ORPHA:33226; Acute encephalopathy with biphasic seizures and late reduced diffusion ORPHA:363549; Mendelian susceptibility to mycobacterial diseases due to complete IL12B deficiency ORPHA:319558; Blau syndrome ORPHA:90340; Predisposition to severe viral infection due to IRF7 deficiency ORPHA:574918; Combined immunodeficiency due to OX40 deficiency ORPHA:431149; Aicardi-Goutieres syndrome ORPHA:51; Congenital isolated ACTH deficiency ORPHA:199296,3.598261936626476e-12; 3.598261936626476e-12; 6.10801728836975e-11; 1.7877420438201673e-08; 2.859667220539484e-06; 3.28973817825433e-05; 3.28973817825433e-05; 3.295782224790152e-05; 0.002691706985611; 0.0133474287859103; 0.0142744270060997; 0.0514345493431829; 0.0514345493431829; 0.0514345493431829; 0.0514345493431829; 0.1927589191138116; 0.1927589191138116; 0.1927589191138116; 0.1927589191138116; 0.1927589191138116; 0.2032240249605243; 0.5312419675785659,Cowpox virus CrmD or CPXV221 protein (gene: CrmD); Variola virus hypothetical protein (gene: G4R); Ectromelia virus ERPV tumor necrosis factor receptor; Horsepox virus HSPV003 (Tumor necrosis factor receptor superfamily members); Monkeypox virus Zaire-96-I-16 J2L (gene: J2L); Cowpox virus CrmB or CPXV005 protein (gene: crmB); Monkeypox virus TNF-alpha-receptor-like protein; Vaccinia virus Ankara Haemagglutinin; Vaccinia virus hemagglutinin (gene: A56R); Cowpox virus CrmC or CPXV191 protein (gene: CrmC); Horsepox virus HSPV177 (Immunoglobulin like); Vaccinia virus secreted TNF-receptor-like protein (gene: A53R); Horsepox virus HSPV175 (Tumor necrosis factor receptor superfamily (TNFRSF)); Monkeypox virus Zaire-96-I-16 B2R (gene: B2R); Yaba-like disease virus 2L protein (gene: 2L); Monkeypox virus Zaire-96-I-16 Tumor necrosis Factor-receptor like protein (gene: K1R); Vaccinia virus TNF-alpha-receptor-like protein (gene: C22L); Variola virus hypothetical protein (gene: J9R); Human adenovirus 18 CR1-beta protein (gene: E3); Cercopithecine betaherpesvirus 5 membrane glycoprotein UL144 (gene: UL144); Vaccinia virus Ankara TNF receptor domain/CrmC; Yaba monkey tumor virus MHC-like TNF binding protein; Human betaherpesvirus 5 membrane glycoprotein UL144 (gene: UL144); Yaba-like disease virus 123R protein (gene: 123R); Ectromelia virus ERPV hemagglutinin; Cowpox virus CPXV194 protein (gene: CPXV194 CDS); Monkeypox virus bifunctional hemagglutinin/type-I membrane glycoprotein; Yaba monkey tumor virus IEV and EEV membrane glycoprotein; Human adenovirus 41 E3 31.6K; Human adenovirus 31 cr1 beta protein (gene: E3 cr1 beta); Human adenovirus 61 E3 CR1 beta; Yaba-like disease virus 141R protein (gene: 141R); Yaba monkey tumor virus Ig domain OX-2-like protein,2.3160451568389139e-07; 5.350651473977266e-07; 5.350651473977266e-07; 5.350651473977266e-07; 9.087104857163152e-07; 1.12171834090951e-06; 1.12171834090951e-06; 0.0096374079669374; 0.0223182816928385; 0.0318026352788518; 0.0401211861299026; 0.0601536450796885; 0.0712548287392585; 0.0816962571184375; 0.086428048188775; 0.154573740353537; 0.1790291529138667; 0.2673783194071986; 0.2880902732733083; 0.3338836035374137; 0.3338836035374137; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.4145707851950257,Escherichia coli;Homo sapiens;In vitro;Unknown,0.35;0.4;0.44;0.56;0.73,Homo sapiens;Vaccinia virus,Homo sapiens;chemical synthesis
TNFAIP2,Rheumatoid Arthritis; cervical cancer; Malignant tumor of cervix; Neoplasm Metastasis; Cervix carcinoma; Glioma; Tumor Progression; Malignant neoplasm of breast; Carcinogenesis; Nasopharyngeal carcinoma; Stomach Carcinoma; Malignant neoplasm of stomach; Breast Carcinoma; Acute Promyelocytic Leukemia; Malignant Head and Neck Neoplasm; Squamous cell carcinoma of the head and neck; Metastatic Neoplasm; Squamous cell carcinoma of esophagus,1.9241179247341838e-10; 1.1722433847661196e-09; 3.683115069310663e-09; 5.670785186683756e-09; 1.5572986293211266e-08; 1.427432458937347e-07; 8.297823048747685e-07; 8.660170029731726e-07; 1.51758575162775e-06; 1.5208470671427406e-06; 2.07112526817849e-06; 2.450940162208615e-06; 5.381279306135013e-06; 1.2304362232150695e-05; 4.3188904868696655e-05; 0.000420950947096172; 0.001746579573497; 0.0062748297137782,Rheumatoid Arthritis,1.241997446075319e-05,"Autosomal dominant hyper-IgE syndrome ORPHA:2314; Chronic lymphoproliferative disorder of natural killer cells ORPHA:512017; STAT3-related early-onset multisystem autoimmune disease ORPHA:438159; T-cell large granular lymphocyte leukemia ORPHA:86872; Lattice corneal dystrophy type I ORPHA:98964; Reis-Bucklers corneal dystrophy ORPHA:98961; Cryptogenic multifocal ulcerous stenosing enteritis ORPHA:468635; Cytosolic phospholipase-A2 alpha deficiency associated bleeding disorder ORPHA:477787; Epithelial basement membrane dystrophy ORPHA:98956; Thiel-Behnke corneal dystrophy ORPHA:98960; Granular corneal dystrophy type I ORPHA:98962; Granular corneal dystrophy type II ORPHA:98963; Metaphyseal anadysplasia ORPHA:1040; Overgrowth-macrocephaly-facial dysmorphism syndrome ORPHA:137634; Thrombomodulin-related bleeding disorder ORPHA:436169; Tumor necrosis factor receptor 1 associated periodic syndrome ORPHA:32960; Heme oxygenase-1 deficiency ORPHA:562509; Mendelian susceptibility to mycobacterial diseases due to complete IFNgammaR2 deficiency ORPHA:319547; Autosomal dominant mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR2 deficiency ORPHA:319589; Autosomal recessive mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR2 deficiency ORPHA:319574; Intermittent hydrarthrosis ORPHA:329967; Clear cell renal carcinoma ORPHA:319276; Glycogen storage disease due to liver glycogen phosphorylase deficiency ORPHA:369; Miyoshi myopathy ORPHA:45448; NON RARE IN EUROPE: Hemochromatosis type 1 ORPHA:139498; Congenital myopathy, Paradas type ORPHA:199329; Recurrent Neisseria infections due to factor D deficiency ORPHA:169467; Diaphragmatic hernia-short bowel-asplenia syndrome ORPHA:527468; Distal myopathy with anterior tibial onset ORPHA:178400; Dysferlin-related  limb-girdle muscular dystrophy R2 ORPHA:268; Sporadic porphyria cutanea tarda ORPHA:443057; Symptomatic form of hemochromatosis type 1 ORPHA:465508",2.859667220539484e-06; 2.859667220539484e-06; 2.859667220539484e-06; 2.859667220539484e-06; 0.0002132495254484572; 0.0002132495254484572; 0.0002132495254484572; 0.0002132495254484572; 0.0002132495254484572; 0.0002132495254484572; 0.0002132495254484572; 0.0002132495254484572; 0.0002132495254484572; 0.0514345493431829; 0.0514345493431829; 0.0514345493431829; 0.0514345493431829; 0.1927589191138116; 0.1927589191138116; 0.1927589191138116; 0.1927589191138116; 0.4838060079820406; 0.4838060079820406; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659,,,Homo sapiens A549 lung carcinoma cell,0.35,SARS-CoV-2,Homo sapiens
TNFAIP3,"Inflammation; Asthma; Psoriasis; Familial M??ni??re disease; Juvenile arthritis; Lymphoma; Multiple Myeloma; Synovitis; Rheumatoid Arthritis; Crohn Disease; Autoimmune Diseases; Ulcerative Colitis; Multiple Sclerosis; Neoplasm Metastasis; Hodgkin Disease; Acute pancreatitis; Graves Disease; Arthritis; Arthritis, Psoriatic; Glioblastoma; leukemia; Diabetes Mellitus; Diabetes; Lupus Erythematosus, Systemic; Coronary Artery Disease; Coronary heart disease; Behcet Syndrome; Sjogren's Syndrome; Van der Woude syndrome; Anoxia; Diffuse Large B-Cell Lymphoma; Myocarditis; Diabetes Mellitus, Insulin-Dependent; Chronic Lymphocytic Leukemia; Malignant neoplasm of breast; Myasthenia Gravis; Coronary Arteriosclerosis; Systemic Scleroderma; Hypersensitivity; Carcinogenesis; Polycystic Ovary Syndrome; Ankylosing spondylitis; B-Cell Lymphomas; Lupus Nephritis; Lymphoma, T-Cell, Cutaneous; Breast Carcinoma; Idiopathic Inflammatory Myopathies; Pustulosis of Palms and Soles; Polymyositis; Epstein-Barr Virus Infections; Sezary Syndrome; Prostatic Neoplasms; Hepatitis, Autoimmune; Systemic Inflammatory Response Syndrome; Primary Sj??gren's syndrome; Celiac Disease; Solid Neoplasm; Classical Hodgkin's Lymphoma; Colorectal Carcinoma; Diabetes Mellitus, Non-Insulin-Dependent; Lymphoma, Follicular; Leukemogenesis; Colorectal Cancer; Nodular Lymphocyte Predominant Hodgkin Lymphoma; Uveomeningoencephalitic Syndrome; Giant Cell Arteritis; Sicca Syndrome; Multiple Sclerosis, Acute Fulminating; Autoimmune thyroid disease; Adult Hodgkin Lymphoma; Trisomy; Lymphoproliferative Disorders; Lymphoma, AIDS-Related; Immune thrombocytopenic purpura; Marginal Zone B-Cell Lymphoma; Squamous cell carcinoma of esophagus; Inflammatory polyarthritis; Psoriasis vulgaris; Cholangitis, Sclerosing; Oligoarticular Juvenile Idiopathic Arthritis; Thrombocytopenia due to platelet alloimmunization; Mucosa-Associated Lymphoid Tissue Lymphoma; Libman-Sacks Disease; Hyperplasia; T-Cell Large Granular Lymphocyte Leukemia; Neoplastic Cell Transformation; Splenic Marginal Zone B-Cell Lymphoma; Autoimmune thrombocytopenia; Periodic Fever Syndrome; Childhood Hodgkin Lymphoma; Pauci-immune Glomerulonephritis associated with Granulomatosis with Polyangiitis; Primary central nervous system lymphoma; Hereditary Autoinflammatory Diseases; Granulomatosis with polyangiitis; Lymphoma, Large-Cell, Follicular; Lymphoma, Follicular, Grade 2; Lymphoma, Mixed-Cell, Follicular; Lymphoma, Small Cleaved-Cell, Follicular; Lymphoma, Follicular, Grade 3; Bone Cysts, Aneurysmal; Granulomatous Slack Skin; Lymphoma, Follicular, Grade 1; Autoimmune Lymphoproliferative Syndrome",2.8114433253573326e-17; 1.803641225501291e-12; 3.118210553589307e-12; 3.861499575207375e-12; 3.861499575207375e-12; 4.5104266881389206e-12; 2.5279022064249716e-11; 1.6797550790254382e-10; 1.9241179247341838e-10; 4.2478505092738466e-10; 5.452288254986118e-10; 1.6767489697325582e-09; 4.546836602575699e-09; 5.670785186683756e-09; 6.195332209150018e-09; 7.713813941246406e-09; 8.269524813140207e-09; 1.587872453479067e-08; 5.071217747675114e-08; 5.518991037343798e-08; 5.784935444423772e-08; 5.8317433871210796e-08; 6.156981490555128e-08; 6.156981490555128e-08; 8.598175402882612e-08; 9.273260676030806e-08; 9.393284022832733e-08; 1.0276547515522002e-07; 1.524221047360518e-07; 2.911052249927245e-07; 3.532371372262103e-07; 3.880986260207744e-07; 6.851652105457608e-07; 7.931659047151387e-07; 8.660170029731726e-07; 8.696626324623331e-07; 1.0094398444517938e-06; 1.10068355868735e-06; 1.1523181751478311e-06; 1.51758575162775e-06; 2.086123696221558e-06; 2.1020461880694925e-06; 2.1624936975752243e-06; 3.4620043828295477e-06; 3.7283259874612974e-06; 5.381279306135013e-06; 5.457492980911677e-06; 5.457492980911677e-06; 6.169876404399104e-06; 8.77532817235926e-06; 1.3410647656206684e-05; 2.0820699372778346e-05; 3.1066725823367694e-05; 5.248375780672949e-05; 8.232890503539995e-05; 8.730297037328594e-05; 0.0001322335978675375; 0.0001431024725510208; 0.00016189346720036038; 0.00016189346720036038; 0.0002484853090912064; 0.0002652452950458932; 0.00038453776693371663; 0.0003987632373118045; 0.0008252744167874381; 0.0008932565002868814; 0.0010244557923259; 0.0011626911115394; 0.0014485445504404; 0.0020049274325175; 0.0026287893312444; 0.0030077293488194; 0.0037244768508078; 0.0060170797120173; 0.0060818298848679; 0.0062748297137782; 0.0083709650732796; 0.0088561754221927; 0.0093598514945993; 0.0097159454554601; 0.0167904807006824; 0.0203198961621158; 0.021125667706065; 0.0269131580640034; 0.0319682790952413; 0.0320403652557597; 0.0324016809159931; 0.0380438970214283; 0.0471006425252053; 0.0897127848630768; 0.0908772402064694; 0.0987575443309834; 0.1206032442301429; 0.1456466465256486; 0.1591507626487054; 0.181710614199711; 0.181710614199711; 0.181710614199711; 0.1881045022168423; 0.1932166112700285; 0.1932166112700285; 0.2048516463561299; 0.236709594559292,Palmoplantar Pustules; Rheumatoid Arthritis; Ulcerative Colitis; Psoriasis; B-Cell Lymphoma; Malignant Neoplasm; Nonbacterial Verrucal Endocardiosis; Hodgkin Disease; Multiple Sclerosis; Crohn Disease; Psoriasis Vulgaris; Systemic Lupus Erythematosus; Lupus Erythematosus; Scleroderma; Eczema; Autoimmune Lymphoproliferative Disorder; Autoimmune Diseases; Lymphoma; Cholangitis; Ankylosing Spondylitis; Granulomatous Slack Skin; Sjogren`s Syndrome; Autoinflammatory Disease; Oral Ulcer,5.775106030172258e-06; 1.241997446075319e-05; 0.0002754573766813309; 0.00044166586682199737; 0.0186439654623197; 0.021392225047824; 0.0446679463927015; 0.0668923554370046; 0.0682669288241704; 0.0682669288241704; 0.0682669288241704; 0.0841735094076256; 0.087745240825312; 0.1110148026021272; 0.1110148026021272; 0.175139305620004; 0.1847583217632609; 0.1946052298376077; 0.2039740835961235; 0.2072542702968064; 0.2326651051170249; 0.2389892939730545; 0.3076038681026417; 0.504775797017495,Charcot-Marie-Tooth disease type 1D ORPHA:101084; Charcot-Marie-Tooth disease type 4E ORPHA:99951; Nasopharyngeal carcinoma ORPHA:150; Systemic-onset juvenile idiopathic arthritis ORPHA:85414; Hereditary pediatric Behcet-like disease ORPHA:476102; Autosomal dominant hyper-IgE syndrome ORPHA:2314; NON RARE IN EUROPE: Psoriatic arthritis ORPHA:40050; Chronic lymphoproliferative disorder of natural killer cells ORPHA:512017; STAT3-related early-onset multisystem autoimmune disease ORPHA:438159; T-cell large granular lymphocyte leukemia ORPHA:86872; Autosomal dominant dopa-responsive dystonia ORPHA:98808; GTP cyclohydrolase I deficiency ORPHA:2102; Hypohidrotic ectodermal dysplasia with immunodeficiency ORPHA:98813; Pediatric systemic lupus erythematosus ORPHA:93552; Herpes simplex virus encephalitis ORPHA:1930; Autosomal recessive mendelian susceptibility to mycobacterial diseases due to partial JAK1 deficiency ORPHA:574957; MALT lymphoma ORPHA:52417; Singleton-Merten dysplasia ORPHA:85191; Immunodeficiency by defective expression of MHC class I ORPHA:34592; Birdshot chorioretinopathy ORPHA:179; Complement hyperactivation-angiopathic thrombosis-protein-losing enteropathy syndrome ORPHA:566175; Generalized glucocorticoid resistance syndrome ORPHA:786; Immune dysregulation-inflammatory bowel disease-arthritis-recurrent infections-lymphopenia syndrome ORPHA:529977; Systemic lupus erythematosus ORPHA:536; MIRAGE syndrome ORPHA:494433; Mendelian susceptibility to mycobacterial diseases due to partial STAT1 deficiency ORPHA:319595; Autoimmune enteropathy and endocrinopathy-susceptibility to chronic infections syndrome ORPHA:391487; Bacterial susceptibility due to TLR signaling pathway deficiency ORPHA:183713; STING-associated vasculopathy with onset in infancy ORPHA:425120; Deficiency in anterior pituitary function-variable immunodeficiency syndrome ORPHA:293978; Susceptibility to viral and mycobacterial infections due to STAT1 deficiency ORPHA:391311; Familial normophosphatemic tumoral calcinosis ORPHA:306658; Waldenstrom macroglobulinemia ORPHA:33226; Vogt-Koyanagi-Harada disease ORPHA:3437; B4GALT1-CDG ORPHA:79332; Combined immunodeficiency due to MALT1 deficiency ORPHA:397964,3.598261936626476e-12; 3.598261936626476e-12; 6.10801728836975e-11; 1.514756890441811e-09; 1.7877420438201673e-08; 2.859667220539484e-06; 2.859667220539484e-06; 2.859667220539484e-06; 2.859667220539484e-06; 2.859667220539484e-06; 3.28973817825433e-05; 3.28973817825433e-05; 3.295782224790152e-05; 0.00021965881189185; 0.00024116799717032887; 0.0019696624570933; 0.0022487953361182; 0.0133474287859103; 0.0133474287859103; 0.0133474287859103; 0.0133474287859103; 0.0133474287859103; 0.0133474287859103; 0.0368542044009867; 0.0514345493431829; 0.0514345493431829; 0.0514345493431829; 0.0514345493431829; 0.0514345493431829; 0.0514345493431829; 0.0514345493431829; 0.0514345493431829; 0.0514345493431829; 0.0514345493431829; 0.1927589191138116; 0.1927589191138116,,,Homo sapiens HEK293T embryonic kidney cell;In vitro;in vivo;yeasx,0.62;0.89,Homo sapiens,Homo sapiens
TNFSF14,"Inflammation; Asthma; Lymphoma; Multiple Myeloma; Dermatitis, Atopic; Rheumatoid Arthritis; Crohn Disease; Autoimmune Diseases; cervical cancer; Colitis; Malignant tumor of cervix; Dermatitis; Multiple Sclerosis; Neoplasm Metastasis; Inflammatory dermatosis; Pulmonary Fibrosis; Hypertensive disease; Eczema; Cervix carcinoma; Arthritis; Cerebrovascular accident; Degenerative polyarthritis; Inflammatory Bowel Diseases; Obesity; Diabetes Mellitus; Diabetes; Ischemic stroke; Diffuse Large B-Cell Lymphoma; Cystic Fibrosis; Chronic Lymphocytic Leukemia; Malignant neoplasm of breast; Graft-vs-Host Disease; Systemic Scleroderma; Anemia, Sickle Cell; Liver carcinoma; Dementia, Vascular; Carcinogenesis; Stomach Carcinoma; B-Cell Lymphomas; Colon Carcinoma; Malignant neoplasm of stomach; Bone Diseases; melanoma; Breast Carcinoma; Angina, Unstable; Stable angina; Eosinophilic disorder; Herpes Simplex Infections; Acute GVH disease; Tumor Immunity; Eosinophilia; Colorectal Carcinoma; Diabetes Mellitus, Non-Insulin-Dependent; Interstitial Cystitis; Scleroderma; Ulcer; Chronic interstitial cystitis; Colorectal Cancer; Amyotrophic Lateral Sclerosis; Secondary malignant neoplasm of liver; Multiple Sclerosis, Acute Fulminating; Hypercholesterolemia; Hepatitis, Chronic; Cardiac Arrest; Thrombosis; Melanoma, B16; Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse; Herpes NOS; Vascular inflammations; Autoimmune arthritis; Burkitt Lymphoma; Hypertriglyceridemia; Hepatitis D Infection; Ciliopathies; Plasmablastic lymphoma; Acute monocytic/monoblastic leukemia; Immunoblastic Large-Cell Lymphoma",2.8114433253573326e-17; 1.803641225501291e-12; 4.5104266881389206e-12; 2.5279022064249716e-11; 7.448716379948652e-11; 1.9241179247341838e-10; 4.2478505092738466e-10; 5.452288254986118e-10; 1.1722433847661196e-09; 1.971893171900314e-09; 3.683115069310663e-09; 3.683115069310663e-09; 4.546836602575699e-09; 5.670785186683756e-09; 6.0322241000340585e-09; 7.547641288501485e-09; 1.0368326871660785e-08; 1.4920329017331753e-08; 1.5572986293211266e-08; 1.587872453479067e-08; 2.0570601164639797e-08; 2.1034803123367165e-08; 2.3137704832524547e-08; 2.412608431251415e-08; 5.8317433871210796e-08; 6.156981490555128e-08; 6.156981490555128e-08; 3.532371372262103e-07; 5.577321626966352e-07; 7.931659047151387e-07; 8.660170029731726e-07; 1.0094667484349083e-06; 1.10068355868735e-06; 1.2482007026109775e-06; 1.3079916134634371e-06; 1.4042419564664515e-06; 1.51758575162775e-06; 2.07112526817849e-06; 2.1624936975752243e-06; 2.205236928124383e-06; 2.450940162208615e-06; 3.282956820548434e-06; 4.179146475474674e-06; 5.381279306135013e-06; 7.095035199288336e-06; 1.1652528807336014e-05; 1.8961926417889813e-05; 2.1109857936882128e-05; 2.365778380659297e-05; 3.971484221432504e-05; 5.248375780672949e-05; 0.00016189346720036038; 0.00016189346720036038; 0.00021116105905857028; 0.00022254302103317592; 0.00026224811620659125; 0.0003539177308293034; 0.00038453776693371663; 0.0009325953874753212; 0.0010244557923259; 0.0011626911115394; 0.0012591553085125; 0.0013309210571735; 0.002135695462532; 0.0025122887786423; 0.0083709650732796; 0.0094642528600355; 0.0096630827054915; 0.0097159454554601; 0.0187299613301643; 0.0196345173194062; 0.0524543292954025; 0.0897127848630768; 0.176056923749369; 0.2108300774722888; 0.2272199982000937; 0.2670582190879765,Rheumatoid Arthritis; Multiple Sclerosis,1.241997446075319e-05; 0.0682669288241704,"NON RARE IN EUROPE: Psoriatic arthritis ORPHA:40050; NON RARE IN EUROPE: Crohn disease ORPHA:206; Galactose mutarotase deficiency ORPHA:570422; Griscelli syndrome type 2 ORPHA:79477; Mendelian susceptibility to mycobacterial diseases due to complete IL12B deficiency ORPHA:319558; Glycerol kinase deficiency, adult form ORPHA:284414; Glycerol kinase deficiency, juvenile form ORPHA:284411; Neonatal acute respiratory distress due to SP-B deficiency ORPHA:217563; Combined immunodeficiency due to IL21R deficiency ORPHA:357329; Familial isolated hypoparathyroidism due to impaired PTH secretion ORPHA:189466; Congenital vertebral-cardiac-renal anomalies syndrome ORPHA:521438; Hypomaturation amelogenesis imperfecta ORPHA:100033; Beta-ureidopropionase deficiency ORPHA:65287; Congenital factor V deficiency ORPHA:326; East Texas bleeding disorder ORPHA:391320; Hemochromatosis type 2 ORPHA:79230",2.859667220539484e-06; 0.002691706985611; 0.0514345493431829; 0.0514345493431829; 0.1927589191138116; 0.1927589191138116; 0.1927589191138116; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4927160916210667; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659,Cowpox virus CrmD or CPXV221 protein (gene: CrmD); Variola virus hypothetical protein (gene: G4R); Ectromelia virus ERPV tumor necrosis factor receptor; Horsepox virus HSPV003 (Tumor necrosis factor receptor superfamily members); Monkeypox virus Zaire-96-I-16 J2L (gene: J2L); Cowpox virus CrmB or CPXV005 protein (gene: crmB); Monkeypox virus TNF-alpha-receptor-like protein; Cowpox virus CrmC or CPXV191 protein (gene: CrmC); Vaccinia virus secreted TNF-receptor-like protein (gene: A53R); Horsepox virus HSPV175 (Tumor necrosis factor receptor superfamily (TNFRSF)); Yaba-like disease virus 2L protein (gene: 2L); Monkeypox virus Zaire-96-I-16 Tumor necrosis Factor-receptor like protein (gene: K1R); Vaccinia virus TNF-alpha-receptor-like protein (gene: C22L); Cercopithecine betaherpesvirus 5 membrane glycoprotein UL144 (gene: UL144); Vaccinia virus Ankara TNF receptor domain/CrmC; Yaba monkey tumor virus MHC-like TNF binding protein; Human betaherpesvirus 5 membrane glycoprotein UL144 (gene: UL144); Cowpox virus vCD30 (gene: vCD30); Horsepox virus HSPV010 (CD-30-like protein; Provisional),2.3160451568389139e-07; 5.350651473977266e-07; 5.350651473977266e-07; 5.350651473977266e-07; 9.087104857163152e-07; 1.12171834090951e-06; 1.12171834090951e-06; 0.0318026352788518; 0.0601536450796885; 0.0712548287392585; 0.086428048188775; 0.154573740353537; 0.1790291529138667; 0.3338836035374137; 0.3338836035374137; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946; 0.3911903778732946,drome,0.62,Homo sapiens,Homo sapiens
TOR4A,"Liver Cirrhosis, Experimental",7.691726899679507e-06,,,Camurati-Engelmann disease ORPHA:1328; Tumor necrosis factor receptor 1 associated periodic syndrome ORPHA:32960; Infantile inflammatory bowel disease with neurological involvement ORPHA:565788; B4GALT1-CDG ORPHA:79332; Solitary fibrous tumor/hemangiopericytoma ORPHA:2126; CLN11 disease ORPHA:314629; Hypocalcemic vitamin D-resistant rickets ORPHA:93160; Dehydrated hereditary stomatocytosis ORPHA:3202; Dysosteosclerosis ORPHA:1782,0.0514345493431829; 0.0514345493431829; 0.0514345493431829; 0.1927589191138116; 0.1927589191138116; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406; 0.4838060079820406,,,Homo sapiens,0.35,Human papillomavirus type 11;Human papillomavirus type 6b;ebvb9,Homo sapiens
UNC13A,"Hyperglycemia; Diabetes Mellitus; Diabetes; Pain; Neurodegenerative Disorders; Amyotrophic Lateral Sclerosis; AMYOTROPHIC LATERAL SCLEROSIS 1; Amyotrophic Lateral Sclerosis With Dementia; Amyotrophic Lateral Sclerosis, Guam Form; Amyotrophic Lateral Sclerosis, Sporadic; Frontotemporal dementia; Anxiety; AMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL RECESSIVE; Depressive disorder; Pick Disease of the Brain; Respiratory Failure; Fatigue; Nerve Degeneration; Movement Disorders; AMYOTROPHIC LATERAL SCLEROSIS 6 (disorder); Neurogenic Muscular Atrophy; Fatigable weakness of respiratory muscles; Fatigable weakness of swallowing muscles; Paralysed; Xerostomia; Neuro-degenerative disease; Dyspnea; Muscle Cramp; Generalized muscle weakness; Mood swings; Anxiety disease; Muscle Spasticity; Skeletal muscle atrophy; Neurogenic muscle atrophy, especially in the lower limbs; Muscle degeneration; Intellectual Disability",4.0898524252942674e-08; 5.8317433871210796e-08; 6.156981490555128e-08; 1.6759866477134858e-07; 0.00010914466609698448; 0.0009325953874753212; 0.0021222176147417; 0.0043470921917622; 0.0059257679306595; 0.0083709650732796; 0.0105367304020196; 0.0365699380189482; 0.0384689641633299; 0.0691714743582008; 0.0760236194881239; 0.0814119493993337; 0.1266767196420385; 0.1272255752567765; 0.1584804022044084; 0.1932166112700285; 0.2499636483007412; 0.2622329318286966; 0.2670582190879765; 0.3587690037565285; 0.384785908220112; 0.3891257446735781; 0.4055175521212118; 0.4748899891767304; 0.4781931916730066; 0.5216180426117877; 0.6767064352850668; 0.7124872261498931; 0.7825541548884823; 0.7825541548884823; 0.8419202800710972; 0.9388725395674395,Amyotrophic Lateral Sclerosis With Dementia; Lateral Sclerosis; Mental Depression; Amyotrophic Lateral Sclerosis; Benign Prostatic Hyperplasia; Laryngospasm; Anxiety Disorder; Mood Swings; Respiratory Failure,0.009505750723671; 0.0183653432224121; 0.0511376198481248; 0.1006919508743788; 0.2173119367816199; 0.367616394854405; 0.577463872112795; 0.664640074476835; 0.7483312569264985,"Autosomal recessive congenital cerebellar ataxia due to GRID2 deficiency ORPHA:363432; Congenital nephrotic syndrome, Finnish type ORPHA:839; Juvenile myoclonic epilepsy ORPHA:307; NON RARE IN EUROPE: Autism ORPHA:106; DEND syndrome ORPHA:79134; KCNQ2-related epileptic encephalopathy ORPHA:439218; Menstrual cycle-dependent periodic fever ORPHA:498251; Autosomal dominant Charcot-Marie-Tooth disease type 2 due to KIF5A mutation ORPHA:324611; Autosomal dominant Charcot-Marie-Tooth disease type 2K ORPHA:99944; Autosomal dominant hyperinsulinism due to SUR1 deficiency ORPHA:276575; Autosomal dominant spastic paraplegia type 10 ORPHA:100991; Autosomal dominant spastic paraplegia type 73 ORPHA:444099; Autosomal recessive Charcot-Marie-Tooth disease with hoarseness ORPHA:101097; Autosomal recessive cerebellar ataxia-psychomotor delay syndrome ORPHA:284271; Autosomal recessive hyperinsulinism due to SUR1 deficiency ORPHA:79643; Autosomal recessive intermediate Charcot-Marie-Tooth disease type A ORPHA:217055; NON RARE IN EUROPE: Non rare obesity ORPHA:521399; Autosomal spastic paraplegia type 30 ORPHA:101010; Autosomal spastic paraplegia type 72 ORPHA:401849; Bilateral generalized polymicrogyria ORPHA:208447; Cerebellar ataxia, Cayman type ORPHA:94122; Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome ORPHA:1171; Charcot-Marie-Tooth disease type 2H ORPHA:101102; Charcot-Marie-Tooth disease type 4A ORPHA:99948; Primary dystonia, DYT2 type ORPHA:99657; Progressive essential tremor-speech impairment-facial dysmorphism-intellectual disability-abnormal behavior syndrome ORPHA:457212; Progressive myoclonic epilepsy type 7 ORPHA:435438; Progressive myoclonic epilepsy with dystonia ORPHA:352596; Rapid-onset dystonia-parkinsonism ORPHA:71517; Rolandic epilepsy-paroxysmal exercise-induced dystonia-writer's cramp syndrome ORPHA:163727; DOORS syndrome ORPHA:79500; Diazoxide-resistant focal hyperinsulinism due to SUR1 deficiency ORPHA:276598; Spinocerebellar ataxia type 14 ORPHA:98763; Spinocerebellar ataxia type 42 ORPHA:458803; Familial gastric type 1 neuroendocrine tumor ORPHA:464756; Focal epilepsy-intellectual disability-cerebro-cerebellar malformation ORPHA:352587; X-linked central congenital hypothyroidism with late-onset testicular enlargement ORPHA:329235; X-linked epilepsy-learning disabilities-behavior disorders syndrome ORPHA:85294; Huntington disease-like 2 ORPHA:98934; Infantile hypotonia-oculomotor anomalies-hyperkinetic movements-developmental delay syndrome ORPHA:522077; Intellectual disability, Birk-Barel type ORPHA:166108; Benign familial neonatal epilepsy ORPHA:1949; Benign familial neonatal-infantile seizures ORPHA:140927; Occipital pachygyria and polymicrogyria ORPHA:280640; PEHO syndrome ORPHA:2836; Familial infantile myoclonic epilepsy ORPHA:352582; Idiopathic ventricular fibrillation, non Brugada type ORPHA:228140; Infantile convulsions and choreoathetosis ORPHA:31709; Isolated congenitally uncorrected transposition of the great arteries ORPHA:216718; Atypical juvenile parkinsonism ORPHA:391411; Congenital fibrosis of extraocular muscles ORPHA:45358; NON RARE IN EUROPE: Hereditary essential tremor ORPHA:862; Benign familial infantile epilepsy ORPHA:306; Dravet syndrome ORPHA:33069; Usher syndrome type 2 ORPHA:231178; Childhood absence epilepsy ORPHA:64280; Generalized epilepsy with febrile seizures-plus ORPHA:36387; Malignant migrating focal seizures of infancy ORPHA:293181; Early infantile epileptic encephalopathy ORPHA:1934; Normosmic congenital hypogonadotropic hypogonadism ORPHA:432; Autosomal dominant non-syndromic intellectual disability ORPHA:178469; Amyotrophic lateral sclerosis ORPHA:803; Non-specific early-onset epileptic encephalopathy ORPHA:442835",0.4838060079820406; 0.4838060079820406; 0.4982782825106929; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5312419675785659; 0.5322893295716875; 0.534880881892026; 0.5352376236648427; 0.5547492750560717; 0.5572570410282548; 0.6023456244152477; 0.6126208467430576; 0.6146353121255729,,,,,,
WAKMAR2,,,Rheumatoid Arthritis; Lupus Erythematosus,1.241997446075319e-05; 0.087745240825312,,,,,,,,
